Enrichment analysis report,,,,,,,,,,,,,
Enrichment by Pathway Maps,,,,,transformed_FC,,,,rna_all_FC,,,,
#,Maps,Total,min(pValue),Min FDR,p-value,FDR,In Data,"Network Objects from
Active Data",p-value,FDR,In Data,"Network Objects from
Active Data",
1,Apoptosis and survival_NGF/ TrkA PI3K-mediated signaling,77,5.804E-09,5.339E-06,1.114E-04,2.483E-03,28,"AKT1, Calcineurin A (catalytic), GRB2, GAB1, H-Ras, PAK2, ERK1/2, p190RhoGAP, Myosin II, PAK1, ILK, RhoG, PI3K reg class IA (p85), FOXO4, p70 S6 kinase1, Calmodulin, Kalirin, MRLC, Bcl-2, VAV-2, Tau (MAPT), PARD6A, VAV-3, LIMK2, AKT(PKB), PDK (PDPK1), PREX1, Tubulin (in microtubules)",5.804E-09,5.339E-06,41,"TrkA, AKT1, ELMO2, Calcineurin A (catalytic), GRB2, GAB1, H-Ras, PAK2, ERK1/2, PKC-zeta, Rac1, BAD, RhoG, PI3K reg class IA (p85), Kalirin, VAV-2, Tau (MAPT), LIMK2, AKT(PKB), PDK (PDPK1), Tubulin (in microtubules), BETA-PIX, Destrin, p190RhoGAP, Myosin II, PAK1, ILK, 4E-BP1, MRCKalpha, FOXO4, p70 S6 kinase1, Cofilin, non-muscle, Calmodulin, N-WASP, MRLC, Bcl-2, FOXO3A, PARD6A, VAV-3, Cofilin, PREX1",
2,Development_PIP3 signaling in cardiac myocytes,47,1.163E-08,5.339E-06,8.684E-05,2.127E-03,20,"Tuberin, G-protein alpha-12 family, GRB2, GAB1, Insulin processed, H-Ras, Cyclin D, p90Rsk, GYS1, p70 S6 kinase1, PI3K reg class IA, PTEN, Insulin receptor, GSK3 alpha/beta, Bcl-XL, IGF-1 receptor, AKT(PKB), IGF-1, PDK (PDPK1), PARD6",1.163E-08,5.339E-06,29,"Tuberin, GRB2, GAB1, Insulin processed, IRS-1, H-Ras, 14-3-3, PKC-zeta, BAD, PI3K reg class IA, Insulin receptor, GSK3 alpha/beta, Bcl-XL, IGF-1 receptor, AKT(PKB), PDK (PDPK1), c-Myc, PARD6, G-protein alpha-12 family, Cyclin D, PTP-1B, Hamartin, GYS1, 4E-BP1, p70 S6 kinase1, PTEN, FOXO3A, IGF-1, PI3K reg class IB (p101)",
3,Development_Positive regulation of WNT/Beta-catenin signaling in the cytoplasm,76,1.378E-08,5.339E-06,5.815E-04,7.718E-03,26,"GSKIP, TBL1X, EGF, BIG1, GRB2, SIAH2, Insulin processed, PP1-cat, Alpha-1 catenin, HSP105, PKA-reg type II (cAMP-dependent), Dsh, ILK, YAP1 (YAp65), BIG2, WNT, Insulin receptor, USP7, FAK1, GSK3 alpha/beta, PP2C alpha, IGF-1 receptor, JNK(MAPK8-10), AKT(PKB), Axin, SET7",1.378E-08,5.339E-06,40,"TBL1X, EGF, BIG1, GRB2, Insulin processed, NKD1, IRS-1, UBE2B, PP1-cat, Alpha-1 catenin, 14-3-3, Makorin-1, Dsh, USP47, ZBED3, Rac1, Insulin receptor, GSK3 alpha/beta, IGF-1 receptor, AKT(PKB), Axin, GSKIP, HECTD1, SIAH2, Tcf(Lef), c-Jun, HSP105, PKA-reg type II (cAMP-dependent), ILK, Trabid, Tankyrases, BIG2, WNT, USP7, FAK1, PP2C alpha, JNK(MAPK8-10), Parathyroid hormone, Frizzled, SET7",
4,Signal transduction_mTORC1 downstream signaling,60,1.429E-08,5.339E-06,3.612E-07,1.079E-04,28,"PDK1, eEF2, SREBP1 (nuclear), G6PD, SCD, PDCD4, MAF1, Cyclin D, eIF4B, HMGCS2, Cytochrome c, MVK, SIN1, ULK1, STAT3, RRN3, p70 S6 kinases, GLUT1, p70 S6 kinase1, MTHFD2, eIF4A, ACSL3, MDM2, 4E-BP2, CLIP170, p70 S6 kinase2, p27KIP1, GRB10",1.429E-08,5.339E-06,34,"SREBP1 (nuclear), SCD, IRS-1, eIF4E, ATF-4, HMGCS2, Cytochrome c, SIN1, ULK1, BAD, p70 S6 kinases, ACSL3, MDM2, 4E-BP2, CLIP170, p27KIP1, YY1, eEF2, G6PD, PDCD4, MAF1, Cyclin D, eEF2K, eIF4B, MVK, 4E-BP1, RRN3, GLUT1, p70 S6 kinase1, MTHFD2, eIF4A, ATG13, p70 S6 kinase2, GRB10",
5,Signal transduction_AKT signaling,43,2.177E-08,6.509E-06,8.129E-04,8.613E-03,17,"Tuberin, GAB1, Cyclin D, p21, GYS1, I-kB, p70 S6 kinase1, PI3K reg class IA, PTEN, MDM2, GSK3 alpha/beta, Bcl-XL, IGF-1 receptor, AKT(PKB), HSP90, PDK (PDPK1), p27KIP1",2.177E-08,6.509E-06,27,"Tuberin, Cyclin D3, GAB1, IRS-1, IKK (cat), p21, BAD, I-kB, PI3K reg class IA, IKK-alpha, MDM2, GSK3 alpha/beta, Bcl-XL, IGF-1 receptor, FasL(TNFSF6), AKT(PKB), HSP90, PDK (PDPK1), p27KIP1, c-Myc, Cyclin D, Hamartin, GYS1, 4E-BP1, p70 S6 kinase1, PTEN, FOXO3A",
6,Development_G-CSF-induced myeloid differentiation,30,5.338E-08,4.349E-05,5.338E-08,4.349E-05,19,"PU.1, E2F1, H-Ras, CCR2, ERK1/2, Lactoferrin, c-Raf-1, ITGAM, PERM, STAT3, Rb protein, CalDAG-GEFII, MEK1/2, G-CSF receptor, Myeloblastin, SHP-1, G-CSF, p27KIP1, C/EBPalpha",3.624E-07,5.548E-05,20,"H-Ras, CCR2, ERK1/2, Lactoferrin, Rb protein, CalDAG-GEFII, C/EBPepsilon, G-CSF receptor, SHP-1, p27KIP1, c-Myc, PU.1, E2F1, c-Jun, ITGAM, PERM, SHP-2, Myeloblastin, G-CSF, C/EBPalpha",
7,Development_Ligand-independent activation of ESR1 and ESR2,44,5.822E-08,4.349E-05,5.822E-08,4.349E-05,24,"MEK1(MAP2K1), EGF, GRB2, ESR1 (nuclear), NCOA3 (pCIP/SRC3), Neuregulin 1, H-Ras, ERK1/2, ErbB3, PKA-reg (cAMP-dependent), c-Raf-1, p90RSK1, ESR2 (nuclear), Adenylate cyclase type V, G-protein alpha-s, ErbB2, PI3K reg class IA, IGF-1 receptor, Cyclin D1, AKT(PKB), TFF1, IGF-1, PDK (PDPK1), ERK1 (MAPK3)",2.382E-04,4.178E-03,21,"EGF, GRB2, ESR1 (nuclear), IRS-1, H-Ras, ERK1/2, ErbB3, PKA-reg (cAMP-dependent), ESR2 (nuclear), Adenylate cyclase type V, ErbB2, PI3K reg class IA, IGF-1 receptor, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), NCOA3 (pCIP/SRC3), G-protein alpha-s, Cyclin D1, TFF1, IGF-1",
8,Regulation of lipid metabolism_Insulin signaling: generic cascades,47,6.178E-08,1.539E-05,3.033E-07,1.079E-04,24,"MEK1(MAP2K1), Tuberin, eEF2, IPP-1, GRB2, eIF2B5, Insulin processed, PDE3B, PP1-cat, H-Ras, ERK1/2, eIF4B, PKA-reg (cAMP-dependent), c-Raf-1, p90RSK1, LIPS, PP1G regulatory subunit, ACLY, p70 S6 kinase1, PI3K reg class IA, Insulin receptor, AKT(PKB), PDK (PDPK1), p70 S6 kinase2",6.178E-08,1.539E-05,28,"Tuberin, GRB2, eIF2B5, Insulin processed, PDE3B, IRS-1, PP1-cat, H-Ras, ERK1/2, PKC-zeta, PKA-reg (cAMP-dependent), GLUT4, PP1G regulatory subunit, PI3K reg class IA, Insulin receptor, AKT(PKB), PDK (PDPK1), eEF2, IPP-1, eEF2K, eIF4B, LIPS, PDHA (somatic), 4E-BP1, ACLY, p70 S6 kinase1, AKT2, p70 S6 kinase2",
9,Development_Negative regulation of WNT/Beta-catenin signaling in the nucleus,89,1.048E-07,2.239E-05,1.612E-03,1.392E-02,28,"ZNF703, KDM2, TBL1X, SP7, AKT1, Calcineurin A (catalytic), WWOX, E2F1, PGAM5, Alpha-1 catenin, NF-AT3(NFATC4), TRIM33, CHD8, TLE, Nitrilase 1, Dsh, KLF4, Menin, FHIT, NLK, SOX2, WNT, eNOS, GPX4, TAB2, Plakoglobin, RUVBL2, Axin",1.048E-07,2.239E-05,43,"ZNF703, TBL1X, SP7, Casein kinase I delta, AKT1, Calcineurin A (catalytic), Lef-1, PGAM5, Alpha-1 catenin, 14-3-3, NF-AT3(NFATC4), PAX7, PC1-CTT, TLE, Nitrilase 1, Dsh, KLF4, Menin, FHIT, RANBP3, CtBP, TAB2, PJA2, Axin, KDM2, WWOX, PKC-delta, Tcf(Lef), E2F1, TRIM33, CHD8, SENP2, NLK, RNF43, SOX2, WNT, FOXO3A, eNOS, GPX4, CHIBBY, Plakoglobin, RUVBL2, Frizzled",
10,Adiponectin in pathogenesis of type 2 diabetes,29,1.888E-07,9.404E-05,1.888E-07,9.404E-05,18,"p38alpha (MAPK14), AdipoR2, ACACA, SREBP1 (nuclear), Adiponectin, Insulin processed, SCD, G6PT, AMPK alpha subunit, FASN, CPT-1B, SREBP1 precursor, CPT-1A, ACACB, Insulin receptor, TORC2, ACOX1, AdipoR1",6.339E-04,8.537E-03,15,"SREBP1 (nuclear), Insulin processed, SCD, FASN, SREBP1 precursor, CPT-1A, ACACB, Insulin receptor, TORC2, ACOX1, AdipoR2, Adiponectin, AMPK alpha subunit, CPT-1B, AdipoR1",
11,Ubiquinone metabolism,74,2.686E-07,5.019E-05,1.634E-06,2.713E-04,31,"NDUFB9, COQ6, NDUFS1, NDUFS3, NDUFS7, NDUFAB1, NDUFC1, TAT, NDUFS4, NDUFA2, NDUFA3, NDUFB4, NDUFA10, NDUFB6, NDUFB10, NDUFA8, NDUFS8, NDUFV1, DAP13, NDUFB1, NDUFB5, NDUFC2, NDUFV3, NDUFA7, NDUFA9, NDUFA13, NDUFA5, NDUFS2, NDUFA1, NDUFA4, NDUFB8",2.686E-07,5.019E-05,37,"NDUFB9, NDUFS1, NDUFS3, NDUFAB1, NDUFC1, TAT, NDUFA2, NDUFA3, NDUFB4, NDUFB6, NDUFA8, NDUFS8, NDUFV1, DAP13, NDUFB1, NDUFB5, NDUFC2, NDUFA7, NDUFA9, COQ3, NDUFA13, NDUFA5, NDUFA4, NDUFB8, NDUFB7, COQ6, NDUFS7, NDUFA6, NDUFS4, NDUFB2, NDUFV2, NDUFA10, NDUFB10, NDUFB3, NDUFV3, NDUFS2, NDUFA1",
12,Cytoskeleton remodeling_Regulation of actin cytoskeleton organization by the kinase effectors of Rho GTPases,58,3.711E-07,5.548E-05,2.957E-04,4.649E-03,22,"Spectrin, SLC9A1, Myosin II, Alpha-actinin, PAK1, RhoB, PIP5KI, MyHC, LIMK, Rac3, MRCK, GIT1, DMPK, PAK, Rac1-related, Cdc42 subfamily, ERM proteins, Rhov, MRLC, RhoA-related, Cortactin, MLCK",3.711E-07,5.548E-05,31,"WRCH-1, Spectrin, SLC9A1, RhoC, Rac1, GIT1, Cdc42 subfamily, ERM proteins, RhoA-related, Cortactin, MLCK, BETA-PIX, Destrin, Myosin II, PAK1, RhoB, PIP5KI, MyHC, LIMK, Rac3, Paxillin, MRCK, DMPK, Actomyosin, MRCKalpha, PAK, Cofilin, non-muscle, Rac1-related, Rhov, MRLC, Cofilin",
13,LRRK2 in neurons in Parkinson's disease,33,5.940E-07,8.073E-05,1.412E-05,7.815E-04,17,"MARK2, LRRK2, ERK1/2, AP2A1, PAK1, eEF1A2, VIL2 (ezrin), Ubiquitin, AP-2 alpha subunits, MEK1/2, Tau (MAPT), RAB-5B, HSP90, CHIP, Clathrin heavy chain, eEF1A, Tubulin (in microtubules)",5.940E-07,8.073E-05,21,"NSF, ERK1/2, 14-3-3, PKC-zeta, eEF1A2, Rac1, VIL2 (ezrin), Ubiquitin, AP-2 alpha subunits, Tau (MAPT), HSP90, Clathrin heavy chain, Tubulin (in microtubules), MARK2, LRRK2, MARKK, PAK1, AP2A2, RAB-5B, CHIP, eEF1A",
14,IL-6 signaling in Prostate Cancer,40,9.204E-07,2.077E-04,9.204E-07,2.077E-04,21,"MEK1(MAP2K1), gp130, MCP, GRB2, GAB1, H-Ras, c-Raf-1, p21, IL6RA, Kallikrein 3 (PSA), STAT3, Androgen receptor, AP-1, ErbB2, PI3K reg class IA, PTEN, Cyclin D1, AKT(PKB), PDK (PDPK1), p27KIP1, IL-6 receptor",1.500E-04,3.296E-03,20,"gp130, GRB2, GAB1, IRS-1, H-Ras, p21, Kallikrein 3 (PSA), Androgen receptor, ErbB2, PI3K reg class IA, AKT(PKB), PDK (PDPK1), p27KIP1, MCP, IL6RA, AP-1, PTEN, SHP-2, Cyclin D1, IL-6 receptor",
15,G protein-coupled receptors signaling in lung cancer,76,9.733E-07,2.077E-04,9.733E-07,2.077E-04,32,"EGF, G-protein alpha-12 family, SSTR2, c-Fos, G-protein alpha-i family, ERK1/2, PKA-reg (cAMP-dependent), BDKRB2, Galpha(q)-specific peptide GPCRs, G-protein alpha-q/11, IL8RA, PGE2R3, STAT3, I-kB, GRP-R, Amphiregulin, p70 S6 kinase1, G-protein alpha-s, Calmodulin, CNR1, NTSR1, Bcl-XL, VIP receptor 1, Galpha(i)-specific peptide GPCRs, Cyclin D1, CCR5, VIP receptor 2, Galpha(i)-specific cannabis GPSRs, AKT(PKB), PDK (PDPK1), SDF-1, IL8RB",2.040E-06,2.346E-04,36,"EGF, SSTR2, c-Fos, ERK1/2, PKA-reg (cAMP-dependent), BDKRB2, G-protein alpha-q/11, I-kB, GRP-R, Amphiregulin, CNR1, IKK-alpha, NTSR1, Bcl-XL, Galpha(i)-specific peptide GPCRs, VIP, CCR5, Galpha(i)-specific cannabis GPSRs, AKT(PKB), PDK (PDPK1), SDF-1, IL8RB, G-protein alpha-12 family, G-protein alpha-i family, Galpha(q)-specific peptide GPCRs, IL8RA, PGE2R3, Bradykinin, p70 S6 kinase1, G-protein alpha-s, Calmodulin, Somatostatin, VIP receptor 1, Cyclin D1, VIP receptor 2, SSTR5",
16,IGF family signaling in colorectal cancer,60,9.911E-07,1.235E-04,1.806E-04,3.459E-03,23,"GRB2, c-Fos, E2F1, H-Ras, ERK1/2, Clusterin, c-Raf-1, I-kB, p70 S6 kinase1, PTEN, c-Myb, GSK3 alpha/beta, Bcl-XL, IGF-1 receptor, MNK2(GPRK7), MEK1/2, Cyclin D1, AKT(PKB), IGF-1, ERK1 (MAPK3), IBP, FosB, C/EBPalpha",9.911E-07,1.235E-04,31,"GRB2, c-Fos, IRS-1, H-Ras, eIF4E, ERK1/2, Clusterin, IKK (cat), Rad51, GIPC, I-kB, IKK-alpha, c-Myb, GSK3 alpha/beta, Bcl-XL, IGF-1 receptor, AKT(PKB), ERK1 (MAPK3), IBP, E2F1, c-Jun, 4E-BP1, ZNF143, p70 S6 kinase1, PTEN, MNK2(GPRK7), Cyclin D1, IGF-1, MAT2A, FosB, C/EBPalpha",
17,Regulation of lipid metabolism_Insulin regulation of glycogen metabolism ,57,1.621E-06,2.713E-04,1.621E-06,2.713E-04,26,"MEK1(MAP2K1), IPP-1, GRB2, PHK gamma (liver), Insulin processed, PDE3B, PP1-cat, G6PT, H-Ras, PHK gamma, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, p90RSK1, PP1G regulatory subunit, GYS1, Calmodulin, PI3K reg class IA, PHK alpha, Insulin receptor, PPCKM, GSK3 alpha/beta, PYGM, PHK beta, AKT(PKB), PDK (PDPK1)",1.161E-04,2.800E-03,26,"GRB2, PHK gamma (liver), Insulin processed, PDE3B, GYS2, IRS-1, PP1-cat, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), GLUT4, PP1G regulatory subunit, PI3K reg class IA, PHK alpha, Insulin receptor, PPCKM, GSK3 alpha/beta, AKT(PKB), PDK (PDPK1), IPP-1, PHK gamma, GYS1, Calmodulin, AKT2, PYGM, PHK beta",
18,Putative role of Estrogen receptor and Androgen receptor signaling in progression of lung cancer,58,2.435E-06,3.191E-04,2.435E-06,3.191E-04,26,"MEK1(MAP2K1), E-cadherin, Tuberin, EGF, GRB2, ESR1 (nuclear), NCOA3 (pCIP/SRC3), G-protein alpha-i family, H-Ras, ERK1/2, ESR1 (membrane), c-Raf-1, Cytochrome c, ESR2 (nuclear), ESR2 (mitochondrial), ESR2 (membrane), Kallikrein 3 (PSA), Androgen receptor, ID2, p70 S6 kinase1, MAPKAPK2, Bcl-2, Bcl-XL, Cyclin D1, p38 MAPK, ERK1 (MAPK3)",1.756E-05,9.225E-04,28,"Tuberin, EGF, GRB2, ESR1 (nuclear), H-Ras, ERK1/2, 14-3-3, ESR1 (membrane), Cytochrome c, ESR2 (nuclear), Kallikrein 3 (PSA), BAD, Androgen receptor, ID2, MAPKAPK2, CYP19, Bcl-XL, ERK1 (MAPK3), E-cadherin, NCOA3 (pCIP/SRC3), G-protein alpha-i family, TAS2R50, ESR2 (mitochondrial), ESR2 (membrane), p70 S6 kinase1, Bcl-2, Cyclin D1, p38 MAPK",
19,Apoptosis and survival_BAD phosphorylation,42,2.598E-06,3.191E-04,2.598E-06,3.191E-04,21,"MEK1(MAP2K1), Calcineurin A (catalytic), GRB2, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, Adenylate cyclase type I, PP2C, Cytochrome c, p90Rsk, p70 S6 kinase1, G-protein alpha-s, PI3K reg class IA, PP1-cat alpha, Bcl-2, Bcl-XL, IGF-1 receptor, AKT(PKB), PDK (PDPK1), p70 S6 kinase2",2.795E-05,1.129E-03,22,"Calcineurin A (catalytic), GRB2, IRS-1, H-Ras, ERK1/2, 14-3-3, PKA-reg (cAMP-dependent), PP2C, Cytochrome c, BAD, PI3K reg class IA, PP1-cat alpha, Bcl-XL, IGF-1 receptor, AKT(PKB), PDK (PDPK1), Adenylate cyclase type I, p70 S6 kinase1, G-protein alpha-s, Bcl-2, Beclin 1, p70 S6 kinase2",
20,Translation _Regulation of EIF2 activity,39,2.709E-06,3.191E-04,2.709E-06,3.191E-04,20,"MEK1(MAP2K1), EGF, GRB2, eIF2B5, GAB1, eIF2AK3, Insulin processed, PP1-cat, H-Ras, ERK1/2, c-Raf-1, PI3K reg class IA, Insulin receptor, PP1-cat alpha, GSK3 alpha/beta, Casein kinase I, eIF2S1, AKT(PKB), PDK (PDPK1), eIF2AK1",3.361E-04,5.367E-03,19,"EGF, GRB2, eIF2B5, GAB1, Insulin processed, IRS-1, PP1-cat, H-Ras, ERK1/2, PI3K reg class IA, Insulin receptor, PP1-cat alpha, GSK3 alpha/beta, eIF2S1, AKT(PKB), PDK (PDPK1), eIF2AK3, Casein kinase I, eIF2AK1",
21,Signal transduction_mTORC2 downstream signaling,68,2.761E-06,2.929E-04,1.405E-03,1.242E-02,23,"Tuberin, cPKC (conventional), ACACA, AKT1, SREBP1 (nuclear), SCD, G6PT, PKA-reg (cAMP-dependent), p21, FASN, Adenylate cyclase type IX, RAG2, FBX29, SLC12A1, PKC, Insulin receptor, MDM2, GSK3 alpha/beta, IGF-1 receptor, Cyclin D1, AKT(PKB), p27KIP1, PREX1",2.761E-06,2.929E-04,33,"Tuberin, AKT1, SREBP1 (nuclear), SCD, IRS-1, PKC-zeta, PRAS40, PKA-reg (cAMP-dependent), GLUT4, p21, FASN, FBX29, Rac1, BAD, Insulin receptor, MDM2, GSK3 alpha/beta, IGF-1 receptor, AKT(PKB), p27KIP1, c-Myc, cPKC (conventional), PKC-delta, Adenylate cyclase type IX, Paxillin, SLC12A1, PKC, Rab-10, FOXO3A, AKT2, Cyclin D1, ENaC, PREX1",
22,Development_Fetal brown fat cell differentiation,55,2.777E-06,3.191E-04,2.777E-06,3.191E-04,25,"MEK1(MAP2K1), SREBP1 (nuclear), GRB2, Insulin processed, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, USF1, FASN, TR-beta, Prolactin receptor, SREBP1 precursor, PI3K reg class IA (p85), p70 S6 kinase1, G-protein alpha-s, Insulin receptor, Adenylate cyclase, IGF-1 receptor, AKT(PKB), IGF-1, PDK (PDPK1), p70 S6 kinase2, Leptin, C/EBPalpha",1.681E-05,9.225E-04,27,"SREBP1 (nuclear), GRB2, Insulin processed, IRS-1, H-Ras, ERK1/2, PKC-zeta, PKA-reg (cAMP-dependent), GLUT4, USF1, FASN, TR-beta, Prolactin receptor, SREBP1 precursor, PI3K reg class IA (p85), Insulin receptor, Adenylate cyclase, IGF-1 receptor, AKT(PKB), PDK (PDPK1), c-Myc, p70 S6 kinase1, G-protein alpha-s, IGF-1, p70 S6 kinase2, Leptin, C/EBPalpha",
23,Possible regulation of HSF-1/ chaperone pathway in Huntington's disease,21,2.939E-06,2.929E-04,7.093E-05,1.879E-03,12,"Huntingtin, HSP90 alpha, E2I, Calmodulin, HSP27, GSK3 alpha/beta, JNK(MAPK8-10), HSP90, PLA2, HSP70, ERK1 (MAPK3), p23 co-chaperone",2.939E-06,2.929E-04,15,"Huntingtin, HSP90 alpha, E2I, GSK3 alpha/beta, HSP40, HSP90, HSP70, ERK1 (MAPK3), HSF1, Calmodulin, SUMO-2, HSP27, JNK(MAPK8-10), PLA2, p23 co-chaperone",
24,Transcription_CREB signaling pathway,49,3.509E-06,3.668E-04,3.509E-06,3.668E-04,23,"MEK1(MAP2K1), cPKC (conventional), Galpha(s)-specific amine GPCRs, GRB2, PP1-cat, H-Ras, ERK1/2, CACNA1C, MSK1/2 (RPS6KA5/4), PKA-reg (cAMP-dependent), c-Raf-1, Adenylate cyclase type I, p90Rsk, G-protein alpha-s, Calmodulin, PI3K reg class IA, MEK6(MAP2K6), IGF-1 receptor, Cyclin D1, AKT(PKB), PDK (PDPK1), HPD, p38 MAPK",5.023E-04,7.017E-03,22,"GRB2, IRS-1, PP1-cat, H-Ras, ERK1/2, MSK1/2 (RPS6KA5/4), PKA-reg (cAMP-dependent), Rac1, PI3K reg class IA, MEK6(MAP2K6), IGF-1 receptor, AKT(PKB), PDK (PDPK1), cPKC (conventional), Galpha(s)-specific amine GPCRs, CACNA1C, Adenylate cyclase type I, G-protein alpha-s, Calmodulin, Cyclin D1, HPD, p38 MAPK",
25,Main pathways of Schwann cells transformation in neurofibromatosis type 1 ,80,3.713E-06,3.668E-04,3.713E-06,3.668E-04,32,"MEK1(MAP2K1), Tuberin, EGF, PDGF-B, c-Fos, K-RAS, Neuregulin 1, H-Ras, TPT1, ERK1/2, ErbB3, c-Raf-1, PAK1, IP3 receptor, PI3K reg class IA (p85), AP-1, Amphiregulin, p70 S6 kinase1, ErbB2, Calmodulin, PTEN, Bcl-2, FAK1, Bcl-XL, IGF-1 receptor, MEK1/2, Cyclin D1, B-FABP, AKT(PKB), PDK (PDPK1), p38 MAPK, SDF-1",9.467E-04,1.097E-02,31,"Tuberin, EGF, PDGF-B, c-Fos, H-Ras, ERK1/2, ErbB3, c-Jun/c-Fos, IP3 receptor, BAD, PI3K reg class IA (p85), Amphiregulin, ErbB2, Bcl-XL, IGF-1 receptor, B-FABP, AKT(PKB), PDK (PDPK1), SDF-1, K-RAS, TPT1, PAK1, miR-106b-5p, AP-1, p70 S6 kinase1, Calmodulin, PTEN, Bcl-2, FAK1, Cyclin D1, p38 MAPK",
26,Mitogenic action of ErbB2 in breast cancer,56,4.157E-06,3.668E-04,4.157E-06,3.668E-04,25,"Tuberin, EGF, GRB2, c-Fos, Neuregulin 1, H-Ras, ERK1/2, ErbB3, JAB1, c-Raf-1, PAK1, p21, I-kB, PI3K reg class IA (p85), p70 S6 kinase1, BRK, ErbB2, MEK1/2, Cyclin D1, MSK1, AKT(PKB), Cullin 3, PDK (PDPK1), p70 S6 kinase2, p27KIP1",7.522E-06,6.248E-04,28,"Tuberin, EGF, GRB2, c-Fos, H-Ras, ERK1/2, ErbB3, Cyclin G2, IKK (cat), p21, Rac1, I-kB, PI3K reg class IA (p85), BRK, ErbB2, IKK-alpha, MSK1, AKT(PKB), Cullin 3, PDK (PDPK1), p27KIP1, c-Myc, JAB1, PAK1, p70 S6 kinase1, FOXO3A, Cyclin D1, p70 S6 kinase2",
27,Androgen receptor activation and downstream signaling in Prostate cancer,110,4.174E-06,3.668E-04,4.174E-06,3.668E-04,40,"MEK1(MAP2K1), E-cadherin, SLC45A3, EGF, gp130, GRB2, GAB1, K-RAS, NCOA3 (pCIP/SRC3), H-Ras, Kallikrein 4, Clusterin, c-Raf-1, FRS2, p21, ESR2 (nuclear), FGFR1, IL6RA, Kallikrein 3 (PSA), VIL2 (ezrin), STAT3, Androgen receptor, Rb protein, ErbB2, PI3K reg class IA (p85-beta), PTEN, Kallikrein 2, MDM2, SCAP, Bcl-XL, IGF-1 receptor, Cyclin D1, Relaxin 1, PSCA, AKT(PKB), IGF-1, PDK (PDPK1), HNF3-alpha, ERK1 (MAPK3), IL-6 receptor",8.612E-05,2.429E-03,43,"EGF, gp130, GRB2, GAB1, IRS-1, H-Ras, Clusterin, FRS2, p21, Bak, ESR2 (nuclear), FGFR1, Kallikrein 3 (PSA), VIL2 (ezrin), Androgen receptor, Rb protein, ErbB2, PI3K reg class IA (p85-beta), MDM2, Bcl-XL, IGF-1 receptor, Relaxin 1, AKT(PKB), PDK (PDPK1), c-Myc, ERK1 (MAPK3), E-cadherin, SLC45A3, K-RAS, NCOA3 (pCIP/SRC3), PKC-delta, FOLH1 (GCP2), IL6RA, PTEN, SHP-2, Kallikrein 2, SCAP, Cyclin D1, microRNA 125b, PSCA, IGF-1, HNF3-alpha, IL-6 receptor",
28,Development_FGF signaling in pancreatic and hepatic differentiation of embryonic stem cells,40,4.498E-06,3.733E-04,4.498E-06,3.733E-04,20,"MEK1(MAP2K1), PTF1-p48, GRB2, FGFR4, H-Ras, ERK1/2, GATA-4, c-Raf-1, FRS2, GSC, FGFR1, FGF4, Alpha 1-antitrypsin, Keratin 18, FGF10, Neurogenin 3, AFP, Keratin 8, HNF6, Albumin",1.546E-03,1.531E-02,18,"GRB2, WNT3A, FGFR4, H-Ras, ERK1/2, GATA-4, FRS2, GSC, FGFR1, FGF4, Alpha 1-antitrypsin, Keratin 18, FGF10, Neurogenin 3, Albumin, SHP-2, Keratin 8, HNF6",
29,Development_Thromboxane A2 signaling pathway,50,5.389E-06,4.078E-04,5.389E-06,4.078E-04,23,"EGF, cPKC (conventional), G-protein alpha-12 family, G-protein alpha-i family, H-Ras, ERK1/2, MSK1/2 (RPS6KA5/4), PKA-reg (cAMP-dependent), c-Raf-1, IP3 receptor, G-protein alpha-13, PI3K reg class IA (p85), p70 S6 kinase1, G-protein alpha-s, PKC, PI3K reg class IA, PLC-beta, Adenylate cyclase, GSK3 alpha/beta, MEK1/2, Cyclin D1, AKT(PKB), p38 MAPK",2.431E-04,4.178E-03,23,"EGF, H-Ras, ERK1/2, MSK1/2 (RPS6KA5/4), PKA-reg (cAMP-dependent), IP3 receptor, G-protein alpha-13, PI3K reg class IA (p85), PI3K reg class IA, PLC-beta, Adenylate cyclase, GSK3 alpha/beta, AKT(PKB), cPKC (conventional), G-protein alpha-12 family, Tcf(Lef), G-protein alpha-i family, p70 S6 kinase1, G-protein alpha-s, PKC, G-protein alpha-q, Cyclin D1, p38 MAPK",
30,Ligand-independent activation of Androgen receptor in Prostate Cancer,67,5.459E-06,4.078E-04,5.459E-06,4.078E-04,28,"MEK1(MAP2K1), EGF, GRB2, GAB1, K-RAS, NCOA3 (pCIP/SRC3), Neuregulin 1, H-Ras, ErbB3, PP2A regulatory, c-Raf-1, FRS2, DDX5, FGFR1, Kallikrein 3 (PSA), Prolactin receptor, STAT3, Androgen receptor, ErbB2, PI3K reg class IA, MDM2, Bcl-XL, IGF-1 receptor, Cyclin D1, AKT(PKB), IGF-1, PDK (PDPK1), ERK1 (MAPK3)",1.521E-04,3.296E-03,29,"EGF, GRB2, GAB1, WNT3A, IRS-1, H-Ras, ErbB3, PP2A regulatory, FRS2, FGFR1, Kallikrein 3 (PSA), Prolactin receptor, Androgen receptor, ErbB2, PI3K reg class IA, MDM2, Bcl-XL, IGF-1 receptor, AKT(PKB), PDK (PDPK1), c-Myc, ERK1 (MAPK3), K-RAS, NCOA3 (pCIP/SRC3), Tcf(Lef), DDX5, Cyclin D1, IGF-1, Frizzled",
31,Regulation of degradation of deltaF508-CFTR in CF,39,5.727E-06,5.351E-04,7.126E-04,8.030E-03,16,"UFD1, HSP105, CFTR, VCP, E2I, DNAJB12, Ubiquitin, RNF4, Csp, Aha1, HSP27, AMFR, HSP90, CHIP, HSP70, Derlin1",5.727E-06,5.351E-04,22,"VCP, Sti1, E2I, Ubiquitin, Csp, HSP90, HSP70, UFD1, HSC70, HSP105, SAE1, DNAJB12, RNF4, USP19, UBE1, Aha1, SUMO-2, HSP27, HSPBP1, AMFR, CHIP, Derlin1",
32,Development_IGF-1 receptor signaling,50,6.311E-06,5.550E-04,7.310E-04,8.030E-03,19,"MEK1(MAP2K1), GRB2, H-Ras, ERK1/2, Cyclin D, c-Raf-1, p90Rsk, GYS1, I-kB, p70 S6 kinase1, PI3K reg class IA, GSK3 alpha/beta, Bcl-XL, IGF-1 receptor, MNK2(GPRK7), AKT(PKB), IGF-1, PDK (PDPK1), p70 S6 kinase2",6.311E-06,5.550E-04,26,"GRB2, IRS-1, H-Ras, eIF4E, ERK1/2, PKC-zeta, IKK (cat), BAD, I-kB, PI3K reg class IA, IKK-alpha, GSK3 alpha/beta, Bcl-XL, IGF-1 receptor, AKT(PKB), PDK (PDPK1), c-Myc, Cyclin D, GYS1, 4E-BP1, 14-3-3 beta/alpha, p70 S6 kinase1, FOXO3A, MNK2(GPRK7), IGF-1, p70 S6 kinase2",
33,Regulation of metabolism_Bile acids regulation of glucose and lipid metabolism via FXR,41,7.291E-06,5.187E-04,7.291E-06,5.187E-04,20,"ACACA, LXR-alpha/RXR-alpha, SREBP1 (nuclear), Insulin processed, SCD, G6PT, FASN, SHP, F16P, SREBP1 precursor, ME1, ACACB, Insulin receptor, NIPK, GSK3 alpha/beta, LXR-alpha, HNF3-gamma, AKT(PKB), HNF3-alpha, HNF3",5.831E-03,3.340E-02,17,"SREBP1 (nuclear), Insulin processed, SCD, HNF1-alpha, APOC2, FASN, F16P, SREBP1 precursor, ME1, ACACB, Insulin receptor, GSK3 alpha/beta, AKT(PKB), HNF3, NIPK, HNF3-gamma, HNF3-alpha",
34,Signal transduction_PDGF signaling via MAPK cascades,65,9.161E-06,6.012E-04,9.161E-06,6.012E-04,27,"NOR1, PDGF-B, GRB2, c-Fos, GAB1, H-Ras, ERK1/2, c-Raf-1, p21, KLF4, p90Rsk, GIT1, AP-1, MAPKAPK2, JunD, HSP27, MEK6(MAP2K6), VAV-2, FAK1, CNK1, MEK1/2, Cyclin D1, JNK(MAPK8-10), SP1, p27KIP1, p38 MAPK, GRB10",2.687E-05,1.129E-03,30,"PDGF-B, GRB2, c-Fos, GAB1, H-Ras, ERK1/2, EGR1, p21, KLF4, Rac1, GIT1, MAPKAPK2, JunD, MEK6(MAP2K6), VAV-2, p27KIP1, c-Myc, NOR1, PKC-delta, c-Jun, AP-1, SHP-2, HSP27, FAK1, CNK1, Cyclin D1, JNK(MAPK8-10), SP1, p38 MAPK, GRB10",
35,Main genetic and epigenetic alterations in lung cancer,48,9.255E-06,6.012E-04,9.255E-06,6.012E-04,22,"DNMT3B, EGF, K-RAS, E2F1, Semaphorin 3B, MGMT, MSP, DNMT3A, MSP receptor (RON), IBP4, FADD, FHIT, Rb protein, LKB1, PTEN, Bcl-2, MDM2, Bcl-XL, IGF-1 receptor, Cyclin D1, IGF-1, IBP",1.128E-04,2.800E-03,23,"DNMT3B, EGF, Semaphorin 3B, FADD, FHIT, Rb protein, MDM2, Bcl-XL, IGF-1 receptor, c-Myc, IBP, K-RAS, E2F1, MGMT, MSP, DNMT3A, MSP receptor (RON), IBP4, LKB1, PTEN, Bcl-2, Cyclin D1, IGF-1",
36,Role of ER stress in obesity and type 2 diabetes,54,1.091E-05,8.586E-04,8.627E-05,2.127E-03,22,"AdipoR2, SREBP1 (nuclear), eIF2AK3, Adiponectin, Insulin processed, SCD, XBP1, G6PT, FASN, SREBP1 (Golgi membrane), SREBP1 precursor, PI3K reg class IA (p85), BI-1, PI3K reg class IA (p85-beta), Insulin receptor, TORC2, NIPK, PPCKM, eIF2S1, IRE1, DnaJB9, C/EBPalpha",1.091E-05,8.586E-04,27,"SREBP1 (nuclear), Insulin processed, SCD, IRS-1, XBP1, GLUT4, FASN, SREBP1 precursor, PI3K reg class IA (p85), HMGCS1, PI3K reg class IA (p85-beta), Resistin, Insulin receptor, TORC2, PPCKM, eIF2S1, IRE1, AdipoR2, eIF2AK3, Adiponectin, PTP-1B, SREBP1 (Golgi membrane), BI-1, NIPK, AKT2, DnaJB9, C/EBPalpha",
37,HSP70 and HSP40-dependent folding in Huntington's disease,25,1.220E-05,9.123E-04,1.301E-04,2.699E-03,13,"Huntingtin, HSP22, Parkin, HSP90 alpha, SGTA, HSPA1A, Ubiquitin, HSP27, HSP90, BAG-1, CHIP, HSP70, Cathepsin D",1.220E-05,9.123E-04,16,"Huntingtin, Parkin, HSP90 alpha, Sti1, Ubiquitin, HSP40, HSP90, BAG-1, HSP70, Cathepsin D, HSC70, HSP22, SGTA, HSPA1A, HSP27, CHIP",
38,Reproduction_Gonadotropin-releasing hormone (GnRH) signaling,73,1.226E-05,7.632E-04,1.226E-05,7.632E-04,29,"MEK1(MAP2K1), p38alpha (MAPK14), GRB2, c-Fos, JunB, GnRH receptor, H-Ras, ERK1/2, CACNA1C, MKP-2, PKA-reg (cAMP-dependent), c-Raf-1, FosB/JunB, G-protein alpha-q/11, p90Rsk, IP3 receptor, MEF2D, AP-1, PER1, G-protein alpha-s, Calmodulin, NUR77, PLC-beta, CG alpha, Adenylate cyclase, MEK6(MAP2K6), MKP-1, JNK(MAPK8-10), FosB",5.233E-05,1.630E-03,32,"GRB2, c-Fos, GnRH receptor, H-Ras, ERK1/2, EGR1, c-Jun/c-Fos, PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, PER1, PLC-beta, CG alpha, Adenylate cyclase, MEK6(MAP2K6), FSH-beta, JunB, PKC-delta, c-Jun, CACNA1C, MKP-2, FosB/JunB, MKK7 (MAP2K7), MEF2D, AP-1, G-protein alpha-s, Calmodulin, NUR77, MEKK1(MAP3K1), MKP-1, JNK(MAPK8-10), FosB",
39,Transcription_Negative regulation of HIF1A function,69,1.293E-05,9.207E-04,2.721E-04,4.371E-03,25,"Sirtuin3, CITED2, FBXW7, MTG16 (CBFA2T3), KLF2, VCP, PSMA7, Sirtuin6, Ubiquitin, ING4, Sirtuin1, EGLN2, EGLN3, Elongin B, PTEN, Sirtuin7, OS-9, EAF2, MDM2, HIF-prolyl hydroxylase, FIH-1, HSP90, CHIP, HSP70, RUVBL2",1.293E-05,9.207E-04,32,"Casein kinase I delta, Sirtuin3, COMMD1 (MURR1), FBXW7, KLF2, VCP, Sirtuin6, Ubiquitin, ING4, EGLN2, EGLN3, Elongin B, OS-9, EAF2, MDM2, HSP40, FIH-1, HSP90, HSP70, HSPA4, HSC70, PRDX2, CITED2, MTG16 (CBFA2T3), PSMA7, Sirtuin1, PTEN, Sirtuin7, Elongin C, HIF-prolyl hydroxylase, CHIP, RUVBL2",
40,Prolactin/ ERK signaling in breast cancer,36,1.352E-05,7.771E-04,1.352E-05,7.771E-04,18,"GRB2, c-Fos, JunB, H-Ras, ERK1/2, c-Raf-1, PAK1, Prolactin receptor, PI3K reg class IA (p85), CAML, VAV-2, FAK1, GSTM1, MEK1/2, Cyclin D1, AKT(PKB), SP1, PDK (PDPK1)",2.076E-05,1.034E-03,20,"GRB2, c-Fos, H-Ras, ERK1/2, Rac1, Prolactin receptor, PI3K reg class IA (p85), VAV-2, GSTM1, AKT(PKB), PDK (PDPK1), c-Myc, JunB, c-Jun, PAK1, Paxillin, CAML, FAK1, Cyclin D1, SP1",
41,PR action in breast cancer: stimulation of cell growth and proliferation,36,1.352E-05,7.771E-04,1.352E-05,7.771E-04,18,"GRB2, c-Fos, ESR1 (nuclear), Neuregulin 1, H-Ras, ERK1/2, ErbB3, ESR1 (membrane), c-Raf-1, PR (membrane), PR (nuclear), STAT3, ErbB2, Bcl-XL, MEK1/2, Cyclin D1, SP1, HSD11B2",3.247E-03,2.301E-02,16,"GRB2, c-Fos, ESR1 (nuclear), H-Ras, ERK1/2, ErbB3, ESR1 (membrane), PR (membrane), PR (nuclear), ErbB2, Bcl-XL, c-Myc, HSD11B2, WNT1, Cyclin D1, SP1",
42,Cell adhesion_Tight junctions,38,1.440E-05,9.225E-04,4.924E-03,2.739E-02,14,"Cingulin, Claudin-2, AF-6, TITF1, Myosin II, Claudin-5, JAM1, JAM3, Claudin-4, Occludin, ZO-3, WNK4, SP1, Claudin-3",1.440E-05,9.225E-04,21,"JAM2, Claudin-2, AF-6, TITF1, Nectin-1, Claudin-5, JAM1, Actin, JAM3, LYRIC, Claudin-7, WNK4, Claudin-3, Cingulin, Tcf(Lef), Myosin II, Actomyosin, Claudin-4, Occludin, ZO-3, SP1",
43,Transport_RAB3 regulation pathway,14,1.540E-05,9.225E-04,1.223E-03,1.126E-02,8,"RAB3IP, Slp5, Rab-3A, Rab-3, Synapsin I, Rabphilin-3A, MSS4, RIMS1",1.540E-05,9.225E-04,11,"NSF, RAB3IP, Slp5, Rab-3A, Rab-3, Synapsin I, RIMS1, GGTase-II, Rabconnectin-3, Rabphilin-3A, MSS4",
44,Signal transduction_mTORC1 upstream signaling,74,1.670E-05,8.647E-04,1.670E-05,8.647E-04,29,"p38alpha (MAPK14), Tuberin, EGF, Insulin processed, GBL, ERK1/2, AGTR1, AMPK alpha subunit, c-Raf-1, p90RSK1, DGK-zeta, Dsh, p90Rsk, GHR, p70 S6 kinase1, MAPKAPK2, DEPTOR, TTI1, WNT, Insulin receptor, IKK-beta, Alpha-1A adrenergic receptor, TELO2, MEK1/2, IL-4, AKT(PKB), PDK (PDPK1), p38 MAPK, Axin",1.107E-03,1.226E-02,29,"Tuberin, EGF, Insulin processed, ERK1/2, PRAS40, DGK-zeta, Dsh, Rac1, MAPKAPK2, DEPTOR, TTI1, IKK-alpha, Insulin receptor, IL-4, AKT(PKB), PDK (PDPK1), Axin, GBL, AGTR1, AMPK alpha subunit, Hamartin, GHR, p70 S6 kinase1, WNT, IKK-beta, Alpha-1A adrenergic receptor, TELO2, p38 MAPK, Frizzled",
45,Development_Self-renewal and pluripotency maintenance of human embryonic stem cells,33,1.677E-05,9.225E-04,6.601E-05,1.861E-03,16,"MDM4, GATA-4, p21, PBX1, KLF4, NANOG, ID2, REM2, SOX2, CGB3, Keratin 18, CG alpha, LIN-28, MDM2, Cyclin D1, Albumin",1.677E-05,9.225E-04,19,"WNT3A, GATA-4, p21, KLF4, ID2, Keratin 18, CG alpha, MDM2, Albumin, c-Myc, MDM4, T brachyury protein, PBX1, NANOG, WNT1, REM2, SOX2, LIN-28, Cyclin D1",
46,Immune response_CD28 signaling,55,1.681E-05,9.225E-04,1.495E-02,5.801E-02,17,"CD80, Calcineurin A (catalytic), GRB2, NF-AT3(NFATC4), PAK1, PIP5KI, NF-AT, IP3 receptor, I-kB, PI3K reg class IA (p85), Calmodulin, CD3, IKK-beta, Bcl-XL, JNK(MAPK8-10), AKT(PKB), p38 MAPK",1.681E-05,9.225E-04,27,"Calcineurin A (catalytic), GRB2, NF-AT1(NFATC2), NF-AT3(NFATC4), IKK (cat), Rac1, IP3 receptor, BAD, I-kB, PI3K reg class IA (p85), ZAP70, IKK-alpha, ITK, Bcl-XL, AKT(PKB), c-Jun, PAK1, MKK7 (MAP2K7), LAT, PIP5KI, NF-AT, Calmodulin, MEKK1(MAP3K1), IKK-beta, JNK(MAPK8-10), TCR alpha/beta, p38 MAPK",
47,Development_Regulation of lung epithelial progenitor cell differentiation,41,1.694E-05,9.225E-04,1.197E-04,2.518E-03,18,"p38alpha (MAPK14), E-cadherin, SP-A, FOXP1, Napsin A, TITF1, SHH, FOXJ1, SP-B, STAT3, Aquaporin 5, WNT, FGF10, ELF5, p130, SP-C, FOXP2, N-Myc",1.694E-05,9.225E-04,22,"WNT3A, FOXP1, Napsin A, TITF1, SP-B, FGF10, p130, E-cadherin, SP-A, Tcf(Lef), Uteroglobin, SHH, FOXJ1, miR-106b-5p, Aquaporin 5, WNT, ELF5, SP-C, SMAD1, FOXP2, N-Myc, Frizzled",
48,"Development_Insulin, IGF-1 and TNF-alpha in brown adipocyte differentiation",53,1.775E-05,8.647E-04,1.775E-05,8.647E-04,23,"MEK1(MAP2K1), A-FABP, AKT1, SREBP1 (nuclear), Adiponectin, Insulin processed, SCD, ERK1/2, UCP2, LIPS, FASN, GATA-2, Factor D, SREBP1 precursor, p70 S6 kinase1, Insulin receptor, PPCKM, IGF-1 receptor, AKT(PKB), IGF-1, p27KIP1, Perilipin, C/EBPalpha",2.439E-05,1.105E-03,26,"AKT1, SREBP1 (nuclear), Insulin processed, SCD, IRS-1, ERK1/2, UCP2, GLUT4, FASN, PRKAR1A, SREBP1 precursor, Insulin receptor, PPCKM, IGF-1 receptor, AKT(PKB), p27KIP1, G3P2, Adiponectin, LIPS, GATA-2, Factor D, p70 S6 kinase1, AKT2, IGF-1, Perilipin, C/EBPalpha",
49,Cell cycle_Influence of Ras and Rho proteins on G1/S Transition,53,1.775E-05,8.647E-04,1.775E-05,8.647E-04,23,"MEK1(MAP2K1), E2F1, H-Ras, ERK1/2, c-Raf-1, PAK1, p21, NFKBIA, STAT3, p70 S6 kinase1, Rb protein, PI3K reg class IA, Tob1, MRLC, MDM2, FAK1, RGL2, Cyclin D1, LIMK2, AKT(PKB), PDK (PDPK1), p27KIP1, MLCK",2.414E-04,4.178E-03,24,"H-Ras, ERK1/2, p21, Rac1, Rb protein, PI3K reg class IA, IKK-alpha, Tob1, MDM2, LIMK2, AKT(PKB), PDK (PDPK1), p27KIP1, c-Myc, MLCK, E2F1, PAK1, NFKBIA, p70 S6 kinase1, MRLC, FAK1, RGL2, Cyclin D1, RalA",
50,Apoptosis and survival_IL-17-induced CIKS-dependent NF-kB signaling and mRNA stabilization,28,1.790E-05,9.225E-04,7.048E-03,3.464E-02,11,"TRAF2, CIKS, TBK1, E2N(UBC13), TRAF4, TRAF5, Ubiquitin, I-kB, IL-17RC, IKK-beta, TAB2",1.790E-05,9.225E-04,17,"CIKS, TBK1, E2N(UBC13), IKK (cat), Ubiquitin, I-kB, IL-17RC, SFRS1 (SF2), IKK-alpha, TAB2, UEV1A, TRAF2, TRAF4, TRAF5, UBE1, IKK-beta, TAB1",
51,FGF signaling in Prostate Cancer,43,1.794E-05,8.647E-04,1.794E-05,8.647E-04,20,"MEK1(MAP2K1), FGFR3, Syndecan-1, GRB2, c-Fos, GAB1, FGF17, FGFR4, H-Ras, c-Raf-1, FRS2, FGFR1, STAT3, Androgen receptor, PI3K reg class IA, PTEN, FGF10, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3)",4.085E-03,2.667E-02,18,"GRB2, c-Fos, GAB1, FGFR4, H-Ras, FRS2, FGFR1, Androgen receptor, PI3K reg class IA, FGF10, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), FGFR3, Syndecan-1, FGF7, PTEN, FGF6",
52,Signal transduction_Adenosine A2B receptor signaling pathway,71,2.025E-05,9.351E-04,2.025E-05,9.351E-04,28,"PDK1, PFKM, Calcineurin A (catalytic), cAMP-GEFI, JunB, ERK1/2, JAB1, CFTR, PKA-reg (cAMP-dependent), G-protein alpha-q/11, IL-12 alpha, IP3 receptor, E3KARP (NHERF2), VIL2 (ezrin), Ubiquitin, PI3K reg class IA (p85), G-protein alpha-s, PKC, PLC-beta, Adenylate cyclase, APIP, eNOS, PER2, MEK1/2, IL-4, AKT(PKB), PDK (PDPK1), p38 MAPK",2.696E-03,2.042E-02,27,"Calcineurin A (catalytic), cAMP-GEFI, ERK1/2, PKA-reg (cAMP-dependent), G-protein alpha-q/11, IL-12 alpha, IP3 receptor, VIL2 (ezrin), Ubiquitin, PI3K reg class IA (p85), PLC-beta, SLC26A6, Adenylate cyclase, IL-4, AKT(PKB), PDK (PDPK1), PFKM, CALDAG-GEFI, JunB, JAB1, E3KARP (NHERF2), G-protein alpha-s, PKC, APIP, eNOS, PER2, p38 MAPK",
53,"Cigarette smoke-induced proliferation, metaplasia and survival of airway epithelial cells ",50,2.066E-05,9.351E-04,2.066E-05,9.351E-04,22,"p38alpha (MAPK14), EGF, GRB2, c-Fos, MMP-1, ERK1/2, ErbB3, c-Raf-1, PAK1, Bik, p90Rsk, PI3K reg class IA (p85), AP-1, Amphiregulin, JunD, nAChR alpha-4, MEK1/2, Cyclin D1, JNK(MAPK8-10), MSK1, PDK (PDPK1), FosB",4.743E-03,2.882E-02,20,"EGF, GRB2, c-Fos, ERK1/2, ErbB3, Bik, PI3K reg class IA (p85), Amphiregulin, p38beta (MAPK11), JunD, nAChR alpha-4, MSK1, PDK (PDPK1), MMP-1, c-Jun, PAK1, AP-1, Cyclin D1, JNK(MAPK8-10), FosB",
54,"Development_NCAM1-mediated neurite outgrowth, synapse assembly and neuronal survival",75,2.256E-05,9.631E-04,2.256E-05,9.631E-04,29,"Neuromodulin, CACNA1H, GRB2, c-Fos, DGL-alpha, H-Ras, NR1, Spectrin, ERK1/2, Protein kinase G, CACNA1C, PKA-reg (cAMP-dependent), c-Raf-1, Ca(II)channel L-type, DNAI1, FRS2, PAK1, DGL-beta, FGFR1, IP3 receptor, Calmodulin, PKC, AP-2 alpha subunits, GFRalpha1, FAK1, MEK1/2, Tau (MAPT), Ca(II)channel T-type, AKT(PKB)",2.527E-04,4.245E-03,31,"CACNA1H, GRB2, c-Fos, DGL-alpha, H-Ras, NR1, Spectrin, ERK1/2, PKA-reg (cAMP-dependent), DNAI1, FRS2, DGL-beta, FGFR1, IP3 receptor, NMDA receptor, AP-2 alpha subunits, GFRalpha1, Tau (MAPT), Ca(II)channel T-type, AKT(PKB), BETA-PIX, Protein kinase G, Ca(II)channel N-type, CACNA1C, Ca(II)channel L-type, PAK1, Calmodulin, PKC, GluR1, FAK1, Cofilin",
55,EGFR family signaling in pancreatic cancer,75,2.256E-05,9.631E-04,2.256E-05,9.631E-04,29,"MEK1(MAP2K1), Tuberin, EGF, GRB2, c-Fos, MLK2(MAP3K10), H-Ras, ERK1/2, ErbB3, c-Raf-1, PAK1, p67-phox, p21, STAT3, I-kB, PI3K reg class IA (p85), p70 S6 kinase1, Rb protein, ErbB2, Bcl-2, VAV-2, Bcl-XL, Cyclin D1, JNK(MAPK8-10), AKT(PKB), SP1, PDK (PDPK1), p27KIP1, p38 MAPK",2.527E-04,4.245E-03,31,"Tuberin, EGF, GRB2, c-Fos, H-Ras, ERK1/2, ErbB3, IKK (cat), p21, Rac1, I-kB, PI3K reg class IA (p85), Rb protein, ErbB2, IKK-alpha, VAV-2, Bcl-XL, AKT(PKB), PDK (PDPK1), p27KIP1, c-Myc, MLK2(MAP3K10), c-Jun, PAK1, MKK7 (MAP2K7), p70 S6 kinase1, Bcl-2, Cyclin D1, JNK(MAPK8-10), SP1, p38 MAPK",
56,Development_FGF2 signaling during embryonic stem cell differentiation,34,2.349E-05,9.748E-04,2.349E-05,9.748E-04,17,"MEK1(MAP2K1), GRB2, H-Ras, ERK1/2, TITF1, c-Raf-1, SHH, FRS2, NEFM, FGFR1, SOX3, MSI1, SOX2, FGF10, AFP, HNF6, Albumin",4.710E-03,2.882E-02,15,"GRB2, WNT3A, H-Ras, ERK1/2, TITF1, FRS2, FGFR1, FGF10, Albumin, SHH, SOX3, MSI1, SOX2, SHP-2, HNF6",
57,Deregulation of canonical WNT signaling in major depressive disorder,31,2.392E-05,1.105E-03,4.189E-02,1.199E-01,10,"AKT1, FRAT1, DVL-1, Dsh, Synapsin I, WNT, PER2, Cyclin D1, Tau (MAPT), Axin",2.392E-05,1.105E-03,18,"AKT1, WNT3A, FRAT1, Lef-1, DVL-1, Dsh, Synapsin I, LRP5, Tau (MAPT), c-Myc, Axin, Tcf(Lef), FZD3, Casein kinase I gamma 1, WNT, PER2, Cyclin D1, Frizzled",
58,Signal transduction_CXCR4 signaling via MAPKs cascades,53,2.439E-05,1.105E-03,1.985E-04,3.623E-03,21,"MEK1(MAP2K1), PDGF-B, c-Fos, K-RAS, G-protein alpha-i family, ERK1/2, c-Raf-1, NFKBIA, G-protein alpha-13, Ubiquitin, AP-1, PAK, CD3, CalDAG-GEFII, ACKR3, Cortactin, MEK1/2, JNK(MAPK8-10), p38 MAPK, SDF-1, PREX1",2.439E-05,1.105E-03,26,"PDGF-B, c-Fos, IRS-1, ERK1/2, EGR1, IKK (cat), Rac1, G-protein alpha-13, BAD, Ubiquitin, ZAP70, CalDAG-GEFII, Cortactin, SDF-1, K-RAS, G-protein alpha-i family, c-Jun, NFKBIA, AP-1, PAK, MEKK1(MAP3K1), ACKR3, JNK(MAPK8-10), TCR alpha/beta, p38 MAPK, PREX1",
59,Role of activation of WNT signaling in the progression of lung cancer,77,2.563E-05,1.127E-03,5.481E-02,1.425E-01,20,"WNT4, E-cadherin, ROR2, hASH1, Livin, WNT9A, DVL-1, beta-TrCP, BMI-1, p21, Dsh, WIF1, ING4, Sirtuin1, LKB1, WNT, Cyclin D1, HOXB9, p38 MAPK, Axin",2.563E-05,1.127E-03,34,"DVL-3, WNT3A, NKD1, Lef-1, DVL-1, p21, Dsh, WIF1, Rac1, ING4, c-Myc, Axin, WNT4, E-cadherin, ROR2, hASH1, Livin, WNT9A, Tcf(Lef), beta-TrCP, BMI-1, FZD3, MKK7 (MAP2K7), WNT1, SFRP4, Sirtuin1, LKB1, MEKK1(MAP3K1), WNT, WNT10B, Cyclin D1, HOXB9, p38 MAPK, Frizzled",
60,ERBB family and HGF signaling in gastric cancer,54,2.565E-05,1.036E-03,2.565E-05,1.036E-03,23,"EGF, GRB2, c-Fos, Neuregulin 1, HDC, H-Ras, GRB7, ERK1/2, ErbB3, c-Raf-1, STAT3, Amphiregulin, ErbB2, PI3K reg class IA, MEK6(MAP2K6), MEK1/2, Cyclin D1, AKT(PKB), SP1, PDK (PDPK1), p27KIP1, p38 MAPK, ERK1 (MAPK3)",9.353E-04,1.092E-02,23,"EGF, GRB2, c-Fos, H-Ras, GRB7, ERK1/2, ErbB3, EGR1, BAD, Amphiregulin, ErbB2, PI3K reg class IA, MEK6(MAP2K6), AKT(PKB), PDK (PDPK1), p27KIP1, c-Myc, ERK1 (MAPK3), c-Jun, MEKK1(MAP3K1), Cyclin D1, SP1, p38 MAPK",
61,Translation_Insulin regulation of translation,42,2.795E-05,1.129E-03,4.696E-05,1.493E-03,19,"MEK1(MAP2K1), Tuberin, eEF2, GRB2, eIF2B5, Insulin processed, PP1-cat, H-Ras, ERK1/2, eIF4B, c-Raf-1, p90RSK1, p70 S6 kinase1, PI3K reg class IA, Insulin receptor, eIF4A, AKT(PKB), PDK (PDPK1), p70 S6 kinase2",2.795E-05,1.129E-03,22,"Tuberin, GRB2, eIF2B5, Insulin processed, IRS-1, PP1-cat, H-Ras, eIF4E, ERK1/2, PKC-zeta, PI3K reg class IA, Insulin receptor, AKT(PKB), PDK (PDPK1), eEF2, eEF2K, eIF4B, Hamartin, 4E-BP1, p70 S6 kinase1, eIF4A, p70 S6 kinase2",
62,Signal transduction_Erk Interactions: Inhibition of Erk,34,2.990E-05,1.146E-03,4.107E-04,6.075E-03,15,"MEK1(MAP2K1), MKP-7, Calcineurin A (catalytic), HePTP, ERK1/2, MKP-2, PKA-reg (cAMP-dependent), VRK3, Calmodulin, PKC, CD3, PEA15, MKP-1, JNK(MAPK8-10), AKT(PKB)",2.990E-05,1.146E-03,19,"Calcineurin A (catalytic), VHR, ERK1/2, PKA-reg (cAMP-dependent), VRK3, MKP-4, NMDA receptor, ZAP70, AKT(PKB), GMF, MKP-7, HePTP, MKP-2, Calmodulin, PKC, MKP-1, JNK(MAPK8-10), STEP, TCR alpha/beta",
63,Oxidative stress_ROS-mediated activation of MAPK via inhibition of phosphatases,34,2.990E-05,1.146E-03,1.038E-04,2.386E-03,16,"MKP-7, PP1-cat, HePTP, ERK1/2, PP2A regulatory, c-Raf-1, PR65-alpha, PP2A structural, Insulin receptor, MEK6(MAP2K6), MKP-1, MEK1/2, JNK(MAPK8-10), SHP-1, PP5, p38 MAPK",2.990E-05,1.146E-03,19,"PP1-cat, VHR, ERK1/2, PP2A regulatory, PR65-alpha, SOD1, PP2A structural, Insulin receptor, MEK6(MAP2K6), SHP-1, PP5, MKP-7, HePTP, PTP-1B, MKK7 (MAP2K7), SHP-2, MKP-1, JNK(MAPK8-10), p38 MAPK",
64,Nociception_Nociceptin receptor signaling,76,3.023E-05,1.128E-03,3.023E-05,1.128E-03,29,"cPKC (conventional), c-Fos, G-protein alpha-i family, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, Ca(II)channel L-type, Kir3.1, AP-2, p90Rsk, IP3 receptor, STAT3, TY3H, Adenylate cyclase type II, PKC, PLC-beta, cPLA2, Adenylate cyclase, MEK1/2, G-protein alpha-z, JNK(MAPK8-10), LIMK2, Ca(II)channel T-type, Beta-arrestin1, G-protein alpha-14, p38 MAPK, ERK1 (MAPK3), GRK2",5.071E-05,1.613E-03,33,"c-Fos, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), Kir3.1, AP-2, Actin, Rac1, IP3 receptor, TY3H, Adenylate cyclase type II, PLC-beta, cPLA2, Adenylate cyclase, LIMK2, Ca(II)channel T-type, G-protein alpha-14, ERK1 (MAPK3), GRK2, cPKC (conventional), G-protein alpha-i family, c-Jun, Ca(II)channel N-type, Ca(II)channel L-type, PKC, Nociceptin, Prepronociceptin, G-protein alpha-z, JNK(MAPK8-10), N-type Ca(II) channel alpha1B, Beta-arrestin1, p38 MAPK, Cofilin",
65,Development_Negative regulation of WNT/Beta-catenin signaling at the receptor level,45,3.092E-05,1.156E-03,2.444E-02,8.204E-02,14,"Tsukushi, ANGPTL4, IBP4, DAB2, WIF1, Krm, WNT, Syndecans, GSK3 alpha/beta, Clathrin, Axin, GRB10, SNX27, Klotho",3.092E-05,1.156E-03,23,"DKK4, Sclerostin, FZD4, DAB2, WIF1, Krm, Syndecans, GSK3 alpha/beta, SFRP, DKK2, Axin, Tsukushi, ANGPTL4, Tcf(Lef), IBP4, RNF43, FRMD8, WNT, Clathrin, GRB10, SNX27, Frizzled, Klotho",
66,Main growth factor signaling cascades in multiple myeloma cells,41,3.094E-05,1.128E-03,3.094E-05,1.128E-03,19,"MEK1(MAP2K1), FGFR3, GRB2, K-RAS, H-Ras, VEGFR-1, c-Raf-1, STAT3, I-kB, PI3K reg class IA (p85), PI3K reg class IA (p85-beta), PI3K reg class IA, PTEN, GSK3 alpha/beta, IGF-1 receptor, AKT(PKB), IGF-1, PDK (PDPK1), ERK1 (MAPK3)",2.305E-04,4.102E-03,20,"GRB2, IRS-1, H-Ras, IKK (cat), BAD, I-kB, PI3K reg class IA (p85), PI3K reg class IA (p85-beta), PI3K reg class IA, IKK-alpha, GSK3 alpha/beta, IGF-1 receptor, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), FGFR3, K-RAS, VEGFR-1, PTEN, IGF-1",
67,Breast cancer (general schema),41,3.094E-05,1.128E-03,3.094E-05,1.128E-03,19,"EGF, ESR1 (nuclear), Neuregulin 1, ErbB3, PTHR1, ESR1 (membrane), TGF-beta, SHH, ESR2 (nuclear), PR (membrane), GHR, Prolactin receptor, PR (nuclear), Androgen receptor, DLL1, ErbB2, LKB1, Leptin, IL-6 receptor",7.410E-04,8.934E-03,19,"EGF, ESR1 (nuclear), ErbB3, PTHR1, ESR1 (membrane), ESR2 (nuclear), PR (membrane), Prolactin receptor, PR (nuclear), Androgen receptor, DLL1, ErbB2, TGF-beta, SHH, DLL4, GHR, LKB1, Leptin, IL-6 receptor",
68,Stem cells_Inhibition of Hedgehog signaling in medulloblastoma stem cells,41,3.094E-05,1.128E-03,3.094E-05,1.128E-03,19,"MEK1(MAP2K1), FGFR3, GRB2, FGFR4, H-Ras, BMI-1, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, SHH, Adenylate cyclase type I, FRS2, PAK1, FGFR1, FGF4, G-protein alpha-s, Cyclin D1, JNK(MAPK8-10), N-Myc",2.305E-04,4.102E-03,20,"GRB2, FGFR4, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), FRS2, FGFR1, Rac1, FGF4, FGFR3, BMI-1, SHH, Adenylate cyclase type I, PAK1, G-protein alpha-s, MEKK1(MAP3K1), SHP-2, Cyclin D1, JNK(MAPK8-10), N-Myc",
69,Signal transduction_Cyclic AMP signaling,38,3.458E-05,1.224E-03,3.458E-05,1.224E-03,18,"Phospholamban, Calcineurin A (catalytic), cAMP-GEFI, G-protein alpha-i family, PHK gamma, Adenylate cyclase type VI, PKA-reg (cAMP-dependent), Adenylate cyclase type I, LIPS, Adenylate cyclase type IX, Adenylate cyclase type V, Adenylate cyclase type II, G-protein alpha-s, Calmodulin, PKC, PHK alpha, GSK3 alpha/beta, Adenylate cyclase type IV",5.900E-05,1.729E-03,20,"Calcineurin A (catalytic), cAMP-GEFI, KDELR, Adenylate cyclase type VI, PKC-zeta, PKA-reg (cAMP-dependent), Adenylate cyclase type V, Adenylate cyclase type II, PHK alpha, GSK3 alpha/beta, PKC-delta, G-protein alpha-i family, PHK gamma, Adenylate cyclase type I, LIPS, Adenylate cyclase type IX, G-protein alpha-s, Calmodulin, PKC, Adenylate cyclase type IV",
70,Development_Adiponectin signaling,48,3.522E-05,1.224E-03,3.522E-05,1.224E-03,21,"MEK1(MAP2K1), p38alpha (MAPK14), AdipoR2, gp130, PDGF-B, GRB2, Adiponectin, H-Ras, ERK1/2, AMPK alpha subunit, APPL2, IP3 receptor, STAT3, Calmodulin, LKB1, PLC-beta, CaMKK, eNOS, AKT(PKB), HSP90, AdipoR1",6.668E-03,3.679E-02,19,"gp130, PDGF-B, GRB2, H-Ras, ERK1/2, A-Raf-1, IP3 receptor, PLC-beta, AKT(PKB), HSP90, AdipoR2, Adiponectin, AMPK alpha subunit, APPL2, Calmodulin, LKB1, CaMKK, eNOS, AdipoR1",
71,Neurophysiological process_Dynein-dynactin motor complex in axonal transport in neurons,54,3.690E-05,1.313E-03,5.317E-03,2.848E-02,18,"Huntingtin, ERK1/2, NEFM, JSAP1, Ubiquitin, Centractins, DYNLL, Tctex-1, Alpha-centractin, Kinesin heavy chain, MAPRE3(EB3), DYNLT, JNK3(MAPK10), AKT(PKB), Snapin, Carboxypeptidase H, SPTBN2, Tubulin (in microtubules)",3.690E-05,1.313E-03,26,"TrkA, Huntingtin, ERK1/2, Importin (karyopherin)-alpha, Ubiquitin, Hap-1, TMEM108, Centractins, DYNLL, Rab-7, Tctex-1, Alpha-centractin, MAPRE3(EB3), DYNLT, JNK3(MAPK10), AKT(PKB), Snapin, NT-3, Tubulin (in microtubules), TrkC, JSAP1, Kinesin heavy chain, Bassoon, Kinesin light chain, Carboxypeptidase H, SPTBN2",
72,Translation_Regulation of EIF4F activity,54,3.690E-05,1.313E-03,2.120E-03,1.650E-02,19,"MEK1(MAP2K1), Tuberin, EGF, GRB2, H-Ras, ERK1/2, eIF4B, c-Raf-1, PAK1, p70 S6 kinase1, PI3K reg class IA, IGBP1, eIF4A, MEK6(MAP2K6), MSK1, AKT(PKB), PDK (PDPK1), p70 S6 kinase2, p38 MAPK",3.690E-05,1.313E-03,26,"Tuberin, EGF, GRB2, IRS-1, H-Ras, eIF4E, ERK1/2, PKC-zeta, Rac1, PI3K reg class IA, IGBP1, eIF4G2, MEK6(MAP2K6), MSK1, AKT(PKB), PDK (PDPK1), eIF4B, PAK1, Hamartin, 4E-BP1, p70 S6 kinase1, MEKK1(MAP3K1), eIF4A, TAB1, p70 S6 kinase2, p38 MAPK",
73,Th2-cytokines-induced mucous metaplasia in asthma,40,4.059E-05,1.411E-03,8.072E-05,2.044E-03,18,"SP-A, GRB2, H-Ras, ERK1/2, TITF1, c-Raf-1, PGE2R3, HAG-2, FOXJ1, VIL2 (ezrin), CLCA1, PI3K reg class IA, Mucin 5AC, MEK1/2, HNF3-gamma, STAT6, IL-4, PDEF",4.059E-05,1.411E-03,21,"GRB2, IRS-1, H-Ras, ERK1/2, TITF1, HAG-2, VIL2 (ezrin), CLCA1, PI3K reg class IA, IL-13, IL-9, IL-4, SP-A, Uteroglobin, PGE2R3, FOXJ1, SHP-2, Mucin 5AC, HNF3-gamma, STAT6, PDEF",
74,Development_Transcription regulation of granulocyte development,32,4.085E-05,1.387E-03,4.085E-05,1.387E-03,16,"PU.1, E2F1, Lactoferrin, p67-phox, GATA-1, RAR-alpha/RXR-alpha, PERM, STAT3, PKC, c-Myb, G-CSF receptor, Myeloblastin, Max, Lysozyme, G-CSF, C/EBPalpha",2.289E-03,1.823E-02,15,"Lactoferrin, C/EBPepsilon, c-Myb, G-CSF receptor, Lysozyme, c-Myc, PU.1, E2F1, RAR-alpha/RXR-alpha, PERM, PKC, Myeloblastin, Max, G-CSF, C/EBPalpha",
75,"SREBP1 cross-talk with PXR, CAR and LXR",26,4.301E-05,1.428E-03,4.301E-05,1.428E-03,14,"LXR-alpha/RXR-alpha, SREBP1 (nuclear), CAR/RXR-alpha, LXR-beta, MED1, SREBP1 (Golgi membrane), PXR, LXR-beta/RXR-alpha, SREBP1 precursor, SCAP, CAR, LXR-alpha, PXR/RXR-alpha, CYP3A4",2.167E-03,1.823E-02,13,"SREBP1 (nuclear), MED1, SREBP1 precursor, INSIG2, CAR, PXR/RXR-alpha, CAR/RXR-alpha, LXR-beta, SREBP1 (Golgi membrane), PXR, CYP2B6, LXR-beta/RXR-alpha, SCAP",
76,Apoptosis and survival_IL-17-induced CIKS-dependent MAPK signaling pathways,32,4.305E-05,1.463E-03,1.802E-04,3.459E-03,15,"TRAF2, ERK1/2, CIKS, E2N(UBC13), ABIN-2, TRAF5, Ubiquitin, AP-1, IL-17RC, IKK-beta, MEK6(MAP2K6), MEK1/2, JNK(MAPK8-10), TAB2, p38 MAPK",4.305E-05,1.463E-03,18,"ERK1/2, CIKS, E2N(UBC13), Ubiquitin, IL-17RC, IKK-alpha, MEK6(MAP2K6), TAB2, UEV1A, TRAF2, ABIN-2, TRAF5, AP-1, UBE1, IKK-beta, TAB1, JNK(MAPK8-10), p38 MAPK",
77,Immune response_IL-4-responsive genes in type 2 immunity,70,4.506E-05,1.463E-03,4.506E-05,1.463E-03,27,"GATA-3, CCL22, CCL17, CCL1, TFF3, AID, Claudin-5, KLF4, CD36, STAT3, ARG1, IL-19, FOXP3, Mucin 5AC, IGHE, IL-24, IGHG3, IL13RA2, CD40(TNFRSF5), IGHG4, STAT6, IL-4, AKT(PKB), SP1, CD23, ALOX15, CD40L(TNFSF5)",2.125E-03,1.823E-02,27,"IL-31, CCL22, CCL17, Claudin-5, KLF4, ARG1, IL-19, CCL13, FOXP3, IL-13, IL-9, IL-4, AKT(PKB), CD23, GATA-3, CCL1, TFF3, AID, CD36, Mucin 5AC, IGHE, IL-24, CD40(TNFRSF5), IGHG4, STAT6, SP1, ALOX15",
78,Development_Negative regulation of WNT/Beta-catenin signaling in the cytoplasm,82,4.699E-05,1.561E-03,1.494E-04,3.017E-03,29,"KLHL12, E-cadherin, CXXC4, E2F1, PP1-cat, HUWE1, beta-TrCP, Presenilin 1, Alpha-1 catenin, CXXC5, DAB2, Dsh, RNF185, Casein kinase I alpha, YAP1/TAZ, YAP1 (YAp65), G-protein alpha-13, WWP1, PEG3, LATS1, Malin, Porf-2, WNT, GSK3 alpha/beta, Ankyrin-G, WDR26, Skp2/TrCP/FBXW, Cyclin D1, Axin",4.699E-05,1.561E-03,35,"Casein kinase I delta, CXXC4, NKD1, PP1-cat, Presenilin 1, Alpha-1 catenin, CXXC5, DAB2, Dsh, Casein kinase I alpha, Rac1, G-protein alpha-13, WWP1, LATS1, GSK3 alpha/beta, Ankyrin-G, WDR26, Skp2/TrCP/FBXW, Axin, KLHL12, E-cadherin, HECTD1, Tcf(Lef), E2F1, HUWE1, beta-TrCP, SENP2, RNF185, PEG3, Malin, Porf-2, WNT, Beclin 1, Cyclin D1, Frizzled",
79,Regulation of GSK3 beta in bipolar disorder,46,4.858E-05,1.579E-03,2.086E-04,3.623E-03,19,"AKT1, GRB2, GAB1, FRAT1, PP1-cat, H-Ras, DVL-1, ERK1/2, PP2A regulatory, c-Raf-1, p90RSK1, Dsh, FGFR1, Neutral sphingomyelinase, WNT, IL-1RI, MEK1/2, AKT(PKB), Axin",4.858E-05,1.579E-03,23,"TrkA, AKT1, GRB2, GAB1, FRAT1, IRS-1, PP1-cat, H-Ras, DVL-1, ERK1/2, PP2A regulatory, Dsh, FGFR1, Neutral sphingomyelinase, IL-1RI, LRP5, AKT(PKB), Axin, NT-3, IPP-2, TrkC, WNT, Frizzled",
80,Transport_Regulation of ATP-binding transporters by Retinoic acid and orphan nuclear receptor PXR,39,5.339E-05,1.662E-03,5.339E-05,1.662E-03,18,"LXR-alpha/RXR-alpha, ABCG1, ABCC6, RARgamma, RXRA, RAR-alpha/RXR-alpha, PXR, RAR-gamma/RXR-alpha, OATP-C, RARalpha, LXR-alpha, MRP3, SP1, PXR/RXR-alpha, CYP3A4, ABCG2, SLC10A1, ABCC2",2.004E-02,7.219E-02,15,"ABCG1, ABCC6, RARgamma, RAR-gamma/RXR-alpha, RARalpha, PXR/RXR-alpha, SLC10A1, RXRA, RAR-alpha/RXR-alpha, PXR, OATP-C, MRP3, SP1, ABCG2, ABCC2",
81,Immune response_Antigen presentation by MHC class II,118,5.372E-05,1.638E-03,4.797E-02,1.317E-01,29,"MHC class II alpha chain, MHC class II, AKT1, ARL14EP, FCGRT, LLIR, Fc epsilon RI gamma, HCLS1, ERK1/2, HSP90 alpha, PSD4, RhoB, PIP5K1A, PKC, Alpha-centractin, CD79A, Kinesin heavy chain, OLR1, Bcl-2, Fc gamma RII beta, JNK(MAPK8-10), Clathrin, HSP90, CD23, MHC class II beta chain, PDK (PDPK1), p38 MAPK, SPTBN2, Tubulin (in microtubules)",5.372E-05,1.638E-03,46,"MHC class II alpha chain, MHC class II, AKT1, Fc epsilon RI gamma, HCLS1, ERK1/2, Fc alpha receptor, HSP90 alpha, FCGR3A, PSD4, Rac1, Cathepsin F, PIP5K1A, Rab-7, Alpha-centractin, CD79A, MyD88, CD209, SWAP-70, HSP90, CD23, MHC class II beta chain, PDK (PDPK1), Tubulin (in microtubules), ARL14EP, FCGRT, HSC70, LLIR, PKC-delta, CD79 complex, RhoB, 14-3-3 beta/alpha, PKC, Kinesin heavy chain, OLR1, CD79B, Bcl-2, Beclin 1, Fc gamma RII beta, JNK(MAPK8-10), Clathrin, TRIF (TICAM1), Kinesin light chain, TCR alpha/beta, p38 MAPK, SPTBN2",
82,Development_Thrombopoietin signaling via ERK1/2 and PI3K,67,5.480E-05,1.638E-03,4.352E-04,6.251E-03,24,"PU.1, PDK1, GRB2, c-Fos, GAB1, PP1-cat, H-Ras, ERK1/2, Glycoprotein VI, c-Raf-1, GATA-1, p21, Thrombopoietin, USF1, PI3K reg class IA (p85), p70 S6 kinase1, Bcl-XL, MEK1/2, AKT(PKB), SP1, PDK (PDPK1), TAL1, p27KIP1, p38 MAPK",5.480E-05,1.638E-03,30,"Cyclin D3, GRB2, c-Fos, GAB1, PP1-cat, H-Ras, ERK1/2, Glycoprotein VI, PKC-zeta, EGR1, p21, Thrombopoietin, USF1, HOXB4, PI3K reg class IA (p85), Bcl-XL, AKT(PKB), PDK (PDPK1), p27KIP1, c-Myc, PU.1, PDHA (somatic), C3G, GP-IX, 4E-BP1, p70 S6 kinase1, SHP-2, FOXO3A, SP1, p38 MAPK",
83,Cytoskeleton remodeling_Keratin filaments,36,5.988E-05,1.759E-03,5.988E-05,1.759E-03,17,"Tubulin beta, Keratin 4, Trichoplein, GRB2, Envoplakin, Keratin 19, Keratin 2, PPL(periplakin), Keratin 13, Tubulin alpha, Keratin 18, Keratin 8/18, Keratin 8, JNK(MAPK8-10), Keratin 1, Keratin 4/13, Tubulin (in microtubules)",3.247E-03,2.301E-02,16,"Keratin 4, GRB2, Keratin 2, PPL(periplakin), Keratin 18, Keratin 1, Tubulin (in microtubules), Tubulin beta, Keratin 7, Trichoplein, Envoplakin, Keratin 19, Tubulin alpha, Keratin 8/18, Keratin 8, JNK(MAPK8-10)",
84,EGFR signaling in Prostate Cancer,46,6.004E-05,1.759E-03,6.004E-05,1.759E-03,20,"MEK1(MAP2K1), Tuberin, EGF, gp130, GRB2, K-RAS, Neuregulin 1, H-Ras, ERK1/2, ErbB3, c-Raf-1, NFKBIA, STAT3, Androgen receptor, PI3K reg class IA (p85), ErbB2, AKT(PKB), PDK (PDPK1), p27KIP1, ERK1 (MAPK3)",9.357E-03,4.500E-02,18,"Tuberin, EGF, gp130, GRB2, H-Ras, ERK1/2, ErbB3, Androgen receptor, PI3K reg class IA (p85), ErbB2, IKK-alpha, AKT(PKB), PDK (PDPK1), p27KIP1, c-Myc, ERK1 (MAPK3), K-RAS, NFKBIA",
85,Transcription_Androgen Receptor nuclear signaling,46,6.004E-05,1.759E-03,6.004E-05,1.759E-03,20,"MEK1(MAP2K1), EGF, AKT1, GRB2, H-Ras, c-Raf-1, p21, Dsh, RAD9, Kallikrein 3 (PSA), VIL2 (ezrin), STAT3, Androgen receptor, WNT, SCAP, IGF-1 receptor, Cyclin D1, AKT(PKB), IGF-1, IL-6 receptor",9.357E-03,4.500E-02,18,"EGF, AKT1, GRB2, H-Ras, p21, Dsh, Kallikrein 3 (PSA), VIL2 (ezrin), Androgen receptor, IGF-1 receptor, AKT(PKB), RAD9, WNT, SCAP, Cyclin D1, IGF-1, IL-6 receptor, Frizzled",
86,Development_Role of growth factors in the maintenance of embryonic stem cell pluripotency,53,6.157E-05,1.769E-03,6.157E-05,1.769E-03,22,"ALK-4, MEK1(MAP2K1), GRB2, c-Fos, GAB1, Neuregulin 1, H-Ras, ERK1/2, ErbB3, Myosin II, c-Raf-1, FRS2, NANOG, FGFR1, PI3K reg class IA (p85), ErbB2, PI3K reg class IA, SOX2, IGF-1 receptor, AKT(PKB), IGF-1, PDK (PDPK1)",4.399E-03,2.763E-02,21,"ALK-4, GRB2, c-Fos, GAB1, IRS-1, H-Ras, ERK1/2, ErbB3, FRS2, FGFR1, PI3K reg class IA (p85), ErbB2, PI3K reg class IA, IGF-1 receptor, AKT(PKB), PDK (PDPK1), Myosin II, NANOG, SOX2, SHP-2, IGF-1",
87,Regulation of metabolism_Role of Adiponectin in regulation of metabolism,43,6.992E-05,1.879E-03,6.992E-05,1.879E-03,19,"p38alpha (MAPK14), AdipoR2, Tuberin, ACACA, Adiponectin, Insulin processed, G6PT, AMPK alpha subunit, Cytochrome c, CPT-1B, SREBP1 precursor, CPT-1A, Sirtuin1, p70 S6 kinase1, LKB1, Insulin receptor, TORC2, ACOX1, AdipoR1",1.582E-04,3.332E-03,21,"Tuberin, Insulin processed, IRS-1, GLUT4, Cytochrome c, SREBP1 precursor, CPT-1A, Insulin receptor, TORC2, ACOX1, AdipoR2, Adiponectin, AMPK alpha subunit, TFAM, Hamartin, CPT-1B, Sirtuin1, p70 S6 kinase1, LKB1, AKT2, AdipoR1",
88,Retinoic acid maintains mucocilliary differentiation and mucins expression in normal and asthmatic airway epithelium,30,7.116E-05,1.879E-03,7.116E-05,1.879E-03,15,"MEK1(MAP2K1), Thyroid hormone receptor, RARgamma, ERK1/2, c-Raf-1, p90RSK1, Mucin 6, MUC1, Mucin 2, Mucin 5AC, RARalpha, SPRR1A, Mucin 5B, SP1, TGM1",2.603E-02,8.416E-02,12,"Thyroid hormone receptor, RARgamma, ERK1/2, MUC1, RARalpha, IL-13, Mucin 5B, Mucin 6, Mucin 2, Mucin 5AC, SP1, TGM1",
89,Development_Cytokine-mediated regulation of megakaryopoiesis,57,7.168E-05,1.879E-03,7.168E-05,1.879E-03,23,"PU.1, gp130, GRB2, GAB1, PP1-cat, ERK1/2, FLT3, GATA-1, p21, Thrombopoietin, STAT3, PI3K reg class IA (p85), GP-IB alpha, p70 S6 kinase1, PI3K reg class IA, MafB, IL-1RI, Bcl-XL, AKT(PKB), SP1, sIL6-RA, p27KIP1, SDF-1",1.161E-04,2.800E-03,26,"gp130, Cyclin D3, GRB2, GAB1, PP1-cat, ERK1/2, FLT3, p21, Thrombopoietin, PI3K reg class IA (p85), PI3K reg class IA, MafB, IL-1RI, Bcl-XL, AKT(PKB), p27KIP1, c-Myc, SDF-1, PU.1, 4E-BP1, GP-IB alpha, p70 S6 kinase1, SHP-2, FOXO3A, SP1, sIL6-RA",
90,"Immune response_IL-3 signaling via JAK/STAT, p38, JNK and NF-kB",93,7.197E-05,2.069E-03,3.304E-03,2.154E-02,28,"PU.1, MHC class II, c-Fos, CSF2RB, XBP1, Granzyme B, H-Ras, RXRA, RAR-alpha/RXR-alpha, STAT3, I-kB, CISH, DPF3, IKK-beta, Bcl-2, MKP-1, RARalpha, Bcl-XL, TCR gamma locus, Cyclin D1, CD40(TNFRSF5), STAT6, IL-4, IRE1, AKT(PKB), PUMA, p38 MAPK, E-selectin",7.197E-05,2.069E-03,38,"MHC class II, Cyclin D3, c-Fos, XBP1, Granzyme B, H-Ras, IKK (cat), IL-3, Rac1, BAD, I-kB, CISH, IKK-alpha, RARalpha, Bcl-XL, TCR gamma locus, IL-4, IRE1, AKT(PKB), c-Myc, PUMA, IL-2R alpha chain, C3aR, E-selectin, PU.1, ARNT, CSF2RB, RXRA, RAR-alpha/RXR-alpha, MKK7 (MAP2K7), DPF3, IKK-beta, Bcl-2, MKP-1, Cyclin D1, CD40(TNFRSF5), STAT6, p38 MAPK",
91,G-protein signaling_G-Protein alpha-i signaling cascades,27,7.447E-05,1.918E-03,7.447E-05,1.918E-03,14,"MEK1(MAP2K1), GRB2, RGS7, RGS18, G-protein alpha-i family, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, Adenylate cyclase type I, RGS10, STAT3, Rap1GAP1, RGS11",6.748E-02,1.646E-01,10,"GRB2, RGS18, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), RGS10, G-protein alpha-i family, Adenylate cyclase type I, Rap1GAP1, RGS11",
92,CHDI_DEGs from Replication data_Causal network,81,8.994E-05,2.490E-03,1.690E-03,1.437E-02,26,"MEK1(MAP2K1), IPP-1, Calcineurin A (catalytic), Huntingtin, GRB2, TRAF2, PP1-cat, H-Ras, ERK1/2, c-Raf-1, NEFM, Dsh, ILK, IP3 receptor, I-kB, Calmodulin, PKC, PTEN, cPLA2, WNT, FAK1, MAGI-3, JNK3(MAPK10), AKT(PKB), SP1, Axin",8.994E-05,2.490E-03,34,"Calcineurin A (catalytic), Huntingtin, GRB2, PP1-cat, H-Ras, ERK1/2, EGR1, Dsh, PLC-beta1, IP3 receptor, I-kB, IKK-alpha, cPLA2, MAGI-3, LRP5, CtBP, JNK3(MAPK10), AKT(PKB), GABA-A receptor beta-2 subunit, Axin, IPP-1, PKC-delta, TRAF2, c-Jun, ILK, Calmodulin, PKC, PTEN, MEKK1(MAP3K1), WNT, FAK1, G-protein alpha-q, SP1, Frizzled",
93,Cell cycle progression in Prostate Cancer,39,9.528E-05,2.494E-03,2.048E-04,3.623E-03,17,"Tuberin, c-Fos, E2F1, ERK1/2, p21, Prolactin receptor, STAT3, Androgen receptor, p70 S6 kinase1, Rb protein, WNT, Cyclin D1, AKT(PKB), SP1, p27KIP1, p38 MAPK, IL-6 receptor",9.528E-05,2.494E-03,20,"Tuberin, c-Fos, ERK1/2, p21, Prolactin receptor, Androgen receptor, Rb protein, AKT(PKB), p27KIP1, Tcf(Lef), E2F1, c-Jun, 4E-BP1, p70 S6 kinase1, WNT, Cyclin D1, SP1, p38 MAPK, IL-6 receptor, Frizzled",
94,Development_EGFR signaling via PIP3,23,9.677E-05,2.494E-03,1.073E-03,1.041E-02,11,"EGF, GRB2, GAB1, MLK2(MAP3K10), ErbB2, PI3K reg class IA, PTEN, VAV-2, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1)",9.677E-05,2.494E-03,14,"EGF, GRB2, GAB1, IRS-1, Rac1, ErbB2, PI3K reg class IA, VAV-2, AKT(PKB), PDK (PDPK1), MLK2(MAP3K10), MKK7 (MAP2K7), PTEN, JNK(MAPK8-10)",
95,Stem cells_Aberrant Wnt signaling in medulloblastoma stem cells,23,9.677E-05,2.494E-03,4.314E-03,2.488E-02,10,"FRAT1, Axin1, DAB2, Dsh, WIF1, Casein kinase I alpha, WNT, Cyclin D1, AKT(PKB), Axin",9.677E-05,2.494E-03,14,"FRAT1, Lef-1, Axin1, DAB2, Dsh, WIF1, Casein kinase I alpha, LRP5, AKT(PKB), c-Myc, Axin, WNT, Cyclin D1, Frizzled",
96,Cytoskeleton remodeling_CDC42 in cellular processes,23,9.677E-05,2.494E-03,1.479E-02,5.785E-02,9,"PAK2, PAK3, SPEC1, c-Raf-1, PAK1, PAK4, WASP, LIMK2, PARD6",9.677E-05,2.494E-03,14,"PAK2, PAK3, PKC-zeta, SPEC1, CEP2, WASP, LIMK2, PARD6, Destrin, PAK1, PAK4, MRCKalpha, N-WASP, Cofilin",
97,Mucin expression in CF airways,69,9.814E-05,2.365E-03,9.814E-05,2.365E-03,26,"p38alpha (MAPK14), GRB2, Neuregulin 1, H-Ras, ERK1/2, ErbB3, CFTR, c-Raf-1, p90RSK1, G-protein alpha-q/11, p90Rsk, NFKBIA, IP3 receptor, I-kB, ErbB2, PLC-beta, Mucin 2, Mucin 5AC, MEK6(MAP2K6), IL-1RI, Mucin 5B, MEK1/2, JNK(MAPK8-10), AKT(PKB), SP1, p38 MAPK",1.558E-02,6.151E-02,24,"GRB2, H-Ras, ERK1/2, ErbB3, c-Jun/c-Fos, G-protein alpha-q/11, IP3 receptor, I-kB, ErbB2, PLC-beta, MEK6(MAP2K6), IL-1RI, Mucin 5B, AKT(PKB), PKC-delta, c-Jun, MKK7 (MAP2K7), NFKBIA, MEKK1(MAP3K1), Mucin 2, Mucin 5AC, JNK(MAPK8-10), SP1, p38 MAPK",
98,Signal transduction_PKA signaling,51,1.035E-04,2.386E-03,1.035E-04,2.386E-03,21,"G-protein alpha-12 family, PDE3B, G-protein alpha-i family, PHK gamma, PP2A regulatory, PKA-reg type II (cAMP-dependent), PKA-reg (cAMP-dependent), p90RSK1, Meprin A, beta, Troponin I, cardiac, NFKBIA, G-protein alpha-13, GABA-A receptor beta-3 subunit, Androgen receptor, G-protein alpha-s, PDE4D, Adenylate cyclase, GSK3 alpha/beta, PHK beta, PDK (PDPK1), PKI",3.482E-04,5.367E-03,23,"PDE3B, KDELR, PP2A regulatory, PKA-reg (cAMP-dependent), G-protein alpha-13, BAD, Androgen receptor, PDE4D, Adenylate cyclase, GSK3 alpha/beta, PDK (PDPK1), GABA-A receptor beta-2 subunit, PKI, G-protein alpha-12 family, G-protein alpha-i family, GABA-A receptor beta-1 subunit, PHK gamma, PKA-reg type II (cAMP-dependent), Troponin I, cardiac, NFKBIA, GABA-A receptor beta-3 subunit, G-protein alpha-s, PHK beta",
99,Anti-apoptotic action of ErbB2 in breast cancer,51,1.035E-04,2.386E-03,1.035E-04,2.386E-03,21,"Tuberin, EGF, AKT1, Neuregulin 1, H-Ras, ERK1/2, ErbB3, c-Raf-1, PAK1, p21, STAT3, I-kB, PI3K reg class IA (p85), ErbB2, Bcl-2, VAV-2, MEK1/2, Max, AKT(PKB), PDK (PDPK1), p27KIP1",2.546E-03,1.952E-02,21,"Tuberin, EGF, AKT1, H-Ras, ERK1/2, ErbB3, p21, Rac1, BAD, I-kB, PI3K reg class IA (p85), ErbB2, VAV-2, AKT(PKB), PDK (PDPK1), p27KIP1, c-Myc, c-Jun, PAK1, Bcl-2, Max",
100,Development_Positive regulation of WNT/Beta-catenin signaling in the nucleus,69,1.066E-04,2.702E-03,1.752E-03,1.462E-02,23,"SOX11, TBL1X, EGF, TWA1, PIAS4, beta-TrCP, Alpha-1 catenin, FOXP1, USP5, SHH, VCP, TLE, ZIP-kinase, Dsh, TDG, Casein kinase I alpha, YAP1 (YAp65), NLK, Sirtuin1, WIP1, WNT, APPL, RUVBL2",1.066E-04,2.702E-03,30,"TBL1X, EGF, Lef-1, Alpha-1 catenin, FOXP1, USP5, VCP, TLE, ZIP-kinase, Dsh, Casein kinase I alpha, UCHL5, WIP1, SOX11, TWA1, Tcf(Lef), PIAS4, beta-TrCP, SHH, FAM53B, DLL4, TDG, NLK, Sirtuin1, CARF, WNT, FOXO3A, APPL, RUVBL2, Frizzled",
101,Development_Gastrin in cell growth and proliferation,62,1.100E-04,2.483E-03,1.100E-04,2.483E-03,24,"MEK1(MAP2K1), p38alpha (MAPK14), E-cadherin, GRB2, c-Fos, H-Ras, ERK1/2, c-Raf-1, PAK1, G-protein alpha-q/11, p90Rsk, IP3 receptor, STAT3, PRKD1, PI3K reg class IA (p85), AP-1, p70 S6 kinase1, MEK6(MAP2K6), FAK1, Cyclin D1, JNK(MAPK8-10), PDK (PDPK1), p70 S6 kinase2, ERK1 (MAPK3)",2.249E-04,4.101E-03,27,"GRB2, c-Fos, IRS-1, H-Ras, ERK1/2, c-Jun/c-Fos, G-protein alpha-q/11, IP3 receptor, PI3K reg class IA (p85), MEK6(MAP2K6), PDK (PDPK1), c-Myc, ERK1 (MAPK3), E-cadherin, PKC-delta, CCKBR, c-Jun, PAK1, PRKD1, AP-1, p70 S6 kinase1, MEKK1(MAP3K1), FAK1, G-protein alpha-q, Cyclin D1, JNK(MAPK8-10), p70 S6 kinase2",
102,Development_FGF and BMP signaling in early embryonic hepatogenesis,31,1.149E-04,2.487E-03,1.149E-04,2.487E-03,15,"MEK1(MAP2K1), GRB2, FGFR4, H-Ras, ERK1/2, GATA-4, c-Raf-1, FRS2, FGFR1, LRH1, Neurogenin 3, AFP, Albumin, HNF3-alpha, Transthyretin",1.537E-03,1.531E-02,15,"GRB2, FGFR4, HNF1-alpha, H-Ras, ERK1/2, GATA-4, FRS2, FGFR1, LRH1, Neurogenin 3, Albumin, SHP-2, SMAD1, HNF3-alpha, Transthyretin",
103,Mechanisms of K-RAS addiction in lung cancer cells,31,1.149E-04,2.487E-03,1.149E-04,2.487E-03,15,"E-cadherin, K-RAS, ERK1/2, TBK1, MSP receptor (RON), RalGDS, PROM2, NFKBIA, p70 S6 kinase1, PTEN, Bcl-2, Bcl-XL, Cyclin D1, ANKRD22, AKT(PKB)",4.328E-04,6.470E-03,16,"ERK1/2, TBK1, PROM2, BAD, Bcl-XL, AKT(PKB), E-cadherin, K-RAS, MSP receptor (RON), RalGDS, NFKBIA, p70 S6 kinase1, PTEN, Bcl-2, Cyclin D1, ANKRD22",
104,Oxidative stress_ROS-induced cellular signaling,108,1.188E-04,2.819E-03,2.409E-04,4.089E-03,35,"p38alpha (MAPK14), Chk2, Tuberin, ACACA, SREBP1 (nuclear), SCD, ERK1/2, AMPK alpha subunit, PKA-reg (cAMP-dependent), Glutaredoxin 1, p21, Cytochrome c, FASN, E2I, NFKBIA, HSPA1A, PRKD1, Sirtuin1, p70 S6 kinase1, EGLN3, PKC, LKB1, PTEN, HSP27, IKK-beta, GRP75, MDM2, Cyclin D1, JNK(MAPK8-10), HIF-prolyl hydroxylase, FIH-1, AKT(PKB), SP1, PUMA, p38 MAPK",1.188E-04,2.819E-03,42,"Tuberin, SREBP1 (nuclear), SCD, ERK1/2, EGR1, c-Jun/c-Fos, PKA-reg (cAMP-dependent), IKK (cat), p21, Bak, Cytochrome c, FASN, E2I, EGLN3, IKK-alpha, IRP2, GRP75, MDM2, FIH-1, AKT(PKB), PUMA, Suv39H1, Thioredoxin, AMPK alpha subunit, NFKBIA, HSPA1A, HSF1, PRKD1, Sirtuin1, p70 S6 kinase1, PKC, LKB1, PTEN, MEKK1(MAP3K1), HSP27, IKK-beta, DLC1 (Dynein LC8a), Cyclin D1, JNK(MAPK8-10), HIF-prolyl hydroxylase, SP1, p38 MAPK",
105,Development_Muscle progenitor cell migration in hypaxial myogenesis,41,1.197E-04,2.518E-03,1.197E-04,2.518E-03,18,"MEK1(MAP2K1), GRB2, GAB1, E2A, FGFR4, G-protein alpha-i family, H-Ras, ERK1/2, c-Raf-1, FRS2, FGFR1, MYOG, DLL1, FGF4, PAX3, MYOD/E47, SDF-1, MYOD",2.175E-03,1.823E-02,18,"GRB2, GAB1, E2A, FGFR4, H-Ras, ERK1/2, FRS2, FGFR1, MYOG, DLL1, FGF4, PAX3, SDF-1, G-protein alpha-i family, MAML1, SHP-2, MYOD/E47, MYOD",
106,Neurogenesis_NGF/ TrkA MAPK-mediated signaling,105,1.282E-04,2.994E-03,2.987E-04,4.649E-03,34,"MATK, Efs/Sin, RIN, GRB2, c-Fos, JunB, K-RAS, SAC, H-Ras, ERK1/2, PP2A regulatory, PKA-reg (cAMP-dependent), c-Raf-1, FRS2, DNAJA3 (TID1), p21, p90Rsk, IP3 receptor, TY3H, AP-1, MAPKAPK2, Calmodulin, NUR77, CalDAG-GEFII, MEK6(MAP2K6), MEK1/2, SUR-8, Cyclin D1, MSK1, SP1, JMJD3, RUSC1 (NESCA), p38 MAPK, FosB",1.282E-04,2.994E-03,41,"TrkA, GRB2, c-Fos, SAC, H-Ras, ERK1/2, PKC-zeta, EGR1, PP2A regulatory, PKA-reg (cAMP-dependent), FRS2, DNAJA3 (TID1), p21, VGF, IP3 receptor, TY3H, MAPKAPK2, CalDAG-GEFII, SNX26 (TCGAP), MEK6(MAP2K6), MSK1, RUSC1 (NESCA), MATK, Efs/Sin, RIN, JunB, K-RAS, PKC-delta, c-Jun, C3G, SH2B, AP-1, Calmodulin, NUR77, SHP-2, SUR-8, Cyclin D1, SP1, JMJD3, p38 MAPK, FosB",
107,"Development_The role of GDNF ligand family/ RET receptor in cell survival, growth and proliferation",92,1.320E-04,3.036E-03,2.780E-03,1.959E-02,28,"p38alpha (MAPK14), GRB2, c-Fos, GAB1, GFRalpha2, H-Ras, PSPN, ERK1/2, VEGFR-1, c-Raf-1, FRS2, NFKBIA, IP3 receptor, STAT3, PI3K reg class IA (p85), Calmodulin, Dopamine transporter, GFRalpha1, IKK-beta, Bcl-2, VAV-2, FAK1, Bcl-XL, MEK1/2, Cyclin D1, AKT(PKB), RET, PDK (PDPK1)",1.320E-04,3.036E-03,37,"GRB2, c-Fos, GAB1, IRS-1, H-Ras, ERK1/2, EGR1, IKK (cat), IRS5(DOK4), FRS2, Rac1, IP3 receptor, PI3K reg class IA (p85), GFRalpha4, IKK-alpha, Dopamine transporter, GFRalpha1, VAV-2, Bcl-XL, AKT(PKB), RET, PDK (PDPK1), GFRalpha2, PSPN, c-Jun, VEGFR-1, C3G, NFKBIA, Paxillin, Calmodulin, MEKK1(MAP3K1), SHP-2, IKK-beta, Bcl-2, FAK1, Cyclin D1, Cofilin",
108,Immune response_IL-6 signaling pathway via MEK/ERK and PI3K/AKT cascades,74,1.374E-04,2.812E-03,1.374E-04,2.812E-03,27,"Tuberin, gp130, GRB2, c-Fos, GAB1, JunB, K-RAS, H-Ras, ERK1/2, c-Raf-1, p90RSK1, TRPV1, Btk, IP3 receptor, IL6RA, STAT3, PI3K reg class IA (p85), Hck, p70 S6 kinase1, PI3K reg class IA, MEK1/2, AKT(PKB), sIL6-RA, PDK (PDPK1), p27KIP1, IL-6 receptor, PI3K reg class IA (p55-gamma)",1.891E-04,3.671E-03,31,"Tuberin, gp130, GRB2, c-Fos, GAB1, H-Ras, eIF4E, ERK1/2, EGR1, TRPV1, PLC-beta1, IP3 receptor, BAD, PI3K reg class IA (p85), Hck, PI3K reg class IA, AKT(PKB), PDK (PDPK1), p27KIP1, PI3K reg class IA (p55-gamma), JunB, K-RAS, PKC-delta, c-Jun, Btk, IL6RA, 4E-BP1, p70 S6 kinase1, SHP-2, sIL6-RA, IL-6 receptor",
109,Development_Negative feedback regulation of WNT/Beta-catenin signaling,37,1.389E-04,3.146E-03,1.038E-02,4.369E-02,13,"ZNF703, KLHL12, HUWE1, G-protein alpha-i family, CXXC5, Dsh, DDB2, WNT, GSK3 alpha/beta, Cyclin D1, Clathrin, TAB2, Axin",1.389E-04,3.146E-03,19,"ZNF703, NKD1, CXXC5, Dsh, GSK3 alpha/beta, TAB2, Axin, KLHL12, PKC-delta, Tcf(Lef), HUWE1, G-protein alpha-i family, RNF43, DDB2, WNT, G-protein alpha-q, Cyclin D1, Clathrin, Frizzled",
110,Recurrent gene fusions in Prostate Cancer,40,1.500E-04,3.296E-03,9.900E-04,9.795E-03,16,"SLC45A3, C19orf25, C15orf21, Soluble calcium-activated nucleotidase 1, HSPC134 (Chmp4b), YY2, DDX5, ZNF649, Androgen receptor, RPS14, ERG, Kallikrein 2, MgDP1, MIPOL1, ZNF577, WDR55",1.500E-04,3.296E-03,20,"C19orf25, RBM4, HSPC134 (Chmp4b), YY2, ZNF370, ZNF649, Androgen receptor, ERG, MgDP1, MIPOL1, WDR55, SLC45A3, Soluble calcium-activated nucleotidase 1, Cyclophilin A, RBM14, DDX5, RPS14, MRPS10, Kallikrein 2, ZNF577",
111,MAPK-independent proliferation of normal and asthmatic smooth muscle cells,64,1.573E-04,3.332E-03,1.393E-03,1.238E-02,22,"EGF, PDGF-B, G-protein alpha-i family, G-protein alpha-q/11, Tryptase, p21, FGFR1, STAT3, I-kB, PI3K reg class IA (p85), p70 S6 kinase1, Rb protein, ErbB2, PI3K reg class IA, IKK-beta, Cyclin D1, IL-4, AKT(PKB), PDK (PDPK1), p70 S6 kinase2, CysLT1 receptor, p27KIP1",1.573E-04,3.332E-03,28,"EGF, PDGF-B, Cyclin D3, IKK (cat), G-protein alpha-q/11, p21, FGFR1, Rac1, I-kB, PI3K reg class IA (p85), Rb protein, ErbB2, PI3K reg class IA, Thrombin, IKK-alpha, IL-13, IL-4, AKT(PKB), PDK (PDPK1), CysLT1 receptor, p27KIP1, c-Myc, G-protein alpha-i family, Tryptase, p70 S6 kinase1, IKK-beta, Cyclin D1, p70 S6 kinase2",
112,Signal transduction_CXCR4 signaling via PI3K cascade,46,1.638E-04,3.338E-03,2.944E-02,9.358E-02,14,"AKT1, G-protein alpha-i family, G6PT, NFKBIA, Ubiquitin, PI3K reg class IA (p85), p70 S6 kinase1, DEPTOR, eNOS, WASP, AKT(PKB), PDK (PDPK1), SDF-1, PREX1",1.638E-04,3.338E-03,22,"AKT1, IKK (cat), Rac1, BAD, Ubiquitin, PI3K reg class IA (p85), DEPTOR, WASP, AKT(PKB), PDK (PDPK1), SDF-1, PARP-1, G-protein alpha-i family, c-Jun, NFKBIA, 4E-BP1, p70 S6 kinase1, FOXO3A, eNOS, AKT2, PI3K reg class IB (p101), PREX1",
113,Signal transduction_PTEN pathway,46,1.638E-04,3.338E-03,6.660E-04,8.030E-03,18,"MEK1(MAP2K1), Tuberin, EGF, GRB2, H-Ras, ERK1/2, c-Raf-1, p21, ILK, PI3K reg class IA, PTEN, MDM2, FAK1, MAGI-3, IGF-1 receptor, AKT(PKB), IGF-1, PDK (PDPK1)",1.638E-04,3.338E-03,22,"Tuberin, EGF, GRB2, IRS-1, H-Ras, ERK1/2, p21, BAD, PI3K reg class IA, MDM2, MAGI-3, IGF-1 receptor, AKT(PKB), PDK (PDPK1), Tcf(Lef), c-Jun, ILK, Paxillin, PTEN, FOXO3A, FAK1, IGF-1",
114,Immune response_IL-15 signaling,58,1.652E-04,3.338E-03,2.957E-04,4.649E-03,22,"AKT1, GRB2, c-Fos, TRAF2, H-Ras, ERK1/2, c-Raf-1, Rac3, I-kB, PI3K reg class IA (p85), p70 S6 kinase1, MEK6(MAP2K6), Bcl-2, FAK1, IL-2R beta chain, Bcl-XL, MEK1/2, IL-4, AKT(PKB), PDK (PDPK1), p70 S6 kinase2, p38 MAPK",1.652E-04,3.338E-03,26,"AKT1, GRB2, c-Fos, H-Ras, eIF4E, ERK1/2, IKK (cat), PLC-beta1, I-kB, PI3K reg class IA (p85), MEK6(MAP2K6), Bcl-XL, IL-4, AKT(PKB), PDK (PDPK1), c-Myc, TRAF2, Rac3, 4E-BP1, p70 S6 kinase1, MEKK1(MAP3K1), Bcl-2, FAK1, IL-2R beta chain, p70 S6 kinase2, p38 MAPK",
115,PXR-mediated direct regulation of xenobiotic metabolizing enzymes / Human version,42,1.742E-04,3.425E-03,1.742E-04,3.425E-03,18,"CYP2C8, OATP-A, S14 protein, CES2, G6PT, CYP3A5, RXRA, PXR, CD36, ACLY, OATP-C, CYP3A43, CYP2A6, MRP3, PXR/RXR-alpha, CYP3A4, ABCG2, ABCC2",7.753E-03,3.997E-02,17,"S14 protein, CES2, CYP3A5, CYP3A43, CYP2C19, PXR/RXR-alpha, OATP-A, RXRA, PXR, CD36, CYP2B6, ACLY, OATP-C, CYP2A6, MRP3, ABCG2, ABCC2",
116,Growth factors in regulation of oligodendrocyte precursor cells survival in multiple sclerosis,42,1.742E-04,3.425E-03,1.742E-04,3.425E-03,18,"CD80, Neuregulin 1, ErbB3, c-Raf-1, p90Rsk, NFKBIA, PI3K reg class IA (p85), p70 S6 kinase1, ErbB2, PI3K reg class IA, Bcl-2, Bcl-XL, IGF-1 receptor, JNK(MAPK8-10), AKT(PKB), IGF-1, PDK (PDPK1), IBP",1.067E-03,1.202E-02,19,"IRS-1, ErbB3, BAD, PI3K reg class IA (p85), ErbB2, PI3K reg class IA, IKK-alpha, Bcl-XL, IGF-1 receptor, AKT(PKB), PDK (PDPK1), IBP, NFKBIA, 4E-BP1, 14-3-3 beta/alpha, p70 S6 kinase1, Bcl-2, JNK(MAPK8-10), IGF-1",
117,Role of IL-6 in obesity and type 2 diabetes in adipocytes,32,1.819E-04,3.611E-03,2.465E-03,1.806E-02,13,"gp130, c-Fos, Adiponectin, Insulin processed, ERK1/2, UCP2, LIPS, IL6RA, STAT3, CPT-1A, Insulin receptor, IL-6 receptor, Perilipin",1.819E-04,3.611E-03,17,"gp130, c-Fos, Insulin processed, IRS-1, ERK1/2, c-Jun/c-Fos, UCP2, GLUT4, CPT-1A, Insulin receptor, Adiponectin, PKC-delta, LIPS, IL6RA, SHP-2, IL-6 receptor, Perilipin",
118,CFTR folding and maturation (normal and CF),24,1.836E-04,3.611E-03,6.210E-03,3.221E-02,10,"HSP105, HSP90 alpha, CFTR, ERp29, Csp, Aha1, BAG-1, HSP70, BAG-3, p23 co-chaperone",1.836E-04,3.611E-03,14,"MA1B1, HSP90 alpha, ERp29, Sti1, Csp, HSP40, BAG-1, HSP70, PARP-1, HSP105, Aha1, HSPBP1, BAG-3, p23 co-chaperone",
119,Development_Role of HDAC and calcium/calmodulin-dependent kinase (CaMK) in control of skeletal myogenesis,53,1.985E-04,3.623E-03,1.985E-04,3.623E-03,21,"p38alpha (MAPK14), Tuberin, Calcineurin A (catalytic), PGAM2, CACNA1C, MEF2, p21, CPT-1B, MYOG, AMP deaminase 1, MEF2D, p70 S6 kinase1, Calmodulin, PI3K reg class IA, CaMKK, MEK6(MAP2K6), IGF-1 receptor, AKT(PKB), IGF-1, PDK (PDPK1), MYOD",6.824E-04,8.811E-03,23,"Tuberin, Calcineurin A (catalytic), NF-AT1(NFATC2), IRS-1, 14-3-3, p21, MYOG, p38beta (MAPK11), PI3K reg class IA, MEK6(MAP2K6), IGF-1 receptor, AKT(PKB), PDK (PDPK1), c-Jun, CACNA1C, MEF2, CPT-1B, MEF2D, p70 S6 kinase1, Calmodulin, CaMKK, IGF-1, MYOD",
120,IL-6 signaling in breast cancer cells,53,1.985E-04,3.623E-03,1.985E-04,3.623E-03,21,"E-cadherin, gp130, GRB2, c-Fos, GAB1, ESR1 (nuclear), H-Ras, ERK1/2, JAB1, c-Raf-1, HSD17B1, IL6RA, STAT3, MUC1, PI3K reg class IA, Bcl-2, Bcl-XL, MEK1/2, Cyclin D1, AKT(PKB), IL-6 receptor",1.796E-03,1.688E-02,22,"gp130, GRB2, c-Fos, GAB1, ESR1 (nuclear), H-Ras, ERK1/2, HSD17B1, MUC1, PI3K reg class IA, CYP19, Bcl-XL, AKT(PKB), c-Myc, E-cadherin, JAB1, IL6RA, SHP-2, Bcl-2, AKT2, Cyclin D1, IL-6 receptor",
121,Transport_Clathrin-coated vesicle cycle,71,1.987E-04,3.809E-03,4.501E-04,6.285E-03,25,"Rab-4, VTI1A, VAMP8, Myosin I, Rabaptin-5, SNAP-25, Rab11-FIP1, GCC2, SAR1A, VTI1B, ARF1, DAB2, GS15, RAB9P40, Myosin VI, SAR1, Rab-11A, PLEKHA8 (FAPP2), VPS45A, HIP12, EEA1, Clathrin, Syntaxin 16, Myosin Vb, Clathrin heavy chain",1.987E-04,3.809E-03,30,"NSF, VTI1A, Myosin I, Rabaptin-5, Rab11-FIP1, GCC2, VTI1B, DAB2, Actin, RAB9P40, RABGEF1, Rab-7, PLEKHA8 (FAPP2), VPS45A, HIP12, EEA1, Syntaxin 16, Clathrin heavy chain, Rab-4, VAMP8, GOS-28, SAR1A, VAMP4, ARF1, GS15, Myosin VI, SAR1, Rab-11A, Clathrin, Myosin Vb",
122,Autocrine Somatotropin signaling in breast cancer,39,2.048E-04,3.623E-03,2.048E-04,3.623E-03,17,"DNMT3B, p38alpha (MAPK14), E-cadherin, GRB2, TFF3, H-Ras, ERK1/2, VEGFR-1, c-Raf-1, DNMT3A, GHR, PDF, CISH, Bcl-2, MEK1/2, Cyclin D1, Plakoglobin",1.077E-03,1.202E-02,18,"DNMT3B, GRB2, H-Ras, ERK1/2, EGR1, CISH, SOD1, c-Myc, MEKK4(MAP3K4), E-cadherin, TFF3, VEGFR-1, DNMT3A, GHR, PDF, Bcl-2, Cyclin D1, Plakoglobin",
123,Development_G-protein-mediated regulation of MAPK-ERK signaling,46,2.086E-04,3.623E-03,2.086E-04,3.623E-03,19,"MEK1(MAP2K1), G-protein alpha-12 family, cAMP-GEFI, GRB2, c-Fos, G-protein alpha-i family, H-Ras, PKA-reg (cAMP-dependent), c-Raf-1, Adenylate cyclase type I, G-protein alpha-q/11, SynGAP, IP3 receptor, G-protein alpha-s, Calmodulin, PLC-beta, Rap1GAP1, MR-GEF, ERK1 (MAPK3)",9.357E-03,4.500E-02,18,"cAMP-GEFI, GRB2, c-Fos, H-Ras, PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, PLC-beta, GMF, ERK1 (MAPK3), G-protein alpha-12 family, G-protein alpha-i family, Adenylate cyclase type I, SynGAP, G-protein alpha-s, Calmodulin, Rap1GAP1, MR-GEF",
124,Role of GIP in pathogenesis of type 2 diabetes,46,2.086E-04,3.623E-03,2.086E-04,3.623E-03,19,"p38alpha (MAPK14), GIPR, Insulin processed, ERK1/2, Adenylate cyclase type VI, AMPK alpha subunit, PKA-reg (cAMP-dependent), Cytochrome c, Ubiquitin, G-protein alpha-s, TORC2, CaMKK, MEK6(MAP2K6), Bcl-2, MEK1/2, Cyclin D1, JNK(MAPK8-10), AKT(PKB), p38 MAPK",1.457E-03,1.513E-02,20,"Insulin processed, ERK1/2, Adenylate cyclase type VI, PKA-reg (cAMP-dependent), Cytochrome c, BAD, Ubiquitin, TORC2, MEK6(MAP2K6), Kv1.4, AKT(PKB), GIPR, AMPK alpha subunit, MKK7 (MAP2K7), G-protein alpha-s, CaMKK, Bcl-2, Cyclin D1, JNK(MAPK8-10), p38 MAPK",
125,NF-AT signaling in cardiac hypertrophy,65,2.169E-04,4.038E-03,2.578E-04,4.208E-03,24,"gp130, Calcineurin A (catalytic), GRB2, GAB1, G-protein alpha-i family, AGTR1, NF-AT3(NFATC4), GATA-4, MYBPC3, G-protein alpha-q/11, Troponin I, cardiac, MEF2D, PRKD1, G-protein alpha-s, Calmodulin, PI3K reg class IA, ANP, CaMKK, CAMTA2, IGF-1 receptor, AKT(PKB), Troponin T, cardiac, IGF-1, IL-6 receptor",2.169E-04,4.038E-03,28,"gp130, Calcineurin A (catalytic), GRB2, GAB1, Cardiotrophin-1, IRS-1, NF-AT3(NFATC4), GATA-4, MYBPC3, G-protein alpha-q/11, PI3K reg class IA, ANP, IGF-1 receptor, AKT(PKB), G-protein alpha-i family, AGTR1, Troponin I, cardiac, alpha-MHC, MEF2D, PRKD1, G-protein alpha-s, Calmodulin, SHP-2, CaMKK, CAMTA2, Troponin T, cardiac, IGF-1, IL-6 receptor",
126,Transcription_Role of AP-1 in regulation of cellular metabolism,38,2.188E-04,4.038E-03,1.321E-02,5.249E-02,13,"c-Fos, JunB, ERK1/2, FosB/JunB, p21, AP-1, ALDOA, CGB3, CG alpha, Cyclin D1, JNK(MAPK8-10), HBE, NQO1",2.188E-04,4.038E-03,19,"c-Fos, ERK1/2, FXYD2, c-Jun/c-Fos, IL-3, p21, CG alpha, FasL(TNFSF6), JunB, c-Jun, FosB/JunB, AP-1, PIT1, ALDOA, Alpha1-globin, IL5RA, Cyclin D1, JNK(MAPK8-10), NQO1",
127,WNT signaling in proliferative-type melanoma cells,38,2.188E-04,4.038E-03,4.924E-03,2.739E-02,14,"MSG1, beta-TrCP, ERK1/2, Dsh, WIF1, NRCAM, Casein kinase I alpha, NUR77, WNT, MEK1/2, POU3F2 (BRN2), Cyclin D1, NURR1, Axin",2.188E-04,4.038E-03,19,"DVL-3, WNT3A, Lef-1, ERK1/2, Dsh, WIF1, NRCAM, Casein kinase I alpha, POU3F2 (BRN2), c-Myc, Axin, MSG1, beta-TrCP, NUR77, WNT, WNT10B, Cyclin D1, NURR1, Frizzled",
128,Protein folding and maturation_Insulin processing,20,2.274E-04,3.906E-03,2.274E-04,3.906E-03,11,"Insulin processed, Proinsulin, Diarginyl insulin, Split (32,33) proinsulin, Split (64,65) proinsulin, Des(31,32) proinsulin, Proinsulin C-peptide, Insulin, Des (64,65) proinsulin, PC2, Carboxypeptidase H",1.778E-03,1.688E-02,11,"Insulin processed, Proinsulin, Split (32,33) proinsulin, Split (64,65) proinsulin, Diarginyl insulin, Des(31,32) proinsulin, Proinsulin C-peptide, Insulin, Des (64,65) proinsulin, PC2, Carboxypeptidase H",
129,Prostaglandins and leukotrienes-mediated induction of expression of mucins in normal and asthmatic epithelium ,43,2.493E-04,4.139E-03,2.493E-04,4.139E-03,18,"MEK1(MAP2K1), G-protein alpha-i family, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, p90RSK1, G-protein alpha-q/11, LTBR1, NFKBIA, IP3 receptor, G-protein alpha-s, PLC-beta, Mucin 2, Mucin 5AC, Adenylate cyclase, Mucin 5B, LTBR2, CysLT1 receptor",4.829E-02,1.325E-01,15,"ERK1/2, PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, PLC-beta, Adenylate cyclase, Mucin 5B, LTBR2, CysLT1 receptor, G-protein alpha-i family, LTBR1, NFKBIA, G-protein alpha-s, Mucin 2, Mucin 5AC",
130,HGF receptor (Met) and MSP receptor (RON) signaling pathways in SCLC,43,2.493E-04,4.139E-03,2.493E-04,4.139E-03,18,"p38alpha (MAPK14), AKT1, GRB2, GAB1, ERK1/2, MSP, MSP receptor (RON), STAT3, PI3K reg class IA (p85), p70 S6 kinase1, Rb protein, MAPKAPK2, MEK6(MAP2K6), FAK1, MEK1/2, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1)",2.312E-02,7.874E-02,16,"AKT1, GRB2, GAB1, ERK1/2, PI3K reg class IA (p85), Rb protein, MAPKAPK2, MEK6(MAP2K6), AKT(PKB), PDK (PDPK1), MSP, MSP receptor (RON), Paxillin, p70 S6 kinase1, FAK1, JNK(MAPK8-10)",
131,Chemotaxis_Lysophosphatidic acid signaling via GPCRs,129,2.591E-04,4.208E-03,2.591E-04,4.208E-03,40,"E-cadherin, cPKC (conventional), G-protein alpha-12 family, AKT1, PLC-eta 1, c-Fos, G-protein alpha-i family, H-Ras, MKL2, ERK1/2, c-Raf-1, G-protein alpha-q/11, p21, LIMK, CD36, IP3 receptor, E3KARP (NHERF2), YAP1 (YAp65), LPAR4, PRKD1, PI3K reg class IA (p85), AP-1, PAK, p70 S6 kinase1, PKC, PLC-beta, LPAR6, Bcl-2, FAK1, SIVA1, Bcl-XL, MEK1/2, Rho GTPase, IL13RA2, JNK(MAPK8-10), MSK1, AKT(PKB), PDK (PDPK1), p38 MAPK, PREX1",2.977E-04,4.944E-03,47,"AKT1, c-Fos, H-Ras, LARG, ERK1/2, PKC-zeta, EGR1, G-protein alpha-q/11, p21, Rac1, IP3 receptor, LPAR4, PI3K reg class IA (p85), PLC-beta, LPAR6, Bcl-XL, MSK1, AKT(PKB), PDK (PDPK1), E-cadherin, cPKC (conventional), G-protein alpha-12 family, PLC-eta 1, PKC-delta, Tcf(Lef), G-protein alpha-i family, c-Jun, MKL2, LIMK, CD36, Paxillin, E3KARP (NHERF2), 4E-BP1, PRKD1, AP-1, Caspase-7, PAK, p70 S6 kinase1, PKC, Bcl-2, FAK1, SIVA1, Rho GTPase, JNK(MAPK8-10), p38 MAPK, Cofilin, PREX1",
132,Development_Transcription factors in segregation of hepatocytic lineage,30,3.131E-04,4.822E-03,3.131E-04,4.822E-03,14,"CPSM, Keratin 19, p21, Activin B, Alpha 1-antitrypsin, FGF10, Activin, AFP, Cyclin D1, OC-2, HNF6, Albumin, TBX3, C/EBPalpha",1.002E-03,1.144E-02,15,"CPSM, HNF1-alpha, p21, Activin B, Alpha 1-antitrypsin, FGF10, Activin, OC-2, Albumin, Keratin 7, Keratin 19, Cyclin D1, HNF6, TBX3, C/EBPalpha",
133,Skeletal muscle atrophy in COPD,57,3.325E-04,5.367E-03,1.702E-03,1.437E-02,20,"ALK-4, p38alpha (MAPK14), Tuberin, eIF2B5, ERK1/2, Myostatin, MuRF1, MyHC, NFKBIA, MYOG, MYBPC1, Myosin-IIA, I-kB, FOXO4, p70 S6 kinase1, JunD, AKT(PKB), IGF-1, p38 MAPK, MYOD",3.325E-04,5.367E-03,25,"ALK-4, Tuberin, eIF2B5, UBE2B, ERK1/2, 14-3-3, MYOG, MYBPC1, I-kB, JunD, AKT(PKB), Myostatin, MuRF1, eIF3S5, MyHC, NEDD4, NFKBIA, Myosin-IIA, 4E-BP1, FOXO4, p70 S6 kinase1, FOXO3A, IGF-1, p38 MAPK, MYOD",
134,Immune response_Antigen presentation by MHC class I: cross-presentation,99,3.346E-04,5.367E-03,8.500E-03,3.884E-02,28,"CLEC12A, Rab-4A, FCGRT, VAMP8, LLIR, Fc epsilon RI gamma, HSP105, HSP90 alpha, VCP, p67-phox, Rab-35, RanBPM, HSPA1A, Fc gamma RI, Rab-6, Rab-11A, cPLA2, OLR1, IKK-beta, Connexin 43, ARF6, CD40(TNFRSF5), RAB-5B, HSP60, HSP90, CHIP, HSP70, SNAP-23",3.346E-04,5.367E-03,38,"CLEC12A, Fc epsilon RI gamma, HSP90 alpha, FCGR3A, VCP, Rab-3C, Rab-6, Rab-7, IRAP, MyD88, cPLA2, CD209, ARF6, HSP60, HSP90, Syntaxin 4, HSP70, EHD1, Rab-4A, FCGRT, VAMP8, LLIR, HSP105, Rab-35, RanBPM, HSPA1A, Fc gamma RI, TIM-3, Rab-11A, Rab-10, OLR1, IKK-beta, CD40(TNFRSF5), RAB-5B, TRIF (TICAM1), CHIP, SNAP-23, TCR alpha/beta",
135,Immune response_HSP60 and HSP70/ TLR signaling pathway,54,3.416E-04,5.367E-03,5.317E-03,2.848E-02,18,"CD80, MHC class II, ERK1/2, TIRAP (Mal), E2N(UBC13), IL-12 alpha, Ubiquitin, I-kB, AP-1, IKK-beta, MEK6(MAP2K6), MEK1/2, JNK(MAPK8-10), CD40(TNFRSF5), TAB2, HSP60, HSP70, p38 MAPK",3.416E-04,5.367E-03,24,"MHC class II, ERK1/2, c-Jun/c-Fos, E2N(UBC13), IKK (cat), IL-12 alpha, Ubiquitin, I-kB, MyD88, IKK-alpha, MEK6(MAP2K6), TAB2, HSP60, UEV1A, HSP70, c-Jun, TIRAP (Mal), AP-1, UBE1, IKK-beta, TAB1, JNK(MAPK8-10), CD40(TNFRSF5), p38 MAPK",
136,Immune response_BAFF-induced signaling,51,3.482E-04,5.367E-03,1.550E-02,5.952E-02,16,"Tuberin, AKT1, TRAF2, ERK1/2, c-Raf-1, Ubiquitin, PI3K reg class IA (p85), p70 S6 kinase1, MAPKAPK2, MEK6(MAP2K6), GSK3 alpha/beta, MEK1/2, AKT(PKB), PDK (PDPK1), p38 MAPK, ERK1 (MAPK3)",3.482E-04,5.367E-03,23,"Tuberin, AKT1, eIF4E, ERK1/2, BAD, Ubiquitin, PI3K reg class IA (p85), MAPKAPK2, MEK6(MAP2K6), GSK3 alpha/beta, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), PKC-delta, TRAF2, Pim-2, c-Jun, MKK7 (MAP2K7), 4E-BP1, p70 S6 kinase1, MEKK1(MAP3K1), FOXO3A, p38 MAPK",
137,Immune response_NF-AT in immune response,51,3.482E-04,5.367E-03,1.550E-02,5.952E-02,16,"CD80, MHC class II, Calcineurin A (catalytic), BLNK, NF-AT3(NFATC4), Btk, NF-AT, IP3 receptor, TRIM, I-kB, PI3K reg class IA (p85), Calmodulin, CD3, IKK-beta, GSK3 alpha/beta, AKT(PKB)",3.482E-04,5.367E-03,23,"MHC class II, Calcineurin A (catalytic), NF-AT1(NFATC2), NF-AT3(NFATC4), IKK (cat), Rac1, IP3 receptor, TRIM, I-kB, PI3K reg class IA (p85), ZAP70, IKK-alpha, ITK, GSK3 alpha/beta, AKT(PKB), BLNK, CD79 complex, LAT, Btk, NF-AT, Calmodulin, IKK-beta, TCR alpha/beta",
138,IGF signaling in lung cancer,44,3.511E-04,5.352E-03,3.511E-04,5.352E-03,18,"MEK1(MAP2K1), Tuberin, GRB2, H-Ras, ERK1/2, MSK1/2 (RPS6KA5/4), c-Raf-1, IBP4, p90Rsk, p70 S6 kinase1, PI3K reg class IA, Bcl-XL, IGF-1 receptor, AKT(PKB), IGF-1, PDK (PDPK1), p38 MAPK, IBP",5.464E-03,3.179E-02,18,"Tuberin, GRB2, IRS-1, H-Ras, ERK1/2, MSK1/2 (RPS6KA5/4), BAD, PI3K reg class IA, Bcl-XL, IGF-1 receptor, AKT(PKB), PDK (PDPK1), IBP, IBP4, 4E-BP1, p70 S6 kinase1, IGF-1, p38 MAPK",
139,Immune response_IL-3 signaling via ERK and PI3K,102,3.706E-04,5.592E-03,3.706E-04,5.592E-03,33,"SGK3, cPKC (conventional), Calcineurin A (catalytic), GRB2, c-Fos, Fc epsilon RI gamma, CSF2RB, H-Ras, ERK1/2, c-Raf-1, PAK1, GATA-1, GATA-2, PDE4, p90Rsk, IP3 receptor, p70 S6 kinases, GLUT1, PI3K reg class IA (p85), Calmodulin, FLII, cPLA2, Bcl-2, MDM2, FAK1, GSK3 alpha/beta, Bcl-XL, MEK1/2, IL-4, AKT(PKB), PDK (PDPK1), p27KIP1, PUMA",6.628E-04,8.769E-03,38,"Calcineurin A (catalytic), GRB2, c-Fos, Fc epsilon RI gamma, H-Ras, ERK1/2, EGR1, IL-3, A-Raf-1, Rac1, IP3 receptor, BAD, p70 S6 kinases, PI3K reg class IA (p85), cPLA2, MDM2, GSK3 alpha/beta, Bcl-XL, IL-4, AKT(PKB), PDK (PDPK1), p27KIP1, PUMA, SGK3, cPKC (conventional), CSF2RB, PAK1, C3G, GATA-2, PDE4, Paxillin, GLUT1, Calmodulin, FLII, SHP-2, Bcl-2, FOXO3A, FAK1",
140,Development_FGF2-dependent induction of EMT,20,3.752E-04,5.724E-03,1.179E-03,1.101E-02,10,"GRB2, GAB1, FRS2, FGFR1, PI3K reg class IA (p85), AP-1, IL-1RI, AKT(PKB), PDK (PDPK1), p27KIP1",3.752E-04,5.724E-03,12,"GRB2, GAB1, FRS2, FGFR1, Rac1, PI3K reg class IA (p85), IKK-alpha, IL-1RI, AKT(PKB), PDK (PDPK1), p27KIP1, AP-1",
141,Development_S1P1 receptor signaling via beta-arrestin,34,4.107E-04,6.075E-03,4.107E-04,6.075E-03,15,"MEK1(MAP2K1), Tuberin, GRB2, GAB1, G-protein alpha-i family, H-Ras, ERK1/2, c-Raf-1, p90Rsk, p70 S6 kinases, Clathrin, Beta-arrestin1, p70 S6 kinase2, ERK1 (MAPK3), GRK2",6.721E-02,1.644E-01,12,"Tuberin, GRB2, GAB1, H-Ras, ERK1/2, p70 S6 kinases, ERK1 (MAPK3), GRK2, G-protein alpha-i family, Clathrin, Beta-arrestin1, p70 S6 kinase2",
142,Neurophysiological process_Activity-dependent synaptic AMPA receptor removal,64,4.197E-04,6.338E-03,1.631E-02,6.155E-02,19,"eEF2, IPP-1, cPKC (conventional), Calcineurin A (catalytic), PP1-cat, Clathrin light chain, IP3 receptor, GluR2, ARC, PIPKI gamma, Calmodulin, PKC, PLC-beta, AP-2 alpha subunits, PICK1, HPCA, ARF6, Clathrin, IQSEC1",4.197E-04,6.338E-03,27,"NSF, Calcineurin A (catalytic), PP1-cat, DRD1IP, IP3 receptor, NMDA receptor, PLC-beta, AP-2 alpha subunits, ARF6, IQSEC1, Endophilin A3, eEF2, IPP-1, cPKC (conventional), eEF2K, Clathrin light chain, GRIP, GluR2, ARC, PIPKI gamma, Calmodulin, PKC, PICK1, GluR1, G-protein alpha-q, Clathrin, RalA",
143,ErbB2-induced breast cancer cell invasion,67,4.352E-04,6.251E-03,4.352E-04,6.251E-03,24,"EGF, GRB2, c-Fos, Neuregulin 1, MMP-1, PDCD4, H-Ras, ERK1/2, ErbB3, c-Raf-1, PAK1, IP3 receptor, I-kB, PI3K reg class IA (p85), ErbB2, MEK6(MAP2K6), VAV-2, FAK1, MEK1/2, MSK1, AKT(PKB), PDK (PDPK1), p38 MAPK, SLK",2.304E-03,1.823E-02,26,"EGF, GRB2, c-Fos, H-Ras, ERK1/2, ErbB3, Rac1, IP3 receptor, I-kB, PI3K reg class IA (p85), ErbB2, IKK-alpha, MEK6(MAP2K6), VAV-2, MSK1, AKT(PKB), PDK (PDPK1), MMP-1, PDCD4, PAK1, Cofilin, non-muscle, FAK1, p120-catenin, p38 MAPK, SLK, Cofilin",
144,Development_Growth factors in regulation of oligodendrocyte progenitor cell proliferation,67,4.352E-04,6.251E-03,4.352E-04,6.251E-03,24,"MEK1(MAP2K1), FGFR3, GRB2, c-Fos, FGF17, Neuregulin 1, H-Ras, ERK1/2, PLP1, c-Raf-1, FRS2, FGFR1, Vitronectin, PI3K reg class IA (p85), p70 S6 kinase1, ErbB2, PKC, PI3K reg class IA, KV1.6, IGF-1 receptor, Cyclin D1, AKT(PKB), IGF-1, PDK (PDPK1)",5.080E-03,3.013E-02,25,"TrkA, GRB2, c-Fos, IRS-1, H-Ras, ERK1/2, PLP1, FRS2, FGFR1, PI3K reg class IA (p85), ErbB2, PI3K reg class IA, KV1.6, IGF-1 receptor, AKT(PKB), PDK (PDPK1), FGFR3, KV1.5, Vitronectin, p70 S6 kinase1, FGF18, PKC, SHP-2, Cyclin D1, IGF-1",
145,Signal transduction_Adenosine A2A receptor signaling pathway,52,4.448E-04,6.285E-03,4.448E-04,6.285E-03,20,"ENPP1, Adenosine A1 receptor, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), Ca(II)channel L-type, Kir6.2, Cytohesin2, I-kB, Synapsin I, G-protein alpha-s, Adenylate cyclase, eNOS, ARF6, MEK1/2, AKT(PKB), SFK, p38 MAPK, Adenosine A2a receptor, Cathepsin K",7.906E-03,4.020E-02,20,"TrkA, ENPP1, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), Kir6.2, Cytohesin2, I-kB, Synapsin I, Adenylate cyclase, ARF6, AKT(PKB), SFK, Adenosine A1 receptor, Ca(II)channel L-type, G-protein alpha-s, eNOS, p38 MAPK, Adenosine A2a receptor, Cathepsin K",
146,Development_EGFR signaling pathway,71,4.501E-04,6.285E-03,4.501E-04,6.285E-03,25,"MEK1(MAP2K1), p38alpha (MAPK14), EGF, GRB2, c-Fos, MLK2(MAP3K10), H-Ras, ERK1/2, MKP-2, c-Raf-1, PAK1, ILK, STAT3, I-kB, PI3K reg class IA (p85), Amphiregulin, ErbB2, IKK-beta, MKP-1, FAK1, PKC-gamma, AKT(PKB), PDK (PDPK1), p38 MAPK, ERK1 (MAPK3)",1.194E-03,1.293E-02,28,"EGF, GRB2, c-Fos, H-Ras, ERK1/2, IKK (cat), Rac1, I-kB, PI3K reg class IA (p85), Amphiregulin, ErbB2, PKC-gamma, AKT(PKB), PDK (PDPK1), c-Myc, ERK1 (MAPK3), PARP-1, MLK2(MAP3K10), c-Jun, MKP-2, PAK1, MKK7 (MAP2K7), ILK, Caspase-7, IKK-beta, MKP-1, FAK1, p38 MAPK",
147,Signal transduction_Leptin signaling in non-neuronal cells,58,4.592E-04,6.796E-03,8.278E-04,8.648E-03,21,"TRPC4, SUR1, PDE3B, AMPK alpha subunit, Kir6.2, AMPK alpha 2 subunit, CPT-1B, STAT3, I-kB, CPT-1A, PI3K reg class IA (p85), Calmodulin, PTEN, ACACB, Bcl-2, Bcl-XL, CD40(TNFRSF5), AKT(PKB), PDK (PDPK1), Leptin, CaMKK2",4.592E-04,6.796E-03,25,"SUR1, PDE3B, IRS-1, IKK (cat), Kir6.2, NMDA receptor, I-kB, CPT-1A, PI3K reg class IA (p85), ACACB, Bcl-XL, AKT(PKB), PDK (PDPK1), ACSL1, AMPK alpha subunit, SENP2, AMPK alpha 2 subunit, SH2B, CPT-1B, Calmodulin, PTEN, Bcl-2, CD40(TNFRSF5), Leptin, CaMKK2",
148,G-protein signaling_RhoA regulation pathway,34,4.670E-04,6.845E-03,4.608E-03,2.627E-02,13,"G-protein alpha-12 family, Rhophilin 1, Ephrin-A receptors, G-protein alpha-q/11, VIL2 (ezrin), RhoGAP1, ARHGEF3, FAK1, IGF-1 receptor, DBS, Ephrin-A, p200RhoGAP, IGF-1",4.670E-04,6.845E-03,17,"LARG, G-protein alpha-q/11, Rac1, VIL2 (ezrin), RhoGAP1, ARHGEF3, IGF-1 receptor, DBS, G-protein alpha-12 family, RhoGDI gamma, Rhophilin 1, Ephrin-A receptors, RhoGDI beta, FAK1, Ephrin-A, p200RhoGAP, IGF-1",
149,"SREBP1 cross-talk with PXR, CAR and LXR/ Rodent version",31,4.764E-04,6.590E-03,4.764E-04,6.590E-03,14,"LXR-alpha/RXR-alpha, SREBP1 (nuclear), CAR/RXR-alpha, LXR-beta, MED1, SREBP1 (Golgi membrane), PXR, LXR-beta/RXR-alpha, SREBP1 precursor, SCAP, CAR, LXR-alpha, PXR/RXR-alpha, CYP3A4",1.359E-02,5.754E-02,13,"SREBP1 (nuclear), MED1, SREBP1 precursor, INSIG2, CAR, PXR/RXR-alpha, CAR/RXR-alpha, LXR-beta, SREBP1 (Golgi membrane), PXR, CYP2B6, LXR-beta/RXR-alpha, SCAP",
150,Tau pathology in Alzheimer disease,55,4.764E-04,6.848E-03,1.026E-03,1.002E-02,20,"p38alpha (MAPK14), MARK2, Calcineurin A (catalytic), SYVN1, Syndecan-1, eIF2AK3, p38delta (MAPK13), ERK1/2, VCP, PP2C, MARK1, Ubiquitin, Tau tubulin kinase 1, PKC, GSK3 alpha/beta, JNK(MAPK8-10), Tau (MAPT), IRE1, p38 MAPK, Tubulin (in microtubules)",4.764E-04,6.848E-03,24,"Casein kinase I delta, Calcineurin A (catalytic), SYVN1, p38delta (MAPK13), ERK1/2, VCP, PP2C, NMDA receptor, Ubiquitin, Tau tubulin kinase 1, p38beta (MAPK11), NR2, GSK3 alpha/beta, Tau (MAPT), IRE1, Tubulin (in microtubules), MARK2, Syndecan-1, eIF2AK3, MARK1, Caspase-7, PKC, JNK(MAPK8-10), p38 MAPK",
151,Development_WNT/Beta-catenin signaling in the cytoplasm,55,4.764E-04,6.848E-03,1.495E-02,5.801E-02,17,"p38alpha (MAPK14), E-cadherin, FRAT1, DAAM1, Axin1, PAK1, Dsh, Casein kinase I alpha, Hck, G-protein alpha-s, IP3KB, WNT, VAV-2, GSK3 alpha/beta, AKT(PKB), NOX1, Axin",4.764E-04,6.848E-03,24,"Casein kinase I delta, FRAT1, IPMK, Axin1, Dsh, Casein kinase I alpha, PLC-beta1, Rac1, Hck, IP3KB, VAV-2, GSK3 alpha/beta, AKT(PKB), NOX1, Axin, E-cadherin, DAAM1, Tcf(Lef), PAK1, G-protein alpha-s, WNT, G-protein alpha-q, p120-catenin, Frizzled",
152,Mechanisms of resistance to EGFR inhibitors in lung cancer,45,4.870E-04,6.614E-03,4.870E-04,6.614E-03,18,"MEK1(MAP2K1), E-cadherin, GRB2, GAB1, K-RAS, H-Ras, ErbB3, c-Raf-1, PI3K reg class IA (p85), p70 S6 kinase1, ErbB2, PTEN, Claudin-4, IGF-1 receptor, AKT(PKB), HSP90, PDK (PDPK1), ERK1 (MAPK3)",2.860E-03,2.138E-02,19,"GRB2, GAB1, IRS-1, H-Ras, ErbB3, PI3K reg class IA (p85), ErbB2, Claudin-7, IGF-1 receptor, AKT(PKB), HSP90, PDK (PDPK1), ERK1 (MAPK3), E-cadherin, K-RAS, 4E-BP1, p70 S6 kinase1, PTEN, Claudin-4",
153,Development_Membrane-bound ESR1: interaction with growth factors signaling,45,4.870E-04,6.614E-03,4.870E-04,6.614E-03,18,"MEK1(MAP2K1), GRB2, c-Fos, ESR1 (nuclear), NCOA3 (pCIP/SRC3), H-Ras, ERK1/2, ErbB3, ESR1 (membrane), p90RSK1, ErbB2, PI3K reg class IA, eNOS, GSK3 alpha/beta, IGF-1 receptor, Cyclin D1, AKT(PKB), PDK (PDPK1)",1.668E-02,6.424E-02,17,"GRB2, c-Fos, ESR1 (nuclear), IRS-1, H-Ras, ERK1/2, ErbB3, ESR1 (membrane), ErbB2, PI3K reg class IA, GSK3 alpha/beta, IGF-1 receptor, AKT(PKB), PDK (PDPK1), NCOA3 (pCIP/SRC3), eNOS, Cyclin D1",
154,Immune response_IL-4 signaling pathway,94,4.983E-04,7.017E-03,3.908E-03,2.413E-02,28,"p38alpha (MAPK14), Tuberin, GRB2, PDE3B, ERK1/2, c-Raf-1, p90RSK1, PAK1, PDE4, NFKBIA, IP3 receptor, STAT3, AP-1, p70 S6 kinase1, Tubulin alpha, PKC, JunD, MEK6(MAP2K6), Bcl-2, GSK3 alpha/beta, Bcl-XL, MEK1/2, JNK(MAPK8-10), STAT6, IL-4, AKT(PKB), PDK (PDPK1), p38 MAPK",4.983E-04,7.017E-03,36,"Tuberin, GRB2, PDE3B, IRS-1, ERK1/2, PKC-zeta, IKK (cat), Rac1, IP3 receptor, BAD, p38beta (MAPK11), JunD, IKK-alpha, MEK6(MAP2K6), GSK3 alpha/beta, Bcl-XL, IL-4, SHIP, AKT(PKB), PDK (PDPK1), PKC-delta, c-Jun, PAK1, PDE4, NFKBIA, 4E-BP1, AP-1, p70 S6 kinase1, Tubulin alpha, PKC, MEKK1(MAP3K1), Bcl-2, FOXO3A, JNK(MAPK8-10), STAT6, p38 MAPK",
155,Development_Stimulation of differentiation of mouse embryonic fibroblasts into adipocytes by extracellular factors,71,5.005E-04,7.017E-03,1.128E-03,1.060E-02,24,"MEK1(MAP2K1), Tuberin, A-FABP, AKT1, GRB2, DRIP130, Insulin processed, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, Factor D, SREBP1 precursor, PI3K reg class IA (p85), G-protein alpha-s, Insulin receptor, Adenylate cyclase, IGF-1 receptor, IGF-1, PDK (PDPK1), Leptin, p38 MAPK, ERK1 (MAPK3), C/EBPalpha",5.005E-04,7.017E-03,29,"Tuberin, AKT1, GRB2, Insulin processed, IRS-1, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), GLUT4, SREBP1 precursor, PI3K reg class IA (p85), Prostacyclin receptor, Resistin, Insulin receptor, Adenylate cyclase, IGF-1 receptor, PDK (PDPK1), ERK1 (MAPK3), DRIP130, Factor D, G-protein alpha-s, SHP-2, TAB1, AKT2, SMAD1, IGF-1, Leptin, p38 MAPK, C/EBPalpha",
156,"Regulation of lipid metabolism_Regulation of lipid metabolism via LXR, NF-Y and SREBP",38,5.043E-04,6.787E-03,5.043E-04,6.787E-03,16,"ACACA, LXR-alpha/RXR-alpha, SREBP1 (nuclear), SCD, AMPK beta subunit, RXRA, AMPK alpha subunit, AMPK gamma subunit, FASN, SREBP1 (Golgi membrane), SREBP1 precursor, ACLY, RARalpha, SCAP, LXR-alpha, SP1",3.535E-02,1.061E-01,14,"SREBP1 (nuclear), SCD, AMPK beta subunit, AMPK gamma subunit, FASN, SREBP1 precursor, RARalpha, YY1, RXRA, AMPK alpha subunit, SREBP1 (Golgi membrane), ACLY, SCAP, SP1",
157,Development_WNT/Beta-catenin signaling pathway. Signalosome,43,5.101E-04,7.062E-03,1.636E-02,6.155E-02,14,"E-cadherin, G-protein alpha-i family, PAK1, ARF1, PIP5KI, Dsh, Casein kinase I alpha, WNT, GSK3 alpha/beta, ARF6, ATP6V0C, Clathrin, Axin, ATP6AP2",5.101E-04,7.062E-03,20,"Casein kinase I delta, Dsh, Casein kinase I alpha, GSK3 alpha/beta, ARF6, Axin, E-cadherin, G-protein alpha-i family, Casein kinase I gamma 1, PAK1, ARF1, PIP5KI, PPP2R5E, WNT, ATP6V0C, G-protein alpha-q, Clathrin, p120-catenin, Frizzled, ATP6AP2",
158,Stem cells_CD30 signaling in transformed embryonic stem cells,18,5.334E-04,7.316E-03,8.977E-03,4.052E-02,8,"TRAF2, TCL1A, UTF1, TRAF5, KLF4, NANOG, I-kB, SOX2",5.334E-04,7.316E-03,11,"TCL1A, IKK (cat), KLF4, I-kB, c-Myc, TRAF2, UTF1, TRAF5, NANOG, CD30L (TNFSF8), SOX2",
159,Signal transduction_mTORC2 upstream signaling,65,5.639E-04,7.664E-03,1.751E-03,1.462E-02,22,"Tuberin, EGF, RPL7, Insulin processed, GBL, RPL23, RPL23a, SIN1, DEPTOR, RPS16, PI3K reg class IA, TTI1, Insulin receptor, PRR5, IKK-beta, TELO2, IGF-1 receptor, IL-4, AKT(PKB), HSP70, IGF-1, PDK (PDPK1)",5.639E-04,7.664E-03,27,"Tuberin, EGF, WNT3A, Insulin processed, RPL23, SIN1, Rac1, DEPTOR, RPS16, PI3K reg class IA, TTI1, IKK-alpha, Insulin receptor, IGF-1 receptor, IL-4, AKT(PKB), HSP70, PDK (PDPK1), RPL7, GBL, RPL23a, Hamartin, PRR5, IKK-beta, TELO2, IGF-1, Frizzled",
160,CFTR-dependent regulation of ion channels in CF,42,5.901E-04,7.718E-03,5.901E-04,7.718E-03,17,"gamma-ENaC, beta-ENaC, alpha-ENaC, ACCN3 (ASIC3), CFTR, EBP50, PKA-reg type II (cAMP-dependent), KCNQ1, PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, E3KARP (NHERF2), YAP1 (YAp65), VIL2 (ezrin), PLC-beta, P2Y2, CLCA2",1.829E-02,6.753E-02,16,"gamma-ENaC, beta-ENaC, ACCN3 (ASIC3), KCNQ1, PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, VIL2 (ezrin), PLC-beta, CLCA2, alpha-ENaC, EBP50, PKA-reg type II (cAMP-dependent), E3KARP (NHERF2), P2Y2, ENaC",
161,EGFR signaling pathway in lung cancer,53,5.941E-04,7.718E-03,5.941E-04,7.718E-03,20,"EGF, gp130, GRB2, c-Fos, Neuregulin 1, ERK1/2, ErbB3, NFKBIA, STAT3, PI3K reg class IA (p85), Amphiregulin, p70 S6 kinase1, ErbB2, PTEN, Bcl-2, Bcl-XL, Cyclin D1, AKT(PKB), SP1, PDK (PDPK1)",4.399E-03,2.763E-02,21,"EGF, gp130, GRB2, c-Fos, ERK1/2, ErbB3, EGR1, PI3K reg class IA (p85), Amphiregulin, ErbB2, IKK-alpha, Bcl-XL, AKT(PKB), PDK (PDPK1), c-Jun, NFKBIA, p70 S6 kinase1, PTEN, Bcl-2, Cyclin D1, SP1",
162,Proliferative action of Gastrin in gastric cancer,53,5.941E-04,7.718E-03,5.941E-04,7.718E-03,20,"MEK1(MAP2K1), E-cadherin, cPKC (conventional), GRB2, H-Ras, ERK1/2, c-Raf-1, PAK1, G-protein alpha-q/11, p90Rsk, IP3 receptor, PI3K reg class IA (p85), p70 S6 kinase1, PKC, FAK1, Cyclin D1, PKC-gamma, SP1, PDK (PDPK1), p70 S6 kinase2",1.796E-03,1.688E-02,22,"GRB2, IRS-1, H-Ras, ERK1/2, G-protein alpha-q/11, ICRF, IP3 receptor, PI3K reg class IA (p85), PKC-gamma, PDK (PDPK1), c-Myc, E-cadherin, cPKC (conventional), CCKBR, PAK1, p70 S6 kinase1, PKC, FAK1, G-protein alpha-q, Cyclin D1, SP1, p70 S6 kinase2",
163,Transcription_Role of the non-genomic action of Retinoic acid and phosphorylation of Retinoic acid receptors in the initiation of transcription,35,5.993E-04,7.718E-03,5.993E-04,7.718E-03,15,"p38alpha (MAPK14), NCOA3 (pCIP/SRC3), RARgamma, RXRA, RAR-alpha/RXR-alpha, CDK7, Cyclin H, CAK complex, RARalpha, MSK1, PSMC5, PDK (PDPK1), Transthyretin, p38 MAPK, MAT1",2.281E-03,1.823E-02,16,"RARgamma, CDK7, CAK complex, RARalpha, MSK1, PSMC5, PDK (PDPK1), NCOA3 (pCIP/SRC3), PKC-delta, RXRA, RAR-alpha/RXR-alpha, Cyclin H, G-protein alpha-q, Transthyretin, p38 MAPK, MAT1",
164,Signal transduction_Angiotensin II signaling via Beta-arrestin,57,6.351E-04,8.030E-03,6.351E-04,8.030E-03,21,"MEK1(MAP2K1), ERK1/2, AGTR1, CACNA1C, c-Raf-1, p90Rsk, Cytohesin2, p70 S6 kinases, AP-2 alpha subunits, MRLC, Bcl-XL, ARF6, DGK, Clathrin, JNK3(MAPK10), AKT(PKB), Beta-arrestin1, p27KIP1, Clathrin heavy chain, MLCK, p23 co-chaperone",2.231E-03,1.823E-02,23,"eIF4E, ERK1/2, 14-3-3, BAD, Cytohesin2, STAR, p70 S6 kinases, AP-2 alpha subunits, Bcl-XL, ARF6, DGK, JNK3(MAPK10), AKT(PKB), p27KIP1, Clathrin heavy chain, MLCK, AGTR1, CACNA1C, MRLC, Clathrin, Beta-arrestin1, Cofilin, p23 co-chaperone",
165,Regulation of Beta-catenin activity in colorectal cancer,56,6.555E-04,8.750E-03,8.102E-03,3.794E-02,18,"E-cadherin, eEF2, PDCD4, ERK1/2, PKA-reg (cAMP-dependent), KLF4, ILK, IP3 receptor, PI3K reg class IA (p85), MUC1, G-protein alpha-s, Calmodulin, PLC-beta, PTEN, Adenylate cyclase, MEK1/2, AKT(PKB), Axin",6.555E-04,8.750E-03,24,"DVL-3, ERK1/2, PKA-reg (cAMP-dependent), KLF4, IP3 receptor, PI3K reg class IA (p85), MUC1, PLC-beta, IKK-alpha, Adenylate cyclase, AKT(PKB), Axin, E-cadherin, eEF2, PKC-delta, PDCD4, MAML1, c-Jun, eEF2K, ILK, G-protein alpha-s, Calmodulin, PTEN, G-protein alpha-q",
166,Apoptosis and survival_IL-17-induced CIKS-independent signaling pathways,46,6.660E-04,8.030E-03,6.660E-04,8.030E-03,18,"MEK1(MAP2K1), p38alpha (MAPK14), STAT2, AKT1, c-Fos, ERK1/2, c-Raf-1, p90Rsk, STAT3, PI3K reg class IA (p85), AP-1, IL-17RC, MAPKAPK2, PI3K reg class IA, MKP-1, JNK(MAPK8-10), PDK (PDPK1), p38 MAPK",8.250E-02,1.909E-01,15,"AKT1, c-Fos, ERK1/2, c-Jun/c-Fos, PI3K reg class IA (p85), IL-17RC, MAPKAPK2, PI3K reg class IA, PDK (PDPK1), STAT2, c-Jun, AP-1, MKP-1, JNK(MAPK8-10), p38 MAPK",
167,Transcription_Hypoxia- and receptor-mediated HIF-1 activation,46,6.660E-04,8.030E-03,6.660E-04,8.030E-03,18,"EGF, LRRK2, NCOA3 (pCIP/SRC3), Insulin processed, Neuregulin 1, ERK1/2, STAT3, p70 S6 kinase1, BRK, ErbB2, MDM2, MNK2(GPRK7), MEK1/2, HIF-prolyl hydroxylase, AKT(PKB), IGF-1, PDK (PDPK1), p38 MAPK",3.847E-03,2.556E-02,19,"EGF, FSH, Insulin processed, eIF4E, ERK1/2, BRK, ErbB2, MDM2, AKT(PKB), PDK (PDPK1), ARNT, LRRK2, NCOA3 (pCIP/SRC3), 4E-BP1, p70 S6 kinase1, MNK2(GPRK7), HIF-prolyl hydroxylase, IGF-1, p38 MAPK",
168,Development_Endothelin-1/EDNRA transactivation of EGFR,46,6.660E-04,8.030E-03,6.660E-04,8.030E-03,18,"MEK1(MAP2K1), Tuberin, GRB2, c-Fos, H-Ras, ERK1/2, CACNA1C, c-Raf-1, G-protein alpha-q/11, IP3 receptor, p70 S6 kinase1, Calmodulin, PI3K reg class IA, PLC-beta, AKT(PKB), SP1, PDK (PDPK1), p70 S6 kinase2",2.098E-02,7.467E-02,17,"Tuberin, GRB2, c-Fos, H-Ras, ERK1/2, G-protein alpha-q/11, IP3 receptor, PI3K reg class IA, PLC-beta, AKT(PKB), PDK (PDPK1), PKC-delta, CACNA1C, p70 S6 kinase1, Calmodulin, SP1, p70 S6 kinase2",
169,FGF signaling in pancreatic cancer,46,6.660E-04,8.030E-03,6.660E-04,8.030E-03,18,"MEK1(MAP2K1), E-cadherin, Syndecan-1, GRB2, c-Fos, GAB1, H-Ras, ERK1/2, c-Raf-1, FRS2, NFKBIA, Alpha-catenin, FGFR1, PI3K reg class IA (p85), FGF10, Cyclin D1, AKT(PKB), PDK (PDPK1)",9.357E-03,4.500E-02,18,"GRB2, c-Fos, GAB1, H-Ras, ERK1/2, FRS2, FGFR1, PI3K reg class IA (p85), IKK-alpha, FGF10, AKT(PKB), PDK (PDPK1), E-cadherin, Syndecan-1, NFKBIA, Alpha-catenin, FGF7, Cyclin D1",
170,Aryl hydrocarbon receptor signaling,53,6.824E-04,8.811E-03,4.251E-03,2.471E-02,18,"CCL1, c-Fos, ESR1 (nuclear), ENTPD2-alpha, H-cadherin, CYP2A13, TY3H, CYP1A2, DAD-1, FOXP3, ITGB7, SOCS2, AHRR, IRF3, ABCG2, TGM1, NQO1, Cathepsin D",6.824E-04,8.811E-03,23,"c-Fos, ESR1 (nuclear), H-cadherin, CYP2A13, TY3H, CYP1A2, DAD-1, TGM3, FOXP3, ITGB7, AHRR, c-Myc, Cathepsin D, ARNT, CCL1, ENTPD2-alpha, DNA polymerase kappa, GSTA1, SOCS2, IRF3, ABCG2, TGM1, NQO1",
171,"Stem cells_Cooperation between Hedgehog, IGF-2 and HGF signaling pathways in medulloblastoma stem cells",32,6.837E-04,8.811E-03,2.104E-02,7.261E-02,11,"GAB1, BMI-1, SHH, PI3K reg class IA, Bcl-2, Bcl-XL, IGF-1 receptor, Cyclin D1, AKT(PKB), PDK (PDPK1), N-Myc",6.837E-04,8.811E-03,16,"GAB1, IRS-1, Lef-1, BAD, PI3K reg class IA, Bcl-XL, IGF-1 receptor, AKT(PKB), PDK (PDPK1), c-Myc, Tcf(Lef), BMI-1, SHH, Bcl-2, Cyclin D1, N-Myc",
172,Sorafenib-induced inhibition of cell proliferation and angiogenesis in HCC,16,6.967E-04,8.030E-03,6.967E-04,8.030E-03,9,"PDGF-B, c-Fos, H-Ras, ERK1/2, VEGFR-1, c-Raf-1, MEK1/2, Cyclin D1, ERK1 (MAPK3)",5.128E-02,1.389E-01,7,"PDGF-B, c-Fos, H-Ras, ERK1/2, ERK1 (MAPK3), VEGFR-1, Cyclin D1",
173,Regulation of lipid metabolism_Regulation of acetyl-CoA carboxylase 2 activity in muscle,19,7.035E-04,8.030E-03,7.035E-04,8.030E-03,10,"AMPK beta subunit, AMPK alpha subunit, AMPK gamma subunit, CPT-1B, MYOG, ACLY, ACACB, MYOD/E47, SP1, MYOD",4.399E-03,2.763E-02,10,"AMPK beta subunit, AMPK gamma subunit, MYOG, ACACB, AMPK alpha subunit, CPT-1B, ACLY, MYOD/E47, SP1, MYOD",
174,Protein folding_Membrane trafficking and signal transduction of G-alpha (i) heterotrimeric G-protein,19,7.035E-04,8.030E-03,7.035E-04,8.030E-03,10,"RGS7, RGS18, G-protein alpha-i family, Adenylate cyclase type VI, G-protein gamma 1, Adenylate cyclase type I, Adenylate cyclase type II, PLC-beta, G-protein gamma, Rap1GAP1",1.591E-02,6.212E-02,9,"RGS18, Adenylate cyclase type VI, G-protein gamma 1, Adenylate cyclase type II, PLC-beta, G-protein gamma, G-protein alpha-i family, Adenylate cyclase type I, Rap1GAP1",
175,Pro-inflammatory action of Gastrin in gastric cancer,50,7.058E-04,8.929E-03,2.806E-02,8.956E-02,15,"MEK1(MAP2K1), p38alpha (MAPK14), GRB2, c-Fos, H-Ras, ERK1/2, c-Raf-1, G-protein alpha-q/11, I-kB, PI3K reg class IA (p85), AP-1, IKK-beta, MEK6(MAP2K6), FAK1, AKT(PKB)",7.058E-04,8.929E-03,22,"GRB2, c-Fos, IRS-1, H-Ras, LARG, ERK1/2, c-Jun/c-Fos, IKK (cat), G-protein alpha-q/11, I-kB, PI3K reg class IA (p85), IKK-alpha, MEK6(MAP2K6), AKT(PKB), PKC-delta, CCKBR, c-Jun, AP-1, MEKK1(MAP3K1), IKK-beta, FAK1, G-protein alpha-q",
176,IGF-1 signaling in multiple myeloma,50,7.058E-04,8.929E-03,2.052E-03,1.650E-02,18,"GRB2, H-Ras, ERK1/2, c-Raf-1, I-kB, PRKD1, FOXO4, p70 S6 kinase1, PI3K reg class IA, PTEN, FAK1, GSK3 alpha/beta, IGF-1 receptor, MEK1/2, AKT(PKB), IGF-1, PDK (PDPK1), ERK1 (MAPK3)",7.058E-04,8.929E-03,22,"GRB2, IRS-1, H-Ras, ERK1/2, IKK (cat), BAD, I-kB, PI3K reg class IA, IKK-alpha, GSK3 alpha/beta, IGF-1 receptor, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), Paxillin, PRKD1, FOXO4, p70 S6 kinase1, PTEN, FOXO3A, FAK1, IGF-1",
177,Role of tumor microenvironment in plexiform neurofibroma formation in neurofibromatosis type 1,39,7.126E-04,8.030E-03,7.126E-04,8.030E-03,16,"MEK1(MAP2K1), PDGF-B, GRB2, K-RAS, MMP-1, H-Ras, ERK1/2, c-Raf-1, PAK1, Tryptase, MGF, PI3K reg class IA (p85), MEK1/2, AKT(PKB), PDK (PDPK1), p38 MAPK",4.392E-02,1.255E-01,14,"TrkA, PDGF-B, GRB2, H-Ras, ERK1/2, PI3K reg class IA (p85), AKT(PKB), PDK (PDPK1), K-RAS, MMP-1, PAK1, Tryptase, MGF, p38 MAPK",
178,TrkB signaling in Huntington's disease,39,7.126E-04,8.030E-03,7.126E-04,8.030E-03,16,"MEK1(MAP2K1), Dopamine D1A receptor, AKT1, Huntingtin, GRB2, H-Ras, NR1, ERK1/2, c-Raf-1, p90Rsk, IP3 receptor, PI3K reg class IA (p85), Calmodulin, PKC, SP1, PDK (PDPK1)",4.392E-02,1.255E-01,14,"AKT1, Huntingtin, GRB2, H-Ras, NR1, ERK1/2, IP3 receptor, PI3K reg class IA (p85), PDK (PDPK1), Dopamine D1A receptor, Calmodulin, PKC, GluR1, SP1",
179,Development_ERBB-family signaling,39,7.126E-04,8.030E-03,7.126E-04,8.030E-03,16,"MEK1(MAP2K1), EGF, GRB2, c-Fos, Neuregulin 1, H-Ras, GRB7, ERK1/2, ErbB3, c-Raf-1, I-kB, Amphiregulin, Neuregulin 3, ErbB2, PI3K reg class IA, AKT(PKB)",2.004E-02,7.219E-02,15,"EGF, GRB2, c-Fos, H-Ras, GRB7, ERK1/2, ErbB3, IKK (cat), I-kB, Amphiregulin, ErbB2, PI3K reg class IA, AKT(PKB), c-Myc, Neuregulin 3",
180,Immune response_TSLP signalling,39,7.126E-04,8.030E-03,7.126E-04,8.030E-03,16,"CCL17, H-Ras, ERK1/2, c-Raf-1, NFKBIA, STAT3, CISH, PI3K reg class IA, Bcl-2, MEK1/2, JNK(MAPK8-10), STAT6, IL-4, AKT(PKB), PDK (PDPK1), p38 MAPK",8.315E-03,4.186E-02,16,"CCL17, H-Ras, ERK1/2, CISH, PI3K reg class IA, IKK-alpha, Claudin-7, IL-4, AKT(PKB), PDK (PDPK1), c-Myc, NFKBIA, Bcl-2, JNK(MAPK8-10), STAT6, p38 MAPK",
181,Signal transduction_Leptin signaling via JAK/STAT and MAPK cascade,39,7.126E-04,8.030E-03,7.126E-04,8.030E-03,16,"Thyroliberin, GRB2, c-Fos, G6PT, ERK1/2, Cytochrome c, p90Rsk, STAT3, AP-1, cPLA2, Bcl-XL, MEK1/2, JNK(MAPK8-10), SP1, Leptin, CART",4.392E-02,1.255E-01,14,"GRB2, c-Fos, ERK1/2, Cytochrome c, cPLA2, Bcl-XL, Thyroliberin, c-Jun, AP-1, SHP-2, JNK(MAPK8-10), SP1, Leptin, CART",
182,PXR-mediated direct regulation of xenobiotic metabolizing enzymes / Rodent version,39,7.126E-04,8.030E-03,7.126E-04,8.030E-03,16,"CYP2C8, OATP-A, S14 protein, CES2, G6PT, CYP3A5, RXRA, PXR, CD36, ACLY, CYP3A43, MRP3, PXR/RXR-alpha, CYP3A4, ABCG2, ABCC2",2.004E-02,7.219E-02,15,"S14 protein, CES2, CYP3A5, CYP3A43, CYP2C19, PXR/RXR-alpha, OATP-A, RXRA, PXR, CD36, CYP2B6, ACLY, MRP3, ABCG2, ABCC2",
183,Production and activation of TGF-beta in airway smooth muscle cells,35,7.167E-04,8.929E-03,1.665E-02,6.159E-02,12,"c-Fos, G-protein alpha-i family, ERK1/2, AGTR1, TGF-beta, Beta-tryptase 2, Tryptase, NFKBIA, AP-1, TGF-beta 3, LTBP1, MEK1/2",7.167E-04,8.929E-03,17,"c-Fos, ERK1/2, EGR1, c-Jun/c-Fos, Beta-tryptase 2, Plasminogen, MyD88, G-protein alpha-i family, c-Jun, AGTR1, TGF-beta, Plasmin, Tryptase, NFKBIA, AP-1, TGF-beta 3, LTBP1",
184,TNF-alpha and IL-1 beta induce hyperglycemia in obesity and type 2 diabetes in adipocytes,35,7.167E-04,8.929E-03,6.134E-03,3.211E-02,13,"MEK1(MAP2K1), GM3 synthase, Insulin processed, TRAF2, TRADD, GRB14, NFKBIA, MAPKAPK2, Insulin receptor, IKK-beta, MEK6(MAP2K6), IL-1RI, p38 MAPK",7.167E-04,8.929E-03,17,"GPX3, GM3 synthase, Insulin processed, IRS-1, PKC-zeta, TRADD, GLUT4, MAPKAPK2, Insulin receptor, MEK6(MAP2K6), IL-1RI, TRAF2, PTP-1B, NFKBIA, IKK-beta, AKT2, p38 MAPK",
185,Canonical Notch signaling pathway in colorectal cancer,47,7.245E-04,8.934E-03,3.515E-02,1.048E-01,14,"AES (GRG), p21, KLF4, Lunatic fringe, DLL1, p70 S6 kinase1, Mucin 2, WNT, Cyclin D1, AKT(PKB), TLE1, NOX1, p27KIP1, Keratin 20",7.245E-04,8.934E-03,21,"Lef-1, AES (GRG), p21, KLF4, DLL1, Radical fringe, AKT(PKB), TLE1, NOX1, p27KIP1, Keratin 20, MAML1, Ephrin-B receptor 3, DLL4, Lunatic fringe, 4E-BP1, p70 S6 kinase1, Mucin 2, WNT, HES6, Cyclin D1",
186,Neurophysiological process_Leptin signaling in neurons,50,7.310E-04,8.030E-03,7.310E-04,8.030E-03,19,"IRS-4, MaxiK alpha subunit, ACACA, PDE3B, AMPK alpha subunit, RFX1, Kir6.2, AMPK alpha 2 subunit, STAT3, TY3H, PI3K reg class IA (p85), CPT-1C, p70 S6 kinase1, PTEN, IFT20, KIF3A, AKT(PKB), PDK (PDPK1), Leptin",1.098E-02,4.886E-02,19,"MaxiK alpha subunit, PDE3B, IRS-1, RFX1, Kir6.2, TY3H, PI3K reg class IA (p85), CPT-1C, IFT20, KIF3A, AKT(PKB), PDK (PDPK1), IRS-4, AMPK alpha subunit, AMPK alpha 2 subunit, SH2B, p70 S6 kinase1, PTEN, Leptin",
187,Survival pathways in Prostate Cancer,50,7.310E-04,8.030E-03,7.310E-04,8.030E-03,19,"MEK1(MAP2K1), Tuberin, H-Ras, CCR2, c-Raf-1, FADD, STAT3, Androgen receptor, I-kB, PI3K reg class IA, PTEN, Bcl-2, MDM2, Bcl-XL, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), TRID(TNFRSF10C), IL-6 receptor",1.098E-02,4.886E-02,19,"Tuberin, H-Ras, CCR2, IKK (cat), FADD, BAD, Androgen receptor, I-kB, PI3K reg class IA, IKK-alpha, MDM2, Bcl-XL, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), PTEN, Bcl-2, TRID(TNFRSF10C), IL-6 receptor",
188,Apoptosis and survival_HTR1A signaling,50,7.310E-04,8.030E-03,7.310E-04,8.030E-03,19,"MEK1(MAP2K1), GRB2, G-protein alpha-i family, H-Ras, SLC9A1, PP2A regulatory, PKA-reg (cAMP-dependent), c-Raf-1, Cytochrome c, STAT3, I-kB, Calmodulin, PP2A structural, Adenylate cyclase, Bcl-2, AKT(PKB), PDK (PDPK1), HTR1A, ERK1 (MAPK3)",1.098E-02,4.886E-02,19,"GRB2, H-Ras, SLC9A1, PP2A regulatory, PKA-reg (cAMP-dependent), IKK (cat), Cytochrome c, I-kB, IKK-alpha, PP2A structural, Adenylate cyclase, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), PARP-1, G-protein alpha-i family, Calmodulin, Bcl-2, PI3K reg class IB (p101)",
189,Development_Flt3 signaling,44,7.368E-04,8.934E-03,8.358E-03,3.854E-02,15,"MEK1(MAP2K1), GRB2, GAB1, H-Ras, ERK1/2, c-Raf-1, FLT3, PAK1, p90Rsk, PI3K reg class IA (p85), MEK6(MAP2K6), Bcl-XL, AKT(PKB), PDK (PDPK1), p38 MAPK",7.368E-04,8.934E-03,20,"GRB2, GAB1, H-Ras, ERK1/2, FLT3, Rac1, BAD, PI3K reg class IA (p85), MEK6(MAP2K6), Bcl-XL, SHIP, AKT(PKB), PDK (PDPK1), MEKK4(MAP3K4), c-Jun, PAK1, MKK7 (MAP2K7), MEKK1(MAP3K1), SHP-2, p38 MAPK",
190,CHDI_Correlations from Replication data_Causal network (positive correlations),79,7.389E-04,8.934E-03,3.986E-02,1.170E-01,21,"CD80, MHC class II, Calcineurin A (catalytic), Huntingtin, MSK1/2 (RPS6KA5/4), MEF2, IP3 receptor, VIL2 (ezrin), I-kB, PI3K reg class IA (p85), Calmodulin, CD3, IKK-beta, IL-1RI, IP3R1, JNK(MAPK8-10), CD40(TNFRSF5), AKT(PKB), HSP70, p38 MAPK, SDF-1",7.389E-04,8.934E-03,31,"MHC class II, Calcineurin A (catalytic), Huntingtin, NF-AT1(NFATC2), MSK1/2 (RPS6KA5/4), IP3 receptor, VIL2 (ezrin), NMDA receptor, I-kB, PI3K reg class IA (p85), MyD88, ZAP70, IKK-alpha, NR2, ITK, IL-1RI, AKT(PKB), HSP70, SDF-1, MEKK4(MAP3K4), c-Jun, MEF2, LAT, Calmodulin, IKK-beta, IP3R1, JNK(MAPK8-10), CD40(TNFRSF5), PI3K reg class IB (p101), TCR alpha/beta, p38 MAPK",
191,GTP metabolism,54,7.848E-04,8.435E-03,7.848E-04,8.435E-03,20,"NDPK C, PDE6C, NDPK complex, KGUA, PDE6B, GUCY1B2, Guanylate cyclase alpha, PDE6G, GUCY1A2, NDPK 6, Guanylate cyclase beta, PDE1B, NDPK A, NDPK 8, Guanylate cyclase 2D (RETGC1), NDPK D (mitochondrial), ENP3, Guanylate Cyclase 1, soluble, ENP1, NDPK B",1.259E-02,5.409E-02,20,"NDPK complex, PDE6B, GUCY1B2, NDPK 6, PDE1B, Guanylate Cyclase 1, soluble, ENP1, NDPK C, PDE6C, KGUA, Guanylate cyclase alpha, PDE6G, GUCY1A2, Guanylate cyclase beta, NDPK A, NDPK 8, Guanylate cyclase 2D (RETGC1), NDPK D (mitochondrial), ENP3, NDPK B",
192,Regulation of AKT(PKB)/ GSK3 beta cascade in bipolar disorder,54,7.848E-04,8.435E-03,7.848E-04,8.435E-03,20,"GRB2, GAB1, Neuregulin 1, G-protein alpha-i family, H-Ras, ESR1 (membrane), FGFR1, Epo receptor, PI3K reg class IA (p85), Calmodulin, PTEN, CNR1, GFRalpha1, IGF-1 receptor, AKT(PKB), RET, IGF-1, PDK (PDPK1), HTR1A, Epo",9.353E-04,1.092E-02,23,"TrkA, GRB2, GAB1, IRS-1, H-Ras, ESR1 (membrane), FGFR1, NMDA receptor, PI3K reg class IA (p85), CNR1, GFRalpha1, IGF-1 receptor, AKT(PKB), RET, PDK (PDPK1), Epo, G-protein alpha-i family, Epo receptor, 14-3-3 beta/alpha, Calmodulin, PTEN, SHP-2, IGF-1",
193,Development_Differentiation of white adipocytes ,54,7.848E-04,8.435E-03,7.848E-04,8.435E-03,20,"MEK1(MAP2K1), p38alpha (MAPK14), A-FABP, SREBP1 (nuclear), GRB2, Insulin processed, H-Ras, ERK1/2, c-Raf-1, p90RSK1, LIPS, Factor D, SREBP1 precursor, Rb protein, Insulin receptor, MEK1/2, LXR-alpha, Leptin, Perilipin, C/EBPalpha",8.977E-02,2.037E-01,17,"SREBP1 (nuclear), GRB2, Insulin processed, H-Ras, ERK1/2, PRKAR1A, SREBP1 precursor, Rb protein, Resistin, Insulin receptor, LIPS, Factor D, TAB1, SMAD1, Leptin, Perilipin, C/EBPalpha",
194,Immune response_IL-18 signaling,63,7.967E-04,9.529E-03,2.724E-03,1.938E-02,21,"GRB2, c-Fos, H-Ras, ERK1/2, c-Raf-1, p67-phox, I-kB, AP-1, PI3K reg class IA, IKK-beta, MEK6(MAP2K6), Bcl-2, Bcl-XS, MEK1/2, JNK(MAPK8-10), TAB2, AKT(PKB), SP1, PDK (PDPK1), p38 MAPK, E-selectin",7.967E-04,9.529E-03,26,"GRB2, c-Fos, H-Ras, ERK1/2, c-Jun/c-Fos, IKK (cat), Rac1, I-kB, PI3K reg class IA, MyD88, IKK-alpha, MEK6(MAP2K6), Bcl-XS, FasL(TNFSF6), TAB2, AKT(PKB), PDK (PDPK1), E-selectin, c-Jun, AP-1, IKK-beta, Bcl-2, TAB1, JNK(MAPK8-10), SP1, p38 MAPK",
195,Nicotine / nAChR alpha-7 signaling in NSCLC,43,8.129E-04,8.613E-03,8.129E-04,8.613E-03,17,"MEK1(MAP2K1), Tuberin, E2F1, H-Ras, ERK1/2, CACNA1C, c-Raf-1, AP-2A, p90Rsk, PI3K reg class IA (p85), Rb protein, Calmodulin, Cyclin D1, AKT(PKB), SP1, Beta-arrestin1, PDK (PDPK1)",9.246E-02,2.069E-01,14,"Tuberin, H-Ras, ERK1/2, PI3K reg class IA (p85), Rb protein, AKT(PKB), PDK (PDPK1), E2F1, CACNA1C, AP-2A, Calmodulin, Cyclin D1, SP1, Beta-arrestin1",
196,Neurophysiological process _Visual perception,29,8.250E-04,8.648E-03,8.250E-04,8.648E-03,13,"SLC24A1, CNGB1, GCAP1, SLC24A2, R9AP, Rhodopsin, S-arrestin, PDE6G, Calmodulin, CNG, Guanylate cyclase 2D (RETGC1), GCAP2, CNG-alpha",2.255E-03,1.823E-02,14,"CNGB1, GCAP1, Rhodopsin, CNG, GCAP2, CNG-alpha, SLC24A1, SLC24A2, R9AP, Transducin, rod-specific, S-arrestin, PDE6G, Calmodulin, Guanylate cyclase 2D (RETGC1)",
197,Development_EPO-induced Jak-STAT pathway,36,8.568E-04,8.806E-03,8.568E-04,8.806E-03,15,"MEK1(MAP2K1), GRB2, H-Ras, ERK1/2, c-Raf-1, STAT3, Epo receptor, CISH, Calmodulin, Bcl-2, Bcl-XL, MSK1, SHP-1, Epo, ERK1 (MAPK3)",2.192E-02,7.602E-02,14,"GRB2, H-Ras, ERK1/2, CISH, Bcl-XL, MSK1, SHP-1, c-Myc, Epo, ERK1 (MAPK3), Epo receptor, Calmodulin, SHP-2, Bcl-2",
198,HBV signaling via protein kinases leading to HCC,36,8.568E-04,8.806E-03,8.568E-04,8.806E-03,15,"MEK1(MAP2K1), cPKC (conventional), GRB2, c-Fos, NCOA6 (TRBP), H-Ras, ERK1/2, JAB1, c-Raf-1, Androgen receptor, AP-1, PKC, FAK1, JNK(MAPK8-10), SP1",1.072E-03,1.202E-02,17,"GRB2, c-Fos, NCOA6 (TRBP), H-Ras, ERK1/2, c-Jun/c-Fos, Androgen receptor, c-Myc, cPKC (conventional), c-Jun, JAB1, AP-1, PKC, MEKK1(MAP3K1), FAK1, JNK(MAPK8-10), SP1",
199,"Immune response_IL-2 signaling via ERK, PI3K, and PLC-gamma",73,8.570E-04,1.017E-02,3.959E-03,2.424E-02,23,"GRB2, c-Fos, E2F1, H-Ras, ERK1/2, c-Raf-1, STAT3, p70 S6 kinases, PI3K reg class IA (p85), Sirtuin1, p70 S6 kinase1, Rb protein, Aiolos, Bcl-2, c-Myb, IL-2R beta chain, Bcl-XL, MEK1/2, PYGM, AKT(PKB), p70 S6 kinase2, p27KIP1, ERK1 (MAPK3)",8.570E-04,1.017E-02,29,"Cyclin D3, GRB2, c-Fos, IRS-1, H-Ras, ERK1/2, Rac1, p70 S6 kinases, PI3K reg class IA (p85), Rb protein, Aiolos, c-Myb, Bcl-XL, AKT(PKB), p27KIP1, c-Myc, IL-2R alpha chain, ERK1 (MAPK3), E2F1, c-Jun, 4E-BP1, Sirtuin1, p70 S6 kinase1, SHP-2, Bcl-2, FOXO3A, IL-2R beta chain, PYGM, p70 S6 kinase2",
200,Regulation of CFTR activity (normal and CF),62,8.606E-04,8.806E-03,8.606E-04,8.806E-03,22,"Calcineurin A (catalytic), SHANK2, AMPK beta subunit, G-protein alpha-i family, PRKAR2A, PDZK1, CFTR, EBP50, PP2A regulatory, AMPK gamma1, PKA-reg type II (cAMP-dependent), PKA-reg (cAMP-dependent), PP2C, E3KARP (NHERF2), VIL2 (ezrin), G-protein alpha-s, PDE4D, Filamin B (TABP), PP2A structural, Adenylate cyclase, SNAP-23, Tubulin (in microtubules)",3.466E-03,2.366E-02,24,"Calcineurin A (catalytic), SHANK2, COMMD1 (MURR1), AMPK beta subunit, PDZK1, PP2A regulatory, PKA-reg (cAMP-dependent), PP2C, Syntaxin 1A, VIL2 (ezrin), PDE4D, PP2A structural, Adenylate cyclase, Tubulin (in microtubules), MUNC18, G-protein alpha-i family, PRKAR2A, EBP50, AMPK gamma1, PKA-reg type II (cAMP-dependent), E3KARP (NHERF2), G-protein alpha-s, Filamin B (TABP), SNAP-23",
201,Development_TGF-beta-dependent induction of EMT via MAPK ,47,8.987E-04,9.090E-03,8.987E-04,9.090E-03,18,"MEK1(MAP2K1), p38alpha (MAPK14), E-cadherin, GRB2, c-Fos, H-Ras, ERK1/2, TGF-beta, c-Raf-1, DAB2, AP-1, PTEN, TGF-beta 3, MEK6(MAP2K6), FAK1, Occludin, JNK(MAPK8-10), p38 MAPK",5.099E-03,3.013E-02,19,"GRB2, c-Fos, H-Ras, ERK1/2, c-Jun/c-Fos, DAB2, Rac1, MEK6(MAP2K6), E-cadherin, c-Jun, TGF-beta, MKK7 (MAP2K7), AP-1, PTEN, TGF-beta 3, FAK1, Occludin, JNK(MAPK8-10), p38 MAPK",
202,Signal transduction_HTR2A signaling outside the nervous system,74,9.066E-04,9.090E-03,9.066E-04,9.090E-03,25,"PFKM, cPKC (conventional), E2F1, G-protein alpha-i family, H-Ras, SLC9A1, ERK1/2, c-Raf-1, Ca(II)channel L-type, G-protein alpha-q/11, ARF1, STAT3, PI3K reg class IA (p85), GP-IB alpha, p70 S6 kinase1, Rb protein, Calmodulin, PKC, PLC-beta, Adenylate cyclase, MEK1/2, Cyclin D1, AKT(PKB), p38 MAPK, GP-V",2.012E-02,7.231E-02,25,"IRS-1, H-Ras, SLC9A1, ERK1/2, EGR1, G-protein alpha-q/11, PI3K reg class IA (p85), Rb protein, PLC-beta, Adenylate cyclase, AKT(PKB), PFKM, cPKC (conventional), E2F1, G-protein alpha-i family, KV1.5, Ca(II)channel L-type, ARF1, GP-IB alpha, p70 S6 kinase1, Calmodulin, PKC, Cyclin D1, p38 MAPK, GP-V",
203,Neurophysiological process_Regulation of intrinsic membrane properties and excitability of cortical pyramidal neurons,74,9.066E-04,9.090E-03,9.066E-04,9.090E-03,25,"Dopamine D1A receptor, MaxiK alpha subunit, cPKC (conventional), TRPC4, Calcineurin A (catalytic), Adenosine A1 receptor, G-protein alpha-i family, CACNA1C, PKA-reg (cAMP-dependent), Neurocalcin delta, Alpha-2A adrenergic receptor, G-protein alpha-q/11, NAV1.9, ACM1, Kir2.2, IP3 receptor, CACNA1D, KCNQ3, G-protein alpha-s, Calmodulin, PKC, Adenylate cyclase, HPCA, SK2, HTR1A",1.055E-02,4.816E-02,26,"MaxiK alpha subunit, Calcineurin A (catalytic), PKA-reg (cAMP-dependent), Neurocalcin delta, G-protein alpha-q/11, Kir2.2, PLC-beta1, IP3 receptor, KCNQ3, HTR2C (HTR1C), Adenylate cyclase, SK2, Dopamine D1A receptor, cPKC (conventional), Adenosine A1 receptor, G-protein alpha-i family, CACNA1C, Alpha-2A adrenergic receptor, ACM1, CACNA1D, G-protein alpha-s, Calmodulin, PKC, G-protein alpha-q, KCNQ2, N-type Ca(II) channel alpha1B",
204,IL-6 signaling in multiple myeloma,51,9.695E-04,9.657E-03,9.695E-04,9.657E-03,19,"MEK1(MAP2K1), gp130, GRB2, K-RAS, E2F1, ERK1/2, c-Raf-1, p21, IL6RA, STAT3, PI3K reg class IA (p85), Rb protein, MDM2, Bcl-XL, Cyclin D1, AKT(PKB), PDK (PDPK1), p27KIP1, IL-6 receptor",1.384E-02,5.844E-02,19,"gp130, GRB2, ERK1/2, p21, BAD, PI3K reg class IA (p85), Rb protein, MDM2, Bcl-XL, AKT(PKB), PDK (PDPK1), p27KIP1, K-RAS, E2F1, c-Jun, IL6RA, SHP-2, Cyclin D1, IL-6 receptor",
205,Role of neuropeptides in pathogenesis of SCLC,67,9.865E-04,1.060E-02,1.119E-03,1.060E-02,23,"Substance P extracellular region, CCK8, cPKC (conventional), G-protein alpha-12 family, GRB2, c-Fos, H-Ras, ERK1/2, ErbB3, BDKRB1, c-Raf-1, BDKRB2, G-protein alpha-q/11, p90Rsk, IP3 receptor, GRP-R, p70 S6 kinase1, ErbB2, PKC, PLC-beta, NTSR1, MEK1/2, AKT(PKB)",9.865E-04,1.134E-02,27,"Substance P extracellular region, GRB2, c-Fos, H-Ras, ERK1/2, ErbB3, BDKRB1, BDKRB2, G-protein alpha-q/11, PLC-beta1, IP3 receptor, GRP-R, ErbB2, PLC-beta, NTSR1, AKT(PKB), CCK8, cPKC (conventional), G-protein alpha-12 family, PKC-delta, CCKBR, c-Jun, Bradykinin, 4E-BP1, p70 S6 kinase1, PKC, G-protein alpha-q",
206,Development_EGF-induced proliferation of Type C cells in SVZ of adult brain,33,1.025E-03,1.002E-02,1.025E-03,1.002E-02,14,"MEK1(MAP2K1), EGF, GRB2, H-Ras, ERK1/2, c-Raf-1, SHH, Prolactin receptor, PI3K reg class IA (p85), SOX2, AKT(PKB), PDK (PDPK1), p27KIP1, SUFU",5.438E-02,1.424E-01,12,"EGF, GRB2, H-Ras, ERK1/2, Prolactin receptor, PI3K reg class IA (p85), AKT(PKB), PDK (PDPK1), p27KIP1, SUFU, SHH, SOX2",
207,Transcription_Sirtuin6 regulation and functions ,63,1.099E-03,1.060E-02,1.099E-03,1.060E-02,22,"PFKM, ACACA, SREBP1 (nuclear), SCD, AMPK beta subunit, G6PT, GCN5, AMPK alpha subunit, AMPK gamma subunit, Sirtuin6, FASN, SREBP1 (Golgi membrane), CD36, Ubiquitin, SREBP1 precursor, CPT-1A, GLUT1, Sirtuin1, LKB1, SCAP, ACOX1, CHIP",1.933E-03,1.795E-02,25,"SREBP1 (nuclear), SCD, AMPK beta subunit, GCN5, ATF-4, AMPK gamma subunit, Sirtuin6, FASN, Ubiquitin, SREBP1 precursor, CPT-1A, HMGCS1, ACOX1, miR-33a-5p, PFKM, PARP-1, AMPK alpha subunit, SREBP1 (Golgi membrane), CD36, GLUT1, Sirtuin1, LKB1, FOXO3A, SCAP, CHIP",
208,Immune response_IL-11 signaling pathway via MEK/ERK and PI3K/AKT cascades,67,1.119E-03,1.060E-02,1.119E-03,1.060E-02,23,"SP7, gp130, GRB2, c-Fos, H-Ras, ERK1/2, c-Raf-1, p90Rsk, NFKBIA, YAP1 (YAp65), I-kB, p70 S6 kinases, PI3K reg class IA (p85), Rb protein, Bone sialoprotein, MEK1/2, Cyclin D1, Myeloblastin, IL-4, AKT(PKB), PDK (PDPK1), SFK, p27KIP1",2.304E-03,1.823E-02,26,"SP7, gp130, GRB2, c-Fos, H-Ras, ERK1/2, IKK (cat), IL11RA, I-kB, p70 S6 kinases, PI3K reg class IA (p85), Rb protein, IKK-alpha, Bone sialoprotein, IL-4, AKT(PKB), PDK (PDPK1), SFK, p27KIP1, c-Jun, IL-11 receptor, NFKBIA, sIL11-RA, SHP-2, Cyclin D1, Myeloblastin",
209,Development_Positive regulation of STK3/4 (Hippo) pathway and negative regulation of YAP/TAZ function,71,1.128E-03,1.060E-02,1.128E-03,1.060E-02,24,"Dopamine D1A receptor, E-cadherin, SCRIB, AMPK beta subunit, beta-TrCP, Alpha-1 catenin, AMPK alpha subunit, AMPK gamma subunit, EBP50, PKA-reg (cAMP-dependent), c-Raf-1, KIBRA, MARK1, Alpha-catenin, YAP1 (YAp65), CRB3, LATS1, G-protein alpha-s, LKB1, Adenylate cyclase, CCDC85C, MARK4, Skp2/TrCP/FBXW, Axin",1.194E-03,1.293E-02,28,"Casein kinase I delta, SCRIB, INADL, AMPK beta subunit, Alpha-1 catenin, 14-3-3, AMPK gamma subunit, PKA-reg (cAMP-dependent), CRB3, LATS1, Adenylate cyclase, CCDC85C, Skp2/TrCP/FBXW, Axin, GCGR, Dopamine D1A receptor, E-cadherin, beta-TrCP, AMPK alpha subunit, EBP50, MARKK, KIBRA, MARK1, Alpha-catenin, MALS-3, G-protein alpha-s, LKB1, MARK4",
210,Immune response_IL-6 signaling pathway via JAK/STAT,71,1.194E-03,1.293E-02,2.471E-02,8.276E-02,20,"SP7, gp130, GRB2, c-Fos, JunB, ROR-gamma, p21, IL6RA, STAT3, Fc gamma RI, AP-1, CISH, Insulin receptor, IL23R, SOCS2, AKT(PKB), SP1, sIL6-RA, p27KIP1, IL-6 receptor",1.194E-03,1.293E-02,28,"SP7, gp130, GRB2, c-Fos, IRS-1, c-Jun/c-Fos, p21, Rac1, CISH, Insulin receptor, IL23R, AKT(PKB), ICOS, p27KIP1, JunB, PKC-delta, ROR-gamma, c-Jun, IL6RA, Fc gamma RI, AP-1, MEKK1(MAP3K1), SHP-2, FOXO3A, SOCS2, SP1, sIL6-RA, IL-6 receptor",
211,Development_Growth factors in regulation of oligodendrocyte precursor cell survival,37,1.202E-03,1.116E-02,1.202E-03,1.116E-02,15,"Neuregulin 1, ErbB3, c-Raf-1, p90Rsk, NFKBIA, PI3K reg class IA (p85), p70 S6 kinase1, ErbB2, PI3K reg class IA, Bcl-2, Bcl-XL, IGF-1 receptor, AKT(PKB), IGF-1, PDK (PDPK1)",1.567E-03,1.531E-02,17,"IRS-1, ErbB3, BAD, PI3K reg class IA (p85), ErbB2, PI3K reg class IA, IKK-alpha, Bcl-XL, IGF-1 receptor, AKT(PKB), PDK (PDPK1), NFKBIA, 4E-BP1, 14-3-3 beta/alpha, p70 S6 kinase1, Bcl-2, IGF-1",
212,Development_FGF10 in development of subcutaneous white adipose tissue in embryogenesis,17,1.243E-03,1.126E-02,1.243E-03,1.126E-02,9,"MEK1(MAP2K1), A-FABP, GRB2, H-Ras, ERK1/2, c-Raf-1, FRS2, FGF10, C/EBPalpha",7.053E-02,1.695E-01,7,"GRB2, H-Ras, ERK1/2, FRS2, FGF10, c-Jun, C/EBPalpha",
213,DeltaF508-CFTR traffic / ER-to-Golgi in CF,17,1.243E-03,1.126E-02,1.243E-03,1.126E-02,9,"CFTR, MAST205, EBP50, SAR1A, Ubiquitin, Sec24, SAR1, Sec31, Sec23",7.053E-02,1.695E-01,7,"Ubiquitin, Sec31, Sec23, EBP50, SAR1A, Sec24, SAR1",
214,wtCFTR traffic / ER-to-Golgi (normal),17,1.243E-03,1.126E-02,1.243E-03,1.126E-02,9,"CFTR, MAST205, EBP50, SAR1A, Ubiquitin, Sec24, SAR1, Sec31, Sec23",7.053E-02,1.695E-01,7,"Ubiquitin, Sec31, Sec23, EBP50, SAR1A, Sec24, SAR1",
215,MAPK-mediated proliferation of normal and asthmatic smooth muscle cells,56,1.328E-03,1.195E-02,1.328E-03,1.195E-02,20,"p38alpha (MAPK14), EGF, PDGF-B, c-Fos, K-RAS, G-protein alpha-i family, ERK1/2, c-Raf-1, p90Rsk, FGFR1, IP3 receptor, p70 S6 kinases, Amphiregulin, Rb protein, ErbB2, PLC-beta, MKP-1, MEK1/2, Cyclin D1, IL-4",6.920E-02,1.679E-01,18,"EGF, PDGF-B, c-Fos, ERK1/2, FGFR1, IP3 receptor, p70 S6 kinases, Amphiregulin, Rb protein, ErbB2, Thrombin, PLC-beta, IL-13, IL-4, K-RAS, G-protein alpha-i family, MKP-1, Cyclin D1",
216,Neurophysiological process_Synaptic vesicle fusion and recycling in nerve terminals,52,1.334E-03,1.434E-02,3.368E-03,2.154E-02,18,"Calcineurin A (catalytic), SNAP-25, Rab-3A, SNAPalpha, Complexin, MUNC13-1, Synaptotagmin I, SGTA, PIPKI gamma, Synapsin I, Calmodulin, DNAJC6, Csp, Rabphilin-3A, Clathrin, RIMS1, Snapin, Amphiphysin I",1.334E-03,1.434E-02,22,"NSF, Calcineurin A (catalytic), Rab-3A, Complexin, Syntaxin 1A, Synaptotagmin I, Synapsin I, Csp, RIMS1, Snapin, Amphiphysin I, HSC70, MUNC18, SNAPalpha, SGTA, PIPKI gamma, Calmodulin, DNAJC6, Rabphilin-3A, SYP, Clathrin, N-type Ca(II) channel alpha1B",
217,IGF-1 receptor/EGFR cooperation in lung cancer,25,1.366E-03,1.449E-02,2.627E-02,8.495E-02,9,"Tuberin, p90Rsk, Amphiregulin, p70 S6 kinase1, PI3K reg class IA, IGF-1 receptor, AKT(PKB), IGF-1, PDK (PDPK1)",1.366E-03,1.449E-02,13,"Tuberin, IRS-1, PKC-zeta, BAD, Amphiregulin, PI3K reg class IA, IGF-1 receptor, AKT(PKB), PDK (PDPK1), PKC-delta, 4E-BP1, p70 S6 kinase1, IGF-1",
218,Apoptosis and survival_Role of nuclear PI3K in NGF/ TrkA signaling,25,1.366E-03,1.449E-02,2.627E-02,8.495E-02,9,"AKT1, E2F1, Ebp1, RPS3, Acinus, PI3K reg class IA (p85), PIKE(CENTG1), AKT(PKB), PDK (PDPK1)",1.366E-03,1.449E-02,13,"TrkA, AKT1, PKC-zeta, Acinus, PI3K reg class IA (p85), PIKE(CENTG1), Nucleophosmin, AKT(PKB), PDK (PDPK1), PKC-delta, E2F1, Ebp1, RPS3",
219,EGFR signaling pathway in colorectal cancer,60,1.368E-03,1.223E-02,1.368E-03,1.223E-02,21,"EGF, AKT1, GRB2, c-Fos, K-RAS, MMP-1, H-Ras, ERK1/2, p90Rsk, I-kB, PI3K reg class IA (p85), Amphiregulin, ErbB2, PTEN, NTSR1, Bcl-XL, MEK1/2, Cyclin D1, Beta-arrestin1, PDK (PDPK1), ABCC2",4.804E-03,2.898E-02,23,"EGF, AKT1, GRB2, c-Fos, H-Ras, ERK1/2, BAD, I-kB, PI3K reg class IA (p85), Amphiregulin, ErbB2, Thrombin, IKK-alpha, NTSR1, Bcl-XL, PDK (PDPK1), K-RAS, MMP-1, PTEN, FOXO3A, Cyclin D1, Beta-arrestin1, ABCC2",
220,Ovarian cancer (main signaling cascades),65,1.382E-03,1.455E-02,9.228E-03,4.116E-02,20,"E-cadherin, EGF, GRB2, c-Fos, ESR1 (nuclear), K-RAS, G-protein alpha-i family, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), ILK, Androgen receptor, I-kB, ErbB2, PI3K reg class IA, PTEN, MEK1/2, Cyclin D1, AKT(PKB), SP1",1.382E-03,1.455E-02,26,"EGF, GRB2, c-Fos, ESR1 (nuclear), H-Ras, ERK1/2, PKA-reg (cAMP-dependent), Androgen receptor, I-kB, ErbB2, PI3K reg class IA, IKK-alpha, AKT(PKB), c-Myc, LH receptor, E-cadherin, FSH-beta, K-RAS, Tcf(Lef), G-protein alpha-i family, ILK, PTEN, MEKK1(MAP3K1), Cyclin D1, SP1, PI3K reg class IB (p101)",
221,Transcription_N-CoR/ SMRT complex-mediated epigenetic gene silencing,49,1.398E-03,1.462E-02,4.208E-03,2.471E-02,17,"TR-alpha, TBL1X, c-Fos, PBX1a/HOXB1, RXRA, CORO2A, RAR-alpha/RXR-alpha, PBX1, TRa/RXRa, TR-beta, Ubiquitin, ETO, AP-1, BAF170, RARalpha, T3Rbeta/RXR-alpha, HOXB1",1.398E-03,1.462E-02,21,"TR-alpha, TBL1X, c-Fos, PBX1a/HOXB1, c-Jun/c-Fos, TRa/RXRa, TR-beta, Ubiquitin, ETO, RARalpha, HOXB1, REV-ERBalpha, c-Jun, RXRA, CORO2A, RAR-alpha/RXR-alpha, PBX1, AP-1, PIT1, BAF170, T3Rbeta/RXR-alpha",
222,Pancreatic cancer cell resistance to Tarceva (erlotinib),27,1.430E-03,1.250E-02,1.430E-03,1.250E-02,12,"E-cadherin, Tuberin, EGF, Neuregulin 1, ErbB3, PI3K reg class IA (p85), p70 S6 kinase1, ErbB2, PTEN, Plakoglobin, AKT(PKB), PDK (PDPK1)",2.822E-02,8.938E-02,11,"Tuberin, EGF, ErbB3, PI3K reg class IA (p85), ErbB2, AKT(PKB), PDK (PDPK1), E-cadherin, p70 S6 kinase1, PTEN, Plakoglobin",
223,Desensitization of Beta-2 adrenergic receptor signaling and reduction of relaxation,27,1.430E-03,1.250E-02,1.430E-03,1.250E-02,12,"GRB2, G-protein alpha-i family, H-Ras, ERK1/2, MSK1/2 (RPS6KA5/4), c-Raf-1, PGE2R3, p90Rsk, PDE4D, MEK1/2, Beta-arrestin1, GRK2",1.414E-01,2.746E-01,9,"GRB2, H-Ras, ERK1/2, MSK1/2 (RPS6KA5/4), PDE4D, GRK2, G-protein alpha-i family, PGE2R3, Beta-arrestin1",
224,Mitogenic action of Estradiol / ESR1 (nuclear) in breast cancer,28,1.472E-03,1.518E-02,7.048E-03,3.464E-02,11,"c-Fos, ESR1 (nuclear), NCOA3 (pCIP/SRC3), E2F1, CHD8, p21, LRP16, WIP1, p130, Cyclin D1, SP1",1.472E-03,1.518E-02,14,"c-Fos, ESR1 (nuclear), c-Jun/c-Fos, p21, LRP16, WIP1, IKK-alpha, p130, c-Myc, NCOA3 (pCIP/SRC3), E2F1, CHD8, Cyclin D1, SP1",
225,Role of DNA methylation in progression of multiple myeloma,45,1.478E-03,1.284E-02,1.478E-03,1.284E-02,17,"IRF8, E-cadherin, ESR1 (nuclear), beta-TrCP, MGMT, WIF1, TDG, NIP3, STAT3, AP-1, RAD23B, WNT, MDM2, Cyclin D1, SHP-1, MLH1, Dexras1",7.201E-03,3.761E-02,18,"ESR1 (nuclear), EGR1, WIF1, NIP3, MDM2, SHP-1, E-cadherin, beta-TrCP, MGMT, TDG, SFRP4, AP-1, RAD23B, WNT, Cyclin D1, MLH1, Dexras1, Frizzled",
226,"Chemotaxis_CCL16-, CCL20-, CXCL16- and CCL25-mediated cell migration",43,1.508E-03,1.531E-02,1.636E-02,6.155E-02,14,"MMP-1, CXCR6, G-protein alpha-i family, CCR2, CCR1, CCR6, IP3 receptor, Calmodulin, PLC-beta, CCR8, CCR5, AKT(PKB), PDK (PDPK1), MLCK",1.508E-03,1.531E-02,19,"Histamine H4 receptor, CXCR6, CCR2, CCR1, IP3 receptor, PLC-beta, CCR8, CCR9, CCR5, AKT(PKB), PDK (PDPK1), MLCK, PKC-delta, MMP-1, G-protein alpha-i family, Beta-defensin 2, CCR6, Calmodulin, PI3K reg class IB (p101)",
227,IL-1 beta-dependent CFTR expression,31,1.537E-03,1.531E-02,4.189E-02,1.199E-01,10,"ECSIT, Pellino 3, TOLLIP, CFTR, E2N(UBC13), Ubiquitin, I-kB, IKK-beta, IL-1RI, TAB2",1.537E-03,1.531E-02,15,"ECSIT, E2N(UBC13), IKK (cat), Ubiquitin, I-kB, MyD88, IKK-alpha, IL-1RI, TAB2, UEV1A, Pellino 3, TOLLIP, MEKK1(MAP3K1), IKK-beta, TAB1",
228,Development_Embryonal epaxial myogenesis,31,1.537E-03,1.531E-02,9.422E-02,2.064E-01,9,"Myostatin, STK36, SHH, MYOG, DLL1, WNT, PAX3, SUFU, MYOD",1.537E-03,1.531E-02,15,"WNT3A, Lef-1, MYF5, KIF27, MYOG, DLL1, PAX3, SUFU, Myostatin, STK36, SHH, WNT1, WNT, Frizzled, MYOD",
229,Transcription_CoREST complex-mediated epigenetic gene silencing,37,1.567E-03,1.531E-02,1.038E-02,4.369E-02,13,"E-cadherin, ZNF217, RREB1, CoREST, EHMT1, NR1, HMG20B, BAF57, Synapsin I, BAF170, c-Myb, ELAC2, ZNF516",1.567E-03,1.531E-02,17,"ZNF217, EHMT1, NR1, HMG20B, NMDA receptor, BAF57, Synapsin I, NRSF, c-Myb, CtBP, E-cadherin, BHC80, RREB1, CoREST, BAF170, ZNF516, CtBP1",
230,G-protein signaling_Regulation of p38 and JNK signaling mediated by G-proteins,37,1.567E-03,1.531E-02,1.191E-01,2.445E-01,10,"G-protein alpha-12 family, G-protein alpha-i family, PAK1, G-protein alpha-q/11, Btk, PLC-beta, MEK6(MAP2K6), VAV-2, JNK(MAPK8-10), p38 MAPK",1.567E-03,1.531E-02,17,"LARG, G-protein alpha-q/11, Rac1, PLC-beta, MEK6(MAP2K6), VAV-2, MEKK4(MAP3K4), G-protein alpha-12 family, G-protein alpha-i family, c-Jun, PAK1, MKK7 (MAP2K7), Btk, MEKK1(MAP3K1), JNK(MAPK8-10), PI3K reg class IB (p101), p38 MAPK",
231,wtCFTR and deltaF508-CFTR traffic / Generic schema (normal and CF),38,1.657E-03,1.423E-02,1.657E-03,1.423E-02,15,"Rab-4, VAMP8, SNAP-25, CFTR, EBP50, VTI1B, CHMP4B, DAB2, Vps25, Ubiquitin, Rab-11A, Clathrin, Myosin Vb, TSG101, Clathrin heavy chain",1.553E-02,6.151E-02,15,"VTI1B, CHMP4B, DAB2, Vps25, Ubiquitin, Rab-7, TSG101, Clathrin heavy chain, Rab-4, VAMP8, EBP50, Rab-11A, Clathrin, Myosin Vb, STAM2",
232,Immune response_TLR2 and TLR4 signaling pathways,69,1.660E-03,1.612E-02,4.063E-03,2.471E-02,22,"Pellino 3, H-Ras, ERK1/2, TIRAP (Mal), MSK1/2 (RPS6KA5/4), E2N(UBC13), p90Rsk, CD36, Ubiquitin, I-kB, PI3K reg class IA (p85), AP-1, Hck, IKK-beta, MEK6(MAP2K6), IRF5, MEK1/2, JNK(MAPK8-10), TAB2, AKT(PKB), PDK (PDPK1), p38 MAPK",1.660E-03,1.612E-02,27,"H-Ras, ERK1/2, c-Jun/c-Fos, MSK1/2 (RPS6KA5/4), E2N(UBC13), Rac1, Ubiquitin, I-kB, PI3K reg class IA (p85), Hck, MyD88, IKK-alpha, MEK6(MAP2K6), TAB2, AKT(PKB), UEV1A, PDK (PDPK1), Pellino 3, c-Jun, TIRAP (Mal), CD36, AP-1, IKK-beta, IRF5, TAB1, JNK(MAPK8-10), p38 MAPK",
233,Transcription_Epigenetic regulation of gene expression,57,1.702E-03,1.437E-02,1.702E-03,1.437E-02,20,"DNMT3B, Sirtuin3, SETDB1, PLU-1, MOZ, GCN5, PRMT1, PRMT5, DNMT3A, SMCX, Sirtuin6, DOT1, HBOA, Sirtuin1, DNMT3L, MYST1, SET8, MORF, JMJD3, SET7",1.145E-02,5.035E-02,21,"DNMT3B, Sirtuin3, MOZ, GCN5, PRMT1, PRMT5, Sirtuin6, DOT1, DNMT3L, MYST1, Suv39H1, SETDB1, PLU-1, DNMT3A, SMCX, HBOA, Sirtuin1, SET8, MORF, JMJD3, SET7",
234,Regulation of degradation of wtCFTR,20,1.778E-03,1.688E-02,5.099E-03,2.813E-02,9,"UFD1, HSP105, CFTR, VCP, Ubiquitin, Csp, HSP90, CHIP, Derlin1",1.778E-03,1.688E-02,11,"VCP, Ubiquitin, Csp, HSP90, UFD1, HSC70, HSP105, UBE1, HSPBP1, CHIP, Derlin1",
235,Apoptosis and survival_Role of PKR in stress-induced apoptosis,53,1.796E-03,1.688E-02,1.510E-01,2.829E-01,13,"TRAF2, ERK1/2, PP2A regulatory, p21, NFKBIA, I-kB, TARBP2, IFN-alpha, IKK-beta, PPP2R5A, IRF3, eIF2S1, TAB2",1.796E-03,1.688E-02,22,"eIF4E, ERK1/2, ATF-4, PP2A regulatory, IKK (cat), p21, I-kB, IKK-alpha, IFN-alpha, PPP2R5A, FasL(TNFSF6), eIF2S1, TAB2, c-Myc, TRAF2, NFKBIA, 4E-BP1, Caspase-7, TARBP2, IKK-beta, IRF3, TRIF (TICAM1)",
236,Transport_ACM3 signaling in salivary glands,42,1.823E-03,1.513E-02,1.823E-03,1.513E-02,16,"SNAP-25, G-protein alpha-i family, Protein kinase G, G-protein alpha-11, Adenylate cyclase type VI, PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, VAMP1, Calmodulin, PKC, PLC-beta, Aquaporin 5, eNOS, Guanylate Cyclase 1, soluble, MLCK",7.753E-03,3.997E-02,17,"Adenylate cyclase type VI, PKA-reg (cAMP-dependent), G-protein alpha-q/11, Syntaxin 1A, IP3 receptor, PLC-beta, Guanylate Cyclase 1, soluble, MLCK, G-protein alpha-i family, Protein kinase G, G-protein alpha-11, VAMP1, Calmodulin, PKC, Aquaporin 5, eNOS, G-protein alpha-q",
237,Development_GM-CSF signaling,50,1.900E-03,1.775E-02,5.319E-03,2.848E-02,17,"MEK1(MAP2K1), GRB2, c-Fos, CSF2RB, H-Ras, ERK1/2, c-Raf-1, STAT3, I-kB, PI3K reg class IA (p85), Hck, CISH, PI3K reg class IA (p85-beta), Bcl-2, Bcl-XL, Cyclin D1, AKT(PKB)",1.900E-03,1.775E-02,21,"Cyclin D3, GRB2, c-Fos, H-Ras, ERK1/2, EGR1, IKK (cat), BAD, I-kB, PI3K reg class IA (p85), Hck, CISH, PI3K reg class IA (p85-beta), IKK-alpha, Bcl-XL, AKT(PKB), c-Myc, CSF2RB, SHP-2, Bcl-2, Cyclin D1",
238,TMPRSS2-ERG fusion in Prostate Cancer,46,1.954E-03,1.613E-02,1.954E-03,1.613E-02,17,"SLC45A3, IGSF5 (JAM4), C21orf13, PEP-19, YB-1, AP-2A, Kallikrein 3 (PSA), C21orf88, Androgen receptor, AP-1, WDR9, ERG, eNOS, GPX4, DSCAM, SP1, TAL1",3.847E-03,2.556E-02,19,"Kallikrein 3 (PSA), Androgen receptor, ERG, c-Myc, SLC45A3, IGSF5 (JAM4), C21orf13, 21-GARP, PEP-19, AP-2A, C21orf88, Rnf14 (ARA54), AP-1, WDR9, eNOS, GPX4, DSCAM, SP1, PANDER",
239,CHDI_Correlations from Discovery data_Causal network,73,1.957E-03,1.806E-02,3.959E-03,2.424E-02,23,"MEK1(MAP2K1), Dopamine D1A receptor, Substance P extracellular region, Tuberin, Huntingtin, G-protein alpha-i family, H-Ras, ERK1/2, c-Raf-1, CCR1, MEF2, p21, Dsh, p90Rsk, IP3 receptor, PI3K reg class IA (p85), Calmodulin, PLC-beta, PTEN, WNT, AKT(PKB), SP1, Axin",1.957E-03,1.806E-02,28,"Substance P extracellular region, Tuberin, Huntingtin, H-Ras, ERK1/2, CCR1, p21, Dsh, IP3 receptor, PI3K reg class IA (p85), PLC-beta, nAChR, AKT(PKB), c-Myc, YY1, Axin, Dopamine D1A receptor, G-protein alpha-i family, CD79 complex, MEF2, 4E-BP1, Calmodulin, PTEN, WNT, G-protein alpha-q, SP1, PI3K reg class IB (p101), Frizzled",
240,Canonical Leptin pathways in breast cancer,47,2.000E-03,1.813E-02,6.663E-03,3.318E-02,16,"GRB2, ESR1 (nuclear), H-Ras, ERK1/2, c-Raf-1, STAT3, I-kB, PI3K reg class IA, IL-1RI, MEK1/2, Cyclin D1, AKT(PKB), SP1, PDK (PDPK1), Leptin, Axin",2.000E-03,1.813E-02,20,"GRB2, ESR1 (nuclear), IRS-1, H-Ras, ERK1/2, IKK (cat), I-kB, PI3K reg class IA, CYP19, IL-1RI, AKT(PKB), PDK (PDPK1), c-Myc, Axin, Tcf(Lef), c-Jun, SHP-2, Cyclin D1, SP1, Leptin",
241,Development_WNT5A signaling,47,2.000E-03,1.813E-02,1.598E-02,6.074E-02,15,"Protein kinase G1, ROR2, Calcineurin A (catalytic), MLK2(MAP3K10), Dsh, NLK, PI3K reg class IA (p85), Calmodulin, PDE6 reg, PLC-beta, IP3R1, JNK(MAPK8-10), PDE6 cat, Axin, IRAG",2.000E-03,1.813E-02,20,"Protein kinase G1, Calcineurin A (catalytic), NF-AT1(NFATC2), FZD4, Dsh, PI3K reg class IA (p85), PDE6 reg, PLC-beta, LRP5, Axin, ROR2, Tcf(Lef), MLK2(MAP3K10), c-Jun, MKK7 (MAP2K7), NLK, Calmodulin, IP3R1, JNK(MAPK8-10), PDE6 cat",
242,wtCFTR and deltaF508 traffic / Membrane expression (normal and CF),47,2.000E-03,1.813E-02,2.552E-03,1.851E-02,17,"Rab-4, Rabaptin-5, CFTR, EBP50, PKA-reg type II (cAMP-dependent), PKA-reg (cAMP-dependent), PIP5KI, E3KARP (NHERF2), VIL2 (ezrin), Ubiquitin, Rab-11A, Keratin 18, Filamin B (TABP), Keratin 8, Myosin Vb, SNAP-23, Tubulin (in microtubules)",2.000E-03,1.813E-02,20,"Rabaptin-5, PKA-reg (cAMP-dependent), Syntaxin 1A, Rac1, VIL2 (ezrin), Ubiquitin, Keratin 18, EHD1, Tubulin (in microtubules), Rab-4, MUNC18, EBP50, PKA-reg type II (cAMP-dependent), PIP5KI, E3KARP (NHERF2), Rab-11A, Filamin B (TABP), Keratin 8, Myosin Vb, SNAP-23",
243,Th2-cytokines induced expression of Mucin 5AC and maintenance of mucous cell phenotype in normal airway epithelium,35,2.024E-03,1.650E-02,2.024E-03,1.650E-02,14,"p38alpha (MAPK14), SP-A, ERK1/2, TITF1, HAG-2, FOXJ1, CLCA1, Mucin 5AC, HNF3-gamma, IL13RA2, STAT6, IL-4, SP1, PDEF",6.532E-03,3.644E-02,15,"ERK1/2, TITF1, HAG-2, CLCA1, IL-13, IL-9, IL-4, SP-A, Uteroglobin, FOXJ1, Mucin 5AC, HNF3-gamma, STAT6, SP1, PDEF",
244,Neurophysiological process_Corticoliberin signaling via CRHR1 ,50,2.052E-03,1.650E-02,2.052E-03,1.650E-02,18,"MEK1(MAP2K1), cPKC (conventional), Pitx1, c-Fos, CACNA1C, PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, G-protein alpha-s, Calmodulin, NUR77, PLC-beta, JunD, Adenylate cyclase, CRHR1, Keratin 1, Clathrin, NURR1",4.685E-02,1.314E-01,17,"Pitx1, c-Fos, EGR1, PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, PLC-beta, JunD, Adenylate cyclase, Keratin 1, cPKC (conventional), CACNA1C, G-protein alpha-s, Calmodulin, NUR77, Clathrin, NURR1",
245,Immune response_C5a signaling,50,2.052E-03,1.650E-02,2.052E-03,1.650E-02,18,"C5aR, c-Fos, G-protein alpha-i family, ERK1/2, c-Raf-1, p67-phox, p90Rsk, I-kB, AP-1, PKC, PLC-beta, Bcl-2, MEK1/2, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1), p38 MAPK, PREX1",1.098E-02,4.886E-02,19,"c-Fos, ERK1/2, c-Jun/c-Fos, IKK (cat), Rac1, BAD, I-kB, PLC-beta, AKT(PKB), PDK (PDPK1), C5aR, G-protein alpha-i family, c-Jun, AP-1, PKC, Bcl-2, JNK(MAPK8-10), p38 MAPK, PREX1",
246,Epigenetic alterations in ovarian cancer,82,2.056E-03,1.650E-02,2.056E-03,1.650E-02,26,"DNMT3B, E-cadherin, FGFR3, TIMP3, ESR1 (nuclear), MGMT, GATA-4, H-cadherin, DNMT3A, p21, DAB2, ESR2 (nuclear), WIF1, FGFR1, ErbB2, Gamma-synuclein, Dlec1, Vasohibin-1, CARD5, Claudin-4, SSTR1, GATA-5, BLU, HSD3B2, MLH1, p27KIP1",3.214E-03,2.301E-02,30,"DNMT3B, TrkA, TIMP3, ESR1 (nuclear), GATA-4, H-cadherin, p21, DAB2, ESR2 (nuclear), CTCF, WIF1, FGFR1, STAR, ErbB2, Vasohibin-1, CARD5, HSD3B2, p27KIP1, E-cadherin, FGFR3, PARP-1, MGMT, DNMT3A, Aurora-A, Gamma-synuclein, Dlec1, Claudin-4, GATA-5, BLU, MLH1",
247,Immune response_ICOS signaling pathway in T-helper cell,60,2.079E-03,1.823E-02,3.401E-03,2.154E-02,20,"MHC class II, ICOS-L, Calcineurin A (catalytic), ROR-gamma, PAK3, CXCR5, KLF2, PAK1, IP3 receptor, PI3K reg class IA (p85), AP-1, p70 S6 kinase1, Calmodulin, PI3K reg class IA, CD3, FOXP3, IL23R, IL-4, AKT(PKB), CD40L(TNFSF5)",2.079E-03,1.823E-02,24,"MHC class II, ICOS-L, Calcineurin A (catalytic), NF-AT1(NFATC2), PAK3, KLF2, Rac1, IP3 receptor, PI3K reg class IA (p85), PI3K reg class IA, FOXP3, ITK, IL23R, IL-13, IL-4, AKT(PKB), ICOS, ROR-gamma, PAK1, 4E-BP1, AP-1, p70 S6 kinase1, Calmodulin, TCR alpha/beta",
248,Signal transduction_MIF signaling pathway,60,2.079E-03,1.823E-02,3.401E-03,2.154E-02,20,"PU.1, G-protein alpha-i family, ERK1/2, c-Raf-1, AP-1, PI3K reg class IA, cPLA2, ACKR3, Bcl-2, Bcl-XL, MEK1/2, JNK(MAPK8-10), MSK1, Clathrin, AKT(PKB), Beta-arrestin1, PDK (PDPK1), SFK, NQO1, IL8RB",2.079E-03,1.823E-02,24,"ERK1/2, BAD, PI3K reg class IA, ZAP70, cPLA2, Bcl-XL, MSK1, AKT(PKB), PDK (PDPK1), SFK, IL8RB, PU.1, G-protein alpha-i family, c-Jun, PRDX1, AP-1, ACKR3, Bcl-2, FOXO3A, JNK(MAPK8-10), Clathrin, Beta-arrestin1, PI3K reg class IB (p101), NQO1",
249,FGF2 in multiple myeloma,18,2.089E-03,1.650E-02,2.089E-03,1.650E-02,9,"FGFR3, Syndecan-1, FGFR4, FGFR1, PI3K reg class IA, MEK1/2, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3)",3.442E-02,1.046E-01,8,"FGFR4, FGFR1, PI3K reg class IA, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), FGFR3, Syndecan-1",
250,Populations of skin dendritic cells involved in contact hypersensitivity,18,2.089E-03,1.650E-02,2.089E-03,1.650E-02,9,"E-cadherin, CD1a, MHC class II, CCR7, ITGAM, CCR6, CD36, ITGAX, CD40(TNFRSF5)",3.442E-02,1.046E-01,8,"MHC class II, ITGAX, E-cadherin, CCR7, ITGAM, CCR6, CD36, CD40(TNFRSF5)",
251,K-RAS signaling in pancreatic cancer,44,2.094E-03,1.823E-02,2.009E-02,7.199E-02,14,"MEK1(MAP2K1), K-RAS, FGFR4, ERK1/2, c-Raf-1, RalGDS, p21, NFKBIA, GLUT1, PTEN, Bcl-2, GSK3 alpha/beta, AKT(PKB), PDK (PDPK1)",2.094E-03,1.823E-02,19,"FGFR4, HNF1-alpha, ERK1/2, p21, Rac1, IKK-alpha, GSK3 alpha/beta, AKT(PKB), PDK (PDPK1), c-Myc, K-RAS, RalGDS, NFKBIA, GLUT1, PTEN, MEKK1(MAP3K1), Bcl-2, AKT2, RalA",
252,Leptin signaling in colorectal cancer,44,2.094E-03,1.823E-02,3.176E-03,2.154E-02,16,"E-cadherin, c-Fos, ERK1/2, ABIN-2, NFKBIA, STAT3, p70 S6 kinase1, PI3K reg class IA, PTEN, FAK1, Bcl-XL, MEK1/2, Cyclin D1, JNK(MAPK8-10), AKT(PKB), Leptin",2.094E-03,1.823E-02,19,"c-Fos, ERK1/2, Rac1, PI3K reg class IA, IKK-alpha, Bcl-XL, AKT(PKB), c-Myc, E-cadherin, PKC-delta, c-Jun, ABIN-2, NFKBIA, p70 S6 kinase1, PTEN, FAK1, Cyclin D1, JNK(MAPK8-10), Leptin",
253,Role of Diethylhexyl Phthalate and Tributyltin in fat cell differentiation ,28,2.094E-03,1.650E-02,2.094E-03,1.650E-02,12,"A-FABP, Adiponectin, RXRA, MED1, CD36, GLPK, ACSBG1, OLR1, LXR-alpha, Leptin, DLK, C/EBPalpha",8.433E-02,1.934E-01,10,"MED1, ACSL1, Adiponectin, RXRA, CD36, GLPK, ACSBG1, OLR1, Leptin, C/EBPalpha",
254,Development_FGFR signaling pathway,54,2.120E-03,1.650E-02,2.120E-03,1.650E-02,19,"MEK1(MAP2K1), Syndecan-1, GRB2, GAB1, H-Ras, ERK1/2, c-Raf-1, FRS2, PAK1, FGFR1, IP3 receptor, Ubiquitin, MAPKAPK2, PI3K reg class IA, MEK6(MAP2K6), JNK(MAPK8-10), AKT(PKB), PDK (PDPK1), p38 MAPK",2.387E-03,1.878E-02,22,"GRB2, GAB1, H-Ras, ERK1/2, FRS2, FGFR1, Rac1, IP3 receptor, Ubiquitin, MAPKAPK2, PI3K reg class IA, MEK6(MAP2K6), AKT(PKB), PDK (PDPK1), Syndecan-1, PKC-delta, c-Jun, PAK1, MEKK1(MAP3K1), SHP-2, JNK(MAPK8-10), p38 MAPK",
255,Growth factors in regulation of oligodendrocyte precursor cells proliferation in multiple sclerosis,54,2.120E-03,1.650E-02,2.120E-03,1.650E-02,19,"MEK1(MAP2K1), FGFR3, GRB2, c-Fos, H-Ras, ERK1/2, PLP1, c-Raf-1, FRS2, FGFR1, Vitronectin, PI3K reg class IA (p85), p70 S6 kinase1, PKC, PI3K reg class IA, KV1.6, Cyclin D1, AKT(PKB), PDK (PDPK1)",1.259E-02,5.409E-02,20,"TrkA, GRB2, c-Fos, H-Ras, ERK1/2, PLP1, FRS2, FGFR1, PI3K reg class IA (p85), PI3K reg class IA, KV1.6, AKT(PKB), PDK (PDPK1), FGFR3, KV1.5, Vitronectin, p70 S6 kinase1, PKC, SHP-2, Cyclin D1",
256,Aberrant production of IL-2 and IL-17 in SLE T cells,58,2.163E-03,1.674E-02,2.163E-03,1.674E-02,20,"MHC class II, GRB2, c-Fos, Fc epsilon RI gamma, ROR-gamma, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, DNMT3A, I-kB, AP-1, Calmodulin, CD3, SAP, MEK1/2, CD3 epsilon, AKT(PKB), SP1, p70 S6 kinase2",1.418E-02,5.913E-02,21,"MHC class II, GRB2, c-Fos, NF-AT1(NFATC2), Fc epsilon RI gamma, H-Ras, ERK1/2, c-Jun/c-Fos, PKA-reg (cAMP-dependent), I-kB, ZAP70, AKT(PKB), CD229, ROR-gamma, DNMT3A, LAT, AP-1, Calmodulin, SP1, p70 S6 kinase2, TCR alpha/beta",
257,Immune response_Fc epsilon RI pathway: Lyn-mediated cytokine production,87,2.164E-03,1.823E-02,1.009E-02,4.369E-02,25,"CARD9, Calcineurin A (catalytic), GRB2, CCL1, c-Fos, Fc epsilon RI gamma, H-Ras, ERK1/2, c-Raf-1, PAK1, GATA-1, GATA-2, Btk, NFKBIA, NF-AT, IP3 receptor, AP-1, Calmodulin, PKC, IKK-beta, MEK6(MAP2K6), MEK1/2, JNK(MAPK8-10), IL-4, p38 MAPK",2.164E-03,1.823E-02,32,"CARD9, Calcineurin A (catalytic), GRB2, c-Fos, NF-AT1(NFATC2), Fc epsilon RI gamma, H-Ras, ERK1/2, EGR1, Rac1, IP3 receptor, MEK6(MAP2K6), IL-13, IL-9, IL-4, CCL1, PKC-delta, c-Jun, PAK1, MKK7 (MAP2K7), LAT, GATA-2, Btk, NFKBIA, NF-AT, AP-1, Calmodulin, PKC, MEKK1(MAP3K1), IKK-beta, JNK(MAPK8-10), p38 MAPK",
258,CREB1-dependent transcription deregulation in Huntington's Disease,26,2.167E-03,1.823E-02,3.606E-03,2.245E-02,11,"Huntingtin, NDUFS3, UCP2, Cytochrome c, TAF4 (TAFII130), COX VIIc, NDUFB5, COX VIa-1, Bcl-2, GRP75, Adenosine A2a receptor",2.167E-03,1.823E-02,13,"Huntingtin, NDUFS3, UCP2, Cytochrome c, SOD1, NDUFB5, COX VIa-1, GRP75, TFAM, TAF4 (TAFII130), COX VIIc, Bcl-2, Adenosine A2a receptor",
259,Development_Neurotrophin family signaling,41,2.175E-03,1.823E-02,1.098E-01,2.317E-01,11,"MEK1(MAP2K1), GRB2, GAB1, H-Ras, ERK1/2, c-Raf-1, NRAGE(MAGED1), PI3K reg class IA (p85), PI3K reg class IA, JNK(MAPK8-10), AKT(PKB)",2.175E-03,1.823E-02,18,"TrkA, GRB2, GAB1, H-Ras, ERK1/2, Rac1, PI3K reg class IA (p85), PI3K reg class IA, AKT(PKB), NT-3, TrkC, c-Jun, NRAGE(MAGED1), C3G, SH2B, MEKK1(MAP3K1), SHP-2, JNK(MAPK8-10)",
260,Signal transduction_Adenosine A1 receptor signaling pathway,62,2.183E-03,1.681E-02,2.183E-03,1.681E-02,21,"Adenosine A1 receptor, G-protein alpha-i family, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, G-protein alpha-q/11, IP3 receptor, STAT3, I-kB, PI3K reg class IA (p85), GLRA3, Calmodulin, PKC, PLC-beta, Adenylate cyclase, MEK1/2, AKT(PKB), PDK (PDPK1), SFK, p38 MAPK",3.054E-02,9.511E-02,21,"H-Ras, ERK1/2, PKA-reg (cAMP-dependent), IKK (cat), G-protein alpha-q/11, IP3 receptor, BAD, I-kB, PI3K reg class IA (p85), PLC-beta, Adenylate cyclase, AKT(PKB), PDK (PDPK1), SFK, TTC1, Adenosine A1 receptor, G-protein alpha-i family, GLRA3, Calmodulin, PKC, p38 MAPK",
261,Immune response_Delta-type opioid receptor signaling in T-cells,29,2.255E-03,1.823E-02,6.542E-02,1.613E-01,9,"MEK1(MAP2K1), c-Fos, G-protein alpha-i family, c-Raf-1, PAK1, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1), ERK1 (MAPK3)",2.255E-03,1.823E-02,14,"c-Fos, Rac1, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), Delta-type opioid receptor, PKC-delta, G-protein alpha-i family, c-Jun, PAK1, MKK7 (MAP2K7), MEKK1(MAP3K1), JNK(MAPK8-10), PI3K reg class IB (p101)",
262,Development_Regulation of telomere length and cellular immortalization,35,2.281E-03,1.823E-02,1.665E-02,6.159E-02,12,"TERC, E2F1, Staufen, TIN-2, RPL22, hRap1, Max, AKT(PKB), SP1, HSP90, PDK (PDPK1), p23 co-chaperone",2.281E-03,1.823E-02,16,"Staufen, TIN-2, RPL22, hnRNP C, AKT(PKB), HSP90, PDK (PDPK1), c-Myc, hnRNP A1, E2F1, Tankyrase 2, hRap1, Max, TEP1, SP1, p23 co-chaperone",
263,Anti-apoptotic action of Gastrin in pancreatic cancer,35,2.281E-03,1.823E-02,1.703E-01,3.058E-01,9,"p38alpha (MAPK14), Cytochrome c, NFKBIA, PI3K reg class IA (p85), MEK6(MAP2K6), Bcl-2, FAK1, AKT(PKB), PDK (PDPK1)",2.281E-03,1.823E-02,16,"IRS-1, LARG, Cytochrome c, BAD, PI3K reg class IA (p85), IKK-alpha, MEK6(MAP2K6), AKT(PKB), PDK (PDPK1), MEKK4(MAP3K4), CCKBR, NFKBIA, Bcl-2, FOXO3A, FAK1, G-protein alpha-q",
264,Cell cycle_ESR1 regulation of G1/S transition,35,2.281E-03,1.823E-02,6.134E-03,3.211E-02,13,"c-Fos, ESR1 (nuclear), NCOA3 (pCIP/SRC3), E2F1, ERK1/2, p21, Ubiquitin, Rb protein, p130, Skp2/TrCP/FBXW, Cyclin D1, SP1, p27KIP1",2.281E-03,1.823E-02,16,"c-Fos, ESR1 (nuclear), ERK1/2, c-Jun/c-Fos, p21, Ubiquitin, Rb protein, p130, Skp2/TrCP/FBXW, p27KIP1, c-Myc, NCOA3 (pCIP/SRC3), E2F1, c-Jun, Cyclin D1, SP1",
265,Cell cycle_Role of Nek in cell cycle regulation,32,2.289E-03,1.823E-02,7.645E-03,3.671E-02,12,"Tubulin beta, Insulin processed, NEK6, Nek11, p70 S6 kinase1, Tubulin alpha, PI3K reg class IA, Insulin receptor, PDK (PDPK1), Nek8, Ran, Tubulin (in microtubules)",2.289E-03,1.823E-02,15,"Insulin processed, IRS-1, Nek11, PI3K reg class IA, Insulin receptor, PDK (PDPK1), Ran, Tubulin (in microtubules), Tubulin beta, Tubulin gamma, NEK6, Aurora-A, p70 S6 kinase1, Tubulin alpha, Nek8",
266,Cytoskeleton remodeling_Reverse signaling by Ephrin-B,32,2.289E-03,1.806E-02,2.465E-03,1.806E-02,13,"RGS3, G-protein alpha-i family, H-Ras, c-Raf-1, PAK1, ILK, Tubulin alpha, FAK1, Tau (MAPT), Axin, SDF-1, WIRE, Tubulin (in microtubules)",2.289E-03,1.823E-02,15,"H-Ras, Tau (MAPT), Axin, SDF-1, Tubulin (in microtubules), RGS3, G-protein alpha-i family, PAK1, ILK, Paxillin, Tubulin alpha, N-WASP, FAK1, Ephrin-B receptors, WIRE",
267,Inhibition of LKB1 / AMPK signaling in breast cancer,32,2.289E-03,1.806E-02,2.465E-03,1.806E-02,13,"E-cadherin, Tuberin, ACACA, AMPK gamma1, FASN, p70 S6 kinase1, LKB1, AMPK beta1, PTEN, TORC2, Cyclin D1, AKT(PKB), p70 S6 kinase2",2.289E-03,1.823E-02,15,"Tuberin, FASN, AMPK beta1, TORC2, CYP19, AKT(PKB), E-cadherin, TFAM, AMPK gamma1, 4E-BP1, p70 S6 kinase1, LKB1, PTEN, Cyclin D1, p70 S6 kinase2",
268,Development_Schema: Histone H3 demethylases in stem cells,32,2.289E-03,1.806E-02,2.465E-03,1.806E-02,13,"PLU-1, CoREST, IRX3, GATA-4, p21, AP-2A, HP1, NANOG, TIF1-beta, KDM2B, PTEN, JMJD3, p27KIP1",2.289E-03,1.823E-02,15,"GATA-4, p21, HP1, TIF1-beta, NRSF, p27KIP1, PLU-1, CoREST, IRX3, AP-2A, BCoR, NANOG, KDM2B, PTEN, JMJD3",
269,Role of tumor-infiltrating B cells in anti-tumor immunity,91,2.329E-03,1.785E-02,2.329E-03,1.785E-02,28,"MIG, MHC class II, Syndecan-1, CD20, CTAG2, GAS11, G-protein alpha-i family, Granzyme B, MAGE-1 antigen, CXCR5, AID, PASD1, CD19, Btk, STAT3, XAGE1, SOX2, IFN-alpha, GAGE2, CD27(TNFRSF7), MAGE-4 antigen, MAGEB2, CD40(TNFRSF5), STAT6, IL-4, CD23, SDF-1, CD40L(TNFSF5)",4.836E-03,2.898E-02,32,"MHC class II, CD20, CTAG2, Granzyme B, MAGE-1 antigen, PASD1, CD19, Perforin, IFN-alpha, GAGE2, CD27(TNFRSF7), MAGEB2, FasL(TNFSF6), IL-4, CT47A, CD23, SDF-1, G3P2, Syndecan-1, GAS11, G-protein alpha-i family, CD79 complex, AID, Btk, CXCR3, NY-ESO-1, XAGE1, SOX2, CD40(TNFRSF5), STAT6, MAGEC2, TCR alpha/beta",
270,"POMC, alpha-MSH and AGRP in regulation of food intake and energy expenditure in obesity in hypothalamus",43,2.422E-03,1.806E-02,2.422E-03,1.806E-02,16,"Thyroliberin, G-protein alpha-i family, Adenylate cyclase type VI, PKA-reg (cAMP-dependent), c-Raf-1, IP3 receptor, Adenylate cyclase type II, G-protein alpha-s, PLC-beta, MC3R, MEK1/2, Clathrin, Adenylate cyclase type IV, Beta-arrestin1, PC2, ERK1 (MAPK3)",2.312E-02,7.874E-02,16,"Adenylate cyclase type VI, PKA-reg (cAMP-dependent), IP3 receptor, Adenylate cyclase type II, PLC-beta, MC4R, ERK1 (MAPK3), Thyroliberin, G-protein alpha-i family, G-protein alpha-s, MC3R, G-protein alpha-q, Clathrin, Adenylate cyclase type IV, Beta-arrestin1, PC2",
271,ESR1 (membrane) 36 kDa isoform signaling in breast cancer,43,2.422E-03,1.806E-02,2.422E-03,1.806E-02,16,"E-cadherin, GRB2, H-Ras, ERK1/2, ESR1 (membrane), c-Raf-1, IP3 receptor, PI3K reg class IA, Gamma-synuclein, PLC-beta, MEK1/2, Cyclin D1, JNK(MAPK8-10), AKT(PKB), HSP90, PDK (PDPK1)",1.015E-02,4.713E-02,17,"GRB2, H-Ras, ERK1/2, ESR1 (membrane), IP3 receptor, PI3K reg class IA, PLC-beta, AKT(PKB), HSP90, PDK (PDPK1), c-Myc, E-cadherin, c-Jun, Gamma-synuclein, G-protein alpha-q, Cyclin D1, JNK(MAPK8-10)",
272,Signal transduction_Modulation of calcium and potassium channels by Adenosine A1 receptor,43,2.422E-03,1.806E-02,2.422E-03,1.806E-02,16,"MaxiK alpha subunit, cPKC (conventional), SUR1, Adenosine A1 receptor, G-protein alpha-i family, CACNA1C, PKA-reg (cAMP-dependent), Ca(II)channel L-type, Kir6.2, IP3 receptor, Calmodulin, cPLA2, Adenylate cyclase, SUR2, SK2, Caveolin-3",4.085E-03,2.667E-02,18,"MaxiK alpha subunit, SUR1, PKA-reg (cAMP-dependent), Kir6.2, IP3 receptor, cPLA2, Adenylate cyclase, SUR2, SK2, Caveolin-3, cPKC (conventional), Adenosine A1 receptor, G-protein alpha-i family, Ca(II)channel N-type, CACNA1C, Ca(II)channel L-type, Calmodulin, N-type Ca(II) channel alpha1B",
273,Regulation of Tissue factor signaling in cancer,43,2.422E-03,1.806E-02,2.422E-03,1.806E-02,16,"MEK1(MAP2K1), EGF, JunD/c-Fos, K-RAS, ERK1/2, c-Raf-1, Coagulation factor VII, AP-1, p70 S6 kinase1, JunD, PTEN, CD40(TNFRSF5), AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), CD40L(TNFSF5)",2.312E-02,7.874E-02,16,"EGF, ERK1/2, EGR1, Coagulation factor VII, JunD, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), JunD/c-Fos, K-RAS, c-Jun, AP-1, p70 S6 kinase1, PTEN, c-Jun/c-Jun, CD40(TNFRSF5)",
274,Putative pathways for stimulation of fat cell differentiation by Bisphenol A,32,2.465E-03,1.806E-02,2.465E-03,1.806E-02,13,"A-FABP, ESR1 (nuclear), SCD, GPD1, FASN, GATA-2, Androgen receptor, SREBP1 precursor, PI3K reg class IA, AKT(PKB), PDK (PDPK1), Leptin, C/EBPalpha",6.834E-03,3.742E-02,14,"ESR1 (nuclear), SCD, GLUT4, FASN, Androgen receptor, SREBP1 precursor, PI3K reg class IA, AKT(PKB), PDK (PDPK1), GPD1, GATA-2, Esrrg, Leptin, C/EBPalpha",
275,Development_Positive regulation of WNT/Beta-catenin signaling at the receptor level,64,2.495E-03,1.952E-02,5.000E-01,6.577E-01,12,"p38alpha (MAPK14), FGFR3, ROR2, UBPY, RAB3IP, ERK1/2, TMEM59, Dsh, WNT, MEK1/2, DPY19L3, Clathrin",2.495E-03,1.952E-02,25,"TrkA, UBPY, RAB3IP, LYPD6, ERK1/2, Dsh, Tenascin-N, IQGAP, R-spondin 1, p38beta (MAPK11), LRP5, DPY19L3, DKK2, FGFR3, ROR2, Tcf(Lef), R-spondins, TMEM59, MKK7 (MAP2K7), RNF43, USP19, WNT, Clathrin, Formin 2, Frizzled",
276,Development_Signaling pathways in embryonic hepatocyte maturation,51,2.546E-03,1.898E-02,2.642E-03,1.898E-02,18,"E-cadherin, gp130, CPSM, GRB2, GAB1, K-RAS, G6PT, TAT, FADD, PXR, STAT3, PI3K reg class IA, LRH1, Cyclin D1, HNF6, AKT(PKB), Epo, C/EBPalpha",2.546E-03,1.952E-02,21,"gp130, CPSM, GRB2, GAB1, HNF1-alpha, TAT, APOC2, FADD, PI3K reg class IA, LRH1, AKT(PKB), Epo, E-cadherin, K-RAS, PAH, PXR, APOC3, Cyclin D1, HNF6, p120-catenin, C/EBPalpha",
277,microRNA in Prostate Cancer,51,2.546E-03,1.952E-02,4.484E-01,6.112E-01,10,"SLC45A3, PDCD4, E2F1, p21, Sirtuin1, Bcl-2, Cyclin D1, eIF2C2 (Argonaute-2), p27KIP1, Ran",2.546E-03,1.952E-02,21,"WNT3A, microRNA 23a, p21, Bak, eIF2C2 (Argonaute-2), p27KIP1, c-Myc, Ran, SLC45A3, microRNA 106b, microRNA 141, Dicer, microRNA 32, PDCD4, E2F1, Sirtuin1, microRNA 23b, Bcl-2, Cyclin D1, microRNA 125b, microRNA 222",
278,Some pathways of EMT in cancer cells,51,2.546E-03,1.952E-02,6.658E-03,3.318E-02,17,"E-cadherin, Tuberin, EGF, PDGF-B, GRB2, TRAF2, H-Ras, TRADD, DDX5, ILK, STAT3, I-kB, PI3K reg class IA, IKK-beta, Bcl-2, AKT(PKB), Axin",2.546E-03,1.952E-02,21,"Tuberin, EGF, PDGF-B, GRB2, H-Ras, Lef-1, IKK (cat), TRADD, I-kB, PI3K reg class IA, IKK-alpha, AKT(PKB), Axin, E-cadherin, TRAF2, DDX5, ILK, 4E-BP1, IKK-beta, Bcl-2, TAB1",
279,Immune response_Histamine H1 receptor signaling in immune response,47,2.552E-03,1.851E-02,2.552E-03,1.851E-02,17,"MEK1(MAP2K1), Calcineurin A (catalytic), c-Fos, MMP-1, c-Raf-1, G-protein alpha-q/11, NFKBIA, IP3 receptor, I-kB, Calmodulin, PLC-beta, cPLA2, IKK-beta, eNOS, JNK(MAPK8-10), p38 MAPK, ERK1 (MAPK3)",2.606E-02,8.416E-02,17,"Calcineurin A (catalytic), c-Fos, c-Jun/c-Fos, G-protein alpha-q/11, IP3 receptor, I-kB, PLC-beta, cPLA2, ERK1 (MAPK3), MMP-1, c-Jun, NFKBIA, Calmodulin, IKK-beta, eNOS, JNK(MAPK8-10), p38 MAPK",
280,Inflammatory factors-induced expression of mucins in normal and asthmatic epithelium,51,2.642E-03,1.898E-02,2.642E-03,1.898E-02,18,"MEK1(MAP2K1), GRB2, H-Ras, SF4, ERK1/2, c-Raf-1, p90RSK1, IL8RA, CLCA1, I-kB, Mucin 2, Mucin 5AC, IKK-beta, IL-1RI, Mucin 5B, PGES2, IL-6 receptor, IL8RB",5.584E-02,1.454E-01,17,"GRB2, H-Ras, SF4, ERK1/2, CLCA1, I-kB, IL-1RI, Mucin 5B, PGES2, C3aR, IL8RB, IL8RA, Mucin 2, SHP-2, Mucin 5AC, IKK-beta, IL-6 receptor",
281,Immune response_NF-AT signaling and leukocyte interactions,48,2.705E-03,2.042E-02,8.175E-02,1.884E-01,13,"MHC class II, Calcineurin A (catalytic), CCR3, NF-AT, IP3 receptor, CD3, cPLA2, IGHE, CD40(TNFRSF5), STAT6, IL-4, Ca(II) channels, CD40L(TNFSF5)",2.705E-03,2.042E-02,20,"MHC class II, Calcineurin A (catalytic), NF-AT1(NFATC2), IP3 receptor, ZAP70, cPLA2, ITK, IL-13, FasL(TNFSF6), IL-4, CCR3, CD79 complex, LAT, IL-5 receptor, NF-AT, IGHE, CD40(TNFRSF5), STAT6, TCR alpha/beta, Ca(II) channels",
282,GLP-1 in beta cell apoptosis in type 2 diabetes,48,2.705E-03,2.042E-02,8.175E-02,1.884E-01,13,"AKT1, ERK1/2, ChREBP, PKA-reg (cAMP-dependent), p90RSK1, Cytochrome c, I-kB, Bcl-2, MDM2, IL-1RI, IGF-1 receptor, Beta-arrestin1, IGF-1",2.705E-03,2.042E-02,20,"AKT1, IRS-1, ERK1/2, ChREBP, PKA-reg (cAMP-dependent), IKK (cat), Cytochrome c, BAD, I-kB, IKK-alpha, MDM2, IL-1RI, IGF-1 receptor, Amylin, Thioredoxin, c-Jun, MKK7 (MAP2K7), Bcl-2, Beta-arrestin1, IGF-1",
283,Inhibition of apoptosis in pancreatic cancer,59,2.723E-03,1.938E-02,2.723E-03,1.938E-02,20,"EGF, K-RAS, G-protein alpha-i family, ERK1/2, Cytochrome c, LTBR1, NFKBIA, STAT3, PI3K reg class IA (p85), PKR1, PER1, ErbB2, ALOX12, PTEN, Bcl-2, Bcl-XL, AKT(PKB), LTBR2, IGF-1, IL-6 receptor",1.740E-02,6.553E-02,21,"EGF, ERK1/2, 14-3-3, Cytochrome c, BAD, PI3K reg class IA (p85), PER1, ErbB2, IKK-alpha, Bcl-XL, AKT(PKB), LTBR2, K-RAS, G-protein alpha-i family, LTBR1, NFKBIA, PKR1, PTEN, Bcl-2, IGF-1, IL-6 receptor",
284,Upregulation of MITF in melanoma,36,2.767E-03,1.959E-02,2.767E-03,1.959E-02,14,"Livin, E2F1, ERK1/2, p90RSK1, p21, PM17, MGF, E2I, TYRP1, Rb protein, PDE4D, Bcl-2, TBX2, p27KIP1",8.878E-03,4.380E-02,15,"ERK1/2, p21, E2I, Rb protein, PDE4D, Tyro3, p27KIP1, miR-340-5p, Livin, E2F1, PM17, MGF, TYRP1, Bcl-2, TBX2",
285,Regulation of relaxation of airway smooth muscle cells,45,2.860E-03,2.138E-02,2.444E-02,8.204E-02,14,"cAMP-GEFI, Protein kinase G, Adenylate cyclase type VI, PKA-reg (cAMP-dependent), PAK1, PGE2R3, IP3 receptor, Adenylate cyclase type II, G-protein alpha-s, VIP receptor 1, VIP receptor 2, Adenylate cyclase type IV, Guanylate Cyclase 1, soluble, MLCK",2.860E-03,2.138E-02,19,"cAMP-GEFI, 14-3-3, Adenylate cyclase type VI, PKA-reg (cAMP-dependent), Rac1, IP3 receptor, Adenylate cyclase type II, Prostacyclin receptor, VIP, Guanylate Cyclase 1, soluble, MLCK, Protein kinase G, PAK1, PGE2R3, G-protein alpha-s, VIP receptor 1, VIP receptor 2, Adenylate cyclase type IV, Cofilin",
286,EGF- and HGF-dependent stimulation of metastasis in gastric cancer,22,2.905E-03,2.037E-02,2.905E-03,2.037E-02,10,"MEK1(MAP2K1), E-cadherin, EGF, GRB2, H-Ras, ERK1/2, c-Raf-1, FAK1, VAV-3, SP1",4.425E-02,1.255E-01,9,"EGF, GRB2, H-Ras, ERK1/2, E-cadherin, Paxillin, FAK1, VAV-3, SP1",
287,Development_Beta-catenin destruction complex signaling,21,2.971E-03,2.210E-02,7.059E-02,1.708E-01,7,"beta-TrCP, Casein kinase I alpha, Ubiquitin, GSK3 alpha/beta, Skp2/TrCP/FBXW, Clathrin, Axin",2.971E-03,2.210E-02,11,"Casein kinase I delta, Lef-1, Casein kinase I alpha, Ubiquitin, GSK3 alpha/beta, CtBP, Skp2/TrCP/FBXW, Axin, Tcf(Lef), beta-TrCP, Clathrin",
288,Development_Schema: Methods of somatic cell reprogramming into induced pluripotent stem cells,6,2.985E-03,2.210E-02,1.185E-02,4.861E-02,4,"KLF4, NANOG, SOX2, LIN-28",2.985E-03,2.210E-02,5,"KLF4, c-Myc, NANOG, SOX2, LIN-28",
289,Development_FGF2-induced self-renewal of adult neural stem cells,40,3.002E-03,2.096E-02,3.002E-03,2.096E-02,15,"MEK1(MAP2K1), hASH1, GRB2, GAB1, H-Ras, ERK1/2, c-Raf-1, FRS2, FGFR1, IP3 receptor, Cystatin C, PKC, PI3K reg class IA, AKT(PKB), PDK (PDPK1)",2.547E-02,8.368E-02,15,"GRB2, GAB1, H-Ras, ERK1/2, FRS2, FGFR1, IP3 receptor, Cystatin C, PI3K reg class IA, AKT(PKB), PDK (PDPK1), MBD1, hASH1, PKC, SHP-2",
290,Chemoresistance pathways mediated by constitutive activation of PI3K pathway and BCL-2 in small cell lung cancer,42,3.006E-03,2.214E-02,1.318E-02,5.249E-02,14,"MGF, FGFR1, PI3K reg class IA (p85), FOXO4, p70 S6 kinase1, PI3K reg class IA, Bcl-2, FAK1, Bcl-XL, IGF-1 receptor, AKT(PKB), IGF-1, PDK (PDPK1), p70 S6 kinase2",3.006E-03,2.214E-02,18,"IRS-1, FGFR1, PI3K reg class IA (p85), PI3K reg class IA, Bcl-XL, IGF-1 receptor, AKT(PKB), PDK (PDPK1), PARP-1, MGF, 4E-BP1, Caspase-7, FOXO4, p70 S6 kinase1, Bcl-2, FAK1, IGF-1, p70 S6 kinase2",
291,Role of neurotrophins in activation of p53 in major depressive disorder,39,3.138E-03,2.289E-02,2.669E-01,4.228E-01,9,"AKT1, GRB2, GAB1, H-Ras, p21, NRAGE(MAGED1), PI3K reg class IA, Bcl-2, JNK(MAPK8-10)",3.138E-03,2.289E-02,17,"TrkA, AKT1, GRB2, GAB1, H-Ras, p21, Rac1, Plasminogen, PI3K reg class IA, NT-3, TrkC, Plasmin, NRAGE(MAGED1), MKK7 (MAP2K7), MEKK1(MAP3K1), Bcl-2, JNK(MAPK8-10)",
292,Activation of Notch signaling in breast cancer,39,3.138E-03,2.289E-02,3.880E-02,1.141E-01,12,"E-cadherin, Neuregulin 1, H-Ras, Presenilin 1, Presenilin, KLF4, STAT3, DLL1, ErbB2, MSI1, MEK6(MAP2K6), p38 MAPK",3.138E-03,2.289E-02,17,"microRNA 200c, H-Ras, Presenilin 1, KLF4, Rac1, miR-141-3p, miR-200c-3p, DLL1, ErbB2, MEK6(MAP2K6), HEY1, E-cadherin, microRNA 141, c-Jun, Presenilin, MSI1, p38 MAPK",
293,Immune response_CRTH2 signaling in Th2 cells,44,3.176E-03,2.154E-02,3.176E-03,2.154E-02,16,"Calcineurin A (catalytic), CRTH2, G-protein alpha-i family, Cytochrome c, ITGAM, IP3 receptor, Calmodulin, PKC, PLC-beta, Adenylate cyclase, Bcl-XL, CD40(TNFRSF5), IL-4, AKT(PKB), PDK (PDPK1), CD40L(TNFSF5)",5.464E-03,3.179E-02,18,"Calcineurin A (catalytic), 14-3-3, Cytochrome c, IP3 receptor, BAD, PLC-beta, Adenylate cyclase, IL-13, Bcl-XL, IL-4, AKT(PKB), PDK (PDPK1), G-protein alpha-i family, ITGAM, Calmodulin, PKC, CD40(TNFRSF5), PI3K reg class IB (p101)",
294,Huntingtin-depended transcription deregulation in Huntington's Disease,24,3.197E-03,2.301E-02,6.210E-03,3.221E-02,10,"NFYB, Huntingtin, NR1, ARLY, HSPA1A, TAF4 (TAFII130), TR-beta, CNR1, SP1, C/EBPalpha",3.197E-03,2.301E-02,12,"NFYB, Huntingtin, NR1, ARLY, TR-beta, CNR1, TBP, HSPA1A, TAF4 (TAFII130), SP1, CtBP1, C/EBPalpha",
295,Tinnitus-associated changes in auditory pathway ,82,3.214E-03,2.301E-02,5.715E-02,1.450E-01,21,"nAChR alpha-10, GluR5, NR1, GABA-A receptor delta subunit, mGluR4A, Gephyrin, GABA-A receptor alpha-5 subunit, GBR2, GluR2, GABA-A receptor beta-3 subunit, GRIK4, KCNQ3, GABA-A receptor, GRIK5, GluR3, GABA-A receptor alpha-6 subunit, GABA-A receptor alpha-3 subunit, GABRG1, GRID2, GABA-A receptor gamma-2 subunit, GLRA",3.214E-03,2.301E-02,30,"nAChR alpha-10, GluR5, NR1, GABA-A receptor delta subunit, mGluR4A, NMDA receptor, KCNQ3, GABA-A receptor, GRIK5, GABA-A receptor alpha-6 subunit, nAChR, GABA-A receptor alpha-2 subunit, GABA-A receptor gamma-3 subunit, GABA-A receptor gamma-2 subunit, GLRA, GABA-A receptor beta-2 subunit, GABA-A receptor alpha-4 subunit, GABA-A receptor beta-1 subunit, mGluR3, GABA-A receptor alpha-1 subunit, GABA-A receptor alpha-4/beta-2/delta, Gephyrin, GABA-A receptor alpha-5 subunit, GBR2, GluR2, GABA-A receptor beta-3 subunit, GRIK4, GluR1, NR2D, KCNQ2",
296,Higher ESR1 / ESR2 ratio in breast cancer,36,3.247E-03,2.301E-02,8.037E-03,3.788E-02,13,"PDGF-B, ESR1 (nuclear), ErbB3, BTG2, p21, ESR2 (nuclear), ErbB2, PTEN, p130, Cyclin D1, AKT(PKB), SP1, p27KIP1",3.247E-03,2.301E-02,16,"PDGF-B, ESR1 (nuclear), ErbB3, p21, ESR2 (nuclear), ErbB2, p130, AKT(PKB), p27KIP1, c-Myc, ARNT, c-Jun, BTG2, PTEN, Cyclin D1, SP1",
297,Neuroendocrine transdifferentiation in Prostate Cancer,48,3.295E-03,2.154E-02,3.295E-03,2.154E-02,17,"MEK1(MAP2K1), Tuberin, GRB2, H-Ras, PKA-reg (cAMP-dependent), c-Raf-1, p21, AMACR, STAT3, p70 S6 kinase1, Keratin 18, IGF-1 receptor, AKT(PKB), IGF-1, PDK (PDPK1), ERK1 (MAPK3), IL-6 receptor",1.520E-02,6.141E-02,18,"Tuberin, GRB2, H-Ras, PKA-reg (cAMP-dependent), p21, AMACR, PCDH11Y, Keratin 18, IGF-1 receptor, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), Chromogranin A, Tcf(Lef), PTP-1B, p70 S6 kinase1, IGF-1, IL-6 receptor",
298,Signal transduction_Adenosine A3 receptor signaling pathway,48,3.295E-03,2.154E-02,3.295E-03,2.154E-02,17,"G-protein alpha-i family, H-Ras, ERK1/2, G-protein alpha-q/11, NFKBIA, IP3 receptor, STAT3, PI3K reg class IA (p85), PKC, PLC-beta, Adenylate cyclase, Bcl-2, MEK1/2, Rho GTPase, AKT(PKB), PDK (PDPK1), p38 MAPK",1.520E-02,6.141E-02,18,"H-Ras, ERK1/2, G-protein alpha-q/11, IP3 receptor, BAD, PI3K reg class IA (p85), PLC-beta, Adenylate cyclase, AKT(PKB), PDK (PDPK1), PKC-delta, G-protein alpha-i family, NFKBIA, PKC, Bcl-2, Rho GTPase, PI3K reg class IB (p101), p38 MAPK",
299,Muscle contraction_Relaxin signaling pathway,48,3.295E-03,2.154E-02,3.295E-03,2.154E-02,17,"MEK1(MAP2K1), Relaxin 2, G-protein alpha-i family, ERK1/2, Adenylate cyclase type VI, PKA-reg (cAMP-dependent), PDE8B, INSL3, p90Rsk, NFKBIA, I-kB, Adenylate cyclase type V, G-protein alpha-s, PDE4D, eNOS, AKT(PKB), PDE4B",3.202E-02,9.850E-02,17,"ERK1/2, Adenylate cyclase type VI, PKC-zeta, PKA-reg (cAMP-dependent), I-kB, Adenylate cyclase type V, PDE4D, AKT(PKB), LGR8, Relaxin 2, G-protein alpha-i family, PDE8B, INSL3, NFKBIA, G-protein alpha-s, eNOS, PDE4B",
300,IL-17-induced mucin expression in CF airways,48,3.295E-03,2.154E-02,3.295E-03,2.154E-02,17,"CD80, MHC class II, ROR-alpha, ROR-gamma, ERK1/2, CIKS, CFTR, I-kB, AP-1, IL-17RC, Mucin 5AC, IKK-beta, Mucin 5B, MSK1, SP1, p38 MAPK, IL-6 receptor",3.202E-02,9.850E-02,17,"TLR5, MHC class II, ERK1/2, CIKS, IKK (cat), I-kB, IL-17RC, Mucin 5B, MSK1, ROR-gamma, AP-1, Mucin 5AC, IKK-beta, SP1, TCR alpha/beta, p38 MAPK, IL-6 receptor",
301,Development_Role of Thyroid hormone in regulation of oligodendrocyte differentiation,48,3.295E-03,2.154E-02,3.295E-03,2.154E-02,17,"TR-alpha, AKT1, OATP-A, E2F1, GLNA, PLP1, MCT8, OLIG1, p21, TR-beta, ID2, p70 S6 kinase1, Cyclin D1, 4E-BP2, AKT(PKB), PDK (PDPK1), p27KIP1",6.668E-03,3.679E-02,19,"TR-alpha, AKT1, PLP1, OLIG1, p21, TR-beta, ID2, 4E-BP2, AKT(PKB), PDK (PDPK1), p27KIP1, OATP-A, E2F1, GLNA, MCT8, 4E-BP1, p70 S6 kinase1, MAG, Cyclin D1",
302,Development_VEGF signaling via VEGFR2 - generic cascades,93,3.304E-03,2.154E-02,3.304E-03,2.154E-02,28,"MEK1(MAP2K1), Calcineurin A (catalytic), GRB2, H-Ras, PAK2, ERK1/2, c-Raf-1, PAK1, p90Rsk, IP3 receptor, I-kB, COX-1 (PTGS1), MAPKAPK2, Calmodulin, PKC, PI3K reg class IA, HSP27, IKK-beta, eNOS, FAK1, MSK1, AKT(PKB), HSP90, PDK (PDPK1), PLA2G5, p38 MAPK, ERK1 (MAPK3), MLCK",1.287E-02,5.499E-02,31,"Calcineurin A (catalytic), GRB2, H-Ras, PAK2, eIF4E, ERK1/2, c-Jun/c-Fos, IKK (cat), Rac1, IP3 receptor, I-kB, MAPKAPK2, PI3K reg class IA, MSK1, AKT(PKB), HSP90, PDK (PDPK1), ERK1 (MAPK3), MLCK, c-Jun, PAK1, Paxillin, Calmodulin, PKC, MEKK1(MAP3K1), HSP27, IKK-beta, eNOS, FAK1, PLA2G5, p38 MAPK",
303,Development_Generation of pancreatic beta-cells from induced pluripotent stem cells,27,3.316E-03,2.309E-02,4.290E-02,1.205E-01,9,"EGF, HB9, KLF4, NANOG, SOX2, Neurogenin 3, Insulin, HNF6, MafA",3.316E-03,2.309E-02,13,"EGF, WNT3A, KLF4, Neurogenin 3, Nkx2.2, c-Myc, HB9, NANOG, FGF7, SOX2, Insulin, HNF6, MafA",
304,DeltaF508-CFTR traffic / Sorting endosome formation in CF,27,3.316E-03,2.309E-02,1.586E-02,6.044E-02,10,"Rabaptin-5, SNAP-25, CFTR, CHMP4B, DAB2, Vps25, Ubiquitin, VPS45A, EEA1, TSG101",3.316E-03,2.309E-02,13,"NSF, Rabaptin-5, COMMD1 (MURR1), CHMP4B, DAB2, Vps25, Ubiquitin, RABGEF1, Rab-7, VPS45A, EEA1, TSG101, STAM2",
305,IL-2 as a growth factor for T cells in multiple sclerosis,33,3.323E-03,2.309E-02,1.007E-02,4.369E-02,12,"Tuberin, E2F1, PI3K reg class IA (p85), p70 S6 kinase1, Rb protein, Bcl-2, c-Myb, Bcl-XL, p130, AKT(PKB), PDK (PDPK1), p27KIP1",3.323E-03,2.309E-02,15,"Tuberin, Cyclin D3, PI3K reg class IA (p85), Rb protein, c-Myb, Bcl-XL, p130, AKT(PKB), PDK (PDPK1), p27KIP1, c-Myc, E2F1, p70 S6 kinase1, Bcl-2, FOXO3A",
306,HCV-mediated liver damage and predisposition to HCC progression via p53,19,3.335E-03,2.154E-02,3.335E-03,2.154E-02,9,"MEK1(MAP2K1), GRB2, H-Ras, ERK1/2, c-Raf-1, p21, CDK7, Rb protein, CAK complex",1.201E-01,2.474E-01,7,"GRB2, H-Ras, ERK1/2, p21, CDK7, Rb protein, CAK complex",
307,Cytoskeleton remodeling_Alpha-1A adrenergic receptor-dependent inhibition of PI3K,19,3.335E-03,2.154E-02,3.335E-03,2.154E-02,9,"CACNA1C, Myosin II, Calmodulin, Alpha-1A adrenergic receptor, MRLC, AKT(PKB), MELC, PDK (PDPK1), MLCK",4.399E-03,2.763E-02,10,"AKT(PKB), PDK (PDPK1), MLCK, CACNA1C, Myosin II, Calmodulin, Alpha-1A adrenergic receptor, MRLC, G-protein alpha-q, MELC",
308,Regulation of lipid metabolism_Regulation of fatty acid synthase activity in hepatocytes,19,3.335E-03,2.154E-02,3.335E-03,2.154E-02,9,"LXR-alpha/RXR-alpha, SREBP1 (nuclear), RXRA, FASN, SREBP1 (Golgi membrane), TR-beta, SREBP1 precursor, LXR-alpha, SP1",1.201E-01,2.474E-01,7,"SREBP1 (nuclear), FASN, TR-beta, SREBP1 precursor, RXRA, SREBP1 (Golgi membrane), SP1",
309,"Regulation of lipid metabolism_RXR-dependent regulation of lipid metabolism via PPAR, RAR and VDR",30,3.351E-03,2.309E-02,4.173E-03,2.471E-02,12,"VDR/RXR-alpha, SCD, RARgamma, RXRA, HMGCS2, RAR-alpha/RXR-alpha, CYP4F2, SHP, CPT-1A, RARalpha, CAR, SP1",3.351E-03,2.309E-02,14,"VDR/RXR-alpha, SCD, RARgamma, HMGCS2, CYP4F2, CPT-1A, RARalpha, CYP19, CAR, ACSL1, RXRA, RAR-alpha/RXR-alpha, APOC3, SP1",
310,Inhibition of Ephrin receptors in colorectal cancer,30,3.351E-03,2.309E-02,1.629E-01,2.972E-01,8,"E-cadherin, Ephrin-A receptor 1, Ephrin-A receptors, Ephrin-A receptor 7, WNT, VAV-2, FAK1, Ephrin-A",3.351E-03,2.309E-02,14,"Ephrin-A receptor 3, Rac1, Ephrin-A receptor 7, VAV-2, E-cadherin, Ephrin-A receptor 1, Ephrin-A receptors, Ephrin-B receptor 3, Paxillin, WNT, FAK1, Ephrin-A, Ephrin-B receptors, Frizzled",
311,Development_FGF-family signaling,52,3.367E-03,2.154E-02,3.368E-03,2.154E-02,18,"MEK1(MAP2K1), FGFR3, GRB2, GAB1, FGFR4, H-Ras, c-Raf-1, FRS2, FGFR1, IP3 receptor, FGF4, PI3K reg class IA, FGF10, MEK6(MAP2K6), AKT(PKB), PDK (PDPK1), p38 MAPK, ERK1 (MAPK3)",3.367E-03,2.309E-02,21,"GRB2, GAB1, FGFR4, H-Ras, FRS2, FGFR1, Rac1, IP3 receptor, FGF4, PI3K reg class IA, FGF10, MEK6(MAP2K6), AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), FGFR3, PKC-delta, FGF7, SHP-2, FGF6, p38 MAPK",
312,G-protein signaling_Proinsulin C-peptide signaling,52,3.367E-03,2.154E-02,3.368E-03,2.154E-02,18,"MEK1(MAP2K1), TRAF2, G-protein alpha-i family, H-Ras, ERK1/2, c-Raf-1, IP3 receptor, I-kB, PI3K reg class IA (p85), PI3K reg class IA, PLC-beta, IKK-beta, Bcl-2, eNOS, Proinsulin C-peptide, Cyclin D1, AKT(PKB), PDK (PDPK1)",3.367E-03,2.309E-02,21,"H-Ras, ERK1/2, IKK (cat), IP3 receptor, I-kB, PI3K reg class IA (p85), PI3K reg class IA, PLC-beta, IKK-alpha, AKT(PKB), PDK (PDPK1), PKC-delta, TRAF2, G-protein alpha-i family, c-Jun, IKK-beta, Bcl-2, eNOS, Proinsulin C-peptide, Cyclin D1, PI3K reg class IB (p101)",
313,Development_Endothelin-1/EDNRA signaling,52,3.368E-03,2.154E-02,3.368E-03,2.154E-02,18,"MEK1(MAP2K1), p38alpha (MAPK14), GRB2, G-protein alpha-i family, H-Ras, ERK1/2, GATA-4, c-Raf-1, G-protein alpha-q/11, IP3 receptor, G-protein alpha-s, Calmodulin, PI3K reg class IA, Adenylate cyclase, MEK6(MAP2K6), Cyclin D1, JNK(MAPK8-10), AKT(PKB)",1.725E-02,6.513E-02,19,"GRB2, H-Ras, ERK1/2, GATA-4, G-protein alpha-q/11, Rac1, IP3 receptor, PI3K reg class IA, Adenylate cyclase, MEK6(MAP2K6), AKT(PKB), MEKK4(MAP3K4), PKC-delta, G-protein alpha-i family, G-protein alpha-s, Calmodulin, MEKK1(MAP3K1), Cyclin D1, JNK(MAPK8-10)",
314,Signal transduction_Activation of PKC via G-Protein coupled receptor,52,3.368E-03,2.154E-02,3.368E-03,2.154E-02,18,"MEK1(MAP2K1), PKC-eta, Calcineurin A (catalytic), ERK1/2, NF-AT3(NFATC4), c-Raf-1, MEF2, G-protein alpha-q/11, IP3 receptor, I-kB, PRKD1, Calmodulin, NUR77, PLC-beta, IKK-beta, PKC-gamma, MELC, MLCK",7.906E-03,4.020E-02,20,"PKC-eta, Calcineurin A (catalytic), NF-AT1(NFATC2), ERK1/2, PKC-zeta, NF-AT3(NFATC4), IKK (cat), G-protein alpha-q/11, IP3 receptor, I-kB, PLC-beta, PKC-gamma, MLCK, PKC-delta, MEF2, PRKD1, Calmodulin, NUR77, IKK-beta, MELC",
315,Glucagon-induced glucose upregulation in type 2 diabetes in liver ,52,3.368E-03,2.154E-02,3.368E-03,2.154E-02,18,"Calcineurin A (catalytic), PHK gamma (liver), G-protein alpha-i family, G6PT, PFKL, PKA-reg (cAMP-dependent), G-protein alpha-q/11, PHK alpha (liver), IP3 receptor, F261, G-protein alpha-s, Calmodulin, PLC-beta, TORC2, Adenylate cyclase, PPCKM, PYC, PHK beta",7.906E-03,4.020E-02,20,"Calcineurin A (catalytic), PHK gamma (liver), GYS2, PFKL, PKA-reg (cAMP-dependent), G-protein alpha-q/11, PHK alpha (liver), IP3 receptor, F261, PLC-beta, TORC2, Adenylate cyclase, PPCKM, GCGR, G-protein alpha-i family, 14-3-3 beta/alpha, G-protein alpha-s, Calmodulin, PYC, PHK beta",
316,Development_Thyroliberin signaling,60,3.401E-03,2.154E-02,3.401E-03,2.154E-02,20,"MEK1(MAP2K1), Thyroliberin, GRB2, c-Fos, JunB, H-Ras, ERK1/2, G-protein alpha-11, CACNA1C, PKA-reg (cAMP-dependent), c-Raf-1, G-protein alpha-q/11, IP3 receptor, G-protein alpha-s, Calmodulin, CG alpha, Adenylate cyclase, MKP-1, LHX3, SP1",2.116E-02,7.498E-02,21,"GRB2, c-Fos, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), G-protein alpha-q/11, PLC-beta1, IP3 receptor, CG alpha, Adenylate cyclase, Thyroliberin, JunB, PKC-delta, G-protein alpha-11, CACNA1C, G-protein alpha-s, Calmodulin, MKP-1, LHX3, G-protein alpha-q, SP1",
317,Development_EGFR signaling via small GTPases,33,3.402E-03,2.154E-02,3.402E-03,2.154E-02,13,"EGF, GRB2, c-Fos, K-RAS, MLK2(MAP3K10), H-Ras, ERK1/2, c-Raf-1, ErbB2, PI3K reg class IA, VAV-2, MEK1/2, JNK(MAPK8-10)",9.421E-03,4.500E-02,14,"EGF, GRB2, c-Fos, H-Ras, ERK1/2, Rac1, ErbB2, PI3K reg class IA, VAV-2, c-Myc, K-RAS, MLK2(MAP3K10), MKK7 (MAP2K7), JNK(MAPK8-10)",
318,Neurophysiological process_HTR2A signaling in the nervous system,49,3.606E-03,2.450E-02,1.035E-02,4.369E-02,16,"cPKC (conventional), Calcineurin A (catalytic), ERK1/2, CACNA1C, KCC2, PAK1, G-protein alpha-q/11, IP3 receptor, Calmodulin, PKC, GABA-A receptor, PLC-beta, Kalirin, AKT(PKB), GABA-A receptor gamma-2 subunit, SFK",3.606E-03,2.450E-02,20,"Calcineurin A (catalytic), ERK1/2, EGR1, G-protein alpha-q/11, PLC-beta1, Rac1, IP3 receptor, NMDA receptor, GABA-A receptor, PLC-beta, Kalirin, AKT(PKB), GABA-A receptor gamma-2 subunit, SFK, cPKC (conventional), CACNA1C, KCC2, PAK1, Calmodulin, PKC",
319,Hedgehog signaling in prostate cancer,26,3.606E-03,2.245E-02,3.606E-03,2.245E-02,11,"E-cadherin, PKC-eta, BMI-1, STK36, SHH, p21, Bcl-2, Cyclin D1, HIP, HSP90, SUFU",7.218E-03,3.761E-02,12,"PKC-eta, p21, KIF27, HSP90, c-Myc, SUFU, E-cadherin, BMI-1, STK36, SHH, Bcl-2, Cyclin D1",
320,Cell adhesion_Endothelial cell contacts by junctional mechanisms,26,3.606E-03,2.245E-02,3.606E-03,2.245E-02,11,"Cingulin, AF-6, Alpha-actinin, Claudin-5, JAM1, Alpha-catenin, Plakophilin 4, Connexin 43, Occludin, Plakoglobin, Claudin-3",2.094E-02,7.467E-02,11,"JAM2, AF-6, Claudin-5, JAM1, Claudin-3, Cingulin, Alpha-catenin, Plakophilin 4, Occludin, Plakoglobin, p120-catenin",
321,Signal transduction_HTR2A-dependent arachidonic acid production,26,3.606E-03,2.245E-02,3.606E-03,2.245E-02,11,"G-protein alpha-12 family, DGL-alpha, G-protein alpha-i family, ERK1/2, G-protein alpha-q/11, DGL-beta, PLC-beta, cPLA2, FAAH, RhoA-related, p38 MAPK",2.094E-02,7.467E-02,11,"DGL-alpha, ERK1/2, G-protein alpha-q/11, DGL-beta, PLC-beta, cPLA2, FAAH, RhoA-related, G-protein alpha-12 family, G-protein alpha-i family, p38 MAPK",
322,Immune response_CD16 signaling in NK cells,69,3.705E-03,2.506E-02,6.368E-02,1.594E-01,18,"MEK1(MAP2K1), Calcineurin A (catalytic), GRB2, c-Fos, NKG2A, H-Ras, ERK1/2, c-Raf-1, IP3 receptor, PIP5K1A, AP-1, Calmodulin, PI3K reg class IA, ARF6, WASP, SHP-1, IL-4, PLA2",3.705E-03,2.506E-02,26,"Calcineurin A (catalytic), GRB2, c-Fos, NF-AT1(NFATC2), NKG2A, H-Ras, ERK1/2, c-Jun/c-Fos, FCGR3A, IL-3, Rac1, IP3 receptor, PIP5K1A, PI3K reg class IA, ZAP70, ARF6, WASP, SHP-1, FasL(TNFSF6), IL-4, SHIP, c-Jun, LAT, AP-1, Calmodulin, PLA2",
323,Cytoskeleton remodeling_Substance P mediated membrane blebbing,16,3.717E-03,2.304E-02,3.717E-03,2.304E-02,8,"Substance P extracellular region, G-protein alpha-12 family, Myosin II, PAK1, Tubulin alpha, MRLC, MLCK, Tubulin (in microtubules)",1.566E-02,6.151E-02,8,"Substance P extracellular region, MLCK, Tubulin (in microtubules), G-protein alpha-12 family, Myosin II, PAK1, Tubulin alpha, MRLC",
324,Neurophysiological process_Constitutive and activity-dependent synaptic AMPA receptor delivery,59,3.759E-03,2.532E-02,1.022E-01,2.190E-01,15,"Chapsyn-110, Rab-4, Complexin, SHANK, GluR2, Calmodulin, PKC, Rab-11A, SAP102, Kinesin heavy chain, PICK1, Guanylate Cyclase 1, soluble, Myosin Vb, SNAP-23, GRIPAP1",3.759E-03,2.532E-02,23,"Chapsyn-110, NSF, PKC-zeta, Complexin, SHANK, NMDA receptor, Hap-1, 4.1N, Guanylate Cyclase 1, soluble, Syntaxin 4, GRIPAP1, Rab-4, GRIP, GluR2, Calmodulin, PKC, Rab-11A, SAP102, Kinesin heavy chain, PICK1, GluR1, Myosin Vb, SNAP-23",
325,Cytoskeleton remodeling_Regulation of actin cytoskeleton nucleation and polymerization by Rho GTPases,46,3.847E-03,2.556E-02,5.264E-03,2.848E-02,16,"DAAM1, BAIAP2, WASF subunit, WASF3 (WAVE3), RhoB, PIP5KI, Rac3, RhoD, DRF, CYFIP2, Rac1-related, Cdc42 subfamily, RhoA-related, WASP, FHOD1, FNBP1L",3.847E-03,2.556E-02,19,"BAIAP2, RhoC, Rac1, RhoD, DRF, CYFIP2, Cdc42 subfamily, RhoA-related, WASP, FHOD1, DAAM1, WASF subunit, WASF3 (WAVE3), RhoB, PIP5KI, Rac3, Rac1-related, N-WASP, FNBP1L",
326,Apoptosis and survival_Endoplasmic reticulum stress response pathway,56,4.071E-03,2.667E-02,7.030E-02,1.708E-01,15,"p38alpha (MAPK14), eIF2AK3, TRAF2, XBP1, PP1-cat, Cytochrome c, I-kB, PP1-cat alpha, Bcl-2, IP3R1, JNK(MAPK8-10), eIF2S1, IRE1, Derlin1, HERP",4.071E-03,2.667E-02,22,"XBP1, PP1-cat, ATF-4, c-Jun/c-Fos, IKK (cat), Bak, Cytochrome c, I-kB, PP1-cat alpha, eIF2S1, IRE1, eIF2AK3, TRAF2, c-Jun, Caspase-7, Bcl-2, IP3R1, JNK(MAPK8-10), DNAJC3, Derlin1, HERP, JIK",
327,Immune response_IL-5 signaling via JAK/STAT,56,4.071E-03,2.667E-02,3.686E-02,1.097E-01,16,"DUSP5, c-Fos, JunB, CSF2RB, XBP1, AID, UCP2, GATA-1, NFKBIA, STAT3, Amphiregulin, CISH, Bcl-2, MKP-1, SOCS2, CysLT1 receptor",4.071E-03,2.667E-02,22,"Cyclin D3, c-Fos, NF-AT1(NFATC2), XBP1, UCP2, Amphiregulin, CISH, IL-13, LPPL, CysLT1 receptor, c-Myc, DUSP5, JunB, CSF2RB, c-Jun, AID, IL-5 receptor, NFKBIA, IL5RA, Bcl-2, MKP-1, SOCS2",
328,SCAP/SREBP Transcriptional Control of Cholesterol and FA Biosynthesis,45,4.113E-03,2.471E-02,4.113E-03,2.471E-02,16,"ACACA, GGPS1, SREBP1 (nuclear), Insulin processed, SCD, HMGCS2, FASN, SREBP1 (Golgi membrane), MVK, ACSA, SREBP1 precursor, ACLY, ERG1, ELOVL3, ACSS1, SCAP",7.201E-03,3.761E-02,18,"GGPS1, SREBP1 (nuclear), Insulin processed, SCD, HMGCS2, FASN, ACSA, SREBP1 precursor, INSIG2, HMGCS1, Resistin, ACSS1, SREBP1 (Golgi membrane), MVK, ACLY, ERG1, ELOVL3, SCAP",
329,Cell adhesion_Ephrin signaling,45,4.113E-03,2.471E-02,4.113E-03,2.471E-02,16,"GRB2, RHO6, RGS3, G-protein alpha-i family, H-Ras, GRB7, Ephrin-A receptor 8, Ephrin-A receptors, c-Raf-1, PAK1, Kalirin, VAV-2, FAK1, Ephrin-A, SLAP, GRB10",1.668E-02,6.424E-02,17,"GRB2, H-Ras, GRB7, Rac1, Kalirin, VAV-2, RHO6, RGS3, G-protein alpha-i family, Ephrin-A receptor 8, Ephrin-A receptors, PAK1, Paxillin, FAK1, Ephrin-A, Ephrin-B receptors, GRB10",
330,Signal transduction_Angiotensin II/ AGTR1 signaling via JAK/STAT,45,4.113E-03,2.471E-02,4.113E-03,2.471E-02,16,"c-Fos, ERK1/2, AGTR1, AMPK alpha subunit, GATA-4, c-Raf-1, p21, NFKBIA, STAT3, I-kB, PKC, ANP, IP3R1, MEK1/2, SHP-1, STAT6",7.201E-03,3.761E-02,18,"c-Fos, IRS-1, ERK1/2, GATA-4, p21, Rac1, I-kB, ANP, SHP-1, c-Jun, AGTR1, AMPK alpha subunit, PTP-1B, NFKBIA, PKC, SHP-2, IP3R1, STAT6",
331,Production of arachidonic acid derivatives by mast cells in asthma,30,4.173E-03,2.471E-02,4.173E-03,2.471E-02,12,"ERK1/2, PLA2G12, MGF, PG12B, COX-1 (PTGS1), PLA2(hGIIA), PLA2G3, cPLA2, PLA2G2F, PLA2G10, PLA2G2D, PLA2G5",6.056E-02,1.529E-01,11,"ERK1/2, PG12B, PLA2G3, PLA2G1B, cPLA2, PLA2G2F, PLA2G10, PLA2G12, MGF, PLA2(hGIIA), PLA2G5",
332,Neutrophil-derived granule proteins and cytokines in asthma,49,4.208E-03,2.471E-02,4.208E-03,2.471E-02,17,"Substance P extracellular region, CCL17, Fc epsilon RI gamma, ERK1/2, Lactoferrin, Tryptase, LTBR1, IL8RA, PERM, Hck, PKC, MEK1/2, IL-4, CysLT1 receptor, Alpha-defensin, IL9R, IL8RB",3.893E-02,1.152E-01,17,"Substance P extracellular region, CCL17, Fc epsilon RI gamma, ERK1/2, Lactoferrin, Hck, IL-13, IL-9, IL-4, CysLT1 receptor, IL8RB, Tryptase, LTBR1, IL8RA, PERM, PKC, IL9R",
333,Signal transduction_IP3 signaling,49,4.208E-03,2.471E-02,4.208E-03,2.471E-02,17,"MEK1(MAP2K1), GRB2, H-Ras, ERK1/2, c-Raf-1, MEF2, G-protein alpha-q/11, IP3 receptor, Galpha(q)-specific nucleotide-like GPCRs, Calmodulin, PI3K reg class IA, PLC-beta, CD3, CaMKK, PKC-gamma, AKT(PKB), PDK (PDPK1)",1.903E-02,6.971E-02,18,"GRB2, H-Ras, ERK1/2, G-protein alpha-q/11, IP3 receptor, PI3K reg class IA, PLC-beta, ZAP70, PKC-gamma, AKT(PKB), PDK (PDPK1), CD79 complex, MEF2, LAT, Galpha(q)-specific nucleotide-like GPCRs, Calmodulin, CaMKK, TCR alpha/beta",
334,Development_G-CSF signaling,49,4.208E-03,2.471E-02,4.208E-03,2.471E-02,17,"MEK1(MAP2K1), GRB2, H-Ras, ERK1/2, c-Raf-1, STAT3, PI3K reg class IA (p85), Hck, Bcl-2, Bcl-XL, G-CSF receptor, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1), G-CSF, p38 MAPK, IL8RB",1.903E-02,6.971E-02,18,"Cyclin D3, GRB2, H-Ras, ERK1/2, PI3K reg class IA (p85), Hck, Bcl-XL, G-CSF receptor, SHIP, AKT(PKB), PDK (PDPK1), c-Myc, IL8RB, SHP-2, Bcl-2, JNK(MAPK8-10), G-CSF, p38 MAPK",
335,Ca(2+)-dependent NF-AT signaling in cardiac hypertrophy,57,4.250E-03,2.471E-02,4.250E-03,2.471E-02,19,"Calcineurin A (catalytic), G-protein alpha-i family, SLC9A1, AGTR1, G-protein alpha-11, Adenylate cyclase type VI, CACNA1C, NF-AT3(NFATC4), GATA-4, PKA-reg (cAMP-dependent), MEF2, G-protein alpha-q/11, IP3 receptor, MEF2D, Adenylate cyclase type V, G-protein alpha-s, Calmodulin, Alpha-1A adrenergic receptor, PKC-gamma",1.145E-02,5.035E-02,21,"Calcineurin A (catalytic), SLC9A1, Adenylate cyclase type VI, NF-AT3(NFATC4), GATA-4, PKA-reg (cAMP-dependent), G-protein alpha-q/11, PLC-beta1, IP3 receptor, Adenylate cyclase type V, PKC-gamma, G-protein alpha-i family, AGTR1, G-protein alpha-11, CACNA1C, MEF2, MEF2D, G-protein alpha-s, Calmodulin, Alpha-1A adrenergic receptor, G-protein alpha-q",
336,ENaC regulation in normal and CF airways ,53,4.251E-03,2.471E-02,4.251E-03,2.471E-02,18,"Dopamine D1A receptor, cPKC (conventional), gamma-ENaC, cAMP-GEFI, beta-ENaC, alpha-ENaC, ERK1/2, Protein kinase G, AMPK alpha subunit, CFTR, PKA-reg (cAMP-dependent), G-protein alpha-q/11, G-protein alpha-s, PI3K reg class IA, PLC-beta, P2Y2, Adenylate cyclase, Prostasin",4.399E-03,2.763E-02,21,"gamma-ENaC, cAMP-GEFI, beta-ENaC, ERK1/2, PKA-reg (cAMP-dependent), G-protein alpha-q/11, Syntaxin 1A, PI3K reg class IA, PLC-beta, Adenylate cyclase, Dopamine D1A receptor, cPKC (conventional), alpha-ENaC, Protein kinase G, AMPK alpha subunit, C3G, NEDD4, G-protein alpha-s, P2Y2, Prostasin, ENaC",
337,Role of Leptin in regulation of eating behavior in obesity,23,4.314E-03,2.488E-02,4.314E-03,2.488E-02,10,"MEK1(MAP2K1), ACACA, ERK1/2, AMPK alpha subunit, STAT3, p70 S6 kinase1, AKT(PKB), SP1, Leptin, CART",1.322E-01,2.614E-01,8,"ERK1/2, AKT(PKB), AMPK alpha subunit, PTP-1B, p70 S6 kinase1, SP1, Leptin, CART",
338,WNT signaling in HCC,40,4.315E-03,2.763E-02,4.426E-01,6.061E-01,8,"WNT4, GLNA, DVL-1, Dsh, WNT, Cyclin D1, Axin, TBX3",4.315E-03,2.763E-02,17,"DVL-3, WNT3A, DVL-1, Dsh, LRP5, c-Myc, Axin, WNT4, Tcf(Lef), GLNA, FZD3, WNT1, SFRP4, WNT, Cyclin D1, TBX3, Frizzled",
339,Activation of Cortisol production in major depressive disorder,40,4.315E-03,2.763E-02,8.264E-03,3.846E-02,14,"CYP11B1, ASAH, SREBP1 (nuclear), ERK1/2, Adenylate cyclase type VI, FALP, PKA-reg (cAMP-dependent), SPHK2, Adenylate cyclase type V, G-protein alpha-s, MKP-1, MEK1/2, SP1, IL-6 receptor",4.315E-03,2.763E-02,17,"CYP11B1, ASAH, SREBP1 (nuclear), ERK1/2, Adenylate cyclase type VI, PKA-reg (cAMP-dependent), STAR, Adenylate cyclase type V, CYP11B2, FALP, CYP17, SPHK2, G-protein alpha-s, MKP-1, SP1, MC2R, IL-6 receptor",
340,Development_Role of Activin A in cell differentiation and proliferation,40,4.315E-03,2.763E-02,4.659E-02,1.282E-01,12,"ALK-4, Pitx1, GnRH receptor, VDR, PKA-reg (cAMP-dependent), p21, NANOG, G-protein alpha-s, Adenylate cyclase, LHX3, SP1, p27KIP1",4.315E-03,2.763E-02,17,"ALK-4, Pitx1, GnRH receptor, PKA-reg (cAMP-dependent), p21, STAR, Adenylate cyclase, p27KIP1, c-Myc, LH receptor, FSH-beta, VDR, Lefty-1, NANOG, G-protein alpha-s, LHX3, SP1",
341,The role of UV radiation in melanoma development,40,4.315E-03,2.763E-02,1.758E-01,3.127E-01,10,"TRAF2, ERK1/2, p21, USF1, NFKBIA, Amphiregulin, MEK6(MAP2K6), JNK(MAPK8-10), AKT(PKB), p38 MAPK",4.315E-03,2.763E-02,17,"ERK1/2, p21, XRCC3, USF1, Amphiregulin, MEK6(MAP2K6), FasL(TNFSF6), AKT(PKB), PARP-1, TRAF2, c-Jun, MKK7 (MAP2K7), NFKBIA, MEKK1(MAP3K1), JNK(MAPK8-10), p38 MAPK, XPD",
342,Development_Early embryonal hypaxial myogenesis,37,4.528E-03,2.832E-02,2.605E-02,8.495E-02,12,"FGFR4, Myostatin, STK36, PKA-reg (cAMP-dependent), SHH, Dsh, MYOG, PKC, Adenylate cyclase, PAX3, SUFU, MYOD",4.528E-03,2.832E-02,16,"FGFR4, Lef-1, MYF5, PKA-reg (cAMP-dependent), KIF27, Dsh, MYOG, Adenylate cyclase, PAX3, SUFU, Myostatin, STK36, SHH, PKC, Frizzled, MYOD",
343,Apoptosis and survival_Role of CDK5 in neuronal death and survival,34,4.608E-03,2.627E-02,4.608E-03,2.627E-02,13,"MEK1(MAP2K1), Neuregulin 1, H-Ras, ERK1/2, ErbB3, c-Raf-1, Cytochrome c, PI3K reg class IA (p85), ErbB2, Bcl-2, JNK3(MAPK10), AKT(PKB), PDK (PDPK1)",4.710E-03,2.882E-02,15,"TrkA, H-Ras, ERK1/2, ErbB3, EGR1, Cytochrome c, BAD, PI3K reg class IA (p85), ErbB2, JNK3(MAPK10), AKT(PKB), PDK (PDPK1), PKC-delta, c-Jun, Bcl-2",
344,Development_CNTF receptor signaling,34,4.608E-03,2.627E-02,4.608E-03,2.627E-02,13,"MEK1(MAP2K1), Tuberin, gp130, GRB2, c-Fos, H-Ras, ERK1/2, c-Raf-1, STAT3, p70 S6 kinase1, PI3K reg class IA, AKT(PKB), p70 S6 kinase2",6.721E-02,1.644E-01,12,"Tuberin, gp130, GRB2, c-Fos, H-Ras, ERK1/2, PI3K reg class IA, AKT(PKB), CNTFR alpha, p70 S6 kinase1, SHP-2, p70 S6 kinase2",
345,Hypertrophy of  asthmatic airway smooth muscle cells ,70,4.639E-03,2.882E-02,1.202E-01,2.449E-01,17,"Tuberin, EGF, gp130, PDGF-B, eIF2B5, KLF4, STAT3, Smooth muscle myosin, p70 S6 kinase1, Rb protein, TGF-beta 3, LIN-28, Max, IL-4, AKT(PKB), MLCK, C/EBPalpha",4.639E-03,2.882E-02,26,"Tuberin, EGF, gp130, PDGF-B, eIF2B5, miR-26a-5p, Cardiotrophin-1, eIF4E, KLF4, Smooth muscle myosin, Rb protein, SOD1, Thrombin, IL-13, IL-4, AKT(PKB), c-Myc, MLCK, 4E-BP1, p70 S6 kinase1, MYH11, TGF-beta 3, LIN-28, Max, Actin muscle, C/EBPalpha",
346,Ubiquitin-proteasome system in Huntington's disease,22,4.729E-03,2.882E-02,1.960E-01,3.354E-01,6,"Huntingtin, SYVN1, NR1, Parkin, Ubiquitin, CHIP",4.729E-03,2.882E-02,11,"Huntingtin, SYVN1, NR1, Parkin, NMDA receptor, Ubiquitin, NR2, CDC34, HIP-2, PA28 (11S regulator), CHIP",
347,Role of Huntingtin in regulation of BDNF in Huntington's disease,22,4.729E-03,2.882E-02,3.334E-02,1.013E-01,8,"Calcineurin A (catalytic), Huntingtin, PI3K reg class IA, IGF-1 receptor, AKT(PKB), SP1, IGF-1, PDK (PDPK1)",4.729E-03,2.882E-02,11,"Calcineurin A (catalytic), Huntingtin, Hap-1, PI3K reg class IA, NRSF, IGF-1 receptor, AKT(PKB), PDK (PDPK1), SP1, Kinesin light chain, IGF-1",
348,Transport_The role of AVP in regulation of Aquaporin 2 and renal water reabsorption,50,4.743E-03,2.848E-02,5.319E-03,2.848E-02,17,"p38alpha (MAPK14), cAMP-GEFI, c-Fos, ERK1/2, Adenylate cyclase type VI, PRKAR2A, Myosin II, PKA-reg type II (cAMP-dependent), PKA-reg (cAMP-dependent), MyHC, G-protein alpha-s, Calmodulin, PRKAR2B, Syntaxin 3, MRLC, SNAP-23, MLCK",4.743E-03,2.882E-02,20,"cAMP-GEFI, c-Fos, ERK1/2, Adenylate cyclase type VI, c-Jun/c-Fos, PKA-reg (cAMP-dependent), PRKAR2B, Syntaxin 4, MLCK, PRKAR2A, Myosin II, PKA-reg type II (cAMP-dependent), MyHC, G-protein alpha-s, Calmodulin, Syntaxin 3, V2 receptor, MRLC, Aquaporin 2, SNAP-23",
349,Role of inhibition of WNT signaling in the progression of lung cancer,31,4.846E-03,2.898E-02,3.262E-01,4.898E-01,7,"E-cadherin, DAAM1, p21, Dsh, Keratin 18, Keratin 8, Axin",4.846E-03,2.898E-02,14,"p21, Dsh, Rac1, Keratin 18, SPRY4, Axin, E-cadherin, CD82, DAAM1, c-Jun, MKK7 (MAP2K7), MEKK1(MAP3K1), Keratin 8, Frizzled",
350,Influence of low doses of Arsenite on glucose uptake in adipocytes,31,4.846E-03,2.898E-02,1.644E-02,6.155E-02,11,"A-FABP, Rab-4A, Insulin processed, RXRA, p21, PI3K reg class IA, Insulin receptor, AKT(PKB), PDK (PDPK1), C/EBPalpha, Tubulin (in microtubules)",4.846E-03,2.898E-02,14,"Insulin processed, IRS-1, PKC-zeta, GLUT4, p21, PI3K reg class IA, Insulin receptor, AKT(PKB), PDK (PDPK1), Tubulin (in microtubules), Rab-4A, RXRA, KIF3B, C/EBPalpha",
351,Cell cycle_Regulation of G1/S transition (part 2),28,4.914E-03,2.927E-02,2.075E-02,7.261E-02,10,"c-Fos, E2F1, ERK1/2, Cyclin D, Rb protein, CAK complex, p130, Cyclin D1, AKT(PKB), SP1",4.914E-03,2.927E-02,13,"Cyclin D3, c-Fos, ERK1/2, Rb protein, IKK-alpha, CAK complex, p130, AKT(PKB), E2F1, c-Jun, Cyclin D, Cyclin D1, SP1",
352,Apoptosis and survival_Anti-apoptotic action of membrane-bound ESR1,38,4.924E-03,2.739E-02,4.924E-03,2.739E-02,14,"MEK1(MAP2K1), ERK1/2, CACNA1C, ESR1 (membrane), c-Raf-1, p90RSK1, Cytochrome c, PI3K reg class IA (p85), Bcl-2, eNOS, Bcl-XL, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1)",1.369E-01,2.675E-01,12,"ERK1/2, ESR1 (membrane), Cytochrome c, BAD, PI3K reg class IA (p85), Bcl-XL, AKT(PKB), PDK (PDPK1), CACNA1C, Bcl-2, eNOS, JNK(MAPK8-10)",
353,Insulin-like growth factor family signaling in melanoma,38,4.924E-03,2.739E-02,4.924E-03,2.739E-02,14,"MEK1(MAP2K1), H-Ras, ERK1/2, PKC, PI3K reg class IA, MDM2, FAK1, IGF-1 receptor, Cyclin D1, AKT(PKB), Beta-arrestin1, IGF-1, p27KIP1, p38 MAPK",1.553E-02,6.151E-02,15,"IRS-1, H-Ras, ERK1/2, PI3K reg class IA, MDM2, IGF-1 receptor, AKT(PKB), p27KIP1, c-Jun, PKC, FAK1, Cyclin D1, Beta-arrestin1, IGF-1, p38 MAPK",
354,Neutrophil chemotaxis in asthma,38,4.924E-03,2.739E-02,4.924E-03,2.739E-02,14,"C5aR, Substance P extracellular region, CCR3, G-protein alpha-i family, CCR2, Tissue kallikreins, ERK1/2, BDKRB1, VEGFR-1, CCR1, LTBR1, IL8RA, HSP70, IL8RB",1.553E-02,6.151E-02,15,"Substance P extracellular region, CCR2, ERK1/2, BDKRB1, CCR1, HSP70, IL8RB, C5aR, CCR3, G-protein alpha-i family, Tissue kallikreins, VEGFR-1, LTBR1, IL8RA, PI3K reg class IB (p101)",
355,"Dysregulation of Adiponectin secretion from adipocytes in obesity, type 2 diabetes and metabolic syndrome X",38,4.924E-03,2.739E-02,4.924E-03,2.739E-02,14,"MEK1(MAP2K1), SREBP1 (nuclear), AP-2B, Adiponectin, Insulin processed, ERK1/2, NF-AT3(NFATC4), Sirtuin1, Insulin receptor, IKK-beta, JNK(MAPK8-10), AKT(PKB), SP1, C/EBPalpha",1.553E-02,6.151E-02,15,"SREBP1 (nuclear), AP-2B, Insulin processed, ERK1/2, NF-AT3(NFATC4), Insulin receptor, AKT(PKB), ACSL1, Adiponectin, Sirtuin1, IKK-beta, AKT2, JNK(MAPK8-10), SP1, C/EBPalpha",
356,Th2-cytokine-induced airway epithelium mucous metaplasia in COPD,70,4.931E-03,2.739E-02,4.931E-03,2.739E-02,22,"VAMP8, p38delta (MAPK13), SNAP-25, ERK1/2, Protein kinase G, CFTR, PP2A regulatory, TMEM16A, p90RSK1, G-protein alpha-q/11, HAG-2, MUNC13, IP3 receptor, CLCA1, Calmodulin, PLC-beta, Mucin 5AC, P2Y2, STAT6, IL-4, Guanylate Cyclase 1, soluble, PDEF",3.456E-02,1.046E-01,23,"p38delta (MAPK13), ERK1/2, PP2A regulatory, G-protein alpha-q/11, Syntaxin 1A, HAG-2, MUNC13, IP3 receptor, CLCA1, PLC-beta, IL-13, IL-9, IL-4, Guanylate Cyclase 1, soluble, VAMP8, PKC-delta, Protein kinase G, TMEM16A, Calmodulin, Mucin 5AC, P2Y2, STAT6, PDEF",
357,Insulin-dependent stimulation of SREBP-1 in type 2 diabetes in liver,27,5.102E-03,2.813E-02,5.102E-03,2.813E-02,11,"ACACA, SREBP1 (nuclear), Insulin processed, FASN, SREBP1 (Golgi membrane), SREBP1 precursor, Insulin receptor, SCAP, LXR-alpha, SP1, PDK (PDPK1)",2.822E-02,8.938E-02,11,"SREBP1 (nuclear), Insulin processed, IRS-1, FASN, SREBP1 precursor, INSIG2, Insulin receptor, PDK (PDPK1), SREBP1 (Golgi membrane), SCAP, SP1",
358,"TNF-alpha, IL-1 beta induce dyslipidemia and inflammation in obesity and type 2 diabetes in adipocytes ",42,5.137E-03,2.822E-02,5.137E-03,2.822E-02,15,"Apelin, PDE3B, TRAF2, ERK1/2, PKA-reg (cAMP-dependent), PEDF-R (iPLA2-zeta), TRADD, LIPS, NFKBIA, SREBP1 precursor, IKK-beta, eNOS, IL-1RI, Beta-arrestin1, Perilipin",3.951E-02,1.165E-01,15,"PDE3B, ERK1/2, PKA-reg (cAMP-dependent), PEDF-R (iPLA2-zeta), TRADD, SREBP1 precursor, IL-1RI, Apelin, TRAF2, LIPS, NFKBIA, IKK-beta, eNOS, Beta-arrestin1, Perilipin",
359,Transcription_HIF-1 targets,95,5.280E-03,3.108E-02,9.009E-03,4.054E-02,27,"PDK1, PDGF-B, ROR-alpha, CITED2, HXK1, PFKL, SLC9A1, VEGFR-1, p21, MGF, Stanniocalcin 2, NANOG, NIP3, ID2, GLUT1, Carbonic anhydrase XII, ALDOA, NUR77, SOX2, TGF-beta 3, HXK2, CX3CR1, LOXL4, ABCG2, Leptin, Epo, SDF-1",5.280E-03,3.108E-02,33,"PDGF-B, PFKL, SLC9A1, Cyclin G2, p21, Stanniocalcin 2, NIP3, ID2, FECH, Nucleophosmin, HXK2, LOXL4, c-Myc, Epo, SDF-1, G3P2, ARNT, CITED2, HXK1, GPI, VEGFR-1, MGF, NANOG, Mxi1, GLUT1, Carbonic anhydrase XII, ALDOA, NUR77, SOX2, TGF-beta 3, CX3CR1, ABCG2, Leptin",
360,Proteases and EGFR-activated mucin production in airway epithelium in COPD,50,5.319E-03,2.848E-02,5.319E-03,2.848E-02,17,"EGF, Neuregulin 1, ERK1/2, ErbB3, p90RSK1, p67-phox, NFKBIA, AP-1, ErbB2, PTEN, Mucin 5AC, Bcl-2, Mucin 5B, MSK1, AKT(PKB), SP1, p38 MAPK",1.098E-02,4.886E-02,19,"EGF, ERK1/2, ErbB3, c-Jun/c-Fos, Rac1, ErbB2, Mucin 5B, MSK1, AKT(PKB), PKC-delta, c-Jun, NFKBIA, AP-1, PTEN, Mucin 5AC, Bcl-2, SP1, Kallikrein 1, p38 MAPK",
361,Signal transduction_CXCR4 signaling via second messengers and JAK/STAT,50,5.319E-03,2.848E-02,5.319E-03,2.848E-02,17,"MaxiK alpha subunit, alpha-1 Adrenergic receptor, G-protein alpha-i family, CACNA1C, Ca(II)channel L-type, IP3 receptor, STAT3, Ubiquitin, G-protein alpha-s, Calmodulin, Adenylate cyclase, Alpha-1A adrenergic receptor, MRLC, Bcl-2, Bcl-XL, SDF-1, MLCK",4.685E-02,1.314E-01,17,"MaxiK alpha subunit, alpha-1 Adrenergic receptor, IP3 receptor, Ubiquitin, Adenylate cyclase, Bcl-XL, SDF-1, MLCK, G-protein alpha-i family, CACNA1C, Ca(II)channel L-type, Paxillin, G-protein alpha-s, Calmodulin, Alpha-1A adrenergic receptor, MRLC, Bcl-2",
362,Role of TLR signaling in skin sensitization,44,5.464E-03,3.179E-02,4.409E-02,1.231E-01,13,"TBK1, TIRAP (Mal), I-kB, AP-1, HSP27, IKK-beta, MEK6(MAP2K6), JNK(MAPK8-10), IRF3, CD40(TNFRSF5), TAB2, HSP70, p38 MAPK",5.464E-03,3.179E-02,18,"TBK1, IKK (cat), I-kB, MyD88, IKK-alpha, MEK6(MAP2K6), TAB2, HSP70, TIRAP (Mal), AP-1, HSP27, IKK-beta, TAB1, JNK(MAPK8-10), IRF3, CD40(TNFRSF5), TRIF (TICAM1), p38 MAPK",
363,HGF signaling in colorectal cancer,64,5.559E-03,3.208E-02,7.666E-03,3.671E-02,20,"E-cadherin, HPGD, AKT1, GRB2, GAB1, HAI-1, H-Ras, ERK1/2, c-Raf-1, MACC1, VIL2 (ezrin), p70 S6 kinase1, PI3K reg class IA, JunD, PTEN, FAK1, MEK1/2, Cyclin D1, JNK(MAPK8-10), AKT(PKB)",5.559E-03,3.208E-02,24,"HPGD, AKT1, GRB2, GAB1, HAI-1, H-Ras, ERK1/2, Rac1, VIL2 (ezrin), PI3K reg class IA, Thrombin, JunD, AKT(PKB), c-Myc, E-cadherin, HGFA, MACC1, p70 S6 kinase1, PTEN, SHP-2, FAK1, AKT2, Cyclin D1, JNK(MAPK8-10)",
364,Eosinophil chemotaxis in asthma,64,5.559E-03,3.208E-02,1.055E-01,2.252E-01,16,"CCL28, C5aR, Substance P extracellular region, CCL1, CCR3, CRTH2, G-protein alpha-i family, VEGFR-1, CCR1, LTBR1, IL8RA, CCR6, CCR8, P2Y2, CysLT1 receptor, IL8RB",5.559E-03,3.208E-02,24,"Substance P extracellular region, Histamine H4 receptor, TrkA, CCR1, IL-3, CCL13, CCR8, VIP, CysLT1 receptor, C3aR, IL8RB, CCL28, C5aR, CCL1, CCR3, G-protein alpha-i family, VEGFR-1, LTBR1, IL8RA, CCR6, IL-5 receptor, CXCR3, P2Y2, PI3K reg class IB (p101)",
365,Regulation of lipid metabolism_FXR-dependent negative-feedback regulation of bile acids concentration,31,5.702E-03,3.043E-02,5.702E-03,3.043E-02,12,"LXR-alpha/RXR-alpha, Gastrotropin, PXR, SHP, LRH1, UGT2B4, LXR-alpha, PXR/RXR-alpha, CYP3A4, HNF3-alpha, VLCSH2, PON1",4.118E-01,5.797E-01,8,"LRH1, PXR/RXR-alpha, VLCSH2, Gastrotropin, PXR, CYP2B6, UGT2B4, HNF3-alpha",
366,Transcription_Sin3 and NuRD in transcription regulation,41,5.831E-03,3.340E-02,4.722E-01,6.310E-01,8,"TR-alpha, RXRA, RAR-alpha/RXR-alpha, MTA3, RARalpha, SDS3, RAR-alpha/TR-alpha, MTA1",5.831E-03,3.340E-02,17,"TR-alpha, ARID4A, Mi-2 beta, NRSF, RARalpha, ARID4B, p66beta, RAR-alpha/TR-alpha, MTA1, Mi-2, RXRA, RAR-alpha/RXR-alpha, MTA3, MTA2, SAP18, SDS3, MBD3",
367,Immune response_IL-9 signaling pathway,61,6.079E-03,3.468E-02,9.569E-03,4.217E-02,19,"JunB, CITED2, Granzyme B, ERK1/2, c-Raf-1, Bcl-3, p90Rsk, STAT3, PI3K reg class IA (p85), CISH, Mucin 2, Mucin 5AC, Bcl-2, MEK1/2, SOCS2, IL-4, AKT(PKB), PDK (PDPK1), IL9R",6.079E-03,3.468E-02,23,"Scinderin, IRS-1, Granzyme B, ERK1/2, Bcl-3, PI3K reg class IA (p85), CISH, CCL13, Chymase, IL-13, IL-9, IL-4, AKT(PKB), PDK (PDPK1), c-Myc, JunB, CITED2, IL5RA, Mucin 2, Mucin 5AC, Bcl-2, SOCS2, IL9R",
368,Pro-oncogenic action of Androgen receptor in breast cancer,35,6.134E-03,3.211E-02,6.134E-03,3.211E-02,13,"E-cadherin, PIP, c-Fos, ERK1/2, ErbB3, p90RSK1, FASN, Kallikrein 3 (PSA), Androgen receptor, MUC1, ErbB2, Kallikrein 2, HNF3-alpha",1.685E-02,6.424E-02,14,"PIP, c-Fos, ERK1/2, ErbB3, FASN, Kallikrein 3 (PSA), Androgen receptor, MUC1, ErbB2, TMF1, E-cadherin, Kallikrein 15, Kallikrein 2, HNF3-alpha",
369,Development_Angiopoietin - Tie2 signaling,35,6.134E-03,3.211E-02,6.134E-03,3.211E-02,13,"GRB2, GRB7, ABIN-2, PAK1, p21, GRB14, TIE, STAT3, I-kB, ELF2, PI3K reg class IA, Angiopoietin 3, AKT(PKB)",8.186E-02,1.900E-01,12,"GRB2, GRB7, IKK (cat), p21, I-kB, ELF2, PI3K reg class IA, Angiopoietin 3, AKT(PKB), ABIN-2, PAK1, SHP-2",
370,IL-6 signaling pathway in lung cancer,35,6.134E-03,3.211E-02,6.134E-03,3.211E-02,13,"gp130, GRB2, GAB1, ERK1/2, IL6RA, STAT3, I-kB, PI3K reg class IA, MEK6(MAP2K6), AKT(PKB), PDK (PDPK1), p38 MAPK, IL-6 receptor",6.532E-03,3.644E-02,15,"gp130, GRB2, GAB1, ERK1/2, IKK (cat), I-kB, PI3K reg class IA, IKK-alpha, MEK6(MAP2K6), AKT(PKB), PDK (PDPK1), IL6RA, SHP-2, p38 MAPK, IL-6 receptor",
371,Inflammatory mechanisms of pancreatic cancerogenesis,67,6.146E-03,3.211E-02,6.146E-03,3.211E-02,21,"EGF, MCP, c-Fos, G-protein alpha-i family, AGTR1, SHH, IL8RA, CCR6, NFKBIA, STAT3, AP-1, IKK-beta, Bcl-2, IL-1RI, C/EBP, Bcl-XL, CD40(TNFRSF5), SDF-1, IL-6 receptor, CD40L(TNFSF5), IL8RB",1.057E-02,4.816E-02,24,"EGF, c-Fos, c-Jun/c-Fos, IKK (cat), MyD88, IKK-alpha, IL-1RI, Bcl-XL, SDF-1, IL8RB, MCP, G-protein alpha-i family, c-Jun, AGTR1, SHH, IL8RA, CCR6, NFKBIA, AP-1, IKK-beta, Bcl-2, C/EBP, CD40(TNFRSF5), IL-6 receptor",
372,PI3K signaling in gastric cancer,51,6.160E-03,3.502E-02,3.329E-02,1.013E-01,15,"EGF, Neuregulin 1, ErbB3, CCXCR1, G-protein alpha-q/11, I-kB, PI3K reg class IA (p85), PI3K reg class IA, PTEN, HSP27, FAK1, Cyclin D1, AKT(PKB), PDK (PDPK1), IL8RB",6.160E-03,3.502E-02,20,"EGF, IRS-1, ErbB3, IKK (cat), G-protein alpha-q/11, BAD, I-kB, PI3K reg class IA (p85), PI3K reg class IA, IKK-alpha, AKT(PKB), PDK (PDPK1), IL8RB, CCKBR, c-Jun, PTEN, HSP27, FAK1, G-protein alpha-q, Cyclin D1",
373,Development_Noncanonical WNT signaling in cardiac myogenesis,38,6.191E-03,3.506E-02,3.828E-01,5.468E-01,8,"DAAM1, GATA-4, Dsh, Troponin I, cardiac, PKC, PLC-beta, ANP, JNK(MAPK8-10)",6.191E-03,3.506E-02,16,"GATA-4, Dsh, Rac1, PLC-beta, ANP, DAAM1, PKC-delta, c-Jun, MKK7 (MAP2K7), Troponin I, cardiac, alpha-MHC, PKC, MEKK1(MAP3K1), G-protein alpha-q, SMAD1, JNK(MAPK8-10)",
374,Macrophage-induced immunosuppression in the tumor microenvironment,97,6.305E-03,3.260E-02,6.305E-03,3.260E-02,28,"CCL22, Calcineurin A (catalytic), CCL17, GRB2, c-Fos, GAB1, NKG2A, CCR2, ERK1/2, MSP, MSP receptor (RON), CCR6, KLF4, S1P3 receptor, ULK1, STAT3, ARG1, Calmodulin, CCR8, ALOX15B, STAT6, IL-4, TAB2, ENP1, p38 MAPK, CAT-2, SDF-1, CD163",2.376E-02,7.967E-02,31,"CCL22, Calcineurin A (catalytic), CCL17, GRB2, c-Fos, GAB1, NKG2A, CCR2, ERK1/2, TIM-4, KLF4, S1P3 receptor, ULK1, ARG1, CCR8, IL-13, IL-4, TAB2, ENP1, SDF-1, c-Jun, MSP, MSP receptor (RON), CCR6, Calmodulin, TAB1, ALOX15B, STAT6, p38 MAPK, CAT-2, CD163",
375,Noise-induced hair cell death and spiral ganglion neuron degeneration,96,6.321E-03,3.556E-02,1.042E-02,4.369E-02,27,"p38alpha (MAPK14), AKT1, SLC17A8, Calcineurin A (catalytic), Aif, SNAP-25, AMPK beta subunit, RIPK3, AMPK alpha subunit, AMPK gamma subunit, Ca(II)channel L-type, p67-phox, Cytochrome c, Endonuclease G, CACNA1D, GluR2, STAT3, VAMP1, Rb protein, LKB1, ERM proteins, NOX3, GFRalpha1, JNK(MAPK8-10), Ca(II)channel T-type, CACNA1I, RET",6.321E-03,3.556E-02,33,"TrkA, AKT1, SLC17A8, Calcineurin A (catalytic), AMPK beta subunit, AMPK gamma subunit, Bak, Cytochrome c, Syntaxin 1A, Actin, Endonuclease G, Rac1, BAD, NMDA receptor, Rb protein, CCL13, ERM proteins, NOX3, GFRalpha1, Ca(II)channel T-type, RET, NT-3, Aif, TrkC, RIPK3, AMPK alpha subunit, Ca(II)channel L-type, CACNA1D, GluR2, VAMP1, LKB1, JNK(MAPK8-10), CACNA1I",
376,Immune response_Gastrin in inflammatory response,68,6.327E-03,3.556E-02,3.047E-02,9.615E-02,19,"MEK1(MAP2K1), p38alpha (MAPK14), GRB2, c-Fos, H-Ras, c-Raf-1, MEF2, G-protein alpha-q/11, IP3 receptor, I-kB, MEF2D, PI3K reg class IA (p85), IKK-beta, MEK6(MAP2K6), FAK1, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1), ERK1 (MAPK3)",6.327E-03,3.556E-02,25,"GRB2, c-Fos, IRS-1, H-Ras, LARG, IKK (cat), G-protein alpha-q/11, IP3 receptor, I-kB, PI3K reg class IA (p85), IKK-alpha, MEK6(MAP2K6), AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), PKC-delta, CCKBR, c-Jun, MEF2, MEF2D, MEKK1(MAP3K1), IKK-beta, FAK1, G-protein alpha-q, JNK(MAPK8-10)",
377,Development_PACAP signaling in neural cells,39,6.422E-03,3.286E-02,6.422E-03,3.286E-02,14,"MEK1(MAP2K1), cPKC (conventional), cAMP-GEFI, c-Fos, ERK1/2, PKA-reg (cAMP-dependent), Adenylate cyclase type I, G-protein alpha-q/11, Cytochrome c, IP3 receptor, TY3H, G-protein alpha-s, PLC-beta, Bcl-2",8.755E-02,1.999E-01,13,"cAMP-GEFI, c-Fos, ERK1/2, PKA-reg (cAMP-dependent), G-protein alpha-q/11, Cytochrome c, IP3 receptor, TY3H, PLC-beta, cPKC (conventional), Adenylate cyclase type I, G-protein alpha-s, Bcl-2",
378,Resistance of melanoma cells to Apo-2L(TNFSF10)-induced apoptosis,39,6.422E-03,3.286E-02,6.422E-03,3.286E-02,14,"MEK1(MAP2K1), ERK1/2, c-Raf-1, Cytochrome c, FADD, STAT3, PI3K reg class IA (p85), IFN-alpha, Bcl-2, Bcl-XL, MAGE-D2, IGF-1, Smac/Diablo, TRID(TNFRSF10C)",1.588E-01,2.975E-01,12,"ERK1/2, Bak, Cytochrome c, FADD, PI3K reg class IA (p85), IFN-alpha, Bcl-XL, Bcl-2, MAGE-D2, IGF-1, Smac/Diablo, TRID(TNFRSF10C)",
379,Cell adhesion_PLAU signaling,39,6.422E-03,3.286E-02,6.422E-03,3.286E-02,14,"MEK1(MAP2K1), EGF, gp130, Protein C inhibitor, GRB2, GAB1, H-Ras, ERK1/2, c-Raf-1, ILK, Vitronectin, PI3K reg class IA, FAK1, AKT(PKB)",4.392E-02,1.255E-01,14,"EGF, gp130, Protein C inhibitor, GRB2, GAB1, H-Ras, ERK1/2, Plasminogen, PI3K reg class IA, AKT(PKB), Plasmin, ILK, Vitronectin, FAK1",
380,Role of Thyroid hormone in regulation of oligodendrocyte differentiation in multiple sclerosis,55,6.591E-03,3.318E-02,6.591E-03,3.318E-02,18,"TR-alpha, AKT1, OATP-A, E2F1, GLNA, PLP1, MCT8, OLIG1, p21, TR-beta, ID2, p70 S6 kinase1, Cyclin D1, 4E-BP2, AKT(PKB), PDK (PDPK1), p27KIP1, Transthyretin",1.564E-02,6.151E-02,20,"TR-alpha, AKT1, PLP1, OLIG1, p21, TR-beta, ID2, 4E-BP2, AKT(PKB), PDK (PDPK1), p27KIP1, OATP-A, E2F1, GLNA, MCT8, 4E-BP1, p70 S6 kinase1, MAG, Cyclin D1, Transthyretin",
381,Translation_Non-genomic (rapid) action of Androgen Receptor,43,6.591E-03,3.318E-02,6.591E-03,3.318E-02,15,"MEK1(MAP2K1), Tuberin, EGF, GRB2, Neuregulin 1, H-Ras, c-Raf-1, Dsh, Androgen receptor, p70 S6 kinase1, ErbB2, PTEN, WNT, MDM2, AKT(PKB)",1.015E-02,4.713E-02,17,"Tuberin, EGF, GRB2, IRS-1, H-Ras, Dsh, Androgen receptor, ErbB2, MDM2, AKT(PKB), Tcf(Lef), 4E-BP1, p70 S6 kinase1, PTEN, WNT, FOXO3A, Frizzled",
382,Th2-cytokines-induced expression of mucins in asthma ,43,6.591E-03,3.318E-02,6.591E-03,3.318E-02,15,"MEK1(MAP2K1), p38alpha (MAPK14), H-Ras, ERK1/2, c-Raf-1, p90RSK1, STAT3, CLCA1, Mucin 2, Mucin 5AC, Mucin 5B, IL13RA2, STAT6, IL-4, ALOX15",3.881E-01,5.574E-01,11,"H-Ras, ERK1/2, CLCA1, IL-13, Mucin 5B, IL-9, IL-4, Mucin 2, Mucin 5AC, STAT6, ALOX15",
383,Neurophysiological process_HTR1A receptor signaling in neuronal cells,43,6.591E-03,3.318E-02,6.591E-03,3.318E-02,15,"MEK1(MAP2K1), IPP-1, AKT1, PP1-cat, Kir3.2, G-protein alpha-i family, H-Ras, PKA-reg (cAMP-dependent), c-Raf-1, Kir3.1, PLC-beta, Adenylate cyclase, PDK (PDPK1), HTR1A, ERK1 (MAPK3)",2.312E-02,7.874E-02,16,"AKT1, PP1-cat, H-Ras, PKA-reg (cAMP-dependent), Kir3.1, NMDA receptor, PLC-beta, Adenylate cyclase, PDK (PDPK1), ERK1 (MAPK3), IPP-1, Kir3.2, G-protein alpha-i family, GluR1, N-type Ca(II) channel alpha1B, PI3K reg class IB (p101)",
384,"Immune response_TLR5, TLR7, TLR8 and TLR9 signaling pathways",58,6.642E-03,3.679E-02,2.526E-02,8.385E-02,17,"ERK1/2, E2N(UBC13), STAT3, Ubiquitin, I-kB, PI3K reg class IA (p85), AP-1, IFN-alpha, IKK-beta, MEK6(MAP2K6), IRF5, MEK1/2, JNK(MAPK8-10), TAB2, AKT(PKB), PDK (PDPK1), p38 MAPK",6.642E-03,3.679E-02,22,"TLR5, ERK1/2, c-Jun/c-Fos, E2N(UBC13), Ubiquitin, I-kB, PI3K reg class IA (p85), MyD88, IKK-alpha, IFN-alpha, MEK6(MAP2K6), TAB2, AKT(PKB), UEV1A, PDK (PDPK1), c-Jun, AP-1, IKK-beta, IRF5, TAB1, JNK(MAPK8-10), p38 MAPK",
385,Development_Hedgehog signaling,47,6.663E-03,3.318E-02,6.663E-03,3.318E-02,16,"SPOP, MLK2(MAP3K10), beta-TrCP, STK36, SHH, Ubiquitin, Casein kinase I, Skp2/TrCP/FBXW, HIP, KIF3A, Cullin 3, HSP90, Beta-arrestin1, SUFU, GRK2, HHAT",1.200E-02,5.200E-02,18,"SPOP, KIF27, Ubiquitin, BOC, Skp2/TrCP/FBXW, KIF3A, Cullin 3, HSP90, SUFU, GRK2, MLK2(MAP3K10), beta-TrCP, STK36, SHH, SAP18, Casein kinase I, Beta-arrestin1, HHAT",
386,Development_Schema: FGF signaling in embryonic stem cell self-renewal and differentiation,47,6.663E-03,3.318E-02,6.663E-03,3.318E-02,16,"PTF1-p48, TITF1, SHH, NEFM, MGF, GSC, GATA-2, FGF4, SOX2, CD34, Keratin 18, FGF10, AFP, HNF6, Albumin, TAL1",1.652E-01,3.060E-01,14,"WNT3A, TITF1, GSC, FGF4, CD34, Keratin 18, FGF10, Albumin, T brachyury protein, SHH, MGF, GATA-2, SOX2, HNF6",
387,Protein folding and maturation_Bradykinin / Kallidin maturation,32,6.834E-03,3.742E-02,5.358E-01,6.888E-01,6,"ENPEP, Tissue kallikreins, BDKRB1, BDKRB2, Thimet oligopeptidase, ACE1",6.834E-03,3.742E-02,14,"BDKRB1, BDKRB2, Thimet oligopeptidase, Kallidin, ACE1, ENPEP, Tissue kallikreins, des-Arg9-bradykinin, Carboxypeptidase N (cat), Plasmin, Bradykinin, KNG, Aminopeptidase P2, des-Arg10-kallidin",
388,CCL2 in Prostate Cancer,20,7.019E-03,3.761E-02,5.543E-02,1.425E-01,7,"Tuberin, G-protein alpha-i family, CCR2, p70 S6 kinase1, PTEN, AKT(PKB), PDK (PDPK1)",7.019E-03,3.761E-02,10,"Tuberin, CCR2, Rac1, AKT(PKB), PDK (PDPK1), G-protein alpha-i family, PCNT1, p70 S6 kinase1, PTEN, PI3K reg class IB (p101)",
389,HGF signaling in pancreatic cancer,28,7.048E-03,3.464E-02,7.048E-03,3.464E-02,11,"MEK1(MAP2K1), GRB2, c-Fos, GAB1, MMP-1, H-Ras, ERK1/2, c-Raf-1, PI3K reg class IA (p85), MUC1, p27KIP1",1.441E-02,5.934E-02,12,"GRB2, c-Fos, GAB1, H-Ras, ERK1/2, PI3K reg class IA (p85), MUC1, p27KIP1, c-Myc, HGFA, MMP-1, c-Jun",
390,IL-17 and IL-17F-induced inflammatory signaling in normal and asthmatic airway epithelium,28,7.048E-03,3.464E-02,7.048E-03,3.464E-02,11,"MEK1(MAP2K1), ERK1/2, c-Raf-1, p90Rsk, IL-19, I-kB, IL-17RC, MSK1, IGF-1, G-CSF, p38 MAPK",8.433E-02,1.934E-01,10,"ERK1/2, IKK (cat), IL-19, I-kB, IL-17RC, MSK1, CXCR3, IGF-1, G-CSF, p38 MAPK",
391,Apoptosis and survival_nAChR in apoptosis inhibition and cell cycle progression,29,7.074E-03,3.761E-02,9.528E-03,4.212E-02,11,"Tuberin, nAChR alpha, GSK3 alpha, c-Raf-1, PI3K reg class IA (p85), p70 S6 kinase1, Rb protein, GSK3 alpha/beta, AKT(PKB), Beta-arrestin1, PDK (PDPK1)",7.074E-03,3.761E-02,13,"Tuberin, GSK3 alpha, nAChR beta, PI3K reg class IA (p85), Rb protein, nAChR, GSK3 alpha/beta, AKT(PKB), PDK (PDPK1), nAChR alpha, 4E-BP1, p70 S6 kinase1, Beta-arrestin1",
392,"Mechanism of Pioglitazone/Glimepiride and Rosiglitazone/Glimepiride cooperative action in Diabetes mellitus, Type 2",11,7.087E-03,3.471E-02,7.087E-03,3.471E-02,6,"SUR1, Insulin processed, Proinsulin, RXRA, Kir6.2, Insulin receptor",2.210E-02,7.648E-02,6,"SUR1, Insulin processed, Proinsulin, Kir6.2, Insulin receptor, RXRA",
393,Chemotaxis_SDF-1/ CXCR4-induced chemotaxis of immune cells,79,7.144E-03,3.761E-02,1.130E-01,2.361E-01,19,"G-protein alpha-i family, PAK2, ERK1/2, PKA-reg (cAMP-dependent), PAK1, Btk, G-protein alpha-13, PI3K reg class IA (p85), PIPKI gamma, PAK, p70 S6 kinase1, PLC-beta, CD3, FAK1, MEK1/2, WASP, AKT(PKB), SFK, SDF-1",7.144E-03,3.761E-02,28,"PAK2, ERK1/2, PKC-zeta, PKA-reg (cAMP-dependent), Rac1, G-protein alpha-13, PI3K reg class IA (p85), PLC-beta, ZAP70, ITK, WASP, AKT(PKB), SFK, SDF-1, BETA-PIX, CALDAG-GEFI, G-protein alpha-i family, PAK1, Btk, Paxillin, 4E-BP1, PIPKI gamma, PAK, p70 S6 kinase1, FAK1, PI3K reg class IB (p101), TCR alpha/beta, Cofilin",
394,Neurophysiological process_Glutamic acid regulation of Dopamine D1A receptor signaling,45,7.201E-03,3.761E-02,5.208E-02,1.394E-01,13,"Dopamine D1A receptor, SG2NA, IPP-1, Calcineurin A (catalytic), PP1-cat, PP2A regulatory, PKA-reg (cAMP-dependent), IP3 receptor, GABA-A receptor beta-3 subunit, Adenylate cyclase type V, G-protein alpha-s, Calmodulin, PP2A structural",7.201E-03,3.761E-02,18,"SG2NA, Calcineurin A (catalytic), PP1-cat, PP2A regulatory, PKA-reg (cAMP-dependent), PLC-beta1, IP3 receptor, NMDA receptor, Adenylate cyclase type V, PP2A structural, GABA-A receptor beta-2 subunit, Dopamine D1A receptor, IPP-1, GABA-A receptor beta-1 subunit, GABA-A receptor beta-3 subunit, G-protein alpha-s, Calmodulin, G-protein alpha-q",
395,Immune response_TNF-R2 signaling pathways,45,7.201E-03,3.761E-02,5.208E-02,1.394E-01,13,"TRAF2, ERK1/2, I-kB, PI3K reg class IA (p85), AP-1, PI3K reg class IA, IKK-beta, Bcl-2, Bcl-XL, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1), p38 MAPK",7.201E-03,3.761E-02,18,"AIP1 (DAB2ip), ERK1/2, c-Jun/c-Fos, IKK (cat), I-kB, PI3K reg class IA (p85), PI3K reg class IA, IKK-alpha, Bcl-XL, AKT(PKB), PDK (PDPK1), TRAF2, c-Jun, AP-1, IKK-beta, Bcl-2, JNK(MAPK8-10), p38 MAPK",
396,Proinflammatory mediators production and activation of basophils in asthma,45,7.201E-03,3.761E-02,1.013E-01,2.175E-01,12,"MHC class II, Calcineurin A (catalytic), CRTH2, Granzyme B, ERK1/2, I-kB, PI3K reg class IA (p85), ITGB7, IL-4, AKT(PKB), Leptin, p38 MAPK",7.201E-03,3.761E-02,18,"TrkA, MHC class II, Calcineurin A (catalytic), Granzyme B, ERK1/2, ENPP3, IKK (cat), IL-3, I-kB, PI3K reg class IA (p85), IKK-alpha, IL-13, ITGB7, IL-4, AKT(PKB), Leptin, TCR alpha/beta, p38 MAPK",
397,G-protein signaling_Regulation of Cyclic AMP levels by ACM,45,7.201E-03,3.761E-02,1.048E-02,4.369E-02,15,"cAMP-GEFI, G-protein alpha-i family, G-protein alpha-11, Adenylate cyclase type VI, Adenylate cyclase type I, G-protein alpha-q/11, ACM1, PDE1B, IP3 receptor, Adenylate cyclase type V, Adenylate cyclase type II, G-protein alpha-s, Calmodulin, PLC-beta, Adenylate cyclase type IV",7.201E-03,3.761E-02,18,"cAMP-GEFI, Adenylate cyclase type VI, G-protein alpha-q/11, PDE1B, IP3 receptor, Adenylate cyclase type V, Adenylate cyclase type II, PLC-beta, PKC-delta, ACM2, G-protein alpha-i family, G-protein alpha-11, Adenylate cyclase type I, ACM1, G-protein alpha-s, Calmodulin, G-protein alpha-q, Adenylate cyclase type IV",
398,G-protein signaling_Ras family GTPases in kinase cascades,26,7.218E-03,3.761E-02,1.188E-02,4.861E-02,10,"MEK1(MAP2K1), p38alpha (MAPK14), c-Fos, K-RAS, H-Ras, ERK1/2, c-Raf-1, PAK1, JNK(MAPK8-10), p38 MAPK",7.218E-03,3.761E-02,12,"c-Fos, H-Ras, ERK1/2, Rac1, p38beta (MAPK11), MEKK4(MAP3K4), K-RAS, c-Jun, PAK1, MEKK1(MAP3K1), JNK(MAPK8-10), p38 MAPK",
399,KLF6 and regulation of KLF6 alternative splicing in HCC,23,7.220E-03,3.761E-02,1.479E-02,5.785E-02,9,"EGF, AKT1, GRB2, H-Ras, p21, Rb protein, Bcl-XL, Cyclin D1, PDK (PDPK1)",7.220E-03,3.761E-02,11,"EGF, AKT1, GRB2, H-Ras, p21, Rb protein, SFRS1 (SF2), Bcl-XL, PDK (PDPK1), PARP-1, Cyclin D1",
400,Action of GSK3 beta in bipolar disorder,23,7.220E-03,3.761E-02,2.272E-01,3.743E-01,6,"Synapsin I, HTR1B, Bcl-2, PER2, Cyclin D1, Tau (MAPT)",7.220E-03,3.761E-02,11,"Lef-1, Synapsin I, Tau (MAPT), c-Myc, REV-ERBalpha, Tcf(Lef), HTR1B, Bcl-2, PER2, Cyclin D1, KCNQ2",
401,Production of reactive oxygen species and arachidonic acid metabolites by neutrophils in asthma,68,7.406E-03,3.616E-02,7.406E-03,3.616E-02,21,"Substance P extracellular region, AKT1, G-protein alpha-i family, ERK1/2, p67-phox, LTBR1, IL8RA, Btk, IP3 receptor, PERM, PI3K reg class IA (p85), PKC, PLC-beta, AP-2 alpha subunits, LTA4H, Clathrin, p40-phox, Beta-arrestin1, PDK (PDPK1), CysLT1 receptor, p38 MAPK",7.702E-02,1.819E-01,21,"Substance P extracellular region, AKT1, ERK1/2, PKC-zeta, IP3 receptor, PI3K reg class IA (p85), PLC-beta, AP-2 alpha subunits, PDK (PDPK1), CysLT1 receptor, G-protein alpha-i family, LTBR1, IL8RA, Btk, PERM, PKC, LTA4H, Clathrin, p40-phox, Beta-arrestin1, p38 MAPK",
402,Inhibition of tumor suppressive pathways in pancreatic cancer,21,7.506E-03,3.653E-02,7.506E-03,3.653E-02,9,"P53AIP1, E2F1, p21, Rb protein, LKB1, PIDD, MDM2, PIG3, Cyclin D1",3.256E-02,9.954E-02,9,"P53AIP1, p21, Rad51, Rb protein, PIDD, MDM2, E2F1, LKB1, Cyclin D1",
403,ATP metabolism,107,7.552E-03,3.663E-02,7.552E-03,3.663E-02,30,"NDPK C, PDE3B, NDPK complex, ENPP1, NAD synthetase 1, ENTPD2-alpha, FLAD1, PAPSS2, Adenylate cyclase type VI, PDE8B, Adenylate cyclase type I, AP4A, Adenylate cyclase type IX, NDPK 6, FHIT, NUD9, Adenylate cyclase type V, Adenylate cyclase type II, COASY, PDE4D, NDPK A, NMNA3, Connexin 43, RIFK, NDPK D (mitochondrial), ENP3, Adenylate cyclase type IV, PDE4B, ENP1, NDPK B",5.314E-02,1.416E-01,32,"PDE3B, NDPK complex, ENPP1, NAD synthetase 1, ENPP3, Adenylate cyclase type VI, NDPK 6, FHIT, BPNT1, Adenylate cyclase type V, Adenylate cyclase type II, COASY, PDE4D, RIFK, ENP1, AK1, NDPK C, ENTPD2-alpha, FLAD1, PAPSS2, PDE8B, Adenylate cyclase type I, AP4A, Adenylate cyclase type IX, NUD9, NDPK A, NMNA3, NDPK D (mitochondrial), ENP3, Adenylate cyclase type IV, PDE4B, NDPK B",
404,Development_Negative regulation of STK3/4 (Hippo) pathway and positive regulation of YAP/TAZ function,62,7.619E-03,3.955E-02,2.389E-02,8.092E-02,18,"EGF, G-protein alpha-12 family, SIAH2, ASPP1, ERK1/2, AGTR1, KIBRA, G-protein alpha-q/11, WBP-2, MASK, ILK, YAP1 (YAp65), LATS1, PP1-cat alpha, JNK(MAPK8-10), PDK (PDPK1), ERK1 (MAPK3), Nek8",7.619E-03,3.955E-02,23,"EGF, ASPP1, LARG, ERK1/2, G-protein alpha-q/11, LATS1, Thrombin, PP1-cat alpha, PJA2, PDK (PDPK1), ERK1 (MAPK3), G-protein alpha-12 family, SIAH2, LIMD1, AGTR1, RASSF6, KIBRA, WBP-2, MASK, NEDD4, ILK, JNK(MAPK8-10), Nek8",
405,EML4/ALK fusion protein in nonsmoking-related lung cancer ,32,7.645E-03,3.671E-02,7.645E-03,3.671E-02,12,"MEK1(MAP2K1), c-Fos, K-RAS, H-Ras, ERK1/2, TITF1, c-Raf-1, STAT3, I-kB, PI3K reg class IA (p85), ErbB2, AKT(PKB)",1.821E-02,6.753E-02,13,"c-Fos, IRS-1, H-Ras, ERK1/2, TITF1, IKK (cat), I-kB, PI3K reg class IA (p85), ErbB2, IKK-alpha, AKT(PKB), c-Myc, K-RAS",
406,Hedgehog signaling in pancreatic cancer,32,7.645E-03,3.671E-02,7.645E-03,3.671E-02,12,"MEK1(MAP2K1), E-cadherin, K-RAS, ERK1/2, STK36, SHH, p21, Bcl-2, Bcl-XL, Cyclin D1, HIP, SUFU",9.195E-02,2.069E-01,11,"ERK1/2, p21, KIF27, Bcl-XL, SUFU, E-cadherin, K-RAS, STK36, SHH, Bcl-2, Cyclin D1",
407,"Immune response_IL-5 signaling via PI3K, MAPK and NF-kB",76,7.877E-03,4.020E-02,2.675E-02,8.557E-02,21,"GRB2, CSF2RB, H-Ras, ERK1/2, c-Raf-1, ITGAM, FADD, Btk, NFKBIA, PI3K reg class IA (p85), Unc-119, AP-1, cPLA2, ICAM3, Bcl-XL, Fc gamma RII beta, MEK1/2, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1), p38 MAPK",7.877E-03,4.020E-02,27,"GRB2, H-Ras, ERK1/2, Fc alpha receptor, IKK (cat), FADD, PI3K reg class IA (p85), Unc-119, cPLA2, Bcl-XL, AKT(PKB), PDK (PDPK1), PKC-delta, CSF2RB, c-Jun, ITGAM, Btk, IL-5 receptor, NFKBIA, AP-1, IL5RA, SHP-2, FOXO3A, ICAM3, Fc gamma RII beta, JNK(MAPK8-10), p38 MAPK",
408,A shift from oxidative to glycolytic muscle fiber phenotype in quadriceps muscles in COPD,60,7.901E-03,3.747E-02,7.901E-03,3.747E-02,19,"MKL2, Esrra, AMPK alpha subunit, DCMC, ATP5B, MEF2, Cytochrome c, PDK2, CPT-1B, CD36, COX IV-1, CPT-1A, Sirtuin1, LKB1, Fatty acid-binding protein, TNNT1, Myoglobin, COX IV, COX Vb",2.116E-02,7.498E-02,21,"Esrra, DCMC, Cytochrome c, PDK2, CPT-1A, Fatty acid-binding protein, TNNT1, Myoglobin, ATP(F1), COX IV, MKL2, AMPK alpha subunit, TFAM, ATP5B, MEF2, CPT-1B, CD36, COX IV-1, Sirtuin1, LKB1, COX Vb",
409,Immune response_LTBR1 signaling,60,7.901E-03,3.747E-02,7.901E-03,3.747E-02,19,"cAMP-GEFI, G-protein alpha-i family, H-Ras, ERK1/2, c-Raf-1, G-protein alpha-q/11, LTBR1, IP3 receptor, I-kB, Calmodulin, PKC, PLC-beta, Adenylate cyclase, eNOS, MEK1/2, JNK(MAPK8-10), AKT(PKB), LTBR2, PDK (PDPK1)",1.041E-02,4.775E-02,22,"cAMP-GEFI, H-Ras, ERK1/2, IKK (cat), G-protein alpha-q/11, Rac1, IP3 receptor, I-kB, PLC-beta, IKK-alpha, Adenylate cyclase, AKT(PKB), LTBR2, PDK (PDPK1), PKC-delta, G-protein alpha-i family, LTBR1, Calmodulin, PKC, eNOS, JNK(MAPK8-10), PI3K reg class IB (p101)",
410,Pro-oncogenic action of Estradiol/ Estrogen receptors in ovarian cancer,60,7.901E-03,3.747E-02,7.901E-03,3.747E-02,19,"Keratin 4, c-Fos, ESR1 (nuclear), NCOA3 (pCIP/SRC3), GnRH receptor, TERC, ESR1 (membrane), p21, ESR2 (nuclear), STAT3, I-kB, PI3K reg class IA, TRAP-1, JNK(MAPK8-10), AKT(PKB), TFF1, Leptin, SDF-1, GPR30",1.041E-02,4.775E-02,22,"Keratin 4, c-Fos, ESR1 (nuclear), GnRH receptor, ESR1 (membrane), IKK (cat), p21, ESR2 (nuclear), I-kB, PI3K reg class IA, IKK-alpha, TRAP-1, AKT(PKB), c-Myc, SDF-1, Keratin 7, NCOA3 (pCIP/SRC3), MKK7 (MAP2K7), JNK(MAPK8-10), TFF1, Leptin, GPR30",
411,IGF-1 signaling in pancreatic cancer,36,8.037E-03,3.788E-02,8.037E-03,3.788E-02,13,"MEK1(MAP2K1), AKT1, GRB2, H-Ras, ERK1/2, c-Raf-1, STAT3, PI3K reg class IA, FAK1, IGF-1 receptor, SP1, IGF-1, PDK (PDPK1)",9.836E-02,2.137E-01,12,"AKT1, GRB2, IRS-1, H-Ras, ERK1/2, PKC-zeta, PI3K reg class IA, IGF-1 receptor, PDK (PDPK1), FAK1, SP1, IGF-1",
412,Muscle contraction_Regulation of eNOS activity in cardiomyocytes,56,8.102E-03,3.794E-02,8.102E-03,3.794E-02,18,"Phospholamban, Protein kinase G1, G-protein alpha-i family, Adenylate cyclase type VI, CACNA1C, PRKAR2A, PKA-reg type II (cAMP-dependent), PKA-reg (cAMP-dependent), Troponin I, cardiac, IP3 receptor, Adenylate cyclase type V, G-protein alpha-s, Calmodulin, PLC-beta, eNOS, Guanylate Cyclase 1, soluble, Troponin T, cardiac, Caveolin-3",6.920E-02,1.679E-01,18,"Protein kinase G1, Adenylate cyclase type VI, PKA-reg (cAMP-dependent), IP3 receptor, Adenylate cyclase type V, PLC-beta, Guanylate Cyclase 1, soluble, Caveolin-3, ACM2, G-protein alpha-i family, CACNA1C, PRKAR2A, PKA-reg type II (cAMP-dependent), Troponin I, cardiac, G-protein alpha-s, Calmodulin, eNOS, Troponin T, cardiac",
413,CAR-mediated direct regulation of xenobiotic metabolizing enzymes / Human version,40,8.264E-03,3.846E-02,8.264E-03,3.846E-02,14,"CYP2C8, CAR/RXR-alpha, CYP3A5, RXRA, SHP, CYP2A13, CYP1A2, CAR, CYP2A6, MRP3, ACOX1, CYP3A4, NQO1, ABCC2",5.385E-02,1.424E-01,14,"CYP3A5, CYP2A13, CYP1A2, CAR, CYP2C19, ACOX1, CAR/RXR-alpha, RXRA, CYP2E1, CYP2B6, CYP2A6, MRP3, NQO1, ABCC2",
414,Transcription_p53 signaling pathway,39,8.315E-03,4.186E-02,1.660E-02,6.159E-02,13,"MKP-7, c-Fos, E2F1, VEGFR-1, p21, TDG, Rb protein, HSP27, Bcl-2, MKP-1, MDM2, JNK(MAPK8-10), XPA",8.315E-03,4.186E-02,16,"c-Fos, XPC, p21, Rb protein, MDM2, MKP-7, E2F1, VEGFR-1, MTA2, TDG, MEKK1(MAP3K1), HSP27, Bcl-2, MKP-1, JNK(MAPK8-10), XPA",
415,Blood coagulation_Blood coagulation,39,8.315E-03,4.186E-02,4.127E-01,5.790E-01,8,"HC II, Protein C inhibitor, Antithrombin III, Thrombomodulin, Coagulation factor VII, Alpha 1-antitrypsin, Coagulation factor XII, von Willebrand factor",8.315E-03,4.186E-02,16,"Protein C inhibitor, Fibrinogen beta, Thrombomodulin, Coagulation factor VII, Plasminogen, Thrombin, Alpha 1-antitrypsin, Coagulation factor XII, von Willebrand factor, HC II, Antithrombin III, Coagulation factor IX, Plasmin, Bradykinin, KNG, Fibrinogen gamma",
416,Neuropeptide signaling in pancreatic cancer,48,8.347E-03,3.854E-02,8.347E-03,3.854E-02,16,"MEK1(MAP2K1), Substance P extracellular region, CCK8, PKC-eta, c-Fos, ERK1/2, AGTR1, G-protein alpha-11, c-Raf-1, G-protein alpha-q/11, NFKBIA, IP3 receptor, GRP-R, PRKD1, PLC-beta, NTSR1",1.520E-02,6.141E-02,18,"Substance P extracellular region, PKC-eta, c-Fos, ERK1/2, G-protein alpha-q/11, IP3 receptor, GRP-R, PLC-beta, IKK-alpha, NTSR1, c-Myc, CCK8, CCKBR, AGTR1, G-protein alpha-11, NFKBIA, PRKD1, G-protein alpha-q",
417,Development_Regulation of cytoskeleton proteins in oligodendrocyte differentiation and myelination,59,8.356E-03,4.192E-02,5.707E-02,1.450E-01,16,"Tubulin beta, KLHL1, p190RhoGAP, Myosin II, PAK1, Tubulin alpha, MAP6, Netrin-1, MRLC, FAK1, Dcc, Cortactin, WASP, Tau (MAPT), MELC, Tubulin (in microtubules)",8.356E-03,4.192E-02,22,"Rac1, PCBP-1, Netrin-1, Dcc, Cortactin, WASP, Tau (MAPT), Tubulin (in microtubules), Tubulin beta, KLHL1, p190RhoGAP, Myosin II, PAK1, Paxillin, Tubulin alpha, MAP6, N-WASP, MRLC, FAK1, MAG, MELC, Cofilin",
418,Influence of smoking on activation of EGFR signaling in lung cancer cells,44,8.358E-03,3.854E-02,8.358E-03,3.854E-02,15,"MEK1(MAP2K1), p38alpha (MAPK14), EGF, GRB2, c-Fos, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, Amphiregulin, G-protein alpha-s, Adenylate cyclase, MEK6(MAP2K6), JNK(MAPK8-10), ERK1 (MAPK3)",5.834E-02,1.501E-01,15,"EGF, GRB2, c-Fos, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), Amphiregulin, p38beta (MAPK11), Adenylate cyclase, MEK6(MAP2K6), ERK1 (MAPK3), c-Jun, G-protein alpha-s, MEKK1(MAP3K1), JNK(MAPK8-10)",
419,Transport_RAB1A regulation pathway,12,8.388E-03,4.194E-02,5.025E-02,1.355E-01,5,"Rabaptin-5, p115, Golgin-95, Golgin-84, SNAPs",8.388E-03,4.194E-02,7,"Rabaptin-5, p115, Golgin-84, SNAPs, GGTase-II, Rab-1A, Golgin-95",
420,Mast cell migration in asthma,73,8.497E-03,3.884E-02,8.497E-03,3.884E-02,22,"C5aR, MIG, CCL22, CCL17, CCR7, CCR3, CXCR6, G-protein alpha-i family, CCR2, ERK1/2, VEGFR-1, CCR1, MGF, LTBR1, IL8RA, FGFR1, Vitronectin, TGF-beta 3, P2Y2, LTBR2, p38 MAPK, SDF-1",1.689E-02,6.424E-02,25,"CCL22, CCL17, CXCR6, CCR2, ERK1/2, CCR1, IL-3, FGFR1, LTBR2, SDF-1, C3aR, C5aR, CCR7, CCR3, G-protein alpha-i family, VEGFR-1, MGF, LTBR1, IL8RA, CXCR3, Vitronectin, TGF-beta 3, P2Y2, PI3K reg class IB (p101), p38 MAPK",
421,Regulation and signaling of HGF receptor (Met) and MSP receptor (RON) in lung cancer,73,8.497E-03,3.884E-02,8.497E-03,3.884E-02,22,"p38alpha (MAPK14), GRB2, c-Fos, GAB1, K-RAS, H-Ras, ERK1/2, MSP, MSP receptor (RON), p90Rsk, STAT3, PI3K reg class IA (p85), AP-1, p70 S6 kinase1, Rb protein, MEK6(MAP2K6), FAK1, Delta-catenin, AKT(PKB), SP1, PDK (PDPK1), IL-6 receptor",8.687E-03,4.315E-02,26,"GRB2, c-Fos, GAB1, H-Ras, ERK1/2, PKC-zeta, c-Jun/c-Fos, Rac1, PI3K reg class IA (p85), Rb protein, MEK6(MAP2K6), AKT(PKB), PDK (PDPK1), K-RAS, PKC-delta, c-Jun, MSP, MSP receptor (RON), Paxillin, AP-1, p70 S6 kinase1, MEKK1(MAP3K1), FAK1, Delta-catenin, SP1, IL-6 receptor",
422,Mechanisms of drug resistance in multiple myeloma,49,8.608E-03,4.290E-02,4.888E-02,1.335E-01,14,"H-Ras, ERK1/2, p21, IL8RA, Casein kinase I alpha, NFKBIA, STAT3, FANCF, IKK-beta, Bcl-2, GSK3 alpha/beta, MEK1/2, Cyclin D1, IL8RB",8.608E-03,4.290E-02,19,"WNT3A, H-Ras, ERK1/2, PKC-zeta, FZD4, p21, Casein kinase I alpha, BAD, FANCF, IKK-alpha, GSK3 alpha/beta, c-Myc, IL8RB, IL8RA, NFKBIA, IKK-beta, Bcl-2, Cyclin D1, Frizzled",
423,Role of Nicotine-induced Leptin resistance in hypothalamus in development of obesity,25,8.695E-03,3.936E-02,8.695E-03,3.936E-02,10,"MEK1(MAP2K1), ACACA, Thyroliberin, ERK1/2, AMPK alpha subunit, STAT3, p70 S6 kinase1, AKT(PKB), Leptin, CART",3.379E-01,5.066E-01,7,"ERK1/2, AKT(PKB), Thyroliberin, AMPK alpha subunit, p70 S6 kinase1, Leptin, CART",
424,Apoptosis and survival_Apoptotic Activin A signaling,25,8.695E-03,3.936E-02,8.695E-03,3.936E-02,10,"ALK-4, MEK1(MAP2K1), c-Fos, H-Ras, c-Raf-1, SIVA1, Bcl-XL, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3)",9.469E-02,2.091E-01,9,"ALK-4, c-Fos, H-Ras, Bcl-XL, SHIP, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), SIVA1",
425,Transcription_Transcription regulation of aminoacid metabolism,25,8.695E-03,3.936E-02,8.695E-03,3.936E-02,10,"p38alpha (MAPK14), ERK1/2, GATA-1, AP-2A, AP-1, Rb protein, PKC, Max, SP1, NFE2L1",1.513E-02,6.141E-02,11,"ERK1/2, FECH, Rb protein, MafK, c-Myc, AP-2A, AP-1, PKC, Max, SP1, NFE2L1",
426,DNA damage_Nucleotide excision repair,36,8.878E-03,4.380E-02,2.096E-02,7.261E-02,12,"XAB2, RPA3, Centrin-2, DNA ligase I, ERCC8, Ubiquitin, DDB2, RAD23B, DNA ligase III, POLD reg (p12), XPA, POLD reg (p50)",8.878E-03,4.380E-02,15,"RPA3, Centrin-2, XPC, DNA ligase I, ERCC8, Ubiquitin, XAB2, ERCC6, DDB1, DDB2, RAD23B, DNA ligase III, POLD reg (p12), XPA, POLD reg (p50)",
427,Development_Keratinocyte differentiation,56,9.158E-03,4.500E-02,1.793E-02,6.583E-02,17,"MEK1(MAP2K1), p38alpha (MAPK14), c-Fos, VDR, p38delta (MAPK13), H-Ras, ERK1/2, c-Raf-1, G-protein alpha-q/11, p21, IP3 receptor, JunD, MEK6(MAP2K6), Keratin 1, SP1, TGM1, C/EBPalpha",9.158E-03,4.500E-02,21,"c-Fos, p38delta (MAPK13), H-Ras, ERK1/2, c-Jun/c-Fos, G-protein alpha-q/11, p21, PLC-beta1, IP3 receptor, JunD, IKK-alpha, MEK6(MAP2K6), Keratin 1, PKC-delta, VDR, c-Jun, MKK7 (MAP2K7), MEKK1(MAP3K1), SP1, TGM1, C/EBPalpha",
428,Development_Role of IL-8 in angiogenesis,65,9.228E-03,4.116E-02,9.228E-03,4.116E-02,20,"MEK1(MAP2K1), SREBP1 (nuclear), c-Fos, G-protein alpha-i family, ERK1/2, E2N(UBC13), PAK1, IL8RA, FASN, SREBP1 (Golgi membrane), STAT3, Ubiquitin, SREBP1 precursor, I-kB, PI3K reg class IA (p85), FAK1, SCAP, AKT(PKB), PDK (PDPK1), IL8RB",2.749E-02,8.819E-02,22,"SREBP1 (nuclear), c-Fos, ERK1/2, E2N(UBC13), IKK (cat), FASN, Rac1, Ubiquitin, SREBP1 precursor, I-kB, PI3K reg class IA (p85), AKT(PKB), PDK (PDPK1), IL8RB, G-protein alpha-i family, PAK1, IL8RA, SREBP1 (Golgi membrane), Paxillin, FAK1, SCAP, PI3K reg class IB (p101)",
429,Role of Tissue factor-induced Thrombin signaling in cancerogenesis,65,9.228E-03,4.116E-02,9.228E-03,4.116E-02,20,"MEK1(MAP2K1), G-protein alpha-12 family, G-protein alpha-i family, ERK1/2, VEGFR-1, c-Raf-1, G-protein alpha-q/11, Coagulation factor VII, IP3 receptor, ErbB2, Calmodulin, IKK-beta, MRLC, FAK1, AKT(PKB), MELC, PAR4, PDK (PDPK1), ERK1 (MAPK3), MLCK",1.424E-02,5.913E-02,23,"LARG, ERK1/2, G-protein alpha-q/11, Coagulation factor VII, IP3 receptor, ErbB2, Thrombin, IKK-alpha, AKT(PKB), PAR4, PDK (PDPK1), ERK1 (MAPK3), MLCK, G-protein alpha-12 family, G-protein alpha-i family, c-Jun, VEGFR-1, Paxillin, Calmodulin, IKK-beta, MRLC, FAK1, MELC",
430,G-protein signaling_Regulation of CDC42 activity,33,9.421E-03,4.500E-02,1.293E-01,2.572E-01,9,"ACK1, FGFR1, VIL2 (ezrin), RhoGAP1, DOCK6, DBS, DBL, p200RhoGAP, ASEF2",9.421E-03,4.500E-02,14,"Zizimin 1, ACK1, FGFR1, VIL2 (ezrin), RhoGAP1, DBS, ASEF2, RhoGDI gamma, Frabin, B-chimaerin, RhoGDI beta, DOCK6, DBL, p200RhoGAP",
431,Apoptosis and survival_Regulation of Apoptosis by Mitochondrial Proteins,33,9.421E-03,4.369E-02,1.007E-02,4.369E-02,12,"Aif, MAP1, c-Raf-1, VDAC 2, Bik, Cytochrome c, Bcl-2, Bcl-XL, IGF-1 receptor, PUMA, Smac/Diablo, ANT",9.421E-03,4.500E-02,14,"Bcl-W, VDAC 2, Bik, Bak, Cytochrome c, BAD, Bcl-XL, IGF-1 receptor, PUMA, ANT, Aif, MAP1, Bcl-2, Smac/Diablo",
432,Role of GSK3 beta in cardioprotection against myocardial infarction,33,9.421E-03,4.500E-02,1.293E-01,2.572E-01,9,"Kir6.1, BDKRB2, Kir6.2, Epo receptor, PI3K reg class IA (p85), PI3K reg class IA, AKT(PKB), Epo, ANT",9.421E-03,4.500E-02,14,"TOM20, AM-R, BDKRB2, Kir6.2, PI3K reg class IA (p85), PI3K reg class IA, AKT(PKB), Epo, ANT, Delta-type opioid receptor, Kir6.1, RAMP3, Bradykinin, Epo receptor",
433,Development_Activation of astroglial cells proliferation by ACM3,33,9.421E-03,4.500E-02,1.293E-01,2.572E-01,9,"ErbB3, ARF1, IP3 receptor, G-protein alpha-13, PI3K reg class IA (p85), p70 S6 kinase1, ARF6, AKT(PKB), PDK (PDPK1)",9.421E-03,4.500E-02,14,"eIF4E, ErbB3, PKC-zeta, PLC-beta1, IP3 receptor, G-protein alpha-13, PI3K reg class IA (p85), ARF6, AKT(PKB), PDK (PDPK1), ARF1, 4E-BP1, p70 S6 kinase1, G-protein alpha-q",
434,Transport_Macropinocytosis regulation by growth factors,63,9.465E-03,4.506E-02,9.429E-02,2.064E-01,16,"EGF, PDGF-B, GRB2, K-RAS, PDE3B, BAIAP2, AMPK beta subunit, H-Ras, EHD4, AMPK alpha subunit, AMPK gamma subunit, PAK1, VAV-2, WASP, AKT(PKB), Leptin",9.465E-03,4.506E-02,23,"EGF, TrkA, PDGF-B, GRB2, PDE3B, BAIAP2, IRS-1, AMPK beta subunit, H-Ras, EHD4, AMPK gamma subunit, PLC-beta1, Rac1, VAV-2, WASP, AKT(PKB), K-RAS, Destrin, AMPK alpha subunit, PAK1, Leptin, CtBP1, Cofilin",
435,Pro-oncogenic action of PTHrP in breast cancer,29,9.528E-03,4.212E-02,9.528E-03,4.212E-02,11,"c-Fos, H-Ras, ERK1/2, PTHR1, c-Raf-1, G-protein alpha-q/11, IP3 receptor, PLC-beta, Bcl-2, Bcl-XL, MEK1/2",1.035E-01,2.229E-01,10,"c-Fos, H-Ras, ERK1/2, PTHR1, G-protein alpha-q/11, IP3 receptor, PLC-beta, Bcl-XL, c-Jun, Bcl-2",
436,Histone deacetylases in Prostate Cancer,29,9.528E-03,4.212E-02,9.528E-03,4.212E-02,11,"Sirtuin4, Sirtuin3, HDAC11, Sirtuin6, p21, Kallikrein 3 (PSA), Androgen receptor, Sirtuin1, Tubulin alpha, Sirtuin7, HSP90",4.790E-02,1.319E-01,11,"Sirtuin3, HDAC11, Sirtuin6, p21, Kallikrein 3 (PSA), Androgen receptor, HSP90, Sirtuin4, Sirtuin1, Tubulin alpha, Sirtuin7",
437,Immune response_IFN-alpha/beta signaling via MAPKs,77,9.552E-03,4.534E-02,9.247E-02,2.044E-01,19,"ERK1/2, GCH1, PRMT1, ZNF145, p21, ULK1, Ubiquitin, AP-1, MAPKAPK2, IFN-alpha, Filamin B (TABP), MEK6(MAP2K6), p130, Cyclin D1, JNK(MAPK8-10), MSK1, AKT(PKB), p27KIP1, p38 MAPK",9.552E-03,4.534E-02,27,"ERK1/2, GCH1, PRMT1, ZNF145, p21, Rac1, ULK1, Ubiquitin, MAPKAPK2, ZAP70, IFN-alpha, MEK6(MAP2K6), p130, MSK1, AKT(PKB), p27KIP1, HIP-2, PKC-delta, c-Jun, MAPKAPK3, AP-1, MEKK1(MAP3K1), Filamin B (TABP), FOXO3A, Cyclin D1, JNK(MAPK8-10), p38 MAPK",
438,HSP22 and BAG-3-dependend macroautophagy in Huntington's disease,15,9.754E-03,4.614E-02,1.195E-01,2.445E-01,5,"Huntingtin, HSP22, eIF2S1, BAG-3, Cathepsin D",9.754E-03,4.614E-02,8,"Huntingtin, ATF-4, eIF2S1, Cathepsin D, HSP22, Beclin 1, BAG-3, APG12",
439,Development_Non-genomic action of Retinoic acid in cell differentiation,57,9.879E-03,4.341E-02,9.879E-03,4.341E-02,18,"c-Fos, RARgamma, ERK1/2, RXRA, PKA-reg type II (cAMP-dependent), c-Raf-1, p90RSK1, PAK1, p90Rsk, IP3 receptor, PI3K reg class IA (p85), Rb protein, PRKAR2B, RARalpha, MEK1/2, MSK1, AKT(PKB), PDK (PDPK1)",3.093E-01,4.761E-01,15,"c-Fos, RARgamma, ERK1/2, Rac1, IP3 receptor, PI3K reg class IA (p85), Rb protein, PRKAR2B, RARalpha, MSK1, AKT(PKB), PDK (PDPK1), RXRA, PKA-reg type II (cAMP-dependent), PAK1",
440,Signal transduction_Additional pathways of NF-kB activation (in the nucleus),30,9.921E-03,4.664E-02,1.263E-02,5.113E-02,11,"p38alpha (MAPK14), ERK1/2, TBK1, PKA-reg (cAMP-dependent), PRMT5, p90RSK1, NFKBIA, I-kB, Adenylate cyclase, IKK-beta, MSK1",9.921E-03,4.664E-02,13,"ERK1/2, TBK1, PKC-zeta, PKA-reg (cAMP-dependent), PRMT5, IKK (cat), I-kB, IKK-alpha, Adenylate cyclase, MSK1, PKC-delta, NFKBIA, IKK-beta",
441,Cytoskeleton remodeling_RalA regulation pathway,30,9.921E-03,4.664E-02,7.903E-02,1.842E-01,9,"REPS1, REPS2, H-Ras, RalGDS, ARF1, RalGEF2, Calmodulin, RGL, Beta-arrestin1",9.921E-03,4.664E-02,13,"REPS1, REPS2, H-Ras, Rac1, RalGEF2, RGL, RalGDS, ARF1, Aurora-A, HSF1, Calmodulin, Beta-arrestin1, RalA",
442,Development_Role of PKR1 and ILK in cardiac progenitor cells,33,1.007E-02,4.369E-02,1.007E-02,4.369E-02,12,"MEK1(MAP2K1), GRB2, H-Ras, ERK1/2, c-Raf-1, G-protein alpha-q/11, ILK, Islet-1, PKR1, PLC-beta, Cyclin D1, AKT(PKB)",5.438E-02,1.424E-01,12,"Prokineticin 2, GRB2, H-Ras, Lef-1, ERK1/2, G-protein alpha-q/11, PLC-beta, AKT(PKB), Tcf(Lef), ILK, PKR1, Cyclin D1",
443,Neurophysiological process_Long-term depression in cerebellum,53,1.015E-02,4.369E-02,1.015E-02,4.369E-02,17,"MEK1(MAP2K1), H-Ras, ERK1/2, Protein kinase G, c-Raf-1, PIB4, IP3 receptor, GluR2, Galpha(s)-specific CRF GPCRs, G-protein alpha-s, PLC-beta, PICK1, cPLA2, IGF-1 receptor, GRID2, Guanylate Cyclase 1, soluble, IGF-1",3.129E-01,4.807E-01,14,"H-Ras, ERK1/2, PIB4, IP3 receptor, PLC-beta, cPLA2, IGF-1 receptor, Guanylate Cyclase 1, soluble, Protein kinase G, GluR2, G-protein alpha-s, PICK1, G-protein alpha-q, IGF-1",
444,Effect of H. pylori infection on gastric epithelial cells motility,43,1.015E-02,4.713E-02,3.700E-02,1.097E-01,13,"E-cadherin, MARK2, ERK1/2, Alpha-actinin, PAK1, JAM1, Alpha-catenin, VIL2 (ezrin), Connexin 43, FAK1, Occludin, Cortactin, JNK(MAPK8-10)",1.015E-02,4.713E-02,17,"Connexin 32, ERK1/2, JAM1, Actin, Rac1, VIL2 (ezrin), Cortactin, E-cadherin, MARK2, PAK1, Alpha-catenin, Paxillin, SHP-2, FAK1, Occludin, JNK(MAPK8-10), p120-catenin",
445,Development_WNT/Beta-catenin signaling in embryogenesis,43,1.015E-02,4.713E-02,1.426E-01,2.728E-01,11,"KLF4, NANOG, DLL1, LHX8, SOX2, LRH1, WNT, Mesogenin 1, PAX3, Cyclin D1, TBX3",1.015E-02,4.713E-02,17,"Lef-1, KLF4, DLL1, Sp8, LHX8, LRH1, CDX4, PAX3, Tcf(Lef), T brachyury protein, NANOG, SOX2, WNT, Cyclin D1, Esrrb, TBX3, Frizzled",
446,Neurophysiological process_GABA-A receptor life cycle,27,1.034E-02,4.775E-02,1.008E-01,2.171E-01,8,"PP1-cat, Gephyrin, Clathrin light chain, GABA-A receptor, Clathrin, GABA-A receptor gamma-2 subunit, Clathrin heavy chain, Tubulin (in microtubules)",1.034E-02,4.775E-02,12,"NSF, PP1-cat, GABA-A receptor, GABA-A receptor gamma-2 subunit, GABA-A receptor beta-2 subunit, Clathrin heavy chain, Tubulin (in microtubules), GABA-A receptor alpha-1 subunit, Gephyrin, Clathrin light chain, GABA-A receptor alpha-1/beta-2/gamma-2, Clathrin",
447,Development_Melanocyte development and pigmentation,49,1.035E-02,4.369E-02,1.035E-02,4.369E-02,16,"MEK1(MAP2K1), Protein kinase G1, GRB2, Galpha(s)-specific peptide GPCRs, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), Adenylate cyclase type I, p90RSK1, MGF, TYRP1, G-protein alpha-s, PI3K reg class IA, PAX3, AKT(PKB), PDK (PDPK1)",3.893E-02,1.152E-01,17,"Protein kinase G1, GRB2, WNT3A, H-Ras, Lef-1, ERK1/2, PKA-reg (cAMP-dependent), PI3K reg class IA, PAX3, AKT(PKB), PDK (PDPK1), Galpha(s)-specific peptide GPCRs, Adenylate cyclase type I, MGF, TYRP1, G-protein alpha-s, Frizzled",
448,Cytoskeleton remodeling_Integrin outside-in signaling,49,1.035E-02,4.369E-02,1.035E-02,4.369E-02,16,"MEK1(MAP2K1), GRB2, H-Ras, ERK1/2, Alpha-actinin, c-Raf-1, PAK1, ILK, Vitronectin, PIPKI gamma, FAK1, WASP, Cyclin D1, Collagen II, AKT(PKB), WIRE",3.893E-02,1.152E-01,17,"GRB2, H-Ras, ERK1/2, Rac1, WASP, Collagen II, AKT(PKB), Tcf(Lef), c-Jun, PAK1, ILK, Paxillin, Vitronectin, PIPKI gamma, FAK1, Cyclin D1, WIRE",
449,Signal transduction_Soluble CXCL16 signaling,49,1.035E-02,4.369E-02,1.035E-02,4.369E-02,16,"Tuberin, MMP-1, CXCR6, G-protein alpha-i family, ERK1/2, c-Raf-1, STAT3, I-kB, p70 S6 kinase1, IKK-beta, MEK1/2, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1), p38 MAPK, CD163",3.893E-02,1.152E-01,17,"Tuberin, CXCR6, ERK1/2, IKK (cat), I-kB, IKK-alpha, AKT(PKB), PDK (PDPK1), MMP-1, G-protein alpha-i family, 4E-BP1, p70 S6 kinase1, IKK-beta, JNK(MAPK8-10), p38 MAPK, CD163, Cofilin",
450,FGFR3 signaling in multiple myeloma,37,1.038E-02,4.369E-02,1.038E-02,4.369E-02,13,"MEK1(MAP2K1), FGFR3, GRB2, K-RAS, H-Ras, ERK1/2, c-Raf-1, STAT3, PI3K reg class IA (p85-beta), Bcl-XL, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3)",3.276E-01,4.972E-01,10,"GRB2, H-Ras, ERK1/2, PI3K reg class IA (p85-beta), Bcl-XL, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), FGFR3, K-RAS",
451,Development_Beta-adrenergic receptors transactivation of EGFR,37,1.038E-02,4.369E-02,1.038E-02,4.369E-02,13,"MEK1(MAP2K1), Tuberin, GRB2, GAB1, G-protein alpha-i family, H-Ras, ERK1/2, c-Raf-1, AP-1, p70 S6 kinase1, PI3K reg class IA, p70 S6 kinase2, ERK1 (MAPK3)",6.013E-02,1.529E-01,13,"Tuberin, GRB2, GAB1, H-Ras, ERK1/2, c-Jun/c-Fos, PI3K reg class IA, ERK1 (MAPK3), G-protein alpha-i family, c-Jun, AP-1, p70 S6 kinase1, p70 S6 kinase2",
452,Oxidative stress_Role of Sirtuin1 and PGC1-alpha in activation of antioxidant defense system,60,1.041E-02,4.775E-02,3.462E-02,1.041E-01,17,"SCPX, PRDX3, GSHB, AMPK beta subunit, Esrra, AMPK alpha subunit, AMPK gamma subunit, UCP2, GSHR, GSTM5, Sirtuin1, PRDX5, LKB1, Sestrin 1, TXNRD2, SP1, NQO1",1.041E-02,4.775E-02,22,"SCPX, PRDX3, GSHB, AMPK beta subunit, Esrra, AMPK gamma subunit, UCP2, GSTM5, PRDX5, SOD1, Sestrin 1, Thioredoxin, MT-TRX, AMPK alpha subunit, PRDX1, GSHR, Sirtuin1, LKB1, FOXO3A, TXNRD2, SP1, NQO1",
453,Development_EPO-induced MAPK pathway,45,1.048E-02,4.369E-02,1.048E-02,4.369E-02,15,"MEK1(MAP2K1), GRB2, c-Fos, K-RAS, H-Ras, ERK1/2, PAK3, c-Raf-1, PAK1, MGF, Btk, IP3 receptor, Epo receptor, JNK(MAPK8-10), Epo",1.668E-02,6.424E-02,17,"GRB2, c-Fos, H-Ras, ERK1/2, PAK3, Rac1, IP3 receptor, SHIP, Epo, K-RAS, c-Jun, PAK1, MGF, C3G, Btk, Epo receptor, JNK(MAPK8-10)",
454,Development_Growth hormone-releasing hormone (GH-RH) signaling,41,1.050E-02,4.369E-02,1.050E-02,4.369E-02,14,"MEK1(MAP2K1), cPKC (conventional), c-Fos, H-Ras, ERK1/2, CACNA1C, PKA-reg (cAMP-dependent), c-Raf-1, NAV1.9, IP3 receptor, GH-RH, G-protein alpha-s, PLC-beta, Adenylate cyclase",2.075E-01,3.599E-01,12,"c-Fos, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), IP3 receptor, GH-RH, PLC-beta, Adenylate cyclase, cPKC (conventional), CACNA1C, PIT1, G-protein alpha-s",
455,Immune response_Neurotensin-induced activation of IL-8 in colonocytes,41,1.050E-02,4.369E-02,1.050E-02,4.369E-02,14,"MEK1(MAP2K1), GRB2, c-Fos, G-protein alpha-i family, H-Ras, G-protein alpha-11, c-Raf-1, PAK1, IP3 receptor, I-kB, Calmodulin, IKK-beta, NTSR1, ERK1 (MAPK3)",1.428E-02,5.913E-02,16,"GRB2, c-Fos, H-Ras, IKK (cat), PLC-beta1, Rac1, IP3 receptor, I-kB, NTSR1, ERK1 (MAPK3), G-protein alpha-i family, G-protein alpha-11, PAK1, Calmodulin, IKK-beta, G-protein alpha-q",
456,Maturation and migration of dendritic cells in skin sensitization,41,1.050E-02,4.369E-02,1.050E-02,4.369E-02,14,"MHC class II alpha chain, E-cadherin, CD80, MHC class II, CCR7, TRAF2, ERK1/2, TRADD, I-kB, MEK6(MAP2K6), JNK(MAPK8-10), CD40(TNFRSF5), MHC class II beta chain, p38 MAPK",1.428E-02,5.913E-02,16,"MHC class II alpha chain, MHC class II, ERK1/2, IKK (cat), TRADD, I-kB, MEK6(MAP2K6), MHC class II beta chain, E-cadherin, CCR7, TRAF2, c-Jun, MEKK1(MAP3K1), JNK(MAPK8-10), CD40(TNFRSF5), p38 MAPK",
457,Development_S1P4 receptor signaling pathway,22,1.069E-02,4.425E-02,1.069E-02,4.425E-02,9,"MEK1(MAP2K1), G-protein alpha-12 family, G-protein alpha-i family, H-Ras, ERK1/2, c-Raf-1, S1P4 receptor, IP3 receptor, PLC-beta",2.192E-01,3.736E-01,7,"H-Ras, ERK1/2, IP3 receptor, PLC-beta, G-protein alpha-12 family, G-protein alpha-i family, S1P4 receptor",
458,Development_Mu-type opioid receptor signaling via Beta-arrestin,22,1.069E-02,4.425E-02,1.069E-02,4.425E-02,9,"MEK1(MAP2K1), G-protein alpha-i family, ERK1/2, c-Raf-1, p90Rsk, STAT3, Clathrin, ERK1 (MAPK3), GRK2",2.192E-01,3.736E-01,7,"ERK1/2, ERK1 (MAPK3), GRK2, Delta-type opioid receptor, G-protein alpha-i family, SYP, Clathrin",
459,Modulation of tumor response to cytotoxic T cells by hypoxia in tumors,50,1.098E-02,4.886E-02,1.065E-01,2.270E-01,13,"CD80, Granzyme B, ERK1/2, PIG11, NANOG, NIP3, STAT3, Ubiquitin, Bcl-2, HIF-prolyl hydroxylase, AKT(PKB), ENP1, Adenosine A2a receptor",1.098E-02,4.886E-02,19,"Granzyme B, ERK1/2, Perforin, NIP3, Ubiquitin, microRNA 210, FasL(TNFSF6), AKT(PKB), ENP1, ARNT, miR-210-3p, PTP-1B, PIG11, NANOG, Bcl-2, Beclin 1, HIF-prolyl hydroxylase, TCR alpha/beta, Adenosine A2a receptor",
460,The role of PTEN and PI3K signaling in melanoma,50,1.098E-02,4.886E-02,5.698E-02,1.450E-01,14,"E-cadherin, AKT1, Aif, Livin, STAT3, Epo receptor, PI3K reg class IA (p85), p70 S6 kinase1, PTEN, FAK1, Tau (MAPT), AKT(PKB), PDK (PDPK1), Epo",1.098E-02,4.886E-02,19,"AKT1, RhoC, Rac1, BAD, PI3K reg class IA (p85), Tau (MAPT), FasL(TNFSF6), AKT(PKB), PDK (PDPK1), Epo, E-cadherin, Aif, Livin, Epo receptor, p70 S6 kinase1, PTEN, FOXO3A, FAK1, AKT2",
461,Apoptosis and survival_NGF activation of NF-kB,40,1.098E-02,4.886E-02,9.521E-02,2.064E-01,11,"Neuromodulin, hASH1, NFKBIA, I-kB, PI3K reg class IA, IKK-beta, Neurogenin 3, Bcl-2, Bcl-XL, AKT(PKB), PDK (PDPK1)",1.098E-02,4.886E-02,16,"TrkA, PKC-zeta, IKK (cat), I-kB, PI3K reg class IA, MyD88, IKK-alpha, Neurogenin 3, Bcl-XL, AKT(PKB), PDK (PDPK1), hASH1, PTP-1B, NFKBIA, IKK-beta, Bcl-2",
462,Possible role of neonatal nicotine exposure in development of postnatal obesity,5,1.103E-02,4.892E-02,2.250E-01,3.723E-01,2,"nAChR alpha-4, Leptin",1.103E-02,4.892E-02,4,"nAChR alpha-4, nAChR alpha4/beta2, nAChR beta-2, Leptin",
463,Immune response_B cell antigen receptor (BCR) pathway,110,1.138E-02,4.695E-02,1.138E-02,4.695E-02,30,"MEK1(MAP2K1), Calcineurin A (catalytic), GRB2, c-Fos, K-RAS, H-Ras, ERK1/2, BLNK, c-Raf-1, PIP5KI, CD19, Btk, NFKBIA, IP3 receptor, PI3K reg class IA (p85), p70 S6 kinase1, Rb protein, Calmodulin, CD79A, CalDAG-GEFII, IKK-beta, MEK6(MAP2K6), VAV-2, GSK3 alpha/beta, Bcl-XL, MEK1/2, WASP, AKT(PKB), PDK (PDPK1), p38 MAPK",1.829E-02,6.753E-02,35,"Calcineurin A (catalytic), GRB2, c-Fos, H-Ras, ERK1/2, EGR1, CD19, Rac1, IP3 receptor, BAD, PI3K reg class IA (p85), Rb protein, CD79A, IKK-alpha, CalDAG-GEFII, MEK6(MAP2K6), VAV-2, GSK3 alpha/beta, Bcl-XL, WASP, AKT(PKB), PDK (PDPK1), MEKK4(MAP3K4), K-RAS, BLNK, CD79 complex, PIP5KI, Btk, NFKBIA, p70 S6 kinase1, Calmodulin, MEKK1(MAP3K1), IKK-beta, CD79B, p38 MAPK",
464,MicroRNAs in melanoma,57,1.145E-02,5.035E-02,4.631E-01,6.250E-01,11,"E-cadherin, MaxiK alpha subunit, AP-2C, E2F5, E2F1, ZNF145, HOXB7, HOXC8, POU3F2 (BRN2), Cyclin D1, p27KIP1",1.145E-02,5.035E-02,21,"MaxiK alpha subunit, Cyclin D3, E2F5, ZNF145, miR-let-7a-5p, POU3F2 (BRN2), miR-532-5p, p27KIP1, miR-152-3p, E-cadherin, miR-222-3p, AP-2C, E2F1, miR-196a-5p, HOXB7, HOXC8, miR-182-5p, FOXO3A, Cyclin D1, microRNA 222, CtBP1",
465,Development_Alpha-2 adrenergic receptor activation of ERK,62,1.151E-02,4.736E-02,1.151E-02,4.736E-02,19,"MEK1(MAP2K1), Alpha-2C-1 adrenergic receptor, CYP2C8, GRB2, DGL-alpha, G-protein alpha-i family, H-Ras, ERK1/2, c-Raf-1, Alpha-2A adrenergic receptor, DGL-beta, IP3 receptor, Calmodulin, PI3K reg class IA, cPLA2, Monoglyceride lipase, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3)",2.324E-01,3.851E-01,17,"GRB2, DGL-alpha, H-Ras, ERK1/2, DGL-beta, IP3 receptor, PI3K reg class IA, cPLA2, Monoglyceride lipase, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), Alpha-2C-1 adrenergic receptor, G-protein alpha-i family, c-Jun, Alpha-2A adrenergic receptor, Calmodulin",
466,Blood coagulation_GPCRs in platelet aggregation,71,1.166E-02,5.110E-02,1.326E-01,2.611E-01,17,"G-protein alpha-i family, Myosin II, PKA-reg (cAMP-dependent), P2Y12, Alpha-2A adrenergic receptor, Calmyrin, IP3 receptor, G-protein alpha-13, G-protein alpha-s, Adenylate cyclase, MRLC, IP3R1, G-protein alpha-z, LIMK2, MELC, PAR4, SNAP-23",1.166E-02,5.110E-02,25,"LARG, PKA-reg (cAMP-dependent), Calmyrin, IP3 receptor, G-protein alpha-13, Prostacyclin receptor, Thrombin, Adenylate cyclase, LIMK2, Syntaxin 4, PAR4, CALDAG-GEFI, G-protein alpha-i family, Myosin II, P2Y12, Alpha-2A adrenergic receptor, G-protein alpha-s, MRLC, IP3R1, G-protein alpha-q, G-protein alpha-z, MELC, PI3K reg class IB (p101), SNAP-23, Cofilin",
467,Immune response_Oncostatin M signaling via MAPK,37,1.184E-02,5.177E-02,2.605E-02,8.495E-02,12,"MEK1(MAP2K1), gp130, GRB2, c-Fos, MMP-1, H-Ras, ERK1/2, c-Raf-1, AP-1, JNK(MAPK8-10), p38 MAPK, ERK1 (MAPK3)",1.184E-02,5.177E-02,15,"gp130, GRB2, c-Fos, H-Ras, ERK1/2, EGR1, Rac1, ERK1 (MAPK3), MMP-1, c-Jun, AP-1, MEKK1(MAP3K1), SHP-2, JNK(MAPK8-10), p38 MAPK",
468,TGF-beta signaling via kinase cascades in breast cancer,58,1.195E-02,4.880E-02,1.195E-02,4.880E-02,18,"MEK1(MAP2K1), p38alpha (MAPK14), GRB2, c-Fos, Neuregulin 1, ERK1/2, ErbB3, NFKBIA, Ubiquitin, AP-1, Amphiregulin, IKK-beta, MEK6(MAP2K6), FAK1, JNK(MAPK8-10), TAB2, AKT(PKB), p38 MAPK",2.834E-02,8.938E-02,20,"GRB2, c-Fos, ERK1/2, ErbB3, Rac1, Ubiquitin, Amphiregulin, p38beta (MAPK11), IKK-alpha, MEK6(MAP2K6), TAB2, AKT(PKB), c-Jun, NFKBIA, AP-1, IKK-beta, TAB1, FAK1, JNK(MAPK8-10), p38 MAPK",
469,Development_HGF signaling pathway,47,1.200E-02,5.200E-02,3.515E-02,1.048E-01,14,"MEK1(MAP2K1), E-cadherin, Syndecan-1, GRB2, c-Fos, GAB1, H-Ras, ERK1/2, c-Raf-1, STAT3, PI3K reg class IA, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1)",1.200E-02,5.200E-02,18,"GRB2, c-Fos, GAB1, H-Ras, ERK1/2, EGR1, Rac1, PI3K reg class IA, AKT(PKB), PDK (PDPK1), E-cadherin, Syndecan-1, HGFA, c-Jun, C3G, MKK7 (MAP2K7), MEKK1(MAP3K1), JNK(MAPK8-10)",
470,"Development_TNF-alpha, IL-1 alpha and WNT5A-dependent regulation of osteogenesis and adipogenesis in mesenchymal stem cells",47,1.200E-02,5.200E-02,1.309E-01,2.584E-01,12,"ROR2, TRAF2, TRADD, NFKBIA, IP3 receptor, Calmodulin, PLC-beta, IKK-beta, IL-1RI, LXR-alpha, JNK(MAPK8-10), TAB2",1.200E-02,5.200E-02,18,"14-3-3, c-Jun/c-Fos, IKK (cat), TRADD, IP3 receptor, PLC-beta, IKK-alpha, IL-1RI, TAB2, ROR2, TRAF2, c-Jun, NFKBIA, 14-3-3 beta/alpha, Calmodulin, IKK-beta, TAB1, JNK(MAPK8-10)",
471,Dysregulation of indirect glucose-induced inhibition of Glucagon secretion from alpha-cells in type 2 diabetes ,54,1.259E-02,5.409E-02,5.319E-02,1.407E-01,15,"AKT1, SUR1, Insulin processed, SNAP-25, SLC39A1 (ZIP1), Kir6.2, MUNC13-1, GABA-A receptor beta-3 subunit, GABA-A receptor, PI3K reg class IA, Insulin receptor, Synaptotagmin VII, ZnT-8, PC2, PDK (PDPK1)",1.259E-02,5.409E-02,20,"AKT1, SUR1, Insulin processed, IRS-1, SLC39A1 (ZIP1), Kir6.2, Syntaxin 1A, GABA-A receptor, PI3K reg class IA, Insulin receptor, Synaptotagmin VII, GABA-A receptor alpha-2 subunit, PDK (PDPK1), GABA-A receptor beta-2 subunit, GABA-A receptor alpha-2/beta-3/gamma-2, GABA-A receptor alpha-1 subunit, GABA-A receptor beta-3 subunit, GABA-A receptor alpha-1/beta-2/gamma-2, ZnT-8, PC2",
472,DNA damage_Brca1 as a transcription regulator,30,1.263E-02,5.113E-02,1.263E-02,5.113E-02,11,"Chk2, ESR1 (nuclear), E2F1, p21, DDB2, Rb protein, IGF-1 receptor, ZBRK1, Cyclin D1, SP1, p27KIP1",2.603E-02,8.416E-02,12,"ESR1 (nuclear), XPC, p21, Rb protein, IGF-1 receptor, ZBRK1, p27KIP1, c-Myc, E2F1, DDB2, Cyclin D1, SP1",
473,Transport_Aldosterone-mediated regulation of ENaC sodium transport,30,1.263E-02,5.113E-02,1.263E-02,5.113E-02,11,"gamma-ENaC, K-RAS, beta-ENaC, alpha-ENaC, c-Raf-1, SAHH, MEK1/2, DSIPI (GILZ), AKT(PKB), PDK (PDPK1), COMTD1",1.250E-01,2.542E-01,10,"gamma-ENaC, beta-ENaC, AKT(PKB), PDK (PDPK1), COMTD1, K-RAS, alpha-ENaC, SAHH, DSIPI (GILZ), ENaC",
474,G-protein signaling_G-Protein alpha-q signaling cascades,34,1.272E-02,5.449E-02,3.298E-02,1.013E-01,11,"GRB2, RGS3, H-Ras, G-protein alpha-q/11, Btk, IP3 receptor, I-kB, PLC-beta, AKT(PKB), PDK (PDPK1), GRK2",1.272E-02,5.449E-02,14,"GRB2, H-Ras, LARG, IKK (cat), G-protein alpha-q/11, IP3 receptor, I-kB, PLC-beta, IKK-alpha, AKT(PKB), PDK (PDPK1), GRK2, RGS3, Btk",
475,G-protein signaling_G-Protein beta/gamma signaling cascades,34,1.305E-02,5.249E-02,1.305E-02,5.249E-02,12,"MEK1(MAP2K1), GRB2, RGS3, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, Btk, Adenylate cyclase type V, Adenylate cyclase type II, AKT(PKB), PDK (PDPK1)",1.316E-01,2.614E-01,11,"GRB2, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), Adenylate cyclase type V, Adenylate cyclase type II, AKT(PKB), PDK (PDPK1), RGS3, Btk, PI3K reg class IB (p101)",
476,Ethanol/Acetaldehyde-dependent stimulation of MMP-9 expression in HCC,19,1.308E-02,5.249E-02,1.308E-02,5.249E-02,8,"c-Fos, beta-TrCP, ADH7, ADH1, NFKBIA, Skp2/TrCP/FBXW, JNK(MAPK8-10), p38 MAPK",4.787E-02,1.319E-01,8,"c-Fos, ADH7, Skp2/TrCP/FBXW, beta-TrCP, c-Jun, NFKBIA, JNK(MAPK8-10), p38 MAPK",
477,Inhibition of remyelination in multiple sclerosis: regulation of cytoskeleton proteins,44,1.310E-02,5.580E-02,8.821E-02,1.967E-01,12,"Tubulin beta, p190RhoGAP, Myosin II, TGF-beta, PAK1, Tubulin alpha, MRLC, FAK1, WASP, Tau (MAPT), MELC, Tubulin (in microtubules)",1.310E-02,5.580E-02,17,"Lingo1, Rac1, PCBP-1, WASP, Tau (MAPT), Tubulin (in microtubules), Tubulin beta, p190RhoGAP, Myosin II, TGF-beta, PAK1, Paxillin, Tubulin alpha, MRLC, FAK1, MELC, Cofilin",
478,Transcription targets of Androgen receptor involved in Prostate Cancer,42,1.318E-02,5.249E-02,1.318E-02,5.249E-02,14,"E-cadherin, SLC45A3, Kallikrein 4, Clusterin, p21, Kallikrein 3 (PSA), VIL2 (ezrin), Androgen receptor, Kallikrein 2, SCAP, Bcl-XL, Cyclin D1, Relaxin 1, IGF-1",1.829E-02,6.753E-02,16,"Clusterin, p21, Kallikrein 3 (PSA), VIL2 (ezrin), Androgen receptor, Bcl-XL, Relaxin 1, c-Myc, E-cadherin, SLC45A3, PKC-delta, Kallikrein 2, SCAP, Cyclin D1, microRNA 125b, IGF-1",
479,Development_Gastrin in differentiation of the gastric mucosa,38,1.321E-02,5.249E-02,1.321E-02,5.249E-02,13,"MEK1(MAP2K1), cPKC (conventional), PKC-eta, HDC, ERK1/2, c-Raf-1, G-protein alpha-q/11, IP3 receptor, PKC, PKC-gamma, SP1, TFF1, TFF2",1.553E-02,6.151E-02,15,"PKC-eta, ERK1/2, EGR1, G-protein alpha-q/11, ICRF, IP3 receptor, PKC-gamma, Chromogranin A, cPKC (conventional), CCKBR, PKC, G-protein alpha-q, SP1, TFF1, TFF2",
480,Cell cycle_Regulation of G1/S transition (part 1),38,1.321E-02,5.249E-02,1.321E-02,5.249E-02,13,"Chk2, JunB, beta-TrCP, Cyclin D, PP2A regulatory, p21, SARA, Ubiquitin, p70 S6 kinase1, Skp2/TrCP/FBXW, Cyclin D1, SP1, p27KIP1",7.301E-02,1.744E-01,13,"Cyclin D3, PP2A regulatory, p21, Ubiquitin, Skp2/TrCP/FBXW, p27KIP1, JunB, beta-TrCP, Cyclin D, SARA, p70 S6 kinase1, Cyclin D1, SP1",
481,Putative glucocorticoid- and LABA-mediated inhibition of pro-fibrotic signaling in airway fibroblasts/myofibroblasts,31,1.359E-02,5.754E-02,1.644E-02,6.155E-02,11,"cAMP-GEFI, ERK1/2, PKA-reg (cAMP-dependent), p21, AP-1, G-protein alpha-s, MKP-1, JNK(MAPK8-10), SP1, p38 MAPK, C/EBPalpha",1.359E-02,5.754E-02,13,"cAMP-GEFI, ERK1/2, c-Jun/c-Fos, PKA-reg (cAMP-dependent), p21, c-Jun, AP-1, G-protein alpha-s, MKP-1, JNK(MAPK8-10), SP1, p38 MAPK, C/EBPalpha",
482,Development_Prolactin receptor signaling,58,1.418E-02,5.913E-02,4.964E-02,1.343E-01,16,"MEK1(MAP2K1), GRB2, H-Ras, Lactogen, ERK1/2, c-Raf-1, Prolactin receptor, STAT3, PI3K reg class IA (p85), Bcl-2, VAV-2, Bcl-XL, Cyclin D1, AKT(PKB), SP1, CSH1 (somatomammotropin A)",1.418E-02,5.913E-02,21,"GRB2, IRS-1, H-Ras, ERK1/2, Rac1, Prolactin receptor, Lactoglobulin, PI3K reg class IA (p85), VAV-2, Bcl-XL, AKT(PKB), CSH1 (somatomammotropin A), c-Myc, PKC-delta, Lactogen, c-Jun, SHP-2, Beta-casein, Bcl-2, Cyclin D1, SP1",
483,Role of integrins in eosinophil degranulation in asthma,58,1.418E-02,5.913E-02,4.964E-02,1.343E-01,16,"Galectin-3, Substance P extracellular region, CCR3, CSF2RB, G-protein alpha-i family, ERK1/2, c-Raf-1, CD9, ITGAM, Hck, PKC, SP-D, PERE, MEK1/2, CysLT1 receptor, p38 MAPK",1.418E-02,5.913E-02,21,"Galectin-3, Substance P extracellular region, ERK1/2, Fc alpha receptor, PKC-zeta, FCGR3A, IL-3, Plastin, Hck, CCL13, SP-D, CysLT1 receptor, CCR3, CSF2RB, G-protein alpha-i family, CD9, ITGAM, CD67, PKC, PERE, p38 MAPK",
484,Immune response_CCR5 signaling in macrophages and T lymphocytes,58,1.418E-02,5.913E-02,4.964E-02,1.343E-01,16,"MEK1(MAP2K1), Calcineurin A (catalytic), c-Fos, G-protein alpha-i family, PAK2, ERK1/2, Adenylate cyclase type I, IP3 receptor, STAT3, MAPKAPK2, Calmodulin, JNK(MAPK8-10), CCR5, AKT(PKB), PDK (PDPK1), p38 MAPK",1.418E-02,5.913E-02,21,"Calcineurin A (catalytic), c-Fos, PAK2, ERK1/2, PLC-beta1, Rac1, IP3 receptor, MAPKAPK2, CCR5, AKT(PKB), PDK (PDPK1), MEKK4(MAP3K4), G-protein alpha-i family, c-Jun, Adenylate cyclase type I, Paxillin, Calmodulin, G-protein alpha-q, JNK(MAPK8-10), PI3K reg class IB (p101), p38 MAPK",
485,Possible influence of low doses of Arsenite on glucose uptake in muscle,28,1.441E-02,5.934E-02,5.339E-02,1.407E-01,9,"Rab-4A, Insulin processed, MYOG, p70 S6 kinase1, PI3K reg class IA, Insulin receptor, AKT(PKB), PDK (PDPK1), MYOD",1.441E-02,5.934E-02,12,"Insulin processed, IRS-1, PKC-zeta, GLUT4, MYOG, PI3K reg class IA, Insulin receptor, AKT(PKB), PDK (PDPK1), Rab-4A, p70 S6 kinase1, MYOD",
486,Immune response_IFN-alpha/beta signaling via PI3K and NF-kB pathways,94,1.469E-02,5.785E-02,1.469E-02,5.785E-02,26,"PU.1, Tuberin, AKT1, TRAF2, PDCD4, E2F1, ERK1/2, eIF4B, c-Raf-1, p90RSK1, p21, STAT3, I-kB, p70 S6 kinases, PI3K reg class IA (p85), Rb protein, EMSY, IFN-alpha, CAK complex, eIF4A, MNK2(GPRK7), p130, MEK1/2, AKT(PKB), PDK (PDPK1), p27KIP1",1.511E-02,6.141E-02,31,"Tuberin, AKT1, Cyclin D3, IRS-1, eIF4E, ERK1/2, IKK (cat), p21, I-kB, p70 S6 kinases, PI3K reg class IA (p85), Rb protein, EMSY, IKK-alpha, IFN-alpha, CAK complex, p130, AKT(PKB), PDK (PDPK1), p27KIP1, c-Myc, PU.1, PKC-delta, TRAF2, PDCD4, E2F1, eIF4B, 4E-BP1, eIF4A, FOXO3A, MNK2(GPRK7)",
487,Cytoskeleton remodeling_ESR1 action on cytoskeleton remodeling and cell migration,23,1.479E-02,5.785E-02,1.479E-02,5.785E-02,9,"ESR1 (nuclear), ESR1 (membrane), EBP50, ILK, G-protein alpha-13, PI3K reg class IA (p85), ERM proteins, FAK1, AKT(PKB)",5.843E-02,1.501E-01,9,"ESR1 (nuclear), ESR1 (membrane), G-protein alpha-13, PI3K reg class IA (p85), ERM proteins, AKT(PKB), EBP50, ILK, FAK1",
488,FGF signaling in gastric cancer,23,1.479E-02,5.785E-02,1.479E-02,5.785E-02,9,"E-cadherin, GRB2, FGFR4, H-Ras, c-Raf-1, FRS2, FGFR1, MEK1/2, ERK1 (MAPK3)",5.843E-02,1.501E-01,9,"GRB2, FGFR4, H-Ras, FRS2, FGFR1, ERK1 (MAPK3), E-cadherin, FGF7, SHP-2",
489,Transcription_ChREBP regulation pathway,23,1.479E-02,5.785E-02,1.479E-02,5.785E-02,9,"AMPK beta subunit, G-protein alpha-i family, AMPK alpha subunit, AMPK gamma subunit, ChREBP, PKA-reg (cAMP-dependent), Adenylate cyclase type I, Acyl-CoA synthetase, G-protein alpha-s",5.843E-02,1.501E-01,9,"AMPK beta subunit, AMPK gamma subunit, ChREBP, PKA-reg (cAMP-dependent), G-protein alpha-i family, AMPK alpha subunit, Adenylate cyclase type I, Acyl-CoA synthetase, G-protein alpha-s",
490,Aberrant B-Raf signaling in melanoma progression,55,1.495E-02,5.801E-02,1.495E-02,5.801E-02,17,"MEK1(MAP2K1), Tuberin, AKT1, ERK1/2, SRp55, AMPK alpha subunit, p90RSK1, p21, p90Rsk, FOXO4, LKB1, Bcl-2, MEK1/2, POU3F2 (BRN2), JNK(MAPK8-10), RKIP, AKT(PKB)",1.035E-01,2.229E-01,17,"Tuberin, AKT1, ERK1/2, SRp55, p21, BAD, POU3F2 (BRN2), AKT(PKB), AMPK alpha subunit, FOXO4, LKB1, Bcl-2, FOXO3A, Kinase MYT1, JNK(MAPK8-10), RKIP, RalA",
491,Transport_RAB5A regulation pathway,25,1.513E-02,6.141E-02,2.937E-01,4.507E-01,6,"Tuberin, EGF, Rabaptin-5, OCRL, Rabep-2, RAP6",1.513E-02,6.141E-02,11,"Tuberin, EGF, Rabaptin-5, RABGEF1, Rabep-2, Syntaxin 4, GGTase-II, RAP6, Rab5ip, RUFY2, OCRL",
492,Inhibition of oligodendrocyte precursor cells differentiation by Wnt signaling in multiple sclerosis,25,1.513E-02,6.141E-02,4.844E-01,6.421E-01,5,"WNT9A, Dsh, ID2, WNT, Axin",1.513E-02,6.141E-02,11,"WNT3A, Lef-1, FZD4, Dsh, ID2, LRP5, Axin, WNT9A, WNT1, WNT, Frizzled",
493,Development_Beta-adrenergic receptors signaling via Cyclic AMP,51,1.550E-02,5.952E-02,1.550E-02,5.952E-02,16,"Phospholamban, CACNA1C, PRKAR2A, PKA-reg type II (cAMP-dependent), PKA-reg (cAMP-dependent), LIPS, Troponin I, cardiac, PHK alpha (muscle), G-protein alpha-s, Calmodulin, PDE4D, Adenylate cyclase, MEK6(MAP2K6), PYGM, p38 MAPK, Perilipin",5.584E-02,1.454E-01,17,"PKA-reg (cAMP-dependent), PHK alpha (muscle), PDE4D, Adenylate cyclase, MEK6(MAP2K6), MEKK4(MAP3K4), BETA-PIX, CACNA1C, PRKAR2A, PKA-reg type II (cAMP-dependent), LIPS, Troponin I, cardiac, G-protein alpha-s, Calmodulin, PYGM, p38 MAPK, Perilipin",
494,Epithelial cell anoikis in COPD,51,1.550E-02,5.952E-02,1.550E-02,5.952E-02,16,"GRB2, MMP-1, H-Ras, ERK1/2, Alpha-actinin, c-Raf-1, ILK, PI3K reg class IA, MEK6(MAP2K6), Bcl-2, FAK1, MEK1/2, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1), p38 MAPK",2.885E-02,9.062E-02,18,"GRB2, IRS-1, H-Ras, ERK1/2, Bak, BAD, PI3K reg class IA, MEK6(MAP2K6), AKT(PKB), PDK (PDPK1), MMP-1, MKK7 (MAP2K7), ILK, Paxillin, Bcl-2, FAK1, JNK(MAPK8-10), p38 MAPK",
495,Defective efferocytosis in COPD,38,1.553E-02,6.151E-02,3.828E-01,5.468E-01,8,"SP-A, ELMO1, CD36, SP-D, P2Y2, CX3CR1, FAK1, ICAM3",1.553E-02,6.151E-02,15,"Stabilin-2, ELMO1, TIM-4, Rac1, SP-D, MBL2, SP-A, CD36, TIM-1, TIM-3, P2Y2, CX3CR1, FAK1, ICAM3, BAI1",
496,Oxidative stress_Role of ASK1 under oxidative stress,55,1.564E-02,6.151E-02,2.873E-01,4.507E-01,12,"TRAF2, JSAP1, PRKD1, Glutaredoxin, MEK6(MAP2K6), PPM1L, JNK(MAPK8-10), HIPK1, JNK3(MAPK10), PP5, UNRIP, p38 MAPK",1.564E-02,6.151E-02,20,"14-3-3, SOD1, Gemin5, MEK6(MAP2K6), JNK3(MAPK10), PP5, Thioredoxin, PKC-delta, TRAF2, MT-TRX, MKK7 (MAP2K7), PRDX1, JSAP1, PRKD1, Glutaredoxin, PPM1L, JNK(MAPK8-10), HIPK1, UNRIP, p38 MAPK",
497,GTP-XTP metabolism,90,1.565E-02,5.994E-02,1.565E-02,5.994E-02,25,"RRP41, RPOM, NDPK C, NDPK complex, RPB8, IMD2, KGUA, RPB10, POLR3B, RPB7.0, NDPK 6, POLR3A, POLR1B, 5'-NTC, CSL4, NDPK A, RRP46, NDPK 8, IMD1, PPAL, NDPK D (mitochondrial), POLR2I, GMP2, POLR3K, NDPK B",4.257E-02,1.241E-01,28,"RPOM, NDPK complex, RPB8, PR44 (DIS3), POLR3B, NDPK 6, POLR1B, 5'-NTC, CSL4, RPB5, RRP46, IMD1, PPAL, GMP2, POLR3K, RRP41, NDPK C, IMD2, KGUA, RPB10, RPB7.0, POLR3A, RRP4, NDPK A, NDPK 8, NDPK D (mitochondrial), POLR2I, NDPK B",
498,T regulatory cell migration in asthma,22,1.568E-02,6.151E-02,8.798E-02,1.967E-01,7,"CCL22, CCL17, CCL1, G-protein alpha-i family, CCR8, AKT(PKB), PDK (PDPK1)",1.568E-02,6.151E-02,10,"IL-16 mature, Histamine H4 receptor, CCL22, CCL17, CCR8, AKT(PKB), PDK (PDPK1), CCL1, G-protein alpha-i family, PI3K reg class IB (p101)",
499,Regulation of intrinsic membrane properties and excitability of striatonigral medium spiny neurons in Huntington's disease,62,1.574E-02,6.159E-02,2.389E-02,8.092E-02,18,"Dopamine D1A receptor, MaxiK alpha subunit, cPKC (conventional), PP1-cat, CACNA1C, PKA-reg (cAMP-dependent), G-protein alpha-q/11, ACM1, SHANK, PDE1B, IP3 receptor, CACNA1D, Adenylate cyclase type V, KCNQ3, Calmodulin, PKC, Homer, Guanylate Cyclase 1, soluble",1.574E-02,6.159E-02,22,"MaxiK alpha subunit, PP1-cat, PKA-reg (cAMP-dependent), G-protein alpha-q/11, SHANK, PLC-beta1, PDE1B, IP3 receptor, Adenylate cyclase type V, KCNQ3, Guanylate Cyclase 1, soluble, Dopamine D1A receptor, cPKC (conventional), CACNA1C, ACM1, CACNA1D, Calmodulin, PKC, SK3, Homer, KCNQ2, N-type Ca(II) channel alpha1B",
500,Regulation of VEGF signaling in pancreatic cancer,27,1.586E-02,6.044E-02,1.586E-02,6.044E-02,10,"MEK1(MAP2K1), GRB2, c-Fos, H-Ras, ERK1/2, VEGFR-1, c-Raf-1, STAT3, VEGF-D, SP1",4.212E-01,5.885E-01,7,"GRB2, c-Fos, H-Ras, ERK1/2, VEGF-D, VEGFR-1, SP1",
501,Development_Dopamine-induced transactivation of EGFR in SVZ neural stem cells,31,1.644E-02,6.155E-02,1.644E-02,6.155E-02,11,"MEK1(MAP2K1), EGF, GRB2, c-Fos, G-protein alpha-i family, H-Ras, ERK1/2, c-Raf-1, PKC, PLC-beta, Cyclin D1",1.487E-01,2.853E-01,10,"EGF, GRB2, c-Fos, H-Ras, ERK1/2, PLC-beta, G-protein alpha-i family, c-Jun, PKC, Cyclin D1",
502,"Immune response_Th17, Th22 and Th9 cell differentiation ",39,1.660E-02,6.159E-02,1.660E-02,6.159E-02,13,"PU.1, GATA-3, CD80, MHC class II, ROR-alpha, ROR-gamma, STAT3, AP-1, CD40(TNFRSF5), STAT6, IL-4, IL-6 receptor, CD40L(TNFSF5)",1.588E-01,2.975E-01,12,"MHC class II, NF-AT1(NFATC2), IL-9, IL-4, PU.1, GATA-3, ROR-gamma, AP-1, CD40(TNFRSF5), STAT6, TCR alpha/beta, IL-6 receptor",
503,FGF2 signaling in melanoma,39,1.660E-02,6.159E-02,1.660E-02,6.159E-02,13,"FGFR3, Syndecan-1, GRB2, MMP-1, FGFR4, ERK1/2, FRS2, p21, FGFR1, STAT3, MEK1/2, PAX3, p38 MAPK",1.588E-01,2.975E-01,12,"GRB2, FGFR4, ERK1/2, FRS2, p21, FGFR1, Rac1, PAX3, FGFR3, Syndecan-1, MMP-1, p38 MAPK",
504,Role of alpha-6/beta-4 integrins in carcinoma progression,45,1.668E-02,6.424E-02,5.208E-02,1.394E-01,13,"EGF, AKT1, GAB1, Neuregulin 1, ErbB3, MSP, MSP receptor (RON), PAK1, IP3 receptor, PI3K reg class IA (p85), ErbB2, AKT(PKB), PDK (PDPK1)",1.668E-02,6.424E-02,17,"EGF, AKT1, GAB1, IRS-1, eIF4E, ErbB3, Rac1, IP3 receptor, PI3K reg class IA (p85), ErbB2, AKT(PKB), PDK (PDPK1), MSP, MSP receptor (RON), PAK1, 4E-BP1, Cofilin",
505,Cell adhesion_Histamine H1 receptor signaling in the interruption of cell barrier integrity,45,1.668E-02,6.424E-02,2.444E-02,8.204E-02,14,"E-cadherin, Myosin II, Alpha-actinin, G-protein alpha-q/11, Alpha-catenin, IP3 receptor, Calmodulin, PLC-beta, MRLC, FAK1, Occludin, LIMK2, MELC, MLCK",1.668E-02,6.424E-02,17,"G-protein alpha-q/11, IP3 receptor, PLC-beta, LIMK2, MLCK, E-cadherin, PKC-delta, Myosin II, Alpha-catenin, Paxillin, Calmodulin, MRLC, FAK1, Occludin, MELC, p120-catenin, Cofilin",
506,Autophagy_Autophagy,35,1.685E-02,6.424E-02,2.944E-01,4.507E-01,8,"APG16L1, Rubicon, ULK1, UVRAG, Autophagin-1, Bcl-2, Bcl-XL, Atg101",1.685E-02,6.424E-02,14,"APG16L1, ULK1, BAD, MyD88, Autophagin-1, AMBRA1, Bcl-XL, Atg101, Rubicon, UVRAG, ATG13, Bcl-2, Beclin 1, APG12",
507,Cell adhesion_Alpha-4 integrins in cell migration and adhesion,35,1.685E-02,6.424E-02,1.703E-01,3.058E-01,9,"MAdCAM-1, PAK1, GIT1, PI3K reg class IA (p85), ITGB7, FAK1, ARF6, WASP, GIT2",1.685E-02,6.424E-02,14,"Rac1, GIT1, PI3K reg class IA (p85), ITGB7, ARF6, WASP, BETA-PIX, MAdCAM-1, PAK1, Paxillin, N-WASP, FAK1, GIT2, Cofilin",
508,Neurophysiological process_Ephrin-B receptors in dendritic spine morphogenesis and synaptogenesis,35,1.685E-02,6.424E-02,2.944E-01,4.507E-01,8,"SNAP-25, PAK1, SHANK, GluR2, GABA-A receptor, Kalirin, Synbindin, Cortactin",1.685E-02,6.424E-02,14,"Syntaxin 1A, SHANK, Rac1, NMDA receptor, GABA-A receptor, Kalirin, Synbindin, Cortactin, BETA-PIX, PAK1, GRIP, GluR2, N-WASP, Ephrin-B receptors",
509,Immune response_TREM1 signaling pathway,60,1.713E-02,6.318E-02,1.713E-02,6.318E-02,18,"MEK1(MAP2K1), CARD9, Calcineurin A (catalytic), GRB2, c-Fos, H-Ras, ERK1/2, E2N(UBC13), c-Raf-1, p90RSK1, NFKBIA, IP3 receptor, Ubiquitin, I-kB, PI3K reg class IA, TREM1, AKT(PKB), PDK (PDPK1)",4.034E-02,1.187E-01,20,"CARD9, Calcineurin A (catalytic), GRB2, c-Fos, NF-AT1(NFATC2), H-Ras, ERK1/2, c-Jun/c-Fos, E2N(UBC13), IKK (cat), IP3 receptor, BAD, Ubiquitin, I-kB, PI3K reg class IA, IKK-alpha, TREM1, AKT(PKB), PDK (PDPK1), NFKBIA",
510,Canonical WNT signaling pathway in colorectal cancer,66,1.725E-02,6.513E-02,1.304E-01,2.584E-01,16,"WNT4, Galectin-3, E-cadherin, AKT1, K-RAS, DVL-1, Axin1, p21, Dsh, WIF1, PI3K reg class IA (p85), Mucin 2, WNT, c-Myb, Cyclin D1, Axin",1.725E-02,6.513E-02,23,"Galectin-3, AKT1, DVL-3, Lef-1, DVL-1, Axin1, p21, Dsh, WIF1, Rac1, PI3K reg class IA (p85), c-Myb, c-Myc, Axin, WNT4, E-cadherin, K-RAS, WNT1, SFRP4, Mucin 2, WNT, Cyclin D1, Frizzled",
511,Signal transduction_Additional pathways of NF-kB activation (in the cytoplasm),52,1.725E-02,6.513E-02,7.579E-02,1.792E-01,14,"AKT1, ERK1/2, TBK1, PKA-reg (cAMP-dependent), c-Raf-1, p90RSK1, NFKBIA, I-kB, PRKD1, PI3K reg class IA, Adenylate cyclase, IKK-beta, AKT(PKB), PDK (PDPK1)",1.725E-02,6.513E-02,19,"AKT1, ERK1/2, TBK1, PKC-zeta, PKA-reg (cAMP-dependent), IKK (cat), I-kB, PI3K reg class IA, IKK-alpha, Adenylate cyclase, AKT(PKB), PDK (PDPK1), PKC-delta, NFKBIA, PRKD1, MEKK1(MAP3K1), IKK-beta, AKT2, PI3K reg class IB (p101)",
512,Airway smooth muscle contraction in asthma,56,1.793E-02,6.583E-02,1.793E-02,6.583E-02,17,"Phospholamban, G-protein alpha-i family, CACNA1C, Myosin II, PKA-reg (cAMP-dependent), BDKRB2, G-protein alpha-q/11, MyHC, IP3 receptor, G-protein alpha-s, Calmodulin, PLC-beta, Adenylate cyclase, MRLC, MELC, CysLT1 receptor, MLCK",6.920E-02,1.679E-01,18,"LARG, PKA-reg (cAMP-dependent), BDKRB2, G-protein alpha-q/11, IP3 receptor, PLC-beta, Adenylate cyclase, CysLT1 receptor, MLCK, G-protein alpha-i family, CACNA1C, Myosin II, MyHC, Bradykinin, G-protein alpha-s, Calmodulin, MRLC, MELC",
513,Epithelial cell apoptosis in COPD,32,1.821E-02,6.753E-02,2.104E-02,7.261E-02,11,"eIF2AK3, Prohibitin, NIP3, I-kB, PSMA1, Bcl-2, Bcl-XL, SP-C, AKT(PKB), NQO1, PUMA",1.821E-02,6.753E-02,13,"Prohibitin, NIP3, BAD, I-kB, Bcl-XL, AKT(PKB), PUMA, eIF2AK3, DJ-1, PSMA1, Bcl-2, SP-C, NQO1",
514,Interleukins-induced inflammatory signaling in normal and asthmatic airway epithelium,32,1.821E-02,6.753E-02,3.582E-01,5.226E-01,7,"ERK1/2, IL6RA, IFN-alpha, IL-1RI, IL-4, p38 MAPK, IL-6 receptor",1.821E-02,6.753E-02,13,"ERK1/2, MyD88, IFN-alpha, IL-13, IL-1RI, IL-4, IL-25 (IL-17E), c-Jun, CXCR3, IL6RA, IL-16, p38 MAPK, IL-6 receptor",
515,Immune response_PIP3 signaling in B lymphocytes,42,1.829E-02,6.753E-02,6.524E-02,1.613E-01,12,"CD19, Btk, p90Rsk, IP3 receptor, p70 S6 kinase1, PI3K reg class IA, PLC-beta, PTEN, Fc gamma RII beta, AKT(PKB), PDK (PDPK1), PREX1",1.829E-02,6.753E-02,16,"CD19, Rac1, IP3 receptor, PI3K reg class IA, PLC-beta, SHIP, AKT(PKB), PDK (PDPK1), CD79 complex, Btk, p70 S6 kinase1, PTEN, FOXO3A, Fc gamma RII beta, PI3K reg class IB (p101), PREX1",
516,Development_Growth hormone signaling via PI3K/AKT and MAPK cascades,42,1.829E-02,6.753E-02,3.076E-02,9.615E-02,13,"MEK1(MAP2K1), p38alpha (MAPK14), Tuberin, GRB2, c-Fos, JunB, H-Ras, c-Raf-1, GHR, p70 S6 kinase1, FAK1, SHP-1, AKT(PKB)",1.829E-02,6.753E-02,16,"Tuberin, GRB2, c-Fos, IRS-1, H-Ras, EGR1, SHP-1, AKT(PKB), MEKK4(MAP3K4), JunB, c-Jun, GHR, 4E-BP1, p70 S6 kinase1, SHP-2, FAK1",
517,ATP/ITP metabolism,123,1.838E-02,6.722E-02,1.838E-02,6.722E-02,32,"RRP41, RPOM, NDPK C, NDPK complex, ENTPD2-alpha, RPB8, RPB10, POLR3B, RPB7.0, NDPK 6, POLR3A, AMP deaminase, KAD6, AMP deaminase 1, POLR1B, 5'-NTC, CSL4, EPHX2, RRM2B, NDPK A, ENTPD6, RRP46, PPAL, NDPK D (mitochondrial), ENP3, POLR2I, Adenosine kinase, ENP1, POLR3K, APRT, Small RR subunit, NDPK B",8.383E-02,1.934E-01,35,"RPOM, NDPK complex, RPB8, PR44 (DIS3), POLR3B, NDPK 6, KAD6, POLR1B, 5'-NTC, CSL4, EPHX2, RPB5, ENTPD6, RRP46, PPAL, ADAR3, ENP1, POLR3K, APRT, AK1, RRP41, NDPK C, ENTPD2-alpha, RPB10, RPB7.0, POLR3A, RRP4, RRM2B, NDPK A, NDPK D (mitochondrial), ENP3, POLR2I, Adenosine kinase, Small RR subunit, NDPK B",
518,HBV mediates angiogenesis in HCC,20,1.840E-02,6.722E-02,1.840E-02,6.722E-02,8,"MEK1(MAP2K1), GRB2, H-Ras, ERK1/2, c-Raf-1, STAT3, FAK1, MTA1",4.928E-01,6.613E-01,5,"GRB2, H-Ras, ERK1/2, MTA1, FAK1",
519,SLE genetic marker-specific pathways in B cells,99,1.855E-02,6.829E-02,7.671E-02,1.802E-01,24,"IRF8, STAT2, GRB2, TRAF2, XBP1, H-Ras, ERK1/2, BLNK, c-Raf-1, p67-phox, Btk, IP3 receptor, BANK, IFN-alpha, Aiolos, IRF5, Bcl-2, RIFK, IP3R1, Fc gamma RII beta, MEK1/2, SHP-1, IRE1, p27KIP1",1.855E-02,6.829E-02,32,"Cyclin D3, GRB2, XBP1, H-Ras, ERK1/2, Bak, Rac1, IP3 receptor, SOD1, IFN-alpha, Aiolos, RIFK, CD22, SHP-1, IRE1, p27KIP1, c-Myc, ATF-6 beta, STAT2, Ikaros, PKC-delta, TRAF2, BLNK, CD79 complex, Btk, IL-5 receptor, BANK, IRF5, Bcl-2, IP3R1, Fc gamma RII beta, JIK",
520,Th2 cytokine- and TNF-alpha-induced profibrotic response in asthmatic airway fibroblasts/ myofibroblasts,52,1.871E-02,6.803E-02,1.871E-02,6.803E-02,16,"GRB2, MMP-1, ERK1/2, BDKRB1, c-Raf-1, COX-1 (PTGS1), AP-1, MEK1/2, IL13RA2, JNK(MAPK8-10), STAT6, IL-4, ABCC5, AKT(PKB), SP1, p38 MAPK",6.597E-02,1.625E-01,17,"TrkA, GRB2, ERK1/2, BDKRB1, c-Jun/c-Fos, IL-13, IL-4, AKT(PKB), MMP-1, c-Jun, AP-1, JNK(MAPK8-10), STAT6, ABCC5, SP1, p38 MAPK, des-Arg10-kallidin",
521,IGF signaling in HCC,52,1.871E-02,6.803E-02,1.871E-02,6.803E-02,16,"MEK1(MAP2K1), IRS-4, GRB2, c-Fos, H-Ras, ERK1/2, c-Raf-1, PI3K reg class IA (p85), Amphiregulin, PKC, IGF-1 receptor, RKIP, AKT(PKB), SP1, IGF-1, PDK (PDPK1)",3.499E-02,1.057E-01,18,"GRB2, c-Fos, IRS-1, H-Ras, ERK1/2, EGR1, PI3K reg class IA (p85), Amphiregulin, IGF-1 receptor, AKT(PKB), PDK (PDPK1), IRS-4, c-Jun, PKC, FOXO3A, RKIP, SP1, IGF-1",
522,Cytoskeleton remodeling_RalB regulation pathway,13,1.894E-02,6.870E-02,1.894E-02,6.870E-02,6,"REPS1, REPS2, H-Ras, RalGDS, RGL3, Calmodulin",5.396E-02,1.424E-01,6,"REPS1, REPS2, H-Ras, RalGDS, RGL3, Calmodulin",
523,Cell cycle_Role of SCF complex in cell cycle regulation,29,1.959E-02,7.142E-02,2.666E-02,8.548E-02,10,"E2F1, beta-TrCP, NEDD8, p21, Ubiquitin, Wee1, p130, Skp2/TrCP/FBXW, Cyclin D1, p27KIP1",1.959E-02,7.142E-02,12,"NEDD8, p21, Ubiquitin, Wee1, CDC34, p130, Skp2/TrCP/FBXW, p27KIP1, E2F1, beta-TrCP, UBE1, Cyclin D1",
524,Bone metastases in Prostate Cancer,29,1.959E-02,7.142E-02,2.666E-02,8.548E-02,10,"G-protein alpha-i family, CCR2, PTHR1, Kallikrein 3 (PSA), ErbB2, WNT, Bone sialoprotein, IGF-1 receptor, IGF-1, SDF-1",1.959E-02,7.142E-02,12,"CCR2, PTHR1, Kallikrein 3 (PSA), ErbB2, Bone sialoprotein, LRP5, IGF-1 receptor, SDF-1, G-protein alpha-i family, WNT, IGF-1, Frizzled",
525,Development_Dopamine D2 receptor transactivation of EGFR,24,1.994E-02,7.179E-02,1.994E-02,7.179E-02,9,"MEK1(MAP2K1), GRB2, G-protein alpha-i family, H-Ras, c-Raf-1, PI3K reg class IA, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3)",2.970E-01,4.586E-01,7,"GRB2, H-Ras, PI3K reg class IA, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), G-protein alpha-i family",
526,Development_Signaling of Beta-adrenergic receptors via Beta-arrestins,24,1.994E-02,7.179E-02,1.994E-02,7.179E-02,9,"MEK1(MAP2K1), H-Ras, ERK1/2, GRK4, c-Raf-1, PDE4D, Clathrin, Beta-arrestin1, GRK2",2.970E-01,4.586E-01,7,"H-Ras, ERK1/2, PDE4D, GRK2, GRK4, Clathrin, Beta-arrestin1",
527,Prolactin/ JAK2 signaling in breast cancer,24,1.994E-02,7.179E-02,1.994E-02,7.179E-02,9,"GAB1, HSP90 alpha, PAK1, Prolactin receptor, STAT3, CISH, CAML, c-Myb, Cyclin D1",3.043E-02,9.511E-02,10,"GAB1, HSP90 alpha, Prolactin receptor, CISH, c-Myb, Cyclophilin A, PAK1, SHP-2, CAML, Cyclin D1",
528,HIV-1 signaling via CCR5 in macrophages and T lymphocytes,39,2.004E-02,7.219E-02,4.127E-01,5.790E-01,8,"Calcineurin A (catalytic), GRB2, H-Ras, IP3 receptor, Calmodulin, JNK(MAPK8-10), CCR5, p38 MAPK",2.004E-02,7.219E-02,15,"Calcineurin A (catalytic), GRB2, NF-AT1(NFATC2), H-Ras, PLC-beta1, Rac1, IP3 receptor, CCR5, FasL(TNFSF6), MEKK4(MAP3K4), c-Jun, Calmodulin, G-protein alpha-q, JNK(MAPK8-10), p38 MAPK",
529,Apoptosis and survival_Ubiquitination and phosphorylation in TNF-alpha-induced NF-kB signaling,39,2.004E-02,7.219E-02,1.557E-01,2.885E-01,10,"TRAF2, E2N(UBC13), TRADD, Casein kinase I alpha, NFKBIA, Ubiquitin, Zibra, IKK-beta, Sharpin, TAB2",2.004E-02,7.219E-02,15,"E2N(UBC13), TRADD, Casein kinase I alpha, Ubiquitin, Sharpin, TAB2, UEV1A, PKC-delta, TRAF2, NFKBIA, Zibra, RBCK1, IKK-beta, TAB1, LUBAC E3 ligase",
530,Chemotaxis_C5a-induced chemotaxis,44,2.009E-02,7.199E-02,2.009E-02,7.199E-02,14,"C5aR, p38alpha (MAPK14), G-protein alpha-i family, ERK1/2, c-Raf-1, PAK1, IP3 receptor, MAPKAPK2, PLC-beta, HSP27, MEK1/2, WASP, GIT2, PREX1",1.850E-01,3.329E-01,13,"ERK1/2, Rac1, IP3 receptor, MAPKAPK2, PLC-beta, WASP, C5aR, CALDAG-GEFI, G-protein alpha-i family, PAK1, HSP27, GIT2, PREX1",
531,Induction of mucin secretion in  airway goblet cells by purinergic receptors,61,2.029E-02,7.253E-02,2.029E-02,7.253E-02,18,"SNAP-25, Protein kinase G, CFTR, PP2A regulatory, KCNQ1, MUNC13-2, G-protein alpha-q/11, MUNC13, NFKBIA, IP3 receptor, PLC-beta, Csp, Syntaxin 3, P2Y2, IKK-beta, Guanylate Cyclase 1, soluble, HSP70, MYO5C",2.552E-02,8.368E-02,21,"PP2A regulatory, KCNQ1, IKK (cat), MUNC13-2, G-protein alpha-q/11, Syntaxin 1A, MUNC13, IP3 receptor, PLC-beta, Csp, Guanylate Cyclase 1, soluble, Syntaxin 4, HSP70, MUNC18, PKC-delta, Protein kinase G, NFKBIA, Syntaxin 3, P2Y2, IKK-beta, MYO5C",
532,CAR-mediated direct regulation of xenobiotic metabolizing enzymes / Rodent version,40,2.062E-02,7.261E-02,2.062E-02,7.261E-02,13,"CYP2C8, CAR/RXR-alpha, CYP3A5, RXRA, SHP, CYP2A13, CYP1A2, CAR, MRP3, ACOX1, CYP3A4, NQO1, ABCC2",1.038E-01,2.229E-01,13,"CYP3A5, CYP2A13, CYP1A2, CAR, CYP2C19, ACOX1, CAR/RXR-alpha, RXRA, CYP2E1, CYP2B6, MRP3, NQO1, ABCC2",
533,Neurophysiological process_Netrin-1 in regulation of axon guidance,40,2.062E-02,7.261E-02,2.062E-02,7.261E-02,13,"Protein kinase G1, Calcineurin A (catalytic), PP1-cat, SAC, CACNA1C, PKA-reg (cAMP-dependent), PAK1, IP3 receptor, UNC5B, Calmodulin, Netrin-1, FAK1, Dcc",2.547E-02,8.368E-02,15,"Protein kinase G1, Calcineurin A (catalytic), PP1-cat, SAC, PKA-reg (cAMP-dependent), Rac1, IP3 receptor, UNC5B, Netrin-1, Dcc, CACNA1C, PAK1, Calmodulin, N-WASP, FAK1",
534,Role of Ghrelin in activation eating behavior in obesity,40,2.062E-02,7.261E-02,2.062E-02,7.261E-02,13,"ACACA, Ghrelin, G-protein alpha-11, AMPK alpha subunit, PKA-reg (cAMP-dependent), UCP2, G-protein alpha-q/11, IP3 receptor, CPT-1A, Adenylate cyclase type II, Calmodulin, PLC-beta, CaMKK2",5.385E-02,1.424E-01,14,"Ghrelin, PKA-reg (cAMP-dependent), UCP2, G-protein alpha-q/11, IP3 receptor, CPT-1A, Adenylate cyclase type II, PLC-beta, BSX, G-protein alpha-11, AMPK alpha subunit, Calmodulin, N-type Ca(II) channel alpha1B, CaMKK2",
535,Neurophysiological process_GABA-B receptor signaling in presynaptic nerve terminals,28,2.075E-02,7.261E-02,2.075E-02,7.261E-02,10,"SNAP-25, G-protein alpha-i family, Adenylate cyclase type VI, Adenylate cyclase type I, MUNC13-1, Synaptotagmin I, GBR2, Adenylate cyclase type V, Calmodulin, RIMS1",3.716E-02,1.111E-01,11,"Adenylate cyclase type VI, Syntaxin 1A, Synaptotagmin I, Adenylate cyclase type V, RIMS1, MUNC18, G-protein alpha-i family, Adenylate cyclase type I, GBR2, Calmodulin, N-type Ca(II) channel alpha1B",
536,Development_Regulation of CDK5 in CNS,28,2.075E-02,7.261E-02,2.075E-02,7.261E-02,10,"MEK1(MAP2K1), Dopamine D1A receptor, GRB2, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, Adenylate cyclase type V, G-protein alpha-s, FosB",8.433E-02,1.934E-01,10,"TrkA, GRB2, H-Ras, ERK1/2, EGR1, PKA-reg (cAMP-dependent), Adenylate cyclase type V, Dopamine D1A receptor, G-protein alpha-s, FosB",
537,Th1 and Th17 cells in an autoimmune mechanism of emphysema formation in smokers,28,2.075E-02,7.261E-02,2.075E-02,7.261E-02,10,"MIG, CD1a, CD80, MHC class II, ROR-alpha, ROR-gamma, CCR6, ITGAX, Alpha 1-antitrypsin, CCR5",2.969E-01,4.586E-01,8,"MHC class II, ITGAX, Alpha 1-antitrypsin, CCR5, ROR-gamma, CCR6, CXCR3, TCR alpha/beta",
538,Development_Beta adrenergic receptors in brown adipocyte differentiation,36,2.096E-02,7.261E-02,2.096E-02,7.261E-02,12,"A-FABP, SCD, PKA-reg (cAMP-dependent), LIPS, FASN, KLF4, Factor D, G-protein alpha-s, Adenylate cyclase, MEK6(MAP2K6), PPCKM, p38 MAPK",4.885E-02,1.326E-01,13,"SCD, PKA-reg (cAMP-dependent), GLUT4, FASN, KLF4, PRKAR1A, Adenylate cyclase, MEK6(MAP2K6), PPCKM, LIPS, Factor D, G-protein alpha-s, p38 MAPK",
539,E-cadherin signaling and its regulation in gastric cancer,36,2.096E-02,7.261E-02,2.096E-02,7.261E-02,12,"DNMT3B, E-cadherin, Formin, EGF, GRB2, Alpha-actinin, Dsh, Alpha-catenin, Ubiquitin, WNT, VAV-3, Plakoglobin",2.192E-02,7.602E-02,14,"DNMT3B, EGF, GRB2, Dsh, Actin, Ubiquitin, E-cadherin, Formin, Alpha-catenin, WNT, VAV-3, Plakoglobin, p120-catenin, Frizzled",
540,Role of IL-8 in melanoma,36,2.096E-02,7.261E-02,2.096E-02,7.261E-02,12,"MEK1(MAP2K1), E-cadherin, ZFP36(Tristetraprolin), G-protein alpha-i family, ERK1/2, ITGAM, IL8RA, NFKBIA, Vitronectin, AKT(PKB), p38 MAPK, IL8RB",9.836E-02,2.137E-01,12,"ERK1/2, IKK (cat), AKT(PKB), IL8RB, E-cadherin, ZFP36(Tristetraprolin), G-protein alpha-i family, ITGAM, IL8RA, NFKBIA, Vitronectin, p38 MAPK",
541,Development_SSTR2 in regulation of cell proliferation,36,2.096E-02,7.261E-02,2.096E-02,7.261E-02,12,"MEK1(MAP2K1), SSTR2, G-protein alpha-i family, H-Ras, ERK1/2, PI3K reg class IA (p85), Rb protein, SHP-1, Guanylate Cyclase 1, soluble, AKT(PKB), PDK (PDPK1), p27KIP1",4.885E-02,1.326E-01,13,"SSTR2, H-Ras, ERK1/2, PI3K reg class IA (p85), Rb protein, SHP-1, Guanylate Cyclase 1, soluble, AKT(PKB), PDK (PDPK1), p27KIP1, G-protein alpha-i family, Somatostatin, SHP-2",
542,"Development_TGF-beta-dependent induction of EMT via RhoA,  PI3K and ILK",46,2.098E-02,7.467E-02,1.156E-01,2.398E-01,12,"E-cadherin, H-Ras, MKL2, ILK, I-kB, PI3K reg class IA (p85), TGF-beta 3, Occludin, PARD6A, LIMK2, AKT(PKB), PDK (PDPK1)",2.098E-02,7.467E-02,17,"H-Ras, Lef-1, IKK (cat), Actin, I-kB, PI3K reg class IA (p85), IKK-alpha, LIMK2, AKT(PKB), PDK (PDPK1), E-cadherin, MKL2, ILK, TGF-beta 3, Occludin, PARD6A, Cofilin",
543,Signal transduction_ERK1/2 signaling pathway,32,2.104E-02,7.261E-02,2.104E-02,7.261E-02,11,"MEK1(MAP2K1), cAMP-GEFI, GRB2, K-RAS, H-Ras, ERK1/2, c-Raf-1, MEK1/2, PKC-gamma, ERK1 (MAPK3), GRB10",9.195E-02,2.069E-01,11,"cAMP-GEFI, GRB2, H-Ras, ERK1/2, A-Raf-1, SHC4, PKC-gamma, ERK1 (MAPK3), K-RAS, PKC-delta, GRB10",
544,Mechanisms of drug resistance in SCLC,70,2.127E-02,7.320E-02,2.127E-02,7.320E-02,20,"CD81, TERC, ERK1/2, CD9, Cytochrome c, MGF, HSPA1A, p70 S6 kinase1, PI3K reg class IA, Bcl-2, FAK1, Bcl-XL, IGF-1 receptor, Cyclin D1, ABCC5, AKT(PKB), HSP70, IGF-1, PDK (PDPK1), p70 S6 kinase2",3.456E-02,1.046E-01,23,"CD81, ERK1/2, Cytochrome c, Rad51, BAD, PI3K reg class IA, IKK-alpha, Bcl-XL, IGF-1 receptor, AKT(PKB), HSP70, PDK (PDPK1), CD9, MGF, HSPA1A, HSF1, p70 S6 kinase1, Bcl-2, FAK1, Cyclin D1, ABCC5, IGF-1, p70 S6 kinase2",
545,Chemotaxis_Inhibitory action of lipoxins on IL-8- and Leukotriene B4-induced neutrophil migration,53,2.129E-02,7.506E-02,8.655E-02,1.967E-01,14,"G-protein alpha-i family, ERK1/2, Myosin II, Alpha-actinin, PAK1, LTBR1, IL8RA, PIP5KI, MRLC, AKT(PKB), MELC, PDK (PDPK1), MLCK, PREX1",2.129E-02,7.506E-02,19,"ERK1/2, PKC-zeta, Actin, Rac1, AKT(PKB), PDK (PDPK1), MLCK, G-protein alpha-i family, Myosin II, PAK1, LTBR1, IL8RA, PIP5KI, Actomyosin, MRLC, MELC, PI3K reg class IB (p101), Cofilin, PREX1",
546,Chemotaxis_CCR1 signaling,53,2.129E-02,7.506E-02,2.242E-02,7.682E-02,16,"G-protein alpha-i family, ERK1/2, c-Raf-1, CCR1, IP3 receptor, STAT3, I-kB, Calmodulin, PLC-beta, cPLA2, Adenylate cyclase, IKK-beta, MEK1/2, G-protein alpha-14, p38 MAPK, IL-6 receptor",2.129E-02,7.506E-02,19,"ERK1/2, CCR1, IKK (cat), Rac1, IP3 receptor, I-kB, CCL13, PLC-beta, IKK-alpha, cPLA2, Adenylate cyclase, G-protein alpha-14, PKC-delta, G-protein alpha-i family, Calmodulin, IKK-beta, PI3K reg class IB (p101), p38 MAPK, IL-6 receptor",
547,Signal transduction_Angiotensin II/ AGTR1 signaling via RhoA and JNK,78,2.147E-02,7.554E-02,2.388E-01,3.896E-01,17,"PU.1, G-protein alpha-12 family, c-Fos, ERK1/2, AGTR1, PAK1, G-protein alpha-q/11, IP3 receptor, AP-1, Calmodulin, EPHX2, MRLC, eNOS, FAK1, Cyclin D1, JNK(MAPK8-10), MLCK",2.147E-02,7.554E-02,26,"c-Fos, LARG, ERK1/2, c-Jun/c-Fos, G-protein alpha-q/11, PLC-beta1, Rac1, IP3 receptor, EPHX2, MLCK, PU.1, G-protein alpha-12 family, PKC-delta, c-Jun, AGTR1, PAK1, MKK7 (MAP2K7), Paxillin, AP-1, Calmodulin, MEKK1(MAP3K1), MRLC, eNOS, FAK1, Cyclin D1, JNK(MAPK8-10)",
548,Regulation of lipid metabolism_Insulin regulation of fatty acid metabolism,89,2.166E-02,7.601E-02,2.504E-02,8.354E-02,24,"MEK1(MAP2K1), ACACA, SREBP1 (nuclear), GRB2, Insulin processed, PDE3B, SCD, CISY, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, LIPS, FASN, SREBP1 (Golgi membrane), SREBP1 precursor, ACLY, PI3K reg class IA, Insulin receptor, SCAP, AKT(PKB), SP1, PDK (PDPK1), Perilipin",2.166E-02,7.601E-02,29,"SREBP1 (nuclear), GRB2, Insulin processed, PDE3B, SCD, CISY, IRS-1, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), GLUT4, FASN, SREBP1 precursor, INSIG2, PDH, PI3K reg class IA, Insulin receptor, AKT(PKB), PDK (PDPK1), ACSL1, LIPS, PDHA (somatic), SREBP1 (Golgi membrane), ACLY, PDH alpha, SCAP, AKT2, SP1, Perilipin",
549,WNT signaling in gastric cancer,36,2.192E-02,7.602E-02,1.928E-01,3.318E-01,9,"WNT9A, beta-TrCP, Dsh, Casein kinase I alpha, Ubiquitin, WNT, Skp2/TrCP/FBXW, Cyclin D1, Axin",2.192E-02,7.602E-02,14,"WNT3A, Dsh, Casein kinase I alpha, Ubiquitin, Skp2/TrCP/FBXW, Axin, WNT9A, Tcf(Lef), beta-TrCP, WNT1, WNT, WNT10B, Cyclin D1, Frizzled",
550,G-protein signaling_Regulation of RAC1 activity,36,2.192E-02,7.602E-02,1.928E-01,3.318E-01,9,"ACK1, H-Ras, CD19, VIL2 (ezrin), RhoGAP1, CD3, VAV-2, DBL, p200RhoGAP",2.192E-02,7.602E-02,14,"SRGAP2(WRP), ACK1, H-Ras, CD19, Rac1, VIL2 (ezrin), RhoGAP1, ZAP70, VAV-2, B-chimaerin, RhoGDI beta, DBL, p200RhoGAP, TCR alpha/beta",
551,CHDI_Correlations from Discovery data_Causal network (positive),36,2.192E-02,7.602E-02,1.928E-01,3.318E-01,9,"gp130, GRB2, STAT3, PI3K reg class IA (p85), GABA-A receptor, Kalirin, IFN-alpha, Angiopoietin 3, FAK1",2.192E-02,7.602E-02,14,"gp130, GRB2, Actin, Rac1, PI3K reg class IA (p85), GABA-A receptor, Kalirin, IFN-alpha, Angiopoietin 3, Paxillin, SHP-2, N-WASP, FAK1, Ephrin-B receptors",
552,Non-genomic signaling of ESR2 (membrane) in lung cancer cells,53,2.242E-02,7.682E-02,2.242E-02,7.682E-02,16,"MEK1(MAP2K1), EGF, GRB2, G-protein alpha-i family, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, ESR2 (membrane), PI3K reg class IA (p85), Amphiregulin, G-protein alpha-s, Adenylate cyclase, nAChR alpha-4, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3)",1.322E-01,2.614E-01,16,"EGF, GRB2, ERK1/2, PKA-reg (cAMP-dependent), PI3K reg class IA (p85), Amphiregulin, Adenylate cyclase, nAChR alpha-4, CYP19, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), nAChR alpha4/beta2, G-protein alpha-i family, ESR2 (membrane), G-protein alpha-s",
553,LRRK2 in neuronal apoptosis in Parkinson's disease,17,2.283E-02,7.787E-02,2.283E-02,7.787E-02,7,"PRDX3, KCRU, AKT1, LRRK2, Cytochrome c, FADD, ANT",2.377E-02,7.967E-02,8,"PRDX3, AKT1, Cytochrome c, FADD, ANT, Thioredoxin, KCRU, LRRK2",
554,Involvement of VEGF signaling in the progression of lung cancer,17,2.283E-02,7.787E-02,2.283E-02,7.787E-02,7,"ERK1/2, p190RhoGAP, VEGFR-1, VEGF-D, AKT(PKB), p38 MAPK, C/EBPalpha",7.053E-02,1.695E-01,7,"ERK1/2, VEGF-D, AKT(PKB), p190RhoGAP, VEGFR-1, p38 MAPK, C/EBPalpha",
555,CHDI_Correlations from Replication data_Cytoskeleton and adhesion module,64,2.300E-02,7.874E-02,2.621E-01,4.228E-01,14,"MHC class II, GRB2, Alpha-actinin, PAK1, MyHC, ILK, IP3 receptor, CD3, MRLC, FAK1, WASP, AKT(PKB), MELC, SDF-1",2.300E-02,7.874E-02,22,"MHC class II, GRB2, Rac1, IP3 receptor, Plasminogen, ZAP70, WASP, AKT(PKB), SDF-1, CALDAG-GEFI, Plasmin, PAK1, C3G, MyHC, ILK, Paxillin, MRLC, FAK1, MELC, PI3K reg class IB (p101), TCR alpha/beta, Ephrin-B receptors",
556,Apoptosis and survival_Anti-apoptotic action of Gastrin,43,2.312E-02,7.874E-02,3.700E-02,1.097E-01,13,"MEK1(MAP2K1), ERK1/2, c-Raf-1, PAK1, G-protein alpha-q/11, IP3 receptor, PI3K reg class IA (p85), Bcl-2, FAK1, Bcl-XL, PKC-gamma, AKT(PKB), PDK (PDPK1)",2.312E-02,7.874E-02,16,"IRS-1, ERK1/2, G-protein alpha-q/11, Rac1, IP3 receptor, BAD, PI3K reg class IA (p85), Bcl-XL, PKC-gamma, AKT(PKB), PDK (PDPK1), CCKBR, PAK1, Bcl-2, FAK1, G-protein alpha-q",
557,Immune response_Substance P-stimulated expression of proinflammatory cytokines via MAPKs,43,2.312E-02,7.874E-02,7.618E-02,1.792E-01,12,"Substance P extracellular region, ERK1/2, c-Raf-1, IP3 receptor, I-kB, PLC-beta, IKK-beta, MEK1/2, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1), p38 MAPK",2.312E-02,7.874E-02,16,"Substance P extracellular region, ERK1/2, IKK (cat), IP3 receptor, I-kB, CCL13, PLC-beta, IKK-alpha, AKT(PKB), PDK (PDPK1), PKC-delta, c-Jun, IKK-beta, G-protein alpha-q, JNK(MAPK8-10), p38 MAPK",
558,Tissue Factor signaling in cancer via PAR1 and PAR2,49,2.346E-02,7.983E-02,2.346E-02,7.983E-02,15,"MEK1(MAP2K1), EGF, G-protein alpha-12 family, GRB2, H-Ras, ERK1/2, c-Raf-1, G-protein alpha-q/11, Coagulation factor VII, IP3 receptor, p70 S6 kinase1, PI3K reg class IA, Bcl-XL, AKT(PKB), Beta-arrestin1",3.893E-02,1.152E-01,17,"EGF, GRB2, H-Ras, ERK1/2, EGR1, G-protein alpha-q/11, Coagulation factor VII, PLC-beta1, IP3 receptor, PI3K reg class IA, Bcl-XL, AKT(PKB), G-protein alpha-12 family, c-Jun, p70 S6 kinase1, SHP-2, Beta-arrestin1",
559,Cytoskeleton remodeling_FAK signaling,57,2.346E-02,7.952E-02,4.291E-02,1.205E-01,16,"MEK1(MAP2K1), GRB2, H-Ras, ERK1/2, p190RhoGAP, c-Raf-1, PAK1, G-protein alpha-q/11, IP3 receptor, GRP-R, Calmodulin, PI3K reg class IA, PLC-beta, PTEN, FAK1, AKT(PKB)",2.346E-02,7.952E-02,20,"Cyclin D3, GRB2, H-Ras, ERK1/2, G-protein alpha-q/11, Rac1, IP3 receptor, GRP-R, PI3K reg class IA, PLC-beta, AKT(PKB), p190RhoGAP, PAK1, C3G, MKK7 (MAP2K7), Paxillin, Calmodulin, PTEN, MEKK1(MAP3K1), FAK1",
560,Immune response_Role of PKR in stress-induced antiviral cell response,57,2.346E-02,7.952E-02,1.387E-01,2.707E-01,14,"p38alpha (MAPK14), TRAF2, ERK1/2, TIRAP (Mal), NFKBIA, I-kB, TARBP2, IFN-alpha, IKK-beta, MEK6(MAP2K6), IL-1RI, JNK(MAPK8-10), IRF3, TAB2",2.346E-02,7.952E-02,20,"ERK1/2, IKK (cat), I-kB, MyD88, IKK-alpha, IFN-alpha, MEK6(MAP2K6), IL-1RI, TAB2, c-Myc, TRAF2, c-Jun, TIRAP (Mal), NFKBIA, Caspase-7, TARBP2, IKK-beta, JNK(MAPK8-10), IRF3, TRIF (TICAM1)",
561,IgE- and MGF-induced Lyn-mediated production of cytokines and arachidonic acid metabolites in lung mast cells in asthma,50,2.355E-02,7.960E-02,5.698E-02,1.450E-01,14,"Calcineurin A (catalytic), GRB2, K-RAS, ERK1/2, c-Raf-1, MGF, Btk, IP3 receptor, I-kB, cPLA2, MEK1/2, IL-4, AKT(PKB), p38 MAPK",2.355E-02,7.960E-02,18,"Calcineurin A (catalytic), GRB2, NF-AT1(NFATC2), ERK1/2, IL-3, IP3 receptor, I-kB, IKK-alpha, cPLA2, IL-13, IL-4, AKT(PKB), K-RAS, c-Jun, MGF, LAT, Btk, p38 MAPK",
562,HBV regulation of DNA repair and apoptosis leading to HCC,14,2.359E-02,7.960E-02,2.816E-02,8.970E-02,6,"MAZ, p21, DDB2, MDM2, AFP, SP1",2.359E-02,7.960E-02,7,"p21, MDM2, MAZ, DDB1, DDB2, SP1, XPD",
563,Transcription_Transcription factor Tubby signaling pathways,17,2.377E-02,7.967E-02,7.150E-02,1.715E-01,6,"Insulin processed, G-protein alpha-11, G-protein alpha-q/11, PKC, PLC-beta, Insulin receptor",2.377E-02,7.967E-02,8,"Insulin processed, G-protein alpha-q/11, PLC-beta, HTR2C (HTR1C), Insulin receptor, G-protein alpha-11, PKC, G-protein alpha-q",
564,Prolactin signaling in Prostate Cancer,33,2.392E-02,7.999E-02,3.904E-01,5.570E-01,7,"PIP, AATM, Prolactin receptor, Androgen receptor, AP-1, Bcl-XL, Cyclin D1",2.392E-02,7.999E-02,13,"PIP, c-Jun/c-Fos, Prolactin receptor, Androgen receptor, PDH, Bcl-XL, c-Jun, PDHA (somatic), AATM, AP-1, PDH alpha, ACON, Cyclin D1",
565,Aminoglycoside- and cisplatin-induced hair cell death,112,2.404E-02,8.021E-02,6.729E-02,1.651E-01,27,"SLC31A1, PRDX3, Calcineurin A (catalytic), Aif, c-Fos, SMPD3, H-Ras, ERK1/2, NF-AT3(NFATC4), p67-phox, Cytochrome c, TRPV1, Endonuclease G, AP-1, Sirtuin1, PKC, NOX3, Bcl-2, Bcl-XL, NOL3, JNK(MAPK8-10), STAT6, IL-4, NOX1, PUMA, p38 MAPK, Cathepsin D",2.404E-02,8.021E-02,35,"SLC31A1, PRDX3, Calcineurin A (catalytic), c-Fos, SMPD3, H-Ras, ERK1/2, NF-AT3(NFATC4), c-Jun/c-Fos, Cytochrome c, TRPV1, Endonuclease G, Rac1, NOX3, IL-13, Bcl-XL, FasL(TNFSF6), IL-4, NOX1, PUMA, Cathepsin D, PARP-1, Aif, c-Jun, KCNQ4, MKK7 (MAP2K7), AP-1, Sirtuin1, PKC, Bcl-2, ACON, NOL3, JNK(MAPK8-10), STAT6, p38 MAPK",
566,Differentiation of Th2 cells in asthma,45,2.444E-02,8.204E-02,2.444E-02,8.204E-02,14,"CCL22, CD80, MHC class II, CCL17, CCR2, CCR6, NFKBIA, PI3K reg class IA, CD3, CCR5, STAT6, IL-4, AKT(PKB), PDK (PDPK1)",6.973E-02,1.690E-01,15,"CCL22, MHC class II, CCL17, CCR2, PI3K reg class IA, IKK-alpha, CCR5, IL-4, AKT(PKB), PDK (PDPK1), CCR6, NFKBIA, CXCR3, STAT6, TCR alpha/beta",
567,HCV-dependent transcription regulation leading to HCC,21,2.511E-02,8.354E-02,2.511E-02,8.354E-02,8,"E2F1, p21, HSPA1A, STAT3, Rb protein, Bcl-XL, Cyclin D1, HSP70",1.833E-01,3.306E-01,7,"p21, Rb protein, Bcl-XL, HSP70, E2F1, HSPA1A, Cyclin D1",
568,Role of ZNF202 in regulation of expression of genes involved in atherosclerosis,21,2.511E-02,8.354E-02,2.511E-02,8.354E-02,8,"PU.1, SDP1, ABCG1, HDL proteins, CRABP2, TIF1-beta, IA-1, ZNF24 (ZNF191)",3.256E-02,9.954E-02,9,"SDP1, ABCG1, HDL proteins, CRABP2, TIF1-beta, PU.1, APOC3, IA-1, ZNF24 (ZNF191)",
569,Translation_(L)-selenoaminoacids incorporation in proteins during translation,41,2.532E-02,8.388E-02,2.532E-02,8.388E-02,13,"GPX2, Selenoprotein W, SLA/LP, Selenoprotein O, SEPX1 (Selenoprotein X1), SBP2, SELB, DIO1, RPL30, Selenoprotein P, GPX4, TXNRD2, SEPHS2",6.522E-02,1.617E-01,14,"GPX3, GPX2, Selenoprotein W, SEPHS2, SLA/LP, Selenoprotein O, SEPX1 (Selenoprotein X1), SBP2, SELB, DIO1, RPL30, Selenoprotein P, GPX4, TXNRD2",
570,Apoptosis and survival_Ceramides signaling pathway,40,2.547E-02,8.368E-02,4.659E-02,1.282E-01,12,"MEK1(MAP2K1), H-Ras, ERK1/2, c-Raf-1, TRADD, Cytochrome c, FADD, PI3K reg class IA (p85), Neutral sphingomyelinase, Bcl-2, AKT(PKB), Cathepsin D",2.547E-02,8.368E-02,15,"H-Ras, ERK1/2, PKC-zeta, TRADD, Cytochrome c, FADD, BAD, PI3K reg class IA (p85), Neutral sphingomyelinase, FasL(TNFSF6), AKT(PKB), Cathepsin D, c-Jun, MEKK1(MAP3K1), Bcl-2",
571,Transcription_Role of heterochromatin protein 1 (HP1) family in transcriptional silencing,40,2.547E-02,8.368E-02,9.521E-02,2.064E-01,11,"SETDB1, E2F1, DNMT3A, MEF2, HP1 beta, E2I, HP1, MYOG, TIF1-beta, Rb protein, MYOD",2.547E-02,8.368E-02,15,"E2I, HP1, MYOG, TIF1-beta, Rb protein, CtBP, Suv39H1, Mi-2, SETDB1, E2F1, DNMT3A, MEF2, HP1 beta, MBD3, MYOD",
572,Development_SLIT-ROBO1 signaling,40,2.547E-02,8.368E-02,4.659E-02,1.282E-01,12,"Calcineurin A (catalytic), PAK2, p190RhoGAP, Myosin II, PI3K reg class IA (p85), Calmodulin, FLII, SLIT1, ARF6, WASP, AKT(PKB), PREX1",2.547E-02,8.368E-02,15,"Calcineurin A (catalytic), PAK2, Rac1, PI3K reg class IA (p85), ARF6, WASP, AKT(PKB), Endophilin A2, p190RhoGAP, Myosin II, Calmodulin, FLII, SLIT1, Cofilin, PREX1",
573,Development_WNT/Beta-catenin and NOTCH in induction of osteogenesis,40,2.547E-02,8.368E-02,4.426E-01,6.061E-01,8,"A-FABP, Adiponectin, Dsh, DLL1, WNT, Bone sialoprotein, Axin, C/EBPalpha",2.547E-02,8.368E-02,15,"WNT3A, Dsh, DLL1, Bone sialoprotein, LRP5, Axin, HEY1, Adiponectin, MAML1, WNT1, WNT, WNT10B, SMAD1, Frizzled, C/EBPalpha",
574,CHDI_Correlations from Replication data_Causal network (negative correlations),40,2.547E-02,8.368E-02,4.426E-01,6.061E-01,8,"Huntingtin, Dsh, ILK, PKC, WNT, AKT(PKB), SP1, Axin",2.547E-02,8.368E-02,15,"Huntingtin, Dsh, PLC-beta1, Plasminogen, LRP5, CtBP, AKT(PKB), Axin, Plasmin, ILK, PKC, WNT, G-protein alpha-q, SP1, Frizzled",
575,NRF2 regulation of oxidative stress response,54,2.601E-02,8.416E-02,5.319E-02,1.407E-01,15,"MEK1(MAP2K1), GPX2, GSHB, eIF2AK3, c-Raf-1, GSTM3, Ubiquitin, PKC, PI3K reg class IA, RARalpha, AKT(PKB), GSTA3, PDK (PDPK1), NQO1, ERK1 (MAPK3)",2.601E-02,8.416E-02,19,"GPX2, GSHB, GSTM3, Ubiquitin, SOD1, PI3K reg class IA, RARalpha, MafK, AKT(PKB), GSTA3, PDK (PDPK1), ERK1 (MAPK3), Thioredoxin, eIF2AK3, DJ-1, PRDX1, PKC, GSTA1, NQO1",
576,Development_WNT/Beta-catenin signaling in organogenesis,30,2.603E-02,8.416E-02,2.947E-01,4.507E-01,7,"FoxN1, PLP1, MEPE, WNT, FGF10, Fam132a, MESP1",2.603E-02,8.416E-02,12,"FoxN1, Lef-1, PLP1, MEPE, FGF10, MESP1, PROP1, Tcf(Lef), FAM19A5, PIT1, WNT, Frizzled",
577,Colorectal cancer (general schema),30,2.603E-02,8.416E-02,3.368E-02,1.021E-01,10,"EGF, gp130, SHH, IL8RA, DLL1, WNT, IGF-1 receptor, IGF-1, Leptin, IL8RB",2.603E-02,8.416E-02,12,"EGF, gp130, DLL1, IGF-1 receptor, IL8RB, SHH, IL8RA, WNT, IGF-1, Leptin, Ephrin-B receptors, Frizzled",
578,G-protein signaling_RAC1 in cellular process,37,2.605E-02,8.495E-02,2.605E-02,8.495E-02,12,"BAIAP2, PAK2, PAK3, POR1, PAK1, p67-phox, PIP5KI, DMPK, CYFIP2, DBS, JNK(MAPK8-10), PARD6",6.013E-02,1.529E-01,13,"BAIAP2, PAK2, PAK3, PKC-zeta, Rac1, CYFIP2, DBS, PARD6, POR1, PAK1, PIP5KI, DMPK, JNK(MAPK8-10)",
579,Deregulation of PSD-95-dependent signaling in Huntington's disease,37,2.605E-02,8.495E-02,2.605E-02,8.495E-02,12,"p38alpha (MAPK14), Huntingtin, H-Ras, NR1, ERK1/2, c-Raf-1, SynGAP, p90Rsk, MEK6(MAP2K6), MEK1/2, p38 MAPK, ERK1 (MAPK3)",2.053E-01,3.573E-01,11,"Huntingtin, H-Ras, NR1, ERK1/2, NMDA receptor, NR2, MEK6(MAP2K6), ERK1 (MAPK3), SynGAP, NR2D, p38 MAPK",
580,Development_Delta-type opioid receptor mediated cardioprotection,37,2.605E-02,8.495E-02,2.605E-02,8.495E-02,12,"MEK1(MAP2K1), AKT1, G-protein alpha-i family, Kir6.1, c-Raf-1, Kir6.2, STAT3, PI3K reg class IA, SUR2, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3)",2.053E-01,3.573E-01,11,"AKT1, Kir6.2, PI3K reg class IA, SUR2, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), Delta-type opioid receptor, PKC-delta, G-protein alpha-i family, Kir6.1",
581,Signal transduction_JNK pathway,47,2.606E-02,8.416E-02,1.309E-01,2.584E-01,12,"JunD/c-Fos, GRB2, TRAF2, LZK(MAP3K13), MLK2(MAP3K10), H-Ras, c-Raf-1, TRADD, AP-1, JunD, JNK(MAPK8-10), ZPK(MAP3K12)",2.606E-02,8.416E-02,17,"GRB2, LZK(MAP3K13), H-Ras, TRADD, Rac1, JunD, FasL(TNFSF6), ZPK(MAP3K12), MEKK4(MAP3K4), JunD/c-Fos, TRAF2, MLK2(MAP3K10), c-Jun, MKK7 (MAP2K7), AP-1, MEKK1(MAP3K1), JNK(MAPK8-10)",
582,HBV-dependent transcription regulation leading to HCC,25,2.627E-02,8.495E-02,2.627E-02,8.495E-02,9,"LXR-alpha/RXR-alpha, ESR1 (nuclear), SCD, FASN, EGR3, SREBP1 precursor, NUR77, LXR-alpha, Cyclin D1",9.469E-02,2.091E-01,9,"ESR1 (nuclear), SCD, EGR1, FASN, SREBP1 precursor, FasL(TNFSF6), EGR3, NUR77, Cyclin D1",
583,G-protein signaling_K-RAS regulation pathway,25,2.627E-02,8.495E-02,2.627E-02,8.495E-02,9,"EGF, GRB2, K-RAS, c-Raf-1, RalGDS, Epo receptor, CalDAG-GEFII, RGL2, Epo",4.063E-02,1.189E-01,10,"EGF, GRB2, A-Raf-1, CalDAG-GEFII, Epo, CALDAG-GEFI, K-RAS, RalGDS, Epo receptor, RGL2",
584,Putative pathways of hormone action in neurofibromatosis type 1,25,2.627E-02,8.495E-02,2.627E-02,8.495E-02,9,"ESR1 (nuclear), K-RAS, ESR1 (membrane), EGR3, GHR, PR (nuclear), PI3K reg class IA (p85), PI3K reg class IA, FosB",4.063E-02,1.189E-01,10,"ESR1 (nuclear), ESR1 (membrane), EGR1, PR (nuclear), PI3K reg class IA (p85), PI3K reg class IA, K-RAS, EGR3, GHR, FosB",
585,Resolution of inflammation in healing myocardial infarction,25,2.627E-02,8.495E-02,2.627E-02,8.495E-02,9,"MMP-1, ERK1/2, MGF, STAT3, G-CSF receptor, AKT(PKB), G-CSF, SDF-1, E-selectin",1.917E-01,3.400E-01,8,"ERK1/2, G-CSF receptor, AKT(PKB), SDF-1, E-selectin, MMP-1, MGF, G-CSF",
586,Deficient alpha-MSH signaling in melanoma,33,2.653E-02,8.548E-02,2.653E-02,8.548E-02,11,"p38alpha (MAPK14), ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, TYRP1, Rb protein, PI3K reg class IA, MEK1/2, AKT(PKB), PDK (PDPK1), p38 MAPK",3.312E-01,5.012E-01,9,"ERK1/2, PKA-reg (cAMP-dependent), Rac1, Rb protein, PI3K reg class IA, AKT(PKB), PDK (PDPK1), TYRP1, p38 MAPK",
587,Role of Neuregulin 1 and Thymosin beta-4 in myocardium regeneration after infarction,29,2.666E-02,8.548E-02,2.666E-02,8.548E-02,10,"GRB2, GAB1, Neuregulin 1, Thymosin beta-4, ILK, PI3K reg class IA (p85), ErbB2, ANP, PTEN, AKT(PKB)",1.035E-01,2.229E-01,10,"GRB2, GAB1, PI3K reg class IA (p85), ACTA1, ErbB2, ANP, AKT(PKB), Thymosin beta-4, ILK, PTEN",
588,Muscle contraction_Regulation of eNOS activity in endothelial cells,65,2.749E-02,8.819E-02,3.757E-02,1.109E-01,18,"NOSIP, G-protein alpha-i family, Esrra, KLF2, BDKRB2, ESR2 (nuclear), GATA-2, IP3 receptor, AP-1, Sirtuin1, Calmodulin, PI3K reg class IA, PLC-beta, eNOS, AKT(PKB), SP1, HSP90, FosB",2.749E-02,8.819E-02,22,"Esrra, KLF2, BDKRB2, ESR2 (nuclear), IP3 receptor, PI3K reg class IA, PLC-beta, AKT(PKB), HSP90, ARNT, NOSIP, G-protein alpha-i family, c-Jun, GATA-2, Bradykinin, AP-1, Sirtuin1, Calmodulin, eNOS, G-protein alpha-q, SP1, FosB",
589,Neurophysiological process_Constitutive and regulated NMDA receptor trafficking,65,2.749E-02,8.819E-02,3.757E-02,1.109E-01,18,"Chapsyn-110, Dopamine D1A receptor, cPKC (conventional), Calcineurin A (catalytic), SNAP-25, PP1-cat, G-protein alpha-i family, NR1, PKA-reg (cAMP-dependent), IP3 receptor, G-protein alpha-s, Calmodulin, PKC, SAP102, PLC-beta, Adenylate cyclase, MALS, MIB2",2.749E-02,8.819E-02,22,"Chapsyn-110, Calcineurin A (catalytic), PP1-cat, NR1, PKA-reg (cAMP-dependent), Syntaxin 1A, IP3 receptor, NMDA receptor, PLC-beta, NR2, Adenylate cyclase, MALS, MIB2, Dopamine D1A receptor, cPKC (conventional), G-protein alpha-i family, G-protein alpha-s, Calmodulin, PKC, SAP102, G-protein alpha-q, STEP",
590,Cell adhesion_Role of tetraspanins in the integrin-mediated cell adhesion,37,2.805E-02,8.938E-02,2.165E-01,3.626E-01,9,"CD81, PAK1, CD9, CD63, VIL2 (ezrin), FAK1, CD151, WASP, NAG-2",2.805E-02,8.938E-02,14,"CD81, Actin, Rac1, VIL2 (ezrin), CD151, WASP, NAG-2, CD82, PAK1, CD9, CD63, N-WASP, FAK1, Cofilin",
591,Immune response_Regulation of T cell function by CTLA-4,37,2.805E-02,8.938E-02,1.191E-01,2.445E-01,10,"CD80, GRB2, c-Fos, H-Ras, AP1G1, PI3K reg class IA (p85), CD3, SHP-1, AKT(PKB), PDK (PDPK1)",2.805E-02,8.938E-02,14,"GRB2, c-Fos, NF-AT1(NFATC2), H-Ras, AP1G1, PI3K reg class IA (p85), ZAP70, SHP-1, AKT(PKB), PDK (PDPK1), c-Jun, LAT, SHP-2, TCR alpha/beta",
592,Activation of osteoclast differentiation in bone lesions formation in multiple myeloma,27,2.822E-02,8.938E-02,4.290E-02,1.205E-01,9,"MEK1(MAP2K1), Syndecan-1, c-Fos, ERK1/2, CCR1, NFKBIA, IKK-beta, CCR5, p38 MAPK",2.822E-02,8.938E-02,11,"c-Fos, ERK1/2, CCR1, IKK (cat), IL-3, IKK-alpha, CCR5, Syndecan-1, NFKBIA, IKK-beta, p38 MAPK",
593,Translation_Regulation of translation initiation,27,2.822E-02,8.938E-02,4.290E-02,1.205E-01,9,"eIF6 (ITGB4BP), eIF1, eIF3S3, eIF1A, p70 S6 kinase1, eIF3S8, eIF4A, PDK (PDPK1), p70 S6 kinase2",2.822E-02,8.938E-02,11,"eIF6 (ITGB4BP), eIF4E, eIF3S3, eIF1A, PDK (PDPK1), eIF1, p70 S6 kinase1, eIF3S8, eIF4A, eIF5, p70 S6 kinase2",
594,Role of B cells in SLE,58,2.834E-02,8.938E-02,9.070E-02,2.014E-01,15,"CD80, MHC class II, ICOS-L, CD19, Btk, PI3K reg class IA, IFN-alpha, Bcl-2, Bcl-XL, Fc gamma RII beta, SHP-1, CD40(TNFRSF5), AKT(PKB), IL-6 receptor, CD40L(TNFSF5)",2.834E-02,8.938E-02,20,"MHC class II, ICOS-L, Bak, CD19, PI3K reg class IA, IFN-alpha, Bcl-XL, CD22, SHP-1, SHIP, AKT(PKB), ICOS, CD79 complex, Btk, Bcl-2, Fc gamma RII beta, CD40(TNFRSF5), miR-30a-5p, TCR alpha/beta, IL-6 receptor",
595,Immune response_IFN-gamma signaling via MAPK,51,2.885E-02,9.062E-02,6.594E-02,1.620E-01,14,"MEK1(MAP2K1), ZFP36(Tristetraprolin), ERK1/2, MED1, eIF4B, TIRAP (Mal), c-Raf-1, p90RSK1, MAPKAPK2, PHF8, MEK6(MAP2K6), MNK2(GPRK7), PGES2, p38 MAPK",2.885E-02,9.062E-02,18,"eIF4E, ERK1/2, MED1, TREX1, c-Jun/c-Fos, MAPKAPK2, MyD88, MEK6(MAP2K6), PGES2, MEKK4(MAP3K4), ZFP36(Tristetraprolin), c-Jun, eIF4B, TIRAP (Mal), PHF8, MEKK1(MAP3K1), MNK2(GPRK7), p38 MAPK",
596,Oxidative stress_Activation of NADPH oxidase,59,2.967E-02,9.410E-02,2.967E-02,9.410E-02,17,"cPKC (conventional), AKT1, ERK1/2, PAK1, p67-phox, IP3 receptor, PKC, PI3K reg class IA, PLC-beta, VAV-2, MEK1/2, VAV-3, p40-phox, AKT(PKB), PDK (PDPK1), p38 MAPK, PREX1",3.395E-02,1.036E-01,20,"AKT1, ERK1/2, PKC-zeta, Rac1, IP3 receptor, PI3K reg class IA, PLC-beta, VAV-2, AKT(PKB), PDK (PDPK1), BETA-PIX, cPKC (conventional), PKC-delta, PAK1, PKC, VAV-3, p40-phox, PI3K reg class IB (p101), p38 MAPK, PREX1",
597,Development_MicroRNA-dependent regulation of EMT,24,3.043E-02,9.511E-02,9.918E-01,1.000E+00,1,E-cadherin,3.043E-02,9.511E-02,10,"microRNA 200c, microRNA 200b, miR-141-3p, miR-200c-3p, miR-200b-5p, miR-200b-3p, E-cadherin, microRNA 141, microRNA 429, miR-429-3p",
598,Immune response_Sublytic effects of membrane attack complex,68,3.047E-02,9.615E-02,3.047E-02,9.615E-02,19,"AKT1, GRB2, eIF2AK3, G-protein alpha-i family, H-Ras, ERK1/2, c-Raf-1, IP3 receptor, MAPKAPK2, PKC, cPLA2, HSP27, MEK6(MAP2K6), GRP75, Bcl-XL, MEK1/2, eIF2S1, AKT(PKB), p38 MAPK",1.246E-01,2.542E-01,20,"AKT1, GRB2, H-Ras, ERK1/2, IP3 receptor, BAD, MAPKAPK2, cPLA2, MEK6(MAP2K6), GRP75, Bcl-XL, eIF2S1, AKT(PKB), eIF2AK3, G-protein alpha-i family, PKC, HSP27, C9, PI3K reg class IB (p101), p38 MAPK",
599,Development_WNT/Beta-catenin signaling in the nucleus,62,3.054E-02,9.511E-02,1.416E-01,2.728E-01,15,"LDB1, BAF53, GCN5, MED1, MED12, PYGO2, MEF2, TLE, DOT1, Dsh, WNT, SET8, JNK(MAPK8-10), EP400, p38 MAPK",3.054E-02,9.511E-02,21,"LDB1, Lef-1, GCN5, MED1, MED12, PYGO2, TLE, p15(PAF), DOT1, Dsh, EP400, Tcf(Lef), c-Jun, TBP, MEF2, WNT, SET8, JNK(MAPK8-10), p120-catenin, p38 MAPK, Frizzled",
600,Immune response _CCR3 signaling in eosinophils,77,3.069E-02,9.615E-02,3.069E-02,9.615E-02,21,"MEK1(MAP2K1), CCR3, G-protein alpha-i family, H-Ras, Myosin II, c-Raf-1, PAK1, p67-phox, MyHC, IP3 receptor, Hck, Calmodulin, cPLA2, MRLC, VAV-2, WASP, LIMK2, MELC, PDK (PDPK1), p38 MAPK, MLCK",5.618E-02,1.458E-01,24,"H-Ras, PKC-zeta, Rac1, IP3 receptor, Hck, CCL13, cPLA2, VAV-2, WASP, LIMK2, PDK (PDPK1), MLCK, CCR3, G-protein alpha-i family, Myosin II, PAK1, MyHC, Calmodulin, MEKK1(MAP3K1), MRLC, MELC, PI3K reg class IB (p101), p38 MAPK, Cofilin",
601,Development_VEGF signaling and activation,42,3.076E-02,9.615E-02,3.076E-02,9.615E-02,13,"MEK1(MAP2K1), c-Fos, ESR1 (nuclear), H-Ras, ERK1/2, c-Raf-1, I-kB, PKC, PI3K reg class IA, IKK-beta, AKT(PKB), SP1, E-selectin",7.807E-02,1.832E-01,14,"c-Fos, ESR1 (nuclear), H-Ras, ERK1/2, c-Jun/c-Fos, IKK (cat), I-kB, PI3K reg class IA, AKT(PKB), E-selectin, c-Jun, PKC, IKK-beta, SP1",
602,Transcription_FXR-regulated cholesterol and bile acids cellular transport,42,3.076E-02,9.615E-02,3.076E-02,9.615E-02,13,"SLC22A7, ABCG5, RAR-alpha/RXR-alpha, PXR, SHP, OSTalpha, MDR3, LRH1, ABCG5/ABCG8 heterodimer, PXR/RXR-alpha, ABCG8, SLC10A1, ABCC2",2.340E-01,3.851E-01,12,"ABCG5, LRH1, PXR/RXR-alpha, ABCG8, SLC10A1, SLC22A7, RAR-alpha/RXR-alpha, PXR, OSTalpha, MDR3, ABCG5/ABCG8 heterodimer, ABCC2",
603,Signal transduction_Angiotensin II/ AGTR1 signaling via TGF-beta 1 and SMADs,42,3.076E-02,9.615E-02,3.076E-02,9.615E-02,13,"E-cadherin, SREBP1 (nuclear), GRB2, ERK1/2, AGTR1, FASN, SREBP1 precursor, AP-1, ANP, JNK(MAPK8-10), AKT(PKB), SP1, p38 MAPK",1.412E-01,2.746E-01,13,"SREBP1 (nuclear), GRB2, ERK1/2, FASN, SREBP1 precursor, ANP, AKT(PKB), E-cadherin, AGTR1, AP-1, JNK(MAPK8-10), SP1, p38 MAPK",
604,Immune response_IL-11 signaling via JAK/STAT,34,3.085E-02,9.569E-02,7.432E-02,1.777E-01,10,"A-FABP, gp130, c-Fos, SP-B, STAT3, Bcl-2, RARalpha, Myeloblastin, Pim-3, MYOD",3.085E-02,9.569E-02,13,"gp130, c-Fos, MYF5, SP-B, IL11RA, RARalpha, CYP19, Pim-3, IL-11 receptor, sIL11-RA, Bcl-2, Myeloblastin, MYOD",
605,Development_BMP signaling in cardiac myogenesis,34,3.085E-02,9.569E-02,1.491E-01,2.806E-01,9,"GATA-4, BMP7, ID2, ANP, MEK6(MAP2K6), Bcl-XL, Cyclin D1, p38 MAPK, N-Myc",3.085E-02,9.569E-02,13,"GATA-4, ID2, ACTA1, ANP, MEK6(MAP2K6), Bcl-XL, BMP7, alpha-MHC, TAB1, SMAD1, Cyclin D1, p38 MAPK, N-Myc",
606,Immune response_Platelet activating factor/ PTAFR pathway signaling,55,3.145E-02,9.797E-02,3.145E-02,9.797E-02,16,"STAT2, Calcineurin A (catalytic), G-protein alpha-i family, PKA-reg (cAMP-dependent), NFKBIA, NF-AT, IP3 receptor, STAT3, MAPKAPK2, PI3K reg class IA, PLC-beta, Adenylate cyclase, Clathrin, AKT(PKB), Beta-arrestin1, p38 MAPK",5.910E-02,1.515E-01,18,"Calcineurin A (catalytic), NF-AT1(NFATC2), PKA-reg (cAMP-dependent), IP3 receptor, MAPKAPK2, PI3K reg class IA, PLC-beta, IKK-alpha, Adenylate cyclase, AKT(PKB), STAT2, G-protein alpha-i family, NFKBIA, NF-AT, G-protein alpha-q, Clathrin, Beta-arrestin1, p38 MAPK",
607,Main chemotherapy drugs and their action in SCLC cells,100,3.148E-02,9.797E-02,3.148E-02,9.797E-02,26,"SLC31A1, MEK1(MAP2K1), p38alpha (MAPK14), EGF, G-protein alpha-12 family, Aif, ERK1/2, Cyclin D, c-Raf-1, Glutaredoxin 1, p21, Cytochrome c, p70 S6 kinase1, ErbB2, Bcl-2, MDM2, FAK1, Bcl-XL, Cyclin D1, JNK(MAPK8-10), AKT(PKB), SP1, ABCG2, p70 S6 kinase2, p27KIP1, p38 MAPK",3.354E-01,5.065E-01,25,"SLC31A1, EGF, ERK1/2, p21, Cytochrome c, BAD, ErbB2, IKK-alpha, MDM2, Bcl-XL, AKT(PKB), p27KIP1, G-protein alpha-12 family, Aif, PKC-delta, Cyclin D, p70 S6 kinase1, Bcl-2, FAK1, Cyclin D1, JNK(MAPK8-10), SP1, ABCG2, p70 S6 kinase2, p38 MAPK",
608,Immune response_IL-16 signaling pathway,55,3.148E-02,9.744E-02,6.134E-02,1.551E-01,15,"cPKC (conventional), CCR3, CD9, RAG2, GABP beta1, IP3 receptor, PPP1R12B, PKC, FOXP3, IL-2R beta chain, Skp2/TrCP/FBXW, CCR5, AKT(PKB), p27KIP1, SDF-1",3.148E-02,9.744E-02,19,"IL-16 mature, IP3 receptor, N-terminal IL16, FOXP3, Skp2/TrCP/FBXW, CCR5, AKT(PKB), p27KIP1, IL-2R alpha chain, SDF-1, cPKC (conventional), HSC70, CCR3, CD9, GABP beta1, PPP1R12B, PKC, IL-2R beta chain, IL-16",
609,Regulation of lipid metabolism_Regulation of acetyl-CoA carboxylase 1 activity,18,3.164E-02,9.828E-02,3.164E-02,9.828E-02,7,"ACACA, SREBP1 (nuclear), AMPK beta subunit, AMPK alpha subunit, AMPK gamma subunit, CPT-1A, ACACB",2.104E-01,3.607E-01,6,"SREBP1 (nuclear), AMPK beta subunit, AMPK gamma subunit, CPT-1A, ACACB, AMPK alpha subunit",
610,TNF-alpha-induced inflammatory signaling in normal and asthmatic airway epithelium,38,3.197E-02,9.909E-02,3.197E-02,9.909E-02,12,"MEK1(MAP2K1), CCL17, c-Fos, H-Ras, ERK1/2, c-Raf-1, NFKBIA, I-kB, IKK-beta, STAT6, IL-4, p38 MAPK",7.301E-02,1.744E-01,13,"CCL17, c-Fos, H-Ras, ERK1/2, I-kB, IL-13, IL-4, c-Jun, NFKBIA, MEKK1(MAP3K1), IKK-beta, STAT6, p38 MAPK",
611,Neurophysiological process_ACM regulation of nerve impulse,48,3.202E-02,9.850E-02,4.162E-02,1.199E-01,14,"cPKC (conventional), Calcineurin A (catalytic), CACNA1H, G-protein alpha-i family, G-protein alpha-11, CACNA1C, PKA-reg (cAMP-dependent), G-protein alpha-q/11, ACM1, IP3 receptor, Calmodulin, PKC, PLC-beta, CACNA1I",3.202E-02,9.850E-02,17,"Calcineurin A (catalytic), CACNA1H, PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, PLC-beta, cPKC (conventional), ACM2, G-protein alpha-i family, G-protein alpha-11, CACNA1C, ACM1, Calmodulin, PKC, G-protein alpha-q, CACNA1I, N-type Ca(II) channel alpha1B",
612,Development_Schema: Osteogenic and adipogenic differentiation of mesenchymal stem cells,21,3.256E-02,9.954E-02,3.291E-01,4.917E-01,5,"Insulin processed, BMP7, SHH, Rb protein, IGF-1",3.256E-02,9.954E-02,9,"WNT3A, Insulin processed, Rb protein, BMP7, SHH, WNT1, WNT10B, Parathyroid hormone, IGF-1",
613,Neurophysiological process_NMDA-dependent postsynaptic long-term potentiation in CA1 hippocampal neurons,82,3.269E-02,1.011E-01,3.269E-02,1.011E-01,22,"cAMP-GEFI, GRB2, c-Fos, H-Ras, NR1, ERK1/2, Protein kinase G, PKA-reg (cAMP-dependent), c-Raf-1, Adenylate cyclase type I, Ryanodine receptor 3, p90Rsk, IP3 receptor, GluR2, p70 S6 kinase1, Calmodulin, eNOS, MEK1/2, Guanylate Cyclase 1, soluble, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3)",6.590E-02,1.625E-01,25,"cAMP-GEFI, GRB2, c-Fos, H-Ras, NR1, eIF4E, ERK1/2, PKA-reg (cAMP-dependent), PLC-beta1, IP3 receptor, NMDA receptor, NR2, Guanylate Cyclase 1, soluble, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), Protein kinase G, Adenylate cyclase type I, GluR2, 4E-BP1, p70 S6 kinase1, Calmodulin, GluR1, eNOS, G-protein alpha-q",
614,Nicotine / Beta-adrenergic signaling in lung cancer,34,3.298E-02,1.013E-01,3.298E-02,1.013E-01,11,"MEK1(MAP2K1), GRB2, G-protein alpha-i family, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, G-protein alpha-s, Adenylate cyclase, AKT(PKB), PDK (PDPK1)",1.316E-01,2.614E-01,11,"GRB2, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), BAD, Adenylate cyclase, AKT(PKB), PDK (PDPK1), G-protein alpha-i family, G-protein alpha-s, PI3K reg class IB (p101)",
615,Development_Oligodendrocyte differentiation from adult stem cells,51,3.329E-02,1.013E-01,3.329E-02,1.013E-01,15,"TR-alpha, FGFR3, PDGF-B, OATP-A, ERK1/2, PLP1, MCT8, SHH, p90Rsk, FGFR1, TR-beta, IGF-1 receptor, CNTN6, IGF-1, p38 MAPK",1.003E-01,2.177E-01,16,"TR-alpha, PDGF-B, ERK1/2, PLP1, FGFR1, TR-beta, IGF-1 receptor, FGFR3, OATP-A, MCT8, SHH, MAG, SMAD1, CNTN6, IGF-1, p38 MAPK",
616,Putative pathways of n-3 and n-6 fatty acids in obesity and type 2 diabetes,51,3.329E-02,1.013E-01,3.329E-02,1.013E-01,15,"ACACA, SREBP1 (nuclear), LXR-beta, c-Fos, Adiponectin, PKA-reg (cAMP-dependent), G-protein alpha-q/11, FASN, SREBP1 precursor, COX-1 (PTGS1), G-protein alpha-s, Adenylate cyclase, LXR-alpha, AKT(PKB), GPR120",1.674E-01,3.094E-01,15,"SREBP1 (nuclear), c-Fos, EGR1, PKA-reg (cAMP-dependent), GLUT4, G-protein alpha-q/11, FASN, SREBP1 precursor, Prostacyclin receptor, Adenylate cyclase, AKT(PKB), LXR-beta, Adiponectin, G-protein alpha-s, GPR120",
617,Differences between Langerhans cells and dermal dendritic cells in allergic contact dermatitis,22,3.334E-02,1.013E-01,3.334E-02,1.013E-01,8,"E-cadherin, CD80, MHC class II, ICOS-L, CCR7, CD40(TNFRSF5), SDF-1, CD40L(TNFSF5)",1.065E-01,2.269E-01,8,"MHC class II, ICOS-L, ICOS, SDF-1, E-cadherin, CCR7, CD40(TNFRSF5), TCR alpha/beta",
618,Regulation of Adenylate cyclase and IMPA1 by lithium in major depressive disorder,22,3.334E-02,1.013E-01,3.334E-02,1.013E-01,8,"P2X2, G-protein alpha-i family, PKA-reg (cAMP-dependent), Adenylate cyclase type I, Alpha-2A adrenergic receptor, Adenylate cyclase type II, Adenylate cyclase, GRK2",1.065E-01,2.269E-01,8,"PKA-reg (cAMP-dependent), Adenylate cyclase type II, Adenylate cyclase, GRK2, P2X2, G-protein alpha-i family, Adenylate cyclase type I, Alpha-2A adrenergic receptor",
619,Development_H3K9 demethylases in pluripotency maintenance of stem cells,22,3.334E-02,1.013E-01,3.334E-02,1.013E-01,8,"AKT1, SETDB1, TCL1A, GATA-4, HP1, NANOG, TIF1-beta, AKT(PKB)",4.425E-02,1.255E-01,9,"AKT1, TCL1A, GATA-4, HP1, TIF1-beta, AKT(PKB), SETDB1, T brachyury protein, NANOG",
620,Cell cycle_Initiation of mitosis,26,3.389E-02,1.021E-01,3.389E-02,1.021E-01,9,"p90RSK1, AP-2A, USF1, CDK7, Cyclin H, Wee1, CAK complex, AKT(PKB), MAT1",5.294E-02,1.415E-01,10,"USF1, CDK7, Wee1, CAK complex, AKT(PKB), c-Myc, AP-2A, Cyclin H, Kinase MYT1, MAT1",
621,Pioglitazone and Rosiglitazone in treatment of type 2 diabetes and metabolic syndrome X,26,3.389E-02,1.021E-01,3.389E-02,1.021E-01,9,"A-FABP, Adiponectin, Insulin processed, ABCG1, GPD1, RXRA, CD36, Insulin receptor, LXR-alpha",1.168E-01,2.422E-01,9,"Insulin processed, ABCG1, GLUT4, Resistin, Insulin receptor, Adiponectin, GPD1, RXRA, CD36",
622,CAR signaling via cross-talk / Human Version,26,3.389E-02,1.021E-01,3.389E-02,1.021E-01,9,"CYP2C8, SREBP1 (nuclear), CAR/RXR-alpha, ESR1 (nuclear), G6PT, RXRA, CAR, ACOX1, CYP3A4",3.795E-01,5.508E-01,7,"SREBP1 (nuclear), ESR1 (nuclear), CAR, ACOX1, CAR/RXR-alpha, RXRA, CYP2B6",
623,Chemotaxis_CXCR3-A signaling,69,3.513E-02,1.048E-01,3.513E-02,1.048E-01,19,"MIG, GRB2, ROR-gamma, Granzyme B, H-Ras, ERK1/2, c-Raf-1, p90RSK1, IP3 receptor, Calmodulin, CD3, FAK1, Occludin, MEK1/2, Clathrin, AKT(PKB), Beta-arrestin1, PDK (PDPK1), GRK2",8.786E-02,1.999E-01,21,"GRB2, Granzyme B, H-Ras, ERK1/2, Perforin, Rac1, IP3 receptor, ZAP70, AKT(PKB), PDK (PDPK1), GRK2, ROR-gamma, LAT, CXCR3, Calmodulin, FAK1, Occludin, Clathrin, Beta-arrestin1, PI3K reg class IB (p101), TCR alpha/beta",
624,Mitogenic action of ESR1 (membrane) in breast cancer,47,3.515E-02,1.048E-01,3.515E-02,1.048E-01,14,"c-Fos, ESR1 (nuclear), H-Ras, ERK1/2, ErbB3, ESR1 (membrane), c-Raf-1, ErbB2, IGF-1 receptor, MEK1/2, Cyclin D1, AKT(PKB), PDK (PDPK1), p27KIP1",2.608E-01,4.191E-01,13,"c-Fos, ESR1 (nuclear), H-Ras, ERK1/2, ErbB3, ESR1 (membrane), ErbB2, IGF-1 receptor, AKT(PKB), PDK (PDPK1), p27KIP1, c-Myc, Cyclin D1",
625,Development_Mu-type opioid receptor signaling,38,3.535E-02,1.061E-01,2.412E-01,3.913E-01,9,"Tuberin, G-protein alpha-i family, IP3 receptor, p70 S6 kinase1, VAV-2, 4E-BP2, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1)",3.535E-02,1.061E-01,14,"Tuberin, Rac1, IP3 receptor, VAV-2, 4E-BP2, AKT(PKB), PDK (PDPK1), G-protein alpha-i family, MKK7 (MAP2K7), 4E-BP1, p70 S6 kinase1, MEKK1(MAP3K1), JNK(MAPK8-10), PI3K reg class IB (p101)",
626,Immune response_Role of integrins in NK cells cytotoxicity,38,3.535E-02,1.061E-01,6.970E-02,1.699E-01,11,"MEK1(MAP2K1), GRB2, c-Fos, NKG2A, H-Ras, c-Raf-1, PAK1, ICAM3, SHP-1, p38 MAPK, ERK1 (MAPK3)",3.535E-02,1.061E-01,14,"GRB2, c-Fos, NKG2A, H-Ras, Rac1, SHP-1, FasL(TNFSF6), ERK1 (MAPK3), PAK1, Paxillin, MEKK1(MAP3K1), SHP-2, ICAM3, p38 MAPK",
627,Development_Schema: Embryonal myogenesis,12,3.581E-02,1.073E-01,1.583E-01,2.930E-01,4,"SHH, FGFR1, DLL1, SDF-1",3.581E-02,1.073E-01,6,"WNT3A, FGFR1, DLL1, SDF-1, SHH, WNT1",
628,HGF signaling in melanoma,39,3.880E-02,1.141E-01,3.880E-02,1.141E-01,12,"MEK1(MAP2K1), E-cadherin, GAB1, ERK1/2, RXRA, PI3K reg class IA (p85), Bcl-XL, Cyclin D1, JNK(MAPK8-10), Plakoglobin, AKT(PKB), p38 MAPK",1.588E-01,2.975E-01,12,"GAB1, ERK1/2, EGR1, PI3K reg class IA (p85), Bcl-XL, AKT(PKB), E-cadherin, RXRA, Cyclin D1, JNK(MAPK8-10), Plakoglobin, p38 MAPK",
629,Role of TNF-alpha in type 2 diabetes in skeletal muscle cells,42,3.951E-02,1.165E-01,1.256E-01,2.543E-01,11,"MEK1(MAP2K1), TIMP3, Insulin processed, Esrra, AMPK alpha subunit, NFKBIA, CPT-1A, ACACB, Insulin receptor, IKK-beta, PP2C alpha",3.951E-02,1.165E-01,15,"TIMP3, Insulin processed, IRS-1, Esrra, CPT-1A, p38beta (MAPK11), ACACB, Insulin receptor, PKC-delta, AMPK alpha subunit, PTP-1B, NFKBIA, MEKK1(MAP3K1), IKK-beta, PP2C alpha",
630,Development_c-Kit ligand signaling pathway during hemopoiesis,61,4.016E-02,1.174E-01,4.016E-02,1.174E-01,17,"GRB2, H-Ras, ERK1/2, VEGFR-1, c-Raf-1, MGF, p90Rsk, IP3 receptor, STAT3, PI3K reg class IA (p85), p70 S6 kinase1, MEK1/2, SHP-1, AKT(PKB), PDK (PDPK1), p27KIP1, SDF-1",1.366E-01,2.675E-01,18,"GRB2, H-Ras, ERK1/2, Rac1, IP3 receptor, BAD, PI3K reg class IA (p85), SHP-1, AKT(PKB), PDK (PDPK1), p27KIP1, SDF-1, VEGFR-1, MGF, Paxillin, p70 S6 kinase1, SHP-2, FOXO3A",
631,Stellate cells activation and liver fibrosis,70,4.029E-02,1.174E-01,4.029E-02,1.174E-01,19,"MEK1(MAP2K1), PDGF-B, GRB2, c-Fos, TRAF2, H-Ras, c-Raf-1, TRADD, SHH, DAB2, SARA, Dsh, I-kB, PI3K reg class IA (p85), IL-1RI, Cyclin D1, AKT(PKB), SP1, ERK1 (MAPK3)",6.034E-02,1.529E-01,22,"PDGF-B, GRB2, c-Fos, WNT3A, H-Ras, IKK (cat), TRADD, DAB2, Dsh, I-kB, PI3K reg class IA (p85), MyD88, IL-1RI, AKT(PKB), ERK1 (MAPK3), TRAF2, Tcf(Lef), SHH, SARA, Cyclin D1, SP1, Frizzled",
632,Signal transduction_PDGF signaling via PI3K/AKT and NFkB pathways,70,4.029E-02,1.174E-01,4.029E-02,1.174E-01,19,"PDK1, PDGF-B, GRB2, c-Fos, K-RAS, ERK1/2, YB-1, Thrombomodulin, DDX5, NFKBIA, PI3K reg class IA (p85), Calmodulin, PTEN, HXK2, Cyclin D1, AKT(PKB), SP1, PDK (PDPK1), p27KIP1",6.034E-02,1.529E-01,22,"PDGF-B, GRB2, c-Fos, ERK1/2, Thrombomodulin, IKK (cat), Rac1, PI3K reg class IA (p85), HXK2, AKT(PKB), PDK (PDPK1), p27KIP1, c-Myc, K-RAS, c-Jun, DDX5, NFKBIA, Calmodulin, MYH11, PTEN, Cyclin D1, SP1",
633,Altered Ca2+ handling in heart failure,35,4.047E-02,1.174E-01,4.047E-02,1.174E-01,11,"Phospholamban, IPP-1, Calcineurin A (catalytic), PP1-cat, G-protein alpha-i family, CACNA1C, G-protein alpha-s, Calmodulin, PDE4D, Adenylate cyclase, GRK2",1.543E-01,2.909E-01,11,"Calcineurin A (catalytic), PP1-cat, S100A1, PDE4D, Adenylate cyclase, GRK2, IPP-1, G-protein alpha-i family, CACNA1C, G-protein alpha-s, Calmodulin",
634,Development_Extraembryonic differentiation of embryonic stem cells,35,4.047E-02,1.174E-01,4.047E-02,1.174E-01,11,"GATA-3, GATA-4, BMP7, CD9, ID2, MSX-2, Vitronectin, SOX2, CGB3, AFP, HNF3-alpha",8.186E-02,1.900E-01,12,"GATA-4, ID2, MSX-2, GCMA, HEY1, GATA-3, BMP7, CD9, Vitronectin, SOX2, SMAD1, HNF3-alpha",
635,Role of Tissue factor in cancer independent of coagulation protease signaling,35,4.047E-02,1.174E-01,4.047E-02,1.174E-01,11,"MEK1(MAP2K1), GRB2, H-Ras, ERK1/2, c-Raf-1, PAK1, Coagulation factor VII, FAK1, AKT(PKB), p38 MAPK, ERK1 (MAPK3)",2.624E-01,4.191E-01,10,"GRB2, H-Ras, ERK1/2, Coagulation factor VII, Rac1, AKT(PKB), ERK1 (MAPK3), PAK1, FAK1, p38 MAPK",
636,Role of keratinocytes and Langerhans cells in skin sensitization,25,4.063E-02,1.189E-01,2.937E-01,4.507E-01,6,"E-cadherin, MHC class II, CCR7, I-kB, CARD5, IL-1RI",4.063E-02,1.189E-01,10,"MHC class II, IKK (cat), CARD8, I-kB, MyD88, CARD5, IL-1RI, E-cadherin, CCR7, c-Jun",
637,K-RAS signaling in lung cancer,48,4.162E-02,1.199E-01,4.162E-02,1.199E-01,14,"MEK1(MAP2K1), E-cadherin, K-RAS, PDCD4, ERK1/2, c-Raf-1, BTG2, RhoB, PI3K reg class IA (p85), Amphiregulin, PTEN, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1)",6.236E-02,1.570E-01,16,"ERK1/2, Rac1, PI3K reg class IA (p85), Amphiregulin, FasL(TNFSF6), AKT(PKB), PDK (PDPK1), E-cadherin, K-RAS, PDCD4, c-Jun, BTG2, RhoB, PTEN, MEKK1(MAP3K1), JNK(MAPK8-10)",
638,SHH signaling in colorectal cancer,31,4.189E-02,1.199E-01,4.189E-02,1.199E-01,10,"MEK1(MAP2K1), E-cadherin, AKT1, K-RAS, SHH, p21, WNT, Bcl-2, HIP, SUFU",1.487E-01,2.853E-01,10,"AKT1, p21, c-Myc, SUFU, E-cadherin, K-RAS, SHH, WNT, Bcl-2, Frizzled",
639,NETosis in SLE,31,4.189E-02,1.199E-01,4.189E-02,1.199E-01,10,"ERK1/2, p67-phox, HP1 beta, PERM, PKC, DNase I, IFN-alpha, CAMP, Alpha-defensin, p38 MAPK",4.118E-01,5.797E-01,8,"ERK1/2, IFN-alpha, HP1 beta, PERM, PKC, DNase I, CAMP, p38 MAPK",
640,Neutrophil adhesion and transendothelial migration in asthma,31,4.189E-02,1.199E-01,4.189E-02,1.199E-01,10,"Substance P extracellular region, H-Ras, ERK1/2, c-Raf-1, ITGAM, CD34, cPLA2, MEK1/2, ERK1 (MAPK3), E-selectin",4.118E-01,5.797E-01,8,"Substance P extracellular region, H-Ras, ERK1/2, CD34, cPLA2, ERK1 (MAPK3), E-selectin, ITGAM",
641,TLRs-mediated IFN-alpha production by plasmacytoid dendritic cells in SLE,53,4.204E-02,1.228E-01,4.582E-02,1.270E-01,15,"SSH3, Sec24C, U1-70K, RNU1-1, p70 S6 kinase1, IFN-alpha, IKK-beta, IRF5, CAMP, 4E-BP2, TAB2, AKT(PKB), PDK (PDPK1), p70 S6 kinase2, Alpha-defensin",4.204E-02,1.228E-01,18,"SSH3, MyD88, TIAF1, IKK-alpha, IFN-alpha, 4E-BP2, TAB2, AKT(PKB), PDK (PDPK1), Sec24C, U1-70K, 4E-BP1, p70 S6 kinase1, IKK-beta, IRF5, CAMP, TAB1, p70 S6 kinase2",
642,Development_Alpha-1 adrenergic receptors signaling via Cyclic AMP,19,4.247E-02,1.205E-01,4.247E-02,1.205E-01,7,"PKA-reg (cAMP-dependent), Sirtuin1, FOXO4, G-protein alpha-s, Adenylate cyclase, Alpha-1A adrenergic receptor, p27KIP1",4.787E-02,1.319E-01,8,"PKA-reg (cAMP-dependent), Adenylate cyclase, p27KIP1, Sirtuin1, FOXO4, G-protein alpha-s, Alpha-1A adrenergic receptor, FOXO3A",
643,Anti-apoptotic pathways in endoplasmic reticulum stress response in multiple myeloma,19,4.247E-02,1.205E-01,4.247E-02,1.205E-01,7,"eIF2AK3, XBP1, PP1-cat, Bcl-2, eIF2S1, IRE1, p38 MAPK",1.201E-01,2.474E-01,7,"XBP1, PP1-cat, eIF2S1, IRE1, eIF2AK3, Bcl-2, p38 MAPK",
644,HCV-dependent cytoplasmic signaling leading to HCC,27,4.290E-02,1.205E-01,4.290E-02,1.205E-01,9,"MEK1(MAP2K1), ERK1/2, c-Raf-1, PKC, MKP-1, eIF2S1, AKT(PKB), PDK (PDPK1), p38 MAPK",6.748E-02,1.646E-01,10,"ERK1/2, BAD, eIF2S1, AKT(PKB), PDK (PDPK1), c-Jun, 14-3-3 beta/alpha, PKC, MKP-1, p38 MAPK",
645,CAR signaling via cross-talk / Rodent version,27,4.290E-02,1.205E-01,4.290E-02,1.205E-01,9,"CYP2C8, SREBP1 (nuclear), CAR/RXR-alpha, ESR1 (nuclear), G6PT, RXRA, CAR, ACOX1, CYP3A4",4.212E-01,5.885E-01,7,"SREBP1 (nuclear), ESR1 (nuclear), CAR, ACOX1, CAR/RXR-alpha, RXRA, CYP2B6",
646,Proinflammatory mediators release and arachidonic acid metabolites production in basophils in asthma,57,4.291E-02,1.205E-01,4.291E-02,1.205E-01,16,"C5aR, GRB2, CCR3, G-protein alpha-i family, H-Ras, ERK1/2, c-Raf-1, Btk, IP3 receptor, PI3K reg class IA (p85), PLC-beta, cPLA2, MEK6(MAP2K6), MEK1/2, IL-4, p38 MAPK",8.041E-02,1.881E-01,18,"TrkA, GRB2, H-Ras, ERK1/2, IL-3, IP3 receptor, PI3K reg class IA (p85), PLC-beta, cPLA2, MEK6(MAP2K6), IL-13, IL-4, C5aR, CCR3, G-protein alpha-i family, Btk, IL-5 receptor, p38 MAPK",
647,CCR7 signaling pathways in dendritic cells in allergic contact dermatitis,57,4.291E-02,1.205E-01,4.291E-02,1.205E-01,16,"MEK1(MAP2K1), CCR7, GRB2, G-protein alpha-i family, H-Ras, ERK1/2, Myosin II, c-Raf-1, PAK1, IP3 receptor, WASP, JNK(MAPK8-10), LIMK2, AKT(PKB), PDK (PDPK1), p38 MAPK",4.492E-02,1.269E-01,19,"GRB2, H-Ras, ERK1/2, Rac1, IP3 receptor, WASP, LIMK2, AKT(PKB), PDK (PDPK1), CALDAG-GEFI, CCR7, G-protein alpha-i family, Myosin II, PAK1, Paxillin, JNK(MAPK8-10), PI3K reg class IB (p101), p38 MAPK, Cofilin",
648,Development_Thrombopoietin signaling via JAK-STAT pathway,23,4.324E-02,1.212E-01,4.324E-02,1.212E-01,8,"p21, Thrombopoietin, STAT3, CISH, ERG, Bcl-XL, Cyclin D1, SOCS2",1.322E-01,2.614E-01,8,"p21, Thrombopoietin, CISH, ERG, Bcl-XL, Pim-2, Cyclin D1, SOCS2",
649,Th2 cytokine-induced alternative activation of alveolar macrophages in asthma,32,4.330E-02,1.255E-01,1.110E-01,2.322E-01,9,"Galectin-3, CCL22, CCL17, ARG1, STAT6, IL-4, CD23, JMJD3, TFF2",4.330E-02,1.255E-01,12,"Galectin-3, CCL22, CCL17, ARG1, IL-13, IL-4, CD23, IL-25 (IL-17E), RSNB, STAT6, JMJD3, TFF2",
650,Immune response_BAFF-induced non-canonical NF-kB signaling,32,4.330E-02,1.255E-01,1.110E-01,2.322E-01,9,"TRAF2, beta-TrCP, NEDD8, CIKS, E2N(UBC13), E2I, Ubiquitin, Skp2/TrCP/FBXW, UBC12",4.330E-02,1.255E-01,12,"NEDD8, CIKS, E2N(UBC13), E2I, Ubiquitin, IKK-alpha, Skp2/TrCP/FBXW, UEV1A, TRAF2, beta-TrCP, UBE1, UBC12",
651,Development_H3K4 demethylases in stem cell maintenance,32,4.330E-02,1.255E-01,1.110E-01,2.322E-01,9,"PLU-1, CoREST, IRX3, BMI-1, p21, NANOG, FGF4, PTEN, p27KIP1",4.330E-02,1.255E-01,12,"EGR1, p21, FGF4, NRSF, p27KIP1, PLU-1, CoREST, IRX3, BMI-1, T brachyury protein, NANOG, PTEN",
652,NRSF-dependent transcription deregulation in Huntington's Disease,39,4.392E-02,1.255E-01,5.773E-01,7.297E-01,7,"Huntingtin, CoREST, SNAP-25, NR1, Synapsin I, SCP1, p200RhoGAP",4.392E-02,1.255E-01,14,"Huntingtin, microRNA 124a-3, NR1, V-ATPase H subunit, Synapsin I, NRSF, SCP1, CoREST, nAChR beta-2, miR-9-3p, microRNA 9-1, miR-9-5p, p200RhoGAP, miR-124-3p",
653,Apoptosis and survival_APRIL and BAFF signaling,39,4.392E-02,1.255E-01,1.557E-01,2.885E-01,10,"Calcineurin A (catalytic), TRAF2, TRAF5, I-kB, IKK-beta, CAML, Bcl-2, Bcl-XL, JNK(MAPK8-10), CD23",4.392E-02,1.255E-01,14,"Calcineurin A (catalytic), NF-AT1(NFATC2), IKK (cat), I-kB, IKK-alpha, Bcl-XL, CD23, TRAF2, TRAF5, MEKK1(MAP3K1), IKK-beta, CAML, Bcl-2, JNK(MAPK8-10)",
654,Deregulation of Ca2+-dependent neuronal cell survival in Huntington's disease,39,4.392E-02,1.255E-01,8.184E-02,1.884E-01,11,"IPP-1, Calcineurin A (catalytic), Huntingtin, PP1-cat, SynGAP, PI3K reg class IA (p85), Calmodulin, IP3R1, Cyclin D1, AKT(PKB), PDK (PDPK1)",4.392E-02,1.255E-01,14,"Calcineurin A (catalytic), Huntingtin, PP1-cat, Lef-1, NMDA receptor, Hap-1, PI3K reg class IA (p85), AKT(PKB), PDK (PDPK1), IPP-1, SynGAP, Calmodulin, IP3R1, Cyclin D1",
655,Proliferative action of Gastrin in pancreatic cancer,44,4.409E-02,1.231E-01,4.409E-02,1.231E-01,13,"MEK1(MAP2K1), GRB2, c-Fos, H-Ras, ERK1/2, c-Raf-1, IP3 receptor, STAT3, PI3K reg class IA (p85), p70 S6 kinase1, FAK1, PDK (PDPK1), p70 S6 kinase2",5.834E-02,1.501E-01,15,"GRB2, c-Fos, IRS-1, H-Ras, LARG, ERK1/2, IP3 receptor, PI3K reg class IA (p85), PDK (PDPK1), PKC-delta, CCKBR, p70 S6 kinase1, FAK1, G-protein alpha-q, p70 S6 kinase2",
656,wtCFTR traffic / Sorting endosome formation (normal),22,4.425E-02,1.255E-01,8.798E-02,1.967E-01,7,"Rabaptin-5, SNAP-25, CFTR, DAB2, Ubiquitin, VPS45A, EEA1",4.425E-02,1.255E-01,9,"NSF, Rabaptin-5, COMMD1 (MURR1), DAB2, Ubiquitin, RABGEF1, Rab-7, VPS45A, EEA1",
657,LRRK2 and immune function in Parkinson's disease,22,4.425E-02,1.255E-01,3.682E-01,5.321E-01,5,"MHC class II, LRRK2, PR65-alpha, I-kB, IKK-beta",4.425E-02,1.255E-01,9,"MHC class II, NF-AT1(NFATC2), FCGR3A, PR65-alpha, CSE1L, I-kB, LRRK2, Nron, IKK-beta",
658,Regulation of intrinsic membrane properties and excitability of striatopallidal medium spiny neurons in Huntington's disease,57,4.492E-02,1.269E-01,8.008E-02,1.864E-01,15,"MaxiK alpha subunit, cPKC (conventional), Calcineurin A (catalytic), G-protein alpha-i family, G-protein alpha-q/11, ACM1, SHANK, IP3 receptor, CACNA1D, KCNQ3, Calmodulin, PKC, Homer, Guanylate Cyclase 1, soluble, Adenosine A2a receptor",4.492E-02,1.269E-01,19,"MaxiK alpha subunit, Calcineurin A (catalytic), G-protein alpha-q/11, SHANK, PLC-beta1, IP3 receptor, KCNQ3, Guanylate Cyclase 1, soluble, cPKC (conventional), G-protein alpha-i family, ACM1, CACNA1D, Calmodulin, PKC, SK3, Homer, KCNQ2, N-type Ca(II) channel alpha1B, Adenosine A2a receptor",
659,Dysregulation of direct glucose-induced inhibition of Glucagon secretion from alpha-cells in type 2 diabetes  ,53,4.582E-02,1.270E-01,4.582E-02,1.270E-01,15,"MaxiK alpha subunit, CACNA1H, SUR1, SNAP-25, Kv3.1, CACNA1C, PASK, Kir6.2, MUNC13-1, AMPK alpha 2 subunit, CACNA1D, GLUT1, MafB, Synaptotagmin VII, PC2",2.106E-01,3.607E-01,15,"MaxiK alpha subunit, CACNA1H, SUR1, Kv3.1, PASK, Kir6.2, Syntaxin 1A, MafB, Synaptotagmin VII, CACNA1C, AMPK alpha 2 subunit, CACNA1D, GLUT1, N-type Ca(II) channel alpha1B, PC2",
660,Immune response_HMGB1/RAGE signaling pathway,53,4.582E-02,1.270E-01,4.582E-02,1.270E-01,15,"K-RAS, ERK1/2, c-Raf-1, p90RSK1, NFKBIA, MYOG, I-kB, PI3K reg class IA (p85), MEK6(MAP2K6), FAK1, MEK1/2, JNK(MAPK8-10), AKT(PKB), SP1, p38 MAPK",1.322E-01,2.614E-01,16,"ERK1/2, Rac1, MYOG, I-kB, PI3K reg class IA (p85), MEK6(MAP2K6), AKT(PKB), Chromogranin A, K-RAS, c-Jun, NFKBIA, Paxillin, FAK1, JNK(MAPK8-10), SP1, p38 MAPK",
661,Immune response_Inhibitory PD-1 signaling in T cells,53,4.582E-02,1.270E-01,4.582E-02,1.270E-01,15,"GATA-3, CD80, MHC class II, ERK1/2, PI3K reg class IA (p85), PTEN, CD3, FOXP3, Bcl-XL, Skp2/TrCP/FBXW, SHP-1, AKT(PKB), SP1, PDK (PDPK1), p27KIP1",1.322E-01,2.614E-01,16,"MHC class II, ERK1/2, PI3K reg class IA (p85), ZAP70, FOXP3, Bcl-XL, Skp2/TrCP/FBXW, SHP-1, AKT(PKB), PDK (PDPK1), p27KIP1, GATA-3, PTEN, SHP-2, SP1, TCR alpha/beta",
662,"Immune response_IL-4-induced regulators of cell growth, survival, differentiation and metabolism",62,4.631E-02,1.281E-01,4.631E-02,1.281E-01,17,"GATA-3, A-FABP, ANGPTL4, CCR2, Cyclin D, p21, Cytochrome c, STAT3, CPT-1A, AP-1, CISH, Bcl-2, Bcl-XL, STAT6, IL-4, AKT(PKB), p27KIP1",9.536E-02,2.103E-01,19,"CCR2, p21, Cytochrome c, CPT-1A, CISH, Bcl-XL, FasL(TNFSF6), IL-4, AKT(PKB), p27KIP1, c-Myc, GATA-3, ANGPTL4, Cyclin D, CYP2E1, AP-1, Bcl-2, FOXO3A, STAT6",
663,TGF-beta signaling via microRNA in breast cancer,50,4.685E-02,1.314E-01,4.219E-01,5.868E-01,10,"E-cadherin, Chk2, JunB, RBM35B, DDX5, ID2, Sirtuin1, TGF-beta 3, Bcl-2, c-Myb",4.685E-02,1.314E-01,17,"microRNA 200c, microRNA 200b, RBM35B, ID2, miR-141-3p, miR-200c-3p, c-Myb, miR-200b-3p, E-cadherin, microRNA 141, microRNA 429, JunB, miR-429-3p, DDX5, Sirtuin1, TGF-beta 3, Bcl-2",
664,Immune response_Function of MEF2 in T lymphocytes,50,4.685E-02,1.314E-01,1.831E-01,3.214E-01,12,"p38alpha (MAPK14), Calcineurin A (catalytic), CACNA1C, MEF2, IP3 receptor, MEF2D, Calmodulin, NUR77, CD3, CaMKK, MEK6(MAP2K6), Calcineurin A (beta)",4.685E-02,1.314E-01,17,"Calcineurin A (catalytic), NF-AT1(NFATC2), 14-3-3, IP3 receptor, p38beta (MAPK11), ZAP70, MEK6(MAP2K6), Calcineurin A (beta), c-Jun, CACNA1C, MEF2, LAT, MEF2D, Calmodulin, NUR77, CaMKK, TCR alpha/beta",
665,Immune response_Fc epsilon RI pathway: signaling through Fyn and PI3K,61,4.756E-02,1.319E-01,7.415E-02,1.775E-01,16,"SGK3, GRB2, VAMP8, Fc epsilon RI gamma, ZFP36(Tristetraprolin), NF-AT, SPHK2, I-kB, PI3K reg class IA (p85), AP-1, CalDAG-GEFII, IKK-beta, AKT(PKB), PDK (PDPK1), SNAP-23, Rab-27B",4.756E-02,1.319E-01,20,"GRB2, Fc epsilon RI gamma, IKK (cat), I-kB, PI3K reg class IA (p85), CalDAG-GEFII, IL-13, AKT(PKB), Syntaxin 4, PDK (PDPK1), Rab-27B, SGK3, VAMP8, ZFP36(Tristetraprolin), NF-AT, SPHK2, AP-1, SHP-2, IKK-beta, SNAP-23",
666,DKK1 signaling in multiple myeloma,19,4.787E-02,1.319E-01,4.612E-01,6.229E-01,4,"Krm2, Dsh, JNK(MAPK8-10), Axin",4.787E-02,1.319E-01,8,"WNT3A, Krm2, Dsh, LRP5, Axin, Tcf(Lef), JNK(MAPK8-10), Frizzled",
667,Brca1 and Brca2 in breast cancer,19,4.787E-02,1.319E-01,4.612E-01,6.229E-01,4,"ESR1 (nuclear), ESR1 (membrane), BRIP1, MLH1",4.787E-02,1.319E-01,8,"ESR1 (nuclear), ESR1 (membrane), Rad51, BRIP1, Nibrin, Tubulin gamma, Rad50, MLH1",
668,Inhibition of WNT5A-dependent non-canonical pathway in colorectal cancer,19,4.787E-02,1.319E-01,1.140E-01,2.379E-01,6,"ROR2, SIAH2, ROR-alpha, NLK, Calmodulin, Cyclin D1",4.787E-02,1.319E-01,8,"Lef-1, c-Myc, ROR2, SIAH2, c-Jun, NLK, Calmodulin, Cyclin D1",
669,Cigarette smoke-mediated regulation of NRF2-antioxidant pathway in airway epithelial cells,29,4.790E-02,1.319E-01,4.336E-01,5.976E-01,6,"GPX2, G6PD, GSHR, ME1, TALDO, NQO1",4.790E-02,1.319E-01,11,"GPX2, GSTO1, ME1, G6PD, PKC-delta, DJ-1, PRDX1, GSHR, GSTA1, TALDO, NQO1",
670,EZH2 in Prostate Cancer,29,4.790E-02,1.319E-01,6.542E-02,1.613E-01,9,"E-cadherin, Protein kinase G1, AKT1, NckAP1L, p21, PGE2R3, SOCS2, Relaxin 1, SDF-1",4.790E-02,1.319E-01,11,"AIP1 (DAB2ip), Protein kinase G1, AKT1, p21, Relaxin 1, YY1, SDF-1, E-cadherin, NckAP1L, PGE2R3, SOCS2",
671,Immune response_CD137 signaling in immune cell,29,4.790E-02,1.319E-01,6.542E-02,1.613E-01,9,"MEK1(MAP2K1), TRAF2, ERK1/2, NFKBIA, MEK6(MAP2K6), Bcl-2, Bcl-XL, IL-4, p38 MAPK",4.790E-02,1.319E-01,11,"ERK1/2, IKK-alpha, MEK6(MAP2K6), Bcl-XL, IL-4, TRAF2, c-Jun, NFKBIA, MEKK1(MAP3K1), Bcl-2, p38 MAPK",
672,"NF-kB-, AP-1- and MAPKs-mediated proinflammatory cytokine production by eosinophils in asthma",43,4.829E-02,1.325E-01,7.618E-02,1.792E-01,12,"CCL22, CCL17, ERK1/2, Tryptase, MGF, AP-1, JNK(MAPK8-10), Myeloblastin, STAT6, IL-4, Leptin, p38 MAPK",4.829E-02,1.325E-01,15,"CCL22, CCL17, ERK1/2, Chymase, IL-4, IL-25 (IL-17E), c-Jun, Tryptase, MGF, AP-1, JNK(MAPK8-10), Myeloblastin, STAT6, Leptin, p38 MAPK",
673,Statin action on the PI3K/ Akt pathway in COPD,36,4.885E-02,1.326E-01,4.905E-02,1.335E-01,11,"NIP3, p70 S6 kinases, FOXO4, p70 S6 kinase1, PI3K reg class IA, eNOS, AKT(PKB), HSP90, p70 S6 kinase2, p27KIP1, PUMA",4.885E-02,1.326E-01,13,"NIP3, p70 S6 kinases, PI3K reg class IA, FasL(TNFSF6), AKT(PKB), HSP90, p27KIP1, PUMA, FOXO4, p70 S6 kinase1, FOXO3A, eNOS, p70 S6 kinase2",
674,iNKT cell-keratinocyte interactions in allergic contact dermatitis,36,4.885E-02,1.326E-01,6.578E-01,8.008E-01,6,"MEK1(MAP2K1), ERK1/2, CD161, CD3, CD3 epsilon, IL-4",4.885E-02,1.326E-01,13,"TCR alpha subunit, TCR beta subunit, NF-AT1(NFATC2), ERK1/2, TCR beta variable 11-2, ITK, FasL(TNFSF6), IL-4, CXCR3, CD161, MEKK1(MAP3K1), TCR alpha variable 24, TCR alpha/beta",
675,Immune response_HMGB1/TLR signaling pathway,36,4.885E-02,1.326E-01,1.928E-01,3.318E-01,9,"p38alpha (MAPK14), TIRAP (Mal), E2N(UBC13), Ubiquitin, I-kB, IFN-alpha, IKK-beta, MEK6(MAP2K6), TAB2",4.885E-02,1.326E-01,13,"E2N(UBC13), Ubiquitin, I-kB, MyD88, IKK-alpha, IFN-alpha, MEK6(MAP2K6), TAB2, UEV1A, TIRAP (Mal), UBE1, IKK-beta, TAB1",
676,Development_Hedgehog and PTH signaling pathways in bone and cartilage development,36,4.885E-02,1.326E-01,4.905E-02,1.335E-01,11,"c-Fos, VDR, PTHR1, PKA-reg (cAMP-dependent), SHH, Adenylate cyclase type I, G-protein alpha-q/11, G-protein alpha-s, PLC-beta, Bone sialoprotein, Cyclin D1",4.885E-02,1.326E-01,13,"c-Fos, PTHR1, EGR1, PKA-reg (cAMP-dependent), G-protein alpha-q/11, PLC-beta, Bone sialoprotein, VDR, SHH, Adenylate cyclase type I, G-protein alpha-s, Cyclin D1, Parathyroid hormone",
677,Regulation of lipid metabolism_Regulation of lipid metabolism by niacin and isoprenaline,49,4.888E-02,1.335E-01,4.888E-02,1.335E-01,14,"Calcineurin A (catalytic), G-protein alpha-i family, Adenylate cyclase type VI, PKA-reg (cAMP-dependent), Adenylate cyclase type I, LIPS, Adenylate cyclase type IX, Adenylate cyclase type V, Adenylate cyclase type II, G-protein alpha-s, Calmodulin, PKC, Adenylate cyclase type IV, AQP6",7.373E-02,1.758E-01,16,"Calcineurin A (catalytic), Adenylate cyclase type VI, PKC-zeta, PKA-reg (cAMP-dependent), Adenylate cyclase type V, Adenylate cyclase type II, AQP6, PKC-delta, G-protein alpha-i family, Adenylate cyclase type I, LIPS, Adenylate cyclase type IX, G-protein alpha-s, Calmodulin, PKC, Adenylate cyclase type IV",
678,Activation of TNF-alpha-dependent pro-tumoral effect in colorectal cancer,49,4.888E-02,1.335E-01,4.888E-02,1.335E-01,14,"GRB2, K-RAS, MADD, TRAF2, H-Ras, ERK1/2, c-Raf-1, TRADD, I-kB, G-protein alpha-s, IKK-beta, MEK1/2, p38 MAPK, Axin",3.165E-01,4.848E-01,13,"GRB2, MADD, H-Ras, ERK1/2, TRADD, I-kB, IKK-alpha, Axin, K-RAS, TRAF2, G-protein alpha-s, IKK-beta, p38 MAPK",
679,Dual role of p53 in transcription deregulation in Huntington's Disease,12,5.025E-02,1.355E-01,5.025E-02,1.355E-01,5,"Huntingtin, FLJ11259, p21, HSPA1A, PUMA",1.155E-01,2.414E-01,5,"Huntingtin, p21, PUMA, FLJ11259, HSPA1A",
680,Role of cell adhesion molecules in progression of pancreatic cancer,45,5.208E-02,1.394E-01,5.208E-02,1.394E-01,13,"MEK1(MAP2K1), E-cadherin, GRB2, K-RAS, SIAT8D, H-Ras, ERK1/2, c-Raf-1, Alpha-catenin, FAK1, IL-1RI, Cyclin D1, Plakoglobin",1.258E-01,2.552E-01,14,"GRB2, H-Ras, ERK1/2, IL-1RI, c-Myc, E-cadherin, K-RAS, SIAT8D, Tcf(Lef), Alpha-catenin, Caspase-7, FAK1, Cyclin D1, Plakoglobin",
681,Immune response_OX40L/ OX40 signaling pathway,69,5.224E-02,1.405E-01,1.084E-01,2.301E-01,17,"Calcineurin A (catalytic), TRAF2, CXCR5, TRAF5, IP3 receptor, I-kB, PI3K reg class IA (p85), Calmodulin, CD3, FOXP3, IKK-beta, IL23R, Bcl-2, Bcl-XL, IL-4, AKT(PKB), PDK (PDPK1)",5.224E-02,1.405E-01,22,"Calcineurin A (catalytic), IKK (cat), Perforin, IP3 receptor, I-kB, PI3K reg class IA (p85), FOXP3, IKK-alpha, IL23R, IL-13, Bcl-XL, IL-9, IL-4, AKT(PKB), PDK (PDPK1), IL-2R alpha chain, TRAF2, TRAF5, Calmodulin, IKK-beta, Bcl-2, TCR alpha/beta",
682,Th9 cells in asthma,47,5.225E-02,1.405E-01,4.873E-01,6.432E-01,9,"PU.1, GATA-3, MHC class II, GCN5, TGF-beta, PKA-reg (cAMP-dependent), MGF, STAT6, IL-4",5.225E-02,1.405E-01,16,"MHC class II, NF-AT1(NFATC2), GCN5, PKA-reg (cAMP-dependent), CCL13, IKK-alpha, IL-9, IL-4, PU.1, GATA-3, IL-25 (IL-17E), TGF-beta, MGF, IL-5 receptor, STAT6, TCR alpha/beta",
683,Chemotaxis_Lipoxin inhibitory action on Formyl-Met-Leu-Phe-induced neutrophil chemotaxis,47,5.225E-02,1.405E-01,3.429E-01,5.072E-01,10,"G-protein alpha-i family, LTBR1, Hck, MAPKAPK2, HSP27, MEK6(MAP2K6), AKT(PKB), PDK (PDPK1), p38 MAPK, PREX1",5.225E-02,1.405E-01,16,"PKC-zeta, Rac1, Hck, MAPKAPK2, MEK6(MAP2K6), AKT(PKB), PDK (PDPK1), G-protein alpha-i family, LTBR1, MEKK1(MAP3K1), HSP27, Fibrinogen gamma, PI3K reg class IB (p101), p38 MAPK, Cofilin, PREX1",
684,Transport_Alpha-2 adrenergic receptor regulation of ion channels,47,5.225E-02,1.405E-01,7.088E-02,1.708E-01,13,"Alpha-2C-1 adrenergic receptor, G-protein alpha-i family, Adenylate cyclase type VI, CACNA1C, PKA-reg (cAMP-dependent), Alpha-2A adrenergic receptor, IP3 receptor, Adenylate cyclase type V, G-protein alpha-s, PKC, IP3R1, AKT(PKB), PDK (PDPK1)",5.225E-02,1.405E-01,16,"Adenylate cyclase type VI, PKC-zeta, PKA-reg (cAMP-dependent), IP3 receptor, Adenylate cyclase type V, AKT(PKB), PDK (PDPK1), Alpha-2C-1 adrenergic receptor, G-protein alpha-i family, CACNA1C, Alpha-2A adrenergic receptor, G-protein alpha-s, PKC, IP3R1, G-protein alpha-q, N-type Ca(II) channel alpha1B",
685,Macrophage and dendritic cell phenotype shift in cancer,100,5.269E-02,1.407E-01,5.269E-02,1.407E-01,25,"CD80, MHC class II, ESR1 (nuclear), XBP1, ITGAM, ESR2 (nuclear), ILT4, IL-12 alpha, STAT3, ARG1, I-kB, DLL1, PI3K reg class IA, IFN-alpha, IRF5, IL-1RI, SHP-1, CD40(TNFRSF5), STAT6, IL-4, IRE1, JMJD3, p38 MAPK, IL-6 receptor, CD40L(TNFSF5)",1.864E-01,3.350E-01,27,"MHC class II, ESR1 (nuclear), XBP1, IKK (cat), ESR2 (nuclear), ILT4, IL-12 alpha, ARG1, I-kB, DLL1, PI3K reg class IA, IFN-alpha, IL-13, IL-1RI, SHP-1, IL-4, IRE1, SHIP, ILT3, ITGAM, DLL4, IRF5, CD40(TNFRSF5), STAT6, JMJD3, p38 MAPK, IL-6 receptor",
686,Neurophysiological process_GABA-B receptor signaling at postsynaptic sides of synapses,26,5.294E-02,1.415E-01,8.367E-02,1.914E-01,8,"Kir3.2, G-protein alpha-i family, GRK4, NOVA2, Kir3.1, GBR2, Calmodulin, ATF-5",5.294E-02,1.415E-01,10,"ATF-4, Kir3.1, NMDA receptor, ATF-5, Kir3.2, G-protein alpha-i family, GRK4, NOVA2, GBR2, Calmodulin",
687,Cell adhesion_Classical cadherin-mediated cell adhesion,26,5.294E-02,1.415E-01,8.367E-02,1.914E-01,8,"E-cadherin, Formin, BAIAP2, Alpha-actinin, Alpha-catenin, VAV-2, Cortactin, Plakoglobin",5.294E-02,1.415E-01,10,"BAIAP2, Rac1, VAV-2, Cortactin, E-cadherin, Formin, Alpha-catenin, N-WASP, Plakoglobin, p120-catenin",
688,Immune response_IL-33 signaling pathway,58,5.299E-02,1.415E-01,1.540E-01,2.866E-01,14,"p38alpha (MAPK14), ERK1/2, Ubiquitin, I-kB, PI3K reg class IA, IKK-beta, MEK6(MAP2K6), eNOS, MEK1/2, JNK(MAPK8-10), MSK1, TAB2, AKT(PKB), E-selectin",5.299E-02,1.415E-01,19,"ERK1/2, IKK (cat), Ubiquitin, I-kB, PI3K reg class IA, MyD88, IKK-alpha, MEK6(MAP2K6), IL-13, MSK1, TAB2, AKT(PKB), E-selectin, c-Jun, MKK7 (MAP2K7), IKK-beta, TAB1, eNOS, JNK(MAPK8-10)",
689,Apoptosis and survival_CXCR3-B signaling,63,5.310E-02,1.407E-01,5.310E-02,1.407E-01,17,"GATA-3, MIG, ERK1/2, PKA-reg (cAMP-dependent), p21, Cytochrome c, IP3 receptor, STAT3, G-protein alpha-s, Adenylate cyclase, Bcl-2, Bcl-XL, Clathrin, STAT6, IL-4, p38 MAPK, GRK2",1.086E-01,2.303E-01,19,"ERK1/2, PKA-reg (cAMP-dependent), p21, Cytochrome c, IP3 receptor, Adenylate cyclase, IL-13, Bcl-XL, IL-4, GRK2, GATA-3, PARP-1, CXCR3, G-protein alpha-s, Bcl-2, Beclin 1, Clathrin, STAT6, p38 MAPK",
690,Transcription_PPAR Pathway,63,5.310E-02,1.407E-01,5.310E-02,1.407E-01,17,"MEK1(MAP2K1), p38alpha (MAPK14), GRB2, H-Ras, ERK1/2, RXRA, MED1, PKA-reg (cAMP-dependent), c-Raf-1, Adenylate cyclase type I, SHP, G-protein alpha-s, PI3K reg class IA, Insulin receptor, MEK6(MAP2K6), AKT(PKB), p38 MAPK",5.924E-01,7.436E-01,14,"GRB2, IRS-1, H-Ras, ERK1/2, MED1, PKA-reg (cAMP-dependent), PI3K reg class IA, Insulin receptor, MEK6(MAP2K6), AKT(PKB), RXRA, Adenylate cyclase type I, G-protein alpha-s, p38 MAPK",
691,Membrane-bound ESR1: interaction with G-proteins signaling,54,5.319E-02,1.407E-01,5.319E-02,1.407E-01,15,"MEK1(MAP2K1), GRB2, c-Fos, G-protein alpha-i family, H-Ras, ERK1/2, ESR1 (membrane), PKA-reg (cAMP-dependent), c-Raf-1, IP3 receptor, G-protein alpha-s, Adenylate cyclase, eNOS, PKC-gamma, GPR30",2.339E-01,3.851E-01,15,"GRB2, c-Fos, H-Ras, ERK1/2, ESR1 (membrane), PKA-reg (cAMP-dependent), PLC-beta1, IP3 receptor, Adenylate cyclase, PKC-gamma, G-protein alpha-i family, G-protein alpha-s, eNOS, G-protein alpha-q, GPR30",
692,Immune response_Innate immune response to RNA viral infection,28,5.339E-02,1.407E-01,5.339E-02,1.407E-01,9,"TBK1, TRADD, FADD, I-kB, IFN-alpha, IKK-beta, LGP2, IRF3, E-selectin",8.433E-02,1.934E-01,10,"TBK1, IKK (cat), TRADD, FADD, I-kB, IFN-alpha, E-selectin, IKK-beta, LGP2, IRF3",
693,Development_Mu-type opioid receptor regulation of proliferation,28,5.339E-02,1.407E-01,5.339E-02,1.407E-01,9,"MEK1(MAP2K1), GRB2, c-Fos, JunB, G-protein alpha-i family, H-Ras, ERK1/2, c-Raf-1, Calmodulin",2.969E-01,4.586E-01,8,"GRB2, c-Fos, H-Ras, ERK1/2, PLC-beta1, JunB, G-protein alpha-i family, Calmodulin",
694,Development_H3K27 demethylases in differentiation of stem cells,40,5.385E-02,1.424E-01,9.521E-02,2.064E-01,11,"ALK-4, HOXC4, BMI-1, HOXB2, RYBP, M33, RARalpha, MLL2, RBBP5, JMJD3, HOXB1",5.385E-02,1.424E-01,14,"ALK-4, RYBP, M33, RARalpha, HOXB1, YY1, HOXC4, BMI-1, T brachyury protein, HOXB2, MLL2, SMAD1, RBBP5, JMJD3",
695,Stem cells_Pancreatic cancer stem cells in tumor metastasis,40,5.385E-02,1.424E-01,9.521E-02,2.064E-01,11,"G-protein alpha-i family, Myosin II, MyHC, IP3 receptor, G-protein alpha-13, Calmodulin, MRLC, FAK1, MELC, SDF-1, MLCK",5.385E-02,1.424E-01,14,"LARG, Rac1, IP3 receptor, G-protein alpha-13, SDF-1, MLCK, G-protein alpha-i family, Myosin II, MyHC, Calmodulin, MRLC, FAK1, MELC, PI3K reg class IB (p101)",
696,"Mechanism of Pioglitazone/ Metformin and Rosiglitazone/ Metformin  cooperative action in Diabetes mellitus, Type 2",16,5.432E-02,1.425E-01,5.432E-02,1.425E-01,6,"AdipoR2, Adiponectin, AMPK alpha subunit, AMPK gamma subunit, LKB1, AdipoR1",1.358E-01,2.675E-01,6,"AMPK gamma subunit, AdipoR2, Adiponectin, AMPK alpha subunit, LKB1, AdipoR1",
697,c-Myc in multiple myeloma,16,5.432E-02,1.425E-01,5.432E-02,1.425E-01,6,"YB-1, p21, STAT3, CD33, p38 MAPK, C/EBPalpha",1.358E-01,2.675E-01,6,"eIF4E, p21, c-Myc, hnRNP A1, p38 MAPK, C/EBPalpha",
698,G-protein signaling_N-RAS regulation pathway,33,5.438E-02,1.424E-01,1.293E-01,2.572E-01,9,"EGF, MHC class II, GRB2, c-Raf-1, RalGDS, IP3 receptor, CD3, CalDAG-GEFII, RGL2",5.438E-02,1.424E-01,12,"EGF, MHC class II, GRB2, A-Raf-1, IP3 receptor, ZAP70, CalDAG-GEFII, CALDAG-GEFI, RalGDS, LAT, RGL2, TCR alpha/beta",
699,"IGF family, invasion and metastasis in colorectal cancer",33,5.438E-02,1.424E-01,1.293E-01,2.572E-01,9,"E-cadherin, Alpha-1 catenin, Vitronectin, PI3K reg class IA, IGF-1 receptor, PKC-gamma, IGF-1, p38 MAPK, ERK1 (MAPK3)",5.438E-02,1.424E-01,12,"IRS-1, Alpha-1 catenin, Rac1, PI3K reg class IA, IGF-1 receptor, PKC-gamma, ERK1 (MAPK3), E-cadherin, PKC-delta, Vitronectin, IGF-1, p38 MAPK",
700,Apoptosis and survival_Granzyme B signaling,33,5.438E-02,1.424E-01,1.293E-01,2.572E-01,9,"NUMA1, Granzyme B, MUNC13-4, Cytochrome c, CD63, FGFR1, Tubulin alpha, Synaptotagmin VII, Smac/Diablo",5.438E-02,1.424E-01,12,"Granzyme B, MUNC13-4, Cytochrome c, Perforin, FGFR1, Synaptotagmin VII, NUMA1, PARP-1, CD63, Caspase-7, Tubulin alpha, Smac/Diablo",
701,Cell adhesion_Integrin inside-out signaling in neutrophils,77,5.481E-02,1.425E-01,5.481E-02,1.425E-01,20,"MEK1(MAP2K1), Protein kinase G1, AKT1, URP2, G-protein alpha-i family, Protein kinase G, LTBR1, IL8RA, PIP5KI, Btk, IP3 receptor, Fc gamma RI, Hck, ARF6, MEK1/2, PDK (PDPK1), p38 MAPK, E-selectin, PREX1, IL8RB",5.618E-02,1.458E-01,24,"Protein kinase G1, AKT1, URP2, PKC-zeta, Rac1, IP3 receptor, Hck, ARF6, PDK (PDPK1), E-selectin, IL8RB, CALDAG-GEFI, PKC-delta, G-protein alpha-i family, Protein kinase G, LTBR1, IL8RA, C3G, PIP5KI, Btk, Fc gamma RI, PI3K reg class IB (p101), p38 MAPK, PREX1",
702,Tissue factor signaling in lung cancer,24,5.489E-02,1.425E-01,5.489E-02,1.425E-01,8,"MEK1(MAP2K1), K-RAS, ERK1/2, c-Raf-1, Coagulation factor VII, PTEN, AKT(PKB), PDK (PDPK1)",2.970E-01,4.586E-01,7,"ERK1/2, Coagulation factor VII, Thrombin, AKT(PKB), PDK (PDPK1), K-RAS, PTEN",
703,Proteolysis_Role of Parkin in the Ubiquitin-Proteasomal Pathway,24,5.489E-02,1.425E-01,5.489E-02,1.425E-01,8,"Tubulin beta, SIAH2, FBXW7, Parkin, Tubulin alpha, DORFIN, CHIP, HSP70",7.523E-02,1.782E-01,9,"FBXW7, Parkin, DORFIN, HSP70, Tubulin beta, SIAH2, UBE1, Tubulin alpha, CHIP",
704,Transcription_Mechanism of activation of the transcription of Retinoid-target genes,24,5.489E-02,1.425E-01,5.489E-02,1.425E-01,8,"NCOA3 (pCIP/SRC3), RXRA, MED1, CRABP2, RAR-alpha/RXR-alpha, CAK complex, RARalpha, PSMC5",7.523E-02,1.782E-01,9,"Cyclin D3, MED1, CRABP2, CAK complex, RARalpha, PSMC5, NCOA3 (pCIP/SRC3), RXRA, RAR-alpha/RXR-alpha",
705,Development_VEGF-family signaling,41,5.539E-02,1.425E-01,5.539E-02,1.425E-01,12,"MEK1(MAP2K1), GRB2, c-Fos, H-Ras, ERK1/2, VEGFR-1, c-Raf-1, IP3 receptor, Vitronectin, VEGF-D, PI3K reg class IA, AKT(PKB)",2.075E-01,3.599E-01,12,"GRB2, c-Fos, H-Ras, ERK1/2, c-Jun/c-Fos, IP3 receptor, VEGF-D, PI3K reg class IA, AKT(PKB), c-Jun, VEGFR-1, Vitronectin",
706,Role of Langerin+ dermal dendritic cells in contact hypersensitivity,20,5.543E-02,1.425E-01,5.543E-02,1.425E-01,7,"CCR7, CCR2, FLT3, ITGAX, STAT3, ITGB7, E-selectin",2.956E-01,4.586E-01,6,"CCR2, FLT3, ITGAX, ITGB7, E-selectin, CCR7",
707,Stem cells_Putative pathways of telomerase regulation in glioblastoma stem cells,20,5.543E-02,1.425E-01,5.543E-02,1.425E-01,7,"TERC, PTEN, AKT(PKB), SP1, HSP90, PDK (PDPK1), p23 co-chaperone",6.433E-02,1.606E-01,8,"AKT(PKB), HSP90, PDK (PDPK1), c-Myc, PTEN, TEP1, SP1, p23 co-chaperone",
708,Development_H3K36 demethylation in stem cell maintenance,20,5.543E-02,1.425E-01,5.543E-02,1.425E-01,7,"p21, AP-2A, KDM2B, Rb protein, RYBP, M33, MDM2",6.433E-02,1.606E-01,8,"p21, Rb protein, RYBP, M33, MDM2, AP-2A, BCoR, KDM2B",
709,DNA damage_Inhibition of telomerase activity and cellular senescence,20,5.543E-02,1.425E-01,5.543E-02,1.425E-01,7,"TERC, E2F1, p21, Rb protein, p130, AKT(PKB), SP1",1.502E-01,2.867E-01,7,"p21, Rb protein, p130, AKT(PKB), E2F1, TEP1, SP1",
710,wtCFTR and deltaF508-CFTR traffic / Clathrin coated vesicles formation (normal and CF),20,5.543E-02,1.425E-01,5.543E-02,1.425E-01,7,"Myosin I, CFTR, DAB2, Myosin VI, HIP12, Clathrin, Clathrin heavy chain",1.502E-01,2.867E-01,7,"Myosin I, DAB2, Actin, HIP12, Clathrin heavy chain, Myosin VI, Clathrin",
711,Regulation of angiogenesis in prostate cancer,51,5.584E-02,1.454E-01,6.594E-02,1.620E-01,14,"Tuberin, EGF, CCR2, AGTR1, VEGFR-1, IL8RA, Androgen receptor, PI3K reg class IA (p85), VEGF-D, IL-1RI, PGES2, AKT(PKB), PDK (PDPK1), IL8RB",5.584E-02,1.454E-01,17,"Tuberin, EGF, CCR2, Plasminogen, Androgen receptor, PI3K reg class IA (p85), VEGF-D, IL-1RI, PGES2, AKT(PKB), PDK (PDPK1), IL8RB, FOLH1 (GCP2), AGTR1, VEGFR-1, Plasmin, IL8RA",
712,Tumor metabolic pathways promoting development of Treg cells,96,5.678E-02,1.450E-01,5.678E-02,1.450E-01,24,"CCL28, PDK1, CCL22, CD80, MHC class II, ICOS-L, ACACA, CCL17, CISY, AMPK alpha subunit, FASN, FGFR1, STAT3, I-kB, GLUT1, ACLY, ErbB2, FOXP3, HIF-prolyl hydroxylase, CCR5, ENP1, Adenosine A2a receptor, LAG3, SDF-1",8.767E-02,1.999E-01,28,"CCL22, MHC class II, ICOS-L, CCL17, CISY, IKK (cat), FASN, FGFR1, I-kB, PDH, ErbB2, FOXP3, CCR5, ICOS, ENP1, c-Myc, IL-2R alpha chain, SDF-1, CCL28, ARNT, AMPK alpha subunit, TIM-3, GLUT1, ACLY, HIF-prolyl hydroxylase, TCR alpha/beta, Adenosine A2a receptor, LAG3",
713,Development_EDNRB signaling,50,5.698E-02,1.450E-01,5.698E-02,1.450E-01,14,"MEK1(MAP2K1), GRB2, c-Fos, G-protein alpha-i family, H-Ras, ERK1/2, Protein kinase G, c-Raf-1, G-protein alpha-q/11, IP3 receptor, PLC-beta, eNOS, Guanylate Cyclase 1, soluble, AKT(PKB)",2.343E-01,3.851E-01,14,"GRB2, c-Fos, H-Ras, ERK1/2, G-protein alpha-q/11, IP3 receptor, PLC-beta, Guanylate Cyclase 1, soluble, AKT(PKB), CALDAG-GEFI, G-protein alpha-i family, Protein kinase G, eNOS, PI3K reg class IB (p101)",
714,HBV-dependent NF-kB and PI3K/AKT pathways leading to HCC,50,5.698E-02,1.450E-01,5.698E-02,1.450E-01,14,"GRB2, H-Ras, c-Raf-1, Bcl-3, NFKBIA, Androgen receptor, I-kB, PI3K reg class IA (p85), PTEN, FAK1, Cyclin D1, AKT(PKB), PDK (PDPK1), p27KIP1",1.477E-01,2.845E-01,15,"GRB2, H-Ras, Bcl-3, BAD, Androgen receptor, I-kB, PI3K reg class IA (p85), IKK-alpha, AKT(PKB), PDK (PDPK1), p27KIP1, NFKBIA, PTEN, FAK1, Cyclin D1",
715,PDE4 regulation of cyto/chemokine expression in inflammatory skin diseases,50,5.698E-02,1.450E-01,5.698E-02,1.450E-01,14,"MIG, G-protein alpha-i family, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, PDE4, IL-12 alpha, NFKBIA, MAPKAPK2, Adenylate cyclase, MEK1/2, MSK1, IL-4, p38 MAPK",1.477E-01,2.845E-01,15,"NF-AT1(NFATC2), ERK1/2, 14-3-3, PKA-reg (cAMP-dependent), IKK (cat), IL-12 alpha, MAPKAPK2, Adenylate cyclase, IL-13, MSK1, IL-4, G-protein alpha-i family, PDE4, NFKBIA, p38 MAPK",
716,Translation_Opioid receptors in regulation of translation ,23,5.843E-02,1.501E-01,2.272E-01,3.743E-01,6,"Tuberin, G-protein alpha-i family, p70 S6 kinase1, 4E-BP2, AKT(PKB), PDK (PDPK1)",5.843E-02,1.501E-01,9,"Tuberin, 4E-BP2, AKT(PKB), PDK (PDPK1), Delta-type opioid receptor, G-protein alpha-i family, 4E-BP1, p70 S6 kinase1, PI3K reg class IB (p101)",
717,Role of red blood cell adhesion to endothelium in vaso-occlusion in Sickle cell disease,37,5.878E-02,1.488E-01,5.878E-02,1.488E-01,11,"cAMP-GEFI, G-protein alpha-i family, ERK1/2, PKA-reg (cAMP-dependent), CD36, GP-IB alpha, LAMA5, BCAM, MEK1/2, von Willebrand factor, E-selectin",3.276E-01,4.972E-01,10,"cAMP-GEFI, ERK1/2, PKA-reg (cAMP-dependent), von Willebrand factor, E-selectin, G-protein alpha-i family, CD36, GP-IB alpha, LAMA5, BCAM",
718,Role of alveolar cell senescence in COPD,37,6.013E-02,1.529E-01,1.191E-01,2.445E-01,10,"MEK1(MAP2K1), ERK1/2, p21, I-kB, Sirtuin1, eNOS, AKT(PKB), NOX1, p38 MAPK, Klotho",6.013E-02,1.529E-01,13,"IRS-1, ERK1/2, IKK (cat), p21, Rac1, I-kB, AKT(PKB), NOX1, Sirtuin1, FOXO3A, eNOS, p38 MAPK, Klotho",
719,"Immune response_Mast cell proliferation, differentiation and survival",30,6.056E-02,1.529E-01,7.903E-02,1.842E-01,9,"GRB2, CSF2RB, ERK1/2, MGF, STAT3, PI3K reg class IA (p85), JNK(MAPK8-10), STAT6, AKT(PKB)",6.056E-02,1.529E-01,11,"GRB2, ERK1/2, IL-3, PI3K reg class IA (p85), SHIP, AKT(PKB), CSF2RB, MGF, SHP-2, JNK(MAPK8-10), STAT6",
720,Regulation of IGF family activity in colorectal cancer,30,6.056E-02,1.529E-01,1.629E-01,2.972E-01,8,"IBP4, IBP2, CEACAM5, IGF-1 receptor, SP1, IBP5, IGF-1, IBP",6.056E-02,1.529E-01,11,"Plasminogen, IGF-1 receptor, IBP5, IBP, Cystatin SN, Plasmin, IBP4, IBP2, CEACAM5, SP1, IGF-1",
721,Role of prenatal nicotine exposure in apoptosis and proliferation of pancreatic beta cells,30,6.056E-02,1.529E-01,1.629E-01,2.972E-01,8,"Insulin processed, Cytochrome c, Insulin receptor, Bcl-2, nAChR alpha-4, nAChR alpha-2, IGF-1 receptor, IGF-1",6.056E-02,1.529E-01,11,"Insulin processed, Cytochrome c, Insulin receptor, nAChR alpha-4, IGF-1 receptor, FasL(TNFSF6), nAChR beta-2, nAChR alpha-6, Bcl-2, nAChR alpha-2, IGF-1",
722,p53 signaling in Prostate Cancer,33,6.216E-02,1.561E-01,6.216E-02,1.561E-01,10,"p21, Androgen receptor, PI3K reg class IA (p85), PTEN, NK31, MDM2, AKT(PKB), PDK (PDPK1), PUMA, Tubulin (in microtubules)",1.107E-01,2.328E-01,11,"p21, Bak, Androgen receptor, PI3K reg class IA (p85), MDM2, AKT(PKB), PDK (PDPK1), PUMA, Tubulin (in microtubules), PTEN, NK31",
723,Nicotine signaling in glutamatergic neurons,33,6.216E-02,1.561E-01,6.216E-02,1.561E-01,10,"SNAP-25, Adenosine A1 receptor, G-protein alpha-i family, PKA-reg (cAMP-dependent), Synapsin I, Adenylate cyclase type V, G-protein alpha-s, Calmodulin, nAChR alpha-4, Adenosine A2a receptor",2.021E-01,3.530E-01,10,"PKA-reg (cAMP-dependent), NMDA receptor, Synapsin I, Adenylate cyclase type V, nAChR alpha-4, Adenosine A1 receptor, G-protein alpha-i family, G-protein alpha-s, Calmodulin, Adenosine A2a receptor",
724,Chemotaxis_CCL19- and CCL21-mediated chemotaxis,33,6.216E-02,1.561E-01,6.216E-02,1.561E-01,10,"CCR7, c-Fos, G-protein alpha-i family, ERK1/2, PKA-reg (cAMP-dependent), IP3 receptor, G-protein alpha-s, Adenylate cyclase, JNK(MAPK8-10), p38 MAPK",1.107E-01,2.328E-01,11,"c-Fos, ERK1/2, PKA-reg (cAMP-dependent), IP3 receptor, Adenylate cyclase, CCR7, G-protein alpha-i family, G-protein alpha-s, JNK(MAPK8-10), p38 MAPK, Cofilin",
725,Muscle contraction_Role of kappa-type opioid receptor in heart,33,6.216E-02,1.561E-01,6.216E-02,1.561E-01,10,"G-protein alpha-i family, Kir6.1, MYBPC3, Kir6.2, Troponin I, cardiac, IP3 receptor, G-protein alpha-s, PLC-beta, Adenylate cyclase, SUR2",2.021E-01,3.530E-01,10,"MYBPC3, Kir6.2, IP3 receptor, PLC-beta, Adenylate cyclase, SUR2, G-protein alpha-i family, Kir6.1, Troponin I, cardiac, G-protein alpha-s",
726,Cell adhesion_Integrin-mediated cell adhesion and migration,48,6.236E-02,1.570E-01,8.175E-02,1.884E-01,13,"GRB2, ERK1/2, p190RhoGAP, Alpha-actinin, PAK1, MyHC, PIPKI gamma, MRLC, FAK1, Collagen II, LIMK2, MELC, MLCK",6.236E-02,1.570E-01,16,"GRB2, ERK1/2, Rac1, Collagen II, LIMK2, MLCK, p190RhoGAP, PAK1, MyHC, Paxillin, PIPKI gamma, N-WASP, MRLC, FAK1, MELC, Cofilin",
727,Immune response_TCR alpha/beta signaling pathway,97,6.296E-02,1.578E-01,6.296E-02,1.578E-01,24,"p38alpha (MAPK14), CD80, MHC class II, Calcineurin A (catalytic), c-Fos, TRAF2, H-Ras, ERK1/2, E2N(UBC13), c-Raf-1, Ca(II)channel L-type, TRPV1, IP3 receptor, I-kB, MEF2D, AP-1, Calmodulin, CD3, CalDAG-GEFII, IKK-beta, MEK1/2, WASP, AKT(PKB), P2X4",6.348E-02,1.595E-01,29,"MHC class II, Calcineurin A (catalytic), c-Fos, NF-AT1(NFATC2), H-Ras, ERK1/2, c-Jun/c-Fos, E2N(UBC13), IKK (cat), TRPV1, IP3 receptor, NMDA receptor, I-kB, ZAP70, CalDAG-GEFII, ITK, WASP, AKT(PKB), UEV1A, TRAF2, Ca(II)channel L-type, LAT, MEF2D, AP-1, Calmodulin, IKK-beta, TAB1, P2X4, TCR alpha/beta",
728,Muscle contraction_GPCRs in the regulation of smooth muscle tone,83,6.394E-02,1.597E-01,6.394E-02,1.597E-01,21,"MaxiK alpha subunit, G-protein alpha-12 family, TRPC4, G-protein alpha-i family, AGTR1, CACNA1C, Myosin II, PKA-reg (cAMP-dependent), G-protein alpha-q/11, MyHC, IP3 receptor, G-protein alpha-s, Calmodulin, PLC-beta, Adenylate cyclase, Alpha-1A adrenergic receptor, MRLC, TRPC7, MELC, CysLT1 receptor, MLCK",1.729E-01,3.164E-01,23,"MaxiK alpha subunit, LARG, PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, Prostacyclin receptor, PLC-beta, Adenylate cyclase, CysLT1 receptor, MLCK, G-protein alpha-12 family, ACM2, G-protein alpha-i family, AGTR1, CACNA1C, Myosin II, MyHC, G-protein alpha-s, Calmodulin, Alpha-1A adrenergic receptor, MRLC, G-protein alpha-q, MELC",
729,Role of XBP1 protein in multiple myeloma,20,6.433E-02,1.606E-01,1.391E-01,2.707E-01,6,"XBP1, PSMA7, SERP1, IRE1, DnaJB9, PSMA6",6.433E-02,1.606E-01,8,"XBP1, SERP1, IRE1, PSMA5, PSMA6, PSMA7, DnaJB9, DNAJC3",
730,Regulation of caspase activity in Huntington's disease,20,6.433E-02,1.606E-01,1.391E-01,2.707E-01,6,"Calcineurin A (catalytic), Huntingtin, Cytochrome c, HSP27, HSP90, HSP70",6.433E-02,1.606E-01,8,"Calcineurin A (catalytic), Huntingtin, Cytochrome c, NMDA receptor, HSP40, HSP90, HSP70, HSP27",
731,Neuroprotective action of lithium,63,6.470E-02,1.612E-01,3.511E-01,5.163E-01,13,"p38alpha (MAPK14), IPP-1, Calcineurin A (catalytic), FRAT1, P2X2, PP1-cat, Dsh, WNT, Bcl-2, Tau (MAPT), HSP70, p38 MAPK, Axin",6.470E-02,1.612E-01,20,"Calcineurin A (catalytic), FRAT1, PP1-cat, Dsh, NMDA receptor, NR2, Tau (MAPT), HSP70, Axin, Thioredoxin, IPP-1, IPP-2, P2X2, c-Jun, MKK7 (MAP2K7), HSF1, WNT, Bcl-2, p38 MAPK, Frizzled",
732,Cytoskeleton remodeling_Role of PKA in cytoskeleton reorganisation,41,6.522E-02,1.617E-01,3.204E-01,4.864E-01,9,"PKA-reg (cAMP-dependent), PAK1, IP3 receptor, G-protein alpha-s, Calmodulin, Adenylate cyclase, LASP1, MELC, MLCK",6.522E-02,1.617E-01,14,"PKA-reg (cAMP-dependent), Rac1, IP3 receptor, Adenylate cyclase, MLCK, BETA-PIX, PAK1, Paxillin, 14-3-3 beta/alpha, G-protein alpha-s, Calmodulin, LASP1, MELC, Cofilin",
733,Apoptosis and survival_Phosphorylation in TNF-alpha-induced NF-kB signaling,41,6.522E-02,1.617E-01,1.098E-01,2.317E-01,11,"AKT1, TRAF2, TBK1, PKA-reg (cAMP-dependent), TRADD, NFKBIA, PI3K reg class IA (p85), Adenylate cyclase, IKK-beta, TAB2, PDK (PDPK1)",6.522E-02,1.617E-01,14,"AKT1, TBK1, PKA-reg (cAMP-dependent), TRADD, PI3K reg class IA (p85), IKK-alpha, Adenylate cyclase, TAB2, PDK (PDPK1), PKC-delta, TRAF2, NFKBIA, IKK-beta, TAB1",
734,Neutrophil resistance to apoptosis in COPD and proresolving impact of lipid mediators,60,6.523E-02,1.613E-01,6.523E-02,1.613E-01,16,"TRAF2, ERK1/2, TRADD, p90RSK1, p67-phox, Cytochrome c, FADD, LTBR1, PERM, PI3K reg class IA, MEK6(MAP2K6), Bcl-XL, p40-phox, AKT(PKB), Smac/Diablo, p38 MAPK",1.209E-01,2.485E-01,18,"ERK1/2, 14-3-3, TRADD, Bak, Cytochrome c, FADD, BAD, PI3K reg class IA, MEK6(MAP2K6), Bcl-XL, FasL(TNFSF6), AKT(PKB), TRAF2, LTBR1, PERM, p40-phox, Smac/Diablo, p38 MAPK",
735,Immune response_IL-17 signaling pathways,60,6.523E-02,1.613E-01,6.523E-02,1.613E-01,16,"MEK1(MAP2K1), c-Fos, MMP-1, ERK1/2, CIKS, I-kB, IL-17RC, PI3K reg class IA, Mucin 5AC, IKK-beta, MEK6(MAP2K6), Mucin 5B, AKT(PKB), SP1, G-CSF, p38 MAPK",7.210E-02,1.727E-01,19,"c-Fos, ERK1/2, CIKS, c-Jun/c-Fos, IKK (cat), I-kB, IL-17RC, PI3K reg class IA, MEK6(MAP2K6), Mucin 5B, AKT(PKB), MMP-1, c-Jun, Beta-defensin 2, Mucin 5AC, IKK-beta, SP1, G-CSF, p38 MAPK",
736,GLP-1 in inhibition of beta cell proliferation and function in type 2 diabetes,42,6.524E-02,1.613E-01,6.524E-02,1.613E-01,12,"AKT1, E2F1, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, p90RSK1, G-protein alpha-s, IGF-1 receptor, MEK1/2, Cyclin D1, Insulin, PDK (PDPK1)",2.340E-01,3.851E-01,12,"AKT1, ERK1/2, PKC-zeta, EGR1, PKA-reg (cAMP-dependent), IGF-1 receptor, Amylin, PDK (PDPK1), E2F1, G-protein alpha-s, Cyclin D1, Insulin",
737,Development_TGF-beta family mediated differentiation of embryonic stem cells,42,6.524E-02,1.613E-01,6.524E-02,1.613E-01,12,"ALK-4, Thrombomodulin, GSC, GATA-2, NANOG, SOX3, SOX2, CD34, SIX1, AFP, FAST-1/2, Transthyretin",1.412E-01,2.746E-01,13,"ALK-4, Thrombomodulin, GSC, CD34, OLIG3, T brachyury protein, GATA-2, NANOG, SOX3, SOX2, SIX1, FAST-1/2, Transthyretin",
738,Development_TGF-beta receptor signaling,52,6.597E-02,1.625E-01,7.579E-02,1.792E-01,14,"MEK1(MAP2K1), H-Ras, ERK1/2, c-Raf-1, p21, SARA, NFKBIA, ErbB2, IKK-beta, MEK6(MAP2K6), FAST-1/2, MSK1, SP1, p38 MAPK",6.597E-02,1.625E-01,17,"H-Ras, eIF4E, ERK1/2, p21, ErbB2, IKK-alpha, MEK6(MAP2K6), MSK1, YY1, MEKK4(MAP3K4), SARA, NFKBIA, IKK-beta, TAB1, FAST-1/2, SP1, p38 MAPK",
739,Development_Self-renewal of adult neural stem cells,52,6.597E-02,1.625E-01,2.225E-01,3.698E-01,12,"hASH1, NeuroD2, CoREST, BMI-1, SHH, p21, NeuroD4, DLL1, NeuroD3, PTEN, SOX2, Cyclin D1",6.597E-02,1.625E-01,17,"NeuroD2, p21, DLL1, NRSF, hASH1, CoREST, MAML1, BMI-1, TBP, SHH, DLL4, microRNA 9-1, NeuroD3, PTEN, SOX2, miR-9-5p, Cyclin D1",
740,Apoptosis and survival_Caspase cascade,34,6.721E-02,1.644E-01,2.661E-01,4.228E-01,8,"NUMA1, TRADD, Cytochrome c, FADD, RAIDD, IGF-1 receptor, AKT(PKB), IGF-1",6.721E-02,1.644E-01,12,"IRS-1, TRADD, Cytochrome c, FADD, IGF-1 receptor, FasL(TNFSF6), AKT(PKB), NUMA1, PARP-1, Caspase-7, RAIDD, IGF-1",
741,Role of Apo-2L(TNFSF10) in Prostate Cancer cell apoptosis,34,6.721E-02,1.644E-01,1.491E-01,2.806E-01,9,"TRAF2, TRADD, Cytochrome c, FADD, I-kB, Bcl-2, Bcl-XL, Smac/Diablo, TRID(TNFRSF10C)",6.721E-02,1.644E-01,12,"IKK (cat), TRADD, Bak, Cytochrome c, FADD, I-kB, Bcl-XL, TRAF2, Caspase-7, Bcl-2, Smac/Diablo, TRID(TNFRSF10C)",
742,"Signal transduction_Angiotensin II/ AGTR1 signaling via p38, ERK and PI3K",98,6.960E-02,1.699E-01,6.960E-02,1.699E-01,24,"PDGF-B, GRB2, c-Fos, H-Ras, ERK1/2, GCN5, AGTR1, c-Raf-1, p21, p70 S6 kinases, Calmodulin, NUR77, ALOX12, cPLA2, CalDAG-GEFII, MEK6(MAP2K6), IGF-1 receptor, MEK1/2, Cyclin D1, AKT(PKB), ATOX1, SP1, PDK (PDPK1), p38 MAPK",7.122E-02,1.709E-01,29,"PDGF-B, GRB2, c-Fos, H-Ras, eIF4E, ERK1/2, GCN5, PKC-zeta, EGR1, p21, p70 S6 kinases, cPLA2, CalDAG-GEFII, MEK6(MAP2K6), IGF-1 receptor, AKT(PKB), PDK (PDPK1), MEKK4(MAP3K4), CYP11B2, PKC-delta, AGTR1, 4E-BP1, Calmodulin, NUR77, G-protein alpha-q, Cyclin D1, ATOX1, SP1, p38 MAPK",
743,Cytoskeleton remodeling_ACM3 and ACM4 in keratinocyte migration,38,6.970E-02,1.699E-01,6.970E-02,1.699E-01,11,"Protein kinase G1, G-protein alpha-i family, G-protein alpha-11, Adenylate cyclase type VI, PKA-reg (cAMP-dependent), Adenylate cyclase type I, G-protein alpha-q/11, IP3 receptor, Calmodulin, PLC-beta, Guanylate Cyclase 1, soluble",1.369E-01,2.675E-01,12,"Protein kinase G1, Adenylate cyclase type VI, PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, PLC-beta, Guanylate Cyclase 1, soluble, G-protein alpha-i family, G-protein alpha-11, Adenylate cyclase type I, Calmodulin, G-protein alpha-q",
744,IgE-dependent production of pro-inflammatory mediators by neutrophils in asthma,38,6.970E-02,1.699E-01,6.970E-02,1.699E-01,11,"Galectin-3, Substance P extracellular region, Calcineurin A (catalytic), HDC, ERK1/2, Nk3R, PERM, Calmodulin, CD23, Alpha-defensin, p38 MAPK",3.613E-01,5.327E-01,10,"Galectin-3, Substance P extracellular region, Calcineurin A (catalytic), ERK1/2, Nk3R, IL-9, CD23, PERM, Calmodulin, p38 MAPK",
745,Impaired inhibitory action of lipoxins on neutrophil migration in CF,56,7.030E-02,1.708E-01,7.030E-02,1.708E-01,15,"G-protein alpha-i family, ERK1/2, Myosin II, CFTR, Alpha-actinin, PAK1, LTBR1, IL8RA, PIP5KI, MRLC, AKT(PKB), MELC, PDK (PDPK1), MLCK, PREX1",1.184E-01,2.449E-01,17,"ERK1/2, PKC-zeta, Rac1, AKT(PKB), PDK (PDPK1), MLCK, G-protein alpha-i family, Myosin II, PAK1, LTBR1, IL8RA, PIP5KI, MRLC, MELC, PI3K reg class IB (p101), Cofilin, PREX1",
746,G-protein signaling_Rap2A regulation pathway,17,7.053E-02,1.695E-01,7.150E-02,1.715E-01,6,"cAMP-GEFI, G-protein alpha-i family, PKA-reg (cAMP-dependent), Adenylate cyclase type I, G-protein alpha-s, MR-GEF",7.053E-02,1.695E-01,7,"cAMP-GEFI, PKA-reg (cAMP-dependent), RPIP8, G-protein alpha-i family, Adenylate cyclase type I, G-protein alpha-s, MR-GEF",
747,Development_Beta-adrenergic receptor-induced regulation of ERK,47,7.088E-02,1.708E-01,7.088E-02,1.708E-01,13,"MEK1(MAP2K1), cAMP-GEFI, GRB2, G-protein alpha-i family, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, IP3 receptor, G-protein alpha-s, CalDAG-GEFII, Adenylate cyclase, PDK (PDPK1)",2.608E-01,4.191E-01,13,"cAMP-GEFI, GRB2, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), IP3 receptor, CalDAG-GEFII, Adenylate cyclase, PDK (PDPK1), G-protein alpha-i family, c-Jun, G-protein alpha-s, PI3K reg class IB (p101)",
748,Role of proinflammatory cytokines in activation of p53 in major depressive disorder,47,7.088E-02,1.708E-01,7.088E-02,1.708E-01,13,"KMO, TIMP3, Reprimo, TGF-beta, p21, Arylformamidase, NFKBIA, Rb protein, IFN-alpha, Bcl-2, Keratin 8, JNK(MAPK8-10), PUMA",1.652E-01,3.060E-01,14,"KMO, TIMP3, p21, Arylformamidase, NMDA receptor, Rb protein, IFN-alpha, PUMA, Reprimo, TGF-beta, NFKBIA, Bcl-2, Keratin 8, JNK(MAPK8-10)",
749,Neurophysiological process_Dopamine D2 receptor signaling in CNS,47,7.088E-02,1.708E-01,7.088E-02,1.708E-01,13,"Calcineurin A (catalytic), Kir3.2, G-protein alpha-i family, CACNA1C, PKA-reg (cAMP-dependent), Adenylate cyclase type I, DDC, Kir3.1, IP3 receptor, TY3H, Adenylate cyclase type V, Adenylate cyclase type II, Adenylate cyclase type IV",9.668E-02,2.122E-01,15,"Calcineurin A (catalytic), PKA-reg (cAMP-dependent), DDC, Kir3.1, PLC-beta1, IP3 receptor, TY3H, Adenylate cyclase type V, Adenylate cyclase type II, Kir3.2, G-protein alpha-i family, CACNA1C, Adenylate cyclase type I, Adenylate cyclase type IV, N-type Ca(II) channel alpha1B",
750,IL-1 production in melanoma,17,7.150E-02,1.715E-01,7.150E-02,1.715E-01,6,"ERK1/2, I-kB, CARD5, IL-1RI, MEK1/2, MSK1",1.714E-01,3.144E-01,6,"ERK1/2, IKK (cat), I-kB, CARD5, IL-1RI, MSK1",
751,Transport_ACM3 signaling in lacrimal glands,75,7.452E-02,1.778E-01,7.452E-02,1.778E-01,19,"MEK1(MAP2K1), MaxiK alpha subunit, SP-A, H-Ras, SLC9A1, ERK1/2, Lactoferrin, CFTR, c-Raf-1, G-protein alpha-q/11, IP3 receptor, Chitotriosidase, Calmodulin, PLC-beta, Aquaporin 5, SP-D, Lacritin, Mucin 5B, Lysozyme",4.462E-01,6.147E-01,18,"MaxiK alpha subunit, H-Ras, SLC9A1, ERK1/2, Lactoferrin, G-protein alpha-q/11, IP3 receptor, PLC-beta, SP-D, Mucin 5B, Lysozyme, SP-A, LBP, PKC-delta, Chitotriosidase, Calmodulin, Aquaporin 5, CLCN3",
752,Apoptosis and survival_Role of IAP-proteins in apoptosis,31,7.523E-02,1.782E-01,9.422E-02,2.064E-01,9,"Aif, Presenilin 1, TRADD, Cytochrome c, FADD, Ubiquitin, HSP70, Smac/Diablo, NAIP",7.523E-02,1.782E-01,11,"Presenilin 1, TRADD, Cytochrome c, FADD, Ubiquitin, FasL(TNFSF6), HSP70, NAIP, Aif, Caspase-7, Smac/Diablo",
753,Role of IL-2 in the enhancement of NK cell cytotoxicity in multiple sclerosis,31,7.523E-02,1.782E-01,1.868E-01,3.254E-01,8,"AKT1, Granzyme B, Bcl-3, Ubiquitin, I-kB, PI3K reg class IA (p85), CX3CR1, PDK (PDPK1)",7.523E-02,1.782E-01,11,"AKT1, Granzyme B, IKK (cat), Bcl-3, Perforin, Ubiquitin, I-kB, PI3K reg class IA (p85), FasL(TNFSF6), PDK (PDPK1), CX3CR1",
754,Development_ACM2 and ACM4 activation of ERK,43,7.618E-02,1.792E-01,7.618E-02,1.792E-01,12,"MEK1(MAP2K1), GRB2, c-Fos, G-protein alpha-i family, H-Ras, ERK1/2, c-Raf-1, p90RSK1, IP3 receptor, Calmodulin, PLC-beta, Rap1GAP1",2.618E-01,4.191E-01,12,"GRB2, c-Fos, H-Ras, ERK1/2, EGR1, IP3 receptor, PLC-beta, PKC-delta, ACM2, G-protein alpha-i family, Calmodulin, Rap1GAP1",
755,Immune response_IL-7 signaling in B lymphocytes,43,7.618E-02,1.792E-01,7.618E-02,1.792E-01,12,"MEK1(MAP2K1), GRB2, E2A, H-Ras, ERK1/2, c-Raf-1, RAG2, STAT3, Bcl-XL, AKT(PKB), PDK (PDPK1), N-Myc",5.307E-01,6.946E-01,10,"GRB2, E2A, H-Ras, ERK1/2, Bcl-XL, AKT(PKB), PDK (PDPK1), Ig heavy chain, pre-BCR, N-Myc",
756,Cytoskeleton remodeling_Hyaluronic acid/ CD44 signaling pathways,43,7.618E-02,1.792E-01,7.618E-02,1.792E-01,12,"GRB2, GAB1, H-Ras, ERK1/2, c-Raf-1, VIL2 (ezrin), Calmodulin, VAV-2, IP3R1, Cortactin, MEK1/2, MLCK",1.624E-01,3.019E-01,13,"GRB2, GAB1, H-Ras, LARG, ERK1/2, Actin, Rac1, VIL2 (ezrin), VAV-2, Cortactin, MLCK, Calmodulin, IP3R1",
757,Role of epigenetic alterations in survival and migration of SCLC cells,43,7.618E-02,1.792E-01,7.618E-02,1.792E-01,12,"DNMT3B, K-RAS, Semaphorin 3B, MAP1, MGMT, H-cadherin, DNMT3A, DAB2, FHIT, CARD5, Bcl-2, Bcl-XL",1.624E-01,3.019E-01,13,"DNMT3B, AIP1 (DAB2ip), Semaphorin 3B, H-cadherin, DAB2, FHIT, CARD5, Bcl-XL, K-RAS, MAP1, MGMT, DNMT3A, Bcl-2",
758,Role of platelets in allograft rejection,43,7.618E-02,1.792E-01,7.618E-02,1.792E-01,12,"Glycoprotein VI, TGF-beta, P2Y12, sCD40L, COX-1 (PTGS1), GP-IB alpha, von Willebrand factor, CD40(TNFRSF5), PAR4, GP-V, CD40L(TNFSF5), Kainate receptor",3.881E-01,5.574E-01,11,"Glycoprotein VI, Thrombin, von Willebrand factor, PAR4, TGF-beta, P2Y12, GP-IX, GP-IB alpha, CD40(TNFRSF5), GP-V, Kainate receptor",
759,B cell signaling in hematological malignancies,80,7.696E-02,1.805E-01,7.696E-02,1.805E-01,20,"CD20, TRAF2, TRAF5, CD19, Btk, IP3 receptor, STAT3, Ubiquitin, I-kB, PI3K reg class IA (p85), CD79A, IKK-beta, Bcl-2, CD27(TNFRSF7), SHP-1, CD40(TNFRSF5), AKT(PKB), PDK (PDPK1), IL-6 receptor, CD40L(TNFSF5)",8.263E-02,1.909E-01,24,"CD20, CD19, IP3 receptor, Ubiquitin, I-kB, PI3K reg class IA (p85), CD79A, MyD88, ZAP70, IKK-alpha, CD27(TNFRSF7), CD22, SHP-1, AKT(PKB), PDK (PDPK1), TRAF2, CD79 complex, TRAF5, Btk, IKK-beta, CD79B, Bcl-2, CD40(TNFRSF5), IL-6 receptor",
760,Immune response_Fc epsilon RI pathway: calcium-dependent signaling,68,7.702E-02,1.819E-01,9.739E-02,2.109E-01,17,"Fc epsilon RI gamma, ERK1/2, Myosin II, P3C2B, PAK1, DGK-zeta, ARF1, PIP5KI, Btk, IP3 receptor, Calmodulin, ERM proteins, cPLA2, CalDAG-GEFII, ARF6, WASP, AKT(PKB)",7.702E-02,1.819E-01,21,"DOCK5, Fc epsilon RI gamma, ERK1/2, DGK-zeta, Rac1, IP3 receptor, ERM proteins, cPLA2, CalDAG-GEFII, ARF6, WASP, AKT(PKB), Myosin II, P3C2B, PAK1, ARF1, PIP5KI, Btk, Paxillin, Calmodulin, SHP-2",
761,Translation_Translation regulation by Alpha-1 adrenergic receptors,53,7.727E-02,1.822E-01,1.510E-01,2.829E-01,13,"MEK1(MAP2K1), Tuberin, eEF2, H-Ras, G-protein alpha-11, c-Raf-1, IP3 receptor, p70 S6 kinase1, Calmodulin, Alpha-1A adrenergic receptor, eIF4A, VAV-2, p70 S6 kinase2",7.727E-02,1.822E-01,17,"Tuberin, H-Ras, eIF4E, PLC-beta1, IP3 receptor, VAV-2, eEF2, PKC-delta, G-protein alpha-11, eEF2K, 4E-BP1, p70 S6 kinase1, Calmodulin, Alpha-1A adrenergic receptor, eIF4A, G-protein alpha-q, p70 S6 kinase2",
762,Development_NOTCH in inhibition of WNT/Beta-catenin-induced osteogenesis,42,7.807E-02,1.832E-01,5.015E-01,6.577E-01,8,"A-FABP, Dsh, Factor D, DLL1, WNT, TLE1, Axin, C/EBPalpha",7.807E-02,1.832E-01,14,"WNT3A, Dsh, DLL1, LRP5, TLE1, Axin, HEY1, MAML1, Factor D, WNT1, WNT, WNT10B, Frizzled, C/EBPalpha",
763,Apoptosis and survival_Lymphotoxin-beta receptor signaling,42,7.807E-02,1.832E-01,5.015E-01,6.577E-01,8,"TRAF2, Cytochrome c, TRAF5, I-kB, IKK-beta, JNK(MAPK8-10), Smac/Diablo, SDF-1",7.807E-02,1.832E-01,14,"IKK (cat), Cytochrome c, I-kB, IKK-alpha, SDF-1, TRAF2, c-Jun, MKK7 (MAP2K7), TRAF5, Caspase-7, MEKK1(MAP3K1), IKK-beta, JNK(MAPK8-10), Smac/Diablo",
764,Role of histone modificators in progression of multiple myeloma,30,7.903E-02,1.842E-01,7.903E-02,1.842E-01,9,"K-RAS, E2F1, p21, Rb protein, Tubulin alpha, SUV420H2, Cyclin D1, SP1, p27KIP1",1.250E-01,2.542E-01,10,"p21, Rb protein, SUV420H2, p27KIP1, Suv39H1, K-RAS, E2F1, Tubulin alpha, Cyclin D1, SP1",
765,T regulatory cells in asthma,30,7.903E-02,1.842E-01,7.903E-02,1.842E-01,9,"CD80, MHC class II, ICOS-L, STAT3, PI3K reg class IA (p85), CD3, FOXP3, SHP-1, PDE4B",2.290E-01,3.851E-01,9,"MHC class II, ICOS-L, PI3K reg class IA (p85), FOXP3, SHP-1, ICOS, DLL4, PDE4B, TCR alpha/beta",
766,Role of epigenetic alterations in proliferation and differentiation of SCLC cells,72,7.910E-02,1.853E-01,1.458E-01,2.779E-01,17,"DNMT3B, hASH1, K-RAS, GATA-4, DNMT3A, USF1, E4F1, YAP1 (YAp65), Synapsin I, Rb protein, CCDC140, LIN-28, GATA-5, PAX3, NFIA, p27KIP1, C/EBPalpha",7.910E-02,1.853E-01,22,"DNMT3B, miR-let-7g-5p, microRNA let-7g, GATA-4, USF1, E4F1, Synapsin I, Rb protein, NRSF, miR-let-7a-5p, PAX3, p27KIP1, c-Myc, hASH1, K-RAS, DNMT3A, LIN-28, GATA-5, SYP, AKT2, NFIA, C/EBPalpha",
767,T follicular helper cell dysfunction in SLE,90,8.106E-02,1.884E-01,8.106E-02,1.884E-01,22,"CD80, MHC class II, ICOS-L, Roquin, TRAF2, BATF, CXCR5, KLF2, STAT3, TRIM, I-kB, PI3K reg class IA (p85), p70 S6 kinase1, IFN-alpha, IKK-beta, SAP, CD40(TNFRSF5), STAT6, IL-4, AKT(PKB), IL-6 receptor, CD40L(TNFSF5)",3.941E-01,5.638E-01,22,"MHC class II, ICOS-L, BATF, KLF2, IKK (cat), TRIM, I-kB, PI3K reg class IA (p85), IKK-alpha, IFN-alpha, IL-4, AKT(PKB), ICOS, Roquin, TRAF2, 4E-BP1, p70 S6 kinase1, IKK-beta, CD40(TNFRSF5), STAT6, TCR alpha/beta, IL-6 receptor",
768,Common mechanisms of Th17 cell migration,48,8.175E-02,1.884E-01,8.175E-02,1.884E-01,13,"MIG, CCL22, CCL17, CXCR6, G-protein alpha-i family, CCR2, CCR6, IP3 receptor, CD161, PLC-beta, Collagen II, CCR5, E-selectin",1.123E-01,2.353E-01,15,"CCL22, CCL17, CXCR6, CCR2, IP3 receptor, PLC-beta, CCR9, Collagen II, CCR5, E-selectin, G-protein alpha-i family, CCR6, CXCR3, CD161, PI3K reg class IB (p101)",
769,"Chemokines in inflammation in adipose tissue and liver in obesity, type 2 diabetes and metabolic syndrome X",48,8.175E-02,1.884E-01,8.175E-02,1.884E-01,13,"MHC class II, CCR2, ITGAM, ITGAL, CD36, ITGAX, Fc gamma RI, CD3, CD34, CX3CR1, CCR5, CD163, E-selectin",2.883E-01,4.565E-01,13,"MHC class II, CCR2, FCGR3A, ITGAL, ITGAX, CD34, CCR5, E-selectin, ITGAM, CD36, Fc gamma RI, CX3CR1, CD163",
770,NF-kB pathway in multiple myeloma,35,8.186E-02,1.900E-01,8.786E-02,1.967E-01,10,"TRAF2, I-kB, IKK-beta, Bcl-2, Bcl-XL, IGF-1 receptor, Cyclin D1, CD40(TNFRSF5), IGF-1, CD40L(TNFSF5)",8.186E-02,1.900E-01,12,"IKK (cat), I-kB, IKK-alpha, Bcl-XL, IGF-1 receptor, c-Myc, TRAF2, IKK-beta, Bcl-2, Cyclin D1, CD40(TNFRSF5), IGF-1",
771,Cell adhesion_Plasmin signaling,35,8.186E-02,1.900E-01,4.546E-01,6.169E-01,7,"LEKTI, FRS2, FGFR1, PI3K reg class IA, Coagulation factor XII, MEK6(MAP2K6), p38 MAPK",8.186E-02,1.900E-01,12,"FRS2, FGFR1, Plasminogen, PI3K reg class IA, Coagulation factor XII, MEK6(MAP2K6), LEKTI, Neuroserpin, Plasmin, PZP, TAB1, p38 MAPK",
772,Neurophysiological process_Thyroliberin in cell hyperpolarization and excitability,35,8.186E-02,1.900E-01,8.786E-02,1.967E-01,10,"MaxiK alpha subunit, cPKC (conventional), Thyroliberin, G-protein alpha-11, CACNA1C, Kir3.1, IP3 receptor, G-protein alpha-13, KCNH7, KCNK2",8.186E-02,1.900E-01,12,"MaxiK alpha subunit, Kir3.1, PLC-beta1, IP3 receptor, G-protein alpha-13, KCNH7, cPKC (conventional), Thyroliberin, G-protein alpha-11, CACNA1C, G-protein alpha-q, KCNK2",
773,Neurophysiological process_Receptor-mediated axon growth repulsion,46,8.250E-02,1.909E-01,1.156E-01,2.398E-01,12,"RHO6, GRB7, Ephrin-A receptors, c-Raf-1, PAK1, VAV-2, Cortactin, Tau (MAPT), LIMK2, Plexin B1, Ephrin-A, Tubulin (in microtubules)",8.250E-02,1.909E-01,15,"GRB7, LARG, Rac1, VAV-2, Cortactin, Tau (MAPT), LIMK2, Tubulin (in microtubules), RHO6, Destrin, Ephrin-A receptors, PAK1, Plexin B1, Ephrin-A, Cofilin",
774,Neurophysiological process_Dopamine D2 receptor transactivation of PDGFR in CNS,26,8.367E-02,1.914E-01,8.367E-02,1.914E-01,8,"SG2NA, G-protein alpha-i family, NR1, PP2A regulatory, IP3 receptor, Calmodulin, PKC, PP2A structural",1.168E-01,2.422E-01,9,"SG2NA, NR1, PP2A regulatory, IP3 receptor, NMDA receptor, PP2A structural, G-protein alpha-i family, Calmodulin, PKC",
775,Immune response_Role of HMGB1 in dendritic cell maturation and migration,26,8.367E-02,1.914E-01,8.367E-02,1.914E-01,8,"CD80, MHC class II, CCR7, ERK1/2, IL-12 alpha, CD40(TNFRSF5), p38 MAPK, SDF-1",3.795E-01,5.508E-01,7,"MHC class II, ERK1/2, IL-12 alpha, SDF-1, CCR7, CD40(TNFRSF5), p38 MAPK",
776,Regulation of VEGF expression in lung cancer,53,8.655E-02,1.967E-01,8.655E-02,1.967E-01,14,"gp130, c-Fos, ERK1/2, MGF, STAT3, PI3K reg class IA (p85), VEGF-D, p70 S6 kinase1, ErbB2, PI3K reg class IA, IL-1RI, AKT(PKB), HSP90, PDK (PDPK1)",1.322E-01,2.614E-01,16,"gp130, c-Fos, ERK1/2, c-Jun/c-Fos, RhoC, PI3K reg class IA (p85), VEGF-D, ErbB2, PI3K reg class IA, IL-1RI, AKT(PKB), HSP90, PDK (PDPK1), c-Jun, MGF, p70 S6 kinase1",
777,Development_BMP7 in brown adipocyte differentiation,39,8.755E-02,1.999E-01,5.773E-01,7.297E-01,7,"p38alpha (MAPK14), BMP7, Cytochrome c, COX IV-1, ELOVL3, COX Vb, DLK",8.755E-02,1.999E-01,13,"Cytochrome c, Resistin, CtBP, TrkC, TFAM, BMP7, MEL1, COX IV-1, ELOVL3, TAB1, CtBP1, COX Vb, Necdin",
778,Role of microRNAs in cell proliferation in colorectal cancer,69,8.786E-02,1.999E-01,4.884E-01,6.440E-01,13,"K-RAS, FBXW7, DNMT3A, p21, RhoB, MACC1, p70 S6 kinase1, Rb protein, PI3K reg class IA (p85-beta), PTEN, IGF-1 receptor, Cyclin D1, Rab-22A",8.786E-02,1.999E-01,21,"IRS-1, FBXW7, p21, Rb protein, PI3K reg class IA (p85-beta), miR-let-7a-5p, IGF-1 receptor, Rab-22A, c-Myc, miR-342-5p, K-RAS, CCKBR, c-Jun, DNMT3A, SNX1, RhoB, MACC1, p70 S6 kinase1, PTEN, Cyclin D1, miR-30a-5p",
779,Interleukins-induced inflammatory response in asthmatic airway fibroblasts,35,8.786E-02,1.967E-01,8.786E-02,1.967E-01,10,"p38alpha (MAPK14), c-Fos, ERK1/2, CIKS, MGF, IL-1RI, MEK1/2, MSK1, G-CSF, p38 MAPK",2.624E-01,4.191E-01,10,"c-Fos, ERK1/2, CIKS, IL-1RI, MSK1, IL-25 (IL-17E), c-Jun, MGF, G-CSF, p38 MAPK",
780,Development_Transcriptional regulation of megakaryopoiesis,35,8.786E-02,1.967E-01,8.786E-02,1.967E-01,10,"Glycoprotein VI, GATA-1, GATA-2, CD36, GP-IB alpha, EKLF1, CD34, von Willebrand factor, TAL1, GP-V",4.033E-01,5.725E-01,9,"Glycoprotein VI, EKLF1, CD34, von Willebrand factor, GATA-2, GP-IX, CD36, GP-IB alpha, GP-V",
781,Role of growth factor receptors transactivation by Hyaluronic acid / CD44 signaling in tumor progression,35,8.786E-02,1.967E-01,8.786E-02,1.967E-01,10,"AKT1, GRB2, H-Ras, ERK1/2, c-Raf-1, p67-phox, ErbB2, VAV-2, FAK1, MEK1/2",1.543E-01,2.909E-01,11,"AKT1, GRB2, H-Ras, LARG, ERK1/2, Rac1, ErbB2, VAV-2, PKC-delta, c-Jun, FAK1",
782,Estrone metabolism,35,8.786E-02,1.967E-01,8.786E-02,1.967E-01,10,"SULT2B1, CYP3A5, HSD17B3, HSD17B8, COMT, STS, HSD17B1, CYP1A2, HSD17B2, CYP3A4",5.623E-01,7.195E-01,8,"SULT2B1, CYP3A5, COMT, STS, HSD17B1, CYP1A2, CYP2C19, HSD17B8",
783,Action of lithium on synaptic transmission and autophagy,35,8.786E-02,1.967E-01,8.786E-02,1.967E-01,10,"Dopamine D1A receptor, AKT1, P2X2, PP2A regulatory, PKA-reg (cAMP-dependent), Adenylate cyclase type V, Adenylate cyclase type II, G-protein alpha-s, PLC-beta, Adenylate cyclase",2.624E-01,4.191E-01,10,"AKT1, PP2A regulatory, PKA-reg (cAMP-dependent), Adenylate cyclase type V, Adenylate cyclase type II, PLC-beta, Adenylate cyclase, Dopamine D1A receptor, P2X2, G-protein alpha-s",
784,PXR signaling via cross-talk / Rodent version,22,8.798E-02,1.967E-01,8.798E-02,1.967E-01,7,"CYP2C8, LXR-alpha/RXR-alpha, G6PT, PXR, CD36, CPT-1A, PXR/RXR-alpha",7.733E-01,8.955E-01,4,"CPT-1A, PXR/RXR-alpha, PXR, CD36",
785,PXR signaling via cross-talk / Human Version,22,8.798E-02,1.967E-01,8.798E-02,1.967E-01,7,"CYP2C8, LXR-alpha/RXR-alpha, G6PT, PXR, CD36, CPT-1A, PXR/RXR-alpha",7.733E-01,8.955E-01,4,"CPT-1A, PXR/RXR-alpha, PXR, CD36",
786,Immune response_IL-15 signaling via JAK-STAT cascade,22,8.798E-02,1.967E-01,8.798E-02,1.967E-01,7,"STAT2, STAT3, Bcl-2, IL-2R beta chain, Bcl-XL, STAT6, IL-4",3.861E-01,5.572E-01,6,"Bcl-XL, IL-4, STAT2, Bcl-2, IL-2R beta chain, STAT6",
787,"Development_Activation of Erk by ACM1, ACM3 and ACM5",44,8.821E-02,1.967E-01,8.821E-02,1.967E-01,12,"MEK1(MAP2K1), GRB2, c-Fos, H-Ras, ERK1/2, G-protein alpha-11, c-Raf-1, p90RSK1, ACM1, IP3 receptor, Calmodulin, cPLA2",1.084E-01,2.301E-01,14,"GRB2, c-Fos, H-Ras, ERK1/2, EGR1, c-Jun/c-Fos, PLC-beta1, IP3 receptor, cPLA2, CALDAG-GEFI, G-protein alpha-11, ACM1, Calmodulin, G-protein alpha-q",
788,Neurophysiological process_Melatonin signaling,44,8.821E-02,1.967E-01,8.821E-02,1.967E-01,12,"MaxiK alpha subunit, ROR-alpha, Kir3.2, G-protein alpha-i family, G-protein alpha-11, PKA-reg (cAMP-dependent), Kir3.1, STS, HSD17B1, IP3 receptor, Calmodulin, Adenylate cyclase",1.850E-01,3.329E-01,13,"MaxiK alpha subunit, PKA-reg (cAMP-dependent), GLUT4, Kir3.1, STS, HSD17B1, IP3 receptor, Adenylate cyclase, CYP19, Kir3.2, G-protein alpha-i family, G-protein alpha-11, Calmodulin",
789,Immune response_IFN-gamma actions on extracellular matrix and cell differentiation,54,8.977E-02,2.037E-01,2.651E-01,4.228E-01,12,"GCH1, SHH, Osteoglycin, PSME1, MYOG, JARID2, TSA-1, RNaseL, Casein kinase I, Collagen II, Cathepsin K, MYOD",8.977E-02,2.037E-01,17,"GCH1, Osteoglycin, MYOG, TSA-1, ACTA1, PSME2, Collagen II, RFX5, LMOD2, SHH, PSME1, JARID2, MYH11, RNaseL, Casein kinase I, Cathepsin K, MYOD",
790,Cell adhesion_Integrin inside-out signaling,58,9.070E-02,2.014E-01,9.070E-02,2.014E-01,15,"G-protein alpha-12 family, G-protein alpha-i family, ERK1/2, AGTR1, G-protein alpha-q/11, Calmyrin, IP3 receptor, PIPKI gamma, Calmodulin, PLC-beta, FAK1, Collagen II, PAR4, ERK1 (MAPK3), SDF-1",2.332E-01,3.851E-01,16,"ERK1/2, G-protein alpha-q/11, Calmyrin, IP3 receptor, Thrombin, PLC-beta, Collagen II, PAR4, ERK1 (MAPK3), SDF-1, G-protein alpha-12 family, G-protein alpha-i family, AGTR1, PIPKI gamma, Calmodulin, FAK1",
791,NMDA-independent presynaptic long-term potentiation in Huntington's disease,58,9.070E-02,2.014E-01,9.070E-02,2.014E-01,15,"GluR5, SNAP-25, Rab-3A, PKA-reg (cAMP-dependent), HCN, Adenylate cyclase type I, MUNC13-1, Synaptotagmin I, IP3 receptor, Calmodulin, GABA-A receptor, PLC-beta, GluR7, Rabphilin-3A, RIMS1",2.332E-01,3.851E-01,16,"GluR5, Rab-3A, PKA-reg (cAMP-dependent), Syntaxin 1A, Synaptotagmin I, IP3 receptor, GABA-A receptor, PLC-beta, RIMS1, Complexin 2, HCN, Adenylate cyclase type I, Calmodulin, GluR7, Rabphilin-3A, G-protein alpha-q",
792,Rb proteins signaling in multiple myeloma,18,9.143E-02,2.027E-01,9.143E-02,2.027E-01,6,"E2F1, Rb protein, p130, Cyclin D1, JNK(MAPK8-10), p27KIP1",9.351E-02,2.083E-01,7,"Cyclin D3, Rb protein, p130, p27KIP1, E2F1, Cyclin D1, JNK(MAPK8-10)",
793,Selective Insulin resistance in type 2 diabetes in liver,32,9.195E-02,2.069E-01,1.110E-01,2.322E-01,9,"AKT1, Insulin processed, G6PT, SHP, Insulin receptor, IKK-beta, GSK3 alpha/beta, AKT(PKB), PDK (PDPK1)",9.195E-02,2.069E-01,11,"AKT1, Insulin processed, GYS2, IRS-1, Insulin receptor, GSK3 alpha/beta, AKT(PKB), PDK (PDPK1), PTP-1B, IKK-beta, AKT2",
794,The role of KEAP1/NRF2 pathway in skin sensitization,32,9.195E-02,2.069E-01,2.121E-01,3.568E-01,8,"E-cadherin, CCR7, ERK1/2, Ubiquitin, JNK(MAPK8-10), HSP70, NQO1, ERK1 (MAPK3)",9.195E-02,2.069E-01,11,"ERK1/2, Ubiquitin, MyD88, MafK, HSP70, ERK1 (MAPK3), Thioredoxin, E-cadherin, CCR7, JNK(MAPK8-10), NQO1",
795,"Nicotine signaling in dopaminergic neurons, Pt. 2 - axon terminal",43,9.246E-02,2.069E-01,1.426E-01,2.728E-01,11,"Dopamine D1A receptor, Calcineurin A (catalytic), SNAP-25, PP1-cat, G-protein alpha-i family, PKA-reg (cAMP-dependent), IP3 receptor, Adenylate cyclase type V, G-protein alpha-s, Calmodulin, PLC-beta",9.246E-02,2.069E-01,14,"Calcineurin A (catalytic), PP1-cat, PKA-reg (cAMP-dependent), IP3 receptor, NMDA receptor, Plasminogen, Adenylate cyclase type V, PLC-beta, Dopamine D1A receptor, G-protein alpha-i family, Plasmin, G-protein alpha-s, Calmodulin, G-protein alpha-q",
796,Development_EPO-induced PI3K/AKT pathway and Ca(2+) influx,43,9.246E-02,2.069E-01,1.426E-01,2.728E-01,11,"GRB2, GAB1, MSP receptor (RON), GATA-1, Btk, IP3 receptor, Epo receptor, PI3K reg class IA (p85), AKT(PKB), PDK (PDPK1), Epo",9.246E-02,2.069E-01,14,"GRB2, GAB1, TRPC2, Rac1, IP3 receptor, PI3K reg class IA (p85), SHIP, AKT(PKB), PDK (PDPK1), Epo, MSP receptor (RON), Btk, Epo receptor, Alpha1-globin",
797,Development_S1P3 receptor signaling pathway,43,9.246E-02,2.069E-01,1.426E-01,2.728E-01,11,"G-protein alpha-i family, IP3 receptor, S1P3 receptor, G-protein alpha-13, Calmodulin, PI3K reg class IA, PLC-beta, Adenylate cyclase, eNOS, AKT(PKB), PDK (PDPK1)",9.246E-02,2.069E-01,14,"Rac1, IP3 receptor, S1P3 receptor, G-protein alpha-13, PI3K reg class IA, PLC-beta, Adenylate cyclase, AKT(PKB), PDK (PDPK1), G-protein alpha-i family, Calmodulin, eNOS, G-protein alpha-q, PI3K reg class IB (p101)",
798,Apoptosis and survival_TNFR1 signaling pathway,43,9.246E-02,2.069E-01,3.757E-01,5.398E-01,9,"TRAF2, TRADD, Cytochrome c, FADD, I-kB, RAIDD, Bcl-2, JNK(MAPK8-10), Smac/Diablo",9.246E-02,2.069E-01,14,"IKK (cat), TRADD, Cytochrome c, FADD, I-kB, TRAF2, c-Jun, MKK7 (MAP2K7), Caspase-7, MEKK1(MAP3K1), RAIDD, Bcl-2, JNK(MAPK8-10), Smac/Diablo",
799,Blood coagulation_GPIb-IX-V-dependent platelet activation,77,9.247E-02,2.044E-01,9.247E-02,2.044E-01,19,"MEK1(MAP2K1), p38alpha (MAPK14), Protein kinase G1, AKT1, Fc epsilon RI gamma, Glycoprotein VI, Alpha-actinin, c-Raf-1, IP3 receptor, PI3K reg class IA (p85), GP-IB alpha, Calmodulin, Filamin B (TABP), cPLA2, eNOS, von Willebrand factor, SHIP2, SNAP-23, GP-V",1.417E-01,2.747E-01,22,"Protein kinase G1, AKT1, Fc epsilon RI gamma, Glycoprotein VI, Actin, IP3 receptor, PI3K reg class IA (p85), cPLA2, von Willebrand factor, Syntaxin 4, SHIP2, MEKK4(MAP3K4), CALDAG-GEFI, LAT, GP-IX, GP-IB alpha, Calmodulin, Filamin B (TABP), eNOS, SNAP-23, GP-V, Cofilin",
800,Effect of H. pylori infection on gastric epithelial cell proliferation,58,9.275E-02,2.073E-01,1.540E-01,2.866E-01,14,"MEK1(MAP2K1), p38alpha (MAPK14), E-cadherin, Calcineurin A (catalytic), GRB2, H-Ras, ERK1/2, c-Raf-1, p21, IP3 receptor, AP-1, Skp2/TrCP/FBXW, Cyclin D1, p27KIP1",9.275E-02,2.073E-01,18,"Calcineurin A (catalytic), GRB2, H-Ras, ERK1/2, EGR1, p21, Rac1, IP3 receptor, Skp2/TrCP/FBXW, p27KIP1, c-Myc, MEKK4(MAP3K4), E-cadherin, c-Jun, C3G, AP-1, SHP-2, Cyclin D1",
801,Multiple myeloma (general schema),18,9.351E-02,2.083E-01,2.161E-01,3.626E-01,5,"FGFR3, K-RAS, MafB, Cyclin D1, IGF-1",9.351E-02,2.083E-01,7,"Cyclin D3, MafB, c-Myc, FGFR3, K-RAS, Cyclin D1, IGF-1",
802,Development_Activation of ERK by Kappa-type opioid receptor,31,9.422E-02,2.064E-01,9.422E-02,2.064E-01,9,"MEK1(MAP2K1), GRB2, G-protein alpha-i family, H-Ras, c-Raf-1, IP3 receptor, PLC-beta, PDK (PDPK1), ERK1 (MAPK3)",2.618E-01,4.191E-01,9,"GRB2, H-Ras, PKC-zeta, IP3 receptor, PLC-beta, PDK (PDPK1), ERK1 (MAPK3), G-protein alpha-i family, PI3K reg class IB (p101)",
803,Immune response_IL-23 signaling pathway,31,9.422E-02,2.064E-01,9.422E-02,2.064E-01,9,"AKT1, ROR-gamma, NFKBIA, STAT3, Ubiquitin, PI3K reg class IA, IL23R, AKT(PKB), PDK (PDPK1)",2.618E-01,4.191E-01,9,"AKT1, Ubiquitin, PI3K reg class IA, IKK-alpha, IL23R, AKT(PKB), PDK (PDPK1), ROR-gamma, NFKBIA",
804,Development_Transactivation of PDGFR in non-neuronal cells by Dopamine D2 receptor,31,9.422E-02,2.064E-01,9.422E-02,2.064E-01,9,"MEK1(MAP2K1), GRB2, G-protein alpha-i family, H-Ras, c-Raf-1, IP3 receptor, PI3K reg class IA, PKC-gamma, ERK1 (MAPK3)",5.812E-01,7.338E-01,7,"GRB2, H-Ras, IP3 receptor, PI3K reg class IA, PKC-gamma, ERK1 (MAPK3), G-protein alpha-i family",
805,Putative pathways of activation of monoclonal protein secretion in multiple myeloma,25,9.469E-02,2.091E-01,2.937E-01,4.507E-01,6,"SSR-delta, XBP1, SERP1, DAD-1, IRE1, DnaJB9",9.469E-02,2.091E-01,9,"XBP1, IGHM, SERP1, DAD-1, IRE1, SSR-delta, Ig heavy chain, DnaJB9, DNAJC3",
806,Defective macrophage-mediated bacterial phagocytosis in COPD,25,9.469E-02,2.091E-01,1.529E-01,2.852E-01,7,"RhoB, CD36, Tubulin alpha, SP-D, C1qRp, AKT(PKB), Tubulin (in microtubules)",9.469E-02,2.091E-01,9,"FCGR3A, SP-D, AKT(PKB), Tubulin (in microtubules), MBL2, RhoB, CD36, Tubulin alpha, C1qRp",
807,Immune response_IL-2 signaling via JAK/ STAT,25,9.469E-02,2.091E-01,1.529E-01,2.852E-01,7,"c-Fos, Granzyme B, STAT3, FOXP3, Bcl-2, IL-2R beta chain, Bcl-XL",9.469E-02,2.091E-01,9,"c-Fos, Granzyme B, Perforin, FOXP3, Bcl-XL, c-Myc, IL-2R alpha chain, Bcl-2, IL-2R beta chain",
808,Dual role of BMP signaling in gastric cancer,25,9.469E-02,2.091E-01,2.937E-01,4.507E-01,6,"E-cadherin, I-kB, PI3K reg class IA (p85), Mucin 2, AKT(PKB), PDK (PDPK1)",9.469E-02,2.091E-01,9,"IKK (cat), I-kB, PI3K reg class IA (p85), IKK-alpha, AKT(PKB), PDK (PDPK1), E-cadherin, Mucin 2, SMAD1",
809,Reproduction_Progesterone-mediated oocyte maturation,40,9.521E-02,2.064E-01,9.521E-02,2.064E-01,11,"MEK1(MAP2K1), G-protein alpha-i family, H-Ras, ESR1 (membrane), PKA-reg (cAMP-dependent), c-Raf-1, p90RSK1, p90Rsk, PR (membrane), Adenylate cyclase, SPDY1",7.218E-01,8.558E-01,8,"H-Ras, ESR1 (membrane), PKA-reg (cAMP-dependent), PR (membrane), Adenylate cyclase, G-protein alpha-i family, Aurora-A, Kinase MYT1",
810,IFN-gamma and Th2 cytokines-induced inflammatory signaling in normal and asthmatic airway epithelium,40,9.521E-02,2.064E-01,9.521E-02,2.064E-01,11,"MIG, CCL17, CXCR6, ERK1/2, IFN-alpha, IL13RA2, JNK(MAPK8-10), STAT6, IL-4, IGF-1, p38 MAPK",2.927E-01,4.586E-01,11,"CCL17, CXCR6, ERK1/2, IFN-alpha, IL-13, IL-4, CXCR3, JNK(MAPK8-10), STAT6, IGF-1, p38 MAPK",
811,Inhibition of Vitamin D pathway in Prostate Cancer,40,9.521E-02,2.064E-01,9.521E-02,2.064E-01,11,"p38alpha (MAPK14), VDR/RXR-alpha, VDR, RXRA, p21, Androgen receptor, Rb protein, Bcl-2, Bcl-XL, Cyclin D1, p27KIP1",1.824E-01,3.301E-01,12,"VDR/RXR-alpha, TRIP15, VDB, p21, Androgen receptor, Rb protein, Bcl-XL, p27KIP1, VDR, RXRA, Bcl-2, Cyclin D1",
812,Immune response_Induction of apoptosis and inhibition of proliferation mediated by IFN-gamma,47,9.668E-02,2.122E-01,2.214E-01,3.687E-01,11,"STAT2, E2F1, RIPK3, p21, ZIP-kinase, KLF4, Rb protein, IFN-alpha, Par-4, Cyclin D1, p27KIP1",9.668E-02,2.122E-01,15,"p21, ZIP-kinase, KLF4, Rb protein, IFN-alpha, Par-4, FasL(TNFSF6), p27KIP1, c-Myc, STAT2, E2F1, RIPK3, C3G, Caspase-7, Cyclin D1",
813,Regulation of mast cell survival in asthma,47,9.668E-02,2.122E-01,4.873E-01,6.432E-01,9,"ERK1/2, MGF, Bcl-2, Bcl-XL, MEK1/2, IL-4, AKT(PKB), PUMA, IL-6 receptor",9.668E-02,2.122E-01,15,"TrkA, ERK1/2, IL-3, BAD, Chymase, Bcl-XL, FasL(TNFSF6), IL-4, AKT(PKB), PUMA, MGF, Bcl-2, FOXO3A, TSLC1, IL-6 receptor",
814,Signal transduction_PDGF signaling via JAK-STAT and reactive oxygen species (ROS),66,9.764E-02,2.137E-01,1.304E-01,2.584E-01,16,"MIG, PDGF-B, c-Fos, H-Ras, ERK1/2, p190RhoGAP, PRMT1, PKA-reg (cAMP-dependent), PAK1, STAT3, HXK2, cPLA2, Bcl-2, TM7SF4, SP1, PDK (PDPK1)",9.764E-02,2.137E-01,20,"PDGF-B, Cyclin D3, c-Fos, H-Ras, ERK1/2, EGR1, PRMT1, PKA-reg (cAMP-dependent), Rac1, CCL13, HXK2, cPLA2, PDK (PDPK1), c-Myc, p190RhoGAP, PAK1, Bcl-2, TM7SF4, SP1, Cofilin",
815,Eosinophil granule protein release in asthma,54,9.823E-02,2.124E-01,9.823E-02,2.124E-01,14,"cPKC (conventional), PDGF-B, CCR3, CRTH2, ERK1/2, Lactoferrin, VEGFR-1, P2Y12, Tryptase, LTBR1, PKC, PERE, CAMP, p38 MAPK",2.339E-01,3.851E-01,15,"PDGF-B, ERK1/2, Lactoferrin, IL-3, NT-3, cPKC (conventional), CCR3, VEGFR-1, P2Y12, Tryptase, LTBR1, PKC, PERE, CAMP, p38 MAPK",
816,Immune response_IL-6-induced acute-phase response in hepatocytes,36,9.836E-02,2.137E-01,1.928E-01,3.318E-01,9,"APCS, gp130, c-Fos, G6PT, IL6RA, STAT3, Hemopexin, SP1, IL-6 receptor",9.836E-02,2.137E-01,12,"gp130, c-Fos, HNF1-alpha, Fibrinogen beta, c-Jun/c-Fos, Hemopexin, AGP1 (ORM1), c-Jun, IL6RA, Fibrinogen gamma, SP1, IL-6 receptor",
817,Immune response_IL-22 signaling pathway,36,9.836E-02,2.137E-01,3.235E-01,4.877E-01,8,"MHC class II, c-Fos, ERK1/2, STAT3, Bcl-2, Bcl-XL, JNK(MAPK8-10), p38 MAPK",9.836E-02,2.137E-01,12,"MHC class II, c-Fos, ERK1/2, c-Jun/c-Fos, Bcl-XL, IL-9, c-Myc, c-Jun, Bcl-2, JNK(MAPK8-10), TCR alpha/beta, p38 MAPK",
818,Propionate metabolism p.1,36,9.836E-02,2.137E-01,3.235E-01,4.877E-01,8,"PCCB, MMSA, ACSA, ALDH2, MUTA, HCD2, HCDH, MCEE",9.836E-02,2.137E-01,12,"PCCB, ACSA, THEM2, MUTA, HCDH, MCEE, PCC, PCCA, MMSA, ALDH2, HCD2, BCKD-E2",
819,"Development_Lipoxin inhibitory action on PDGF, EGF and LTD4 signaling",36,9.836E-02,2.137E-01,1.928E-01,3.318E-01,9,"EGF, PDGF-B, G-protein alpha-i family, PKA-reg (cAMP-dependent), G-protein alpha-q/11, PI3K reg class IA (p85), Adenylate cyclase, SOCS2, CysLT1 receptor",9.836E-02,2.137E-01,12,"EGF, PDGF-B, PKA-reg (cAMP-dependent), G-protein alpha-q/11, PI3K reg class IA (p85), Adenylate cyclase, CysLT1 receptor, Thioredoxin, PRDX2, G-protein alpha-i family, SHP-2, SOCS2",
820,Activation of TGF-beta signaling in pancreatic cancer,27,1.008E-01,2.171E-01,1.008E-01,2.171E-01,8,"MEK1(MAP2K1), PDGF-B, GRB2, K-RAS, c-Raf-1, DAB2, Claudin-4, SP1",6.029E-01,7.480E-01,6,"PDGF-B, GRB2, DAB2, K-RAS, Claudin-4, SP1",
821,HCV-dependent regulation of membrane receptors signaling in HCC,27,1.008E-01,2.171E-01,1.008E-01,2.171E-01,8,"MEK1(MAP2K1), TRAF2, H-Ras, ERK1/2, c-Raf-1, TRADD, I-kB, IKK-beta",2.602E-01,4.191E-01,8,"H-Ras, ERK1/2, IKK (cat), TRADD, I-kB, TRAF2, c-Jun, IKK-beta",
822,LKB1 signaling pathway in lung cancer cells,45,1.013E-01,2.175E-01,1.013E-01,2.175E-01,12,"E-cadherin, Tuberin, ERK1/2, AMPK alpha subunit, STRAD, PAK1, STAT3, p70 S6 kinase1, LKB1, PTEN, FAK1, p70 S6 kinase2",1.258E-01,2.552E-01,14,"Tuberin, microRNA 200c, ERK1/2, miR-200c-3p, c-Myc, E-cadherin, AMPK alpha subunit, STRAD, PAK1, p70 S6 kinase1, LKB1, PTEN, FAK1, p70 S6 kinase2",
823,Arachidonic acid production,74,1.014E-01,2.197E-01,1.109E-01,2.322E-01,18,"PLA2G4C, PLC-eta 1, DGL-alpha, iPLA2-eta (GS2), PTE1, PEDF-R (iPLA2-zeta), PTE2, DGL-beta, PIB4, ACSBG2, PLA2(hGIIA), PLA2G3, Monoglyceride lipase, PLA2G10, FAAH, SLC27A4, PLA2G2D, PLA2G5",1.014E-01,2.197E-01,22,"PLA2G4C, ELOVL7, DGL-alpha, ELOVL5, PTE1, PEDF-R (iPLA2-zeta), DGL-beta, PIB4, PLC-beta1, THEM2, PLA2G3, Monoglyceride lipase, PLA2G10, FAAH, PLC-eta 2, PLC-eta 1, iPLA2-eta (GS2), PTE2, ACSBG2, PLA2(hGIIA), SLC27A4, PLA2G5",
824,Cigarette smoke-induced inflammatory signaling in airway epithelial cells,36,1.028E-01,2.200E-01,1.028E-01,2.200E-01,10,"C5aR, p38alpha (MAPK14), GRB2, ERK1/2, ErbB3, PKA-reg (cAMP-dependent), c-Raf-1, NFKBIA, Amphiregulin, MEK1/2",7.448E-01,8.733E-01,7,"GRB2, ERK1/2, ErbB3, PKA-reg (cAMP-dependent), Amphiregulin, C5aR, NFKBIA",
825,Role of glycosphingolipids in inhibition of Insulin signaling,40,1.038E-01,2.229E-01,6.059E-01,7.550E-01,7,"UGCG, GM3 synthase, Insulin processed, PAK1, Insulin receptor, AKT(PKB), PDK (PDPK1)",1.038E-01,2.229E-01,13,"GM3 synthase, Insulin processed, IRS-1, PKC-zeta, GLUT4, Rac1, Insulin receptor, AKT(PKB), PDK (PDPK1), UGCG, PAK1, C3G, Rab-10",
826,G-protein signaling_Rap1A regulation pathway,40,1.038E-01,2.229E-01,1.758E-01,3.127E-01,10,"Tuberin, cAMP-GEFI, G-protein alpha-i family, c-Raf-1, Adenylate cyclase type I, RalGDS, G-protein alpha-s, CD3, Rap1GAP1, MR-GEF",1.038E-01,2.229E-01,13,"Tuberin, cAMP-GEFI, ZAP70, CALDAG-GEFI, G-protein alpha-i family, Adenylate cyclase type I, RalGDS, C3G, NEDD4, G-protein alpha-s, Rap1GAP1, MR-GEF, TCR alpha/beta",
827,Development_Ligand-dependent activation of the ESR1/AP-1 pathway,15,1.041E-01,2.233E-01,5.290E-01,6.825E-01,3,"c-Fos, ESR1 (nuclear), AP-1",1.041E-01,2.233E-01,6,"c-Fos, ESR1 (nuclear), c-Jun/c-Fos, c-Jun, AP-1, CtBP1",
828,Oxidative stress in adipocyte dysfunction in type 2 diabetes and metabolic syndrome X,64,1.055E-01,2.252E-01,1.055E-01,2.252E-01,16,"PU.1, PRDX3, A-FABP, Adiponectin, Insulin processed, G6PD, p67-phox, NFKBIA, CD36, PI3K reg class IA (p85), Insulin receptor, IKK-beta, p40-phox, AKT(PKB), PLA2, GSTA4",1.229E-01,2.517E-01,19,"PRDX3, GPX3, Insulin processed, IRS-1, GLUT4, PI3K reg class IA (p85), SOD1, Insulin receptor, AKT(PKB), GSTA4, PU.1, Adiponectin, G6PD, AL3A2, NFKBIA, CD36, IKK-beta, p40-phox, PLA2",
829,Transcription_CREM signaling in testis,22,1.065E-01,2.269E-01,3.682E-01,5.321E-01,5,"PKA-reg (cAMP-dependent), Adenylate cyclase type I, G-protein alpha-s, HXK2, ACE1",1.065E-01,2.269E-01,8,"PKA-reg (cAMP-dependent), LDHC, HXK2, ACE1, Tnp1, FSH-beta, Adenylate cyclase type I, G-protein alpha-s",
830,Translation_Role of Retinoic acid signaling in the initiation of translation,22,1.065E-01,2.269E-01,1.960E-01,3.354E-01,6,"H-Ras, ERK1/2, c-Raf-1, p70 S6 kinase1, RARalpha, MEK1/2",1.065E-01,2.269E-01,8,"H-Ras, eIF4E, ERK1/2, NMDA receptor, RARalpha, 4E-BP1, p70 S6 kinase1, GluR1",
831,Inhibition of RUNX3 signaling in gastric cancer,22,1.065E-01,2.269E-01,3.682E-01,5.321E-01,5,"JAB1, p21, Bcl-2, Cyclin D1, p27KIP1",1.065E-01,2.269E-01,8,"p21, p27KIP1, JAB1, LMO1, Caspase-7, Bcl-2, FOXO3A, Cyclin D1",
832,G-protein signaling_Cross-talk between Ras-family GTPases,23,1.076E-01,2.286E-01,1.076E-01,2.286E-01,7,"H-Ras, c-Raf-1, RalGDS, DBS, MR-GEF, AKT(PKB), PDK (PDPK1)",1.322E-01,2.614E-01,8,"H-Ras, Rac1, DBS, AKT(PKB), PDK (PDPK1), RalGDS, MR-GEF, RalA",
833,Development_Delta- and kappa-type opioid receptors signaling via beta-arrestin,23,1.076E-01,2.286E-01,1.076E-01,2.286E-01,7,"c-Fos, G-protein alpha-i family, PKC, Clathrin, Beta-arrestin1, p27KIP1, GRK2",1.322E-01,2.614E-01,8,"c-Fos, p27KIP1, GRK2, Delta-type opioid receptor, G-protein alpha-i family, PKC, Clathrin, Beta-arrestin1",
834,Apoptosis and survival_FAS signaling cascades,44,1.084E-01,2.301E-01,2.668E-01,4.228E-01,10,"NUMA1, PAK2, Cytochrome c, FADD, DcR3(TNFRSF6B), HSP27, RAIDD, Bcl-2, JNK(MAPK8-10), Smac/Diablo",1.084E-01,2.301E-01,14,"PAK2, Cytochrome c, FADD, FasL(TNFSF6), NUMA1, PARP-1, Caspase-7, DcR3(TNFRSF6B), MEKK1(MAP3K1), HSP27, RAIDD, Bcl-2, JNK(MAPK8-10), Smac/Diablo",
835,Role of Bregs in attenuation of T and NK cells mediated anti-tumor immune responses,41,1.098E-01,2.317E-01,1.098E-01,2.317E-01,11,"MIG, CD80, Granzyme B, STAT3, PI3K reg class IA (p85), CD3, FOXP3, IL-4, ENP1, Adenosine A2a receptor, LAG3",3.239E-01,4.941E-01,11,"Granzyme B, PI3K reg class IA (p85), FOXP3, FasL(TNFSF6), IL-4, ENP1, IL-2R alpha chain, CXCR3, TCR alpha/beta, Adenosine A2a receptor, LAG3",
836,Development_Oxytocin receptor signaling,41,1.098E-01,2.317E-01,1.098E-01,2.317E-01,11,"cPKC (conventional), Protein kinase G1, CACNA1C, GATA-4, G-protein alpha-q/11, IP3 receptor, MYOG, Calmodulin, ANP, eNOS, Guanylate Cyclase 1, soluble",1.217E-01,2.495E-01,13,"Protein kinase G1, GATA-4, G-protein alpha-q/11, PLC-beta1, IP3 receptor, MYOG, ANP, Guanylate Cyclase 1, soluble, cPKC (conventional), CACNA1C, alpha-MHC, Calmodulin, eNOS",
837,Cell cycle_Spindle assembly and chromosome separation,33,1.107E-01,2.328E-01,5.681E-01,7.211E-01,6,"DCTN2, NUMA1, Ubiquitin, Tubulin alpha, Ran, Tubulin (in microtubules)",1.107E-01,2.328E-01,11,"DCTN2, Separase, Importin (karyopherin)-alpha, Kid, CSE1L, Ubiquitin, Ran, Tubulin (in microtubules), NUMA1, Aurora-A, Tubulin alpha",
838,Normal and pathological TGF-beta-mediated regulation of cell proliferation,33,1.107E-01,2.328E-01,1.293E-01,2.572E-01,9,"PDGF-B, GRB2, DDX5, SARA, MEK6(MAP2K6), Cyclin D1, JNK(MAPK8-10), p38 MAPK, Axin",1.107E-01,2.328E-01,11,"PDGF-B, GRB2, Rac1, MEK6(MAP2K6), c-Myc, Axin, DDX5, SARA, Cyclin D1, JNK(MAPK8-10), p38 MAPK",
839,Immune response_TLR3 and TLR4 induced TICAM1-specific signaling pathway,33,1.107E-01,2.328E-01,1.293E-01,2.572E-01,9,"RIPK3, TBK1, TIRAP (Mal), Btk, PI3K reg class IA (p85), IFN-alpha, IRF3, AKT(PKB), PDK (PDPK1)",1.107E-01,2.328E-01,11,"TBK1, PI3K reg class IA (p85), IFN-alpha, AKT(PKB), PDK (PDPK1), RIPK3, TIRAP (Mal), Btk, Beclin 1, IRF3, TRIF (TICAM1)",
840,Cytoskeleton remodeling_Thyroliberin in cytoskeleton remodeling,33,1.107E-01,2.328E-01,1.293E-01,2.572E-01,9,"Thyroliberin, G-protein alpha-11, CACNA1C, PKA-reg (cAMP-dependent), IP3 receptor, G-protein alpha-s, Adenylate cyclase, Keratin 8, Tau (MAPT)",1.107E-01,2.328E-01,11,"PKA-reg (cAMP-dependent), PLC-beta1, IP3 receptor, Adenylate cyclase, Tau (MAPT), Thyroliberin, G-protein alpha-11, CACNA1C, G-protein alpha-s, Keratin 8, G-protein alpha-q",
841,Activation of ACTH production in pituitary gland in major depressive disorder,32,1.110E-01,2.322E-01,1.110E-01,2.322E-01,9,"gp130, TRAF2, TRADD, STAT3, I-kB, IL-1RI, CRHR1, NURR1, IL-6 receptor",1.744E-01,3.176E-01,10,"gp130, V1b receptor, IKK (cat), TRADD, I-kB, MyD88, IL-1RI, TRAF2, NURR1, IL-6 receptor",
842,Immune response_C3a signaling,48,1.123E-01,2.353E-01,1.473E-01,2.796E-01,12,"MHC class II, G-protein alpha-i family, ERK1/2, NFKBIA, IP3 receptor, PLC-beta, FOXP3, Adenylate cyclase, MEK1/2, CD40(TNFRSF5), AKT(PKB), p38 MAPK",1.123E-01,2.353E-01,15,"MHC class II, ERK1/2, IP3 receptor, PLC-beta, FOXP3, IKK-alpha, Adenylate cyclase, AKT(PKB), C3aR, G-protein alpha-i family, NFKBIA, FOXO3A, CD40(TNFRSF5), PI3K reg class IB (p101), p38 MAPK",
843,Glutathione metabolism,71,1.124E-01,2.353E-01,2.055E-01,3.465E-01,16,"GSTO2, GPX2, GCTG, GSHB, G6PD, GSTM3, GGT1, GSHR, GSTM4, GSTM5, GPX4, GSTM1, GSTM2, MGST3, GSTA3, GSTA4",1.124E-01,2.353E-01,21,"GPX3, GPX2, GSHB, GSTO1, GSTM3, GGT1, GSTM5, GSTM1, MAAI, GSTA3, GSTA4, GSTO2, GCTG, G6PD, GSHR, GSTM4, GSTA1, GPX4, GPX5, GSTM2, MGST3",
844,Stimulation of gastric acid secretion in gastric cancer,60,1.145E-01,2.385E-01,1.145E-01,2.385E-01,15,"MEK1(MAP2K1), HDC, ERK1/2, KCNQ1, PKA-reg (cAMP-dependent), c-Raf-1, G-protein alpha-q/11, IP3 receptor, VIL2 (ezrin), G-protein alpha-s, Calmodulin, PLC-beta, Adenylate cyclase, PKC-gamma, SP1",1.901E-01,3.395E-01,17,"ERK1/2, EGR1, KCNQ1, PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, VIL2 (ezrin), PLC-beta, Adenylate cyclase, PKC-gamma, Chromogranin A, CCKBR, G-protein alpha-s, Calmodulin, ATP4B, G-protein alpha-q, SP1",
845,Immune response_Naive CD4+ T cell differentiation,46,1.156E-01,2.398E-01,1.156E-01,2.398E-01,12,"PU.1, GATA-3, CD80, MHC class II, ROR-alpha, ROR-gamma, STAT3, AP-1, CD40(TNFRSF5), STAT6, IL-4, CD40L(TNFSF5)",2.344E-01,3.851E-01,13,"MHC class II, NF-AT1(NFATC2), IL-13, IL-9, IL-4, PU.1, GATA-3, IL-25 (IL-17E), ROR-gamma, AP-1, CD40(TNFRSF5), STAT6, TCR alpha/beta",
846,Immune response_T cell subsets: cell surface markers,52,1.156E-01,2.414E-01,3.380E-01,5.025E-01,11,"CCR7, CCR3, CRTH2, CCR6, CD161, CD3, CCR8, IL23R, IL-1RI, CCR5, LAG3",1.156E-01,2.414E-01,16,"TCR alpha subunit, TCR beta subunit, TCR beta variable 11-2, CCR8, IL23R, IL-1RI, CCR5, IL-2R alpha chain, CCR7, CCR3, CCR6, CXCR3, CD161, TCR alpha variable 24, TCR alpha/beta, LAG3",
847,Development_MAG-dependent inhibition of neurite outgrowth,37,1.167E-01,2.422E-01,8.266E-01,9.224E-01,5,"Myosin II, MyHC, MRLC, p200RhoGAP, MELC",1.167E-01,2.422E-01,12,"TrkA, Lingo1, NT-3, TrkC, Destrin, Myosin II, MyHC, MRLC, MAG, p200RhoGAP, MELC, Cofilin",
848,Downregulation of MITF in melanoma,26,1.168E-01,2.422E-01,1.784E-01,3.162E-01,7,"JunB, STAT3, IL-1RI, PAX3, POU3F2 (BRN2), JNK(MAPK8-10), p27KIP1",1.168E-01,2.422E-01,9,"IL-1RI, PAX3, POU3F2 (BRN2), p27KIP1, miR-152-3p, JunB, miR-182-5p, JNK(MAPK8-10), Cofilin",
849,Development_S1P2 and S1P3 receptors in cell proliferation and differentiation,26,1.168E-01,2.422E-01,1.784E-01,3.162E-01,7,"MEK1(MAP2K1), c-Fos, H-Ras, ERK1/2, c-Raf-1, S1P3 receptor, G-protein alpha-13",1.168E-01,2.422E-01,9,"c-Fos, H-Ras, ERK1/2, Actin, S1P3 receptor, G-protein alpha-13, MYH11, G-protein alpha-q, Cofilin",
850,Immune response_CD40 signaling,65,1.176E-01,2.436E-01,1.176E-01,2.436E-01,16,"CD80, TRAF2, CIKS, TRAF5, STAT3, I-kB, PI3K reg class IA (p85), IKK-beta, Bcl-XL, CD40(TNFRSF5), AKT(PKB), CD23, PDK (PDPK1), p27KIP1, p38 MAPK, CD40L(TNFSF5)",2.104E-01,3.607E-01,18,"CIKS, IKK (cat), I-kB, PI3K reg class IA (p85), IKK-alpha, Bcl-XL, FasL(TNFSF6), AKT(PKB), CD23, PDK (PDPK1), p27KIP1, TRAF2, c-Jun, TRAF5, MEKK1(MAP3K1), IKK-beta, CD40(TNFRSF5), p38 MAPK",
851,Platelet activation as a result of endothelial dysfunction after stenting,56,1.184E-01,2.449E-01,2.039E-01,3.450E-01,13,"Protein kinase G1, G-protein alpha-i family, Glycoprotein VI, PKA-reg (cAMP-dependent), P2Y12, IP3 receptor, G-protein alpha-13, G-protein alpha-s, PKC, Adenylate cyclase, IP3R1, PAR4, IRAG",1.184E-01,2.449E-01,17,"Protein kinase G1, Glycoprotein VI, PKA-reg (cAMP-dependent), IP3 receptor, G-protein alpha-13, Plasminogen, Prostacyclin receptor, Thrombin, Adenylate cyclase, PAR4, G-protein alpha-i family, P2Y12, Plasmin, G-protein alpha-s, PKC, IP3R1, G-protein alpha-q",
852,IL-6 signaling in colorectal cancer,37,1.191E-01,2.445E-01,1.191E-01,2.445E-01,10,"gp130, TFF3, Clusterin, IL6RA, STAT3, USP7, Bcl-XL, Cyclin D1, sIL6-RA, HSP70",3.276E-01,4.972E-01,10,"gp130, Clusterin, Bcl-XL, HSP70, c-Myc, TFF3, IL6RA, USP7, Cyclin D1, sIL6-RA",
853,Apoptosis and survival_Anti-apoptotic action of nuclear ESR1 and ESR2,37,1.191E-01,2.445E-01,1.191E-01,2.445E-01,10,"MEK1(MAP2K1), p38alpha (MAPK14), Protein kinase G1, ESR1 (nuclear), ERK1/2, c-Raf-1, Cytochrome c, ESR2 (nuclear), Bcl-2, Guanylate Cyclase 1, soluble",2.053E-01,3.573E-01,11,"Protein kinase G1, ESR1 (nuclear), ERK1/2, c-Jun/c-Fos, Cytochrome c, ESR2 (nuclear), Guanylate Cyclase 1, soluble, c-Myc, Thioredoxin, c-Jun, Bcl-2",
854,Stem cells_Aberrant Hedgehog signaling in medulloblastoma stem cells,15,1.195E-01,2.445E-01,1.195E-01,2.445E-01,5,"BMI-1, SHH, Cyclin D1, SUFU, N-Myc",2.432E-01,3.992E-01,5,"SUFU, BMI-1, SHH, Cyclin D1, N-Myc",
855,Tumor-stroma interactions in pancreatic cancer,28,1.198E-01,2.445E-01,1.198E-01,2.445E-01,8,"Galectin-3, PDGF-B, MMP-1, STK36, SHH, FGFR1, IGF-1, SUFU",1.685E-01,3.106E-01,9,"Galectin-3, PDGF-B, KIF27, FGFR1, SUFU, MMP-1, STK36, SHH, IGF-1",
856,GLP-1 in inhibition of insulin secretion in type 2 diabetes,28,1.198E-01,2.445E-01,1.198E-01,2.445E-01,8,"Insulin processed, Adenylate cyclase type VI, CACNA1C, Kir6.2, CACNA1D, G-protein alpha-s, Calmodulin, PDK (PDPK1)",1.685E-01,3.106E-01,9,"Insulin processed, Adenylate cyclase type VI, PKC-zeta, Kir6.2, PDK (PDPK1), CACNA1C, CACNA1D, G-protein alpha-s, Calmodulin",
857,Pro-oncogenic action of Androgen receptor in ovarian cancer,28,1.198E-01,2.445E-01,1.198E-01,2.445E-01,8,"RASEF, Rab-25, HSD17B3, SGTA, Rab-35, G-protein alpha-13, Androgen receptor, RERG",4.626E-01,6.309E-01,7,"Rab-25, G-protein alpha-13, Androgen receptor, RERG, RASEF, SGTA, Rab-35",
858,Development_Delta-type opioid receptor signaling via G-protein alpha-14,28,1.198E-01,2.445E-01,1.198E-01,2.445E-01,8,"MEK1(MAP2K1), H-Ras, c-Raf-1, IP3 receptor, STAT3, Calmodulin, G-protein alpha-14, ERK1 (MAPK3)",2.969E-01,4.586E-01,8,"H-Ras, PLC-beta1, Rac1, IP3 receptor, G-protein alpha-14, ERK1 (MAPK3), Delta-type opioid receptor, Calmodulin",
859,"Development_Hedgehog, BMP and Parathyroid hormone in osteogenesis",51,1.204E-01,2.450E-01,1.204E-01,2.450E-01,13,"MEK1(MAP2K1), SP7, ERK1/2, PTHR1, PKA-reg (cAMP-dependent), BMP7, SHH, G-protein alpha-q/11, G-protein alpha-s, PLC-beta, Bone sialoprotein, Adenylate cyclase, SUFU",1.674E-01,3.094E-01,15,"SP7, ERK1/2, PTHR1, PKA-reg (cAMP-dependent), G-protein alpha-q/11, PLC-beta, Bone sialoprotein, Adenylate cyclase, SUFU, PKC-delta, BMP7, SHH, G-protein alpha-s, SMAD1, Parathyroid hormone",
860,Pro-tumoral TNF-alpha signaling in melanoma,41,1.217E-01,2.495E-01,4.722E-01,6.310E-01,8,"AKT1, p21, NFKBIA, TYRP1, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1), IL8RB",1.217E-01,2.495E-01,13,"AKT1, IKK (cat), p21, AKT(PKB), PDK (PDPK1), IL8RB, c-Jun, NFKBIA, TYRP1, RhoGDI beta, MEKK1(MAP3K1), AKT2, JNK(MAPK8-10)",
861,Eosinophil adhesion and transendothelial migration in asthma,68,1.246E-01,2.542E-01,3.457E-01,5.108E-01,14,"C5aR, Galectin-3, CCR3, CRTH2, ERK1/2, ITGAM, MGF, LTBR1, Vitronectin, Calmodulin, PKC, P2Y2, CysLT1 receptor, p38 MAPK",1.246E-01,2.542E-01,20,"Galectin-3, Histamine H4 receptor, ERK1/2, IL-3, CCL13, CysLT1 receptor, C3aR, C5aR, CCR3, PKC-delta, ITGAM, MGF, LTBR1, CD67, IL-5 receptor, Vitronectin, Calmodulin, PKC, P2Y2, p38 MAPK",
862,Stem cells_Neovascularization of glioblastoma in response to hypoxia,30,1.250E-01,2.542E-01,2.947E-01,4.507E-01,7,"VEGFR-1, IP3 receptor, Ubiquitin, I-kB, IKK-beta, HIF-prolyl hydroxylase, SDF-1",1.250E-01,2.542E-01,10,"c-Jun/c-Fos, IKK (cat), IP3 receptor, Ubiquitin, I-kB, SDF-1, ARNT, VEGFR-1, IKK-beta, HIF-prolyl hydroxylase",
863,Disruption of methionine metabolism in induction and progression of HCC,42,1.256E-01,2.543E-01,1.256E-01,2.543E-01,11,"DNMT3B, MTR, MAT1A, ADH7, ADH1, DNMT3A, SAHH, GNMT, c-Myb, Bcl-XS, SP1",2.340E-01,3.851E-01,12,"DNMT3B, MAT1A, ADH7, c-Myb, Bcl-XS, c-Myc, MTR, DNMT3A, SAHH, GNMT, SP1, MAT2A",
864,Stromal-epithelial interaction in Prostate Cancer,42,1.256E-01,2.543E-01,1.256E-01,2.543E-01,11,"E-cadherin, PDGF-B, FGFR1, Androgen receptor, TGF-beta 3, Keratin 18, FGF10, IGF-1 receptor, SP1, IGF-1, IL-6 receptor",1.412E-01,2.746E-01,13,"PDGF-B, FGFR1, Androgen receptor, Keratin 18, FGF10, IGF-1 receptor, E-cadherin, c-Jun, FGF7, TGF-beta 3, SP1, IGF-1, IL-6 receptor",
865,Estradiol metabolism,42,1.256E-01,2.543E-01,1.256E-01,2.543E-01,11,"CYP2C8, UGT2A1, SULT1A3, CYP3A5, COMT, SULT1A1, UGT2B11, CYP1A2, UGT2B28, CYP3A4, UGT2B17",4.976E-01,6.647E-01,10,"UGT2A1, SULT1A3, CYP3A5, COMT, UGT2B11, CYP1A2, CYP2C19, SULT1A1, UGT2B28, UGT2B17",
866,Regulation of lipid metabolism_Stimulation of Arachidonic acid production by ACM receptors,72,1.261E-01,2.555E-01,1.458E-01,2.779E-01,17,"MEK1(MAP2K1), DGL-alpha, ERK1/2, G-protein alpha-11, c-Raf-1, PAK1, DGL-beta, ARF1, ACM1, IP3 receptor, G-protein alpha-13, Calmodulin, PKC, cPLA2, Monoglyceride lipase, ARF6, p38 MAPK",1.261E-01,2.555E-01,21,"DGL-alpha, ERK1/2, DGL-beta, PLC-beta1, Rac1, IP3 receptor, G-protein alpha-13, cPLA2, Monoglyceride lipase, ARF6, BETA-PIX, ACM2, G-protein alpha-11, PAK1, ARF1, ACM1, Calmodulin, PKC, MEKK1(MAP3K1), G-protein alpha-q, p38 MAPK",
867,Retinoic acid regulation of oligodendrocyte differentiation in multiple sclerosis,24,1.292E-01,2.572E-01,1.292E-01,2.572E-01,7,"ANGPTL4, RARgamma, PLP1, RXRA, OLIG1, RARalpha, Transthyretin",2.970E-01,4.586E-01,7,"RARgamma, PLP1, OLIG1, RARalpha, ANGPTL4, RXRA, Transthyretin",
868,Role of metalloproteases and heparanase in progression of pancreatic cancer,33,1.293E-01,2.572E-01,1.293E-01,2.572E-01,9,"MEK1(MAP2K1), GRB2, MMP-1, H-Ras, c-Raf-1, Alpha 1-antitrypsin, MMP-15, Occludin, ERK1 (MAPK3)",4.886E-01,6.575E-01,8,"GRB2, H-Ras, Alpha 1-antitrypsin, MMP-15, FasL(TNFSF6), ERK1 (MAPK3), MMP-1, Occludin",
869,Influence of multiple myeloma cells on bone marrow stromal cells,33,1.293E-01,2.572E-01,1.293E-01,2.572E-01,9,"FGFR3, CD80, Syndecan-1, FGFR4, FGFR1, IL-1RI, CD40(TNFRSF5), IGF-1, CD40L(TNFSF5)",6.526E-01,7.968E-01,7,"FGFR4, FGFR1, IL-1RI, FGFR3, Syndecan-1, CD40(TNFRSF5), IGF-1",
870,SHH signaling in melanoma,33,1.293E-01,2.572E-01,1.293E-01,2.572E-01,9,"MEK1(MAP2K1), E-cadherin, AKT1, H-Ras, BMI-1, STK36, SHH, PDK (PDPK1), SUFU",3.312E-01,5.012E-01,9,"AKT1, H-Ras, KIF27, PDK (PDPK1), SUFU, E-cadherin, BMI-1, STK36, SHH",
871,Immune response_PGE2 common pathways,47,1.309E-01,2.584E-01,1.309E-01,2.584E-01,12,"MEK1(MAP2K1), G-protein alpha-i family, PKA-reg (cAMP-dependent), c-Raf-1, PGE2R3, IP3 receptor, COX-1 (PTGS1), G-protein alpha-s, PLC-beta, Adenylate cyclase, AKT(PKB), ERK1 (MAPK3)",7.758E-01,8.977E-01,9,"PKA-reg (cAMP-dependent), IP3 receptor, PLC-beta, Adenylate cyclase, AKT(PKB), ERK1 (MAPK3), G-protein alpha-i family, PGE2R3, G-protein alpha-s",
872,Neurophysiological process_Circadian rhythm,47,1.309E-01,2.584E-01,1.309E-01,2.584E-01,12,"MEK1(MAP2K1), ROR-alpha, ERK1/2, c-Raf-1, p90Rsk, CRY2, PER1, Calmodulin, PER2, Guanylate Cyclase 1, soluble, CRY1, Dexras1",3.812E-01,5.523E-01,12,"Casein kinase I delta, ERK1/2, CRY2, NMDA receptor, PER1, CLOCK, Guanylate Cyclase 1, soluble, CRY1, REV-ERBalpha, Calmodulin, PER2, Dexras1",
873,Th2 cell migration in asthma,34,1.316E-01,2.614E-01,1.491E-01,2.806E-01,9,"CCL22, CCL17, CCL1, CCR3, CRTH2, G-protein alpha-i family, LTBR1, CCR8, GRK2",1.316E-01,2.614E-01,11,"IL-16 mature, Histamine H4 receptor, CCL22, CCL17, CCR8, GRK2, CCL1, CCR3, G-protein alpha-i family, LTBR1, PI3K reg class IB (p101)",
874,Development_Epigenetic and transcriptional regulation of oligodendrocyte precursor cell differentiation and myelination,34,1.316E-01,2.614E-01,5.993E-01,7.511E-01,6,"SOX11, hASH1, PLP1, ID2, SP1, p27KIP1",1.316E-01,2.614E-01,11,"WNT3A, MYT1, PLP1, ID2, Nkx2.2, p27KIP1, YY1, SOX11, hASH1, SP1, Frizzled",
875,Development_Histone acetylation in embryonic stem cells,34,1.316E-01,2.614E-01,1.491E-01,2.806E-01,9,"GCN5, GATA-4, DNMT3A, p21, NANOG, SCAMP1, SOX2, EP400, p27KIP1",1.316E-01,2.614E-01,11,"GCN5, GATA-4, p21, EP400, p27KIP1, c-Myc, DNMT3A, NANOG, SCAMP1, SOX2, MBD3",
876,Development_Role of cell-cell and ECM-cell interactions in oligodendrocyte differentiation and myelination,34,1.316E-01,2.614E-01,5.993E-01,7.511E-01,6,"Semaphorin 5A, CD81, PLP1, CD9, Connexin 43, FAK1",1.316E-01,2.614E-01,11,"Semaphorin 5A, CD81, Connexin 32, Lingo1, PLP1, CD82, Tenascin-R, CD9, Neurofascin, FAK1, MAG",
877,"Apoptosis and survival_Cytoplasmic/mitochondrial transport of proapoptotic proteins Bid, Bmf and Bim",34,1.316E-01,2.614E-01,4.226E-01,5.868E-01,7,"TRAF2, DLC2 (Dynein LC8b), TRADD, Cytochrome c, FADD, Bcl-2, Smac/Diablo",1.316E-01,2.614E-01,11,"TRADD, Cytochrome c, FADD, FasL(TNFSF6), TRAF2, DLC2 (Dynein LC8b), MKK7 (MAP2K7), MEKK1(MAP3K1), DLC1 (Dynein LC8a), Bcl-2, Smac/Diablo",
878,Proteolysis_Putative ubiquitin pathway,23,1.322E-01,2.614E-01,2.272E-01,3.743E-01,6,"FBXW7, Parkin, E2N(UBC13), Ubiquitin, CHIP, HSP70",1.322E-01,2.614E-01,8,"FBXW7, Parkin, E2N(UBC13), Ubiquitin, UEV1A, HSP70, UBE1, CHIP",
879,Apoptosis and survival_NO signaling in apoptosis,23,1.322E-01,2.614E-01,6.215E-01,7.705E-01,4,"Protein kinase G1, PAK1, MEK6(MAP2K6), p38 MAPK",1.322E-01,2.614E-01,8,"Protein kinase G1, Bak, Rac1, MEK6(MAP2K6), G3P2, PAK1, MKK7 (MAP2K7), p38 MAPK",
880,Huntington's disease (general schema),3,1.322E-01,2.614E-01,4.514E-01,6.147E-01,1,Huntingtin,1.322E-01,2.614E-01,2,"Huntingtin, NMDA receptor",
881,Inhibition of neutrophil migration by proresolving lipid mediators in COPD,71,1.326E-01,2.611E-01,1.326E-01,2.611E-01,17,"C5aR, cPKC (conventional), G-protein alpha-i family, Alpha-actinin, PAK1, LTBR1, IL8RA, IP3 receptor, VIL2 (ezrin), Calmodulin, PKC, CD34, IL-1RI, CCR5, p38 MAPK, PREX1, IL8RB",1.726E-01,3.163E-01,20,"c-Jun/c-Fos, Rac1, IP3 receptor, VIL2 (ezrin), CD34, IL-1RI, CCR5, IL8RB, C5aR, cPKC (conventional), G-protein alpha-i family, c-Jun, PAK1, LTBR1, IL8RA, Calmodulin, PKC, PI3K reg class IB (p101), p38 MAPK, PREX1",
882,Stem cells_mGluR3 signaling in glioblastoma stem cells,52,1.352E-01,2.658E-01,1.352E-01,2.658E-01,13,"MEK1(MAP2K1), GRB2, K-RAS, SLC1A2/EAAT2, G-protein alpha-i family, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, PTEN, Adenylate cyclase, AKT(PKB), PDK (PDPK1)",1.884E-01,3.373E-01,15,"GRB2, SLC1A2/EAAT2, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), Adenylate cyclase, AKT(PKB), PDK (PDPK1), K-RAS, G-protein alpha-i family, SLC1A1/EAAT3, mGluR3, PTEN, N-type Ca(II) channel alpha1B, PI3K reg class IB (p101)",
883,G-protein signaling_RhoB regulation pathway,16,1.358E-01,2.675E-01,1.491E-01,2.806E-01,5,"Rhotekin, RhoB, VIL2 (ezrin), ARHGEF3, VAV-2",1.358E-01,2.675E-01,6,"Rhotekin, VIL2 (ezrin), ARHGEF3, VAV-2, RhoGDI gamma, RhoB",
884,Immune response_M-CSF-receptor signaling pathway,81,1.361E-01,2.671E-01,1.361E-01,2.671E-01,19,"PU.1, MEK1(MAP2K1), GRB2, c-Fos, H-Ras, ERK1/2, c-Raf-1, IP3 receptor, STAT3, GLUT1, PI3K reg class IA (p85), AP-1, Hck, Calmodulin, PKC, WASP, Cyclin D1, AKT(PKB), PDK (PDPK1)",2.887E-01,4.568E-01,21,"GRB2, c-Fos, H-Ras, ERK1/2, c-Jun/c-Fos, Rac1, IP3 receptor, PI3K reg class IA (p85), Hck, WASP, AKT(PKB), PDK (PDPK1), c-Myc, PU.1, Tcf(Lef), c-Jun, GLUT1, AP-1, Calmodulin, PKC, Cyclin D1",
885,G-protein signaling_G-Protein alpha-12 signaling pathway,38,1.367E-01,2.675E-01,1.367E-01,2.677E-01,10,"MEK1(MAP2K1), G-protein alpha-12 family, ERK1/2, c-Raf-1, PAK1, Btk, PI3K reg class IA (p85), JNK(MAPK8-10), MR-GEF, p38 MAPK",1.369E-01,2.675E-01,12,"LARG, ERK1/2, Rac1, PI3K reg class IA (p85), G-protein alpha-12 family, PAK1, Btk, 14-3-3 beta/alpha, MEKK1(MAP3K1), JNK(MAPK8-10), MR-GEF, p38 MAPK",
886,WNT signaling in invasive-type melanoma cells,38,1.367E-01,2.677E-01,1.367E-01,2.677E-01,10,"E-cadherin, cPKC (conventional), ROR2, STAT3, Calmodulin, PKC, PDE6 reg, PAX3, JNK(MAPK8-10), PDE6 cat",2.331E-01,3.851E-01,11,"WNT3A, PDE6 reg, PAX3, E-cadherin, cPKC (conventional), ROR2, MKK7 (MAP2K7), Calmodulin, PKC, JNK(MAPK8-10), PDE6 cat",
887,Activation of Ca2+-dependent neuronal cell death in Huntington's disease,38,1.369E-01,2.675E-01,5.478E-01,7.013E-01,7,"IPP-1, Calcineurin A (catalytic), Huntingtin, PP1-cat, MEK6(MAP2K6), IP3R1, p38 MAPK",1.369E-01,2.675E-01,12,"Calcineurin A (catalytic), Huntingtin, PP1-cat, NMDA receptor, Hap-1, MEK6(MAP2K6), Thioredoxin, IPP-1, c-Jun, MKK7 (MAP2K7), IP3R1, p38 MAPK",
888,Impaired macrophage phagocytic function in asthma,38,1.369E-01,2.675E-01,3.828E-01,5.468E-01,8,"SP-A, GSHB, ITGAM, Fc gamma RI, SP-D, ICAM3, GSTM1, IL-4",1.369E-01,2.675E-01,12,"GSHB, FCGR3A, Rac1, SOD1, SP-D, GSTM1, IL-4, SP-A, ITGAM, Fc gamma RI, TIM-3, ICAM3",
889,Lysophospholipid mediators-induced inflammatory signaling in normal and asthmatic airway epithelium,57,1.387E-01,2.707E-01,1.387E-01,2.707E-01,14,"G-protein alpha-12 family, G-protein alpha-i family, ERK1/2, c-Raf-1, NFKBIA, S1P3 receptor, I-kB, PLC-beta, MEK1/2, IL13RA2, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1), p38 MAPK",3.093E-01,4.761E-01,15,"ERK1/2, IKK (cat), S1P3 receptor, I-kB, PLC-beta, IL-13, AKT(PKB), PDK (PDPK1), G-protein alpha-12 family, PKC-delta, G-protein alpha-i family, c-Jun, NFKBIA, JNK(MAPK8-10), p38 MAPK",
890,Neurophysiological process_Olfactory transduction,20,1.391E-01,2.707E-01,1.391E-01,2.707E-01,6,"CNGB1, Olfactory receptor, ANO2, CNGA2, Calmodulin, CNGA4",2.956E-01,4.586E-01,6,"CNGB1, Olfactory receptor, CNGA2, ANO2, Calmodulin, CNGA4",
891,SLE genetic marker-specific pathways in T cells,101,1.397E-01,2.714E-01,1.397E-01,2.714E-01,23,"MHC class II, Calcineurin A (catalytic), GRB2, ESR1 (nuclear), TRAF2, H-Ras, ERK1/2, NF-AT3(NFATC4), c-Raf-1, STAT3, Ubiquitin, I-kB, HSD17B2, Calmodulin, CD3, IFN-alpha, Aiolos, IKK-beta, Bcl-2, IP3R1, MEK1/2, MHC class II beta chain, CD40L(TNFSF5)",2.733E-01,4.346E-01,26,"MHC class II, Calcineurin A (catalytic), TCR beta subunit, GRB2, ESR1 (nuclear), NF-AT1(NFATC2), H-Ras, ERK1/2, NF-AT3(NFATC4), IKK (cat), Rac1, Ubiquitin, I-kB, ZAP70, IKK-alpha, IFN-alpha, Aiolos, MHC class II beta chain, Ikaros, TRAF2, LAT, Calmodulin, IKK-beta, Bcl-2, IP3R1, TCR alpha/beta",
892,Hedgehog signaling in gastric cancer,29,1.405E-01,2.716E-01,1.405E-01,2.716E-01,8,"ROR2, STK36, SHH, p21, MSX-2, Islet-1, HIP, SUFU",5.033E-01,6.700E-01,7,"p21, KIF27, MSX-2, SUFU, ROR2, STK36, SHH",
893,Development_SSTR1 in regulation of cell proliferation and migration,29,1.405E-01,2.716E-01,1.405E-01,2.716E-01,8,"MEK1(MAP2K1), H-Ras, SLC9A1, ERK1/2, c-Raf-1, p21, SSTR1, LIMK2",1.978E-01,3.474E-01,9,"H-Ras, SLC9A1, ERK1/2, EGR1, p21, LIMK2, Somatostatin, SHP-2, PI3K reg class IB (p101)",
894,Abnormalities in cell cycle in SCLC,29,1.405E-01,2.716E-01,1.405E-01,2.716E-01,8,"E2F1, BMI-1, p21, Rb protein, MDM2, Cyclin D1, Max, p27KIP1",1.978E-01,3.474E-01,9,"p21, Rb protein, MDM2, p27KIP1, c-Myc, E2F1, BMI-1, Cyclin D1, Max",
895,Development_Auditory hair cell differentiation in embryogenesis,29,1.405E-01,2.716E-01,1.405E-01,2.716E-01,8,"FGFR3, FGFR1, Lunatic fringe, DLL1, Myosin VIIA, Myosin VI, SOX2, p27KIP1",1.978E-01,3.474E-01,9,"FGFR1, DLL1, Myosin VIIA, BARHL1, p27KIP1, FGFR3, Lunatic fringe, Myosin VI, SOX2",
896,Apoptosis and survival_Anti-apoptotic TNFs/NF-kB/IAP pathway,27,1.414E-01,2.746E-01,3.633E-01,5.285E-01,6,"TRAF2, TRADD, TRAF5, I-kB, TL1A(TNFSF15), IKK-beta",1.414E-01,2.746E-01,9,"IKK (cat), TRADD, I-kB, IKK-alpha, TRAF2, TRAF5, CD30L (TNFSF8), TL1A(TNFSF15), IKK-beta",
897,Immune response_IL-10 signaling pathway,62,1.416E-01,2.728E-01,1.416E-01,2.728E-01,15,"CD80, HPGD, MHC class II, Bcl-3, STAT3, Fc gamma RI, p70 S6 kinase1, PI3K reg class IA, Bcl-2, Bcl-XL, Fc gamma RII beta, AKT(PKB), CD23, PDK (PDPK1), G-CSF",2.324E-01,3.851E-01,17,"HPGD, MHC class II, Bcl-3, PCBP-1, PI3K reg class IA, Bcl-XL, SHIP, AKT(PKB), CD23, PDK (PDPK1), miR-187-3p, Fc gamma RI, p70 S6 kinase1, Bcl-2, microRNA 187, Fc gamma RII beta, G-CSF",
898,Role of platelets in the initiation of in-stent restenosis,43,1.426E-01,2.728E-01,1.426E-01,2.728E-01,11,"PDGF-B, Glycoprotein VI, P2Y12, sCD40L, JAM3, GP-IB alpha, von Willebrand factor, CD40(TNFRSF5), PAR4, GP-V, CD40L(TNFSF5)",3.881E-01,5.574E-01,11,"PDGF-B, Glycoprotein VI, JAM3, Thrombin, von Willebrand factor, PAR4, P2Y12, GP-IX, GP-IB alpha, CD40(TNFRSF5), GP-V",
899,Apoptosis and survival_TNF-alpha-induced Caspase-8 signaling,43,1.426E-01,2.728E-01,1.426E-01,2.728E-01,11,"AKT1, HSP90 alpha, PP2A regulatory, TRADD, Cytochrome c, FADD, ErbB2, PP2A structural, AKT(PKB), HSP90, Cathepsin D",1.624E-01,3.019E-01,13,"AKT1, HSP90 alpha, PP2A regulatory, TRADD, Cytochrome c, FADD, ErbB2, PP2A structural, AKT(PKB), HSP90, Cathepsin D, Caspase-7, AKT2",
900,Immune response_Inhibitory action of Lipoxins on pro-inflammatory TNF-alpha signaling,46,1.448E-01,2.804E-01,3.171E-01,4.833E-01,10,"AKT1, TRAF2, TRADD, STAT3, I-kB, PI3K reg class IA (p85), IKK-beta, AKT(PKB), PDK (PDPK1), p27KIP1",1.448E-01,2.804E-01,14,"AKT1, 14-3-3, PKC-zeta, IKK (cat), TRADD, I-kB, PI3K reg class IA (p85), IKK-alpha, AKT(PKB), PDK (PDPK1), p27KIP1, TRAF2, SHP-2, IKK-beta",
901,Angiotensin II Signaling in Cardiac Hypertrophy,72,1.458E-01,2.779E-01,1.458E-01,2.779E-01,17,"Calcineurin A (catalytic), c-Fos, SLC9A1, ERK1/2, AGTR1, Kv4.3 channel, NF-AT3(NFATC4), GATA-4, Ca(II)channel L-type, G-protein alpha-q/11, IP3 receptor, PRKD1, Calmodulin, MEK6(MAP2K6), CAML, JNK(MAPK8-10), p38 MAPK",2.730E-01,4.346E-01,19,"Calcineurin A (catalytic), c-Fos, SLC9A1, ERK1/2, NF-AT3(NFATC4), GATA-4, G-protein alpha-q/11, IP3 receptor, SOD1, MEK6(MAP2K6), Thioredoxin, AGTR1, Kv4.3 channel, Ca(II)channel L-type, PRKD1, Calmodulin, CAML, JNK(MAPK8-10), p38 MAPK",
902,Oxidative stress_Role of IL-8 signaling pathway in respiratory burst,48,1.473E-01,2.796E-01,1.473E-01,2.796E-01,12,"G-protein alpha-i family, ERK1/2, PAK1, p67-phox, IL8RA, Btk, IP3 receptor, p40-phox, AKT(PKB), p38 MAPK, PREX1, IL8RB",1.870E-01,3.352E-01,14,"ERK1/2, PKC-zeta, IP3 receptor, AKT(PKB), IL8RB, PKC-delta, G-protein alpha-i family, PAK1, IL8RA, Btk, p40-phox, PI3K reg class IB (p101), p38 MAPK, PREX1",
903,Immune response_IL-12 signaling pathway,48,1.473E-01,2.796E-01,1.473E-01,2.796E-01,12,"p38alpha (MAPK14), AKT1, IL-12 alpha, STAT3, Ubiquitin, SPHK2, GADD45 gamma, PI3K reg class IA, MEK6(MAP2K6), JNK(MAPK8-10), AKT(PKB), PDK (PDPK1)",1.870E-01,3.352E-01,14,"AKT1, Cyclin D3, IL-12 alpha, Ubiquitin, PI3K reg class IA, MEK6(MAP2K6), AKT(PKB), PDK (PDPK1), c-Myc, MEKK4(MAP3K4), c-Jun, SPHK2, GADD45 gamma, JNK(MAPK8-10)",
904,TGF-beta 1-induced transactivation of membrane receptors signaling in HCC,50,1.477E-01,2.845E-01,4.219E-01,5.868E-01,10,"E-cadherin, TGF-beta, PAK1, DDX5, PI3K reg class IA, PTEN, FAK1, Cyclin D1, AKT(PKB), Axin",1.477E-01,2.845E-01,15,"Lef-1, Actin, Rac1, PI3K reg class IA, AKT(PKB), c-Myc, Axin, E-cadherin, TGF-beta, PAK1, DDX5, PTEN, FAK1, Cyclin D1, Cofilin",
905,Immune response_IL-13 signaling via PI3K-ERK pathway,50,1.477E-01,2.845E-01,2.896E-01,4.507E-01,11,"MEK1(MAP2K1), GRB2, H-Ras, ERK1/2, c-Raf-1, Adenylate cyclase type I, IP3 receptor, Calmodulin, Mucin 5AC, IGHE, AKT(PKB)",1.477E-01,2.845E-01,15,"GRB2, IRS-1, H-Ras, ERK1/2, PKC-zeta, IP3 receptor, IL-13, AKT(PKB), c-Myc, PKC-delta, Adenylate cyclase type I, Calmodulin, SHP-2, Mucin 5AC, IGHE",
906,Linoleic acid metabolism,31,1.487E-01,2.853E-01,1.868E-01,3.254E-01,8,"PLA2G12, CYP2J2, CYP1A2, PLA2(hGIIA), PLA2G10, ALOX15B, ALOX15, PLA2G5",1.487E-01,2.853E-01,10,"CYP1A2, PLA2G10, CYP2C19, CYP2E1, PLA2G12, CYP2J2, PLA2(hGIIA), ALOX15B, ALOX15, PLA2G5",
907,Development_HGF-dependent inhibition of TGF-beta-induced EMT,34,1.491E-01,2.806E-01,1.491E-01,2.806E-01,9,"MEK1(MAP2K1), GRB2, c-Fos, H-Ras, ERK1/2, c-Raf-1, p90Rsk, PGES2, SP1",6.854E-01,8.263E-01,7,"GRB2, c-Fos, H-Ras, ERK1/2, PGES2, c-Jun, SP1",
908,wtCFTR and deltaF508 traffic / Late endosome and lysosome (normal and CF),16,1.491E-01,2.806E-01,1.491E-01,2.806E-01,5,"VAMP8, Slp5, CFTR, VTI1B, MUNC13-4",2.921E-01,4.586E-01,5,"Slp5, VTI1B, MUNC13-4, Rab-7, VAMP8",
909,Blood coagulation_GPVI-dependent platelet activation,54,1.500E-01,2.867E-01,5.263E-01,6.814E-01,10,"Fc epsilon RI gamma, Glycoprotein VI, Btk, IP3 receptor, GP-IB alpha, von Willebrand factor, SHP-1, VAV-3, SNAP-23, GP-V",1.500E-01,2.867E-01,16,"Fc epsilon RI gamma, Glycoprotein VI, Rac1, IP3 receptor, von Willebrand factor, SHP-1, Syntaxin 4, CALDAG-GEFI, LAT, GP-IX, Btk, GP-IB alpha, SHP-2, VAV-3, SNAP-23, GP-V",
910,"Immune response_Antigen presentation by MHC class I, classical pathway",54,1.500E-01,2.867E-01,1.678E-01,3.031E-01,13,"PSMB1, PSMB5, HSP90 alpha, Impas 1, PSME1, Sec24, NPEPPS, Thimet oligopeptidase, ACE1, Sec23, CHIP, HSP70, IDE",1.500E-01,2.867E-01,16,"PSMB1, PSMB5, HSP90 alpha, Impas 1, PSME2, NPEPPS, Thimet oligopeptidase, ACE1, Sec23, HSP70, PA28 (11S regulator), PSME1, Sec24, CHIP, IDE, TCR alpha/beta",
911,Proinflammatory cytokine production by Th17 cells in asthma,53,1.510E-01,2.829E-01,1.510E-01,2.829E-01,13,"C5aR, GATA-3, CD80, MHC class II, ROR-alpha, CRTH2, ROR-gamma, CCR6, STAT3, IL-1RI, JNK(MAPK8-10), IL-4, IL-6 receptor",2.106E-01,3.607E-01,15,"MHC class II, c-Jun/c-Fos, IL-13, IL-1RI, IL-9, IL-4, C3aR, C5aR, GATA-3, ROR-gamma, c-Jun, CCR6, JNK(MAPK8-10), TCR alpha/beta, IL-6 receptor",
912,CTP/UTP metabolism,107,1.511E-01,2.829E-01,1.511E-01,2.829E-01,24,"RRP41, RPOM, NDPK C, CTP synthase II, PCY1A, NDPK complex, RPB8, RPB10, POLR3B, AID, UCK1, RPB7.0, NDPK 6, POLR3A, POLR1B, CSL4, NDPK A, RRP46, NDPK D (mitochondrial), ENP3, POLR2I, ENP1, POLR3K, NDPK B",2.330E-01,3.851E-01,28,"RPOM, PCY1A, NDPK complex, RPB8, PR44 (DIS3), POLR3B, NDPK 6, POLR1B, CSL4, RPB5, RRP46, ENP1, POLR3K, AK1, RRP41, NDPK C, CTP synthase II, RPB10, AID, UCK1, RPB7.0, POLR3A, RRP4, NDPK A, NDPK D (mitochondrial), ENP3, POLR2I, NDPK B",
913,Cytoskeleton remodeling_Neurofilaments,25,1.529E-01,2.852E-01,1.529E-01,2.852E-01,7,"Tubulin beta, DCTN2, NEFM, Tubulin alpha, Kinesin heavy chain, Peripherin, Tubulin (in microtubules)",1.917E-01,3.400E-01,8,"DCTN2, Peripherin, Tubulin (in microtubules), Tubulin beta, Tubulin gamma, MUNC18, Tubulin alpha, Kinesin heavy chain",
914,Development_Role of nicotinamide in G-CSF-induced granulopoiesis,13,1.540E-01,2.909E-01,1.976E-01,3.377E-01,4,"Sirtuin1, G-CSF receptor, G-CSF, C/EBPalpha",1.540E-01,2.909E-01,5,"Lef-1, G-CSF receptor, Sirtuin1, G-CSF, C/EBPalpha",
915,SHH signaling in oligodendrocyte precursor cells differentiation in multiple sclerosis,13,1.540E-01,2.909E-01,4.283E-01,5.941E-01,3,"PLP1, SHH, SUFU",1.540E-01,2.909E-01,5,"PLP1, Nkx2.2, SUFU, SHH, MAG",
916,Development_TGF-beta-dependent induction of EMT via SMADs ,35,1.543E-01,2.909E-01,1.703E-01,3.058E-01,9,"E-cadherin, E2A, MKL2, TGF-beta, ILK, ID2, TGF-beta 3, Occludin, SP1",1.543E-01,2.909E-01,11,"E2A, Lef-1, ID2, HEY1, E-cadherin, MKL2, TGF-beta, ILK, TGF-beta 3, Occludin, SP1",
917,G-protein signaling_S1P2 receptor signaling pathway,35,1.543E-01,2.909E-01,2.944E-01,4.507E-01,8,"G-protein alpha-i family, IP3 receptor, G-protein alpha-13, PTEN, Adenylate cyclase, FAK1, AKT(PKB), PDK (PDPK1)",1.543E-01,2.909E-01,11,"PLC-beta1, IP3 receptor, G-protein alpha-13, Adenylate cyclase, AKT(PKB), PDK (PDPK1), G-protein alpha-i family, PTEN, FAK1, G-protein alpha-q, PI3K reg class IB (p101)",
918,Immune response_Lipoxins and Resolvin E1 inhibitory action on neutrophil functions,35,1.543E-01,2.909E-01,6.292E-01,7.756E-01,6,"c-Fos, G-protein alpha-i family, ERK1/2, LTBR1, NFKBIA, I-kB",1.543E-01,2.909E-01,11,"c-Fos, ERK1/2, PKC-zeta, c-Jun/c-Fos, I-kB, SOD1, IKK-alpha, G-protein alpha-i family, LTBR1, NFKBIA, PI3K reg class IB (p101)",
919,Development_Growth hormone signaling via STATs and PLC/IP3,35,1.543E-01,2.909E-01,6.292E-01,7.756E-01,6,"c-Fos, GHR, STAT3, FAK1, SOCS2, IGF-1",1.543E-01,2.909E-01,11,"c-Fos, Fibrinogen beta, PKC-delta, c-Jun, PTP-1B, C3G, Paxillin, GHR, FAK1, SOCS2, IGF-1",
920,Glucose-excited neurons of arcuate nucleus in obesity (rodent model),35,1.543E-01,2.909E-01,1.703E-01,3.058E-01,9,"Tuberin, SUR1, CACNA1C, AMPK alpha subunit, UCP2, Kir6.2, AMPK alpha 2 subunit, GLUT1, p70 S6 kinase1",1.543E-01,2.909E-01,11,"Tuberin, SUR1, UCP2, GLUT4, Kir6.2, CACNA1C, AMPK alpha subunit, AMPK alpha 2 subunit, GLUT1, p70 S6 kinase1, N-type Ca(II) channel alpha1B",
921,Development_WNT and Notch signaling in early cardiac myogenesis,35,1.543E-01,2.909E-01,7.867E-01,8.965E-01,5,"GATA-4, Dsh, WNT, HEY2, SOX13",1.543E-01,2.909E-01,11,"TBX5, WNT3A, GATA-4, Dsh, LRP5, WNT1, WNT, CHIBBY, HEY2, Frizzled, SOX13",
922,Immune response_HMGB1 release from the cell,39,1.557E-01,2.885E-01,1.557E-01,2.885E-01,10,"HSPA1A, IP3 receptor, PI3K reg class IA (p85), Calmodulin, PI3K reg class IA, IL-1RI, MEK1/2, JNK(MAPK8-10), PKC-gamma, PDK (PDPK1)",2.624E-01,4.191E-01,11,"IP3 receptor, PI3K reg class IA (p85), PI3K reg class IA, MyD88, IL-1RI, PKC-gamma, PDK (PDPK1), PARP-1, HSPA1A, Calmodulin, JNK(MAPK8-10)",
923,Immune response_Distinct metabolic pathways in naive and effector CD8+ T cells,74,1.564E-01,2.944E-01,8.098E-01,9.121E-01,11,"Tuberin, CISY, DHE4, ERK1/2, GLUT1, PI3K reg class IA (p85), ACLY, DHE3, SLC38A1, AKT(PKB), PDK (PDPK1)",1.564E-01,2.944E-01,21,"Tuberin, CISY, ERK1/2, IL-3, PI3K reg class IA (p85), DHE3, ASCT2 (SLC1A5), GLSL, AKT(PKB), PDK (PDPK1), c-Myc, ARNT, Pim-2, DHE4, Hamartin, 4E-BP1, GLUT1, ACLY, AP-4, SLC38A1, TCR alpha/beta",
924,Apoptosis and survival_NO signaling in survival,24,1.607E-01,3.006E-01,2.599E-01,4.198E-01,6,"Protein kinase G1, H-Ras, eNOS, AKT(PKB), PDK (PDPK1), p38 MAPK",1.607E-01,3.006E-01,8,"Protein kinase G1, IRS-1, H-Ras, BAD, AKT(PKB), PDK (PDPK1), eNOS, p38 MAPK",
925,Immune response_IL-13 signaling via JAK-STAT,44,1.608E-01,2.961E-01,1.608E-01,2.961E-01,11,"CCL17, FOXJ1, STAT3, ARG1, IGHE, IL13RA2, SHP-1, IGHG4, STAT6, CD23, ALOX15",2.906E-01,4.582E-01,12,"CCL17, ARG1, IL-13, SHP-1, CD23, RSNB, PKC-delta, FOXJ1, IGHE, IGHG4, STAT6, ALOX15",
926,Transport_cAMP/ Ca(2+)-dependent Insulin secretion,44,1.608E-01,2.961E-01,1.608E-01,2.961E-01,11,"SUR1, cAMP-GEFI, Insulin processed, SNAP-25, CACNA1C, PKA-reg (cAMP-dependent), Kir6.2, MUNC13-1, IP3 receptor, CACNA1D, Calmodulin",5.631E-01,7.195E-01,10,"SUR1, cAMP-GEFI, Insulin processed, PKA-reg (cAMP-dependent), Kir6.2, Syntaxin 1A, IP3 receptor, CACNA1C, CACNA1D, Calmodulin",
927,Regulation of metabolism_Triiodothyronine and Thyroxine signaling,44,1.608E-01,2.961E-01,1.608E-01,2.961E-01,11,"TR-alpha, AKT1, S14 protein, MCT8, Bcl-3, FASN, TR-beta, GLUT1, p70 S6 kinase1, DIO1, p70 S6 kinase2",4.206E-01,5.885E-01,11,"TR-alpha, AKT1, S14 protein, Bcl-3, FASN, TR-beta, MCT8, GLUT1, p70 S6 kinase1, DIO1, p70 S6 kinase2",
928,Arachidonic acid metabolites production in eosinophils in asthma,44,1.608E-01,2.961E-01,1.608E-01,2.961E-01,11,"LTC4S, CCR3, CRTH2, G-protein alpha-i family, COX-1 (PTGS1), PKC, cPLA2, PLA2G10, JNK(MAPK8-10), PLA2G5, p38 MAPK",4.206E-01,5.885E-01,11,"IL-16 mature, IL-3, cPLA2, PLA2G10, CCR3, G-protein alpha-i family, IL-5 receptor, PKC, JNK(MAPK8-10), PLA2G5, p38 MAPK",
929,Immune response_BAFF-induced canonical NF-kB signaling,43,1.624E-01,3.019E-01,5.302E-01,6.828E-01,8,"TRAF2, E2N(UBC13), Btk, NFKBIA, IP3 receptor, Ubiquitin, IKK-beta, TAB2",1.624E-01,3.019E-01,13,"E2N(UBC13), IKK (cat), IP3 receptor, Ubiquitin, MyD88, IKK-alpha, TAB2, UEV1A, TRAF2, Btk, NFKBIA, UBE1, IKK-beta",
930,Development_Notch Signaling Pathway,43,1.624E-01,3.019E-01,3.757E-01,5.398E-01,9,"FBXW7, GCN5, TLE, NFKBIA, Ubiquitin, Lunatic fringe, DLL1, HEY2, MYOD",1.624E-01,3.019E-01,13,"FBXW7, GCN5, TLE, Ubiquitin, DLL1, Radical fringe, HEY1, MAML1, DLL4, NFKBIA, Lunatic fringe, HEY2, MYOD",
931,Cell adhesion_Gap junctions,30,1.629E-01,2.972E-01,1.629E-01,2.972E-01,8,"Tubulin beta, Cingulin, Tubulin alpha, PKC, Connexin 43, Occludin, ZO-3, Tubulin (in microtubules)",2.290E-01,3.851E-01,9,"Connexin 32, Actin, Tubulin (in microtubules), Tubulin beta, Cingulin, Tubulin alpha, PKC, Occludin, ZO-3",
932,Inhibition of mast cell functions by Fc gamma RII beta in asthma,30,1.629E-01,2.972E-01,1.629E-01,2.972E-01,8,"GRB2, K-RAS, MGF, Btk, IP3 receptor, PI3K reg class IA (p85), Fc gamma RII beta, AKT(PKB)",2.290E-01,3.851E-01,9,"GRB2, IP3 receptor, PI3K reg class IA (p85), SHIP, AKT(PKB), K-RAS, MGF, Btk, Fc gamma RII beta",
933,Transcription_Ligand-dependent activation of the ESR1/SP pathway,30,1.629E-01,2.972E-01,1.629E-01,2.972E-01,8,"c-Fos, ESR1 (nuclear), NCOA3 (pCIP/SRC3), E2F1, Prolactin receptor, RARalpha, Cyclin D1, SP1",3.731E-01,5.453E-01,8,"c-Fos, ESR1 (nuclear), Prolactin receptor, RARalpha, NCOA3 (pCIP/SRC3), E2F1, Cyclin D1, SP1",
934,Putative role of Tregs in COPD,30,1.629E-01,2.972E-01,1.629E-01,2.972E-01,8,"MEK1(MAP2K1), MCP, ROR-gamma, ERK1/2, STAT3, CD3, FOXP3, CD27(TNFRSF7)",2.290E-01,3.851E-01,9,"NF-AT1(NFATC2), ERK1/2, ZAP70, FOXP3, CD27(TNFRSF7), IL-2R alpha chain, MCP, ROR-gamma, LAT",
935,Role of adipose tissue hypoxia in obesity and type 2 diabetes,30,1.629E-01,2.972E-01,1.629E-01,2.972E-01,8,"PDK1, Adiponectin, ANGPTL4, RXRA, CD36, GLUT1, Leptin, C/EBPalpha",5.429E-01,7.034E-01,7,"Adiponectin, ANGPTL4, RXRA, CD36, GLUT1, Leptin, C/EBPalpha",
936,Glucocorticoids-mediated inhibition of pro-constrictory and pro-inflammatory signaling in airway smooth muscle cells,49,1.647E-01,2.997E-01,1.647E-01,2.997E-01,12,"c-Fos, ERK1/2, Myosin II, NFKBIA, G-protein alpha-s, PDE4D, MRLC, MKP-1, JNK(MAPK8-10), PLA2, p38 MAPK, GRK2",3.165E-01,4.848E-01,13,"c-Fos, ERK1/2, PDE4D, GRK2, c-Jun, Myosin II, NFKBIA, G-protein alpha-s, MRLC, MKP-1, JNK(MAPK8-10), PLA2, p38 MAPK",
937,Role and regulation of Prostaglandin E2 in gastric cancer,49,1.647E-01,2.997E-01,1.647E-01,2.997E-01,12,"MEK1(MAP2K1), HPGD, GRB2, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), c-Raf-1, G-protein alpha-s, Adenylate cyclase, PGES2, SP1, CD40L(TNFSF5)",7.082E-01,8.477E-01,10,"HPGD, GRB2, H-Ras, ERK1/2, PKA-reg (cAMP-dependent), Adenylate cyclase, PGES2, CCKBR, G-protein alpha-s, SP1",
938,Inhibition of remyelination in multiple sclerosis: role of cell-cell and ECM-cell interactions,47,1.652E-01,3.060E-01,7.735E-01,8.882E-01,7,"CD81, PLP1, CD9, PKC, Connexin 43, FAK1, HYAL1",1.652E-01,3.060E-01,14,"TrkA, CD81, Connexin 32, Lingo1, PLP1, MyD88, HYAL1, CD82, Tenascin-R, CD9, Neurofascin, PKC, FAK1, MAG",
939,Role of prenatal nicotine exposure in inhibition of pancreatic beta cells differentiation and function,21,1.665E-01,3.020E-01,1.665E-01,3.020E-01,6,"Insulin processed, Kir6.2, Insulin receptor, IGF-1 receptor, Insulin, IGF-1",3.406E-01,5.087E-01,6,"Insulin processed, Kir6.2, Insulin receptor, IGF-1 receptor, Insulin, IGF-1",
940,Development_Role of HGF in hematopoietic stem cell mobilization,21,1.665E-01,3.020E-01,1.665E-01,3.020E-01,6,"Tuberin, PI3K reg class IA, G-CSF receptor, AKT(PKB), PDK (PDPK1), G-CSF",1.833E-01,3.306E-01,7,"Tuberin, PI3K reg class IA, G-CSF receptor, AKT(PKB), PDK (PDPK1), FOXO3A, G-CSF",
941,Development_Role of G-CSF in hematopoietic stem cell mobilization,21,1.665E-01,3.020E-01,1.665E-01,3.020E-01,6,"C5aR, STAT3, G-CSF receptor, G-CSF, Cathepsin K, SDF-1",5.403E-01,7.024E-01,5,"G-CSF receptor, SDF-1, C5aR, G-CSF, Cathepsin K",
942,Th17 cells in CF,54,1.678E-01,3.031E-01,1.678E-01,3.031E-01,13,"CD80, MHC class II, ROR-alpha, ROR-gamma, ERK1/2, CFTR, CCR6, STAT3, IL-17RC, IL-1RI, G-CSF, p38 MAPK, IL-6 receptor",4.638E-01,6.309E-01,13,"MHC class II, ERK1/2, IL-17RC, MyD88, IL-1RI, LBP, ROR-gamma, Beta-defensin 2, CCR6, G-CSF, TCR alpha/beta, p38 MAPK, IL-6 receptor",
943,Role of IL-23/ T17 pathogenic axis in psoriasis,54,1.678E-01,3.031E-01,1.678E-01,3.031E-01,13,"CD80, MHC class II, CARD14, ROR-gamma, ERK1/2, CCR6, STAT3, IL-1RI, IL-2R beta chain, CD40(TNFRSF5), AKT(PKB), IL-6 receptor, CD40L(TNFSF5)",2.339E-01,3.851E-01,15,"MHC class II, NF-AT1(NFATC2), ERK1/2, IL-1F6, IL-1RI, AKT(PKB), CARD14, Beta-defensin 3, ROR-gamma, Beta-defensin 2, CCR6, IL-2R beta chain, CD40(TNFRSF5), TCR alpha/beta, IL-6 receptor",
944,PGE2 pathways in cancer,55,1.691E-01,3.110E-01,1.854E-01,3.240E-01,13,"G-protein alpha-i family, PKA-reg (cAMP-dependent), COX-1 (PTGS1), Amphiregulin, G-protein alpha-s, Adenylate cyclase, Cyclin D1, NURR1, AKT(PKB), Beta-arrestin1, PDK (PDPK1), ERK1 (MAPK3), Axin",1.691E-01,3.110E-01,16,"Lef-1, EGR1, PKA-reg (cAMP-dependent), Amphiregulin, Adenylate cyclase, AKT(PKB), PDK (PDPK1), c-Myc, ERK1 (MAPK3), Axin, Tcf(Lef), G-protein alpha-i family, G-protein alpha-s, Cyclin D1, NURR1, Beta-arrestin1",
945,Immune response_Role of DAP12 receptors in NK cells,55,1.691E-01,3.110E-01,1.854E-01,3.240E-01,13,"MEK1(MAP2K1), GRB2, NKG2A, H-Ras, ERK1/2, c-Raf-1, PAK1, KIR2DL4, PI3K reg class IA, VAV-2, WASP, SHP-1, VAV-3",1.691E-01,3.110E-01,16,"GRB2, NKG2A, H-Ras, ERK1/2, Rac1, PI3K reg class IA, ZAP70, VAV-2, WASP, SHP-1, PAK1, LAT, KIR2DL4, KLRA1, SHP-2, VAV-3",
946,Anti-apoptotic action of Gastrin in gastric cancer,35,1.703E-01,3.058E-01,1.703E-01,3.058E-01,9,"MEK1(MAP2K1), ERK1/2, c-Raf-1, PAK1, Cytochrome c, IP3 receptor, Bcl-2, Bcl-XL, PKC-gamma",2.624E-01,4.191E-01,10,"ERK1/2, Cytochrome c, Rac1, IP3 receptor, BAD, Bcl-XL, PKC-gamma, CCKBR, PAK1, Bcl-2",
947,G-protein signaling_Rac3 regulation pathway,17,1.714E-01,3.144E-01,1.815E-01,3.197E-01,5,"ABLIM1, PAK1, Rac3, Calmyrin, Androgen receptor",1.714E-01,3.144E-01,6,"ABLIM1, HNF1-alpha, Calmyrin, Androgen receptor, PAK1, Rac3",
948,dGTP metabolism,64,1.720E-01,3.084E-01,1.720E-01,3.084E-01,15,"POLE1, NDPK C, NDPK complex, ENTPD2-alpha, KGUA, NDPK 6, 5'-NTC, NDPK A, POLG reg, POLD reg (p12), PPAL, NDPK D (mitochondrial), POLD reg (p50), DNA polymerase lambda, NDPK B",1.905E-01,3.398E-01,18,"NDPK complex, NDPK 6, 5'-NTC, POLG reg, PPAL, POLE3 (YBL1), DNA polymerase lambda, POLE1, NDPK C, ENTPD2-alpha, KGUA, POLE2, NDPK A, POLD reg (p12), NDPK D (mitochondrial), POLD reg (p50), POLG cat, NDPK B",
949,Calcium-dependent regulation of normal and asthmatic smooth muscle contraction,69,1.733E-01,3.105E-01,1.733E-01,3.105E-01,16,"Substance P extracellular region, TRPC4, Neurokinin A, G-protein alpha-i family, CACNA1C, Myosin II, BDKRB2, Ryanodine receptor 3, Tryptase, Nk3R, IP3 receptor, Calmodulin, PLC-beta, MRLC, Neurokinin B, MLCK",2.100E-01,3.607E-01,19,"Substance P extracellular region, Neurokinin A, BDKRB2, Nk3R, IP3 receptor, Thrombin, PLC-beta, HTR2C (HTR1C), Neurokinin B, MLCK, ACM2, G-protein alpha-i family, CACNA1C, Myosin II, Tryptase, Bradykinin, Calmodulin, MRLC, G-protein alpha-q",
950,"Development_Role of Ceramide 1-phosphate, Sphingosine 1-phosphate and Complement cascade in hematopoietic stem cell homing",32,1.744E-01,3.176E-01,3.582E-01,5.226E-01,7,"cAMP-GEFI, ERK1/2, PGE2R3, C1qRp, VAV-2, AKT(PKB), SDF-1",1.744E-01,3.176E-01,10,"cAMP-GEFI, ERK1/2, PKC-zeta, Rac1, VAV-2, AKT(PKB), SDF-1, C3aR, PGE2R3, C1qRp",
951,Upregulation of IL-8 expression in colorectal cancer,32,1.744E-01,3.176E-01,3.582E-01,5.226E-01,7,"WNT4, c-Fos, NFKBIA, WNT, IKK-beta, NTSR1, IL-1RI",1.744E-01,3.176E-01,10,"c-Fos, IKK (cat), NTSR1, IL-1RI, WNT4, NFKBIA, WNT1, WNT, IKK-beta, Frizzled",
952,DNA damage_Mismatch repair,32,1.744E-01,3.176E-01,5.358E-01,6.888E-01,6,"MutLalpha complex, PMS2, RAD9A, DNA ligase I, RPRD1B, MLH1",1.744E-01,3.176E-01,10,"MutLalpha complex, PKC-zeta, PMS2, RAD9A, DNA ligase I, MSH3, MTMR15, RPRD1B, MCM9, MLH1",
953,Cell adhesion_Role of CDK5 in cell adhesion,10,1.750E-01,3.183E-01,2.667E-01,4.228E-01,3,"E-cadherin, Alpha-catenin, ErbB2",1.750E-01,3.183E-01,4,"ErbB2, E-cadherin, Tcf(Lef), Alpha-catenin",
954,Neurophysiological process_Glucose-excited neurons of arcuate nucleus (rodent model),40,1.758E-01,3.127E-01,1.758E-01,3.127E-01,10,"Tuberin, SUR1, CACNA1C, AMPK alpha subunit, Kir6.2, AMPK alpha 2 subunit, GLUT1, p70 S6 kinase1, HIF-prolyl hydroxylase, CART",1.824E-01,3.301E-01,12,"Tuberin, SUR1, GLUT4, Kir6.2, CACNA1C, AMPK alpha subunit, AMPK alpha 2 subunit, GLUT1, p70 S6 kinase1, HIF-prolyl hydroxylase, N-type Ca(II) channel alpha1B, CART",
955,Immune response_Th1 and Th2 cell differentiation,40,1.758E-01,3.127E-01,1.758E-01,3.127E-01,10,"GATA-3, CD80, MHC class II, IL-12 alpha, AP-1, CD3, CD40(TNFRSF5), STAT6, IL-4, CD40L(TNFSF5)",4.297E-01,5.981E-01,10,"MHC class II, NF-AT1(NFATC2), IL-12 alpha, IL-13, IL-4, GATA-3, AP-1, CD40(TNFRSF5), STAT6, TCR alpha/beta",
956,Role of IGH translocations in multiple myeloma,40,1.758E-01,3.127E-01,1.758E-01,3.127E-01,10,"E-cadherin, FGFR3, E2F1, CAC, CCR1, Rb protein, MafB, ITGB7, p130, Cyclin D1",1.824E-01,3.301E-01,12,"Cyclin D3, CAC, CCR1, Rb protein, MafB, ITGB7, p130, c-Myc, E-cadherin, FGFR3, E2F1, Cyclin D1",
957,Development_Astrocyte differentiation from adult stem cells,40,1.758E-01,3.127E-01,1.758E-01,3.127E-01,10,"hASH1, GRB2, E2A, H-Ras, ERK1/2, OLIG1, c-Raf-1, STAT3, ID2, MEK1/2",4.297E-01,5.981E-01,10,"GRB2, E2A, H-Ras, ERK1/2, OLIG1, ID2, Nkx2.2, hASH1, SHP-2, SMAD1",
958,Role of fibroblasts and keratinocytes in the elicitation phase of allergic contact dermatitis,26,1.784E-01,3.162E-01,1.784E-01,3.162E-01,7,"H-Ras, CCR2, IL8RA, CCR6, CCR5, IL-4, IL8RB",2.250E-01,3.832E-01,8,"H-Ras, CCR2, CCR5, IL-4, IL8RB, IL8RA, CCR6, CXCR3",
959,Development_Activation of ERK by Alpha-1 adrenergic receptors,45,1.800E-01,3.182E-01,1.800E-01,3.182E-01,11,"MEK1(MAP2K1), c-Fos, H-Ras, ERK1/2, G-protein alpha-11, CACNA1C, c-Raf-1, IP3 receptor, Calmodulin, Alpha-1A adrenergic receptor, G-protein alpha-14",2.091E-01,3.607E-01,13,"c-Fos, H-Ras, ERK1/2, PLC-beta1, IP3 receptor, G-protein alpha-14, PKC-delta, c-Jun, G-protein alpha-11, CACNA1C, Calmodulin, Alpha-1A adrenergic receptor, G-protein alpha-q",
960,Immune response_PGE2 signaling in immune response,45,1.800E-01,3.182E-01,1.800E-01,3.182E-01,11,"MEK1(MAP2K1), H-Ras, PKA-reg (cAMP-dependent), c-Raf-1, COX-1 (PTGS1), G-protein alpha-s, Adenylate cyclase, CCR5, IL-4, G-CSF, ERK1 (MAPK3)",7.275E-01,8.605E-01,9,"NF-AT1(NFATC2), H-Ras, PKA-reg (cAMP-dependent), Adenylate cyclase, CCR5, IL-4, ERK1 (MAPK3), G-protein alpha-s, G-CSF",
961,"Mechanism of action of DGAT1 inhibitors in obesity and diabetes mellitus, type II (Variant 2)",1,1.813E-01,3.197E-01,1.813E-01,3.197E-01,1,DGAT1,2.280E-01,3.851E-01,1,DGAT1,
962,DNA damage_Role of SUMO in p53 regulation,17,1.815E-01,3.197E-01,1.815E-01,3.197E-01,5,"Chk2, E2I, Ubiquitin, MDM2, AKT(PKB)",3.423E-01,5.103E-01,5,"E2I, Ubiquitin, MDM2, AKT(PKB), SAE1",
963,Stem cells_Response to hypoxia in glioblastoma stem cells,40,1.824E-01,3.301E-01,6.059E-01,7.550E-01,7,"BMP7, p21, Ubiquitin, DLL1, HEY2, Cyclin D1, HIF-prolyl hydroxylase",1.824E-01,3.301E-01,12,"p21, Ubiquitin, DLL1, Nucleophosmin, ARNT, HEY1, BMP7, DLL4, HEY2, SMAD1, Cyclin D1, HIF-prolyl hydroxylase",
964,Immune response_Production and main functions of biologically active leukotrienes and Lipoxin A4,50,1.831E-01,3.214E-01,1.831E-01,3.214E-01,12,"ABCC11, LTC4S, ABCC6, LTBR1, GGT1, ALOX12, LTA4H, cPLA2, DPEP2, LTBR2, CysLT1 receptor, ABCC2",7.332E-01,8.651E-01,10,"ABCC6, GGT1, cPLA2, LTBR2, CysLT1 receptor, ABCC11, LTBR1, LTA4H, DPEP2, ABCC2",
965,VEGF signaling in multiple myeloma,50,1.831E-01,3.214E-01,1.831E-01,3.214E-01,12,"MEK1(MAP2K1), AKT1, GRB2, H-Ras, VEGFR-1, c-Raf-1, IP3 receptor, STAT3, VEGF-D, PI3K reg class IA, PDK (PDPK1), ERK1 (MAPK3)",7.332E-01,8.651E-01,10,"AKT1, GRB2, H-Ras, IP3 receptor, VEGF-D, PI3K reg class IA, PDK (PDPK1), c-Myc, ERK1 (MAPK3), VEGFR-1",
966,Development_Generation of pancreatic beta-cells from embryonic stem cells (early stages),21,1.833E-01,3.306E-01,3.291E-01,4.917E-01,5,"HB9, NANOG, SOX2, FGF10, HNF6",1.833E-01,3.306E-01,7,"WNT3A, FGF10, HB9, NANOG, FGF7, SOX2, HNF6",
967,Proteases and EGFR-induced mucin synthesis in normal and asthmatic epithelium,55,1.854E-01,3.240E-01,1.854E-01,3.240E-01,13,"EGF, ERK1/2, p90RSK1, p67-phox, G-protein alpha-q/11, NFKBIA, IP3 receptor, Amphiregulin, PLC-beta, Mucin 2, Mucin 5AC, Mucin 5B, SP1",3.686E-01,5.413E-01,14,"EGF, ERK1/2, IL-3, G-protein alpha-q/11, IP3 receptor, Amphiregulin, PLC-beta, Mucin 5B, PKC-delta, NFKBIA, Mucin 2, Mucin 5AC, SP1, Kallikrein 1",
968,"Immune response_T cell co-signaling receptors, schema",55,1.854E-01,3.240E-01,1.854E-01,3.240E-01,13,"CD80, MHC class II, ICOS-L, TIGIT, Nectin-2, TL1A(TNFSF15), CD2, CD27(TNFRSF7), Collagen II, CD40(TNFRSF5), BY55, LAG3, CD40L(TNFSF5)",3.686E-01,5.413E-01,14,"MHC class II, ICOS-L, TIM-4, CD27(TNFRSF7), Collagen II, BY55, ICOS, Nectin-2, TIM-1, CD30L (TNFSF8), TIM-3, TL1A(TNFSF15), CD40(TNFRSF5), LAG3",
969,Apoptosis and survival_TNF-alpha-induced ROS-dependent Caspase-3 signaling,60,1.871E-01,3.254E-01,1.871E-01,3.254E-01,14,"p38alpha (MAPK14), FLAD1, TRADD, p67-phox, Glutaredoxin 1, Cytochrome c, PI3K reg class IA (p85), MEK6(MAP2K6), Bcl-2, RIFK, JNK(MAPK8-10), p40-phox, NOX1, NOXA1",5.108E-01,6.785E-01,14,"TRADD, Cytochrome c, Rac1, PI3K reg class IA (p85), SOD1, MEK6(MAP2K6), RIFK, NOX1, NOXA1, FLAD1, MKK7 (MAP2K7), Bcl-2, JNK(MAPK8-10), p40-phox",
970,Oxidative stress_ROS-mediated MAPK activation via canonical pathways,60,1.871E-01,3.254E-01,1.871E-01,3.254E-01,14,"GRB2, GAB1, TRAF2, H-Ras, ERK1/2, c-Raf-1, FGFR1, IP3 receptor, Calmodulin, MEK6(MAP2K6), MEK1/2, JNK(MAPK8-10), SFK, p38 MAPK",2.808E-01,4.461E-01,16,"GRB2, GAB1, H-Ras, ERK1/2, FGFR1, Rac1, IP3 receptor, MEK6(MAP2K6), SFK, PKC-delta, TRAF2, Calmodulin, MEKK1(MAP3K1), SHP-2, JNK(MAPK8-10), p38 MAPK",
971,Role of FSH and Lutropin in ovarian cancer,56,1.894E-01,3.388E-01,2.039E-01,3.450E-01,13,"cAMP-GEFI, ERK1/2, Prohibitin, PKA-reg (cAMP-dependent), COX-1 (PTGS1), G-protein alpha-s, ErbB2, Adenylate cyclase, MDM2, MEK1/2, Cyclin D1, JNK(MAPK8-10), AKT(PKB)",1.894E-01,3.388E-01,16,"FSH, cAMP-GEFI, ERK1/2, Prohibitin, PKA-reg (cAMP-dependent), ErbB2, Adenylate cyclase, MDM2, AKT(PKB), c-Myc, LH receptor, PKC-delta, G-protein alpha-s, AKT2, Cyclin D1, JNK(MAPK8-10)",
972,"Development_ROBO2, ROBO3 and ROBO4 signaling pathways",25,1.917E-01,3.400E-01,4.844E-01,6.421E-01,5,"Myosin II, GIT1, SLIT1, ARF6, WASP",1.917E-01,3.400E-01,8,"Rac1, GIT1, ARF6, WASP, Myosin II, Paxillin, N-WASP, SLIT1",
973,Fenofibrate in treatment of type 2 diabetes and metabolic syndrome X,25,1.917E-01,3.400E-01,2.937E-01,4.507E-01,6,"Adiponectin, ABCG1, APOA5, Acyl-CoA synthetase, LXR-alpha, ACOX1",1.917E-01,3.400E-01,8,"ABCG1, Fibrinogen beta, ACOX1, ACSL1, Adiponectin, Acyl-CoA synthetase, APOC3, Fibrinogen gamma",
974,Inhibition of TGF-beta signaling in gastric cancer,25,1.917E-01,3.400E-01,4.844E-01,6.421E-01,5,"p21, Ubiquitin, TGF-beta 3, CEACAM6, CEACAM5",1.917E-01,3.400E-01,8,"p21, ELF3, Ubiquitin, CEACAM6, LMO1, MEL1, TGF-beta 3, CEACAM5",
975,Th17 cytokines in COPD,36,1.928E-01,3.318E-01,1.928E-01,3.318E-01,9,"CD80, MHC class II, ROR-alpha, ROR-gamma, CCR2, STAT3, Mucin 5AC, Mucin 5B, p38 MAPK",5.974E-01,7.449E-01,8,"MHC class II, CCR2, Mucin 5B, ROR-gamma, CXCR3, Mucin 5AC, TCR alpha/beta, p38 MAPK",
976,Nitrogen metabolism,36,1.928E-01,3.318E-01,1.928E-01,3.318E-01,9,"Carbonic anhydrase VB (mitochondrial), CPSM, DHE4, GLNA, Carbonic anhydrase XIV, Carbonic anhydrase XII, DHE3, Carbonic anhydrase IV, Carbonic anhydrase VII",4.396E-01,6.079E-01,9,"Carbonic anhydrase VB (mitochondrial), CPSM, DHE3, GLSL, DHE4, GLNA, Carbonic anhydrase XIV, Carbonic anhydrase XII, Carbonic anhydrase VA (mitochondrial)",
977,G-protein signaling_G-Protein alpha-s signaling cascades,36,1.928E-01,3.318E-01,1.928E-01,3.318E-01,9,"MEK1(MAP2K1), cAMP-GEFI, H-Ras, ERK1/2, GSK3 alpha, PKA-reg (cAMP-dependent), c-Raf-1, Adenylate cyclase type I, G-protein alpha-s",5.974E-01,7.449E-01,8,"cAMP-GEFI, H-Ras, ERK1/2, GSK3 alpha, PKA-reg (cAMP-dependent), AK1, Adenylate cyclase type I, G-protein alpha-s",
978,Development_Generation of pancreatic beta-cells from embryonic stem cells (late stages),22,1.960E-01,3.354E-01,1.960E-01,3.354E-01,6,"HB9, Neurogenin 3, Insulin, HNF6, IGF-1, MafA",2.192E-01,3.736E-01,7,"Neurogenin 3, Nkx2.2, HB9, Insulin, HNF6, IGF-1, MafA",
979,Amitraz-induced inhibition of Insulin secretion,22,1.960E-01,3.354E-01,1.960E-01,3.354E-01,6,"Insulin processed, G-protein alpha-i family, Adenylate cyclase type VI, CACNA1C, Alpha-2A adrenergic receptor, Adenylate cyclase type V",3.861E-01,5.572E-01,6,"Insulin processed, Adenylate cyclase type VI, Adenylate cyclase type V, G-protein alpha-i family, CACNA1C, Alpha-2A adrenergic receptor",
980,Origin of Langerhans cells in the steady-state and under inflammatory conditions,22,1.960E-01,3.354E-01,1.960E-01,3.354E-01,6,"E-cadherin, CCR2, CCR6, ID2, CXCL14, E-selectin",3.861E-01,5.572E-01,6,"CCR2, ID2, E-selectin, E-cadherin, CCR6, CXCL14",
981,Riboflavin metabolism,14,1.969E-01,3.474E-01,2.394E-01,3.896E-01,4,"ENPP1, FLAD1, PPAL, RIFK",1.969E-01,3.474E-01,5,"ENPP1, ENPP3, PPAL, RIFK, FLAD1",
982,Immune response  _Sialic-acid receptors (Siglecs) signaling,14,1.969E-01,3.474E-01,4.798E-01,6.389E-01,3,"MUC1, CD33, SHP-1",1.969E-01,3.474E-01,5,"MUC1, CD22, SHP-1, CD79 complex, SHP-2",
983,Cell cycle_Nucleocytoplasmic transport of CDK/Cyclins,14,1.969E-01,3.474E-01,4.798E-01,6.389E-01,3,"Cyclin D, Cyclin D1, ERK1 (MAPK3)",1.969E-01,3.474E-01,5,"Cyclin D3, Importin (karyopherin)-alpha, ERK1 (MAPK3), Cyclin D, Cyclin D1",
984,Apoptosis and survival_p53-dependent apoptosis,29,1.978E-01,3.474E-01,4.336E-01,5.976E-01,6,"p38alpha (MAPK14), E2F1, RAD9, Bcl-2, MDM2, JNK(MAPK8-10)",1.978E-01,3.474E-01,9,"BAD, MDM2, MEKK4(MAP3K4), PKC-delta, E2F1, c-Jun, RAD9, Bcl-2, JNK(MAPK8-10)",
985,Proteolysis_Putative SUMO-1 pathway,29,1.978E-01,3.474E-01,4.336E-01,5.976E-01,6,"E2I, NFKBIA, Ubiquitin, c-Myb, MDM2, CBX4",1.978E-01,3.474E-01,9,"E2I, Ubiquitin, c-Myb, MDM2, c-Jun, SAE1, NFKBIA, HSF1, CBX4",
986,Regulatory T cells in human allergic contact dermatitis,7,1.993E-01,3.497E-01,3.715E-01,5.362E-01,2,"MHC class II, CCR7",1.993E-01,3.497E-01,3,"MHC class II, CCR7, TCR alpha/beta",
987,Signal transduction_Calcium signaling,46,2.002E-01,3.411E-01,2.002E-01,3.411E-01,11,"Phospholamban, cPKC (conventional), Calcineurin A (catalytic), PP1-cat, MEF2, IP3 receptor, VIL2 (ezrin), Calmodulin, PLC-beta, CaMKK, IP3R1",3.505E-01,5.203E-01,12,"Calcineurin A (catalytic), NF-AT1(NFATC2), PP1-cat, IP3 receptor, VIL2 (ezrin), PLC-beta, cPKC (conventional), MEF2, 14-3-3 beta/alpha, Calmodulin, CaMKK, IP3R1",
988,High shear stress-induced platelet activation,46,2.002E-01,3.411E-01,2.002E-01,3.411E-01,11,"G-protein alpha-i family, Alpha-actinin, P2Y12, JAM1, sCD40L, PI3K reg class IA (p85), GP-IB alpha, von Willebrand factor, AKT(PKB), PAR4, GP-V",3.505E-01,5.203E-01,12,"JAM1, PI3K reg class IA (p85), Thrombin, Tyro3, von Willebrand factor, AKT(PKB), PAR4, G-protein alpha-i family, P2Y12, GP-IX, GP-IB alpha, GP-V",
989,Nociception_Expression and role of Nociceptin in immune system,46,2.002E-01,3.411E-01,2.002E-01,3.411E-01,11,"ESR1 (nuclear), CaMK II beta, ERK1/2, PKA-reg (cAMP-dependent), Ca(II)channel L-type, STAT3, IL-1RI, CRHR1, MSK1, p38 MAPK, IL-6 receptor",3.505E-01,5.203E-01,12,"ESR1 (nuclear), CaMK II beta, ERK1/2, PKA-reg (cAMP-dependent), IL-1RI, MSK1, NT-3, Ca(II)channel L-type, Nociceptin, Prepronociceptin, p38 MAPK, IL-6 receptor",
990,SDF-1 axis in endothelial progenitor cell recruitment in healing myocardial infarction,33,2.021E-01,3.530E-01,2.385E-01,3.896E-01,8,"Tuberin, ILK, p70 S6 kinase1, ACKR3, eNOS, AKT(PKB), PDK (PDPK1), SDF-1",2.021E-01,3.530E-01,10,"Tuberin, Rac1, AKT(PKB), PDK (PDPK1), SDF-1, ILK, p70 S6 kinase1, ACKR3, eNOS, PI3K reg class IB (p101)",
991,Resistance of pancreatic cancer cells to death receptor signaling,33,2.021E-01,3.530E-01,2.385E-01,3.896E-01,8,"Cytochrome c, FADD, NFKBIA, PRKD1, DcR3(TNFRSF6B), IKK-beta, Bcl-XL, TRID(TNFRSF10C)",2.021E-01,3.530E-01,10,"Cytochrome c, FADD, Bcl-XL, FasL(TNFSF6), NFKBIA, PRKD1, Caspase-7, DcR3(TNFRSF6B), IKK-beta, TRID(TNFRSF10C)",
992,Immune response_Histamine signaling in dendritic cells,51,2.024E-01,3.432E-01,2.024E-01,3.432E-01,12,"IRF8, MEK1(MAP2K1), G-protein alpha-i family, PKA-reg (cAMP-dependent), c-Raf-1, G-protein alpha-q/11, Histamine H3 receptor, IP3 receptor, G-protein alpha-s, PLC-beta, Adenylate cyclase, ERK1 (MAPK3)",6.368E-01,7.835E-01,11,"Histamine H4 receptor, NF-AT1(NFATC2), PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, PLC-beta, Adenylate cyclase, ERK1 (MAPK3), G-protein alpha-i family, Histamine H3 receptor, G-protein alpha-s",
993,HIF-1 in gastric cancer,51,2.024E-01,3.432E-01,2.024E-01,3.432E-01,12,"ERK1/2, p21, Ubiquitin, PDF, GLUT1, ErbB2, Bcl-2, PGES2, AKT(PKB), HSP90, PDK (PDPK1), LAMR1",2.596E-01,4.191E-01,14,"ERK1/2, p21, Rac1, Ubiquitin, ErbB2, PGES2, AKT(PKB), HSP90, PDK (PDPK1), ARNT, PDF, GLUT1, Bcl-2, LAMR1",
994,Development_Endothelial differentiation during embryonic development,51,2.024E-01,3.432E-01,2.024E-01,3.432E-01,12,"MEK1(MAP2K1), FGFR3, ERK1/2, c-Raf-1, SHH, GATA-2, ETV2, PKC, PI3K reg class IA, WNT, HEY2, AKT(PKB)",3.747E-01,5.466E-01,13,"ERK1/2, ETV2, PI3K reg class IA, AKT(PKB), HEY1, FGFR3, SHH, GATA-2, DLL4, PKC, WNT, HEY2, SMAD1",
995,Inhibition of Calcitriol/ VDR signaling in colorectal cancer,51,2.024E-01,3.432E-01,2.024E-01,3.432E-01,12,"E-cadherin, JunB, CITED2, VDR, p21, ZNF44, ID2, Keratin 13, JunD, Occludin, Cystatin D, JMJD3",3.747E-01,5.466E-01,13,"DKK4, p21, ZNF44, ID2, JunD, c-Myc, E-cadherin, JunB, CITED2, VDR, c-Jun, Occludin, JMJD3",
996,"Signal transduction_Angiotensin II/AGTR1 signaling via Notch, Beta-catenin and NF-kB pathways",76,2.054E-01,3.465E-01,2.054E-01,3.465E-01,17,"E-cadherin, ERK1/2, AGTR1, p90RSK1, PAK1, YAP1 (YAp65), I-kB, PRKD1, PKC, IKK-beta, Connexin 43, IGF-1 receptor, HEY2, Cyclin D1, AKT(PKB), PDK (PDPK1), p38 MAPK",3.655E-01,5.384E-01,19,"ERK1/2, IKK (cat), Rac1, I-kB, IKK-alpha, IGF-1 receptor, AKT(PKB), PDK (PDPK1), c-Myc, HEY1, E-cadherin, AGTR1, PAK1, PRKD1, PKC, IKK-beta, HEY2, Cyclin D1, p38 MAPK",
997,Regulation of lipid metabolism_Alpha-1 adrenergic receptors signaling via arachidonic acid,71,2.055E-01,3.465E-01,2.055E-01,3.465E-01,16,"DGL-alpha, H-Ras, ERK1/2, G-protein alpha-11, CACNA1C, c-Raf-1, DGL-beta, IP3 receptor, COX-1 (PTGS1), Calmodulin, cPLA2, Monoglyceride lipase, Alpha-1A adrenergic receptor, VAV-2, MEK1/2, PGES2",5.674E-01,7.225E-01,16,"DGL-alpha, H-Ras, ERK1/2, DGL-beta, PLC-beta1, IP3 receptor, cPLA2, Monoglyceride lipase, VAV-2, PGES2, G-protein alpha-11, CACNA1C, Paxillin, Calmodulin, Alpha-1A adrenergic receptor, G-protein alpha-q",
998,Possible pathway of TGF-beta 1-dependent inhibition of CFTR expression,41,2.075E-01,3.599E-01,3.204E-01,4.864E-01,9,"MLK2(MAP3K10), CFTR, PDE4D, MEK6(MAP2K6), Clathrin, TAB2, Beta-arrestin1, p38 MAPK, GRK2",2.075E-01,3.599E-01,12,"Rac1, PDE4D, MEK6(MAP2K6), TAB2, GRK2, MEKK4(MAP3K4), MLK2(MAP3K10), MEKK1(MAP3K1), TAB1, Clathrin, Beta-arrestin1, p38 MAPK",
999,Apo-2L(TNFSF10)-induced apoptosis in melanoma,45,2.091E-01,3.607E-01,4.318E-01,5.976E-01,9,"Aif, XBP1, TRADD, Cytochrome c, FADD, NFKBIA, IFN-alpha, IRE1, Smac/Diablo",2.091E-01,3.607E-01,13,"XBP1, IKK (cat), TRADD, Bak, Cytochrome c, FADD, IFN-alpha, IRE1, PARP-1, Aif, PKC-delta, NFKBIA, Smac/Diablo",
1000,IgE- and MGF-induced Fyn-mediated activation of lung mast cells in asthma,49,2.101E-01,3.607E-01,2.662E-01,4.228E-01,11,"GRB2, K-RAS, MGF, Btk, PI3K reg class IA (p85), Hck, CalDAG-GEFII, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1), p38 MAPK",2.101E-01,3.607E-01,14,"GRB2, PI3K reg class IA (p85), Hck, CalDAG-GEFII, SHIP, AKT(PKB), PDK (PDPK1), K-RAS, PKC-delta, MGF, Btk, SHP-2, JNK(MAPK8-10), p38 MAPK",
1001,Demyelination in multiple sclerosis,49,2.101E-01,3.607E-01,2.662E-01,4.228E-01,11,"Aif, PAK2, PADI2, FADD, MEK6(MAP2K6), JNK(MAPK8-10), JNK3(MAPK10), AKT(PKB), NOX1, p38 MAPK, Cathepsin D",2.101E-01,3.607E-01,14,"PAK2, FADD, MEK6(MAP2K6), JNK3(MAPK10), FasL(TNFSF6), AKT(PKB), NOX1, Cathepsin D, PARP-1, Aif, PADI2, MEKK1(MAP3K1), JNK(MAPK8-10), p38 MAPK",
1002,Immune response_PD-1-induced metabolic changes in T cells,49,2.101E-01,3.607E-01,2.662E-01,4.228E-01,11,"ERK1/2, PEDF-R (iPLA2-zeta), FASN, CPT-1A, GLUT1, PI3K reg class IA (p85), PTEN, HXK2, SLC38A1, AKT(PKB), PDK (PDPK1)",2.101E-01,3.607E-01,14,"ERK1/2, PEDF-R (iPLA2-zeta), FASN, CPT-1A, PI3K reg class IA (p85), ZAP70, HXK2, AKT(PKB), PDK (PDPK1), GLUT1, PTEN, SHP-2, SLC38A1, TCR alpha/beta",
1003,"Role of inflammasome in macrophages, adipocytes and pancreatic beta cells in type 2 diabetes",18,2.104E-01,3.607E-01,6.594E-01,8.008E-01,3,"ChREBP, CARD5, IL-1RI",2.104E-01,3.607E-01,6,"ChREBP, CARD8, CARD5, IL-1RI, Amylin, Thioredoxin",
1004,DNA damage_ATM/ATR regulation of G1/S checkpoint,32,2.121E-01,3.568E-01,2.121E-01,3.568E-01,8,"Chk2, Cyclin D, p21, ATRIP, RAD9, Ubiquitin, I-kB, MDM2",2.960E-01,4.586E-01,9,"p21, Ubiquitin, I-kB, MDM2, c-Myc, Nibrin, Cyclin D, ATRIP, RAD9",
1005,Development_Retinoic acid and retinoic acid receptors in regulation of oligodendrocyte differentiation,37,2.165E-01,3.626E-01,2.165E-01,3.626E-01,9,"ANGPTL4, RARgamma, PLP1, RXRA, OLIG1, p21, RARalpha, p27KIP1, Transthyretin",4.755E-01,6.434E-01,9,"RARgamma, PLP1, OLIG1, p21, RARalpha, p27KIP1, ANGPTL4, RXRA, Transthyretin",
1006,G-protein signaling_H-RAS regulation pathway,37,2.165E-01,3.626E-01,2.165E-01,3.626E-01,9,"PDGF-B, GRB2, H-Ras, RasGRP4, c-Raf-1, RalGDS, CalDAG-GEFII, GFRalpha1, RET",4.755E-01,6.434E-01,9,"PDGF-B, GRB2, H-Ras, RasGRP4, GIPC, CalDAG-GEFII, GFRalpha1, RET, RalGDS",
1007,Glomerular injury in Lupus Nephritis,92,2.186E-01,3.658E-01,2.186E-01,3.658E-01,20,"C5aR, Otubain1, Protein kinase G1, PDGF-B, MMP-1, H-Ras, ERK1/2, TGF-beta, SLC22A17, c-Raf-1, ErbB2, IFN-alpha, LIN-28, Bcl-2, MEK1/2, Cyclin D1, JNK(MAPK8-10), AKT(PKB), PDK (PDPK1), p38 MAPK",4.391E-01,6.079E-01,22,"Protein kinase G1, PDGF-B, H-Ras, ERK1/2, ATF-4, ErbB2, IFN-alpha, miR-let-7a-5p, FasL(TNFSF6), AKT(PKB), PDK (PDPK1), C5aR, Otubain1, MMP-1, TGF-beta, SLC22A17, LIN-28, Bcl-2, microRNA 26a-2, Cyclin D1, JNK(MAPK8-10), p38 MAPK",
1008,Inhibition of GSK3 beta by lithium in major depressive disorder,22,2.192E-01,3.736E-01,3.682E-01,5.321E-01,5,"PP1-cat, p21, HTR1B, Bcl-2, AKT(PKB)",2.192E-01,3.736E-01,7,"PP1-cat, p21, AKT(PKB), IPP-2, c-Jun, HTR1B, Bcl-2",
1009,Serotonin modulation of dopamine release in nicotine addiction,42,2.194E-01,3.663E-01,2.194E-01,3.663E-01,10,"G-protein alpha-i family, ACM1, PKC, GABA-A receptor, PLC-beta, PTEN, Adenylate cyclase, HTR1B, nAChR alpha-4, HTR1A",2.340E-01,3.851E-01,12,"GABA-A receptor, PLC-beta, HTR2C (HTR1C), Adenylate cyclase, nAChR alpha-4, nAChR alpha4/beta2, G-protein alpha-i family, ACM1, PKC, PTEN, HTR1B, G-protein alpha-q",
1010,Chylomicron dyslipidemia in type 2 diabetes and metabolic syndrome X,42,2.194E-01,3.663E-01,2.194E-01,3.663E-01,10,"NPC1L1, APOB48 receptor, Sec24C, ABCG5, SAR1A, APOA5, CD36, ABCG5/ABCG8 heterodimer, Sec23, ABCG8",4.976E-01,6.647E-01,10,"NPC1L1, ABCG5, APOC2, Sec23, ABCG8, APOB48 receptor, Sec24C, SAR1A, CD36, ABCG5/ABCG8 heterodimer",
1011,Immune response_KLRK1 (NKG2D) signaling pathway,47,2.214E-01,3.687E-01,2.214E-01,3.687E-01,11,"MEK1(MAP2K1), RAET1G, GRB2, c-Fos, ERK1/2, PAK1, IP3 receptor, RAET1E, AP-1, PI3K reg class IA, AKT(PKB)",2.608E-01,4.191E-01,13,"GRB2, c-Fos, ERK1/2, c-Jun/c-Fos, Rac1, IP3 receptor, PI3K reg class IA, ZAP70, AKT(PKB), c-Jun, PAK1, RAET1E, AP-1",
1012,B-regulatory cells and tumor cells intercellular interaction,67,2.230E-01,3.698E-01,2.230E-01,3.698E-01,15,"gp130, CD80, VDR, Granzyme B, CCR2, IL-12 alpha, STAT3, IL-1RI, JNK(MAPK8-10), CD40(TNFRSF5), STAT6, IL-4, p38 MAPK, IL-6 receptor, CD40L(TNFSF5)",6.908E-01,8.322E-01,14,"gp130, Granzyme B, CCR2, IL-12 alpha, IL-1RI, FasL(TNFSF6), IL-4, CD5, VDR, JNK(MAPK8-10), CD40(TNFRSF5), STAT6, p38 MAPK, IL-6 receptor",
1013,Apoptotic pathways and resistance to apoptosis in lung cancer cells,57,2.231E-01,3.698E-01,2.231E-01,3.698E-01,13,"MEK1(MAP2K1), ERK1/2, TRADD, Cytochrome c, FADD, FGFR1, DcR3(TNFRSF6B), PEA15, Bcl-2, Bcl-XL, p70 S6 kinase2, p27KIP1, Smac/Diablo",3.093E-01,4.761E-01,15,"ERK1/2, TRADD, Cytochrome c, FADD, FGFR1, BAD, Bcl-XL, FasL(TNFSF6), p27KIP1, miR-222-3p, DcR3(TNFRSF6B), Bcl-2, microRNA 222, p70 S6 kinase2, Smac/Diablo",
1014,Renin-Angiotensin-Aldosterone System,62,2.233E-01,3.698E-01,2.233E-01,3.698E-01,14,"p38alpha (MAPK14), c-Fos, ERK1/2, AGTR1, G-protein alpha-q/11, IP3 receptor, Renin, PRKD1, Calmodulin, PLC-beta, cPLA2, MEK6(MAP2K6), ACE1, ALOX15",3.312E-01,5.012E-01,16,"c-Fos, ERK1/2, G-protein alpha-q/11, Rac1, IP3 receptor, STAR, Renin, PLC-beta, cPLA2, MEK6(MAP2K6), ACE1, CYP11B2, AGTR1, PRKD1, Calmodulin, ALOX15",
1015,Muscle contraction_Oxytocin signaling in uterus and mammary gland,62,2.233E-01,3.698E-01,2.233E-01,3.698E-01,14,"MEK1(MAP2K1), eEF2, cPKC (conventional), H-Ras, ERK1/2, CACNA1C, c-Raf-1, G-protein alpha-q/11, IP3 receptor, PLA2(hGIIA), Calmodulin, PKC, cPLA2, PGES2",5.658E-01,7.211E-01,14,"H-Ras, LARG, ERK1/2, G-protein alpha-q/11, PLC-beta1, IP3 receptor, cPLA2, PGES2, eEF2, cPKC (conventional), CACNA1C, PLA2(hGIIA), Calmodulin, PKC",
1016,Apoptosis and survival_Beta-2 adrenergic receptor anti-apoptotic action,23,2.272E-01,3.743E-01,2.272E-01,3.743E-01,6,"G-protein alpha-i family, PKA-reg (cAMP-dependent), FOXO4, G-protein alpha-s, AKT(PKB), PDK (PDPK1)",2.572E-01,4.191E-01,7,"PKA-reg (cAMP-dependent), AKT(PKB), PDK (PDPK1), G-protein alpha-i family, FOXO4, G-protein alpha-s, PI3K reg class IB (p101)",
1017,G-protein signaling_Rap1B regulation pathway,11,2.280E-01,3.851E-01,3.209E-01,4.867E-01,3,"Tuberin, GRB2, Ca-ATPase3",2.280E-01,3.851E-01,4,"Tuberin, GRB2, Ca-ATPase3, C3G",
1018,Muscle contraction_S1P2 receptor-mediated smooth muscle contraction,30,2.290E-01,3.851E-01,4.684E-01,6.276E-01,6,"IP3 receptor, G-protein alpha-13, PRKD1, Calmodulin, MRLC, MLCK",2.290E-01,3.851E-01,9,"PKC-zeta, PLC-beta1, IP3 receptor, G-protein alpha-13, MLCK, PRKD1, Calmodulin, MRLC, G-protein alpha-q",
1019,Development_WNT/Beta-catenin signaling in cell differentiation,30,2.290E-01,3.851E-01,6.564E-01,8.007E-01,5,"ROR-gamma, Islet-1, FOXP3, WNT, MYOD",2.290E-01,3.851E-01,9,"Lef-1, MYF5, FOXP3, Tcf(Lef), ROR-gamma, FGF18, WNT, Frizzled, MYOD",
1020,DNA damage_Role of Brca1 and Brca2 in DNA repair,30,2.290E-01,3.851E-01,6.564E-01,8.007E-01,5,"Chk2, DDB2, BRIP1, NTH1, MLH1",2.290E-01,3.851E-01,9,"XPC, Rad51, BRIP1, Nibrin, MSH3, Rad50, DDB2, NTH1, MLH1",
1021,Activation of TGF-beta signaling in advanced colorectal cancer,30,2.290E-01,3.851E-01,4.684E-01,6.276E-01,6,"E-cadherin, H-Ras, PI3K reg class IA, Cyclin D1, AKT(PKB), p38 MAPK",2.290E-01,3.851E-01,9,"H-Ras, PI3K reg class IA, AKT(PKB), c-Myc, E-cadherin, MKK7 (MAP2K7), MEKK1(MAP3K1), Cyclin D1, p38 MAPK",
1022,Proinflammatory cytokine release from eosinophils in asthma,34,2.315E-01,3.851E-01,9.602E-01,1.000E+00,3,"CCR3, ERK1/2, IL-4",2.315E-01,3.851E-01,10,"IL-16 mature, TrkA, ERK1/2, Fc alpha receptor, IL-13, IL-9, IL-4, IL-25 (IL-17E), CCR3, IL-16",
1023,NK cells in allergic contact dermatitis,34,2.315E-01,3.851E-01,4.226E-01,5.868E-01,7,"MIG, MHC class II, NKG2A, CCR2, CCR6, CCR5, NKp46",2.315E-01,3.851E-01,10,"MHC class II, NKG2A, CCR2, Perforin, CCR5, FasL(TNFSF6), CCR6, CXCR3, NKp46, TCR alpha/beta",
1024,Development_SDF-1 signaling in hematopoietic stem cell homing,38,2.331E-01,3.851E-01,2.412E-01,3.913E-01,9,"H-Ras, ERK1/2, c-Raf-1, PAK1, PI3K reg class IA (p85), FAK1, MEK1/2, PDK (PDPK1), SDF-1",2.331E-01,3.851E-01,11,"H-Ras, ERK1/2, PKC-zeta, Rac1, PI3K reg class IA (p85), PDK (PDPK1), SDF-1, PAK1, C3G, Paxillin, FAK1",
1025,Development_Oligodendrocyte differentiation (general schema),38,2.331E-01,3.851E-01,3.828E-01,5.468E-01,8,"FGFR3, EGF, PDGF-B, hASH1, OLIG1, IGF-1 receptor, IL-4, IGF-1",2.331E-01,3.851E-01,11,"EGF, PDGF-B, OLIG1, IGF-1 receptor, IL-4, Nkx2.2, FGFR3, CD82, hASH1, SMAD1, IGF-1",
1026,"Disruption of apoptosis, proliferation and shedding of epithelial cells in asthma",54,2.339E-01,3.851E-01,2.651E-01,4.228E-01,12,"E-cadherin, EGF, ERK1/2, p21, SARA, Amphiregulin, Rb protein, Bcl-2, eNOS, IL-4, SP1, p27KIP1",2.339E-01,3.851E-01,15,"EGF, ERK1/2, p21, Amphiregulin, Rb protein, IL-13, IL-4, p27KIP1, E-cadherin, SARA, Paxillin, Bcl-2, eNOS, SP1, CLCN3",
1027,Signal transduction_WNT/Beta-catenin signaling in tissue homeostasis,42,2.340E-01,3.851E-01,5.015E-01,6.577E-01,8,"Claudin-2, ROR-gamma, KLF4, FOXP3, WNT, Connexin 43, Bcl-XL, Cyclin D1",2.340E-01,3.851E-01,12,"Claudin-2, Lef-1, KLF4, FOXP3, Bcl-XL, c-Myc, Tcf(Lef), ROR-gamma, FGF18, WNT, Cyclin D1, Frizzled",
1028,Impaired inhibition of Th17 cell differentiation by IFN-beta in multiple sclerosis,28,2.342E-01,3.840E-01,2.342E-01,3.840E-01,7,"ROR-alpha, ROR-gamma, STAT3, IL-30, IL23R, IL-1RI, IL-6 receptor",7.988E-01,9.177E-01,5,"IL-30, IL23R, IL-1RI, ROR-gamma, IL-6 receptor",
1029,DNA damage_ATM / ATR regulation of G2 / M checkpoint,28,2.342E-01,3.840E-01,2.342E-01,3.840E-01,7,"p38alpha (MAPK14), Chk2, p21, ATRIP, RAD9, Ubiquitin, Wee1",6.411E-01,7.870E-01,6,"p21, Ubiquitin, Wee1, ATRIP, RAD9, Kinase MYT1",
1030,The role of aberrations in CDKN2 locus and CDK4 in familial melanoma,28,2.342E-01,3.840E-01,2.342E-01,3.840E-01,7,"E2F5, E2F1, p21, Rb protein, MDM2, p130, Cyclin D1",4.626E-01,6.309E-01,7,"E2F5, p21, Rb protein, MDM2, p130, E2F1, Cyclin D1",
1031,Regulation of Beta-catenin activity  in melanoma,28,2.342E-01,3.840E-01,2.342E-01,3.840E-01,7,"E-cadherin, PKA-reg (cAMP-dependent), NRCAM, ErbB2, Bcl-2, Bcl-XL, AKT(PKB)",4.626E-01,6.309E-01,7,"PKA-reg (cAMP-dependent), NRCAM, ErbB2, Bcl-XL, AKT(PKB), E-cadherin, Bcl-2",
1032,Suppression of p53 signaling in multiple myeloma,50,2.343E-01,3.851E-01,7.085E-01,8.440E-01,8,"p21, Cytochrome c, Bcl-2, MDM2, IGF-1 receptor, IGF-1, PUMA, PSMD4",2.343E-01,3.851E-01,14,"p21, Bak, Cytochrome c, MDM2, IGF-1 receptor, miR-181b-5p, c-Myc, PUMA, PSMD4, c-Jun, miR-106b-5p, Bcl-2, miR-32-5p, IGF-1",
1033,Signal transduction_Activin A signaling regulation,33,2.385E-01,3.896E-01,2.385E-01,3.896E-01,8,"ALK-4, MAN1, BAMBI, IGSF1, Ubiquitin, Inhibin, FAST-1/2, Inhibin alpha subunit",6.526E-01,7.968E-01,7,"ALK-4, Ubiquitin, Inhibin alpha subunit, MAN1, BAMBI, Inhibin, FAST-1/2",
1034,Type 2 diabetes (general schema),14,2.394E-01,3.896E-01,2.394E-01,3.896E-01,4,"Adiponectin, Insulin processed, Ghrelin, Leptin",4.003E-01,5.700E-01,4,"Insulin processed, Ghrelin, Adiponectin, Leptin",
1035,IL-6 signaling in tumor-associated monocytes/macrophages in breast cancer,14,2.394E-01,3.896E-01,2.394E-01,3.896E-01,4,"gp130, IL6RA, STAT3, IL-6 receptor",4.003E-01,5.700E-01,4,"gp130, c-Jun, IL6RA, IL-6 receptor",
1036,Cell adhesion_Cell-matrix glycoconjugates,38,2.412E-01,3.913E-01,2.412E-01,3.913E-01,9,"Galectin-3, MMP-1, ITIH2, Lymphotactin, ECM1, MUC1, CEACAM5, A1M, E-selectin",3.613E-01,5.327E-01,10,"Galectin-3, Fibulin-2, MUC1, E-selectin, Tenascin-R, MMP-1, Plasmin, ITIH2, CEACAM5, A1M",
1037,Degranulation of lung mast cells,63,2.424E-01,3.927E-01,2.424E-01,3.927E-01,14,"C5aR, Substance P extracellular region, cPKC (conventional), Neurokinin A, G-protein alpha-i family, BDKRB1, BDKRB2, Tryptase, MGF, PGE2R3, IP3 receptor, PI3K reg class IA (p85), P2Y2, CRHR1",4.727E-01,6.424E-01,15,"Substance P extracellular region, Neurokinin A, BDKRB1, BDKRB2, IP3 receptor, PI3K reg class IA (p85), Chymase, C5aR, cPKC (conventional), G-protein alpha-i family, Tryptase, MGF, PGE2R3, Bradykinin, P2Y2",
1038,Role of cell adhesion in vaso-occlusion in Sickle cell disease,43,2.427E-01,3.929E-01,2.427E-01,3.929E-01,10,"PKA-reg (cAMP-dependent), ITGAM, ITGAL, CD63, CD36, Fc gamma RI, GP-IB alpha, CD3, BCAM, E-selectin",6.727E-01,8.144E-01,9,"PKA-reg (cAMP-dependent), ITGAL, E-selectin, ITGAM, CD63, CD36, Fc gamma RI, GP-IB alpha, BCAM",
1039,"Leucine, isoleucine and valine metabolism.p.2",79,2.473E-01,4.054E-01,2.563E-01,4.144E-01,17,"PCCB, ACAD8, MCC, MCCA, IVD, MMSA, HMGCS2, ACDSB, MCCC2, ALDH2, MUTA, HCD2, HCDH, MCEE, GABT, AOX1, ECHS1",2.473E-01,4.054E-01,21,"PCCB, ACAD8, HMGCS2, ACDSB, MCCC2, MUTA, HCDH, MCEE, AOX1, ECHS1, PCC, MCC, MCCA, PCCA, IVD, MMSA, HADHB, HIBCH, ALDH2, HCD2, GABT",
1040,Eosinophil survival in asthma,67,2.531E-01,4.140E-01,6.913E-01,8.269E-01,11,"CCR3, CSF2RB, ERK1/2, FADD, Bcl-2, Bcl-XL, CD40(TNFRSF5), Guanylate Cyclase 1, soluble, CysLT1 receptor, p38 MAPK, CD40L(TNFSF5)",2.531E-01,4.140E-01,18,"TrkA, ERK1/2, IL-3, FADD, IL-13, Bcl-XL, IL-9, Guanylate Cyclase 1, soluble, CysLT1 receptor, NT-3, CCR3, CSF2RB, IL-5 receptor, IL5RA, SHP-2, Bcl-2, CD40(TNFRSF5), p38 MAPK",
1041,"Role of microRNAs in cell migration, survival and angiogenesis in colorectal cancer",67,2.531E-01,4.140E-01,3.242E-01,4.883E-01,14,"MMP-1, PDCD4, Clusterin, p21, RhoB, MACC1, Sirtuin1, FOXO4, p70 S6 kinase1, MTSS1, PTEN, Bcl-2, IGF-1 receptor, AKT(PKB)",2.531E-01,4.140E-01,18,"Clusterin, p21, miR-let-7a-5p, IGF-1 receptor, AKT(PKB), miR-342-5p, MMP-1, PDCD4, RhoB, MACC1, miR-328-3p, Sirtuin1, FOXO4, p70 S6 kinase1, MTSS1, miR-23a-3p, PTEN, Bcl-2",
1042,Mitochondrial dysfunction in neurodegenerative diseases,59,2.566E-01,4.191E-01,7.669E-01,8.833E-01,9,"KCRU, Huntingtin, UCP2, Cytochrome c, IP3 receptor, PPIF, PLC-beta, IP3R1, ANT",2.566E-01,4.191E-01,16,"Huntingtin, UCP2, Cytochrome c, IP3 receptor, NMDA receptor, Hap-1, PDH, SOD1, PPIF, PLC-beta, ANT, G3P2, KCRU, ACON, IP3R1, G-protein alpha-q",
1043,Development_ERK5 in cell proliferation and neuronal survival,23,2.572E-01,4.191E-01,4.074E-01,5.742E-01,5,"EGF, c-Fos, H-Ras, c-Raf-1, WNK1",2.572E-01,4.191E-01,7,"EGF, TrkA, c-Fos, H-Ras, PKC-zeta, c-Jun, WNK1",
1044,Cell adhesion_ECM remodeling,55,2.582E-01,4.191E-01,2.873E-01,4.507E-01,12,"TIMP3, MMP-1, IBP4, IL8RA, Kallikrein 3 (PSA), VIL2 (ezrin), Vitronectin, MMP-15, Kallikrein 2, IGF-1 receptor, Collagen II, IGF-1",2.582E-01,4.191E-01,15,"TIMP3, Kallikrein 3 (PSA), VIL2 (ezrin), Plasminogen, MMP-15, IGF-1 receptor, Collagen II, MMP-1, Plasmin, IBP4, IL8RA, Vitronectin, Kallikrein 2, IGF-1, Kallikrein 1",
1045,Basophil migration in asthma,55,2.582E-01,4.191E-01,2.873E-01,4.507E-01,12,"C5aR, Substance P extracellular region, CCR3, CRTH2, G-protein alpha-i family, CCR2, CCR1, ITGAM, FPRL2, IL8RA, E-selectin, IL8RB",2.582E-01,4.191E-01,15,"Substance P extracellular region, CCR2, CCR1, IL-3, CCL13, E-selectin, IL8RB, C5aR, CCR3, G-protein alpha-i family, ITGAM, FPRL2, IL8RA, IL-5 receptor, PI3K reg class IB (p101)",
1046,Signal transduction_NF-kB activation pathways,51,2.596E-01,4.191E-01,5.932E-01,7.460E-01,9,"TRAF2, TIRAP (Mal), TRADD, E2I, Ubiquitin, I-kB, IKK-beta, IL-1RI, TAB2",2.596E-01,4.191E-01,14,"IKK (cat), TRADD, E2I, Ubiquitin, I-kB, MyD88, IKK-alpha, IL-1RI, TAB2, TRAF2, TIRAP (Mal), IKK-beta, TAB1, LUBAC E3 ligase",
1047,Development_Inhibition of angiogenesis by PEDF,31,2.618E-01,4.191E-01,3.262E-01,4.898E-01,7,"Presenilin 1, Presenilin, VEGFR-1, PEDF-R (iPLA2-zeta), Cytochrome c, FADD, p38 MAPK",2.618E-01,4.191E-01,9,"NF-AT1(NFATC2), Presenilin 1, PEDF-R (iPLA2-zeta), Cytochrome c, FADD, FasL(TNFSF6), Presenilin, VEGFR-1, p38 MAPK",
1048,Fibroblast differentiation to myofibroblasts in asthmatic airways,31,2.618E-01,4.191E-01,3.262E-01,4.898E-01,7,"ERK1/2, PI3K reg class IA, FAK1, JNK(MAPK8-10), IL-4, AKT(PKB), p38 MAPK",2.618E-01,4.191E-01,9,"ERK1/2, PI3K reg class IA, IL-13, IL-4, AKT(PKB), c-Jun, FAK1, JNK(MAPK8-10), p38 MAPK",
1049,Role of iNKT and B cells in T cell recruitment in allergic contact dermatitis,39,2.624E-01,4.191E-01,5.773E-01,7.297E-01,7,"C5aR, CXCR5, AID, CD19, CD3, STAT6, IL-4",2.624E-01,4.191E-01,11,"NF-AT1(NFATC2), CD19, ITK, IL-4, CD5, C5aR, CD79 complex, AID, CXCR3, STAT6, TCR alpha/beta",
1050,Suppression of TGF-beta signaling in pancreatic cancer,29,2.640E-01,4.228E-01,2.640E-01,4.228E-01,7,"MEK1(MAP2K1), K-RAS, MMP-1, c-Raf-1, p21, MEK6(MAP2K6), p38 MAPK",5.033E-01,6.700E-01,7,"p21, MEK6(MAP2K6), c-Myc, MEKK4(MAP3K4), K-RAS, MMP-1, p38 MAPK",
1051,SLE genetic marker-specific pathways in antigen-presenting cells (APC),84,2.651E-01,4.230E-01,5.711E-01,7.243E-01,15,"IRF8, TRAF2, ICA69, TBK1, ITGAM, Ubiquitin, Fc gamma RIII beta, I-kB, IFN-alpha, IKK-beta, IRF5, IL-1RI, CD40(TNFRSF5), IRE1, CD40L(TNFSF5)",2.651E-01,4.230E-01,22,"Separase, ICA69, TBK1, IKK (cat), Ubiquitin, I-kB, MyD88, IKK-alpha, IFN-alpha, IL-1RI, IRE1, YY1, ATF-6 beta, TRAF2, ITGAM, Fc gamma RIII beta, IKK-beta, IRF5, Beclin 1, CD40(TNFRSF5), TRIF (TICAM1), JIK",
1052,Role of IFN-beta in inhibition of Th1 cell differentiation in multiple sclerosis,34,2.661E-01,4.228E-01,2.661E-01,4.228E-01,8,"CD80, MHC class II, IL-12 alpha, PI3K reg class IA (p85), PI3K reg class IA, SHP-1, AKT(PKB), PDK (PDPK1)",5.260E-01,6.904E-01,8,"MHC class II, IL-12 alpha, PI3K reg class IA (p85), PI3K reg class IA, SHP-1, AKT(PKB), PDK (PDPK1), TCR alpha/beta",
1053,Th17 cells in CF (mouse model),49,2.662E-01,4.228E-01,2.662E-01,4.228E-01,11,"CD80, MHC class II, ROR-gamma, CFTR, SARA, STAT3, IL-17RC, FOXP3, IL-1RI, G-CSF, IL-6 receptor",5.788E-01,7.334E-01,11,"MHC class II, IL-17RC, MyD88, FOXP3, IL-1RI, LBP, ROR-gamma, SARA, G-CSF, TCR alpha/beta, IL-6 receptor",
1054,Breakdown of CD4+ T cell peripheral tolerance in type 1 diabetes mellitus,49,2.662E-01,4.228E-01,2.662E-01,4.228E-01,11,"CD80, MHC class II, CXCR5, RAG2, NF-AT, AP-1, CD3, FOXP3, Bcl-XL, CD40(TNFRSF5), CD40L(TNFSF5)",5.788E-01,7.334E-01,11,"MHC class II, ZAP70, FOXP3, Bcl-XL, ICOS, IL-2R alpha chain, LAT, NF-AT, AP-1, CD40(TNFRSF5), TCR alpha/beta",
1055,Transport_Rab-9 regulation pathway,10,2.667E-01,4.228E-01,2.667E-01,4.228E-01,3,"GCC2, RAB9P40, PRA1",4.075E-01,5.759E-01,3,"GCC2, RAB9P40, PRA1",
1056,Impaired Lipoxin A4 signaling in CF,44,2.668E-01,4.228E-01,2.668E-01,4.228E-01,10,"EGF, PDGF-B, G-protein alpha-i family, CFTR, PKA-reg (cAMP-dependent), G-protein alpha-q/11, PI3K reg class IA (p85), Adenylate cyclase, SOCS2, CysLT1 receptor",2.906E-01,4.582E-01,12,"EGF, PDGF-B, PKA-reg (cAMP-dependent), G-protein alpha-q/11, PI3K reg class IA (p85), Adenylate cyclase, CysLT1 receptor, Thioredoxin, PRDX2, G-protein alpha-i family, SHP-2, SOCS2",
1057,Role of mevalonate pathway in multiple myeloma,44,2.668E-01,4.228E-01,2.668E-01,4.228E-01,10,"GGPS1, K-RAS, H-Ras, ERK1/2, PMVK, c-Raf-1, RhoB, MVK, Rab-6, MEK1/2",5.631E-01,7.195E-01,10,"GGPS1, H-Ras, ERK1/2, PMVK, Rab-6, GGTase-II, K-RAS, RhoB, MVK, IDI2",
1058,Development_S1P1 signaling pathway,44,2.668E-01,4.228E-01,2.668E-01,4.228E-01,10,"AKT1, GRB2, GAB1, G-protein alpha-i family, IP3 receptor, PLC-beta, Adenylate cyclase, eNOS, AKT(PKB), PDK (PDPK1)",4.206E-01,5.885E-01,11,"AKT1, GRB2, GAB1, Rac1, IP3 receptor, PLC-beta, Adenylate cyclase, AKT(PKB), PDK (PDPK1), G-protein alpha-i family, eNOS",
1059,Immune responses in asthma (schema),8,2.675E-01,4.264E-01,7.984E-01,9.027E-01,1,IL-4,2.675E-01,4.264E-01,3,"IL-13, IL-9, IL-4",
1060,Role of GITR in skin sensitization,15,2.830E-01,4.479E-01,2.830E-01,4.479E-01,4,"E-cadherin, CCR7, IL-1RI, p38 MAPK",4.575E-01,6.292E-01,4,"IL-1RI, E-cadherin, CCR7, p38 MAPK",
1061,Transport_Macropinocytosis,12,2.843E-01,4.512E-01,6.687E-01,8.089E-01,2,"EEA1, Tubulin (in microtubules)",2.843E-01,4.512E-01,4,"Rab-7, EEA1, Tubulin (in microtubules), SNX1",
1062,Development_Regulation of endothelial progenitor cell differentiation from adult stem cells,60,2.849E-01,4.504E-01,2.849E-01,4.504E-01,13,"G-protein alpha-i family, Thrombopoietin, MGF, S1P3 receptor, Epo receptor, PI3K reg class IA (p85), CD34, eNOS, von Willebrand factor, AKT(PKB), G-CSF, Epo, SDF-1",5.108E-01,6.785E-01,14,"Thrombopoietin, S1P3 receptor, PI3K reg class IA (p85), CD34, von Willebrand factor, AKT(PKB), Epo, SDF-1, G-protein alpha-i family, MGF, Epo receptor, eNOS, Fibrinogen gamma, G-CSF",
1063,Chemotaxis_CCL2-induced chemotaxis,55,2.873E-01,4.507E-01,2.873E-01,4.507E-01,12,"GRB2, G-protein alpha-i family, H-Ras, CCR2, ERK1/2, c-Raf-1, IP3 receptor, PI3K reg class IA (p85), cPLA2, MEK1/2, WASP, p38 MAPK",4.933E-01,6.614E-01,13,"GRB2, H-Ras, CCR2, ERK1/2, Rac1, IP3 receptor, PI3K reg class IA (p85), cPLA2, WASP, G-protein alpha-i family, Paxillin, PI3K reg class IB (p101), p38 MAPK",
1064,Apoptosis and survival_NO synthesis and signaling,55,2.873E-01,4.507E-01,2.873E-01,4.507E-01,12,"MEK1(MAP2K1), Protein kinase G1, Calcineurin A (catalytic), c-Fos, H-Ras, ERK1/2, c-Raf-1, Calmodulin, IFN-alpha, eNOS, AKT(PKB), PDK (PDPK1)",7.387E-01,8.699E-01,11,"Protein kinase G1, Calcineurin A (catalytic), c-Fos, H-Ras, ERK1/2, NMDA receptor, IFN-alpha, AKT(PKB), PDK (PDPK1), Calmodulin, eNOS",
1065,"Nicotine signaling in dopaminergic neurons, Pt. 1 - cell body",48,2.883E-01,4.565E-01,5.146E-01,6.721E-01,9,"Calcineurin A (catalytic), SNAP-25, G-protein alpha-i family, CACNA1C, IP3 receptor, Calmodulin, GABA-A receptor, PLC-beta, nAChR alpha-4",2.883E-01,4.565E-01,13,"Calcineurin A (catalytic), IP3 receptor, NMDA receptor, GABA-A receptor, PLC-beta, nAChR alpha-4, nAChR alpha4/beta2, G-protein alpha-i family, CACNA1C, nAChR beta-2, nAChR alpha-6, Calmodulin, G-protein alpha-q",
1066,Rheumatoid arthritis (general schema),50,2.896E-01,4.507E-01,2.896E-01,4.507E-01,11,"CD80, MHC class II, MMP-1, TGF-beta, Fc gamma RI, FOXP3, CD2, Collagen II, CD40(TNFRSF5), MHC class II beta chain, CD40L(TNFSF5)",6.083E-01,7.541E-01,11,"MHC class II, FCGR3A, FOXP3, Collagen II, MHC class II beta chain, IL-2R alpha chain, MMP-1, TGF-beta, Fc gamma RI, CD40(TNFRSF5), TCR alpha/beta",
1067,Development_Direct reprogramming of cardiac fibroblasts into cardiomyocytes,20,2.904E-01,4.507E-01,2.904E-01,4.507E-01,5,"GATA-4, Alpha-actinin 2, Islet-1, ANP, Troponin T, cardiac",4.928E-01,6.613E-01,5,"TBX5, GATA-4, ANP, alpha-MHC, Troponin T, cardiac",
1068,TGF-beta 1-mediated induction of EMT in normal and asthmatic airway epithelium,44,2.906E-01,4.582E-01,5.583E-01,7.111E-01,8,"E-cadherin, DDR1, DAB2, AP-1, Occludin, JNK(MAPK8-10), SP1, p38 MAPK",2.906E-01,4.582E-01,12,"DDR1, c-Jun/c-Fos, DAB2, E-cadherin, c-Jun, Uteroglobin, MKK7 (MAP2K7), AP-1, Occludin, JNK(MAPK8-10), SP1, p38 MAPK",
1069,"Role of TNF-alpha, IL-1beta and IL-6 in development of obesity and type 2 diabetes in liver",45,2.917E-01,4.507E-01,2.917E-01,4.507E-01,10,"AKT1, TIMP3, Insulin processed, G6PT, HSP90 alpha, STAT3, NOX3, Insulin receptor, PPCKM, IL-6 receptor",5.945E-01,7.449E-01,10,"AKT1, TIMP3, Insulin processed, IRS-1, HSP90 alpha, NOX3, Insulin receptor, PPCKM, PTP-1B, IL-6 receptor",
1070,Intercellular relations in asthma (general schema),16,2.921E-01,4.586E-01,8.152E-01,9.165E-01,2,"Substance P extracellular region, IL-4",2.921E-01,4.586E-01,5,"Substance P extracellular region, IL-13, IL-9, IL-4, ACM2",
1071,Neurophysiological process_ACM1 and ACM2 in neuronal membrane polarization,40,2.927E-01,4.586E-01,6.059E-01,7.550E-01,7,"Kir3.2, G-protein alpha-11, Kir3.1, ACM1, Kir2.2, IP3 receptor, KCNQ3",2.927E-01,4.586E-01,11,"Kir3.1, Kir2.2, PLC-beta1, IP3 receptor, KCNQ3, ACM2, Kir3.2, G-protein alpha-11, ACM1, G-protein alpha-q, KCNQ2",
1072,Cell adhesion_IL-8 family-dependent cell migration and adhesion,40,2.927E-01,4.586E-01,4.426E-01,6.061E-01,8,"MEK1(MAP2K1), G-protein alpha-i family, ERK1/2, EBP50, IL8RA, IP3 receptor, p38 MAPK, IL8RB",2.927E-01,4.586E-01,11,"ERK1/2, Rac1, IP3 receptor, IL8RB, CALDAG-GEFI, PKC-delta, G-protein alpha-i family, EBP50, IL8RA, PI3K reg class IB (p101), p38 MAPK",
1073,Immune escape mechanisms in Prostate Cancer,25,2.937E-01,4.507E-01,2.937E-01,4.507E-01,6,"CCL22, CCL17, CCR2, TGF-beta, IL-4, IL-6 receptor",3.379E-01,5.066E-01,7,"CCL22, CCL17, CCR2, IL-4, TGF-beta, TCR alpha/beta, IL-6 receptor",
1074,Development_Glucocorticoid receptor signaling,25,2.937E-01,4.507E-01,2.937E-01,4.507E-01,6,"FKBP4, E2I, NFKBIA, HSP90, HSP70, p23 co-chaperone",3.379E-01,5.066E-01,7,"c-Jun/c-Fos, E2I, HSP90, HSP70, FKBP4, NFKBIA, p23 co-chaperone",
1075,Development_Trophectoderm differentiation,25,2.937E-01,4.507E-01,2.937E-01,4.507E-01,6,"ALK-4, NANOG, FGF4, SOX2, ASH2, DLX3",3.379E-01,5.066E-01,7,"ALK-4, FGF4, ASH2, DLX3, NANOG, SOX2, Esrrb",
1076,Gamma-secretase regulation of gastrointestinal epithelial cell development,25,2.937E-01,4.507E-01,2.937E-01,4.507E-01,6,"PTF1-p48, Factor D, DLL1, Neurogenin 3, HEY2, p27KIP1",5.203E-01,6.847E-01,6,"DLL1, Neurogenin 3, p27KIP1, HEY1, Factor D, HEY2",
1077,T cell generation in COPD,25,2.937E-01,4.507E-01,2.937E-01,4.507E-01,6,"CD1a, CD80, MHC class II, CCR7, CCR2, CCR6",3.379E-01,5.066E-01,7,"MHC class II, CCR2, CCL13, CCR7, Beta-defensin 2, CCR6, TCR alpha/beta",
1078,G-protein signaling_TC21 regulation pathway,25,2.937E-01,4.507E-01,2.937E-01,4.507E-01,6,"MEK1(MAP2K1), G-protein alpha-12 family, GRB2, ERK1/2, c-Raf-1, CalDAG-GEFII",5.203E-01,6.847E-01,6,"GRB2, ERK1/2, CalDAG-GEFII, G-protein alpha-12 family, CALDAG-GEFI, C3G",
1079,Th2 cytokine- and TNF-alpha-induced inflammatory response in asthmatic airway fibroblasts,35,2.944E-01,4.507E-01,2.944E-01,4.507E-01,8,"c-Fos, ERK1/2, JNK(MAPK8-10), CD40(TNFRSF5), STAT6, IL-4, G-CSF, CD40L(TNFSF5)",4.033E-01,5.725E-01,9,"c-Fos, ERK1/2, IL-13, IL-4, c-Jun, JNK(MAPK8-10), CD40(TNFRSF5), STAT6, G-CSF",
1080,Immune response_Differentiation of natural regulatory T cells,35,2.944E-01,4.507E-01,2.944E-01,4.507E-01,8,"CD80, MHC class II, STAT3, Ubiquitin, FOXP3, CD40(TNFRSF5), LAG3, CD40L(TNFSF5)",5.623E-01,7.195E-01,8,"MHC class II, NF-AT1(NFATC2), Ubiquitin, FOXP3, IL-2R alpha chain, CD40(TNFRSF5), TCR alpha/beta, LAG3",
1081,Immune response_Th17 cell differentiation,35,2.944E-01,4.507E-01,2.944E-01,4.507E-01,8,"CD80, MHC class II, ROR-alpha, ROR-gamma, STAT3, IL-17RC, IL-1RI, IL-6 receptor",7.162E-01,8.511E-01,7,"MHC class II, NF-AT1(NFATC2), IL-17RC, IL-1RI, ROR-gamma, TCR alpha/beta, IL-6 receptor",
1082,Langerhans cell migration to lymph nodes in allergic contact dermatitis,35,2.944E-01,4.507E-01,2.944E-01,4.507E-01,8,"E-cadherin, CCL17, CCR7, Lactoferrin, CCR6, IL-1RI, IL-4, SDF-1",5.623E-01,7.195E-01,8,"CCL17, Lactoferrin, IL-1RI, IL-4, SDF-1, E-cadherin, CCR7, CCR6",
1083,Influence of low doses of Arsenite on Glucose stimulated Insulin secretion in pancreatic cells,36,2.945E-01,4.586E-01,6.578E-01,8.008E-01,6,"GPX2, SNAP-25, Synaptotagmin I, Calpain 10, Insulin, NQO1",2.945E-01,4.586E-01,10,"GPX2, ATF-4, Syntaxin 1A, Synaptotagmin I, SOD1, Thioredoxin, PRDX1, Calpain 10, Insulin, NQO1",
1084,Inhibition of apoptosis in multiple myeloma,36,2.945E-01,4.586E-01,3.235E-01,4.877E-01,8,"TRADD, FADD, STAT3, Bcl-2, Bcl-XL, IGF-1 receptor, IGF-1, IL-6 receptor",2.945E-01,4.586E-01,10,"EGR1, TRADD, FADD, Bcl-XL, IGF-1 receptor, FasL(TNFSF6), c-Jun, Bcl-2, IGF-1, IL-6 receptor",
1085,Development_Role of BMP signaling in embryonic stem cell neural differentiation,30,2.947E-01,4.507E-01,2.947E-01,4.507E-01,7,"MEK1(MAP2K1), ERK1/2, OTX2, Chordin, BMP7, SOX3, SOX2",7.106E-01,8.479E-01,6,"ERK1/2, Chordin, BMP7, SOX3, SOX2, SMAD1",
1086,Neurophysiological process_Mu-type opioid receptor-mediated analgesia,30,2.947E-01,4.507E-01,2.947E-01,4.507E-01,7,"G-protein alpha-i family, Adenylate cyclase type VI, PKA-reg (cAMP-dependent), Adenylate cyclase type I, Adenylate cyclase type V, Adenylate cyclase type II, Adenylate cyclase type IV",3.731E-01,5.453E-01,8,"Adenylate cyclase type VI, PKA-reg (cAMP-dependent), Adenylate cyclase type V, Adenylate cyclase type II, G-protein alpha-i family, Adenylate cyclase type I, Adenylate cyclase type IV, N-type Ca(II) channel alpha1B",
1087,Putative pathways of Oleic acid sensing in ventromedial hypothalamus in obesity (rodent model),30,2.947E-01,4.507E-01,2.947E-01,4.507E-01,7,"ACACA, SUR1, Kir6.2, CD36, CPT-1A, ACSL3, SLC27A4",7.106E-01,8.479E-01,6,"SUR1, Kir6.2, CPT-1A, ACSL3, CD36, SLC27A4",
1088,Cytoskeleton remodeling_Role of Activin A in cytoskeleton remodeling,20,2.956E-01,4.586E-01,9.009E-01,9.800E-01,2,"ALK-4, SP1",2.956E-01,4.586E-01,6,"ALK-4, c-Jun, MKK7 (MAP2K7), Paxillin, MEKK1(MAP3K1), SP1",
1089,Cytoskeleton remodeling_Fibronectin-binding integrins in cell motility,32,2.960E-01,4.586E-01,3.582E-01,5.226E-01,7,"p190RhoGAP, Alpha-actinin, PAK1, ILK, PI3K reg class IA (p85), FAK1, LIMK2",2.960E-01,4.586E-01,9,"Rac1, PI3K reg class IA (p85), LIMK2, p190RhoGAP, PAK1, ILK, N-WASP, FAK1, Cofilin",
1090,Development_Schema: SMAD-dependent TGF-beta family signaling in embryonic stem cells,24,2.970E-01,4.586E-01,4.462E-01,6.088E-01,5,"BMP7, NANOG, MSX-2, SOX2, FAST-1/2",2.970E-01,4.586E-01,7,"GDF3, MSX-2, BMP7, NANOG, SOX2, FAST-1/2, SMAD1",
1091,Effect of H. pylori infection on inflammation in gastric epithelial cells,61,3.066E-01,4.683E-01,3.066E-01,4.683E-01,13,"MEK1(MAP2K1), p38alpha (MAPK14), GRB2, c-Fos, TRAF2, H-Ras, ERK1/2, c-Raf-1, PAK1, IP3 receptor, I-kB, IKK-beta, JNK(MAPK8-10)",5.385E-01,7.024E-01,14,"GRB2, c-Fos, H-Ras, ERK1/2, IKK (cat), Rac1, IP3 receptor, I-kB, MyD88, TRAF2, c-Jun, PAK1, IKK-beta, JNK(MAPK8-10)",
1092,Immune response_IL-1 signaling pathway,82,3.103E-01,4.753E-01,3.114E-01,4.753E-01,17,"p38alpha (MAPK14), ECSIT, MMP-1, ZFP36(Tristetraprolin), ERK1/2, I-kB, PI3K reg class IA (p85), AP-1, MAPKAPK2, HSP27, MEK6(MAP2K6), IL-1RI, MEK1/2, JNK(MAPK8-10), Collagen II, AKT(PKB), PDK (PDPK1)",3.103E-01,4.773E-01,21,"JAM2, ECSIT, ERK1/2, PKC-zeta, EGR1, IKK (cat), MEK4/7, I-kB, PI3K reg class IA (p85), MAPKAPK2, MEK6(MAP2K6), IL-1RI, Collagen II, AKT(PKB), PDK (PDPK1), MMP-1, ZFP36(Tristetraprolin), AP-1, MEKK1(MAP3K1), HSP27, JNK(MAPK8-10)",
1093,Immune response_Bacterial infections in normal airways,49,3.165E-01,4.848E-01,9.013E-01,9.800E-01,6,"TIRAP (Mal), CFTR, I-kB, IKK-beta, IL-1RI, TAB2",3.165E-01,4.848E-01,13,"TLR5, IKK (cat), I-kB, MyD88, IKK-alpha, IL-1RI, FasL(TNFSF6), TAB2, LBP, TIRAP (Mal), Beta-defensin 2, IKK-beta, TAB1",
1094,Retinal ganglion cell damage in glaucoma,45,3.202E-01,4.900E-01,7.318E-01,8.595E-01,7,"Calcineurin A (catalytic), TBK1, NSGPeroxidase, TRPV1, BNaC2 (ASIC1a), TBC1D17, JNK(MAPK8-10)",3.202E-01,4.900E-01,12,"TrkA, Calcineurin A (catalytic), TBK1, TRPV1, BAD, NMDA receptor, TrkC, c-Jun, NSGPeroxidase, BNaC2 (ASIC1a), TBC1D17, JNK(MAPK8-10)",
1095,Apoptosis and survival_Phosphorylation and acetylation in TNF-alpha-induced NF-kB signaling,41,3.204E-01,4.864E-01,3.204E-01,4.864E-01,9,"p38alpha (MAPK14), TRAF2, ERK1/2, TRADD, NFKBIA, IP3 receptor, PI3K reg class IA (p85), IKK-beta, MSK1",3.239E-01,4.941E-01,11,"ERK1/2, PKC-zeta, TRADD, IP3 receptor, PI3K reg class IA (p85), IKK-alpha, MSK1, PKC-delta, TRAF2, NFKBIA, IKK-beta",
1096,Regulation of beta-adrenergic receptors signaling in pancreatic cancer,41,3.204E-01,4.864E-01,3.204E-01,4.864E-01,9,"G-protein alpha-i family, ERK1/2, PRKAR2A, PKA-reg type II (cAMP-dependent), PKA-reg (cAMP-dependent), G-protein alpha-s, cPLA2, Adenylate cyclase, nAChR alpha-4",4.638E-01,6.309E-01,10,"ERK1/2, PKA-reg (cAMP-dependent), cPLA2, Adenylate cyclase, nAChR alpha-4, nAChR alpha4/beta2, G-protein alpha-i family, PRKAR2A, PKA-reg type II (cAMP-dependent), G-protein alpha-s",
1097,Beta-catenin-dependent transcription regulation in colorectal cancer,36,3.235E-01,4.877E-01,3.235E-01,4.877E-01,8,"AKT1, NRCAM, YAP1 (YAp65), ID2, MTS1 (S100A4), NUR77, Mucin 2, Cyclin D1",5.974E-01,7.449E-01,8,"AKT1, Lef-1, c-Jun/c-Fos, NRCAM, ID2, NUR77, Mucin 2, Cyclin D1",
1098,Urea cycle,36,3.235E-01,4.877E-01,3.235E-01,4.877E-01,8,"CPSM, Aquaporin 3, ARLY, Aquaporin 7, SLC25A2, Aquaporin 10, ARG1, AQP6",5.974E-01,7.449E-01,8,"CPSM, ARLY, Aquaporin 10, ARG1, AQP6, Aquaporin 3, Aquaporin 7, SLC25A2",
1099,Development_Thrombospondin 1 signaling,36,3.235E-01,4.877E-01,3.235E-01,4.877E-01,8,"Protein kinase G1, G-protein alpha-i family, PKA-reg (cAMP-dependent), CD36, Adenylate cyclase, eNOS, Guanylate Cyclase 1, soluble, p38 MAPK",5.974E-01,7.449E-01,8,"Protein kinase G1, PKA-reg (cAMP-dependent), Adenylate cyclase, Guanylate Cyclase 1, soluble, G-protein alpha-i family, CD36, eNOS, p38 MAPK",
1100,Fibroblast/ myofibroblast proliferation in asthmatic airways,41,3.239E-01,4.941E-01,6.334E-01,7.789E-01,7,"ERK1/2, BDKRB1, Tryptase, FGFR1, PKC, JNK(MAPK8-10), IGF-1",3.239E-01,4.941E-01,11,"ERK1/2, BDKRB1, FGFR1, Thrombin, IL-13, c-Jun, Tryptase, PKC, JNK(MAPK8-10), IGF-1, des-Arg10-kallidin",
1101,Down-regulation of mast cell functions through ITIM-containing inhibitory receptors in asthma,37,3.276E-01,4.972E-01,5.174E-01,6.739E-01,7,"E-cadherin, IRp60, K-RAS, Fc epsilon RI gamma, ERK1/2, MGF, SHP-1",3.276E-01,4.972E-01,10,"IRp60, Fc epsilon RI gamma, ERK1/2, OX-2 receptor 1, SHP-1, SHIP, E-cadherin, K-RAS, MGF, SHP-2",
1102,A shift in alveolar macrophage phenotype in COPD,37,3.276E-01,4.972E-01,3.530E-01,5.181E-01,8,"MHC class II, GPX2, ITGAM, ITGAL, ITGAX, ARG1, AKT(PKB), NQO1",3.276E-01,4.972E-01,10,"MHC class II, GPX2, FCGR3A, ITGAL, ITGAX, ARG1, CD209, AKT(PKB), ITGAM, NQO1",
1103,Nicotine / nAChR alpha-3/nAChR beta-2 signaling in NSCLC,26,3.283E-01,4.917E-01,3.283E-01,4.917E-01,6,"AKT1, E2F1, CDC18L (CDC6), AKT(PKB), Beta-arrestin1, PDK (PDPK1)",3.795E-01,5.508E-01,7,"AKT1, AKT(PKB), PDK (PDPK1), E2F1, nAChR beta-2, CDC18L (CDC6), Beta-arrestin1",
1104,Inflammatory response in ischemia-reperfusion injury during myocardial infarction,21,3.291E-01,4.917E-01,3.291E-01,4.917E-01,5,"C5aR, CCR2, IL8RA, HSP60, HSP70",5.403E-01,7.024E-01,5,"CCR2, HSP60, HSP70, C5aR, IL8RA",
1105,Cell cycle_Cell cycle (generic schema),21,3.291E-01,4.917E-01,3.291E-01,4.917E-01,5,"E2F5, E2F1, Cyclin D, Rb protein, p130",5.403E-01,7.024E-01,5,"E2F5, Rb protein, p130, E2F1, Cyclin D",
1106,Cytoskeleton remodeling_PDGF signaling via calcium and Rho GTPases,83,3.305E-01,4.933E-01,3.305E-01,4.933E-01,17,"SLC31A1, AKT1, PDGF-B, CACNA1C, EBP50, PAK1, WASF subunit, WASF3 (WAVE3), IP3 receptor, E3KARP (NHERF2), PI3K reg class IA (p85), Calmodulin, PKC, VAV-2, FAK1, Cortactin, ATOX1",4.307E-01,5.989E-01,20,"SLC31A1, AKT1, PDGF-B, Rac1, IP3 receptor, PI3K reg class IA (p85), VAV-2, Cortactin, CACNA1C, EBP50, PAK1, WASF subunit, WASF3 (WAVE3), Paxillin, E3KARP (NHERF2), Calmodulin, PKC, N-WASP, FAK1, ATOX1",
1107,Role of nicotine in pathogenesis of SCLC,57,3.333E-01,4.970E-01,3.333E-01,4.970E-01,12,"ERK1/2, CACNA1C, c-Raf-1, IP3 receptor, GRP-R, Bcl-2, FAK1, MEK1/2, AKT(PKB), HTR1A, SDF-1, IL8RB",4.256E-01,5.941E-01,14,"ERK1/2, EGR1, PLC-beta1, IP3 receptor, GRP-R, AKT(PKB), c-Myc, SDF-1, IL8RB, CACNA1C, CXCR3, Bcl-2, FAK1, N-type Ca(II) channel alpha1B",
1108,Stem cells_Notch signaling in medulloblastoma stem cells,29,3.347E-01,5.059E-01,4.336E-01,5.976E-01,6,"p21, DLL1, HEY2, Cyclin D1, TLE1, p27KIP1",3.347E-01,5.059E-01,8,"p21, DLL1, TLE1, p27KIP1, HEY1, DLL4, HEY2, Cyclin D1",
1109,A proinflammatory phenotype of senescent alveolar epithelial cells in COPD,25,3.379E-01,5.066E-01,6.893E-01,8.252E-01,4,"p21, I-kB, Sirtuin1, MSK1",3.379E-01,5.066E-01,7,"IKK (cat), p21, I-kB, IKK-alpha, MSK1, Sirtuin1, FOXO3A",
1110,Activation of pro-oncogenic TGF-beta potential in gastric cancer,25,3.379E-01,5.066E-01,6.893E-01,8.252E-01,4,"TGF-beta 3, HSP27, FAK1, SP1",3.379E-01,5.066E-01,7,"PKC-delta, Paxillin, Cofilin, non-muscle, TGF-beta 3, HSP27, FAK1, SP1",
1111,Influence of bone marrow cell environment on progression of multiple myeloma,52,3.380E-01,5.025E-01,3.380E-01,5.025E-01,11,"Syndecan-1, VEGFR-1, SHH, MGF, IP3 receptor, PI3K reg class IA, IGF-1 receptor, CD23, IGF-1, SDF-1, IL-6 receptor",4.044E-01,5.725E-01,13,"IL-3, IP3 receptor, PI3K reg class IA, IGF-1 receptor, CD23, SDF-1, Syndecan-1, VEGFR-1, SHH, MGF, IGF-1, PI3K reg class IB (p101), IL-6 receptor",
1112,Immune response_Lysophosphatidic acid signaling via NF-kB,52,3.380E-01,5.025E-01,3.380E-01,5.025E-01,11,"PKD, ERK1/2, p90Rsk, NFKBIA, PKC, PEA15, IKK-beta, Bcl-XL, Angiogenin, JNK(MAPK8-10), p38 MAPK",4.044E-01,5.725E-01,13,"ERK1/2, IKK (cat), Bcl-XL, PKD, PKC-delta, MKK7 (MAP2K7), NFKBIA, Caspase-7, PKC, IKK-beta, Angiogenin, JNK(MAPK8-10), p38 MAPK",
1113,Immune response_CCL2 signaling,54,3.405E-01,5.087E-01,5.263E-01,6.814E-01,10,"c-Fos, G-protein alpha-i family, CCR2, ERK1/2, Claudin-5, PI3K reg class IA (p85), AP-1, Occludin, WASP, Cadherin 12",3.405E-01,5.087E-01,14,"c-Fos, CCR2, ERK1/2, PKC-zeta, c-Jun/c-Fos, Claudin-5, Rac1, PI3K reg class IA (p85), WASP, G-protein alpha-i family, c-Jun, AP-1, Occludin, Cadherin 12",
1114,Nicotine signaling (general schema),21,3.406E-01,5.087E-01,5.450E-01,6.995E-01,4,"Dopamine D1A receptor, GABA-A receptor, CNR1, nAChR alpha-4",3.406E-01,5.087E-01,6,"NMDA receptor, GABA-A receptor, CNR1, nAChR, nAChR alpha-4, Dopamine D1A receptor",
1115,HCV-dependent regulation of RNA polymerases leading to HCC,21,3.406E-01,5.087E-01,7.614E-01,8.816E-01,3,"RRN3, TAF1C, HSP70",3.406E-01,5.087E-01,6,"TFIIIB, TFIID, TAF1C, HSP70, TBP, RRN3",
1116,Transition of Smoldering multiple myeloma to active multiple myeloma (schema),17,3.423E-01,5.103E-01,3.726E-01,5.373E-01,4,"K-RAS, Rb protein, IL-1RI, IL-6 receptor",3.423E-01,5.103E-01,5,"Rb protein, IL-1RI, c-Myc, K-RAS, IL-6 receptor",
1117,Immune response_PGE2 in immune and neuroendocrine system interactions,47,3.429E-01,5.072E-01,3.429E-01,5.072E-01,10,"p38alpha (MAPK14), G-protein alpha-i family, PGE2R3, COX-1 (PTGS1), PLA2(hGIIA), GABA-A receptor, cPLA2, IL-1RI, PGES2, p38 MAPK",8.709E-01,9.674E-01,8,"GABA-A receptor, cPLA2, IL-1RI, PGES2, G-protein alpha-i family, PGE2R3, PLA2(hGIIA), p38 MAPK",
1118,TGF-beta signaling via SMADs in breast cancer,47,3.429E-01,5.072E-01,3.429E-01,5.072E-01,10,"E-cadherin, JunB, ANGPTL4, CITED2, CUX1, JAM1, MTS1 (S100A4), TGF-beta 3, TBX2, MDM2",6.540E-01,7.968E-01,10,"ITGB5, CUX1, JAM1, MDM2, E-cadherin, JunB, ANGPTL4, CITED2, TGF-beta 3, TBX2",
1119,Regulation of lipid metabolism_PPAR regulation of lipid metabolism,47,3.429E-01,5.072E-01,3.429E-01,5.072E-01,10,"CAC, RXRA, ACOX3, UCP2, CPT II, CPT-1B, CD36, CPT-1A, Fatty acid-binding protein, ACAA1",5.172E-01,6.847E-01,11,"CAC, UCP2, CPT-1A, Fatty acid-binding protein, ACSL1, RXRA, ACOX3, CPT II, CPT-1B, CD36, ACAA1",
1120,Neurophysiological process_PGE2-induced pain processing,47,3.429E-01,5.072E-01,3.429E-01,5.072E-01,10,"PKA-reg (cAMP-dependent), PGE2R3, TRPV1, COX-1 (PTGS1), GLRA3, G-protein alpha-s, cPLA2, Adenylate cyclase, PGES2, GLRA",5.172E-01,6.847E-01,11,"PKA-reg (cAMP-dependent), TRPV1, NMDA receptor, cPLA2, SCN10A, Adenylate cyclase, PGES2, GLRA, PGE2R3, GLRA3, G-protein alpha-s",
1121,Apoptosis and survival_Apoptotic TNF-family pathways,42,3.479E-01,5.126E-01,3.479E-01,5.126E-01,9,"TRAF2, TRADD, FADD, RAIDD, Bcl-2, SIVA1, CD27(TNFRSF7), Bcl-XL, Smac/Diablo",3.558E-01,5.261E-01,11,"TRADD, FADD, CD27(TNFRSF7), Bcl-XL, FasL(TNFSF6), TRAF2, Caspase-7, RAIDD, Bcl-2, SIVA1, Smac/Diablo",
1122,Inhibition of GTPase prenylation by statins in asthma and COPD,42,3.479E-01,5.126E-01,3.479E-01,5.126E-01,9,"ERK1/2, RhoB, CD36, I-kB, PTEN, Mucin 5AC, AKT(PKB), p27KIP1, p38 MAPK",3.558E-01,5.261E-01,11,"ERK1/2, Rac1, I-kB, IKK-alpha, AKT(PKB), p27KIP1, RhoB, CD36, PTEN, Mucin 5AC, p38 MAPK",
1123,Apoptosis and survival_Anti-apoptotic TNFs/NF-kB/Bcl-2 pathway,42,3.479E-01,5.126E-01,3.479E-01,5.126E-01,9,"TRAF2, TRADD, TRAF5, I-kB, IKK-beta, Bcl-2, Bcl-XL, CD40(TNFRSF5), CD40L(TNFSF5)",3.558E-01,5.261E-01,11,"PKC-zeta, IKK (cat), TRADD, I-kB, IKK-alpha, Bcl-XL, TRAF2, TRAF5, IKK-beta, Bcl-2, CD40(TNFRSF5)",
1124,Dual function of Treg cells in cancer development,46,3.505E-01,5.203E-01,4.597E-01,6.229E-01,9,"STAT2, ROR-alpha, ROR-gamma, Granzyme B, STAT3, FOXP3, WNT, ENP1, IL-6 receptor",3.505E-01,5.203E-01,12,"Granzyme B, Perforin, FOXP3, FasL(TNFSF6), ICOS, ENP1, IL-2R alpha chain, STAT2, ROR-gamma, TIM-3, WNT, IL-6 receptor",
1125,O-glycan biosynthesis,63,3.511E-01,5.163E-01,3.511E-01,5.163E-01,13,"SIAT4A, GALNT5, GALNTL3, GALNTL4, GALNT7, B4GT3, GALNTL1, GALNT4, SIA7A, GALNT6, GALNT10, B3Gn-T6, B3GT5",8.037E-01,9.202E-01,12,"SIAT4A, GALNTL4, GALNT11, B4GT3, GALNT10, B3Gn-T6, GALNTL3, GALNT7, GALNTL1, GALNT4, GALNT6, B3GT5",
1126,Immune response_IL-7 signaling in T lymphocytes,37,3.530E-01,5.181E-01,3.530E-01,5.181E-01,8,"RAG2, STAT3, GLUT1, Bcl-2, TCR gamma locus, STAT6, AKT(PKB), PDK (PDPK1)",6.310E-01,7.777E-01,8,"IRS-1, TCR gamma locus, AKT(PKB), PDK (PDPK1), GLUT1, Bcl-2, FOXO3A, STAT6",
1127,IL-1 signaling in melanoma,42,3.558E-01,5.261E-01,6.598E-01,8.008E-01,7,"MMP-1, p21, PM17, I-kB, AP-1, IL-1RI, JNK(MAPK8-10)",3.558E-01,5.261E-01,11,"c-Jun/c-Fos, IKK (cat), p21, I-kB, MyD88, IL-1RI, MMP-1, c-Jun, PM17, AP-1, JNK(MAPK8-10)",
1128,Hyaluronic acid/ CD44 signaling in cancer,58,3.568E-01,5.226E-01,3.568E-01,5.226E-01,12,"AKT1, GAB1, ESR1 (nuclear), PDCD4, SLC9A1, PAK1, DDX5, NANOG, STAT3, Calmodulin, VAV-2, IP3R1",5.789E-01,7.334E-01,13,"AKT1, GAB1, ESR1 (nuclear), LARG, SLC9A1, Rac1, VAV-2, PDCD4, PAK1, DDX5, NANOG, Calmodulin, IP3R1",
1129,Androstenedione and testosterone biosynthesis and metabolism p.2,32,3.582E-01,5.226E-01,3.582E-01,5.226E-01,7,"UGT2A1, AK1D1, UGT2B15, UGT1A8, UGT2B28, AKR1C4, UGT2B17",9.542E-01,1.000E+00,4,"UGT2A1, UGT2B15, UGT2B28, UGT2B17",
1130,Role of Endothelin-1 in inflammation and vasoconstriction in Sickle cell disease,38,3.613E-01,5.327E-01,3.828E-01,5.468E-01,8,"p38alpha (MAPK14), c-Fos, ERK1/2, VEGFR-1, PI3K reg class IA (p85), AP-1, CCR5, AKT(PKB)",3.613E-01,5.327E-01,10,"c-Fos, ERK1/2, c-Jun/c-Fos, PI3K reg class IA (p85), p38beta (MAPK11), CCR5, AKT(PKB), c-Jun, VEGFR-1, AP-1",
1131,Glomerular filtration and renal reabsorption of bile acids / Rodent version,27,3.633E-01,5.285E-01,3.633E-01,5.285E-01,6,"ABCC11, SLC22A8, OATP-A, OATP-C, SLC10A1, ABCC2",6.029E-01,7.480E-01,6,"SLC10A1, ABCC11, SLC22A8, OATP-A, OATP-C, ABCC2",
1132,Histamine metabolism,27,3.633E-01,5.285E-01,3.633E-01,5.285E-01,6,"ALD9A1, HDC, AOC2, ALDH2, AOC3, ABP1",4.212E-01,5.885E-01,7,"HNMT, ALD9A1, AOC2, ALDH2, AOC3, ABP1, MAOB",
1133,Cannabinoid receptor signaling in nicotine addiction,34,3.671E-01,5.401E-01,4.226E-01,5.868E-01,7,"DGL-alpha, SNAP-25, G-protein alpha-i family, CNR1, Monoglyceride lipase, FAAH, nAChR alpha-4",3.671E-01,5.401E-01,9,"DGL-alpha, NMDA receptor, CNR1, Monoglyceride lipase, FAAH, nAChR alpha-4, nAChR alpha4/beta2, G-protein alpha-i family, N-type Ca(II) channel alpha1B",
1134,Immune response_Oncostatin M signaling via JAK-Stat,22,3.682E-01,5.321E-01,3.682E-01,5.321E-01,5,"E-cadherin, gp130, MMP-1, STAT3, Cyclin D1",7.733E-01,8.955E-01,4,"gp130, E-cadherin, MMP-1, Cyclin D1",
1135,Development_Dopamine-induced expression of CNTF in adult neurogenesis,22,3.682E-01,5.321E-01,3.682E-01,5.321E-01,5,"gp130, G-protein alpha-i family, Adenylate cyclase type I, STAT3, Adenylate cyclase type V",5.857E-01,7.364E-01,5,"gp130, Adenylate cyclase type V, CNTFR alpha, G-protein alpha-i family, Adenylate cyclase type I",
1136,Cell cycle_Role of 14-3-3 proteins in cell cycle regulation,22,3.682E-01,5.321E-01,3.682E-01,5.321E-01,5,"Chk2, MAPKAPK2, Wee1, AKT(PKB), p38 MAPK",5.857E-01,7.364E-01,5,"MAPKAPK2, Wee1, AKT(PKB), 14-3-3 beta/alpha, p38 MAPK",
1137,Blood coagulation_Platelet microparticle generation,72,3.712E-01,5.447E-01,4.335E-01,5.976E-01,14,"cPKC (conventional), SLC9A1, Glycoprotein VI, Alpha-2A adrenergic receptor, MyHC, IP3 receptor, GP-IB alpha, Calmodulin, PKC, PLC-beta, cPLA2, von Willebrand factor, PAR4, GP-V",3.712E-01,5.447E-01,18,"SLC9A1, Glycoprotein VI, IP3 receptor, Thrombin, PLC-beta, cPLA2, von Willebrand factor, PAR4, cPKC (conventional), PTP-1B, Alpha-2A adrenergic receptor, MyHC, GP-IX, GP-IB alpha, Calmodulin, PKC, G-protein alpha-q, GP-V",
1138,Apoptosis and survival_Granzyme A signaling,30,3.731E-01,5.453E-01,6.564E-01,8.007E-01,5,"NDUFS3, MUNC13-4, CD63, NDPK A, Synaptotagmin VII",3.731E-01,5.453E-01,8,"NDUFS3, PHAP1 (pp32), TREX1, MUNC13-4, Perforin, Synaptotagmin VII, CD63, NDPK A",
1139,Neurophysiological process_nNOS signaling in neuronal synapses,30,3.731E-01,5.453E-01,6.564E-01,8.007E-01,5,"Calcineurin A (catalytic), CAPON, Calmodulin, NRAMP2, Dexras1",3.731E-01,5.453E-01,8,"Calcineurin A (catalytic), GOCAP1, NMDA receptor, CAPON, NR2, Calmodulin, NRAMP2, Dexras1",
1140,Transcription_Mechanism of repression of the transcription of Retinoid-target genes in the absence of lignad,12,3.751E-01,5.398E-01,3.751E-01,5.398E-01,3,"RXRA, RAR-alpha/RXR-alpha, RARalpha",5.384E-01,7.024E-01,3,"RARalpha, RXRA, RAR-alpha/RXR-alpha",
1141,Regulation of proinflammatory cytokine production by Th2 cells in asthma,43,3.757E-01,5.398E-01,3.757E-01,5.398E-01,9,"p38alpha (MAPK14), GATA-3, CD80, MHC class II, JunB, IL-19, CD3, STAT6, IL-4",3.881E-01,5.574E-01,11,"MHC class II, Importin (karyopherin)-alpha, IL-19, MyD88, IL-13, IL-4, GATA-3, IL-25 (IL-17E), JunB, STAT6, TCR alpha/beta",
1142,Muscle contraction_Delta-type opioid receptor in smooth muscle contraction,26,3.795E-01,5.508E-01,5.216E-01,6.776E-01,5,"G-protein alpha-i family, Myosin II, ILK, IP3 receptor, MRLC",3.795E-01,5.508E-01,7,"IP3 receptor, Delta-type opioid receptor, G-protein alpha-i family, Myosin II, ILK, MRLC, PI3K reg class IB (p101)",
1143,CD8+ Tc1 cells in allergic contact dermatitis,26,3.795E-01,5.508E-01,5.216E-01,6.776E-01,5,"E-cadherin, CD80, MHC class II, Granzyme B, IL-1RI",3.795E-01,5.508E-01,7,"MHC class II, Granzyme B, Perforin, IL-1RI, FasL(TNFSF6), E-cadherin, TCR alpha/beta",
1144,Immune response_Role of DPP4 (CD26) in immune regulation,47,3.812E-01,5.523E-01,4.873E-01,6.432E-01,9,"MHC class II, Granzyme B, TOLLIP, CUX1, IL-12 alpha, Ubiquitin, I-kB, CD3, SDF-1",3.812E-01,5.523E-01,12,"MHC class II, Granzyme B, IKK (cat), CUX1, IL-12 alpha, Ubiquitin, I-kB, ZAP70, FasL(TNFSF6), SDF-1, TOLLIP, TCR alpha/beta",
1145,Sphingolipid metabolism,107,3.820E-01,5.468E-01,3.820E-01,5.468E-01,21,"NEU3, ASAH, ACER1, UGCG, GM3 synthase, LASS2, SMPD3, LASS4, SGPP1, DES1, DEGS2, LASS3, A4GT, SPHK2, SPT2, Asah3l, APHC, Neutral sphingomyelinase, LASS6, SMS2, ENPP7",6.631E-01,8.060E-01,23,"NEU3, ASAH, GM3 synthase, LASS2, SMPD3, DES1, ASAH2, DEGS2, A4GT, SPT2, SPP lyase, Neutral sphingomyelinase, LASS6, SMS2, ACER1, UGCG, LASS4, SGPP1, LASS3, SPHK2, Asah3l, APHC, LASS5",
1146,Development_Regulation of epithelial-to-mesenchymal transition (EMT),64,3.835E-01,5.550E-01,6.289E-01,7.756E-01,11,"E-cadherin, EGF, PDGF-B, E2A, FGFR1, TGF-beta 3, WNT, Bcl-2, IL-1RI, Occludin, SP1",3.835E-01,5.550E-01,16,"EGF, PDGF-B, E2A, Lef-1, FGFR1, IL-1RI, HEY1, E-cadherin, c-Jun, DLL4, TGF-beta 3, WNT, Bcl-2, Occludin, SP1, Frizzled",
1147,Impaired inhibitory action of lipoxins and Resolvin E1 on neutrophil functions in CF,43,3.881E-01,5.574E-01,6.851E-01,8.252E-01,7,"c-Fos, G-protein alpha-i family, ERK1/2, CFTR, LTBR1, NFKBIA, I-kB",3.881E-01,5.574E-01,11,"c-Fos, ERK1/2, PKC-zeta, c-Jun/c-Fos, I-kB, SOD1, IKK-alpha, G-protein alpha-i family, LTBR1, NFKBIA, PI3K reg class IB (p101)",
1148,Cigarette smoke-induced oxidative stress and apoptosis in airway epithelial cells,60,3.901E-01,5.597E-01,8.749E-01,9.611E-01,8,"PRDX3, p21, Cytochrome c, PRDX5, Glutaredoxin, Bcl-2, JNK(MAPK8-10), p38 MAPK",3.901E-01,5.597E-01,15,"PRDX3, c-Jun/c-Fos, p21, Cytochrome c, PRDX5, SOD1, FasL(TNFSF6), Thioredoxin, c-Jun, MKK7 (MAP2K7), PRDX1, Glutaredoxin, Bcl-2, JNK(MAPK8-10), p38 MAPK",
1149,Transport_RAN regulation pathway,18,3.931E-01,5.629E-01,8.642E-01,9.528E-01,2,"E2I, Ran",3.931E-01,5.629E-01,5,"Importin (karyopherin)-alpha, NUP62, E2I, RANBP3, Ran",
1150,Development_PEDF signaling,49,3.955E-01,5.638E-01,3.955E-01,5.638E-01,10,"JunB, ERK1/2, PEDF-R (iPLA2-zeta), NFKBIA, PI3K reg class IA, JunD, Bcl-2, Bcl-XL, AKT(PKB), PDK (PDPK1)",4.433E-01,6.116E-01,12,"ERK1/2, IKK (cat), PEDF-R (iPLA2-zeta), PI3K reg class IA, JunD, IKK-alpha, Bcl-XL, AKT(PKB), PDK (PDPK1), JunB, NFKBIA, Bcl-2",
1151,Fructose metabolism,81,3.962E-01,5.638E-01,3.962E-01,5.638E-01,16,"PFKM, DHSO, HXK1, SUIS, G6PT, PFKL, IGRP, PMM2, F16P, F261, AMYP, ALDOA, G6PC3, HXK2, KHK, AMYC",4.868E-01,6.557E-01,19,"DHSO, PFKL, GALM, AMYS, F16P, F261, HXK2, PFKM, HXK3, HXK1, SUIS, GPI, PMM2, MANA, AMYP, ALDOA, G6PC3, KHK, AMYC",
1152,TNF-alpha and IL-1 beta-mediated regulation of contraction and secretion of inflammatory factors in normal and asthmatic airway smooth muscle,65,3.967E-01,5.638E-01,3.967E-01,5.638E-01,13,"p38alpha (MAPK14), c-Fos, ERK1/2, NFKBIA, PI3K reg class IA (p85), Calmodulin, PLC-beta, IL-1RI, JNK(MAPK8-10), JNK3(MAPK10), AKT(PKB), PLA2, p38 MAPK",5.269E-01,6.910E-01,15,"c-Fos, ERK1/2, IKK (cat), PI3K reg class IA (p85), PLC-beta, MyD88, IL-1RI, JNK3(MAPK10), AKT(PKB), c-Jun, NFKBIA, Calmodulin, JNK(MAPK8-10), PLA2, p38 MAPK",
1153,Dysregulation of germinal center response in SLE,65,3.967E-01,5.638E-01,3.967E-01,5.638E-01,13,"ESR1 (nuclear), HOXC4, CXCR5, AID, RGS16, STAT3, PI3K reg class IA (p85), IFN-alpha, Fc gamma RII beta, CD40(TNFRSF5), STAT6, IL-4, CD40L(TNFSF5)",7.494E-01,8.780E-01,13,"ESR1 (nuclear), PI3K reg class IA (p85), IFN-alpha, FasL(TNFSF6), IL-4, HOXC4, CD79 complex, AID, RGS16, CD79B, Fc gamma RII beta, CD40(TNFRSF5), STAT6",
1154,Muscle contraction_ACM regulation of smooth muscle contraction,56,3.970E-01,5.669E-01,4.380E-01,6.026E-01,11,"TRPC4, CACNA1C, PAK1, Ryanodine receptor 3, IP3 receptor, G-protein alpha-13, Calmodulin, PKC, MRLC, PDK (PDPK1), MLCK",3.970E-01,5.669E-01,14,"PLC-beta1, Rac1, IP3 receptor, G-protein alpha-13, PDK (PDPK1), MLCK, BETA-PIX, ACM2, CACNA1C, PAK1, Calmodulin, PKC, MRLC, G-protein alpha-q",
1155,Development_YAP/TAZ-mediated co-regulation of transcription,56,3.970E-01,5.669E-01,4.380E-01,6.026E-01,11,"GATA-3, TEF-5, NANOG, YAP1 (YAp65), ID2, TEF-3, SOX2, Bcl-XL, PAX3, Cyclin D1, PUMA",3.970E-01,5.669E-01,14,"TEF-5, TBX5, Lef-1, ID2, Bcl-XL, PAX3, c-Myc, PUMA, GATA-3, NANOG, TEF-3, SOX2, SMAD1, Cyclin D1",
1156,Rho-dependent regulation of normal and asthmatic smooth muscle contraction,28,3.985E-01,5.638E-01,3.985E-01,5.638E-01,6,"G-protein alpha-i family, Myosin II, G-protein alpha-q/11, PKC, PLC-beta, MRLC",4.626E-01,6.309E-01,7,"G-protein alpha-q/11, PLC-beta, ACM2, G-protein alpha-i family, Myosin II, PKC, MRLC",
1157,Neurophysiological process_Role of CDK5 in presynaptic signaling,28,3.985E-01,5.638E-01,3.985E-01,5.638E-01,6,"SNAP-25, DDC, Synaptotagmin I, TY3H, Clathrin, Amphiphysin I",4.626E-01,6.309E-01,7,"Syntaxin 1A, DDC, Synaptotagmin I, TY3H, Amphiphysin I, MUNC18, Clathrin",
1158,Development_Role of CNTF and LIF in regulation of oligodendrocyte development,28,3.985E-01,5.638E-01,3.985E-01,5.638E-01,6,"gp130, NFKBIA, STAT3, PI3K reg class IA, AKT(PKB), PDK (PDPK1)",4.626E-01,6.309E-01,7,"gp130, 14-3-3, PI3K reg class IA, IKK-alpha, AKT(PKB), PDK (PDPK1), NFKBIA",
1159,Platelet activation during ADAM-TS13-deficient thrombotic microangiopathy development,28,3.985E-01,5.638E-01,3.985E-01,5.638E-01,6,"CD36, PERM, ADAM-TS13, JAM3, GP-IB alpha, von Willebrand factor",4.626E-01,6.309E-01,7,"ADAM-TS13, JAM3, von Willebrand factor, CALDAG-GEFI, CD36, PERM, GP-IB alpha",
1160,Role of Th17 cells in asthma,28,3.985E-01,5.638E-01,3.985E-01,5.638E-01,6,"ERK1/2, Myosin II, MRLC, p38 MAPK, E-selectin, IL8RB",6.411E-01,7.870E-01,6,"ERK1/2, E-selectin, IL8RB, Myosin II, MRLC, p38 MAPK",
1161,Asthma-specific pathways of airway smooth muscle cell proliferation,14,4.003E-01,5.700E-01,7.511E-01,8.753E-01,2,"Calmodulin, C/EBPalpha",4.003E-01,5.700E-01,4,"eIF4E, TFAM, Calmodulin, C/EBPalpha",
1162,Role of osteoblasts in bone lesions formation in multiple myeloma,35,4.033E-01,5.725E-01,9.657E-01,1.000E+00,3,"SP7, WNT, CCR5",4.033E-01,5.725E-01,9,"SP7, WNT3A, IL-3, LRP5, CCR5, FasL(TNFSF6), WNT, SMAD1, Frizzled",
1163,Role of CD8+ Tc1 cells in COPD,44,4.037E-01,5.707E-01,4.037E-01,5.707E-01,9,"MIG, CXCR6, Granzyme B, STAT3, CX3CR1, Bcl-2, Bcl-XL, CCR5, Leptin",4.206E-01,5.885E-01,11,"CXCR6, Granzyme B, Perforin, Bcl-XL, CCR5, c-Jun, CXCR3, CX3CR1, Bcl-2, Leptin, TCR alpha/beta",
1164,Nicotine signaling in cholinergic neurons,52,4.044E-01,5.725E-01,4.746E-01,6.331E-01,10,"Protein kinase G1, AKT1, GAB1, SNAP-25, Calmodulin, PI3K reg class IA, CHT1, nAChR alpha-4, Tau (MAPT), Guanylate Cyclase 1, soluble",4.044E-01,5.725E-01,13,"TrkA, Protein kinase G1, AKT1, GAB1, PI3K reg class IA, nAChR, CHT1, nAChR alpha-4, Tau (MAPT), Guanylate Cyclase 1, soluble, ACM2, Calmodulin, N-type Ca(II) channel alpha1B",
1165,Role of stellate cells in progression of pancreatic cancer,60,4.045E-01,5.712E-01,4.045E-01,5.712E-01,12,"MEK1(MAP2K1), PDGF-B, GRB2, c-Fos, H-Ras, ERK1/2, c-Raf-1, NFKBIA, PI3K reg class IA (p85), FAK1, AKT(PKB), PDK (PDPK1)",7.441E-01,8.733E-01,12,"PDGF-B, GRB2, c-Fos, H-Ras, ERK1/2, PI3K reg class IA (p85), IKK-alpha, AKT(PKB), PDK (PDPK1), c-Jun, NFKBIA, FAK1",
1166,Role of alpha-V/ beta-6 integrin in colorectal cancer,23,4.074E-01,5.742E-01,4.074E-01,5.742E-01,5,"ERK1/2, PKC, LTBP1, Bcl-2, MEK1/2",4.316E-01,5.991E-01,6,"ERK1/2, Plasminogen, Plasmin, PKC, LTBP1, Bcl-2",
1167,Sitagliptin in treatment of type 2 diabetes and metabolic syndrome X,10,4.075E-01,5.759E-01,5.654E-01,7.195E-01,2,"Insulin processed, Insulin receptor",4.075E-01,5.759E-01,3,"Insulin processed, Insulin receptor, GCGR",
1168,Autocrine production of eosinophil pro-survival cytokines in asthma,31,4.118E-01,5.797E-01,6.861E-01,8.252E-01,5,"ERK1/2, YB-1, CD40(TNFRSF5), IL-4, p38 MAPK",4.118E-01,5.797E-01,8,"ERK1/2, Fc alpha receptor, IL-3, hnRNP C, IL-13, IL-4, CD40(TNFRSF5), p38 MAPK",
1169,Atorvastatin in treatment of type 2 diabetes and metabolic syndrome X,39,4.127E-01,5.790E-01,4.127E-01,5.790E-01,8,"MEK1(MAP2K1), GSHR, CD36, OATP-C, SP1, NOX1, ERK1 (MAPK3), PON1",5.457E-01,7.051E-01,9,"GPX3, Rac1, NOX1, ERK1 (MAPK3), GSHR, CD36, OATP-C, APOC3, SP1",
1170,Immune response_Differentiation and clonal expansion of CD8+ T cells,39,4.127E-01,5.790E-01,4.127E-01,5.790E-01,8,"CD80, MHC class II, Granzyme B, STAT3, IFN-alpha, CD27(TNFRSF7), CD40(TNFRSF5), CD40L(TNFSF5)",5.457E-01,7.051E-01,9,"MHC class II, NF-AT1(NFATC2), Granzyme B, Perforin, IFN-alpha, CD27(TNFRSF7), FasL(TNFSF6), CD40(TNFRSF5), TCR alpha/beta",
1171,Cooperative action of IFN-gamma and TNF-alpha on astrocytes in multiple sclerosis,39,4.127E-01,5.790E-01,4.127E-01,5.790E-01,8,"CD80, MHC class II, PKA-reg (cAMP-dependent), NFKBIA, I-kB, G-protein alpha-s, Adenylate cyclase, IKK-beta",6.933E-01,8.346E-01,8,"MHC class II, PKA-reg (cAMP-dependent), IKK (cat), I-kB, Adenylate cyclase, NFKBIA, G-protein alpha-s, IKK-beta",
1172,Beta-adrenergic-dependent CFTR expression,18,4.173E-01,5.848E-01,4.173E-01,5.848E-01,4,"CFTR, PKA-reg (cAMP-dependent), G-protein alpha-s, Adenylate cyclase",8.136E-01,9.292E-01,3,"PKA-reg (cAMP-dependent), Adenylate cyclase, G-protein alpha-s",
1173,Immune response_Reactive oxygen species (ROS) in IL-4 signaling,66,4.197E-01,5.868E-01,4.197E-01,5.868E-01,13,"cPKC (conventional), Protein kinase G1, PDE3B, PKA-reg (cAMP-dependent), p67-phox, Calmodulin, PKC, eNOS, STAT6, IL-4, p40-phox, NOX1, NOXA1",5.535E-01,7.133E-01,15,"Protein kinase G1, PDE3B, PKA-reg (cAMP-dependent), Rac1, NOXO1, IL-4, NOX1, NOXA1, cPKC (conventional), PTP-1B, Calmodulin, PKC, eNOS, STAT6, p40-phox",
1174,Immune response_T regulatory cell-mediated modulation of antigen-presenting cell functions,66,4.197E-01,5.868E-01,4.197E-01,5.868E-01,13,"IRF8, KMO, CD80, MHC class II, PKA-reg (cAMP-dependent), DAB2, Arylformamidase, IL-12 alpha, FOXP3, Connexin 43, ENP1, Adenosine A2a receptor, LAG3",8.525E-01,9.525E-01,12,"KMO, MHC class II, PKA-reg (cAMP-dependent), DAB2, Arylformamidase, IL-12 alpha, FOXP3, IKK-alpha, ENP1, TCR alpha/beta, Adenosine A2a receptor, LAG3",
1175,Brca1 in ovarian cancer,27,4.212E-01,5.885E-01,5.575E-01,7.107E-01,5,"p21, Ubiquitin, BRIP1, MDM2, AKT(PKB)",4.212E-01,5.885E-01,7,"p21, Ubiquitin, BRIP1, MDM2, AKT(PKB), PARP-1, c-Jun",
1176,Angiogenesis in HCC,50,4.219E-01,5.868E-01,4.219E-01,5.868E-01,10,"Presenilin 1, Presenilin, VEGFR-1, TIE, STAT3, Epo receptor, IGF-1 receptor, PGES2, Leptin, Epo",8.362E-01,9.420E-01,9,"Presenilin 1, IGF-1 receptor, PGES2, Epo, Presenilin, VEGFR-1, Epo receptor, Leptin, Ephrin-B receptors",
1177,Immune response_IFN-gamma in macrophages activation,50,4.219E-01,5.868E-01,4.219E-01,5.868E-01,10,"PU.1, IRF8, MIG, p67-phox, IL-12 alpha, Fc gamma RI, IL-30, DEPTOR, Selenoprotein P, CD40(TNFRSF5)",9.108E-01,9.939E-01,8,"IL-12 alpha, IL-30, DEPTOR, PU.1, C1qc, Fc gamma RI, Selenoprotein P, CD40(TNFRSF5)",
1178,Development_Role of CDK5 in neuronal development,34,4.226E-01,5.868E-01,4.226E-01,5.868E-01,7,"DCTN2, NEFM, PI3K reg class IA (p85), Delta-catenin, Tau (MAPT), AKT(PKB), Tubulin (in microtubules)",6.854E-01,8.263E-01,7,"DCTN2, PI3K reg class IA (p85), Tau (MAPT), DAB1, AKT(PKB), Tubulin (in microtubules), Delta-catenin",
1179,Retinol metabolism,70,4.287E-01,5.978E-01,5.110E-01,6.690E-01,13,"CYP2C8, ALD9A1, Rhodopsin, CYP3A5, RDH14, ADHFE1, UGT1A8, CYP1A2, DGAT1, CYP2A6, CYP3A4, DHRS4, RDH5",4.287E-01,5.978E-01,17,"RDH12, CRABP1, BCDO, Rhodopsin, CYP3A5, RDH14, CYP1A2, CYP2C18, CYP2C19, DHRS4, ALD9A1, CYP2E1, ADHFE1, CYP2B6, LIPP, DGAT1, CYP2A6",
1180,Development_NODAL signaling in early mesendoderm formation,23,4.316E-01,5.991E-01,6.215E-01,7.705E-01,4,"ALK-4, HDAC11, GSC, FAST-1/2",4.316E-01,5.991E-01,6,"ALK-4, HDAC11, GSC, Lefty-1, T brachyury protein, FAST-1/2",
1181,Nicotine signaling in chromaffin cells,45,4.318E-01,5.976E-01,4.318E-01,5.976E-01,9,"Chapsyn-110, SNAP-25, ERK1/2, CACNA1C, PKA-reg (cAMP-dependent), c-Raf-1, TY3H, Calmodulin, MEK1/2",7.275E-01,8.605E-01,9,"Chapsyn-110, ERK1/2, PKA-reg (cAMP-dependent), TY3H, nAChR, DBH, Chromogranin A, CACNA1C, Calmodulin",
1182,Notch signaling in breast cancer,53,4.341E-01,6.021E-01,7.696E-01,8.851E-01,8,"E-cadherin, ESR1 (nuclear), p21, DLL1, MDM2, HEY2, Cyclin D1, TFF1",4.341E-01,6.021E-01,13,"ESR1 (nuclear), p21, DLL1, IKK-alpha, MDM2, c-Myc, HEY1, E-cadherin, MAML1, DLL4, HEY2, Cyclin D1, TFF1",
1183,Microsatellite instability in colorectal cancer,36,4.396E-01,6.079E-01,8.075E-01,9.104E-01,5,"MutLalpha complex, PMS2, TARBP2, c-Myb, MLH1",4.396E-01,6.079E-01,9,"MutLalpha complex, PMS2, c-Myb, RFX5, Dicer, MSH3, TFAM, TARBP2, MLH1",
1184,Enterohepatic circulation of bile acids / Rodent version,40,4.426E-01,6.061E-01,4.426E-01,6.061E-01,8,"ABCC11, OATP-A, Gastrotropin, OATP-C, MRP3, VLCSH2, SLC10A1, ABCC2",7.218E-01,8.558E-01,8,"VLCSH2, SLC10A1, ABCC11, OATP-A, Gastrotropin, OATP-C, MRP3, ABCC2",
1185,DNA damage_NHEJ mechanisms of DSBs repair,19,4.435E-01,6.116E-01,6.965E-01,8.312E-01,3,"Sirtuin, PNKP, DNA polymerase mu",4.435E-01,6.116E-01,5,"PNKP, Nibrin, Sirtuin, Rad50, DNA polymerase mu",
1186,Schema: Initiation of T cell recruitment in allergic contact dermatitis,19,4.435E-01,6.116E-01,9.777E-01,1.000E+00,1,IL-4,4.435E-01,6.116E-01,5,"IL-4, CD5, CD79 complex, CXCR3, TCR alpha/beta",
1187,Hedgehog signaling in breast cancer,24,4.462E-01,6.088E-01,4.462E-01,6.088E-01,5,"E-cadherin, BMI-1, SHH, Rb protein, Cyclin D1",4.765E-01,6.435E-01,6,"Cyclin D3, Rb protein, E-cadherin, BMI-1, SHH, Cyclin D1",
1188,Cell adhesion_Endothelial cell contacts by non-junctional mechanisms,24,4.462E-01,6.088E-01,4.462E-01,6.088E-01,5,"Alpha-actinin, ESAM, Alpha-catenin, Vitronectin, Plakoglobin",6.685E-01,8.112E-01,5,"ESAM, Alpha-catenin, Vitronectin, Plakoglobin, p120-catenin",
1189,G-protein signaling_M-RAS regulation pathway,24,4.462E-01,6.088E-01,4.462E-01,6.088E-01,5,"MEK1(MAP2K1), G-protein alpha-12 family, ERK1/2, c-Raf-1, CalDAG-GEFII",8.309E-01,9.410E-01,4,"ERK1/2, A-Raf-1, CalDAG-GEFII, G-protein alpha-12 family",
1190,Role of free fatty acids in obesity and type 2 diabetes,45,4.531E-01,6.237E-01,7.318E-01,8.595E-01,7,"Insulin processed, NFKBIA, PI3K reg class IA (p85), Insulin receptor, HSP60, AKT(PKB), ALOX15",4.531E-01,6.237E-01,11,"Insulin processed, IRS-1, PI3K reg class IA (p85), MyD88, IKK-alpha, Insulin receptor, HSP60, AKT(PKB), MKK7 (MAP2K7), NFKBIA, ALOX15",
1191,Role of adhesion of SCLC cells in tumor progression,35,4.546E-01,6.169E-01,4.546E-01,6.169E-01,7,"E-cadherin, CD81, CD9, SATB1, FAK1, SDF-1, E-selectin",5.623E-01,7.195E-01,8,"CD81, Rac1, SDF-1, E-selectin, E-cadherin, CD9, SATB1, FAK1",
1192,Extracellular matrix-regulated proliferation of airway smooth muscle cells in asthma,35,4.546E-01,6.169E-01,4.546E-01,6.169E-01,7,"PDGF-B, c-Fos, ERK1/2, DAB2, PI3K reg class IA (p85), JNK(MAPK8-10), p38 MAPK",5.623E-01,7.195E-01,8,"PDGF-B, c-Fos, ERK1/2, DAB2, PI3K reg class IA (p85), MKK7 (MAP2K7), JNK(MAPK8-10), p38 MAPK",
1193,Oxidative stress_NOX and DUOX families of NADPH oxidases ,35,4.546E-01,6.169E-01,4.546E-01,6.169E-01,7,"p67-phox, Calmodulin, PDIP38, NOX3, p40-phox, NOX1, NOXA1",5.623E-01,7.195E-01,8,"Rac1, NOXO1, NOX3, NOX1, NOXA1, Calmodulin, PDIP38, p40-phox",
1194,Role of IL-8 in colorectal cancer,19,4.612E-01,6.229E-01,4.612E-01,6.229E-01,4,"ERK1/2, IL8RA, MEK1/2, IL8RB",8.425E-01,9.442E-01,3,"ERK1/2, IL8RB, IL8RA",
1195,Development_Schema: Adult neurogenesis in the Subventricular Zone,19,4.612E-01,6.229E-01,4.612E-01,6.229E-01,4,"Doublecortin, hASH1, NEFM, TY3H",8.425E-01,9.442E-01,3,"Doublecortin, TY3H, hASH1",
1196,Glucocorticoid- and LABA-mediated inhibition of pro-inflammatory signaling in airway fibroblasts/myofibroblasts,28,4.626E-01,6.309E-01,5.921E-01,7.452E-01,5,"PKA-reg (cAMP-dependent), AP-1, G-protein alpha-s, IL-1RI, IL-4",4.626E-01,6.309E-01,7,"c-Jun/c-Fos, PKA-reg (cAMP-dependent), IL-1RI, IL-4, c-Jun, AP-1, G-protein alpha-s",
1197,Muscle contraction_nNOS signaling in skeletal muscle ,28,4.626E-01,6.309E-01,9.053E-01,9.829E-01,3,"Dystrobrevin alpha, CACNA1C, Calmodulin",4.626E-01,6.309E-01,7,"Dystroglycan, Syntrophin B1, Actin, nAChR, Dystrobrevin alpha, CACNA1C, Calmodulin",
1198,Signaling Transduction_Role of MIF as an intracellular mediator,41,4.638E-01,6.309E-01,6.334E-01,7.789E-01,7,"Aif, E2F1, JAB1, p21, MDM2, JNK(MAPK8-10), p27KIP1",4.638E-01,6.309E-01,10,"p21, MDM2, p27KIP1, PARP-1, Aif, E2F1, c-Jun, JAB1, FGF18, JNK(MAPK8-10)",
1199,TTP metabolism,68,4.656E-01,6.276E-01,4.656E-01,6.276E-01,13,"POLE1, NDPK C, NDPK complex, UPP2, NDPK 6, NDPK A, POLG reg, NDPK 8, POLD reg (p12), NDPK D (mitochondrial), POLD reg (p50), DNA polymerase lambda, NDPK B",4.898E-01,6.585E-01,16,"NDPK complex, NDPK 6, POLG reg, POLE3 (YBL1), DNA polymerase lambda, POLE1, NDPK C, UPP2, POLE2, NDPK A, NDPK 8, POLD reg (p12), NDPK D (mitochondrial), POLD reg (p50), POLG cat, NDPK B",
1200,L-Arginine metabolism,79,4.675E-01,6.276E-01,4.675E-01,6.276E-01,15,"GAMT, KCRU, ALD9A1, CPSM, RARSL, AOC2, GATM, ARLY, KCRS, ARG1, ALDH2, KCRB, eNOS, AOC3, ABP1",6.501E-01,7.966E-01,17,"CPSM, GATM, ARLY, ARG1, cNOS, ARG2, GAMT, KCRU, ALD9A1, RARSL, AOC2, KCRS, ALDH2, bNOS, eNOS, AOC3, ABP1",
1201,Inhibition of mast cell functions by Siglecs in asthma,30,4.684E-01,6.276E-01,4.684E-01,6.276E-01,6,"Fc epsilon RI gamma, Siglec-6, IP3 receptor, SIGLEC5, CD33, SHP-1",5.429E-01,7.034E-01,7,"Fc epsilon RI gamma, IP3 receptor, CD22, SHP-1, LAT, Siglec-6, SIGLEC5",
1202,Development_Osteopontin signaling in osteoclasts,30,4.684E-01,6.276E-01,4.684E-01,6.276E-01,6,"PIP5KI, VIL2 (ezrin), FAK1, WASP, DBS, VAV-3",7.106E-01,8.479E-01,6,"VIL2 (ezrin), WASP, DBS, PIP5KI, FAK1, VAV-3",
1203,Role of CNTF and LIF in regulation of oligodendrocyte development in multiple sclerosis,30,4.684E-01,6.276E-01,4.684E-01,6.276E-01,6,"gp130, NFKBIA, STAT3, PI3K reg class IA, AKT(PKB), PDK (PDPK1)",5.429E-01,7.034E-01,7,"gp130, 14-3-3, PI3K reg class IA, IKK-alpha, AKT(PKB), PDK (PDPK1), NFKBIA",
1204,Inter-cellular relations in COPD (general schema),30,4.684E-01,6.276E-01,4.684E-01,6.276E-01,6,"MIG, EGF, Granzyme B, CCR2, TGF-beta, IL8RB",5.429E-01,7.034E-01,7,"EGF, Granzyme B, CCR2, Perforin, IL8RB, TGF-beta, CXCR3",
1205,Immune response_TLR2-induced platelet activation,41,4.722E-01,6.310E-01,4.722E-01,6.310E-01,8,"ERK1/2, P2Y12, IP3 receptor, PI3K reg class IA (p85), PLC-beta, cPLA2, AKT(PKB), p38 MAPK",6.118E-01,7.578E-01,9,"ERK1/2, IP3 receptor, PI3K reg class IA (p85), PLC-beta, cPLA2, AKT(PKB), P2Y12, G-protein alpha-q, p38 MAPK",
1206,L-Threonine metabolism,50,4.742E-01,6.434E-01,8.267E-01,9.224E-01,7,"ASCT1 (SLC1A4), rBAT, SLC7A8, SDSL, BCKD-E1alpha, SLC38A1, PSP",4.742E-01,6.434E-01,12,"BCKD-E1beta, ASCT2 (SLC1A5), SLC7A10, SLC7A9, ASCT1 (SLC1A4), SLC7A8, SDSL, BCKD-E1alpha, SDHL, SLC38A1, PSP, BCKD-E2",
1207,Gamma-aminobutyrate (GABA) biosynthesis and metabolism,52,4.746E-01,6.331E-01,4.746E-01,6.331E-01,10,"ALD9A1, DHE4, AOC2, GATM, AATM, ALDH2, DHE3, GABT, AOC3, ABP1",5.349E-01,6.990E-01,12,"GATM, DHE3, AATC, ALD9A1, DHE4, AOC2, AATM, ALDH2, GABT, AOC3, ABP1, MAOB",
1208,Role of EPAS1 in obesity,11,4.749E-01,6.434E-01,6.197E-01,7.703E-01,2,"GLUT1, SP1",4.749E-01,6.434E-01,3,"GLUT4, GLUT1, SP1",
1209,Immune response_Generation of memory CD4+ T cells,37,4.755E-01,6.434E-01,5.174E-01,6.739E-01,7,"CD80, MHC class II, CCR7, AP-1, Bcl-2, Bcl-XL, IL-4",4.755E-01,6.434E-01,9,"MHC class II, NF-AT1(NFATC2), Bcl-XL, IL-4, IL-2R alpha chain, CCR7, AP-1, Bcl-2, TCR alpha/beta",
1210,Dual role of TGF-beta 1 in HCC ,24,4.765E-01,6.435E-01,6.565E-01,8.007E-01,4,"p21, NFKBIA, Bcl-2, SP1",4.765E-01,6.435E-01,6,"p21, IKK-alpha, NFKBIA, Bcl-2, TAB1, SP1",
1211,Transcription_Role of VDR in regulation of genes involved in osteoporosis,59,4.826E-01,6.512E-01,6.463E-01,7.920E-01,10,"Thyroid hormone receptor, c-Fos, VDR, PTHR1, RXRA, Androgen receptor, CG alpha, Calcitonin receptor, CYP3A4, IGF-1",4.826E-01,6.512E-01,14,"Thyroid hormone receptor, c-Fos, PTHR1, c-Jun/c-Fos, Androgen receptor, CG alpha, CYP19, FasL(TNFSF6), Calcitonin receptor, VDR, c-Jun, RXRA, Parathyroid hormone, IGF-1",
1212,Development_Cross-talk between VEGF and Angiopoietin 1 signaling pathways,25,4.844E-01,6.421E-01,4.844E-01,6.421E-01,5,"ABIN-2, IP3 receptor, I-kB, IKK-beta, E-selectin",5.203E-01,6.847E-01,6,"IKK (cat), IP3 receptor, I-kB, E-selectin, ABIN-2, IKK-beta",
1213,Generation of cytotoxic CD8+ T cells in COPD,25,4.844E-01,6.421E-01,4.844E-01,6.421E-01,5,"CD80, MHC class II, Granzyme B, CD40(TNFRSF5), CD40L(TNFSF5)",5.203E-01,6.847E-01,6,"MHC class II, NF-AT1(NFATC2), Granzyme B, Perforin, CD40(TNFRSF5), TCR alpha/beta",
1214,L-Alanine and L-cysteine metabolism,46,4.853E-01,6.543E-01,6.122E-01,7.621E-01,8,"GPT2, AGXT, CSAD, AATM, LDH6A, PYC, ALT1, AGT2",4.853E-01,6.543E-01,11,"AGXT, CSAD, AATC, LDHC, LDH6A, THTM, AGT2, GPT2, AATM, PYC, ALT1",
1215,G-protein signaling_Rac2 regulation pathway,36,4.863E-01,6.432E-01,4.863E-01,6.432E-01,7,"PAK1, p67-phox, VIL2 (ezrin), PI3K reg class IA (p85), SP1, NOXA1, PREX1",8.612E-01,9.594E-01,6,"VIL2 (ezrin), PI3K reg class IA (p85), NOXA1, PAK1, SP1, PREX1",
1216,Immune response_IL-12-induced IFN-gamma production,36,4.863E-01,6.432E-01,4.863E-01,6.432E-01,7,"p38alpha (MAPK14), STAT3, I-kB, GADD45 gamma, CD3, MEK6(MAP2K6), JNK(MAPK8-10)",5.974E-01,7.449E-01,8,"IKK (cat), I-kB, MEK6(MAP2K6), MEKK4(MAP3K4), c-Jun, GADD45 gamma, JNK(MAPK8-10), TCR alpha/beta",
1217,Inhibition of apoptosis in gastric cancer,42,4.976E-01,6.647E-01,6.598E-01,8.008E-01,7,"PAK1, Cytochrome c, FADD, Bcl-2, Bcl-XL, AKT(PKB), Smac/Diablo",4.976E-01,6.647E-01,10,"Cytochrome c, FADD, BAD, Bcl-XL, AKT(PKB), CCKBR, PAK1, Caspase-7, Bcl-2, Smac/Diablo",
1218,"Oxidative stress_Activation of NOX1, NOX5, DUOX1 and DUOX2 NADPH Oxidases",42,4.976E-01,6.577E-01,5.015E-01,6.577E-01,8,"cPKC (conventional), PKA-reg (cAMP-dependent), Calmodulin, PKC, VAV-2, MEK1/2, NOX1, NOXA1",4.976E-01,6.647E-01,10,"PKA-reg (cAMP-dependent), Rac1, NOXO1, VAV-2, NOX1, NOXA1, BETA-PIX, cPKC (conventional), Calmodulin, PKC",
1219,TGF-beta-induced fibroblast/ myofibroblast migration and extracellular matrix production in asthmatic airways,64,5.000E-01,6.674E-01,6.289E-01,7.756E-01,11,"TIMP3, MMP-1, H-Ras, ERK1/2, AP-1, TGF-beta 3, JNK(MAPK8-10), ABCC5, AKT(PKB), SP1, p38 MAPK",5.000E-01,6.674E-01,15,"TIMP3, H-Ras, ERK1/2, c-Jun/c-Fos, AKT(PKB), PKC-delta, MMP-1, c-Jun, AP-1, TGF-beta 3, TAB1, JNK(MAPK8-10), ABCC5, SP1, p38 MAPK",
1220,Immune response_Alternative complement pathway,53,5.006E-01,6.577E-01,5.006E-01,6.577E-01,10,"C5aR, CRIg, MCP, C5L2, Clusterin, FHR-5, Factor D, Vitronectin, FHR-4, FHR-3",5.643E-01,7.199E-01,12,"CRIg, Clusterin, FHR-4, FHR-3, C3aR, C5aR, MCP, C5L2, FHR-5, Factor D, Vitronectin, C9",
1221,Neurophysiological process_Kappa-type opioid receptor in transmission of nerve impulses,31,5.025E-01,6.585E-01,5.025E-01,6.585E-01,6,"Kir3.2, G-protein alpha-i family, CACNA1C, EBP50, Kir3.1, AP-1",5.812E-01,7.338E-01,7,"Kir3.1, Kir3.2, G-protein alpha-i family, CACNA1C, EBP50, AP-1, N-type Ca(II) channel alpha1B",
1222,Role of IFN-beta in activation of T cell apoptosis in multiple sclerosis,29,5.033E-01,6.700E-01,6.251E-01,7.737E-01,5,"TRADD, FADD, AKT(PKB), Adenosine A2a receptor, TRID(TNFRSF10C)",5.033E-01,6.700E-01,7,"TRADD, FADD, FasL(TNFSF6), AKT(PKB), Caspase-7, Adenosine A2a receptor, TRID(TNFRSF10C)",
1223,Role of type 2 innate lymphoid cells in airway allergic inflammation and tissue repair,38,5.110E-01,6.785E-01,5.478E-01,7.013E-01,7,"GATA-3, ROR-alpha, CRTH2, Amphiregulin, p70 S6 kinase1, STAT6, IL-4",5.110E-01,6.785E-01,9,"Amphiregulin, IL-13, IL-9, IL-4, IL-2R alpha chain, GATA-3, IL-25 (IL-17E), p70 S6 kinase1, STAT6",
1224,Regulation of lipid metabolism_G-alpha(q) regulation of lipid metabolism,59,5.126E-01,6.706E-01,5.126E-01,6.706E-01,11,"LXR-alpha/RXR-alpha, ABCG1, ERK1/2, G-protein alpha-q/11, CD36, IP3 receptor, COX-1 (PTGS1), PKC, PLC-beta, cPLA2, LXR-alpha",8.938E-01,9.807E-01,10,"ABCG1, ERK1/2, APOC2, G-protein alpha-q/11, IP3 receptor, PLC-beta, cPLA2, CD36, PKC, G-protein alpha-q",
1225,Stimulation of TGF-beta signaling in lung cancer,48,5.146E-01,6.721E-01,5.146E-01,6.721E-01,9,"p38alpha (MAPK14), E-cadherin, Keratin 19, TITF1, TGF-beta, SCUBE3, I-kB, TGF-beta 3, AKT(PKB)",5.484E-01,7.073E-01,11,"TITF1, EGR1, IKK (cat), SCUBE3, I-kB, IKK-alpha, AKT(PKB), E-cadherin, Keratin 19, TGF-beta, TGF-beta 3",
1226,Immune response_Fc gamma R-mediated phagocytosis in macrophages,47,5.172E-01,6.847E-01,6.378E-01,7.823E-01,8,"Fc epsilon RI gamma, Myosin II, PIP5KI, IP3 receptor, Fc gamma RI, Hck, PI3K reg class IA, ARF6",5.172E-01,6.847E-01,11,"Fc epsilon RI gamma, FCGR3A, Rac1, IP3 receptor, Hck, PI3K reg class IA, ARF6, Myosin II, PIP5KI, Paxillin, Fc gamma RI",
1227,Cholehepatic circulation of bile acids / Rodent version,37,5.174E-01,6.739E-01,5.174E-01,6.739E-01,7,"ABCC11, OATP-A, OATP-C, MRP3, VLCSH2, SLC10A1, ABCC2",7.714E-01,8.955E-01,7,"VLCSH2, SLC10A1, ABCC11, OATP-A, OATP-C, MRP3, ABCC2",
1228,Immune response_LPS-induced platelet activation,25,5.203E-01,6.847E-01,6.893E-01,8.252E-01,4,"Protein kinase G1, Glycoprotein VI, PAR4, CD40L(TNFSF5)",5.203E-01,6.847E-01,6,"Protein kinase G1, Glycoprotein VI, Thrombin, MyD88, PAR4, LBP",
1229,Zinc deficiency in Prostate Cancer,25,5.203E-01,6.847E-01,6.893E-01,8.252E-01,4,"SLC39A1 (ZIP1), NFKBIA, IKK-beta, SP1",5.203E-01,6.847E-01,6,"SLC39A1 (ZIP1), IKK-alpha, NFKBIA, IKK-beta, ACON, SP1",
1230,Immune response_T cell subsets: secreted signals,25,5.203E-01,6.847E-01,6.893E-01,8.252E-01,4,"TGF-beta, Lymphotactin, Amphiregulin, IL-4",5.203E-01,6.847E-01,6,"Amphiregulin, IL-13, IL-9, IL-4, IL-25 (IL-17E), TGF-beta",
1231,Cell cycle_Transition and termination of DNA replication,26,5.216E-01,6.776E-01,5.216E-01,6.776E-01,5,"TOP1, DNA ligase I, Ubiquitin, POLD reg (p12), POLD reg (p50)",7.396E-01,8.699E-01,5,"TOP1, DNA ligase I, Ubiquitin, POLD reg (p12), POLD reg (p50)",
1232,Immune response_IFN-gamma signaling via PI3K and NF-kB,56,5.224E-01,6.869E-01,5.762E-01,7.297E-01,10,"ERK1/2, c-Raf-1, SIN1, I-kB, IKK-beta, Occludin, MEK1/2, AKT(PKB), SP1, PDK (PDPK1)",5.224E-01,6.869E-01,13,"ERK1/2, SIN1, I-kB, IKK-alpha, AKT(PKB), PDK (PDPK1), PKC-delta, c-Jun, Alpha1-globin, SHP-2, IKK-beta, Occludin, SP1",
1233,Disruption of epithelial layer restitution in asthma,34,5.260E-01,6.904E-01,5.993E-01,7.511E-01,6,"EGF, RARgamma, RXRG, RXRA, SARA, Vitronectin",5.260E-01,6.904E-01,8,"EGF, RARgamma, Plasminogen, RXRG, RXRA, Plasmin, SARA, Vitronectin",
1234,Androstenedione and testosterone biosynthesis and metabolism p.1,54,5.263E-01,6.814E-01,5.263E-01,6.814E-01,10,"SULT2B1, CYP3A5, HSD17B3, STS, HSD17B1, CYP2A13, CYP1A2, HSD17B2, CYP3A4, HSD3B2",8.960E-01,9.820E-01,9,"SULT2B1, CYP3A5, STS, HSD17B1, CYP2A13, CYP1A2, CYP2C19, HSD3B2, CYP17",
1235,Impaired inhibitory action of lipoxins on ROS production in neutrophils in CF,54,5.263E-01,6.814E-01,5.263E-01,6.814E-01,10,"G-protein alpha-i family, CFTR, PAK1, p67-phox, LTBR1, IL8RA, IP3 receptor, p40-phox, PDK (PDPK1), PREX1",7.151E-01,8.511E-01,11,"PKC-zeta, IP3 receptor, SOD1, PDK (PDPK1), G-protein alpha-i family, PAK1, LTBR1, IL8RA, p40-phox, PI3K reg class IB (p101), PREX1",
1236,L-Lysine metabolism,93,5.280E-01,6.825E-01,5.280E-01,6.825E-01,17,"CRYM, CRAT, SCPDH, OCTN2, CAC, DHTKD1, CROT, SLC25A2, P5CR1, HCD2, HCDH, ODO2, ECHS1, ACAA1, CAT-2, CACL, GCDH",5.605E-01,7.195E-01,21,"CRYM, AGPHD1, CAC, CROT, HCDH, ODO2, ECHS1, CRAT, SLC7A9, SCPDH, OCTN2, DHTKD1, SLC25A2, P5CR1, HCD2, AGXT2L2, ACAA1, CCBL2, CAT-2, CACL, GCDH",
1237,Apoptosis and survival_DNA-damage-induced apoptosis,15,5.290E-01,6.825E-01,5.290E-01,6.825E-01,3,"Chk2, E2F1, RAD9",6.993E-01,8.404E-01,3,"Nibrin, E2F1, RAD9",
1238,Metabolic syndrome X (general schema),15,5.290E-01,6.825E-01,5.290E-01,6.825E-01,3,"Adiponectin, Insulin processed, Leptin",6.993E-01,8.404E-01,3,"Insulin processed, Adiponectin, Leptin",
1239,Regulation of immune cell differentiation by Notch signaling,43,5.302E-01,6.828E-01,5.302E-01,6.828E-01,8,"GATA-3, DLL1, PI3K reg class IA (p85), NUR77, FOXP3, IL-4, AKT(PKB), PDK (PDPK1)",6.727E-01,8.144E-01,9,"DLL1, PI3K reg class IA (p85), FOXP3, IL-4, AKT(PKB), PDK (PDPK1), GATA-3, DLL4, NUR77",
1240,Immune response_Antimicrobial actions of IFN-gamma,43,5.307E-01,6.946E-01,6.851E-01,8.252E-01,7,"Esrra, Hepcidin, p67-phox, ATP5G3, Autophagin-1, SLC26A3 (DRA), NOX1",5.307E-01,6.946E-01,10,"Esrra, Hepcidin, ATP5G3, SLC26A6, Autophagin-1, SLC26A3 (DRA), NOX1, Beta-defensin 3, Beta-defensin 2, ACON",
1241,dCTP/dUTP metabolism,74,5.310E-01,6.946E-01,5.980E-01,7.511E-01,13,"POLE1, NDPK C, NDPK complex, NDPK 6, RRM2B, NDPK A, POLG reg, POLD reg (p12), NDPK D (mitochondrial), POLD reg (p50), DNA polymerase lambda, Small RR subunit, NDPK B",5.310E-01,6.946E-01,17,"NDPK complex, NDPK 6, POLG reg, POLE3 (YBL1), DNA polymerase lambda, AK1, POLE1, NDPK C, POLE2, RRM2B, NDPK A, POLD reg (p12), NDPK D (mitochondrial), POLD reg (p50), POLG cat, Small RR subunit, NDPK B",
1242,Transcription_Effect of Folic acid on genome stability,60,5.368E-01,6.896E-01,5.368E-01,6.896E-01,11,"DNMT3B, MTR, MAT1A, ADH1, DNMT3A, ADHFE1, HCP1, SAHH, SHMT2, FR-beta, AOX1",8.365E-01,9.420E-01,11,"DNMT3B, MAT1A, SHMT2, AOX1, MTR, DNMT3A, ADHFE1, HCP1, SAHH, FR-beta, MAT2A",
1243,Gamma-secretase regulation of mammary cell development,21,5.403E-01,7.024E-01,7.614E-01,8.816E-01,3,"Neuregulin 1, MTG16 (CBFA2T3), Cytochrome c",5.403E-01,7.024E-01,5,"Bak, Cytochrome c, MTG16 (CBFA2T3), DLL4, Beta-casein",
1244,Nicotine signaling in GABAergic neurons,39,5.457E-01,7.051E-01,7.349E-01,8.611E-01,6,"SNAP-25, G-protein alpha-i family, CACNA1C, Calmodulin, GABA-A receptor, nAChR alpha-4",5.457E-01,7.051E-01,9,"Syntaxin 1A, GABA-A receptor, nAChR, nAChR alpha-4, nAChR alpha4/beta2, G-protein alpha-i family, CACNA1C, Calmodulin, N-type Ca(II) channel alpha1B",
1245,dATP/dITP metabolism,94,5.474E-01,7.013E-01,5.474E-01,7.013E-01,17,"POLE1, NDPK C, NDPK complex, ENTPD2-alpha, KGUA, NDPK 6, 5'-NTC, NDPK A, POLG reg, POLD reg (p12), PPAL, NDPK D (mitochondrial), POLD reg (p50), Adenosine kinase, DNA polymerase lambda, Small RR subunit, NDPK B",5.824E-01,7.348E-01,21,"NDPK complex, NDPK 6, 5'-NTC, POLG reg, PPAL, POLE3 (YBL1), DNA polymerase lambda, AK1, POLE1, NDPK C, ENTPD2-alpha, KGUA, POLE2, NDPK A, POLD reg (p12), NDPK D (mitochondrial), POLD reg (p50), Adenosine kinase, POLG cat, Small RR subunit, NDPK B",
1246,Protein folding and maturation_Angiotensin system maturation,48,5.484E-01,7.073E-01,6.624E-01,8.026E-01,8,"ENPEP, AGTR1, Dnpep, Renin, Thimet oligopeptidase, ACE1, Myeloblastin, Cathepsin D",5.484E-01,7.073E-01,11,"Dnpep, Renin, IRAP, Chymase, Thimet oligopeptidase, ACE1, Cathepsin D, ENPEP, AGTR1, Myeloblastin, Kallikrein 1",
1247,Mechanism of Maraviroc action in HIV Infections,4,5.509E-01,7.047E-01,5.509E-01,7.047E-01,1,CCR5,6.448E-01,7.908E-01,1,CCR5,
1248,N-Glycan biosynthesis p1,72,5.553E-01,7.096E-01,5.553E-01,7.096E-01,13,"DPM2 (reg), ALG10-A, GGPS1, ALG10B, DPM3 (reg), GPT, ALG3, ALG5, DOPP1, ALG1, DPM1 (cat), ALG12, ALG8",5.923E-01,7.436E-01,16,"GGPS1, GPT, ALG2, DPM1 (cat), ALG12, ALG8, DPM2 (reg), ALG10-A, ALG6, ALG10B, DPM3 (reg), ALG11, ALG3, ALG5, DOPP1, ALG1",
1249,Inhibition of TGF-beta 1 signaling in early colorectal cancer,27,5.575E-01,7.107E-01,5.575E-01,7.107E-01,5,"E-cadherin, p21, PI3K reg class IA, CEACAM5, AKT(PKB)",6.029E-01,7.480E-01,6,"p21, PI3K reg class IA, AKT(PKB), c-Myc, E-cadherin, CEACAM5",
1250,Stem cells_Cytotoxic effect of temozolomide on glioblastoma cells,27,5.575E-01,7.107E-01,5.575E-01,7.107E-01,5,"MutLalpha complex, MGMT, p21, Ubiquitin, SP1",7.706E-01,8.955E-01,5,"MutLalpha complex, p21, Ubiquitin, MGMT, SP1",
1251,Apoptosis and survival_Inhibition of ROS-induced apoptosis by 17beta-estradiol,44,5.631E-01,7.195E-01,7.090E-01,8.440E-01,7,"p38alpha (MAPK14), ESR1 (mitochondrial), p67-phox, Cytochrome c, ESR2 (nuclear), I-kB, Bcl-2",5.631E-01,7.195E-01,10,"ESR1 (mitochondrial), IKK (cat), Cytochrome c, ESR2 (nuclear), Rac1, I-kB, SOD1, Thioredoxin, PKC-delta, Bcl-2",
1252,Effect of H. pylori infection on apoptosis in gastric epithelial cells,53,5.643E-01,7.199E-01,7.696E-01,8.851E-01,8,"MHC class II, Aif, TRADD, Cytochrome c, FADD, I-kB, Bcl-2, PUMA",5.643E-01,7.199E-01,12,"MHC class II, IKK (cat), TRADD, Bak, Cytochrome c, FADD, I-kB, FasL(TNFSF6), PUMA, PARP-1, Aif, Bcl-2",
1253,Histidine-glutamate-glutamine metabolism,95,5.664E-01,7.202E-01,5.664E-01,7.202E-01,17,"GNA1, HUTU, NAD synthetase 1, HDC, DHE4, GLNA, HUTH, PYCS, GPT2, AL4A1, EARS2, P5CR1, AATM, DHE3, Proline oxidase 1, GABT, ALT1",7.783E-01,8.990E-01,19,"NAD synthetase 1, HUTH, EARS2, PPAT, DHE3, AATC, GFPT1, GLSL, Proline oxidase 1, GNA1, DHE4, GLNA, PYCS, GPT2, AL4A1, P5CR1, AATM, GABT, ALT1",
1254,Immune response_Inhibitory action of lipoxins on superoxide production induced by IL-8 and Leukotriene B4 in neutrophils,50,5.677E-01,7.211E-01,5.677E-01,7.211E-01,9,"G-protein alpha-i family, PAK1, p67-phox, LTBR1, IL8RA, IP3 receptor, p40-phox, PDK (PDPK1), PREX1",7.332E-01,8.651E-01,10,"PKC-zeta, IP3 receptor, PDK (PDPK1), G-protein alpha-i family, PAK1, LTBR1, IL8RA, p40-phox, PI3K reg class IB (p101), PREX1",
1255,Neurophysiological process_Delta-type opioid receptor in the nervous system,40,5.793E-01,7.334E-01,6.059E-01,7.550E-01,7,"G-protein alpha-i family, Adenylate cyclase type VI, PKA-reg (cAMP-dependent), PDE1B, IP3 receptor, Adenylate cyclase type II, Calmodulin",5.793E-01,7.334E-01,9,"Adenylate cyclase type VI, PKA-reg (cAMP-dependent), PDE1B, IP3 receptor, Adenylate cyclase type II, Delta-type opioid receptor, G-protein alpha-i family, Calmodulin, N-type Ca(II) channel alpha1B",
1256,Stem cells_NOTCH1-induced self-renewal of glioblastoma stem cells,40,5.793E-01,7.334E-01,6.059E-01,7.550E-01,7,"EGF, STAT3, DLL1, SOX2, HEY2, Cyclin D1, SP1",5.793E-01,7.334E-01,9,"EGF, DLL1, HEY1, DLL4, SOX2, HEY2, SMAD1, Cyclin D1, SP1",
1257,IL-1 beta- and Endothelin-1-induced fibroblast/ myofibroblast migration and extracellular matrix production in asthmatic airways,40,5.793E-01,7.334E-01,6.059E-01,7.550E-01,7,"PDGF-B, TIMP3, MMP-1, ERK1/2, AP-1, IL-1RI, ABCC5",5.793E-01,7.334E-01,9,"PDGF-B, TIMP3, ERK1/2, c-Jun/c-Fos, IL-1RI, MMP-1, c-Jun, AP-1, ABCC5",
1258,Inhibition of TGF-beta signaling in lung cancer,31,5.812E-01,7.338E-01,6.861E-01,8.252E-01,5,"p38alpha (MAPK14), p21, Rb protein, JNK(MAPK8-10), SP1",5.812E-01,7.338E-01,7,"p21, Rb protein, c-Myc, c-Jun, MKK7 (MAP2K7), JNK(MAPK8-10), SP1",
1259,Cell cycle_Sister chromatid cohesion,22,5.842E-01,7.364E-01,5.842E-01,7.366E-01,4,"TOP1, CHTF18, ESCO1, DCC1",5.857E-01,7.364E-01,5,"TOP1, Separase, CHTF18, ESCO1, DCC1",
1260,Role of fibroblasts in the sensitization phase of allergic contact dermatitis,22,5.842E-01,7.366E-01,5.842E-01,7.366E-01,4,"E-cadherin, AP-1, IL-1RI, SDF-1",7.733E-01,8.955E-01,4,"IL-1RI, SDF-1, E-cadherin, AP-1",
1261,Microsatellite instability in gastric cancer,22,5.842E-01,7.364E-01,5.842E-01,7.366E-01,4,"E-cadherin, MutLalpha complex, PMS2, MLH1",5.857E-01,7.364E-01,5,"MutLalpha complex, PMS2, E-cadherin, MSH3, MLH1",
1262,Neurophysiological process_Bitter taste signaling,28,5.921E-01,7.452E-01,5.921E-01,7.452E-01,5,"P2X2, P2Y2, T2R taste receptors, T2R47, Gustducin",6.411E-01,7.870E-01,6,"TRPM5, T2R47, P2X2, P2Y2, T2R taste receptors, Gustducin",
1263,DNA damage_Role of NFBD1 in DNA damage response,13,5.972E-01,7.449E-01,7.124E-01,8.446E-01,2,"Chk2, ATRIP",5.972E-01,7.449E-01,3,"Nibrin, Rad50, ATRIP",
1264,Role of IFN-beta in the improvement of blood-brain barrier integrity in multiple sclerosis,27,6.029E-01,7.480E-01,7.480E-01,8.727E-01,4,"c-Fos, ITGAL, AP-1, JNK(MAPK8-10)",6.029E-01,7.480E-01,6,"c-Fos, c-Jun/c-Fos, ITGAL, c-Jun, AP-1, JNK(MAPK8-10)",
1265,Regulatory T cells in murine model of contact hypersensitivity,27,6.029E-01,7.480E-01,7.480E-01,8.727E-01,4,"MHC class II, ENP1, Adenosine A2a receptor, E-selectin",6.029E-01,7.480E-01,6,"MHC class II, FasL(TNFSF6), ENP1, E-selectin, TCR alpha/beta, Adenosine A2a receptor",
1266,Th2-cytokines and IFN-mediated regulation of airway smooth muscle contraction,27,6.029E-01,7.480E-01,7.480E-01,8.727E-01,4,"STAT2, PI3K reg class IA (p85), STAT6, IL-4",6.029E-01,7.480E-01,6,"IRS-1, PI3K reg class IA (p85), IL-13, IL-4, STAT2, STAT6",
1267,Androstenedione and testosterone biosynthesis and metabolism p.3,40,6.059E-01,7.550E-01,6.059E-01,7.550E-01,7,"CYP11B1, AK1D1, SULT2B1, UGT2B28, AKR1C4, UGT2B4, UGT2B17",9.672E-01,1.000E+00,5,"CYP11B1, SULT2B1, UGT2B28, UGT2B4, UGT2B17",
1268,Neurophysiological process_Glucose-excited neurons of ventromedial nucleus (rodent model),32,6.178E-01,7.646E-01,7.139E-01,8.451E-01,5,"SUR1, HXK1, CACNA1C, Kir6.2, GABA-A receptor",6.178E-01,7.646E-01,7,"SUR1, GLUT4, Kir6.2, GABA-A receptor, HXK1, CACNA1C, N-type Ca(II) channel alpha1B",
1269,CoA biosynthesis,52,6.180E-01,7.688E-01,6.180E-01,7.688E-01,9,"PPCS, PANK3, ENPP1, MMSA, PTE1, PTE2, CTE1, COASY, ACSL3",7.787E-01,8.990E-01,10,"PPCS, ENPP1, PTE1, CTE1, COASY, ACSL3, ACSL1, PANK3, MMSA, PTE2",
1270,Immune response_T regulatory cell-mediated modulation of effector T cell and NK cell functions,55,6.209E-01,7.678E-01,6.874E-01,8.252E-01,9,"PKA-reg (cAMP-dependent), DAB2, NKp30, DLL1, FOXP3, Connexin 43, eIF2S1, ENP1, Adenosine A2a receptor",6.209E-01,7.678E-01,12,"ATF-4, PKA-reg (cAMP-dependent), DAB2, Perforin, DLL1, FOXP3, FasL(TNFSF6), eIF2S1, ENP1, IL-2R alpha chain, DLL4, Adenosine A2a receptor",
1271,Putative roles of SETDB1 and PLU-1 in melanoma,23,6.215E-01,7.705E-01,6.215E-01,7.705E-01,4,"SETDB1, PLU-1, Rb protein, MED25",8.038E-01,9.202E-01,4,"Rb protein, SETDB1, PLU-1, MED25",
1272,Prostate Cancer: candidate susceptibility genes in inflammatory pathways,29,6.251E-01,7.737E-01,6.251E-01,7.737E-01,5,"IL8RA, PDF, RNaseL, IL-1RI, IL-6 receptor",8.241E-01,9.348E-01,5,"IL-1RI, IL8RA, PDF, RNaseL, IL-6 receptor",
1273,Role of IL-17-producing T cells in allergic contact dermatitis,23,6.285E-01,7.765E-01,8.146E-01,9.164E-01,3,"CD80, MHC class II, MGF",6.285E-01,7.765E-01,5,"MHC class II, FasL(TNFSF6), Beta-defensin 2, MGF, TCR alpha/beta",
1274,Plasminogen activators signaling in pancreatic cancer,35,6.292E-01,7.756E-01,6.292E-01,7.756E-01,6,"MEK1(MAP2K1), GRB2, H-Ras, ERK1/2, c-Raf-1, IL-1RI",7.162E-01,8.511E-01,7,"GRB2, H-Ras, ERK1/2, Angiostatin, Plasminogen, IL-1RI, Plasmin",
1275,Glycogen metabolism,37,6.310E-01,7.777E-01,9.234E-01,9.953E-01,4,"HXK1, GYS1, HXK2, PYGM",6.310E-01,7.777E-01,8,"GYS2, GALM, HXK2, HXK3, HXK1, GPI, GYS1, PYGM",
1276,Attenuation of IFN type I signaling in melanoma cells,37,6.310E-01,7.777E-01,6.849E-01,8.252E-01,6,"p38alpha (MAPK14), STAT2, p21, STAT3, IFN-alpha, Filamin B (TABP)",6.310E-01,7.777E-01,8,"p21, Rac1, IFN-alpha, c-Myc, STAT2, c-Jun, MEKK1(MAP3K1), Filamin B (TABP)",
1277,"Mechanism of Pioglitazone and Rosiglitazon action in Diabetes mellitus, Type 2",5,6.324E-01,7.789E-01,6.324E-01,7.789E-01,1,RXRA,7.258E-01,8.598E-01,1,RXRA,
1278,Aminosugar metabolism,60,6.325E-01,7.789E-01,8.749E-01,9.611E-01,8,"GNA1, Sialic acid synthase, PGM3, HXK1, GALK2, GLUT1, SLC35A1, CMAS",6.325E-01,7.789E-01,13,"Sialic acid synthase, PGM3, GALK2, GLUT4, GFPT1, CMAS, GNA1, GALE, HXK1, GPI, GLUT1, UAP1, SLC35A1",
1279,Mechanisms of deltaF508 CFTR activation by S-nitrosoglutathione,47,6.378E-01,7.823E-01,6.378E-01,7.823E-01,8,"HSP90 alpha, CFTR, Csp, eNOS, TXNRD2, SP1, HSP90, HSP70",6.540E-01,7.968E-01,10,"HSP90 alpha, Sti1, SOD1, Csp, HSP90, HSP70, HSC70, eNOS, TXNRD2, SP1",
1280,Transport_GPR40 signaling pathway in beta cells,47,6.378E-01,7.823E-01,6.378E-01,7.823E-01,8,"GNA1, PGM3, G-protein alpha-q/11, IP3 receptor, CACNA1D, GLUT1, PRKD1, PLC-beta",6.540E-01,7.968E-01,10,"PGM3, G-protein alpha-q/11, IP3 receptor, PLC-beta, GFPT1, GNA1, CACNA1D, GLUT1, PRKD1, UAP1",
1281,Renal tubulointerstitial injury in Lupus Nephritis ,65,6.504E-01,7.965E-01,6.504E-01,7.965E-01,11,"MHC class II, CCR7, TRAF2, CCR2, CXCR5, TRADD, I-kB, IFN-alpha, CCR5, CD40(TNFRSF5), CD40L(TNFSF5)",8.374E-01,9.420E-01,12,"MHC class II, CCR2, IKK (cat), TRADD, I-kB, IKK-alpha, IFN-alpha, CCR5, CCR7, TRAF2, CD40(TNFRSF5), TCR alpha/beta",
1282,Development_BMP signaling,33,6.526E-01,7.968E-01,7.399E-01,8.656E-01,5,"Chordin, BMP7, Tob1, MEK6(MAP2K6), p38 MAPK",6.526E-01,7.968E-01,7,"Chordin, Tob1, MEK6(MAP2K6), BMP7, TAB1, SMAD1, p38 MAPK",
1283,The innate immune response to contact allergens,33,6.526E-01,7.968E-01,8.735E-01,9.610E-01,4,"AP-1, CARD5, IL-1RI, HSP70",6.526E-01,7.968E-01,7,"CARD8, MyD88, CARD5, IL-1RI, HSP70, Thioredoxin, AP-1",
1284,Development_Role of proteases in hematopoietic stem cell mobilization,18,6.594E-01,8.008E-01,6.594E-01,8.008E-01,3,"MGF, Cathepsin K, SDF-1",8.136E-01,9.292E-01,3,"SDF-1, MGF, Cathepsin K",
1285,Immune response_ETV3 affect on CSF1-promoted macrophage differentiation,19,6.596E-01,8.030E-01,6.965E-01,8.312E-01,3,"MSK1/2 (RPS6KA5/4), DDX20, p38 MAPK",6.596E-01,8.030E-01,4,"MSK1/2 (RPS6KA5/4), c-Myc, DDX20, p38 MAPK",
1286,Tyrosine metabolism p.2 (melanin),83,6.623E-01,8.026E-01,6.623E-01,8.026E-01,14,"HGD, AOC2, TAT, DDC, TYRP1, AATM, FAAA, AL3A1, AOX1, ACAA1, AOC3, PERT, ABP1, HPD",8.144E-01,9.294E-01,16,"TAT, DDC, AATC, MAAI, AOX1, PERT, HGD, AOC2, TYRP1, AATM, FAAA, ACAA1, AOC3, ABP1, HPD, MAOB",
1287,Eosinophil-derived cytokines in airway remodeling in asthma,38,6.631E-01,8.060E-01,7.106E-01,8.440E-01,6,"PDGF-B, MMP-17, ERK1/2, Amphiregulin, Angiogenin, p38 MAPK",6.631E-01,8.060E-01,8,"PDGF-B, ERK1/2, IL-3, Amphiregulin, MMP-17, PKC-delta, Angiogenin, p38 MAPK",
1288,Pyruvate metabolism,66,6.675E-01,8.107E-01,7.817E-01,8.949E-01,10,"MPC1, SLC25A1, SLC25A10, PDH beta, ME1, LDHD, PPCKM, PYC, MCT3, MPC2",6.675E-01,8.107E-01,14,"SLC25A11, SLC25A1, SLC25A10, PDH beta, PDH, ME1, PPCKM, MDH2, MPC1, PDH alpha, LDHD, PYC, MCT3, MPC2",
1289,Triacylglycerol metabolism p.1,60,6.681E-01,8.089E-01,6.681E-01,8.089E-01,10,"ALD9A1, AKR7A2, GPD1, GKP3, ALDH2, AKR1C4, GLPK, ACSL3, ALDX, PLCC",8.365E-01,9.420E-01,11,"AKR7A2, ACSL3, ALDX, PLCC, ACSL1, ALD9A1, AL3A2, GPD1, GKP3, ALDH2, GLPK",
1290,Role of Insulin in regulation of eating behavior in obesity,43,6.727E-01,8.144E-01,8.172E-01,9.172E-01,6,"Insulin processed, NFKBIA, Acyl-CoA synthetase, Insulin receptor, IKK-beta, AKT(PKB)",6.727E-01,8.144E-01,9,"Insulin processed, IRS-1, SOD1, Insulin receptor, AKT(PKB), PTP-1B, NFKBIA, Acyl-CoA synthetase, IKK-beta",
1291,Mechanism of action of CCR4 antagonists in asthma and atopic dermatitis (Variant 1),34,6.854E-01,8.263E-01,7.642E-01,8.816E-01,5,"CCL22, CCL17, G-protein alpha-i family, IP3 receptor, PIPKI gamma",6.854E-01,8.263E-01,7,"CCL22, CCL17, IP3 receptor, CALDAG-GEFI, PKC-delta, G-protein alpha-i family, PIPKI gamma",
1292,CCR4-dependent immune cell chemotaxis in asthma and atopic dermatitis ,34,6.854E-01,8.263E-01,7.642E-01,8.816E-01,5,"CCL22, CCL17, G-protein alpha-i family, IP3 receptor, PIPKI gamma",6.854E-01,8.263E-01,7,"CCL22, CCL17, IP3 receptor, CALDAG-GEFI, PKC-delta, G-protein alpha-i family, PIPKI gamma",
1293,Chemotaxis_CCR4-induced chemotaxis of immune cells,34,6.854E-01,8.263E-01,7.642E-01,8.816E-01,5,"CCL22, CCL17, G-protein alpha-i family, IP3 receptor, PIPKI gamma",6.854E-01,8.263E-01,7,"CCL22, CCL17, IP3 receptor, CALDAG-GEFI, PKC-delta, G-protein alpha-i family, PIPKI gamma",
1294,PDE4 regulation of cyto/chemokine expression in arthritis,49,6.860E-01,8.252E-01,6.860E-01,8.252E-01,8,"cAMP-GEFI, PKA-reg (cAMP-dependent), CUX1, PDE4, I-kB, Rap1GAP1, GSK3 alpha/beta, AKT(PKB)",7.082E-01,8.477E-01,10,"cAMP-GEFI, PKA-reg (cAMP-dependent), IKK (cat), CUX1, CARD8, I-kB, GSK3 alpha/beta, AKT(PKB), PDE4, Rap1GAP1",
1295,Arachidonic acid metabolites production in alveolar macrophages in asthma,31,6.861E-01,8.252E-01,6.861E-01,8.252E-01,5,"PLA2(hGIIA), cPLA2, IL-4, CD23, ALOX15",7.417E-01,8.717E-01,6,"cPLA2, IL-13, IL-4, CD23, PLA2(hGIIA), ALOX15",
1296,UMP biosynthesis,19,6.965E-01,8.312E-01,6.965E-01,8.312E-01,3,"CPSM, OPRT, DHODH",8.425E-01,9.442E-01,3,"CPSM, OPRT, DHODH",
1297,Development_TGF-beta-induction of EMT via ROS,20,7.013E-01,8.422E-01,7.305E-01,8.594E-01,3,"p38alpha (MAPK14), GRB2, p38 MAPK",7.013E-01,8.422E-01,4,"GRB2, Rac1, SOD1, p38 MAPK",
1298,HCV-mediated liver damage and predisposition to HCC via cell stress,63,7.059E-01,8.469E-01,7.288E-01,8.594E-01,10,"p38alpha (MAPK14), gp130, XBP1, Cytochrome c, STAT3, IL-1RI, IP3R1, IRE1, HSP60, IL-6 receptor",7.059E-01,8.469E-01,13,"gp130, XBP1, Bak, Cytochrome c, SOD1, MyD88, IL-1RI, IRE1, HSP60, c-Myc, PARP-1, IP3R1, IL-6 receptor",
1299,Axonal degeneration in multiple sclerosis,49,7.082E-01,8.477E-01,8.102E-01,9.121E-01,7,"NCX2, CACNA1C, UCP2, NCX3, CACNA1D, ATP1A3, COX IV",7.082E-01,8.477E-01,10,"UCP2, NCX3, ATP1A3, COX IV, NCX2, NDUFA6, CACNA1C, CACNA1D, Neurofascin, N-type Ca(II) channel alpha1B",
1300,Glucocorticoid-induced elevation of intraocular pressure as glaucoma risk factor,62,7.095E-01,8.440E-01,7.095E-01,8.440E-01,10,"ROR2, MMP-1, Alpha-actinin, PAK1, Srp40, FGFR1, Filamin B (TABP), FAK1, Cdt6 (angiopoietin-like), MLCK",9.623E-01,1.000E+00,9,"Srp40, FGFR1, Rac1, MLCK, ROR2, MMP-1, PAK1, Filamin B (TABP), FAK1",
1301,Substance P-mediated inflammation and pain in Sickle cell disease,38,7.106E-01,8.440E-01,7.106E-01,8.440E-01,6,"Substance P extracellular region, ITGAM, IP3 receptor, PLC-beta, IL-1RI, E-selectin",7.958E-01,9.166E-01,7,"Substance P extracellular region, IP3 receptor, PLC-beta, IL-1RI, E-selectin, ITGAM, G-protein alpha-q",
1302,Development_Neural stem cell lineage commitment (schema),38,7.106E-01,8.440E-01,7.106E-01,8.440E-01,6,"PLP1, SHH, DLL1, ATP1A2, BAG-1, CNTN6",7.958E-01,9.166E-01,7,"PLP1, DLL1, BAG-1, SHH, ATP1A2, MAG, CNTN6",
1303,Role of SHH and Notch in SCLC,30,7.106E-01,8.479E-01,8.196E-01,9.172E-01,4,"hASH1, SHH, DLL1, SUFU",7.106E-01,8.479E-01,6,"DLL1, SUFU, hASH1, MAML1, SHH, SYP",
1304,Hypoxia-induced EMT in cancer and fibrosis,13,7.124E-01,8.446E-01,7.124E-01,8.446E-01,2,"E-cadherin, E2A",8.327E-01,9.416E-01,2,"E2A, E-cadherin",
1305,Immunological synapse between dendritic and CD8+ T cells in allergic contact dermatitis,32,7.139E-01,8.451E-01,7.139E-01,8.451E-01,5,"CD80, ICOS-L, AP-1, CD2, CD27(TNFRSF7)",7.703E-01,8.955E-01,6,"ICOS-L, NF-AT1(NFATC2), CD27(TNFRSF7), ICOS, AP-1, TCR alpha/beta",
1306,Immune response_Inflammasome in inflammatory response,35,7.162E-01,8.511E-01,7.867E-01,8.965E-01,5,"CARD9, I-kB, CARD5, IL-1RI, Nod2 (CARD15)",7.162E-01,8.511E-01,7,"CARD9, IKK (cat), CARD8, I-kB, CARD5, IL-1RI, Nod2 (CARD15)",
1307,NALP3 inflammasome activation in age-related macular degeneration (AMD),35,7.162E-01,8.511E-01,9.657E-01,1.000E+00,3,"VDAC 2, Ubiquitin, CARD5",7.162E-01,8.511E-01,7,"VDAC 2, CARD8, Ubiquitin, CARD5, FasL(TNFSF6), Thioredoxin, Dicer",
1308,Glyoxylate metabolism,26,7.198E-01,8.515E-01,7.198E-01,8.515E-01,4,"AGXT, SAT-1, GRHPR, AGT2",8.757E-01,9.719E-01,4,"AGXT, SAT-1, AGT2, GRHPR",
1309,Memory CD8+ T cells in allergic contact dermatitis,40,7.218E-01,8.558E-01,7.576E-01,8.795E-01,6,"CCL17, CCR7, AP-1, IL-1RI, IL-2R beta chain, E-selectin",7.218E-01,8.558E-01,8,"CCL17, NF-AT1(NFATC2), IL-1RI, E-selectin, CCR7, AP-1, IL-2R beta chain, TCR alpha/beta",
1310,Galactose metabolism,63,7.288E-01,8.594E-01,7.288E-01,8.594E-01,10,"LPH, GALK1, HXK1, G6PT, GALK2, GYS1, Glycogen phosphorylase, HXK2, GALT, PYGM",8.037E-01,9.202E-01,12,"LPH, GALK1, GYS2, GALK2, HXK2, GALT, HXK3, GALE, HXK1, GYS1, Glycogen phosphorylase, PYGM",
1311,Propionate metabolism p.2,63,7.288E-01,8.594E-01,7.288E-01,8.594E-01,10,"ACACA, SCS-G, MMSA, DCMC, SUCLG2, ACSA, ACACB, HCDH, GABT, SUCLG1",8.037E-01,9.202E-01,12,"SCS-G, DCMC, SUCLG2, ACSA, ACACB, HCDH, SUCLG1, SCS-A, MMSA, HADHB, HIBCH, GABT",
1312,Vascular endothelial cell damage in SLE,63,7.288E-01,8.594E-01,7.288E-01,8.594E-01,10,"C5aR, TRAF2, ERK1/2, ADAM-TS13, IFN-alpha, IL-1RI, JNK(MAPK8-10), von Willebrand factor, p38 MAPK, E-selectin",8.800E-01,9.746E-01,11,"ERK1/2, ADAM-TS13, IFN-alpha, IL-1RI, von Willebrand factor, E-selectin, C5aR, TRAF2, Caspase-7, JNK(MAPK8-10), p38 MAPK",
1313,PR action in breast cancer: stimulation of metastasis,20,7.305E-01,8.594E-01,7.305E-01,8.594E-01,3,"PR (membrane), PR (nuclear), FAK1",8.674E-01,9.641E-01,3,"PR (membrane), PR (nuclear), FAK1",
1314,Regulation of lipid metabolism_Regulation of fatty acid synthesis: NLTP and EHHADH,20,7.305E-01,8.594E-01,7.305E-01,8.594E-01,3,"SCPX, ECHS1, ACAA1",8.674E-01,9.641E-01,3,"SCPX, ECHS1, ACAA1",
1315,Complement pathway disruption in thrombotic microangiopathy,39,7.349E-01,8.611E-01,7.349E-01,8.611E-01,6,"C5aR, cPKC (conventional), MCP, Calmodulin, PKC, von Willebrand factor",8.183E-01,9.303E-01,7,"von Willebrand factor, C3aR, C5aR, cPKC (conventional), MCP, Calmodulin, PKC",
1316,Butanoic acid metabolism,39,7.349E-01,8.611E-01,7.349E-01,8.611E-01,6,"PTE1, SLC5A12, HCD2, HCDH, ECHS1, ABCG2",8.183E-01,9.303E-01,7,"PTE1, HCDH, ECHS1, SLC5A12, SLC5A8, HCD2, ABCG2",
1317,Immune response_Immunological synapse formation,55,7.387E-01,8.699E-01,9.497E-01,1.000E+00,6,"CD80, MHC class II, URP2, PI3K reg class IA (p85), CD3, WASP",7.387E-01,8.699E-01,11,"MHC class II, URP2, Rac1, PI3K reg class IA (p85), ZAP70, ITK, WASP, CALDAG-GEFI, C3G, LAT, TCR alpha/beta",
1318,Probable BMP4-mediated induction of EMT in airway epithelium,21,7.392E-01,8.699E-01,7.614E-01,8.816E-01,3,"E-cadherin, SNAI3, Plakoglobin",7.392E-01,8.699E-01,4,"SNAI3, E-cadherin, SMAD1, Plakoglobin",
1319,Aflatoxin B1-dependent induction of HCC,33,7.399E-01,8.656E-01,7.399E-01,8.656E-01,5,"K-RAS, CYP1A2, IGF-1 receptor, SP1, CYP3A4",7.965E-01,9.166E-01,6,"IRS-1, CYP1A2, IGF-1 receptor, K-RAS, TBP, SP1",
1320,Endothelial cell apoptosis in COPD,36,7.448E-01,8.733E-01,8.075E-01,9.104E-01,5,"PI3K reg class IA, Bcl-2, eNOS, AKT(PKB), PDK (PDPK1)",7.448E-01,8.733E-01,7,"BAD, PI3K reg class IA, AKT(PKB), PDK (PDPK1), Caspase-7, Bcl-2, eNOS",
1321,Glycolysis and gluconeogenesis,94,7.483E-01,8.727E-01,7.483E-01,8.727E-01,15,"PFKM, PGAM2, HXK1, G6PT, PFKL, IGRP, F16P, GLUT1, ALDOA, G6PC3, PGK2, HXK2, LDH6A, PYC, ENO4",7.618E-01,8.912E-01,19,"PFKL, G3PT, GALM, GLUT4, F16P, LDHC, PGK2, HXK2, LDH6A, G3P2, PFKM, HXK3, HXK1, GPI, GLUT1, ALDOA, G6PC3, PYC, ENO4",
1322,Serotonin - melatonin biosynthesis and metabolism,46,7.525E-01,8.762E-01,7.532E-01,8.762E-01,7,"DDC, INMT, CYP1A2, ALDH2, HIOM, AOX1, ALDX",7.525E-01,8.810E-01,9,"DDC, INMT, CYP1A2, HIOM, AOX1, CYP2C19, ALDX, ALDH2, MAOB",
1323,Anandamide biosynthesis and metabolism,46,7.532E-01,8.762E-01,7.532E-01,8.762E-01,7,"PLC-delta, HRSL5, PLA2(hGIIA), PLC-beta, PLA2G10, FAAH, PLA2G5",8.548E-01,9.543E-01,8,"HRSL5, PLA2G1B, PLC-beta, PLA2G10, FAAH, PLC-delta, PLA2(hGIIA), PLA2G5",
1324,G-protein signaling_Rap2B regulation pathway,7,7.537E-01,8.762E-01,7.537E-01,8.762E-01,1,MR-GEF,8.366E-01,9.420E-01,1,MR-GEF,
1325,Leukotriene 4 biosynthesis and metabolism,40,7.576E-01,8.795E-01,7.576E-01,8.795E-01,6,"LTC4S, CYP4F12, GGT1, CYP4F2, LTA4H, DPEP2",9.201E-01,1.000E+00,6,"CYP4F12, GGT1, CYP4F2, AL3A2, LTA4H, DPEP2",
1326,Immune response_The effect of IDO1 on T cell metabolism,89,7.627E-01,8.816E-01,7.627E-01,8.816E-01,14,"PFKM, ACACA, G6PD, CISY, DHE4, p21, Arylformamidase, GLUT1, ACLY, DHE3, HXK2, SLC38A1, MDM2, eIF2S1",8.314E-01,9.410E-01,17,"CISY, p21, Arylformamidase, TIGAR (C12orf5), PDH, DHE3, HXK2, ASCT2 (SLC1A5), GLSL, MDM2, eIF2S1, PFKM, G6PD, DHE4, GLUT1, ACLY, SLC38A1",
1327,Regulation of CFTR gating (normal and CF),34,7.642E-01,8.816E-01,7.642E-01,8.816E-01,5,"CFTR, AMPK gamma1, PKA-reg (cAMP-dependent), PDE4D, Adenylate cyclase",9.678E-01,1.000E+00,4,"PKA-reg (cAMP-dependent), PDE4D, Adenylate cyclase, AMPK gamma1",
1328,L-Methionine metabolism,59,7.669E-01,8.833E-01,7.669E-01,8.833E-01,9,"DNMT3B, MTR, MAT1A, DNMT3A, SAHH, APIP, SLC38A1, SLC6A20, ENOPH1",8.938E-01,9.807E-01,10,"DNMT3B, MAT1A, MTR, DNMT3A, SAHH, APIP, SLC38A1, CCBL2, MAT2A, ENOPH1",
1329,Neurophysiological process_GABA-B receptor-mediated regulation of glutamate signaling in Purkinje cells,27,7.706E-01,8.955E-01,8.912E-01,9.740E-01,3,"G-protein alpha-i family, GBR2, IP3 receptor",7.706E-01,8.955E-01,5,"PLC-beta1, IP3 receptor, G-protein alpha-i family, GBR2, G-protein alpha-q",
1330,Neurophysiological process_Sweet taste signaling,27,7.706E-01,8.955E-01,8.912E-01,9.740E-01,3,"P2X2, P2Y2, Gustducin",7.706E-01,8.955E-01,5,"TRPM5, TAS1R3, P2X2, P2Y2, Gustducin",
1331,Sulfur metabolism,42,7.733E-01,8.955E-01,7.988E-01,9.027E-01,6,"GSHB, HSCO, PAPSS2, SUOX, AATM, SQRDL",7.733E-01,8.955E-01,8,"GSHB, SUOX, AATC, THTM, HSCO, PAPSS2, AATM, SQRDL",
1332,FAK1 signaling in melanoma,42,7.733E-01,8.955E-01,7.988E-01,9.027E-01,6,"GRB2, ERK1/2, NFKBIA, Vitronectin, FAK1, MEK1/2",7.733E-01,8.955E-01,8,"GRB2, ERK1/2, RhoC, Rac1, NFKBIA, Paxillin, Vitronectin, FAK1",
1333,TLR and EGFR-induced inflammatory signaling in normal and asthmatic airway epithelium,22,7.733E-01,8.955E-01,7.894E-01,8.976E-01,3,"ERK1/2, IRF3, CysLT1 receptor",7.733E-01,8.955E-01,4,"TLR5, ERK1/2, CysLT1 receptor, IRF3",
1334,Transition of Monoclonal gammopathy of undetermined significance to active multiple myeloma (schema),22,7.733E-01,8.955E-01,7.894E-01,8.976E-01,3,"FGFR3, MafB, Cyclin D1",7.733E-01,8.955E-01,4,"Cyclin D3, MafB, FGFR3, Cyclin D1",
1335,Immune response_IFN-gamma actions on blood cells,28,7.740E-01,8.882E-01,7.740E-01,8.882E-01,4,"PU.1, IRF8, GATA-1, IL-4",7.988E-01,9.177E-01,5,"IL-4, PU.1, c-Jun, Uteroglobin, Alpha1-globin",
1336,Release of pro-inflammatory mediators and elastolytic enzymes by alveolar macrophages in COPD,28,7.740E-01,8.882E-01,7.740E-01,8.882E-01,4,"MMP-1, Sirtuin1, MAPKAPK2, p38 MAPK",9.099E-01,9.936E-01,4,"MAPKAPK2, MMP-1, Sirtuin1, p38 MAPK",
1337,Signal transduction_Amino acid-dependent mTORC1 activation,96,7.771E-01,8.910E-01,7.771E-01,8.910E-01,15,"Tuberin, MAPBPIP, GATS-like3, MP1, p38delta (MAPK13), RagB, HBXIP, DHE3, Calmodulin, TUSC4, FLJ20625, MEK6(MAP2K6), WDR24, NPRL3, FLJ20323",8.589E-01,9.576E-01,18,"Tuberin, MAPBPIP, MP1, p38delta (MAPK13), IPMK, HBXIP, DHE3, FLJ20625, ASCT2 (SLC1A5), MEK6(MAP2K6), NPRL3, GATS-like3, Rab-1A, RagB, Calmodulin, TUSC4, WDR24, FLJ20323",
1338,Cell adhesion_Integrin inside-out signaling in T cells,52,7.787E-01,8.990E-01,8.564E-01,9.469E-01,7,"CCR7, URP2, G-protein alpha-i family, CCR6, PIP5KI, CD3, SDF-1",7.787E-01,8.990E-01,10,"URP2, Rac1, ZAP70, SDF-1, CALDAG-GEFI, CCR7, G-protein alpha-i family, CCR6, PIP5KI, TCR alpha/beta",
1339,Neurophysiological process_Glucose-inhibited neurons of ventromedial and arcuate nuclei (rodent model),41,7.789E-01,8.924E-01,7.789E-01,8.924E-01,6,"HXK1, CACNA1C, AMPK alpha subunit, CFTR, AMPK alpha 2 subunit, Guanylate Cyclase 1, soluble",8.573E-01,9.564E-01,7,"GLUT4, Guanylate Cyclase 1, soluble, HXK1, CACNA1C, AMPK alpha subunit, AMPK alpha 2 subunit, N-type Ca(II) channel alpha1B",
1340,Aberrant lipid trafficking and metabolism in age-related macular degeneration pathogenesis,60,7.843E-01,8.965E-01,7.843E-01,8.965E-01,9,"APCS, Clusterin, Cytochrome c, CD36, Vitronectin, PI3K reg class IA (p85), CD36L2, EEA1, Cathepsin D",9.508E-01,1.000E+00,9,"Clusterin, Cytochrome c, PI3K reg class IA (p85), CD36L2, EEA1, miR-33a-5p, Cathepsin D, CD36, Vitronectin",
1341,Immune response_Regulatory role of C1q in platelet activation,15,7.853E-01,8.965E-01,7.853E-01,8.965E-01,2,"Glycoprotein VI, PKC",8.882E-01,9.803E-01,2,"Glycoprotein VI, PKC",
1342,Mechanisms of CAM-DR in multiple myeloma,35,7.867E-01,8.965E-01,7.867E-01,8.965E-01,5,"gp130, Dsh, STAT3, HSP70, p27KIP1",9.268E-01,1.000E+00,5,"gp130, Dsh, HSP70, p27KIP1, Frizzled",
1343,Development_Schema: Adult neuron differentiation in the Subventricular and Subgranular Zones,35,7.867E-01,8.965E-01,7.867E-01,8.965E-01,5,"Doublecortin, hASH1, NEFM, TY3H, SOX2",8.418E-01,9.442E-01,6,"Doublecortin, WNT3A, TY3H, NT-3, hASH1, SOX2",
1344,Immune response_IFN-gamma signaling via JAK/STAT and PLC-gamma,54,7.877E-01,8.970E-01,7.877E-01,8.970E-01,8,"IRF8, PKA-reg (cAMP-dependent), MEF2B, IP3 receptor, STAT3, MEF2D, Calmodulin, Bcl-XL",9.913E-01,1.000E+00,6,"PKA-reg (cAMP-dependent), Rac1, IP3 receptor, Bcl-XL, MEF2D, Calmodulin",
1345,Interconnectivity between Folic acid and Fluorouracil pathways in gastric cancer,91,7.912E-01,8.989E-01,7.912E-01,8.989E-01,14,"ABCC11, MTR, SLC22A8, CES2, Aquaporin 3, SLC22A7, UPP2, UCK1, OPRT, SHMT2, CYP2A6, MRP3, ABCC5, ABCG2",9.459E-01,1.000E+00,15,"CES2, OPRT, SHMT2, ABCC11, MTR, SLC22A8, Aquaporin 3, SLC22A7, UPP2, UCK1, CYP2A6, MRP3, ABCC5, ABCG2, SLC22A6",
1346,Globo-(isoglobo) series GSL Metabolism,48,7.924E-01,8.996E-01,7.924E-01,8.996E-01,7,"SIAT4A, FUT1, GGTA1, A4GT, B3GT3, ST6GALNAC6, B3GT5",9.437E-01,1.000E+00,7,"SIAT4A, FUT1, GGTA1, A4GT, ST6GALNAC6, B3GT3, B3GT5",
1347,Role of type 2 innate lymphoid cells in asthma,38,7.958E-01,9.166E-01,8.442E-01,9.352E-01,5,"GATA-3, ROR-alpha, CRTH2, p70 S6 kinase1, IL-4",7.958E-01,9.166E-01,7,"IL-13, IL-9, IL-4, IL-2R alpha chain, GATA-3, IL-25 (IL-17E), p70 S6 kinase1",
1348,Cholesterol and Sphingolipid transport / Influx to the early endosome in lung (normal and CF),29,7.979E-01,9.027E-01,7.979E-01,9.027E-01,4,"Rab-4, DAB2, ARH, Clathrin",9.236E-01,1.000E+00,4,"DAB2, ARH, Rab-4, Clathrin",
1349,Cigarette smoke-mediated attenuation of antibacterial and antivirus immune response,29,7.979E-01,9.027E-01,7.979E-01,9.027E-01,4,"NFKBIA, AP-1, IKK-beta, IRF3",8.241E-01,9.348E-01,5,"IKK (cat), NFKBIA, AP-1, IKK-beta, IRF3",
1350,Estrogen biosynthesis,42,7.988E-01,9.027E-01,7.988E-01,9.027E-01,6,"CYP11B1, HSD17B3, HSD17B8, HSD17B1, HSD17B2, CYP3A4",9.766E-01,1.000E+00,5,"CYP11B1, HSD17B1, CYP19, CYP2C19, HSD17B8",
1351,Immune response_Induction of the antigen presentation machinery by IFN-gamma,53,7.993E-01,9.177E-01,8.696E-01,9.581E-01,7,"MHC class II, ASH2L, PRMT5, USF1, PSME1, Sirtuin1, WDR5",7.993E-01,9.177E-01,10,"MHC class II, ASH2L, PRMT5, USF1, PSME2, Nucleophosmin, WDR5, RFX5, PSME1, Sirtuin1",
1352,Immune response_iC3b-induced phagocytosis via alpha-M/beta-2 integrin,61,8.007E-01,9.042E-01,8.007E-01,9.042E-01,9,"PI4K2B, Myosin II, PAK1, PIP5KI, IP3 receptor, PI3K reg class IA (p85), PKC, VAV-3, p40-phox",9.157E-01,9.978E-01,10,"Rac1, IP3 receptor, PI3K reg class IA (p85), PI4K2B, Myosin II, PAK1, PIP5KI, PKC, VAV-3, p40-phox",
1353,Androgen signaling in HCC,18,8.136E-01,9.292E-01,8.642E-01,9.528E-01,2,"E2F1, Androgen receptor",8.136E-01,9.292E-01,3,"EGR1, Androgen receptor, E2F1",
1354,Environmental factors-induced inflammatory signaling in normal and asthmatic airway epithelium,43,8.172E-01,9.172E-01,8.172E-01,9.172E-01,6,"p38alpha (MAPK14), ERK1/2, PKC, PLC-beta, eNOS, p38 MAPK",9.803E-01,1.000E+00,5,"ERK1/2, PLC-beta, PKC, eNOS, p38 MAPK",
1355,Transition of HCC cells to invasive and migratory phenotype,44,8.175E-01,9.288E-01,8.343E-01,9.288E-01,6,"DNMT3B, E-cadherin, c-Fos, MMP-1, AKT(PKB), PDK (PDPK1)",8.175E-01,9.303E-01,8,"DNMT3B, c-Fos, EGR1, AKT(PKB), PDK (PDPK1), E-cadherin, MMP-1, miR-9-5p",
1356,Bacterial infections in CF airways,49,8.176E-01,9.303E-01,9.013E-01,9.800E-01,6,"SP-A, TBK1, CFTR, MUC1, SP-D, IRF3",8.176E-01,9.303E-01,9,"TLR5, TBK1, MUC1, MyD88, SP-D, SP-A, Beta-defensin 2, IRF3, TRIF (TICAM1)",
1357,Nociception_Pro-nociceptive action of Nociceptin in spinal cord at low doses,39,8.183E-01,9.303E-01,9.814E-01,1.000E+00,3,"Substance P, Calmodulin, GABA-A receptor",8.183E-01,9.303E-01,7,"NMDA receptor, GABA-A receptor, NR2, Substance P, Calmodulin, Nociceptin, Prepronociceptin",
1358,Reactive oxygen and nitrogen species production in eosinophils in asthma,59,8.196E-01,9.311E-01,9.688E-01,1.000E+00,6,"C5aR, CCR3, CRTH2, ITGAM, PI3K reg class IA (p85), PERE",8.196E-01,9.311E-01,11,"PKC-zeta, IL-3, PI3K reg class IA (p85), SOD1, C3aR, C5aR, CCR3, PKC-delta, ITGAM, IL-5 receptor, PERE",
1359,Gamma-secretase regulation of angiogenesis,30,8.196E-01,9.172E-01,8.196E-01,9.172E-01,4,"Presenilin 1, Presenilin, VEGFR-1, TIE",8.468E-01,9.476E-01,5,"Presenilin 1, HEY1, Presenilin, VEGFR-1, DLL4",
1360,Fatty Acid Omega Oxidation,30,8.196E-01,9.172E-01,8.196E-01,9.172E-01,4,"SCPX, ADH7, ACADVL, DHB4",8.468E-01,9.476E-01,5,"SCPX, ADH7, DHB4, AL3A2, ACADVL",
1361,L-Carnitine biosynthesis,30,8.196E-01,9.172E-01,8.196E-01,9.172E-01,4,"SLC22A8, ALD9A1, OCTN2, GAT2",9.354E-01,1.000E+00,4,"GAT2, SLC22A8, ALD9A1, OCTN2",
1362,Catecholamine metabolism,75,8.235E-01,9.209E-01,8.235E-01,9.209E-01,11,"ALD9A1, SULT1A3, AOC2, COMT, SULT1A1, DDC, TY3H, ALDH2, AL3A1, ADHB, AOC3",9.439E-01,1.000E+00,12,"SULT1A3, COMT, DDC, TY3H, DBH, ALD9A1, AOC2, PNMT, SULT1A1, ALDH2, AOC3, MAOB",
1363,Immune response_Lectin induced complement pathway,50,8.267E-01,9.224E-01,8.267E-01,9.224E-01,7,"C5aR, MCP, Clusterin, C8gamma, L-Ficolin, C1qRp, H-Ficolin",8.362E-01,9.420E-01,9,"Clusterin, C8gamma, L-Ficolin, C3aR, MBL2, C5aR, MCP, C1qRp, C9",
1364,Peroxisomal branched chain fatty acid oxidation,84,8.292E-01,9.398E-01,8.569E-01,9.469E-01,12,"SCPX, PCCB, CROT, ACOX3, CPT II, CPT-1B, ACOX2, CPT-1A, MUTA, MCEE, ACAA1, DHB4",8.292E-01,9.398E-01,16,"SCPX, PCCB, CROT, ACOX2, CPT-1A, MUTA, MCEE, DHB4, PCC, PCCA, AL3A2, HADHB, ACOX3, CPT II, CPT-1B, ACAA1",
1365,n-3 Polyunsaturated fatty acid biosynthesis,63,8.308E-01,9.263E-01,8.308E-01,9.263E-01,9,"SCPX, ACOX3, ACOX2, ELOVL3, ACSL3, ACOX1, ACAA1, DHB4, ELOVL2",8.800E-01,9.746E-01,11,"SCPX, ELOVL5, ACOX2, ACSL3, ACOX1, DHB4, ELOVL2, ACSL1, ACOX3, ELOVL3, ACAA1",
1366,Release of pro-inflammatory factors and proteases by alveolar macrophages in asthma,44,8.343E-01,9.288E-01,8.343E-01,9.288E-01,6,"MIG, SP-A, MMP-1, IL-30, SP-D, IRF5",9.834E-01,1.000E+00,5,"IL-30, SP-D, SP-A, MMP-1, IRF5",
1367,Stem cells_Excitotoxicity of Glutamate in glioblastoma,45,8.370E-01,9.420E-01,9.739E-01,1.000E+00,4,"GSHB, SLC1A2/EAAT2, G-protein alpha-i family, GSHR",8.370E-01,9.420E-01,8,"GSHB, SLC1A2/EAAT2, NMDA receptor, AATC, G-protein alpha-i family, SLC1A1/EAAT3, mGluR3, GSHR",
1368,Mitochondrial ketone bodies biosynthesis and metabolism,24,8.372E-01,9.306E-01,8.372E-01,9.306E-01,3,"AACS, HMGCS2, BDH",9.356E-01,1.000E+00,3,"AACS, HMGCS2, BDH",
1369,Tyrosine metabolism p.1 (dopamine) ,70,8.401E-01,9.331E-01,8.401E-01,9.331E-01,10,"ALD9A1, AOC2, COMT, DDC, TY3H, ALDH2, AL3A1, ADHB, AOC3, ABP1",9.021E-01,9.873E-01,12,"COMT, DDC, TY3H, DBH, ALD9A1, AOC2, PNMT, PAH, ALDH2, AOC3, ABP1, MAOB",
1370,Development_NOTCH-induced EMT,19,8.425E-01,9.442E-01,9.777E-01,1.000E+00,1,E-cadherin,8.425E-01,9.442E-01,3,"HEY1, E-cadherin, DLL4",
1371,Role of TGF-beta 1 in fibrosis development after myocardial infarction,38,8.442E-01,9.352E-01,8.442E-01,9.352E-01,5,"MMP-1, AGTR1, Thymosin beta-4, ACE1, SP1",9.545E-01,1.000E+00,5,"ACE1, MMP-1, AGTR1, Thymosin beta-4, SP1",
1372,Myeloid-derived suppressor cells and M2 macrophages in cancer,64,8.444E-01,9.352E-01,8.444E-01,9.352E-01,9,"IRF8, VEGFR-1, KLF4, STAT3, ARG1, STAT6, IL-4, G-CSF, CAT-2",9.877E-01,1.000E+00,8,"KLF4, ARG1, IL-13, IL-4, VEGFR-1, STAT6, G-CSF, CAT-2",
1373,Immune response_IFN-alpha/beta signaling via JAK/STAT,64,8.444E-01,9.352E-01,8.444E-01,9.352E-01,9,"MIG, STAT2, p21, STAT3, IFN-alpha, ISG20, Bcl-2, PIG3, STAT6",9.877E-01,1.000E+00,8,"p21, IFN-alpha, STAT2, C3G, Caspase-7, ISG20, Bcl-2, STAT6",
1374,Transport_Intracellular cholesterol transport,83,8.456E-01,9.358E-01,8.456E-01,9.358E-01,12,"SCPX, Rab-4, NPC1L1, ABCG1, ARF1, DAB2, ARH, Rab-11A, CD36L2, PLEKHA8 (FAPP2), ABCG5/ABCG8 heterodimer, StARD5",8.792E-01,9.746E-01,15,"SCPX, NPC1L1, ABCG1, DAB2, ARH, Rab-7, CD36L2, PLEKHA8 (FAPP2), StARD5, EHD1, Rab-4, ARF1, Rab-11A, MLN64, ABCG5/ABCG8 heterodimer",
1375,Tricarbonic acid cycle,61,8.522E-01,9.525E-01,9.430E-01,1.000E+00,7,"SDHC, SCS-G, CISY, SUCLG2, IDH2, ODO2, SUCLG1",8.522E-01,9.525E-01,11,"SCS-G, CISY, SUCLG2, IDH2, ODO2, MDH2, SUCLG1, SCS-A, SDHC, ACON, SUCB1",
1376,"VLDL, LDL dyslipidemia in type 2 diabetes and metabolic syndrome X",39,8.602E-01,9.499E-01,8.602E-01,9.499E-01,5,"APOB48 receptor, Insulin processed, CD36, Insulin receptor, ALOX15",9.079E-01,9.929E-01,6,"Insulin processed, Insulin receptor, APOB48 receptor, CD36, APOC3, ALOX15",
1377,Mechanisms of hapten presentation to T cells in allergic contact dermatitis,20,8.674E-01,9.641E-01,9.009E-01,9.800E-01,2,"MHC class II, ALDH2",8.674E-01,9.641E-01,3,"MHC class II, ALDH2, TCR alpha/beta",
1378,Interaction of deficient alpha-MSH signaling with TNF-alpha in melanoma,33,8.735E-01,9.610E-01,8.735E-01,9.610E-01,4,"E-cadherin, PKA-reg (cAMP-dependent), NFKBIA, IKK-beta",9.008E-01,9.865E-01,5,"PKA-reg (cAMP-dependent), IKK-alpha, E-cadherin, NFKBIA, IKK-beta",
1379,Phospholipid metabolism p.2,47,8.779E-01,9.637E-01,8.779E-01,9.637E-01,6,"PCY1A, HRSL5, CHKA, PCY2, CHPT1, Neutral sphingomyelinase",9.352E-01,1.000E+00,7,"PCY1A, HRSL5, Neutral sphingomyelinase, CHKA, PCY2, CHPT1, EKI1",
1380,Stem cells_Role of ion channels in glioblastoma cell invasion,32,8.850E-01,9.786E-01,9.867E-01,1.000E+00,2,"MaxiK alpha subunit, SLC12A7",8.850E-01,9.786E-01,5,"MaxiK alpha subunit, CLCN2, GluR1, SLC12A7, CLCN3",
1381,Cell cycle_Start of DNA replication in early S phase,32,8.850E-01,9.786E-01,9.465E-01,1.000E+00,3,"RPA3, E2F1, CDC18L (CDC6)",8.850E-01,9.786E-01,5,"RPA3, E2F1, ORC3L, CDC18L (CDC6), ORC5L",
1382,n-6 Polyunsaturated fatty acid biosynthesis,61,8.861E-01,9.719E-01,8.861E-01,9.719E-01,8,"SCPX, ACOX3, ACOX2, ELOVL3, ACOX1, ACAA1, DHB4, ELOVL2",9.157E-01,9.978E-01,10,"SCPX, ELOVL7, ELOVL5, ACOX2, ACOX1, DHB4, ELOVL2, ACOX3, ELOVL3, ACAA1",
1383,Putative pathways of MHC class I-dependent postsynaptic long-term depression in major depressive disorder,21,8.888E-01,9.803E-01,9.851E-01,1.000E+00,1,SHP-1,8.888E-01,9.803E-01,3,"SHP-1, PA28 (11S regulator), SHP-2",
1384,Multiple sclerosis (general schema),21,8.888E-01,9.803E-01,9.156E-01,9.905E-01,2,"WNT9A, Transthyretin",8.888E-01,9.803E-01,3,"FasL(TNFSF6), WNT9A, Transthyretin",
1385,N-Glycan biosynthesis p2,43,8.892E-01,9.803E-01,9.113E-01,9.882E-01,5,"MGAT4A, FUT8, MA1C1, B4GT3, MA2A2",8.892E-01,9.803E-01,7,"MA1B1, MGAT4A, B4GT3, MA2A2, FUT8, MA1C1, GCS1",
1386,Vitamin E (alfa-tocopherol) metabolism,81,8.907E-01,9.740E-01,8.907E-01,9.740E-01,11,"SCPX, PTE1, ACOX3, PTE2, AMACR, CYP4F2, ACOX2, ACSL3, ACOX1, ACAA1, DHB4",9.729E-01,1.000E+00,12,"SCPX, PTE1, AMACR, CYP4F2, ACOX2, ACSL3, ACOX1, DHB4, ACSL1, ACOX3, PTE2, ACAA1",
1387,Aminoacyl-tRNA biosynthesis in mitochondrion,81,8.907E-01,9.740E-01,8.907E-01,9.740E-01,11,"SARS2, RARSL, MARS2, SYPM, IARS2, TARSL1, YARS2, EARS2, DARS2, NARS2, SYHH",9.870E-01,1.000E+00,11,"SARS2, SYPM, EARS2, NARS2, RARSL, MARS2, IARS2, TARSL1, YARS2, DARS2, SYHH",
1388,Triacylglycerol metabolism p.2,27,8.912E-01,9.740E-01,8.912E-01,9.740E-01,3,"LIPS, DGAT1, LIPG",8.940E-01,9.807E-01,4,"CEL, LIPS, LIPP, DGAT1",
1389,Renal secretion of inorganic electrolytes,59,8.938E-01,9.807E-01,9.293E-01,9.974E-01,7,"SLC4A10, Aquaporin 3, SLC4A8, SLC34A3, SLC12A1, Carbonic anhydrase IV, Klotho",8.938E-01,9.807E-01,10,"SLC34A3, SLC12A3, Epithelial calcium channel, SLC4A10, Aquaporin 3, PMCA1, SLC4A8, SLC12A1, Aquaporin 2, Klotho",
1390,Notch signaling in oligodendrocyte precursor cell differentiation in multiple sclerosis,27,8.940E-01,9.807E-01,9.687E-01,1.000E+00,2,"hASH1, CNTN6",8.940E-01,9.807E-01,4,"hASH1, MAML1, MAG, CNTN6",
1391,Cholesterol and Sphingolipid transport / Distribution to the intracellular membrane compartments (normal and CF),38,8.941E-01,9.807E-01,9.783E-01,1.000E+00,3,"SCPX, ABCA3, StARD5",8.941E-01,9.807E-01,6,"SCPX, Rab-7, OSBPL5, StARD5, MLN64, ABCA3",
1392,Cortisol biosynthesis from Cholesterol,38,8.941E-01,9.807E-01,9.783E-01,1.000E+00,3,"CYP11B1, HSD17B2, HSD3B2",8.941E-01,9.807E-01,6,"CYP11B1, STAR, CYP2C19, HSD3B2, CYP11B2, CYP17",
1393,HETE and HPETE biosynthesis and metabolism,82,8.996E-01,9.800E-01,8.996E-01,9.800E-01,11,"CYP2C8, ALOX12B, CYP2J2, CYP4F2, COX-1 (PTGS1), EPHX2, ALOX12, GPX4, MGST3, ALOX15B, ALOX15",9.982E-01,1.000E+00,9,"CYP4F2, EPHX2, ALOX12B, CYP2E1, CYP2J2, GPX4, MGST3, ALOX15B, ALOX15",
1394,Endothelin-1- and TNF-alpha-induced inflammatory response in asthmatic airway fibroblasts,20,9.009E-01,9.800E-01,9.009E-01,9.800E-01,2,"MGF, IL-1RI",9.610E-01,1.000E+00,2,"IL-1RI, MGF",
1395,Beta-alanine metabolism,35,9.012E-01,9.800E-01,9.012E-01,9.800E-01,4,"ALD9A1, CSAD, GABT, ABP1",9.731E-01,1.000E+00,4,"CSAD, ALD9A1, GABT, ABP1",
1396,Gamma-secretase proteolytic targets,76,9.039E-01,9.822E-01,9.039E-01,9.822E-01,10,"E-cadherin, LRP1B (CTF), DLL1 (TMIC), VEGFR-1, DLL1 (IC), DLL1, E-cadherin (CTF2), LRP1B, LRP1B (ICD), E-cadherin (CTF1)",9.882E-01,1.000E+00,10,"DLL1 (IC), DLL1, E-cadherin (CTF2), E-cadherin (CTF1), E-cadherin, LRP1B (CTF), DLL1 (TMIC), VEGFR-1, LRP1B, LRP1B (ICD)",
1397,Putative pathways of activation of classical complement system in major depressive disorder,28,9.099E-01,9.936E-01,9.963E-01,1.000E+00,1,C1qRp,9.099E-01,9.936E-01,4,"C1qc, C1qRp, C1qa, C9",
1398,Protein folding and maturation_Posttranslational processing of neuroendocrine peptides,50,9.115E-01,9.882E-01,9.115E-01,9.882E-01,6,"CCK8, CCK8-Gly, PC2, Carboxypeptidase H, Pro-CCK, CCK8-GlyArgArg",9.830E-01,1.000E+00,6,"CCK8-GlyArgArg, CCK8, CCK8-Gly, PC2, Carboxypeptidase H, Pro-CCK",
1399,Prostaglandin 1 biosynthesis and metabolism,57,9.128E-01,9.889E-01,9.128E-01,9.889E-01,7,"HPGD, CYP4F12, Acyl-CoA synthetase, COX-1 (PTGS1), ZADH1, ALOX15B, PGES2",9.948E-01,1.000E+00,6,"HPGD, CYP4F12, PGES2, Acyl-CoA synthetase, ZADH1, ALOX15B",
1400,Polyamine metabolism,64,9.147E-01,9.903E-01,9.147E-01,9.903E-01,8,"ALD9A1, AOC2, PAOX, GATM, ARG1, ALDH2, AOC3, ABP1",9.413E-01,1.000E+00,10,"PAOX, GATM, ARG1, ARG2, ALD9A1, AOC2, ALDH2, AOC3, ABP1, MAOB",
1401,Cholesterol and Sphingolipid transport / Recycling to plasma membrane in lung (normal and CF),29,9.177E-01,9.921E-01,9.177E-01,9.921E-01,3,"SCPX, ABCG1, Rab-11A",9.236E-01,1.000E+00,4,"SCPX, ABCG1, EHD1, Rab-11A",
1402,Neurophysiological process_GABAergic neurotransmission,51,9.207E-01,9.943E-01,9.207E-01,9.943E-01,6,"G-protein alpha-i family, GLNA, GBR2, GABA-A receptor, GABT, GAT2",9.635E-01,1.000E+00,7,"AATC, GABA-A receptor, GAT2, G-protein alpha-i family, GLNA, GBR2, GABT",
1403,Thiamine metabolism,44,9.211E-01,9.943E-01,9.211E-01,9.943E-01,5,"TPK1, SLC19A2, SLC25A19, SLC44A4, THTPA",9.834E-01,1.000E+00,5,"TPK1, SLC19A2, THTPA, SLC25A19, SLC44A4",
1404,Ascorbate metabolism,23,9.225E-01,1.000E+00,9.900E-01,1.000E+00,1,GSTO2,9.225E-01,1.000E+00,3,"GSTO1, DBH, GSTO2",
1405,Gamma-secretase regulation of osteogenesis,37,9.234E-01,9.953E-01,9.234E-01,9.953E-01,4,"SP7, DLL1, Cyclin D1, Collagen X",9.813E-01,1.000E+00,4,"SP7, DLL1, HEY1, Cyclin D1",
1406,Immune response_TLR ligands,35,9.268E-01,1.000E+00,9.657E-01,1.000E+00,3,"SP-A, HSP60, HSP70",9.268E-01,1.000E+00,5,"TLR5, HSP60, HSP70, SP-A, LBP",
1407,Taurine and hypotaurine metabolism,22,9.282E-01,9.974E-01,9.282E-01,9.974E-01,2,"CSAD, ADO",9.748E-01,1.000E+00,2,"CSAD, ADO",
1408,PDGF activation of prostacyclin synthesis ,30,9.286E-01,9.974E-01,9.286E-01,9.974E-01,3,"PDGF-B, IP3 receptor, Calmodulin",9.354E-01,1.000E+00,4,"PDGF-B, IP3 receptor, Prostacyclin receptor, Calmodulin",
1409,Protein folding and maturation_POMC processing,30,9.286E-01,9.974E-01,9.286E-01,9.974E-01,3,"NAT-1, PC2, Carboxypeptidase H",9.798E-01,1.000E+00,3,"NAT-1, PC2, Carboxypeptidase H",
1410,Signal transduction_Production and main functions of biologically active prostaglandins and Thromboxane A2,59,9.293E-01,9.974E-01,9.293E-01,9.974E-01,7,"CRTH2, SLC16A5, PGE2R3, COX-1 (PTGS1), cPLA2, PGES2, ABCC2",9.964E-01,1.000E+00,6,"SLC16A5, Prostacyclin receptor, cPLA2, PGES2, PGE2R3, ABCC2",
1411,Mitochondrial beta-oxidation of long-chain saturated fatty acids,125,9.293E-01,9.974E-01,9.293E-01,9.974E-01,17,"A-FABP, M-FABP, SLC27A3, CAC, CPT II, CPT-1B, CD36, CPT-1A, ACADVL, ACSBG1, ACSL3, HCD2, HCDH, B-FABP, SLC27A4, ECHS1, VLCSH2",9.870E-01,1.000E+00,19,"SLC27A3, CAC, CPT-1A, ACSL3, HCDH, B-FABP, ECHS1, VLCSH2, ACSL1, M-FABP, HADHB, ACAD-9, CPT II, CPT-1B, CD36, ACADVL, ACSBG1, HCD2, SLC27A4",
1412,Oxidative phosphorylation,41,9.309E-01,1.000E+00,9.863E-01,1.000E+00,3,"SLC25A6, Cytochrome c, SLC25A3",9.309E-01,1.000E+00,6,"Cytochrome c, SLC25A4, ATP(F1), SLC25A6, SLC25A5, SLC25A3",
1413,Aldosterone biosynthesis and metabolism,38,9.327E-01,9.996E-01,9.327E-01,9.996E-01,4,"AK1D1, AKR1C4, UGT2B4, HSD11B2",9.961E-01,1.000E+00,3,"HSD11B2, CYP11B2, UGT2B4",
1414,HDL dyslipidemia in type 2 diabetes and metabolic syndrome X,38,9.327E-01,9.996E-01,9.327E-01,9.996E-01,4,"ABCG1, S1P3 receptor, PERM, PON1",9.961E-01,1.000E+00,3,"ABCG1, S1P3 receptor, PERM",
1415,Immune response_Antiviral actions of Interferons,53,9.367E-01,1.000E+00,9.367E-01,1.000E+00,6,"STAT2, MHC class II, IFN-alpha, RNaseL, IRF3, eIF2S1",9.897E-01,1.000E+00,6,"MHC class II, IFN-alpha, eIF2S1, STAT2, RNaseL, IRF3",
1416,Metabolism of L-Proline and derivatives,74,9.371E-01,1.000E+00,9.380E-01,1.000E+00,9,"CRYM, PYCS, ASCT1 (SLC1A4), AL4A1, P5CR1, AATM, Proline oxidase 1, SLC6A20, SLC6A7",9.371E-01,1.000E+00,12,"CRYM, Proline oxidase 1, SLC6A7, DHDPSL, PYCS, ASCT1 (SLC1A4), AL4A1, OAT, P5CR1, SLC6A17, AATM, DAAO",
1417,Stem cells_MMP-14-induced COX-2 expression in glioblastoma stem cells,23,9.390E-01,1.000E+00,9.390E-01,1.000E+00,2,"cPLA2, AKT(PKB)",9.798E-01,1.000E+00,2,"cPLA2, AKT(PKB)",
1418,Keratan sulfate metabolism p.2,39,9.410E-01,1.000E+00,9.410E-01,1.000E+00,4,"SIAT4A, FUT7, B4GT3, CHST1",9.613E-01,1.000E+00,5,"SIAT4A, B4GT3, CHST1, SIAT4C, FUT7",
1419,"Triacylglycerol biosynthesis in obesity and diabetes mellitus, type II",24,9.483E-01,1.000E+00,9.483E-01,1.000E+00,2,"DGAT1, PLCC",9.838E-01,1.000E+00,2,"PLCC, DGAT1",
1420,Immune response_IL-27 signaling pathway,24,9.483E-01,1.000E+00,9.483E-01,1.000E+00,2,"gp130, STAT3",9.838E-01,1.000E+00,2,"gp130, c-Myc",
1421,"Mechanism of action of DGAT1 inhibitors in obesity and diabetes mellitus, type II (Variant 1)",24,9.483E-01,1.000E+00,9.483E-01,1.000E+00,2,"DGAT1, PLCC",9.838E-01,1.000E+00,2,"PLCC, DGAT1",
1422,Heparan sulfate/heparin metabolism,62,9.489E-01,1.000E+00,9.489E-01,1.000E+00,7,"EXTL1, HSST4, 3-OST4, HS6ST3, HSST2, 3-OST5, OST2",9.994E-01,1.000E+00,5,"HSST4, HSST2, 3-OST5, HSST1, HS6ST3",
1423,L-Tryptophan metabolism (part 2),97,9.522E-01,1.000E+00,9.522E-01,1.000E+00,12,"CRAT, KMO, CAC, DHTKD1, CROT, AATM, HCD2, HCDH, ODO2, ECHS1, ACAA1, GCDH",9.931E-01,1.000E+00,13,"KMO, CAC, CROT, HCDH, ODO2, ECHS1, CRAT, DHTKD1, AATM, HCD2, ACAA1, CCBL2, GCDH",
1424,Cell cycle_Role of APC in cell cycle regulation,32,9.542E-01,1.000E+00,9.867E-01,1.000E+00,2,"CDH1, CDC18L (CDC6)",9.542E-01,1.000E+00,4,"Kid, CDH1, Aurora-A, CDC18L (CDC6)",
1425,Hypothetical role of microRNAs in fibrosis development after myocardial infarction,26,9.558E-01,1.000E+00,9.629E-01,1.000E+00,2,"PTEN, AKT(PKB)",9.558E-01,1.000E+00,3,"AKT(PKB), miR-30c-5p, PTEN",
1426,Development_NOTCH1-mediated pathway for NF-KB activity modulation,26,9.558E-01,1.000E+00,9.629E-01,1.000E+00,2,"NFKBIA, DLL1",9.558E-01,1.000E+00,3,"DLL1, MAML1, NFKBIA",
1427,Phosphatidylinositol metabolism,85,9.590E-01,1.000E+00,9.590E-01,1.000E+00,10,"P3C2B, OCRL, PIB4, PI4Kalpha, MTMR7, IP3KB, PTEN, CDIPT, INPP4B, Jumpy",9.677E-01,1.000E+00,13,"SYNJ2, PIB4, PLC-beta1, MTMR7, IP3KB, CDIPT, Jumpy, P3C2B, OCRL, PI4Kalpha, 3-PAP, PTEN, INPP4B",
1428,Pentose phosphate pathway,34,9.602E-01,1.000E+00,9.602E-01,1.000E+00,3,"G6PD, CARKL, TALDO",9.910E-01,1.000E+00,3,"CARKL, G6PD, TALDO",
1429,Vitamin B6 metabolism,34,9.602E-01,1.000E+00,9.602E-01,1.000E+00,3,"PNPO, Phospho2, AOX1",9.910E-01,1.000E+00,3,"Phospho2, AOX1, PNPO",
1430,Mitochondrial unsaturated fatty acid beta-oxidation,45,9.621E-01,1.000E+00,9.739E-01,1.000E+00,4,"DCI, ACSL3, HCDH, ECHS1",9.621E-01,1.000E+00,6,"ACSL3, HCDH, ECHS1, ACSL1, HADHB, DCI",
1431,L-Tryptophan metabolism (part 1),80,9.664E-01,1.000E+00,9.664E-01,1.000E+00,9,"ALD9A1, DDC, Arylformamidase, INMT, SLC7A8, TPH2, ALDH2, TDO2, OSCP1",9.692E-01,1.000E+00,12,"DDC, Arylformamidase, INMT, TPH2, ASCT2 (SLC1A5), SLC7A9, ALD9A1, SLC7A8, ALDH2, TDO2, OSCP1, MAOB",
1432,Bile Acid Biosynthesis,94,9.667E-01,1.000E+00,9.667E-01,1.000E+00,11,"SCPX, AK1D1, PTE1, PTE2, AMACR, ACOX2, AKR1C4, HSD3B7, ADHB, DHB4, VLCSH2",9.999E-01,1.000E+00,8,"SCPX, PTE1, AMACR, ACOX2, DHB4, VLCSH2, PTE2, HSD3B7",
1433,Putative mechanism of drug action for CCR5 antagonists,17,9.668E-01,1.000E+00,9.668E-01,1.000E+00,1,CCR5,9.877E-01,1.000E+00,1,CCR5,
1434,Cortisone biosynthesis and metabolism,51,9.669E-01,1.000E+00,9.669E-01,1.000E+00,5,"CYP11B1, AK1D1, AKR1C4, HSD3B2, HSD11B2",9.953E-01,1.000E+00,5,"CYP11B1, HSD3B2, HSD11B2, CYP11B2, CYP17",
1435,L-Phenylalanine metabolism,74,9.670E-01,1.000E+00,9.702E-01,1.000E+00,8,"GLYATL1, rBAT, DDC, AATM, SLC7A8, ALDH2, SLC6A20, HPD",9.670E-01,1.000E+00,11,"GLYATL1, DDC, AATC, SLC7A10, SLC7A9, PAH, AATM, SLC7A8, ALDH2, HPD, MAOB",
1436,Saturated fatty acids synthesis to hexadecanoic acid,101,9.671E-01,1.000E+00,9.671E-01,1.000E+00,12,"CBR4, ACACA, FABD, NDUFAB1, SLC25A1, HSD17B8, OXSM, SLC25A10, FASN, ACSF3, ACLY, OLAH",9.994E-01,1.000E+00,11,"NDUFAB1, SLC25A1, SLC25A10, FASN, THEM2, CBR4, FABD, HSD17B8, OXSM, ACSF3, ACLY",
1437,Metabolism in pancreatic cancer cells,66,9.675E-01,1.000E+00,9.675E-01,1.000E+00,7,"GSHB, DHE4, GLUT1, ALDOA, DHE3, SLC38A1, TALDO",9.910E-01,1.000E+00,8,"GSHB, GLUT4, DHE3, DHE4, GLUT1, ALDOA, SLC38A1, TALDO",
1438,Cell cycle_Chromosome condensation in prometaphase,21,9.687E-01,1.000E+00,9.851E-01,1.000E+00,1,TOP1,9.687E-01,1.000E+00,2,"TOP1, Aurora-A",
1439,Chondroitin sulfate and dermatan sulfate metabolism,60,9.724E-01,1.000E+00,9.724E-01,1.000E+00,6,"B3GA3, ST4S6, CHSTD, B3GA2, Uronyl-2-sulfotransferase, XYLT2",9.992E-01,1.000E+00,5,"ST4S6, B3GA2, Uronyl-2-sulfotransferase, XYLT2, B3GA3",
1440,Androgen biosynthetic pathways,82,9.729E-01,1.000E+00,9.729E-01,1.000E+00,9,"CYP11B1, SULT2B1, HSD17B3, STS, HSD17B1, HSD17B2, AKR1C4, HSD3B2, HSD11B2",9.952E-01,1.000E+00,10,"CYP11B1, SULT2B1, STS, HSD17B1, STAR, CYP2C19, HSD3B2, HSD11B2, CYP11B2, CYP17",
1441,Immune response_Classical complement pathway,53,9.730E-01,1.000E+00,9.745E-01,1.000E+00,5,"C5aR, MCP, Clusterin, C8gamma, C1qRp",9.730E-01,1.000E+00,7,"Clusterin, C8gamma, C3aR, C5aR, MCP, C1qRp, C9",
1442,Development_Astrocyte differentiation (general schema),28,9.736E-01,1.000E+00,9.736E-01,1.000E+00,2,"STAT3, DLL1",9.993E-01,1.000E+00,1,DLL1,
1443,Cholesterol and Sphingolipid transport / Transport from Golgi and ER to the apical membrane (normal and CF),37,9.747E-01,1.000E+00,9.747E-01,1.000E+00,3,"SCPX, ARF1, PLEKHA8 (FAPP2)",9.952E-01,1.000E+00,3,"SCPX, PLEKHA8 (FAPP2), ARF1",
1444,Expression targets of Tissue factor signaling in cancer,22,9.748E-01,1.000E+00,9.878E-01,1.000E+00,1,Coagulation factor VII,9.748E-01,1.000E+00,2,"Coagulation factor VII, Thrombin",
1445,Neolacto-series GSL Metabolism p.2,61,9.756E-01,1.000E+00,9.756E-01,1.000E+00,6,"FUT7, GALGT2, FUT6, B4GT3, ST6GALNAC6, CHST1",9.924E-01,1.000E+00,7,"FUT6, B4GT3, ST6GALNAC6, CHST1, SIAT4C, FUT7, GALGT2",
1446,Cigarette smoke components TCDD and Benzo[a]pyrene and receptor AHR signaling in lung epithelial cells,36,9.776E-01,1.000E+00,9.934E-01,1.000E+00,2,"Mucin 5AC, NQO1",9.776E-01,1.000E+00,4,"ARNT, Uteroglobin, Mucin 5AC, NQO1",
1447,Cell cycle_The metaphase checkpoint,36,9.776E-01,1.000E+00,9.934E-01,1.000E+00,2,"HZwint-1, Aurora-C",9.776E-01,1.000E+00,4,"DSN1, Aurora-C, HZwint-1, Aurora-A",
1448,Vitamin D2 (ergocalciferol) metabolism,29,9.777E-01,1.000E+00,9.777E-01,1.000E+00,2,"CYP2R1, CYP3A4",9.995E-01,1.000E+00,1,CYP2R1,
1449,Glycine and L-Serine metabolism,133,9.789E-01,1.000E+00,9.789E-01,1.000E+00,16,"CHDH, GlyT2, AGXT, ASCT1 (SLC1A4), rBAT, KBL, SLC7A8, SDSL, GNMT, GCSP, SLC38A1, SHMT2, PSP, AOC3, GRHPR, SLC25A38",9.827E-01,1.000E+00,21,"AGXT, ASCT2 (SLC1A5), SHMT2, SLC7A10, SLC25A38, SLC7A9, CHDH, SARDH, ASCT1 (SLC1A4), KBL, SLC6A17, SLC7A8, SDSL, SDHL, SFXN1, GNMT, GCSP, SLC38A1, PSP, AOC3, GRHPR",
1450,Renal secretion of drugs / Rodent version ,47,9.804E-01,1.000E+00,9.804E-01,1.000E+00,4,"SLC22A8, SLC22A7, SLCO4C1, ABCC2",9.903E-01,1.000E+00,5,"SLC22A8, SLC22A7, SLCO4C1, SLC22A6, ABCC2",
1451,Alternative complement cascade disruption in age-related macular degeneration,31,9.834E-01,1.000E+00,9.842E-01,1.000E+00,2,"C5aR, Factor D",9.834E-01,1.000E+00,3,"C3aR, C5aR, Factor D",
1452,Neolacto-series GSL Metabolism p.1,72,9.841E-01,1.000E+00,9.841E-01,1.000E+00,7,"FUT7, G3ST2, FUT1, FUT6, B4GT3, Fuc-TIX, B3GA2",9.966E-01,1.000E+00,8,"FUT1, FUT6, B4GT3, B3GA2, SIAT4C, FUT7, G3ST2, Fuc-TIX",
1453,Cholesterol metabolism,87,9.844E-01,1.000E+00,9.844E-01,1.000E+00,9,"SCPX, AK1D1, AMACR, ACOX2, AKR1C4, HSD3B7, ADHB, DHB4, VLCSH2",1.000E+00,1.000E+00,6,"SCPX, AMACR, ACOX2, DHB4, VLCSH2, HSD3B7",
1454,Gamma-Secretase regulation of neuronal cell development and function,57,9.850E-01,1.000E+00,9.850E-01,1.000E+00,5,"c-Fos, Contactin 2, Neuregulin 1, Tau (MAPT), TAB2",9.948E-01,1.000E+00,6,"c-Fos, Contactin 2, NMDA receptor, Tau (MAPT), TAB2, MAG",
1455,Acetylcholine biosynthesis and metabolism,32,9.865E-01,1.000E+00,9.867E-01,1.000E+00,2,"GDPD5, CHPT1",9.865E-01,1.000E+00,3,"LPPL, GDPD5, CHPT1",
1456,Peroxysomal straight-chain fatty acid beta-oxidation,74,9.876E-01,1.000E+00,9.876E-01,1.000E+00,7,"SCPX, CROT, ACOX3, ACOX2, ACOX1, ACAA1, DHB4",9.992E-01,1.000E+00,7,"SCPX, CROT, ACOX2, ACOX1, DHB4, ACOX3, ACAA1",
1457,Folic acid metabolism,64,9.877E-01,1.000E+00,9.943E-01,1.000E+00,5,"HCP1, MTHFD2, SHMT2, FR-beta, FTDH",9.877E-01,1.000E+00,8,"C1TC, SHMT2, FTDH, FOLH1 (GCP2), HCP1, MTHFD2, FR-beta, SLC22A6",
1458,Niacin-HDL metabolism,46,9.884E-01,1.000E+00,9.938E-01,1.000E+00,3,"HDL proteins, LIPS, AOX1",9.884E-01,1.000E+00,5,"HDL proteins, AOX1, CYP2E1, LIPS, LIPP",
1459,Phospholipid metabolism p.3,33,9.888E-01,1.000E+00,9.888E-01,1.000E+00,2,"GDPD5, C3f",9.890E-01,1.000E+00,3,"LPCAT1, GDPD5, C3f",
1460,Antioxidant effects of statins in COPD,60,9.901E-01,1.000E+00,9.901E-01,1.000E+00,5,"p67-phox, RhoB, eNOS, p40-phox, NOX1",9.910E-01,1.000E+00,7,"Rac1, SOD1, NOX1, Thioredoxin, RhoB, eNOS, p40-phox",
1461,Impaired NO signaling in CF airways,52,9.905E-01,1.000E+00,9.905E-01,1.000E+00,4,"Protein kinase G, CFTR, ARG1, eNOS",9.990E-01,1.000E+00,4,"ARG1, Protein kinase G, eNOS, ENaC",
1462,Alcohol metabolism predisposition of HCC development,52,9.905E-01,1.000E+00,9.905E-01,1.000E+00,4,"ADH7, ADH1, MGMT, ALDH2",9.990E-01,1.000E+00,4,"ADH7, MGMT, CYP2E1, ALDH2",
1463,Selenoamino acid metabolism,54,9.913E-01,1.000E+00,9.929E-01,1.000E+00,4,"MAT1A, SLA/LP, SAHH, SEPHS2",9.913E-01,1.000E+00,6,"MAT1A, HNMT, SEPHS2, SLA/LP, SAHH, MAT2A",
1464,Ganglioside Metabolism p2,44,9.915E-01,1.000E+00,9.915E-01,1.000E+00,3,"SIAT4A, NEU3, ST6GALNAC6",9.951E-01,1.000E+00,4,"SIAT4A, NEU3, ST6GALNAC6, SIAT4C",
1465,Keratan sulfate metabolism p.1,35,9.921E-01,1.000E+00,9.921E-01,1.000E+00,2,"B4GT3, CHST1",9.987E-01,1.000E+00,2,"B4GT3, CHST1",
1466,Regulation of microRNAs in colorectal cancer,62,9.925E-01,1.000E+00,9.925E-01,1.000E+00,5,"DDX5, STAT3, NTSR1, DCAMKL1, AKT(PKB)",9.979E-01,1.000E+00,6,"NTSR1, miR-let-7a-5p, AKT(PKB), c-Myc, DDX5, DCAMKL1",
1467,Prostaglandin 2 biosynthesis and metabolism,86,9.927E-01,1.000E+00,9.927E-01,1.000E+00,8,"HPGD, CYP4F12, ALOX12B, COX-1 (PTGS1), LOXE3, ALDX, PGES2, DHRS4",9.997E-01,1.000E+00,8,"HPGD, CYP4F12, ALDX, PGES2, DHRS4, ALOX12B, PRDX1, LOXE3",
1468,Ganglioside Metabolism p1,54,9.929E-01,1.000E+00,9.929E-01,1.000E+00,4,"NEU3, GM3 synthase, SIAT8C, NEU4",9.973E-01,1.000E+00,5,"NEU3, GM3 synthase, NEU4, SIAT8C, Acetyl-coenzyme A transporter",
1469,"Leucine, isoleucine and valine metabolism",43,9.940E-01,1.000E+00,9.981E-01,1.000E+00,2,"BCKD-E1alpha, BCAT2",9.940E-01,1.000E+00,4,"BCKD-E1beta, BCAT2, BCKD-E1alpha, BCKD-E2",
1470,Vitamin B3 and NAD+ metabolism,125,9.941E-01,1.000E+00,9.941E-01,1.000E+00,13,"ENPP1, NAD synthetase 1, SLC5A12, PPNK, NUD12, 5'-NTC, NMNA3, Connexin 43, AOX1, SLC29A2, NAPRT1, CNT2, NADC",9.984E-01,1.000E+00,16,"ENPP1, NAD synthetase 1, ENPP3, PPNK, 5'-NTC, AOX1, MIBP, NAPRT1, CYP2E1, SLC5A12, NUD12, SLC5A8, NMNA3, SLC29A2, CNT2, NADC",
1471,Vitamin B7 (biotin) metabolism,47,9.948E-01,1.000E+00,9.948E-01,1.000E+00,3,"SPC25, SPC12, SPC21",9.994E-01,1.000E+00,3,"SPC12, SPC21, SPC25",
1472,Nicotine metabolism in liver,56,9.948E-01,1.000E+00,9.948E-01,1.000E+00,4,"UGT2B10, INMT, AOX1, CYP2A6",9.982E-01,1.000E+00,5,"UGT2B10, INMT, AOX1, CYP2B6, CYP2A6",
1473,Aspartate and asparagine metabolism,73,9.949E-01,1.000E+00,9.949E-01,1.000E+00,6,"CPSM, ARLY, AATM, DARS2, NARS2, GABT",9.971E-01,1.000E+00,8,"CPSM, ARLY, AATC, NARS2, AATM, DARS2, GABT, PAICS",
1474,"N-Acylethanolamines, HSRL5-transacylation pathway",27,9.955E-01,1.000E+00,9.955E-01,1.000E+00,1,HRSL5,9.991E-01,1.000E+00,1,HRSL5,
1475,De novo IMP biosynthesis,39,9.961E-01,1.000E+00,9.961E-01,1.000E+00,2,"ATIC, PRPS1L1",9.968E-01,1.000E+00,3,"PPAT, ATIC, PAICS",
1476,Unsaturated fatty acid biosynthesis,65,9.961E-01,1.000E+00,9.987E-01,1.000E+00,4,"SCD, ELOVL3, ACSL3, ELOVL2",9.961E-01,1.000E+00,7,"ELOVL7, ELOVL5, SCD, ACSL3, ELOVL2, ACSL1, ELOVL3",
1477,Renal secretion of organic electrolytes / Rodent version ,75,9.961E-01,1.000E+00,9.961E-01,1.000E+00,6,"PEPT1, SLC22A8, OCTN2, ABCC6, NaDC-1, PEPT2",9.993E-01,1.000E+00,7,"ABCC6, NaDC-1, PEPT1, SLC22A8, OCTN2, SLC5A8, SLC22A6",
1478,Phospholipid metabolism p.1,58,9.961E-01,1.000E+00,9.961E-01,1.000E+00,4,"CDS1, C3f, PISD, FAAH",9.997E-01,1.000E+00,4,"CDS1, FAAH, C3f, PISD",
1479,"Metabolism of L-cysteine, D-cysteine and L-cystine",119,9.965E-01,1.000E+00,9.997E-01,1.000E+00,9,"GSHB, SLC1A2/EAAT2, ASCT1 (SLC1A4), rBAT, CSAD, AATM, SLC7A8, LDH6A, SLC38A1",9.965E-01,1.000E+00,16,"GSHB, SLC1A2/EAAT2, CSAD, AATC, LDHC, LDH6A, SLC7A10, THTM, Thioredoxin, SLC7A9, SLC1A1/EAAT3, ASCT1 (SLC1A4), AATM, SLC7A8, DAAO, SLC38A1",
1480,"N-Acylethanolamines, Phospholipase A2 pathway",40,9.967E-01,1.000E+00,9.967E-01,1.000E+00,2,"PLA2(hGIIA), PLA2G5",9.974E-01,1.000E+00,3,"PLA2G1B, PLA2(hGIIA), PLA2G5",
1481,Heme metabolism,103,9.970E-01,1.000E+00,9.992E-01,1.000E+00,8,"Heme oxygenase 2, BVRA, HEM2, UGT2B28, FLRE, Myoglobin, PPOX, UGT2B17",9.970E-01,1.000E+00,13,"Heme oxygenase 2, DHPR, HEM2, FECH, FLRE, Myoglobin, PPOX, BVRA, BGLR, CYP2B6, UGT2B28, Ferritin mitochondrial, UGT2B17",
1482,Mechanism of gemcitabine action in pancreatic cancer,52,9.977E-01,1.000E+00,9.977E-01,1.000E+00,3,"ENT1, NDPK complex, SLC29A2",9.998E-01,1.000E+00,3,"NDPK complex, ENT1, SLC29A2",
1483,Lacto-series GSL Metabolism,63,9.982E-01,1.000E+00,9.982E-01,1.000E+00,4,"G3ST2, FUT1, ST6GALNAC6, B3GT5",9.982E-01,1.000E+00,6,"FUT1, ST6GALNAC6, SIAT4C, B3GNT3, G3ST2, B3GT5",
1484,Arsenite metabolism and transport,54,9.983E-01,1.000E+00,9.983E-01,1.000E+00,3,"Aquaporin 3, Aquaporin 7, ABCC2",9.993E-01,1.000E+00,4,"GSTO1, Aquaporin 3, Aquaporin 7, ABCC2",
1485,N-Acylethanolamines. N-Acyltransferase pathway,32,9.984E-01,1.000E+00,9.984E-01,1.000E+00,1,FAAH,9.997E-01,1.000E+00,1,FAAH,
1486,Transport_Low density lipoproteins assembly and remodeling,34,9.989E-01,1.000E+00,9.989E-01,1.000E+00,1,APOA5,9.999E-01,1.000E+00,1,APOC2,
1487,Neolacto-series GSL Metabolism p.3,68,9.992E-01,1.000E+00,9.992E-01,1.000E+00,4,"FUT7, FUT1, B4GT3, B3GA2",9.998E-01,1.000E+00,5,"FUT1, B4GT3, B3GA2, SIAT4C, FUT7",
1488,Plasmalogen biosynthesis,64,9.997E-01,1.000E+00,9.997E-01,1.000E+00,3,"CHPT1, PLA2, PLCC",1.000E+00,1.000E+00,3,"PLCC, CHPT1, PLA2",
1489,Transport_HDL-mediated reverse cholesterol transport,42,9.998E-01,1.000E+00,9.998E-01,1.000E+00,1,ABCG1,1.000E+00,1.000E+00,1,ABCG1,
1490,Cholesterol Biosynthesis,103,1.000E+00,1.000E+00,1.000E+00,1.000E+00,5,"GGPS1, PMVK, MVK, ERG1, ER24",1.000E+00,1.000E+00,8,"GGPS1, PMVK, HMGCS1, MVK, ERG1, IDI2, ER24, DHC24",
1491,Vitamin K metabolism,97,1.000E+00,1.000E+00,1.000E+00,1.000E+00,4,"VKDGC, CYP4F2, NDOR1, NQO1",1.000E+00,1.000E+00,5,"VKDGC, CYP4F2, NDOR1, NRHQR2, NQO1",
1492,Lipoprotein metabolism,68,1.000E+00,1.000E+00,1.000E+00,1.000E+00,1,ABCG1,1.000E+00,1.000E+00,2,"ABCG1, APOC2",
,,,,,,,,,,,,,
